male	max_count	median	date	n	mean	min_count	filename	nulls	mean_count	sd	female	min	other	median_count	max	study accession	primary phenotype
10.0			2018/03/30	46.0			./data/phs001108.v1.pht007713.v1.p1.demographics.var_report.xml	0.0			36.0					phs001108.v1.p1	Urea Cycle Disorders, Inborn
			2019/11/08				./data/phs001332.v2.pht007455.v2.p1.p7301_12629_eligibili.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			07/10/2017				./data/phs001202.v1.pht005773.v1.p1.OncoArray_Oral_Pharynx_Cancer_Subject.var_report.xml									phs001202.v1.p1	Head and Neck Neoplasms
			2021/10/04				./data/phs001542.v2.pht009643.v2.p1.TOPMed_WGS_GALAI_Sample.var_report.xml									phs001542.v2.p1	
			2020/06/18				./data/phs000280.v7.pht004163.v2.p1.RPAC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
65.0	65.0		11/22/2013	93.0		28.0	./data/phs000251.v2.pht001262.v2.p2.HMP_Cutaneous_Psoriasis_Subject_Phenotypes.var_report.xml	0.0	46.5	7.071	28.0			46.5		phs000251.v2.p2	Psoriasis
			2020/12/21				./data/phs000007.v32.pht003782.v2.p13.vr_fxrev_2018_3b_1177s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/22				./data/phs001666.v1.pht008464.v1.p1.Alisertib_PC_Subject.var_report.xml									phs001666.v1.p1	Adenocarcinoma
			02/06/2017				./data/phs001075.v1.pht006111.v1.p1.CSER_CanSeq_Sample_Attributes.var_report.xml									phs001075.v1.p1	Neoplasms
			09/01/2015				./data/phs000858.v1.pht004463.v1.p1.IVF_Blastocyst_Biopsies_Sample_Attributes.var_report.xml									phs000858.v1.p1	Fertilization in Vitro
			12/03/2009				./data/phs000169.v1.pht000729.v1.p1.HABC_Phenotype.var_report.xml									phs000169.v1.p1	Obesity
			05/24/2016				./data/phs001065.v1.pht005416.v1.p1.mhxchild.var_report.xml									phs001065.v1.p1	Huntington Disease
			10/21/2013				./data/phs000637.v1.pht003534.v1.p1.ALL_Methotrexate_Clearance_Subject.var_report.xml									phs000637.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			2020/12/21				./data/phs000007.v32.pht000149.v7.p13.ecgdigital_18s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/20				./data/phs000605.v1.pht007638.v1.p1.pulmonary_testing_form.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			03/06/2017				./data/phs000574.v1.pht005861.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000574.v1.p1	Rett Syndrome
			06/12/2017				./data/phs000594.v1.pht006490.v1.p1.BMF_5402_Subject.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2019/03/11				./data/phs000286.v6.pht001973.v2.p2.rpaa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007799.v1.p1.PIDTC_6902_Subject.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2018/07/23				./data/phs000742.v1.pht008116.v1.p1.7_9_Diagnostic_Interview_New_Small_Sz.var_report.xml									phs000742.v1.p1	Epilepsy
			2020/12/18				./data/phs002059.v1.pht010421.v1.p1.CIDR_CHD_Subject.var_report.xml									phs002059.v1.p1	Heart Defects, Congenital
			08/20/2013				./data/phs000285.v3.pht001624.v1.p2.B2F09VAS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/18/2015				./data/phs000586.v1.pht004832.v1.p1.Alopecia_Areata_Subject_Phenotypes.var_report.xml									phs000586.v1.p1	Alopecia Areata
			2017/10/04				./data/phs001270.v1.pht006249.v1.p1.SACDS_IGHNSS_Subject.var_report.xml									phs001270.v1.p1	Sleep Wake Disorders
			2017/09/06				./data/phs000554.v1.pht003194.v1.p1.CRPC_Subject.var_report.xml									phs000554.v1.p1	Prostatic Neoplasms
			2018/04/05				./data/phs001553.v1.pht007735.v1.p1.registration.var_report.xml									phs001553.v1.p1	Charcot-Marie-Tooth Disease
			07/30/2015				./data/phs000947.v1.pht004828.v1.p1.SLE_Autoantibodies_Subject_Phenotypes.var_report.xml									phs000947.v1.p1	Systemic Lupus Erythematosus
			05/16/2013				./data/phs000582.v1.pht003243.v1.p1.ESP_FamilialInterstitialPneumonia_Sample.var_report.xml									phs000582.v1.p1	Idiopathic Pulmonary Fibrosis
			05/17/2017				./data/phs001328.v1.pht006315.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
607.0	607.0		2017/09/22	765.0		563.0	./data/phs001394.v1.pht006947.v1.p1.GUARDIAN_HTN_IR_Pedigree.var_report.xml	0.0	585.0	96.87	563.0			585.0		phs001394.v1.p1	Hypertension
			2020/05/13				./data/phs002024.v1.pht010231.v1.p1.DCCT_EDIC_DNAme_Subject.var_report.xml									phs002024.v1.p1	Diabetes Mellitus, Type 1
			2018/05/31				./data/phs001318.v1.pht008023.v1.p1.pastmedicalhistory.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
2294.0	289.0		2020/12/21	5079.0		2294.0	./data/phs000007.v32.pht007777.v2.p13.vr_wkthru_ex32_0_0997s.var_report.xml	0.0	2540.0	99.7	289.0			2540.0		phs000007.v32.p13	Cardiovascular Diseases
			10/25/2010				./data/phs000021.v3.pht000069.v1.p2.EA_GAIN_phenotype_controls_questionnaire.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
			08/12/2016				./data/phs000888.v1.pht005572.v1.p1.AMI.var_report.xml									phs000888.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000671.v7.p13.il18_1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			04/25/2014				./data/phs000587.v1.pht003517.v1.p1.ESP_Family_Studies_MLD_Subject.var_report.xml									phs000587.v1.p1	Hyperlipoproteinemia Type II
			2020/08/24				./data/phs001744.v1.pht008573.v1.p1.CIDR_HCC_Sample_Attributes.var_report.xml									phs001744.v1.p1	Liver Neoplasms
			2020/12/21				./data/phs000007.v32.pht004800.v4.p13.l_cortisol_ex01_3b_0381s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/29				./data/phs002506.v1.pht011540.v1.p1.Drug_Outcome_SNVs_Sample_Attributes.var_report.xml									phs002506.v1.p1	Pharmacology
			2020/12/21				./data/phs000007.v32.pht003312.v1.p13.t_echomvp_ex05_1_0753s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009190.v1.p1.fu_vasculitis_meds_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/05/2014				./data/phs000209.v13.pht002194.v1.p3.MESA_AncilMesaEyeRefraction.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/11/13				./data/phs001612.v1.pht009498.v1.p1.TOPMed_WGS_CARDIA_Sample_Attributes.var_report.xml									phs001612.v1.p1	Cardiovascular Diseases
			08/25/2015				./data/phs000978.v1.pht004941.v1.p1.Malignant_GCT_Pazopanib_Subject.var_report.xml									phs000978.v1.p1	Granular Cell Tumor
			2019/12/12				./data/phs001883.v1.pht009684.v1.p1.S0800_BC_Sample_Attributes.var_report.xml									phs001883.v1.p1	Breast Neoplasms
			Wed Jan 21 13:20:40 2009				./data/phs000144.v1.pht000722.v1.p1.TSP_Subject.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
			2020/11/03				./data/phs002279.v1.pht010632.v1.p1.GIMs_Spermatids_Sample_Attributes.var_report.xml									phs002279.v1.p1	Germ Cells
			10/25/2016				./data/phs000371.v2.pht002987.v2.p1.Huntingtons_Disease_Sample.var_report.xml									phs000371.v2.p1	Huntington Disease
			07/27/2017				./data/phs000596.v1.pht006717.v1.p1.registration.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			01/15/2016				./data/phs000909.v1.pht004876.v1.p1.NEPC_Sample_Attributes.var_report.xml									phs000909.v1.p1	Adenocarcinoma
			2017/09/06	8.0			./data/phs001261.v1.pht006114.v1.p1.Palindromic_Gene_Amplification_Subject_Phenotypes.var_report.xml	0.0			8.0					phs001261.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht006019.v1.p13.vr_meds_ex03_7_0535s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/02/21				./data/phs001281.v2.pht006124.v2.p1.BVMC_6204_Subject.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2019/12/16				./data/phs001932.v1.pht009654.v1.p1.MGS_European_Subject.var_report.xml									phs001932.v1.p1	Schizophrenia
			11/08/2013				./data/phs000200.v9.pht003401.v1.p3.outc_bc_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/02/14				./data/phs000575.v2.pht009884.v1.p1.adverse_event.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			07/27/2017				./data/phs000247.v5.pht001286.v4.p3.HMP_Neonatal_Enterocolitis_Subject_Baseline_Phenotypes.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			2018/10/24				./data/phs001694.v1.pht008495.v1.p1.HIV_CSF_Sample_Attributes.var_report.xml									phs001694.v1.p1	MicroRNAs
1683.0	5862.0		05/16/2017	9552.0		3690.0	./data/phs001252.v1.pht006369.v1.p1.bioimped.var_report.xml	0.0	4776.0	1536	1050.0			4776.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
856.0	856.0		2020/11/30	1323.0		467.0	./data/phs002283.v1.pht010682.v1.p1.Selenium_Chemoprevention_Subject.var_report.xml	0.0	661.5	275.1	467.0			661.5		phs002283.v1.p1	
			2020/03/13				./data/phs000521.v2.pht007036.v2.p1.aprtrs_episode_report.var_report.xml									phs000521.v2.p1	Ataxia
			08/20/2013				./data/phs000285.v3.pht001609.v2.p2.B2F09KID.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/24				./data/phs001641.v1.pht010027.v1.p1.3MonthPost.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2018/09/14				./data/phs001658.v1.pht008342.v1.p1.Adrenocortical_Carcinoma_Subject.var_report.xml									phs001658.v1.p1	Adrenocortical Carcinoma
			2019/03/11				./data/phs000286.v6.pht008728.v1.p2.allevtstroke.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
544.0	544.0		2020/05/26	1276.0		274.0	./data/phs002020.v1.pht010227.v1.p1.ROP_Pedigree.var_report.xml	0.0	425.3	82.03	458.0			458.0		phs002020.v1.p1	Retinopathy of Prematurity
			2021/06/09				./data/phs001345.v3.pht008602.v1.p1.TOPMed_WGS_GENOA_Subject.var_report.xml									phs001345.v3.p1	Hypertension
94.0	750.0		2017/11/13	984.0		94.0	./data/phs001013.v3.pht005311.v2.p2.HVH_Subject_Phenotypes.var_report.xml	0.0	99.0	7.778	9.0			99.0		phs001013.v3.p2	Cardiovascular Disease
			2018/09/19				./data/phs000357.v2.pht002335.v2.p1.Systemic_Sclerosis_Sample_Attributes.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000447.v2.p3.simphen048.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/04/30				./data/phs001322.v2.pht006332.v2.p1.ALS4_Sample_Attributes.var_report.xml									phs001322.v2.p1	Amyotrophic Lateral Sclerosis 4, Juvenile
			03/26/2015				./data/phs000761.v1.pht004496.v1.p1.OPPERA_Subject.var_report.xml									phs000761.v1.p1	Temporomandibular Joint Disorders
42.0			2019/07/26	194.0			./data/phs000588.v1.pht009295.v1.p1.demographic_form.var_report.xml	0.0			151.0					phs000588.v1.p1	Giant Cell Arteritis
			2021/08/23				./data/phs001232.v4.pht006078.v4.p2.UDN_phenotype_code.var_report.xml									phs001232.v4.p2	Rare Diseases
			06/09/2016				./data/phs001041.v1.pht005391.v1.p1.Melanoma_CTLA_4_Blockade_Sample.var_report.xml									phs001041.v1.p1	Melanoma
			2019/03/11				./data/phs000286.v6.pht008780.v1.p2.rdfb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/10/05				./data/phs001304.v1.pht008313.v1.p1.BPV_Sample.var_report.xml									phs001304.v1.p1	Carcinoma, Renal Cell
			2018/03/20				./data/phs000605.v1.pht007642.v1.p1.treatmenttable.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/07/07				./data/phs001938.v2.pht010331.v1.p1.ADT_PC_GEO.var_report.xml									phs001938.v2.p1	Prostatic Neoplasms
			07/27/2017				./data/phs000596.v1.pht006716.v1.p1.physician_examination.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			12/03/2013				./data/phs000631.v1.pht003600.v1.p1.ARDSNet_iSPAAR_Sample.var_report.xml									phs000631.v1.p1	Respiration Disorders
			2020/06/18				./data/phs000280.v7.pht004111.v2.p1.HOM.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/01/2017				./data/phs001306.v1.pht006188.v1.p1.Psoriasis_Associated_Variants_Sample.var_report.xml									phs001306.v1.p1	Psoriasis
			12/01/2015				./data/phs000571.v3.pht003188.v3.p2.MutationResults.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2019/03/28				./data/phs001797.v1.pht008892.v1.p1.mUC_Sample_Attributes.var_report.xml									phs001797.v1.p1	Urogenital Neoplasms
137.0	159.0		2017/10/20	296.0		137.0	./data/phs001156.v2.pht007050.v1.p1.EVE_Subject_Phenotype.var_report.xml	0.0	7.5	9.192	159.0			7.5		phs001156.v2.p1	Asthma
			2020/06/18				./data/phs001787.v1.pht009046.v1.p1.CRC_High_Risk_Families_Sample_Attributes.var_report.xml									phs001787.v1.p1	Colorectal Neoplasms, Hereditary Nonpolyposis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000586.v2.p3.simphen187.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			Mon Oct 27 16:32:31 2008				./data/phs000020.v2.pht000667.v1.p1.NESDA_NTR_mdd_episodes.var_report_2008_10_27.xml									phs000020.v2.p1	Depressive Disorder, Major
539.0	839.0		02/27/2015	3964.0		539.0	./data/phs000170.v2.pht000737.v1.p1.Marshfield_Data_Phenotype.var_report.xml	0.0	689.0	492.1	839.0			689.0		phs000170.v2.p1	Cataract
			Mon Oct 27 17:24:52 2008				./data/phs000130.v1.pht000615.v1.p1.IBD_Subject.var_report_2008_11_06.xml									phs000130.v1.p1	Crohn Disease
2.0	8.0		2018/12/31	10.0		2.0	./data/phs001758.v1.pht008611.v1.p1.FNMTC_Subject_Phenotypes.var_report.xml	0.0	5.0	4.243	8.0			5.0		phs001758.v1.p1	Thyroid Cancer, Papillary
			2021/07/08				./data/phs001543.v2.pht009912.v1.p1.AFLMU_Sample.var_report.xml									phs001543.v2.p1	Atrial Fibrillation
			2021/06/23				./data/phs001027.v4.pht005217.v3.p1.Epigenetics_AML_Sample_Attributes.var_report.xml									phs001027.v4.p1	Acute Myeloid Leukemia
			11/05/2014				./data/phs000209.v13.pht002103.v1.p3.MESA_AncilMesaLungExam4CT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/07/29				./data/phs001624.v2.pht008231.v2.p2.TOPMed_CCDG_BioVU_Subject_Phenotypes.var_report.xml									phs001624.v2.p2	Atrial Fibrillation
			2021/09/24				./data/phs001726.v2.pht009835.v2.p1.TOPMed_WGS_CAMP_Sample.var_report.xml									phs001726.v2.p1	Asthma
			08/27/2013				./data/phs000650.v1.pht003484.v1.p1.PediGFR_CKiD_Subject.var_report.xml									phs000650.v1.p1	Kidney Diseases
			2017/08/22				./data/phs001209.v1.pht006803.v1.p1.MIDCIRS_Sample.var_report.xml									phs001209.v1.p1	Malaria
			08/20/2013				./data/phs000285.v3.pht001592.v2.p2.A5F06VA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/05/01				./data/phs001890.v1.pht009544.v1.p1.CIViC_smMIPs_Subject.var_report.xml									phs001890.v1.p1	
			2020/12/21				./data/phs000007.v32.pht002890.v6.p13.l_icam_2008_m_0431s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/08				./data/phs001422.v2.pht006761.v2.p1.GETHIN_Sample_Attributes.var_report.xml									phs001422.v2.p1	Insulinoma
			2020/04/14				./data/phs001994.v1.pht010009.v1.p1.Tobacco_HNSCC_Sample.var_report.xml									phs001994.v1.p1	Squamous Cell Carcinoma of Head and Neck
			2021/03/11				./data/phs001818.v3.pht009020.v2.p1.sc_GI_Cancer_Subject.var_report.xml									phs001818.v3.p1	Stomach Neoplasms
			09/14/2015				./data/phs000982.v1.pht004981.v1.p1.PsA_Subject.var_report.xml									phs000982.v1.p1	Arthritis, Psoriatic
			2019/04/19				./data/phs001295.v2.pht006239.v2.p1.registration.var_report.xml									phs001295.v2.p1	Charcot-Marie-Tooth Disease
			2020/01/07				./data/phs001953.v1.pht009772.v1.p1.UM_AEB071_Sample.var_report.xml									phs001953.v1.p1	Uveal Neoplasms
			05/08/2017				./data/phs001362.v1.pht006343.v1.p1.Gastric_Cancer_Metastases_Sample.var_report.xml									phs001362.v1.p1	Stomach Neoplasms
			07/06/2016				./data/phs001093.v1.pht005610.v1.p1.T2D_GENES_UK_South_Asian_Subject.var_report.xml									phs001093.v1.p1	Diabetes Mellitus, Type 2
19.0	19.0		11/30/2015	23.0		4.0	./data/phs001007.v1.pht005068.v1.p1.HNSCC_Metastasis_Recurrence_Subject_Phenotypes.var_report.xml	0.0	11.5	10.61	4.0			11.5		phs001007.v1.p1	Carcinoma, squamous cell of head and neck
			01/05/2015				./data/phs000817.v1.pht004417.v1.p1.Varicella_Zoster_Vaccine_Sample_Attributes.var_report.xml									phs000817.v1.p1	Varicella Vaccine
2050.0	2878.0		02/05/2016	4929.0		1.0	./data/phs000944.v1.pht004846.v1.p1.eMERGE_PhaseIII_Partners_Biobank_Subject_Phenotypes.var_report.xml	0.0	1643.0	1481	2878.0			2050.0		phs000944.v1.p1	Hypercholesterolemia
			04/15/2014				./data/phs000508.v2.pht002809.v1.p1.Pediatric_Rhabdoid_CancersP_Subject.var_report.xml									phs000508.v2.p1	Rhabdoid Tumor
			2018/12/10				./data/phs001621.v1.pht008153.v1.p1.Platinum_Study_Sample.var_report.xml									phs001621.v1.p1	
732.0	732.0		2020/06/02	573.0		619.0	./data/phs001841.v1.pht009905.v1.p1.CADD_GADD_Pedigree.var_report.xml	0.0	675.5	79.9	619.0			675.5		phs001841.v1.p1	Opioid-Related Disorders
			2019/11/20				./data/phs000921.v4.pht004884.v3.p1.TOPMed_WGS_SAGE_Sample_Attributes.var_report.xml									phs000921.v4.p1	Lung Diseases
			2018/02/27				./data/phs001206.v1.pht007344.v1.p1.BSP_AA_Sample.var_report.xml									phs001206.v1.p1	Blepharospasm
39.0	85.0		2020/11/24	124.0		39.0	./data/phs001700.v1.pht008502.v1.p1.Moyamoya_Subject_Phenotypes.var_report.xml	0.0	62.0	32.53	85.0			62.0		phs001700.v1.p1	Moyamoya Disease
			2021/07/13				./data/phs001545.v2.pht009964.v1.p1.TOPMed_CCDG_INSPIRE_AF_Subject.var_report.xml									phs001545.v2.p1	Atrial Fibrillation
			2020/02/04				./data/phs001507.v1.pht008697.v1.p1.ET_Turkish_Sample.var_report.xml									phs001507.v1.p1	Essential Tremor
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001697.v2.p2.C1REF.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			09/03/2014				./data/phs000750.v1.pht003935.v1.p1.GOAL_Sample.var_report.xml									phs000750.v1.p1	Population Groups
			2021/03/30				./data/phs001307.v1.pht011049.v1.p1.TGCT_UPenn_Sample_Attributes.var_report.xml									phs001307.v1.p1	Testicular Germ Cell Tumor
70.0	657.0		2019/03/11	88.0		70.0	./data/phs000286.v6.pht002139.v4.p2.JHS_Pedigree.var_report.xml	0.0	510.5	83.44	657.0			510.5		phs000286.v6.p2	Cardiovascular Diseases
			2021/05/20				./data/phs000997.v5.pht005089.v4.p2.TOPMed_WGS_VAFAR_Sample_Attributes.var_report.xml									phs000997.v5.p2	Atrial Fibrillation
			07/05/2017				./data/phs000595.v1.pht006629.v1.p1.adverse_event.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			08/02/2013				./data/phs000644.v1.pht003421.v1.p1.Menstrual_Cycle_Effect_Breast_Subject.var_report.xml									phs000644.v1.p1	Menstrual Cycle
			2020/12/21				./data/phs000007.v32.pht000138.v3.p13.ank0_23s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/28				./data/phs001797.v1.pht008889.v1.p1.mUC_Subject.var_report.xml									phs001797.v1.p1	Urogenital Neoplasms
			2018/10/02				./data/phs001664.v1.pht008437.v1.p1.PDCGC_Subject.var_report.xml									phs001664.v1.p1	Parkinson Disease
			01/19/2010				./data/phs000219.v1.pht001102.v1.p1.d_summary.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			12/17/2014	5152.0			./data/phs000799.v1.pht004295.v1.p1.SBCGS_Breast_Cancer_Chinese_Subject_Phenotypes.var_report.xml	0.0			5152.0					phs000799.v1.p1	Breast Neoplasms
9.0			2019/06/14	136.0			./data/phs000589.v1.pht009186.v1.p1.demographic_form.var_report.xml	0.0			127.0					phs000589.v1.p1	Takayasu Arteritis
			11/28/2011				./data/phs000385.v1.pht002340.v1.p1.Epigenetic_Colorectal_Cancer_Sample.var_report.xml									phs000385.v1.p1	Colorectal Neoplasms
58.0	58.0		2018/05/21	57.0		49.0	./data/phs001198.v1.pht007865.v1.p1.Methamphetamine_Abstinence_Subject_Phenotypes.var_report.xml	0.0	53.5	6.364	49.0			53.5		phs001198.v1.p1	Substance-Related Disorders
409.0			04/04/2014	694.0			./data/phs000734.v1.pht003771.v1.p1.Osteosarcoma_Risk_Subject_Phenotypes.var_report.xml	0.0			285.0					phs000734.v1.p1	Osteosarcoma
			2020/03/12				./data/phs000673.v4.pht003660.v4.p1.CSER_Subject.var_report.xml									phs000673.v4.p1	Neoplasms
4.0	4.0		2018/06/30	4.0		4.0	./data/phs001643.v1.pht008193.v1.p1.Chordoma_Subject_Phenotypes.var_report.xml	0.0	4.0					4.0		phs001643.v1.p1	Chordoma
			2021/07/21				./data/phs002446.v1.pht011403.v1.p1.SjS_Transcriptional_Sample.var_report.xml									phs002446.v1.p1	Sjogren's Syndrome
			2019/08/10				./data/phs001208.v2.pht008654.v1.p1.COGA_SmokeScreen_Subject.var_report.xml									phs001208.v2.p1	Alcoholism
			2020/06/18				./data/phs000280.v7.pht004100.v5.p1.HFCCELPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
573.0			2020/01/07	905.0			./data/phs001741.v1.pht009165.v1.p1.CCDG_TASC_Subject_Phenotypes.var_report.xml	0.0			34.0					phs001741.v1.p1	Autism Spectrum Disorder
			11/08/2013				./data/phs000200.v9.pht002768.v1.p3.outc_fracture_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2017/12/12				./data/phs001405.v1.pht007234.v1.p1.GSK1120212_TNBC_Kinome_GEO.var_report.xml									phs001405.v1.p1	Triple Negative Breast Neoplasms
33.0			06/30/2014	54.0			./data/phs000757.v1.pht003923.v1.p1.Hereditary_Ataxias_Subject_Phenotypes.var_report.xml	0.0			21.0					phs000757.v1.p1	Ataxia
			2020/10/27				./data/phs001616.v2.pht008541.v2.p2.eMERGEseq_Sample.var_report.xml									phs001616.v2.p2	Precision Medicine
1.0	4.0		2018/04/16	5.0		1.0	./data/phs000862.v1.pht007835.v1.p1.SubjectPhenotypes.var_report.xml	0.0	2.5	2.121	4.0			2.5		phs000862.v1.p1	Mucopolysaccharidosis I
			2018/03/23				./data/phs000698.v1.pht007678.v1.p1.inspiratory_core_ctscan_80as.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			04/09/2014				./data/phs000437.v1.pht003687.v1.p1.Auriculocondylar_Syndrome_Subject.var_report.xml									phs000437.v1.p1	Auriculo-condylar syndrome
			2021/02/22				./data/phs002212.v1.pht010985.v1.p1.ZRSR2_MDS_Subject_Phenotypes.var_report.xml									phs002212.v1.p1	Myelodysplastic Syndromes
			2018/06/26				./data/phs001526.v1.pht007612.v1.p1.DIPG_Sample.var_report.xml									phs001526.v1.p1	Glioma
			2018/05/15				./data/phs001311.v1.pht007930.v1.p1.drug_accountability_form.var_report.xml									phs001311.v1.p1	Myotonia
			10/25/2011				./data/phs000406.v1.pht002405.v1.p1.Spatiotemporal_Transcriptome_Brain_Subject_Phenotypes.var_report.xml									phs000406.v1.p1	Aging
			08/02/2012				./data/phs000502.v1.pht002814.v1.p1.Splenic_Marginal_Zone_Lymphoma_Sample.var_report.xml									phs000502.v1.p1	Lymphoma, Non-Hodgkin
			2020/07/10				./data/phs002055.v1.pht010346.v1.p1.GTAC_ALS_FTD_Sample_Attributes.var_report.xml									phs002055.v1.p1	Amyotrophic Lateral Sclerosis
353.0	353.0		2019/08/01	580.0		40.0	./data/phs001740.v1.pht008623.v1.p1.CCDG_SAGE_Subject_Phenotypes.var_report.xml	0.0	193.3	84.85	40.0			226.0		phs001740.v1.p1	Autism Spectrum Disorder
			11/04/2014				./data/phs000086.v3.pht000278.v1.p1.DCCT_bgpdat.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
52.0	52.0		2021/07/29	97.0		55.0	./data/phs001607.v3.pht010151.v3.p2.TOPMed_WGS_IPF_Subject_Phenotypes.var_report.xml	0.0	88.0	93.35	725.0			88.0		phs001607.v3.p2	Idiopathic Pulmonary Fibrosis
			2020/12/21				./data/phs000007.v32.pht000689.v7.p13.ffreq1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/02/2015				./data/phs000810.v1.pht004715.v1.p1.HCHS_SOL_Cohort_Subject_Phenotypes.var_report.xml									phs000810.v1.p1	Cardiovascular Diseases
			2017/12/29				./data/phs000950.v1.pht005971.v1.p1.SEER_Ovarian_FFPE_Sample_Attributes.var_report.xml									phs000950.v1.p1	Neoplasms
36.0	36.0		2018/05/22	50.0		4.0	./data/phs001595.v1.pht007995.v1.p1.study6103_DS.var_report.xml	200.0	25.0	15.56	14.0			25.0		phs001595.v1.p1	Hypotension, Orthostatic
			2021/09/20				./data/phs002407.v1.pht011564.v1.p1.MMRd_MMRp_CRC_GEO.var_report.xml									phs002407.v1.p1	Colorectal Neoplasms
			2019/05/13				./data/phs001811.v1.pht009060.v1.p1.Early_Lung_ADC_Subject.var_report.xml									phs001811.v1.p1	Adenocarcinoma of Lung
			03/12/2013				./data/phs000343.v3.pht002211.v1.p1.GARNET_VISP_Subject.var_report.xml									phs000343.v3.p1	Stroke
			2020/01/23				./data/phs000287.v7.pht001456.v1.p1.CARE_AFIB.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht002725.v1.p1.endstk.var_report.xml									phs000343.v3.p1	Stroke
90.0	90.0		08/13/2015	94.0		76.0	./data/phs000415.v1.pht002414.v1.p1.CIDR_Tourette_Syndrome_Subject_Phenotypes.var_report.xml	0.0	83.0	9.899	76.0			83.0		phs000415.v1.p1	Tourette Syndrome
			2018/06/21				./data/phs001470.v1.pht008167.v1.p1.CIDR_SWAN_Phenotypes_Baseline.var_report.xml									phs001470.v1.p1	Menopause
1310.0	1847.0		02/08/2016	3157.0		1310.0	./data/phs000949.v1.pht005225.v1.p1.CIDR_Facial_Variation_Subject_Phenotypes.var_report.xml	0.0	1579.0	379.7	1847.0			1579.0		phs000949.v1.p1	Anthropometry
			2019/04/23				./data/phs001804.v1.pht008966.v1.p1.GEODB_Sample_Attributes.var_report.xml									phs001804.v1.p1	Opioid-Related Disorders
5.0	5.0		2018/03/27	7.0		3.0	./data/phs001195.v1.pht006861.v1.p1.Atomoxetine_Methamphetamine_Subject_Phenotypes.var_report.xml	0.0	6.5	4.95	3.0			6.5		phs001195.v1.p1	Sex/Gender Identity
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000543.v2.p3.simphen144.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/05/31				./data/phs001318.v1.pht008018.v1.p1.chestxray.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2020/06/18				./data/phs000280.v7.pht004045.v5.p1.CCEBPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/08/06				./data/phs001655.v1.pht008256.v1.p1.Acne_Skin_Metagenome_Subject.var_report.xml									phs001655.v1.p1	Acne Vulgaris
			2019/09/27				./data/phs001709.v1.pht009493.v1.p1.CMI_MBC_Sample.var_report.xml									phs001709.v1.p1	Breast Neoplasms
			2018/06/30				./data/phs001643.v1.pht008192.v1.p1.Chordoma_Sample.var_report.xml									phs001643.v1.p1	Chordoma
			08/18/2015				./data/phs000206.v5.pht000895.v4.p3.CGEMS_PANSCAN_Subject_Phenotypes.var_report.xml									phs000206.v5.p3	Pancreatic Neoplasms
			08/09/2013				./data/phs000636.v1.pht003425.v1.p1.Familial_Intracranial_Aneurysm_Sequence_Subject.var_report.xml									phs000636.v1.p1	Intracranial Aneurysm
712.0	748.0		2020/06/02	899.0		712.0	./data/phs001339.v1.pht006788.v1.p1.22q11_2_Deletion_Syndrome_Subject_Phenotypes.var_report.xml	0.0	730.0	3.536	748.0			730.0		phs001339.v1.p1	DiGeorge Syndrome
			2020/06/18				./data/phs000280.v7.pht004148.v2.p1.PULM21.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/09/2013				./data/phs000636.v1.pht003429.v1.p1.Familial_Intracranial_Aneurysm_Sequence_Sample_Attributes.var_report.xml									phs000636.v1.p1	Intracranial Aneurysm
			05/20/2015				./data/phs000898.v1.pht004641.v1.p1.Colorectal_Cancer_Mb_Scale_Haplotypes_Subject.var_report.xml									phs000898.v1.p1	Colorectal Neoplasms
			2017/10/20				./data/phs001156.v2.pht007051.v1.p1.EVE_Sample_Attributes.var_report.xml									phs001156.v2.p1	Asthma
458.0	510.0		11/14/2016	968.0		458.0	./data/phs000741.v2.pht003916.v2.p1.GOLDN_Lipid_Lowering_Pedigree.var_report.xml	136.0	484.0	66.47	510.0			484.0		phs000741.v2.p1	Metabolomics
			2019/05/24				./data/phs001830.v1.pht009117.v1.p1.FGFR2_CCA_Sample.var_report.xml									phs001830.v1.p1	Cholangiocarcinoma
			2018/05/31				./data/phs001316.v1.pht008008.v1.p1.p5305_12386_outpatien.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			06/01/2017				./data/phs000701.v1.pht005507.v1.p1.AE_MRO_Review.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/02/06				./data/phs001430.v2.pht008061.v2.p1.p7001_15988_behaviore.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			10/09/2014				./data/phs000717.v1.pht003809.v1.p1.Circulating_Tumor_Cells_Sample.var_report.xml									phs000717.v1.p1	Prostatic Neoplasms
			07/09/2013				./data/phs000621.v1.pht003331.v1.p1.Chronic_Lymphocytic_Leukemia_Trial_Sample_Attributes.var_report.xml									phs000621.v1.p1	Leukemia, Lymphoid
987.0	987.0		07/17/2012	764.0		948.0	./data/phs000314.v1.pht002069.v1.p1.CIDR_Clubfoot_Pedigree.var_report.xml	0.0	950.0	52.33	948.0			950.0		phs000314.v1.p1	Clubfoot
			2017/10/11				./data/phs000578.v1.pht007023.v1.p1.short_exrc_tst_inactivedataonl.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
729.0	729.0		2021/09/23	855.0		674.0	./data/phs001089.v4.pht005483.v4.p1.CSER_DD_ID_Children_Subject.var_report.xml	0.0	701.5	81.32	674.0			701.5		phs001089.v4.p1	Intellectual Disability
			2017/08/25				./data/phs001407.v1.pht006667.v1.p1.HNPCC_Sample_Attributes.var_report.xml									phs001407.v1.p1	Lynch syndrome I
3.0	3.0		11/21/2016	6.0		3.0	./data/phs001233.v1.pht005945.v1.p1.Familial_Dysautonomia_Subject_Phenotypes.var_report.xml	0.0	3.0	0	3.0			3.0		phs001233.v1.p1	Dysautonomia, Familial
			08/15/2016				./data/phs000473.v2.pht002597.v2.p2.Schizophrenia_Swedish_Subject.var_report.xml									phs000473.v2.p2	Schizophrenia
			2019/07/01				./data/phs001810.v1.pht009067.v1.p1.COCCaINE_Subject_Phenotypes.var_report.xml									phs001810.v1.p1	Cocaine
706.0	6170.0		11/04/2014	11745.0		5575.0	./data/phs000086.v3.pht000284.v1.p1.EDIC_neph_8yr.var_report.xml	0.0	5873.0	420.7	643.0			5873.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/09/30				./data/phs001951.v1.pht009783.v1.p1.Relapsed_ALL_Sample.var_report.xml									phs001951.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			10/28/2011				./data/phs000352.v1.pht002285.v1.p1.Retinoblastoma_Sample.var_report.xml									phs000352.v1.p1	Retinoblastoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000476.v2.p3.simphen077.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004159.v2.p1.RIPB02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht007768.v1.p13.t_hipshape_2001_m_1082s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/08/01				./data/phs000222.v6.pht003448.v2.p2.aseg.var_report.xml									phs000222.v6.p2	Huntington Disease
			2021/08/26				./data/phs001732.v2.pht010142.v1.p1.TOPMed_WGS_CARE_TREXA_Sample_Attributes.var_report.xml									phs001732.v2.p1	Asthma
			2018/06/30				./data/phs001620.v1.pht008180.v1.p1.GUARDD_AA_Sample.var_report.xml									phs001620.v1.p1	Apolipoprotein L1
20.0			03/01/2012	33.0			./data/phs000401.v1.pht002476.v1.p1.HeartGO_FHS_LDLandEOMI_PhenotypeDataFile.var_report.xml	0.0			54.0					phs000401.v1.p1	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht008083.v2.p1.p7001_15929_behaviore.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
91.0	91.0		2019/03/19	91.0		7.0	./data/phs001168.v2.pht007578.v2.p2.GMKF_OFC_Pedigree.var_report.xml	0.0	84.5	93.34	8.0			84.5		phs001168.v2.p2	Cleft Lip
			2018/10/02				./data/phs001702.v1.pht008428.v1.p1.Lupus_eQTL_Sample_Attributes.var_report.xml									phs001702.v1.p1	Lupus Erythematosus, Systemic
			03/01/2016				./data/phs001054.v1.pht005278.v1.p1.Angiocentric_Glioma_Subject_Phenotypes.var_report.xml									phs001054.v1.p1	Glioma
			2019/03/28				./data/phs001680.v1.pht008914.v1.p1.T_Cell_States_Melanoma_GEO.var_report.xml									phs001680.v1.p1	Immunotherapy
			06/01/2012				./data/phs000484.v1.pht002684.v1.p1.Inherited_Kidney_Dysfunction_Sample_Attributes.var_report.xml									phs000484.v1.p1	Glomerulosclerosis, Focal Segmental 
34.0	34.0		03/10/2015	59.0		25.0	./data/phs000516.v2.pht002830.v2.p1.Pancreatic_Ductal_Adenocarcinoma_Subject_Phenotypes.var_report.xml	0.0	29.5	6.364	25.0			29.5		phs000516.v2.p1	Carcinoma, Pancreatic Ductal
2.0	2.0		2018/12/10	2.0		2.0	./data/phs001720.v1.pht008596.v1.p1.Kidney_On_A_Chip_Subject_Phenotypes.var_report.xml	0.0	2.0					2.0		phs001720.v1.p1	Podocytes
			11/05/2014				./data/phs000209.v13.pht002512.v1.p3.MESA_AncilMesaLpPLA2.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			05/02/2011				./data/phs000349.v1.pht002189.v1.p1.SEA_Phase2_Subject.var_report.xml									phs000349.v1.p1	Atherosclerosis
			11/04/2014				./data/phs000086.v3.pht000221.v1.p1.DCCT_f0471.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/05/07				./data/phs000490.v1.pht002965.v1.p1.Atopic_Dermatitis_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			02/18/2016				./data/phs000932.v1.pht004886.v1.p1.COLO_Sample.var_report.xml									phs000932.v1.p1	Melanoma
			2021/04/09				./data/phs002292.v1.pht011106.v1.p1.Neocortical_Neurons_Sample.var_report.xml									phs002292.v1.p1	Neocortex
			2021/08/24				./data/phs001368.v3.pht007959.v3.p2.TOPMed_WGS_CHS_VTE_Sample_Attributes.var_report.xml									phs001368.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006476.v1.p1.RETV1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/08/19				./data/phs001662.v2.pht010073.v1.p1.LTRC_R040_subject_st_george_quest.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			08/02/2013				./data/phs000644.v1.pht003423.v1.p1.Menstrual_Cycle_Effect_Breast_Subject_Phenotypes.var_report.xml									phs000644.v1.p1	Menstrual Cycle
			2019/03/11				./data/phs001717.v1.pht008581.v1.p1.Placental_Regulation_Sample_Attributes.var_report.xml									phs001717.v1.p1	Control Groups
			03/21/2014				./data/phs000583.v1.pht003295.v1.p1.GENETIC_EPIDEMIOLOGY_LAB_DATABASE_FILE_2011_Phenx.var_report.xml									phs000583.v1.p1	Metabolic Syndrome X
			02/07/2014				./data/phs000632.v1.pht003578.v1.p1.ESP_Hematological_Cancers_Sample.var_report.xml									phs000632.v1.p1	Hemic and Lymphatic Diseases
			2021/09/20				./data/phs002407.v1.pht011357.v1.p1.MMRd_MMRp_CRC_Subject_Phenotypes.var_report.xml									phs002407.v1.p1	Colorectal Neoplasms
392.0	392.0		2021/07/30	720.0		5.0	./data/phs002444.v1.pht011385.v1.p1.Osteosarcoma_Subject_Phenotypes.var_report.xml	0.0	240.0	206.4	323.0			323.0		phs002444.v1.p1	Osteosarcoma
			2020/01/23				./data/phs000287.v7.pht001482.v1.p1.YR15ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			07/16/2015				./data/phs000153.v9.pht000834.v8.p8.shareids_Subject.var_report.xml									phs000153.v9.p8	Social Behavior
			2019/04/19				./data/phs001808.v1.pht008973.v1.p1.B_Lymphocytes_Aging_Sample.var_report.xml									phs001808.v1.p1	Aging
			03/10/2015				./data/phs000516.v2.pht002828.v2.p1.Pancreatic_Ductal_Adenocarcinoma_Subject.var_report.xml									phs000516.v2.p1	Carcinoma, Pancreatic Ductal
			2020/12/21				./data/phs000007.v32.pht000195.v8.p13.brach1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005434.v1.p1.uhdr5.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/03/21				./data/phs001235.v1.pht008447.v1.p1.MDA5_Deficiency_Sample.var_report.xml									phs001235.v1.p1	Immunologic Deficiency Syndromes
			2019/10/31				./data/phs001623.v2.pht008361.v2.p1.HNSCC_Subject.var_report.xml									phs001623.v2.p1	Carcinoma, squamous cell of head and neck
			2020/12/21				./data/phs000007.v32.pht000747.v7.p13.ex1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/03/30				./data/phs001988.v1.pht010929.v1.p1.mCRPC_Subject_Phenotypes.var_report.xml									phs001988.v1.p1	Prostatic Neoplasms
			2020/02/03				./data/phs000815.v2.pht006792.v1.p1.Human_Leukocytes_Sample_Attributes.var_report.xml									phs000815.v2.p1	
2.0	2.0		10/24/2012	4.0		2.0	./data/phs000542.v1.pht003017.v1.p1.Mendelian_Neonatal_Diabetes_Subject_Phenotypes.var_report.xml	0.0	2.0	0	2.0			2.0		phs000542.v1.p1	Pancreatic beta cell agenesis with neonatal diabetes mellitus
			2018/12/06				./data/phs001688.v1.pht008590.v1.p1.Psoriasis_Secukinumab_Subject.var_report.xml									phs001688.v1.p1	Psoriasis
			06/09/2010				./data/phs000255.v1.pht001254.v1.p1.HMP_Crohns_Risk_NOD2_ATG16L1_Genotypes.var_report.xml									phs000255.v1.p1	Crohn Disease
			2019/03/08				./data/phs001759.v1.pht008709.v1.p1.SAH_Subject_Phenotypes.var_report.xml									phs001759.v1.p1	Circulating MicroRNA
			Wed Nov 26 07:49:55 2008				./data/phs000017.v3.pht000369.v1.p1.AA_DiagnosisPage2.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
910.0	926.0		03/25/2011	854.0		910.0	./data/phs000308.v1.pht002086.v1.p1.GLAUGEN_Subject_Phenotypes.var_report_2011_03_25.xml	0.0	717.5	36.77	926.0			717.5		phs000308.v1.p1	Glaucoma, Open-Angle
			06/10/2015				./data/phs000918.v1.pht004748.v1.p1.IPDGC_NeuroX_Sample.var_report.xml									phs000918.v1.p1	Parkinson Disease
			2019/12/12				./data/phs001883.v1.pht009681.v1.p1.S0800_BC_Sample.var_report.xml									phs001883.v1.p1	Breast Neoplasms
			2019/11/08				./data/phs001330.v2.pht007533.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
527.0	527.0		05/08/2015	537.0		6.0	./data/phs000864.v1.pht004492.v1.p1.Combat_Stress_Predictors_Pedigree.var_report.xml	0.0	268.5	365.6	6.0			268.5		phs000864.v1.p1	Stress Disorders, Post-Traumatic
			2019/08/18				./data/phs001869.v1.pht009395.v1.p1.ADHD_Sample.var_report.xml									phs001869.v1.p1	Attention Deficit Disorder with Hyperactivity
	5941.0		2019/10/15	5941.0		638.0	./data/phs000256.v4.pht001239.v4.p3.HMP_Vaginal_Microbiome_Subject_Phenotype.var_report.xml	0.0	5941.0	2196	4800.0			788.0		phs000256.v4.p3	Microbiomes, Human
			2019/03/11				./data/phs000286.v6.pht001946.v2.p2.cesa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/02/10				./data/phs001675.v1.pht010222.v1.p1.OFC_Sample_Attributes.var_report.xml									phs001675.v1.p1	Cleft Lip
			02/12/2014				./data/phs000461.v1.pht003686.v1.p1.GLAUGEN_POAG_Methylation_Sample_Attributes.var_report.xml									phs000461.v1.p1	Glaucoma, Open-Angle
			11/08/2013				./data/phs000200.v9.pht000985.v4.p3.bmdwbody_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			07/15/2013				./data/phs000608.v1.pht003343.v1.p1.Schizophrenia_Methylation_Sample.var_report.xml									phs000608.v1.p1	Schizophrenia
			2021/06/08				./data/phs001215.v4.pht008628.v2.p2.TOPMed_WGS_SAFHS_Subject.var_report.xml									phs001215.v4.p2	Cardiovascular Diseases
			04/12/2012				./data/phs000442.v1.pht002490.v1.p1.Resistant_Hypertension_AA_Sample_Attributes.var_report.xml									phs000442.v1.p1	Hypertension
			02/23/2017				./data/phs001139.v1.pht006159.v1.p1.GENESiPS_Insulin_Resistance_Subject.var_report.xml									phs001139.v1.p1	Insulin Resistance
68.0	70.0		2021/04/28	69.0		68.0	./data/phs002393.v1.pht011138.v1.p1.ABCA4_Subject_Phenotypes.var_report.xml	0.0	69.0	7.778	70.0			69.0		phs002393.v1.p1	Retina
			09/27/2010				./data/phs000103.v1.pht001887.v1.p1.Preterm_Delivery_Subject.var_report_2010_09_27.xml									phs000103.v1.p1	Premature Birth
			2020/05/13				./data/phs002024.v1.pht010234.v1.p1.DCCT_EDIC_DNAme_Sample_Attributes.var_report.xml									phs002024.v1.p1	Diabetes Mellitus, Type 1
			2020/06/18				./data/phs000280.v7.pht004097.v2.p1.GTSB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/21/2016				./data/phs001172.v1.pht005841.v1.p2.NINDS_PD_Subject.var_report.xml									phs001172.v1.p2	Parkinson Disease
			2020/12/21				./data/phs000007.v32.pht000303.v8.p13.icam3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			Fri Feb 20 11:36:01 2009				./data/phs000160.v1.pht000732.v1.p1.LOAD6k_Phenotypes.var_report_2009_02_20.xml									phs000160.v1.p1	Alzheimer Disease
			06/10/2015				./data/phs000545.v1.pht003763.v1.p1.Chemotherapy_Induced_Mucositis_Sample.var_report.xml									phs000545.v1.p1	Multiple Myeloma
1.0	4.0		06/26/2013	6.0		3.0	./data/phs000553.v1.pht003132.v1.p1.Rare_Pediatric_Phenotypes_Pedigree.var_report.xml	0.0	3.0	1.732	4.0			3.0		phs000553.v1.p1	Mendelian
			03/07/2011				./data/phs000252.v2.pht001269.v1.p1.HMP_Gut_Crohns_Diet_FSM_Subject_Phenotypes.var_report.xml									phs000252.v2.p1	Crohn Disease
			2018/05/31				./data/phs001316.v1.pht008015.v1.p1.treatmenttable.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			01/20/2016				./data/phs000902.v1.pht004671.v1.p1.MIGen_Regicor_Sample_Attributes.var_report.xml									phs000902.v1.p1	Coronary Artery Disease
114.0	114.0		12/12/2014	182.0		68.0	./data/phs000691.v2.pht003653.v1.p1.Sickle_Cell_CIP_Subject_Phenotypes.var_report.xml	0.0	91.0	32.53	68.0			91.0		phs000691.v2.p1	Anemia, Sickle Cell
			06/26/2013				./data/phs000553.v1.pht003131.v1.p1.Rare_Pediatric_Phenotypes_Subject.var_report.xml									phs000553.v1.p1	Mendelian
			2019/03/11				./data/phs000286.v6.pht001924.v2.p2.abpa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			06/01/2017				./data/phs001306.v1.pht006190.v1.p1.Psoriasis_Associated_Variants_Sample_Attributes.var_report.xml									phs001306.v1.p1	Psoriasis
			09/14/2015				./data/phs000982.v1.pht004984.v1.p1.PsA_Sample_Attributes.var_report.xml									phs000982.v1.p1	Arthritis, Psoriatic
			01/13/2014				./data/phs000658.v1.pht003496.v1.p1.MDD2000AFFY_Subject.var_report.xml									phs000658.v1.p1	Depressive Disorder, Major
			08/20/2013				./data/phs000285.v3.pht001650.v2.p2.C1CARTDA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht003096.v3.p13.t_bmdhs_2008_1_0748s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
864.0	8098.0		2020/12/21	2072.0		864.0	./data/phs000007.v32.pht003099.v7.p13.vr_dates_2019_a_1175s.var_report.xml	0.0	7572.0	743.9	8098.0			7572.0		phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000469.v2.p3.simphen070.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/11/13				./data/phs002019.v1.pht010173.v1.p1.SCCIS_Sample.var_report.xml									phs002019.v1.p1	Carcinoma in Situ
			2020/07/06				./data/phs001955.v1.pht009793.v1.p1.REDS_III_RBCOmics_Sample.var_report.xml									phs001955.v1.p1	
6.0	6.0		01/05/2015	8.0		6.0	./data/phs000817.v1.pht004414.v1.p1.Varicella_Zoster_Vaccine_Pedigree.var_report.xml	0.0	8.0	2.828	6.0			8.0		phs000817.v1.p1	Varicella Vaccine
			2020/12/21				./data/phs000007.v32.pht000150.v8.p13.t_echo_ex06_1b_0207s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
43.0	43.0		2021/05/21	57.0		698.0	./data/phs002331.v1.pht011101.v1.p1.DASH_Pedigree.var_report.xml	0.0	28.5	895.9	698.0			28.5		phs002331.v1.p1	Drug Users
			01/19/2010				./data/phs000219.v1.pht001095.v1.p1.d_neurexm_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			11/05/2014				./data/phs000209.v13.pht003122.v3.p3.MESA_AncilMesaNeighborScalesExam4.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2018/06/27				./data/phs001006.v1.pht006002.v1.p1.Lobular_Carcinomas_Sample.var_report.xml									phs001006.v1.p1	Carcinoma, Lobular
			2021/08/06				./data/phs001682.v2.pht009762.v1.p1.TOPMed_WGS_PUSH_SCD_Subject.var_report.xml									phs001682.v2.p1	Anemia, Sickle Cell
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000420.v2.p3.simphen021.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
423.0	423.0		2017/11/06	787.0		364.0	./data/phs000288.v2.pht002517.v2.p2.Ciliopathies_Exome_Pedigree.var_report.xml	0.0	393.5	6.364	364.0			393.5		phs000288.v2.p2	Congenital Abnormalities
			2020/12/02				./data/phs002287.v1.pht010711.v1.p1.ER_Positive_BC_Sample.var_report.xml									phs002287.v1.p1	Breast Neoplasms
199.0	225.0		04/17/2017	424.0		199.0	./data/phs000816.v2.pht004343.v2.p1.X_Chromosome_Inactivation_Subject_Phenotypes.var_report.xml	0.0	212.0	18.38	225.0			212.0		phs000816.v2.p1	X Chromosome Inactivation
			07/05/2017				./data/phs000595.v1.pht006635.v1.p1.final_diagnosis.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			06/21/2016				./data/phs001151.v1.pht005538.v1.p1.Retina_RPE_Choroid_Subject.var_report.xml									phs001151.v1.p1	
			2020/06/18				./data/phs000280.v7.pht004208.v2.p1.UBMDALL.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/01/2015				./data/phs000571.v3.pht003184.v3.p2.KaryotypeAbnormalitiesProband.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			07/22/2013				./data/phs000614.v1.pht003291.v1.p1.PLGGs_Sample_Attributes.var_report.xml									phs000614.v1.p1	Astrocytoma
			11/04/2014				./data/phs000086.v3.pht000238.v1.p1.DCCT_f1281.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
68.0			11/16/2015	125.0			./data/phs001026.v1.pht005121.v1.p1.CSER_BASIC3_Subject_Phenotypes.var_report.xml	0.0			57.0					phs001026.v1.p1	Genes, Neoplasm
			08/20/2013				./data/phs000285.v3.pht001596.v2.p2.B2F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/03/26				./data/phs000697.v1.pht007700.v1.p1.efficacyform.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2020/07/17				./data/phs000480.v1.pht002908.v1.p1.FBCS_Sample_Attributes.var_report.xml									phs000480.v1.p1	Breast Neoplasms
			2018/05/15				./data/phs001311.v1.pht007929.v1.p1.aprtrs_episode_report.var_report.xml									phs001311.v1.p1	Myotonia
585.0	968.0		04/24/2015	796.0		585.0	./data/phs000629.v1.pht003387.v1.p1.Familial_Lung_Cancer_Subject_Phenotypes.var_report.xml	0.0	776.5	270.8	968.0			776.5		phs000629.v1.p1	Lung Neoplasms
			2020/12/21				./data/phs000007.v32.pht002432.v4.p13.vr_pase_ex02_3_0642s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1691.0	11882.0		05/16/2017	19313.0		7431.0	./data/phs001252.v1.pht006405.v1.p1.vitals.var_report.xml	0.0	9657.0	3147	1055.0			9657.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/04/29				./data/phs000185.v7.pht010104.v1.p1.Hutterites_NSMR_ExomeSeq_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			11/16/2012				./data/phs000391.v1.pht002994.v1.p1.PAPI_Subject.var_report.xml									phs000391.v1.p1	Platelets
			2020/02/06				./data/phs001430.v2.pht008060.v2.p1.p7001_15909_behaviore.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			06/20/2012				./data/phs000455.v1.pht002577.v1.p1.Developmental_Brain_Disorders_Subject_Phenotypes.var_report.xml									phs000455.v1.p1	Brain Diseases
18.0	18.0		07/25/2014	33.0		15.0	./data/phs000335.v3.pht002114.v1.p2.LHS_COPD_Pedigree.var_report.xml	0.0	16.5	2.121	15.0			16.5		phs000335.v3.p2	COPD
			09/03/2014				./data/phs000750.v1.pht003937.v1.p1.GOAL_Sample_Attributes.var_report.xml									phs000750.v1.p1	Population Groups
			01/11/2016				./data/phs000279.v2.pht001435.v2.p1.ESP_Broad_EOMI_Subject.var_report.xml									phs000279.v2.p1	Myocardial Infarction
95.0	70.0		01/19/2016	94.0		95.0	./data/phs000908.v1.pht004706.v1.p1.PD_Rare_Variants_Pedigree.var_report.xml	0.0	98.5	5.657	70.0			98.5		phs000908.v1.p1	
			10/22/2013				./data/phs000664.v1.pht003544.v1.p1.Genomic_Variations_Multi_Ethnic_Malaysia_Subject_Phenotypes.var_report.xml									phs000664.v1.p1	Population Groups
			2019/06/03				./data/phs000624.v1.pht009132.v1.p1.LGRC_Sample_Attributes.var_report.xml									phs000624.v1.p1	Pulmonary Disease, Chronic Obstructive
			2017/10/11				./data/phs000578.v1.pht007004.v1.p1.ae_mro_review.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
1689.0	89059.0		05/16/2017	144962.0		55903.0	./data/phs001252.v1.pht006401.v1.p1.sysinfl.var_report.xml	0.0	72481.0	23445	1055.0			72481.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/06/18				./data/phs000280.v7.pht004201.v2.p1.TIAB03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004087.v2.p1.ETLB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/02/03				./data/phs000815.v2.pht008164.v1.p1.Human_Leukocytes_Subject_Phenotypes.var_report.xml									phs000815.v2.p1	
			07/06/2017				./data/phs001370.v1.pht006647.v1.p1.Uveal_Melanoma_Sample_Attributes.var_report.xml									phs001370.v1.p1	Melanoma, Uveal
			2018/05/15				./data/phs001311.v1.pht007919.v1.p1.treatmenttable.var_report.xml									phs001311.v1.p1	Myotonia
			02/18/2015				./data/phs000760.v1.pht004265.v1.p1.Flu_Vaccine_Sample_Attributes.var_report.xml									phs000760.v1.p1	Influenza Vaccines
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000426.v2.p3.simphen027.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/08/06				./data/phs001398.v1.pht007141.v1.p1.CCDG_BRAVE_Sample.var_report.xml									phs001398.v1.p1	
			2018/10/22				./data/phs001666.v1.pht008465.v1.p1.Alisertib_PC_Sample.var_report.xml									phs001666.v1.p1	Adenocarcinoma
			2020/06/18				./data/phs000280.v7.pht009459.v2.p1.ADSps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001665.v2.p2.C1F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/10				./data/phs001372.v1.pht006534.v1.p1.CLL_Integrated_Single_Cell_Subject_Phenotypes.var_report.xml									phs001372.v1.p1	Leukemia, Lymphoid
			2020/07/15				./data/phs002054.v1.pht010350.v1.p1.9p_Deletion_Sample_Attributes.var_report.xml									phs002054.v1.p1	Chromosome 9p Deletion Syndrome
406.0	406.0		06/09/2015	764.0		1187.0	./data/phs000718.v1.pht003839.v1.p1.T21NDJ_Pedigree.var_report.xml	0.0	254.7	49.5	357.0			357.0		phs000718.v1.p1	Nondisjunction, Genetic
			2020/12/21				./data/phs000007.v32.pht005157.v3.p13.t_ctlivfat_2011_m_0672s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/12/10				./data/phs001913.v1.pht009513.v1.p1.CCDG_eMERGE_Northwestern_Sample.var_report.xml									phs001913.v1.p1	Cardiovascular Diseases
			02/22/2013				./data/phs000339.v2.pht002135.v1.p1.Mitochondrial_OXPHOS_Diseases_Subject.var_report.xml									phs000339.v2.p1	Mitochondrial Diseases
			08/09/2016				./data/phs001093.v1.pht005611.v1.p1.T2D_GENES_UK_South_Asian_Sample.var_report.xml									phs001093.v1.p1	Diabetes Mellitus, Type 2
			01/22/2014				./data/phs000276.v2.pht002004.v2.p1.NFBC66_Sample.var_report.xml									phs000276.v2.p1	Metabolic Syndrome X
4.0	4.0		2018/05/03	4.0		4.0	./data/phs001587.v1.pht007884.v1.p1.Prostate_Cancer_Organoids_Subject_Phenotypes.var_report.xml	0.0	4.0					4.0		phs001587.v1.p1	Prostatic Neoplasms
			09/02/2016				./data/phs001033.v1.pht005202.v1.p1.PAGE_Global_Reference_Panel_Sample_Attributes.var_report.xml									phs001033.v1.p1	Population
			08/20/2013				./data/phs000285.v3.pht001752.v2.p2.E1CATECH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			06/28/2017				./data/phs001338.v1.pht006363.v1.p1.Tibetan_High_Altitude_Adaptation_Sample.var_report.xml									phs001338.v1.p1	
79.0			2021/06/23	120.0			./data/phs001435.v2.pht009875.v1.p1.TOPMed_WGS_AustralianFamilialAF_Subject_Phenotypes.var_report.xml	0.0			41.0					phs001435.v2.p1	Atrial Fibrillation
			11/04/2014				./data/phs000086.v3.pht000351.v1.p1.EDIC_f0942.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			04/12/2012				./data/phs000442.v1.pht002488.v1.p1.Resistant_Hypertension_AA_Sample.var_report.xml									phs000442.v1.p1	Hypertension
			2021/05/04				./data/phs002317.v1.pht011164.v1.p1.ALL_Bone_Toxicities_Sample.var_report.xml									phs002317.v1.p1	Fractures, Bone
			2018/12/28				./data/phs001663.v1.pht008402.v1.p1.GBM_POLE_Deficiency_Sample.var_report.xml									phs001663.v1.p1	Glioblastoma
			02/01/2016				./data/phs001021.v1.pht005266.v1.p1.CHDWB_Rare_Regulatory_Variants_Subject_Phenotypes.var_report.xml									phs001021.v1.p1	Wellness Center
692.0			05/02/2012	1315.0			./data/phs000456.v1.pht002643.v1.p1.RACE_Cases_Subject_Phenotypes.var_report.xml	0.0			623.0					phs000456.v1.p1	Stroke
			2017/12/19				./data/phs001438.v1.pht006819.v1.p1.Cortical_Neurogenesis_Open_Chromatin_Sample.var_report.xml									phs001438.v1.p1	Chromatin
			02/27/2014				./data/phs000716.v1.pht003708.v1.p1.Lung_Cancer_Never_Smoking_Asian_Sample_Attributes.var_report.xml									phs000716.v1.p1	Lung Neoplasms
			2020/01/23				./data/phs000287.v7.pht001449.v1.p1.ADDITIONAL_BIOMARKERS.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			10/21/2015				./data/phs000813.v1.pht004303.v1.p1.Nicotine_Dependence_Genomic_Regions_Sample.var_report.xml									phs000813.v1.p1	Tobacco Use Disorder
10.0	26.0		2020/02/03	36.0		10.0	./data/phs001931.v1.pht009678.v1.p1.CMI_ASCproject_Subject_Phenotypes.var_report.xml	0.0	18.0	11.31	26.0			18.0		phs001931.v1.p1	Sarcoma
			2020/12/21				./data/phs000007.v32.pht006008.v1.p13.e_exam_ex32_0_0939s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
3.0	9.0		2021/07/21	7.0		3.0	./data/phs002446.v1.pht011402.v1.p1.SjS_Transcriptional_Subject.var_report.xml	0.0	6.0	4.243	9.0			6.0		phs002446.v1.p1	Sjogren's Syndrome
			2018/06/13				./data/phs001490.v1.pht008136.v1.p1.T2D_GENES_BioMe_Sample.var_report.xml									phs001490.v1.p1	Diabetes Mellitus, Type 2
			08/18/2015				./data/phs000586.v1.pht004830.v1.p1.Alopecia_Areata_Subject.var_report.xml									phs000586.v1.p1	Alopecia Areata
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000442.v2.p3.simphen043.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/08/18				./data/phs001725.v2.pht010095.v1.p1.TOPMed_CCDG_GGAF_Sample_Attributes.var_report.xml									phs001725.v2.p1	Atrial Fibrillation
			2018/03/26				./data/phs000697.v1.pht007706.v1.p1.eligibility.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			10/21/2015				./data/phs001002.v1.pht005043.v1.p1.CALGB90401_Prostate_Cancer_Sample.var_report.xml									phs001002.v1.p1	Prostatic Neoplasms
			07/12/2017				./data/phs000592.v1.pht006600.v1.p1.transfusionrecord.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000545.v2.p3.simphen146.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/03/06				./data/phs000603.v1.pht007552.v1.p1.registration.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			2021/09/13				./data/phs002487.v1.pht011545.v1.p1.Schizophrenia_Antipsychotics_Sample_Attributes.var_report.xml									phs002487.v1.p1	Schizophrenic Disorders
	634.0		11/16/2011	1253.0		619.0	./data/phs000096.v4.pht002446.v1.p1.HAPO_Thai_Phenotypes.var_report.xml	0.0	626.5	10.61	1253.0			626.5		phs000096.v4.p1	Pregnancy Complications
			12/11/2009				./data/phs000171.v1.pht000780.v1.p1.MS_DATA_NEURSTAT1.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2017/10/13				./data/phs001212.v1.pht006562.v1.p1.Globin_Sickle_Cell_iPSC_Subject.var_report.xml									phs001212.v1.p1	Anemia, Sickle Cell
			2021/04/28				./data/phs002408.v1.pht011161.v1.p1.CTCF_11p15_Subject_Phenotypes.var_report.xml									phs002408.v1.p1	Beckwith-Wiedemann Syndrome
			11/08/2013				./data/phs000200.v9.pht003413.v1.p3.outc_self_x2_mrc_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/07/10				./data/phs002022.v1.pht010182.v1.p1.pPCL_GEO.var_report.xml									phs002022.v1.p1	Leukemia, Plasma Cell
			2017/08/31				./data/phs000939.v2.pht004788.v2.p1.Lymphoma_Oncogene_Dysregulation_Sample.var_report.xml									phs000939.v2.p1	Lymphoma, B-Cell
1.0	5.0		2020/11/19	6.0		1.0	./data/phs002286.v1.pht010633.v1.p1.HPV16_E7_Subject.var_report.xml	0.0	3.0	2.828	5.0			3.0		phs002286.v1.p1	Neoplasms
			2018/06/01				./data/phs001538.v1.pht008092.v1.p1.Registry_Manifest_1.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
973.0	973.0		2021/05/13	1651.0		678.0	./data/phs001423.v3.pht006983.v3.p2.TIC_Genetics_Subject.var_report.xml	0.0	825.5	208.6	678.0			825.5		phs001423.v3.p2	Tourette Disorder
			11/05/2014				./data/phs000209.v13.pht004318.v1.p3.MESA_ancilmesaurinesexhormone.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			11/24/2015				./data/phs000824.v1.pht005139.v1.p1.Colon_Cancer_Predisposing_Mutations_Sample_Attributes.var_report.xml									phs000824.v1.p1	Colorectal Neoplasms
			2021/03/09				./data/phs002348.v1.pht011051.v1.p1.MSH_Sample.var_report.xml									phs002348.v1.p1	Sickle Cell Disease
			2021/05/20				./data/phs002280.v1.pht010808.v1.p1.scRNA_PBMC_Sample_Attributes.var_report.xml									phs002280.v1.p1	PBMC &#8211; Peripheral Blood Mononuclear Cells
			2021/10/07				./data/phs001918.v2.pht010048.v1.p1.STAMPEED_HCT_Sample.var_report.xml									phs001918.v2.p1	Graft vs Host Disease
			03/26/2015				./data/phs000761.v1.pht004497.v1.p1.OPPERA_Sample.var_report.xml									phs000761.v1.p1	Temporomandibular Joint Disorders
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000599.v2.p3.simphen200.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			12/21/2016				./data/phs001172.v1.pht005842.v1.p2.NINDS_PD_Sample.var_report.xml									phs001172.v1.p2	Parkinson Disease
			2020/12/21				./data/phs000007.v32.pht002078.v7.p13.l_ckd_ex06_1_0536s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/02/2015				./data/phs000639.v1.pht004782.v1.p1.Autism_Spectrum_Disorder_Sample_Attributes.var_report.xml									phs000639.v1.p1	Autism Spectrum Disorder
			2019/03/11				./data/phs000286.v6.pht001983.v6.p2.JHS_Sample.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			02/18/2015				./data/phs000760.v1.pht004263.v1.p1.Flu_Vaccine_Sample.var_report.xml									phs000760.v1.p1	Influenza Vaccines
			01/19/2010				./data/phs000219.v1.pht001052.v1.p1.d_autopsy.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			01/09/2017				./data/phs001244.v1.pht006056.v1.p1.NPC_WES_Sample.var_report.xml									phs001244.v1.p1	Nasopharyngeal Neoplasms
			2017/12/04				./data/phs001419.v1.pht007083.v1.p1.bamf.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			01/13/2012				./data/phs000380.v1.pht002459.v1.p1.METABOCHIP_Sample_Attribute.var_report.xml									phs000380.v1.p1	Obesity
942.0			2019/03/11	694.0			./data/phs000286.v6.pht008731.v1.p2.analysis3.var_report.xml	0.0			894.0					phs000286.v6.p2	Cardiovascular Diseases
			2020/04/29				./data/phs000185.v7.pht003719.v2.p1.Hutterites_Fecal_Microbiome_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			2018/02/15				./data/phs001496.v1.pht007341.v1.p1.Warfarin_Caribbean_Hispanics_Sample_Attributes.var_report.xml									phs001496.v1.p1	Warfarin Sensitivity
			2018/06/20				./data/phs001629.v1.pht008163.v1.p1.BRAF_V600E_Sample_Attributes.var_report.xml									phs001629.v1.p1	Ganglioglioma
			12/16/2010				./data/phs000308.v1.pht002085.v1.p1.GLAUGEN_Sample.var_report_2010_12_16.xml									phs000308.v1.p1	Glaucoma, Open-Angle
			2018/05/01				./data/phs000607.v3.pht003447.v2.p2.Neurodevelopmental_Genomics_Sample_Attributes.var_report.xml									phs000607.v3.p2	Mental Processes
			2018/04/23				./data/phs001219.v1.pht007857.v1.p1.LPD_Subject.var_report.xml									phs001219.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			05/19/2016				./data/phs001115.v1.pht005482.v1.p1.Melanoma_Genetic_Analysis_Sample_Attributes.var_report.xml									phs001115.v1.p1	Melanoma, Cutaneous Malignant
			2020/06/18				./data/phs000280.v7.pht004166.v2.p1.RTABF34.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/12/26				./data/phs001862.v1.pht009749.v1.p1.PBB_Sample_Attributes.var_report.xml									phs001862.v1.p1	Endocrine Disruptors
			10/21/2015				./data/phs000789.v1.pht004288.v1.p1.CSGNM_Subject.var_report.xml									phs000789.v1.p1	
			03/12/2013				./data/phs000343.v3.pht003151.v1.p1.nut.var_report.xml									phs000343.v3.p1	Stroke
			Thu Jan 17 21:45:40 2008				./data/phs000019.v1.pht000179.v1.p1.GAIN_case_institution.var_report_2008_08_12.xml									phs000019.v1.p1	Psoriasis
			2021/06/03				./data/phs001961.v1.pht011145.v1.p1.LungMAP_GEO.var_report.xml									phs001961.v1.p1	Lung
877.0	198.0	4.0	08/20/2013	471.0	3.801	6.0	./data/phs000285.v3.pht001724.v2.p2.D1F45.var_report.xml	0.0	78.5	85.36	976.0	1.0		37.0	9.0	phs000285.v3.p2	Cardiovascular Diseases
847.0		2.0	08/20/2013	447.0	1.6130000000000002		./data/phs000285.v3.pht001781.v2.p2.E1F12PF.var_report.xml	2.0		0.4982	929.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			2019/03/21				./data/phs001235.v1.pht008449.v1.p1.MDA5_Deficiency_Sample_Attributes.var_report.xml									phs001235.v1.p1	Immunologic Deficiency Syndromes
			02/02/2012				./data/phs000417.v2.pht002398.v1.p1.Brain_Cloud_GEO.var_report.xml									phs000417.v2.p1	Aging
			2017/09/08				./data/phs001105.v1.pht006837.v1.p1.Aggressive_Prostate_Tumors_Sample.var_report.xml									phs001105.v1.p1	Prostatic Neoplasms
			2019/03/11				./data/phs000286.v6.pht008770.v1.p2.nbhdattractions.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/02/13				./data/phs001564.v3.pht007990.v3.p1.Urinary_cfDNA_Sample.var_report.xml									phs001564.v3.p1	Bacteriuria
			11/18/2016				./data/phs001243.v1.pht005937.v1.p1.BRCA1_Carrier_Sample_Attributes.var_report.xml									phs001243.v1.p1	Breast Neoplasms
			02/24/2012				./data/phs000001.v3.pht000376.v1.p1.genspecfunduslens.var_report.xml									phs000001.v3.p1	Cataract
			08/20/2013				./data/phs000285.v3.pht001652.v2.p2.C1F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/04/04				./data/phs001455.v1.pht007758.v1.p1.Dystonia_CIZ1_Sample.var_report.xml									phs001455.v1.p1	Dystonia
			2020/11/17				./data/phs002197.v1.pht010609.v1.p1.Taupathy_Sample.var_report.xml									phs002197.v1.p1	Pick Disease of the Brain
			03/06/2017				./data/phs000574.v1.pht005869.v1.p1.initialhistory.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2020/12/21				./data/phs000007.v32.pht010741.v1.p13.t_pft_ex02_7_0732s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/03/05				./data/phs001959.v1.pht009791.v1.p1.CLL_SF3B1_Sample_Attributes.var_report.xml									phs001959.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000411.v2.p3.simphen012.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/12/12				./data/phs001930.v1.pht009669.v1.p1.Vit_E_NAFLD_Sample.var_report.xml									phs001930.v1.p1	Non-alcoholic Fatty Liver Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000592.v2.p3.simphen193.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/07/29				./data/phs001736.v1.pht009327.v1.p1.RCC_European_Subject.var_report.xml									phs001736.v1.p1	Carcinoma, Renal Cell
			2020/12/21				./data/phs000007.v32.pht005167.v1.p13.t_pftdiff_ex03_7_0761s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/05				./data/phs000262.v3.pht001280.v3.p2.HMP_Gut_Ulcerative_Colitis_Sample.var_report.xml									phs000262.v3.p2	Pouchitis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000451.v2.p3.simphen052.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			10/22/2013				./data/phs000664.v1.pht003543.v1.p1.Genomic_Variations_Multi_Ethnic_Malaysia_Sample.var_report.xml									phs000664.v1.p1	Population Groups
465.0			11/02/2015	767.0			./data/phs000639.v1.pht004781.v1.p1.Autism_Spectrum_Disorder_Subject_Phenotypes.var_report.xml	0.0			70.0					phs000639.v1.p1	Autism Spectrum Disorder
1.0	3.0		2019/06/24	4.0		1.0	./data/phs001836.v1.pht009219.v1.p1.Neocortical_Development_Subject_Phenotypes.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs001836.v1.p1	Autism Spectrum Disorder
			2021/04/07				./data/phs001349.v2.pht010328.v1.p1.TGCT_Sample.var_report.xml									phs001349.v2.p1	Testicular Germ Cell Tumor
			2019/10/15				./data/phs001910.v1.pht009536.v1.p1.PNETs_Sample.var_report.xml									phs001910.v1.p1	Neuroendocrine Tumors
			11/05/2014				./data/phs000209.v13.pht001112.v2.p3.MESA_AirNRSpirometry.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht009850.v1.p1.protocol_deviation_report.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
18.0	22.0		2021/01/07	40.0		18.0	./data/phs002073.v1.pht010826.v1.p1.Infant_Immunity_Subject.var_report.xml	0.0	20.0	2.828	22.0			20.0		phs002073.v1.p1	Breast Feeding
			2020/12/21				./data/phs000007.v32.pht003095.v4.p13.l_mma_ex01_3_0602s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/08/17				./data/phs001399.v1.pht006680.v1.p1.Neoadjuvant_Adjuvant_Therapies_Subject.var_report.xml									phs001399.v1.p1	Prostatic Neoplasms
			2021/01/26				./data/phs001427.v2.pht007485.v2.p1.Melanoma_CPB_Resistance_Sample.var_report.xml									phs001427.v2.p1	Immunotherapy
68.0	68.0		2021/01/12	63.0		89.0	./data/phs001617.v1.pht010618.v1.p1.Growth_Disorders_Pedigree.var_report.xml	0.0	97.0	7.778	89.0			97.0		phs001617.v1.p1	Growth Disorders
			04/14/2014				./data/phs000370.v2.pht002384.v1.p1.Head_Neck_Squamous_Cell_Carcinoma_Sample_Attributes.var_report.xml									phs000370.v2.p1	Head and Neck Neoplasms
			2017/08/09				./data/phs000694.v3.pht003755.v3.p2.Clinical_Cancer_Sequencing_Sample.var_report.xml									phs000694.v3.p2	Neoplasms
			2021/09/29				./data/phs001608.v2.pht009733.v1.p1.TOPMed_WGS_OMG_SCD_Subject.var_report.xml									phs001608.v2.p1	Anemia, Sickle Cell
			08/21/2014				./data/phs000772.v1.pht003994.v1.p1.GenePARE_Subject.var_report.xml									phs000772.v1.p1	Prostatic Neoplasms
			2019/03/21				./data/phs001235.v1.pht008445.v1.p1.MDA5_Deficiency_Subject.var_report.xml									phs001235.v1.p1	Immunologic Deficiency Syndromes
			07/21/2016				./data/phs000840.v1.pht005644.v1.p1.GoT2D_Sample_Attributes.var_report.xml									phs000840.v1.p1	Type 2 Diabetes Mellitus
			02/18/2015				./data/phs000857.v1.pht004490.v1.p1.ER_Positive_Breast_Cancer_Sample_Attributes.var_report.xml									phs000857.v1.p1	Breast Neoplasms
			03/28/2017				./data/phs001249.v1.pht006177.v1.p1.SCLC_Chemoresistance_Sample_Attributes.var_report.xml									phs001249.v1.p1	Lung Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000440.v2.p3.simphen041.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			04/29/2014				./data/phs000630.v1.pht003384.v1.p1.NIMH_Controls_Sample_Attributes.var_report.xml									phs000630.v1.p1	Normalcy
			11/08/2013				./data/phs000200.v9.pht003400.v1.p3.outc_bc_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/10/21				./data/phs001138.v4.pht007937.v3.p2.GMKF_CHD_PCGC_Subject.var_report.xml									phs001138.v4.p2	Heart Defects, Congenital
			2017/12/20				./data/phs000577.v1.pht007288.v1.p1.rd_8403_qualityoflife.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			05/05/2015				./data/phs000517.v3.pht002913.v1.p1.Multiethnic_Cohort_Study_Subject.var_report.xml									phs000517.v3.p1	Breast Neoplasms
			2019/03/22				./data/phs000842.v2.pht004402.v2.p1.PediGFR_Subject.var_report.xml									phs000842.v2.p1	Kidney Diseases
			08/21/2015				./data/phs000830.v1.pht004920.v1.p1.cSCC_XPC_Mutation_Rates_Subject.var_report.xml									phs000830.v1.p1	Xeroderma Pigmentosum, Complementation Group C
			2021/04/08				./data/phs002344.v1.pht011122.v1.p1.PAX3_FOXO1_RMS_Sample_Attributes.var_report.xml									phs002344.v1.p1	Rhabdomyosarcoma
7.0			2017/10/10	12.0			./data/phs001424.v1.pht007000.v1.p1.Glioblastoma_Phylogeny_Subject_Phenotypes.var_report.xml	0.0			5.0					phs001424.v1.p1	Glioblastoma
			2021/04/19				./data/phs002394.v1.pht011135.v1.p1.PDAC_Sample_Attributes.var_report.xml									phs002394.v1.p1	pancreatic cancer
			2020/06/02				./data/phs002040.v1.pht010257.v1.p1.IL37_IBD_Subject.var_report.xml									phs002040.v1.p1	Inflammatory Bowel Diseases
			12/01/2015				./data/phs000571.v3.pht003173.v3.p2.PCGC_Subject.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			10/25/2010				./data/phs000021.v3.pht002001.v1.p2.GAIN_Schizophrenia_Subject.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
			11/05/2014				./data/phs000209.v13.pht003607.v1.p3.MESA_AncilMesaNeighborFoodExam3.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006422.v1.p1.CBC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
841.0	984.0		12/16/2014	924.0		841.0	./data/phs000018.v2.pht000062.v1.p1.GOKIND_Phenotype_GAIN.var_report.xml	0.0	912.5	4.243	984.0			912.5		phs000018.v2.p1	Diabetic Nephropathies
			2018/10/24				./data/phs001693.v1.pht008488.v1.p1.Maternal_Fetal_IR_Subject.var_report.xml									phs001693.v1.p1	MicroRNAs
			06/14/2010				./data/phs000263.v1.pht001234.v1.p1.HMP_Skin_Acne_Sample_Attributes.var_report.xml									phs000263.v1.p1	Acne Vulgaris
			2018/03/21				./data/phs001512.v1.pht007666.v1.p1.IR_Signatures_Sample.var_report.xml									phs001512.v1.p1	Immune System Phenomena
1515.0	52256.0		05/16/2017	84717.0		32461.0	./data/phs001252.v1.pht006403.v1.p1.vdlgctp.var_report.xml	0.0	42359.0	13997	992.0			42359.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			03/02/2016				./data/phs000267.v5.pht002355.v2.p2.Autism_Genome_Project_Sample_Attributes.var_report.xml									phs000267.v5.p2	Autistic Disorder
			2018/08/19				./data/phs000101.v5.pht001148.v4.p1.ALS_Subject.var_report.xml									phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			03/06/2017				./data/phs000574.v1.pht005864.v1.p1.deathrecord.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2021/05/07				./data/phs000946.v5.pht004972.v3.p1.TOPMed_WGS_Boston_EO_COPD_Subject.var_report.xml									phs000946.v5.p1	Chronic Obstructive Pulmonary Disease
277.0	409.0		Wed Nov 26 07:49:58 2008	686.0		277.0	./data/phs000017.v3.pht000383.v1.p1.AA_GAIN_phenotype_controls_main_subset.var_report_2008_11_26.xml	0.0	343.0	93.34	409.0			343.0		phs000017.v3.p1	Bipolar Disorder
7431.0	7431.0		07/10/2017	8491.0		851.0	./data/phs001202.v1.pht005775.v1.p1.OncoArray_Oral_Pharynx_Cancer_Subject_Phenotypes.var_report.xml	0.0	802.5	376.9	851.0			802.5		phs001202.v1.p1	Head and Neck Neoplasms
			2019/10/07				./data/phs001351.v1.pht009410.v1.p1.Inherited_Neuropathy_Subject.var_report.xml									phs001351.v1.p1	Inherited Peripheral Neuropathy
			08/20/2013				./data/phs000285.v3.pht001672.v2.p2.C1F31.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/07/21				./data/phs002464.v1.pht011336.v1.p1.Familial_AF_Sample_Attributes.var_report.xml									phs002464.v1.p1	Atrial Fibrillation
			12/02/2016				./data/phs000847.v2.pht004633.v2.p1.T2D_GENES_SAMAFS_Subject.var_report.xml									phs000847.v2.p1	Diabetes Mellitus, Type 2
			2018/07/23				./data/phs000742.v1.pht008110.v1.p1.7_3_Specimens.var_report.xml									phs000742.v1.p1	Epilepsy
			2019/08/01				./data/phs001839.v1.pht009355.v1.p1.Deep_Seq_Cancers_Subject.var_report.xml									phs001839.v1.p1	Neoplasms
55.0	53.0		2021/07/16	83.0		55.0	./data/phs001603.v2.pht009970.v1.p1.TOPMed_WGS_ChildrensHS_IGERA_Subject_Phenotypes.var_report.xml	0.0	80.0	35.36	53.0			80.0		phs001603.v2.p1	Asthma
			10/06/2011				./data/phs000333.v1.pht002311.v1.p1.FIND_Subject.var_report.xml									phs000333.v1.p1	Diabetes Mellitus
			07/15/2010				./data/phs000292.v1.pht001524.v1.p1.GEOS_Subject.var_report_2010_07_15.xml									phs000292.v1.p1	Stroke
			2018/10/30				./data/phs001724.v1.pht008506.v1.p1.Pain_Resilience_Sample.var_report.xml									phs001724.v1.p1	Erythromelalgia
			2020/01/10				./data/phs001954.v1.pht009797.v1.p1.ICPC_LUAD_Taiwan_Sample.var_report.xml									phs001954.v1.p1	Adenocarcinoma of Lung
			01/19/2010				./data/phs000219.v1.pht001066.v1.p1.d_csa02L1_2_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
33.0	33.0		12/27/2012	57.0		24.0	./data/phs000524.v1.pht002918.v1.p1.CRIC_Subject_Phenotypes.var_report.xml	0.0	28.5	6.364	24.0			28.5		phs000524.v1.p1	Chronic Renal Insufficiency
			2021/03/30				./data/phs001988.v1.pht010928.v1.p1.mCRPC_Sample.var_report.xml									phs001988.v1.p1	Prostatic Neoplasms
			02/22/2013				./data/phs000339.v2.pht002137.v1.p1.Mitochondrial_OXPHOS_Diseases_Sample.var_report.xml									phs000339.v2.p1	Mitochondrial Diseases
			2017/12/04				./data/phs001419.v1.pht007092.v1.p1.p6601_12811_cmtss.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
30.0	30.0		2019/06/24	41.0		11.0	./data/phs001784.v1.pht009002.v1.p1.HCC_Imaging_Subject_Phenotypes.var_report.xml	0.0	20.5	13.44	11.0			20.5		phs001784.v1.p1	Carcinoma, Hepatocellular
			2020/07/10				./data/phs001886.v2.pht009416.v2.p1.Placenta_Term_Preterm_Subject.var_report.xml									phs001886.v2.p1	Pregnancy, COVID-19
4.0	4.0		2021/03/31	4.0		4.0	./data/phs002365.v1.pht011087.v1.p1.BWS_Subject.var_report.xml	0.0	4.0					4.0		phs002365.v1.p1	Beckwith-Wiedemann Syndrome
706.0	763.0		2020/12/14	611.0		388.0	./data/phs001984.v1.pht010782.v1.p1.MN_Subject.var_report.xml	0.0	619.0	76.03	388.0			706.0		phs001984.v1.p1	Glomerulonephritis, Membranous
			2021/08/11				./data/phs001785.v1.pht011460.v1.p1.GMKF_Hemangiomas_Sample.var_report.xml									phs001785.v1.p1	Hemangioma
			2018/06/14				./data/phs001238.v2.pht006656.v1.p1.GENOA_EuropeanAmerican_Phase1_Medications.var_report.xml									phs001238.v2.p1	Hypertension
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000519.v2.p3.simphen120.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004048.v5.p1.cderps16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
51.0	51.0		04/05/2017	95.0		83.0	./data/phs000987.v1.pht004970.v1.p1.WES_P1_22q11_Subject_Phenotypes.var_report.xml	0.0	92.0	7.778	83.0			92.0		phs000987.v1.p1	DiGeorge Syndrome
204.0	210.0		03/15/2016	414.0		204.0	./data/phs001074.v1.pht005340.v1.p1.GeneSTAR_Platelet_Aggregation_iPS_MKs_Pedigree.var_report.xml	0.0	207.0	4.243	210.0			207.0		phs001074.v1.p1	Platelet Aggregation
			11/07/2014				./data/phs000826.v1.pht004337.v1.p1.Adjuvant_Trastuzumab_Breast_Cancer_Sample_Attributes.var_report.xml									phs000826.v1.p1	Breast Neoplasms
990.0	1582.0		2018/04/12	2573.0		1.0	./data/phs001458.v1.pht007781.v1.p1.Cannabis_Stimulant_Dependence_Subject_Phenotypes.var_report.xml	0.0	857.7	798.8	1582.0			990.0		phs001458.v1.p1	Marijuana Abuse
			2019/07/26				./data/phs000588.v1.pht009302.v1.p1.lvv_baseline_med_hx_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/07/24				./data/phs001194.v3.pht005820.v2.p2.KaryotypeAbnormalitiesProband.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			04/08/2014				./data/phs000487.v2.pht002925.v1.p1.Prostate_Cancer_Risk_Subject_Phenotypes.var_report.xml									phs000487.v2.p1	Prostatic Neoplasms
			2019/08/01				./data/phs001871.v1.pht009360.v1.p1.CCDG_CCC_AA_Sample.var_report.xml									phs001871.v1.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008791.v1.p2.uldadv.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
71.0			2018/01/18	109.0			./data/phs001513.v1.pht007358.v1.p1.Chemo_Resistance_T_ALL_Subject_Phenotypes.var_report.xml	0.0			38.0					phs001513.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			05/24/2017				./data/phs000576.v1.pht006158.v1.p1.registration.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2021/08/30				./data/phs002457.v1.pht011516.v1.p1.TNBC_BrM_Sample.var_report.xml									phs002457.v1.p1	Triple Negative Breast Neoplasms
64.0	64.0		2020/06/30	117.0		53.0	./data/phs002049.v1.pht010297.v1.p1.Myeloid_Malignancies_Subject_Phenotypes.var_report.xml	0.0	58.5	7.778	53.0			58.5		phs002049.v1.p1	Acute Myeloid Leukemia
			2021/03/31				./data/phs001561.v1.pht010997.v1.p1.CCGO_Sample.var_report.xml									phs001561.v1.p1	Immunologic Deficiency Syndromes
			08/20/2013				./data/phs000285.v3.pht001758.v2.p2.E1F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/01/2016				./data/phs000744.v4.pht003980.v4.p2.Y_CMG_Sample_Attributes.var_report.xml									phs000744.v4.p2	Familial Idiopathic Pulmonary Fibrosis
			2019/10/15				./data/phs001910.v1.pht009537.v1.p1.PNETs_GEO.var_report.xml									phs001910.v1.p1	Neuroendocrine Tumors
			2017/10/10				./data/phs001372.v1.pht006535.v1.p1.CLL_Integrated_Single_Cell_Sample_Attributes.var_report.xml									phs001372.v1.p1	Leukemia, Lymphoid
	3.0		2021/01/08	4.0		1.0	./data/phs002309.v1.pht010838.v1.p1.Melanoma_Associated_Vitiligo_Subject.var_report.xml	0.0	2.0	1.414				2.0		phs002309.v1.p1	Melanoma
			04/06/2016				./data/phs001080.v1.pht005373.v1.p1.Hereditary_Spastic_Paraplegia_Sample_Attributes.var_report.xml									phs001080.v1.p1	Spastic Paraplegia, Hereditary
9.0	9.0		2021/01/06	13.0		4.0	./data/phs002252.v1.pht010670.v1.p1.RCC_Subject_Phenotypes.var_report.xml	0.0	6.5	3.536	4.0			6.5		phs002252.v1.p1	Carcinoma, Renal Cell
			2019/11/14				./data/phs001865.v1.pht009611.v1.p1.AAMP_Subject_Phenotypes.var_report.xml									phs001865.v1.p1	
928.0	927.0		2019/01/29	915.0		862.0	./data/phs001298.v1.pht008648.v1.p1.Psoriasis_European_Subject_Phenotypes.var_report.xml	0.0	899.7	777.7	927.0			920.0		phs001298.v1.p1	Psoriasis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000507.v2.p3.simphen108.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/05/15				./data/phs001311.v1.pht007931.v1.p1.mexelitine_ekg_form.var_report.xml									phs001311.v1.p1	Myotonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000589.v2.p3.simphen190.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
1664.0	2459.0		2021/08/24	2930.0		471.0	./data/phs002185.v1.pht010969.v1.p1.Recipient_Phenotype.var_report.xml	0.0	732.5	353.4	1266.0			648.5		phs002185.v1.p1	Graft vs Host Disease
360.0	399.0		2021/01/08	759.0		360.0	./data/phs000649.v2.pht003760.v2.p2.PEAR1.var_report.xml	0.0	379.5	27.58	399.0			379.5		phs000649.v2.p2	Hypertension
			01/13/2016				./data/phs000928.v1.pht004938.v1.p1.LGG_Probiotics_Transcriptome_Sample.var_report.xml									phs000928.v1.p1	Volunteers, Human
			2018/03/21				./data/phs001529.v1.pht007369.v1.p1.scRNASeq_RA_Microfluidic_Sample.var_report.xml									phs001529.v1.p1	Arthritis, Rheumatoid
			2019/06/14				./data/phs000589.v1.pht009195.v1.p1.patientglobalassessment.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2018/03/21				./data/phs001512.v1.pht007668.v1.p1.IR_Signatures_Sample_Attributes.var_report.xml									phs001512.v1.p1	Immune System Phenomena
			05/08/2017				./data/phs001320.v1.pht006290.v1.p1.Placentation_Pregnancy_CVS_Subject_Phenotypes.var_report.xml									phs001320.v1.p1	Pre-eclampsia
			2020/01/23				./data/phs000287.v7.pht001485.v1.p1.YR16PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			04/10/2014				./data/phs000340.v3.pht002210.v2.p1.ETP_T_ALL_Sample_Attributes.var_report.xml									phs000340.v3.p1	Leukemia, T-cell
			04/01/2010				./data/phs000089.v3.pht000801.v2.p2.ParkinsonsDisease_Subject.var_report_2010_04_01.xml									phs000089.v3.p2	Parkinson Disease
			2018/10/02				./data/phs001702.v1.pht008425.v1.p1.Lupus_eQTL_Subject.var_report.xml									phs001702.v1.p1	Lupus Erythematosus, Systemic
169.0	169.0		2019/08/07	261.0		92.0	./data/phs001823.v1.pht009058.v1.p1.Lung_Cancer_Cell_Lines_Subject_Phenotypes.var_report.xml	18.0	130.5	54.45	92.0			130.5		phs001823.v1.p1	Carcinoma, Non-Small-Cell Lung
398.0	445.0		08/08/2011	843.0		398.0	./data/phs000353.v1.pht002257.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_116.var_report.xml	0.0	421.5	33.23	445.0			421.5		phs000353.v1.p1	Premature Birth
			07/16/2015				./data/phs000153.v9.pht000836.v8.p8.vr_sntwk_2008_m_0641s.var_report.xml									phs000153.v9.p8	Social Behavior
			06/12/2017				./data/phs001371.v1.pht006546.v1.p1.TNF_RA_FLS_Sample_Attributes.var_report.xml									phs001371.v1.p1	Arthritis, Rheumatoid
			2017/09/18				./data/phs001310.v1.pht006873.v1.p1.spirometry.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			10/18/2012				./data/phs000547.v1.pht003008.v1.p1.GARNET_SUCCESS_Sample_Attributes.var_report.xml									phs000547.v1.p1	Breast Neoplasms
			06/13/2016				./data/phs000205.v6.pht001429.v6.p2.ISCA_Subject.var_report.xml									phs000205.v6.p2	Developmental Disabilities
			04/15/2014				./data/phs000719.v1.pht003738.v1.p1.PNTM_Sample_Attributes.var_report.xml									phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
673.0	694.0		2020/03/09	437.0		673.0	./data/phs001299.v2.pht007620.v1.p1.Nicotine_Addiction_Pedigree.var_report.xml	0.0	683.5	48.08	694.0			683.5		phs001299.v2.p1	Behavior, Addictive
			06/16/2017				./data/phs001278.v1.pht006281.v1.p1.promis_assessment_pediatric.var_report.xml									phs001278.v1.p1	Porphyrias
			05/13/2015				./data/phs000769.v1.pht004005.v1.p1.LHMP_Subject_Phenotypes.var_report.xml									phs000769.v1.p1	HIV
			2018/03/06				./data/phs000603.v1.pht007553.v1.p1.treatmenthistoryform.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			12/19/2011				./data/phs000387.v1.pht002443.v1.p1.eMERGE_GeM_AAA_Sample.var_report.xml									phs000387.v1.p1	Abdominal Aortic Aneurysms
			2020/01/23				./data/phs000287.v7.pht001476.v1.p1.YR12ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			04/10/2014				./data/phs000306.v4.pht002480.v1.p1.MEC_Prostate_Cancer_Sample_Attribute.var_report.xml									phs000306.v4.p1	Prostatic Neoplasms
			2018/01/11				./data/phs001421.v1.pht007025.v1.p1.Uveal_Melanoma_Pathogenesis_Subject.var_report.xml									phs001421.v1.p1	Uveal melanoma
			2018/05/03				./data/phs000304.v3.pht001904.v1.p1.GABC_Subject.var_report.xml									phs000304.v3.p1	von Willebrand Disease
			2018/02/20				./data/phs001528.v1.pht007360.v1.p1.SCCOHT_Subject.var_report.xml									phs001528.v1.p1	Ovarian Neoplasms
			2020/03/04				./data/phs000876.v2.pht005184.v2.p1.TRICL_Subject.var_report.xml									phs000876.v2.p1	Lung Neoplasms
			11/30/2015				./data/phs001007.v1.pht005066.v1.p1.HNSCC_Metastasis_Recurrence_Subject.var_report.xml									phs001007.v1.p1	Carcinoma, squamous cell of head and neck
	1.0		03/22/2017	1.0		1.0	./data/phs001181.v1.pht005771.v1.p1.CLL_Multiple_Cell_Clones_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs001181.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			10/17/2011				./data/phs000265.v3.pht001273.v3.p1.HMP_Pediatric_Abdominal_Pain_IBD_Sample.var_report.xml									phs000265.v3.p1	Irritable Bowel Syndrome
			2021/05/07				./data/phs001327.v2.pht011191.v1.p1.schronicconditionsumm.var_report.xml									phs001327.v2.p1	Neoplasm
			11/18/2016				./data/phs001224.v1.pht005938.v1.p1.Platinum_Genomes_Subject.var_report.xml									phs001224.v1.p1	Computational Biology
			08/20/2013				./data/phs000285.v3.pht001669.v2.p2.C1F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000350.v1.p1.EDIC_f0934.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/06/05				./data/phs001835.v1.pht009143.v1.p1.Ocular_Melanocytosis_UM_Sample_Attributes.var_report.xml									phs001835.v1.p1	Uveal melanoma
			07/09/2013				./data/phs000546.v1.pht003144.v1.p1.ESP_ISGS_Sample_Attributes.var_report.xml									phs000546.v1.p1	Stroke
			08/20/2013				./data/phs000285.v3.pht001715.v2.p2.D1F08A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
44.0	44.0		06/01/2015	57.0		7.0	./data/phs000901.v1.pht004674.v1.p1.Parkinson_CSF_Biomarker_Subject_Phenotypes.var_report.xml	0.0	28.5	9.192	7.0			28.5		phs000901.v1.p1	Parkinson Disease
			2020/07/17				./data/phs000480.v1.pht002906.v1.p1.FBCS_Sample.var_report.xml									phs000480.v1.p1	Breast Neoplasms
			2018/05/15				./data/phs001311.v1.pht007936.v1.p1.adverse_event.var_report.xml									phs001311.v1.p1	Myotonia
			08/11/2011				./data/phs000365.v1.pht002264.v1.p1.XMEN_Disease_Subject.var_report.xml									phs000365.v1.p1	Immune System Diseases
			01/19/2010				./data/phs000219.v1.pht001067.v1.p1.d_csa03.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			10/22/2013				./data/phs000664.v1.pht003545.v1.p1.Genomic_Variations_Multi_Ethnic_Malaysia_Sample_Attributes.var_report.xml									phs000664.v1.p1	Population Groups
			10/05/2015				./data/phs000969.v1.pht004928.v1.p1.Sensorineural_Hearing_Loss_Subject.var_report.xml									phs000969.v1.p1	Bilateral deafness
			2020/06/18				./data/phs000280.v7.pht004035.v2.p1.ANTD05.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000983.v4.p3.bmdhip_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/09/18				./data/phs001133.v1.pht007496.v1.p1.FOCI_Sample.var_report.xml									phs001133.v1.p1	Ovarian Neoplasms
			08/20/2013				./data/phs000285.v3.pht001635.v2.p2.B2F30.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			01/27/2017				./data/phs000428.v2.pht002613.v2.p2.HRS_Sample.var_report.xml									phs000428.v2.p2	Aging
			2018/10/19				./data/phs000492.v3.pht002708.v3.p2.Developmental_Brain_Disorders_Sample.var_report.xml									phs000492.v3.p2	Microcephaly
			10/25/2010				./data/phs000021.v3.pht002002.v1.p2.GAIN_Schizophrenia_Sample.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
64.0	64.0		05/23/2012	93.0		29.0	./data/phs000409.v1.pht002737.v1.p1.WGS_Medulloblastoma_Subject_Phenotype.var_report.xml	0.0	46.5	24.75	29.0			46.5		phs000409.v1.p1	Medulloblastoma
8.0	8.0		02/09/2017	9.0		7.0	./data/phs001082.v1.pht005380.v1.p1.VZV_TCell_Pedigree.var_report.xml	0.0	7.5	0.7071	7.0			7.5		phs001082.v1.p1	Herpes Zoster
			08/20/2013				./data/phs000285.v3.pht001872.v1.p2.Z33A06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001692.v2.p2.C1FIBR.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/11/30				./data/phs002295.v1.pht010687.v1.p1.CIMAC_CIDC_NSCLC_Sample.var_report.xml									phs002295.v1.p1	Carcinoma, Non-Small-Cell Lung
3771.0	3771.0		05/11/2016	5890.0		541.0	./data/phs000963.v1.pht004858.v1.p1.Statins_CV_Subject_Phenotypes.var_report.xml	0.0	859.0	718.4	541.0			859.0		phs000963.v1.p1	Myocardial Revascularization
			2020/04/24				./data/phs001676.v1.pht009439.v1.p1.CCDG_Autism_SSC_Sample_Attributes.var_report.xml									phs001676.v1.p1	Autism Spectrum Disorder
			11/05/2014				./data/phs000209.v13.pht002515.v1.p3.MESA_AncilMesaFetuinA.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001510.v2.p3.outc_fracture_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/11/15				./data/phs000784.v3.pht004287.v1.p1.GenSalt_Sample_Attributes.var_report.xml									phs000784.v3.p1	Arterial Pressure, Mean
			2020/07/17				./data/phs001995.v1.pht009991.v1.p1.Himba_Subject.var_report.xml									phs001995.v1.p1	Sex
532.0	532.0		02/13/2015	931.0		834.0	./data/phs000867.v1.pht004483.v1.p1.FUSION_Cohort_Subject_Phenotypes.var_report.xml	0.0	925.0	26.16	834.0			925.0		phs000867.v1.p1	Diabetes Mellitus, Type 2
			2021/02/05				./data/phs002319.v1.pht010926.v1.p1.INVEST_Sample_Attributes.var_report.xml									phs002319.v1.p1	Heart Disease
985.0	94.0		07/27/2012	94.0		985.0	./data/phs000297.v1.pht002393.v1.p1.Resistant_HTN_Subject_Phenotypes.var_report.xml	0.0	75.0	889.1	94.0			75.0		phs000297.v1.p1	Hypertension
			2019/03/22				./data/phs001597.v1.pht008124.v1.p1.Bevacizumab_Hypertension_Subject.var_report.xml									phs001597.v1.p1	Hypertension
			2017/09/11				./data/phs000472.v2.pht002595.v2.p1.BRC77_Subject_Phenotypes.var_report.xml									phs000472.v2.p1	Breast Neoplasms
			2020/03/19				./data/phs001982.v1.pht010005.v1.p1.MFS_UPS_GEO.var_report.xml									phs001982.v1.p1	Sarcoma, Soft Tissue
			07/21/2010				./data/phs000239.v2.pht001219.v1.p1.MS_MZTwins_Subject.var_report_2010_07_21.xml									phs000239.v2.p1	Multiple Sclerosis
			2021/06/08				./data/phs001218.v3.pht005960.v1.p1.TOPMed_WGS_GeneSTAR_Sample_Attributes.var_report.xml									phs001218.v3.p1	Platelet Aggregation
			2018/02/08				./data/phs001488.v1.pht007403.v1.p1.labdose.var_report.xml									phs001488.v1.p1	Huntington Disease
2.0	2.0		2021/03/17	3.0		1.0	./data/phs002364.v1.pht011040.v1.p1.HIV_cART_Subject.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs002364.v1.p1	HIV
			11/25/2013				./data/phs000661.v1.pht003539.v1.p1.Aggressive_Prostate_Carcinoma_Sample.var_report.xml									phs000661.v1.p1	Neoplasms
			2020/06/18				./data/phs000280.v7.pht006486.v1.p1.UC7155LITE.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
72.0	101.0		02/25/2016	173.0		72.0	./data/phs001014.v1.pht005114.v1.p1.IRAS_Classic_Subject_Phenotypes.var_report.xml	0.0	86.5	20.51	101.0			86.5		phs001014.v1.p1	Insulin Resistance
			2020/12/21				./data/phs000007.v32.pht000903.v4.p13.ctaopulm1_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
	56.0		2019/12/19	56.0		56.0	./data/phs001937.v1.pht009710.v1.p1.PEPP3_Subject_Phenotypes.var_report.xml	0.0	56.0	1.414	56.0			56.0		phs001937.v1.p1	Pre-Eclampsia
			2019/10/08				./data/phs000224.v3.pht002180.v3.p2.VitGene_Vitiligo_Subject.var_report.xml									phs000224.v3.p2	Vitiligo
			2020/01/23				./data/phs000287.v7.pht005388.v1.p1.nsrr_chs_id_link2.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht001043.v7.p13.il63_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/07				./data/phs001340.v1.pht009157.v1.p1.RA_Sample_Attributes.var_report.xml									phs001340.v1.p1	Arthritis, Rheumatoid
	16.0		2021/05/21	16.0		16.0	./data/phs002411.v1.pht011239.v1.p1.BRCA1_BRCA2_Subject.var_report.xml	0.0	16.0		16.0			16.0		phs002411.v1.p1	Breast
			2020/12/21				./data/phs000007.v32.pht002429.v1.p13.t_pwaved_1975_m_0644s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/21/2016				./data/phs001151.v1.pht005541.v1.p1.Retina_RPE_Choroid_Sample_Attributes.var_report.xml									phs001151.v1.p1	
			2021/08/03				./data/phs001591.v1.pht009695.v1.p1.CIDR_COHRA_Sample_Attributes.var_report.xml									phs001591.v1.p1	Dental Caries
			10/27/2014				./data/phs000628.v1.pht003505.v1.p1.Metastatic_Cervical_Carcinoma_Sample.var_report.xml									phs000628.v1.p1	Uterine Cervical Neoplasms
			06/05/2017				./data/phs001265.v1.pht006341.v1.p1.OncoArray_DRIVE_Sample_Attributes.var_report.xml									phs001265.v1.p1	Breast Neoplasms
			2020/01/23				./data/phs000287.v7.pht001478.v1.p1.YR13ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			08/26/2015				./data/phs000948.v1.pht004851.v1.p1.eMERGE_PhaseII_Sample_Attributes.var_report.xml									phs000948.v1.p1	
			11/18/2014				./data/phs000825.v1.pht004350.v1.p1.HUES64_HUES63_Sequencing_Subject.var_report.xml									phs000825.v1.p1	Growth and Development
			10/18/2016				./data/phs000669.v1.pht003731.v1.p1.AMBER_Sample.var_report.xml									phs000669.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht000688.v8.p13.insulin3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/01/04				./data/phs000755.v2.pht004993.v1.p1.BrainSpan_Atlas_Project_Subject_Phenotypes.var_report.xml									phs000755.v2.p1	Brain Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000477.v2.p3.simphen078.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			09/29/2014				./data/phs000797.v1.pht004270.v1.p1.CTLA4_Haploinsufficiency_Sample_Attributes.var_report.xml									phs000797.v1.p1	Autoimmune enteropathy
7.0	7.0		2018/06/26	2.0		4.0	./data/phs001526.v1.pht007613.v1.p1.DIPG_Subject_Phenotypes.var_report.xml	0.0	5.5	2.121	5.0			5.5		phs001526.v1.p1	Glioma
			2020/09/29				./data/phs002225.v1.pht010485.v1.p1.HTAN_MCL_PCAPP_Breast_CA_Sample_Attributes.var_report.xml									phs002225.v1.p1	Carcinoma, Intraductal, Noninfiltrating
			07/25/2014				./data/phs000622.v1.pht003956.v1.p1.FaceBase_Orofacial_Shape_Africans_Sample_Attributes.var_report.xml									phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
11.0	11.0		08/08/2011	20.0		9.0	./data/phs000353.v1.pht002252.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_111.var_report.xml	0.0	10.0	1.414	9.0			10.0		phs000353.v1.p1	Premature Birth
			2018/01/18				./data/phs000382.v3.pht002322.v3.p1.CIDR_Joubert_Syndrome_Sample.var_report.xml									phs000382.v3.p1	Joubert syndrome 1
			2020/12/21				./data/phs000007.v32.pht004807.v3.p13.l_pthvitd_ex09_1b_0382s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/08				./data/phs001759.v1.pht008710.v1.p1.SAH_Sample_Attributes.var_report.xml									phs001759.v1.p1	Circulating MicroRNA
			11/08/2013				./data/phs000200.v9.pht002754.v2.p3.f44_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/08/01				./data/phs001786.v1.pht008836.v1.p1.SU2C_GEMM_Subject.var_report.xml									phs001786.v1.p1	Melanoma
			2018/02/27				./data/phs001447.v1.pht007469.v1.p1.MCRPCS_Sample.var_report.xml									phs001447.v1.p1	Prostatic Neoplasms
			06/22/2016				./data/phs001146.v1.pht005544.v1.p1.Endometrial_Cells_eQTL_Sample.var_report.xml									phs001146.v1.p1	Fertility
			2019/05/31				./data/phs001296.v2.pht006357.v2.p1.eligibility.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			2020/06/18				./data/phs000280.v7.pht004181.v2.p1.RTASWM24.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
8.0			2017/12/08	107.0			./data/phs001279.v1.pht007218.v1.p1.relative_questionnaire.var_report.xml	107.0			16.0					phs001279.v1.p1	Bronchiectasis
			11/22/2013				./data/phs000251.v2.pht001263.v2.p2.HMP_Cutaneous_Psoriasis_Sample_Attributes.var_report.xml									phs000251.v2.p2	Psoriasis
			07/05/2017				./data/phs000595.v1.pht006633.v1.p1.eligibility.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
57.0			2021/01/12	47.0			./data/phs001697.v1.pht010578.v1.p1.EAGLE_Never_Smokers_Subject_Phenotypes.var_report.xml	0.0			97.0					phs001697.v1.p1	Lung Neoplasms
			2021/09/14				./data/phs002545.v1.pht011485.v1.p1.MSS_CRC_PDAC_Sample.var_report.xml									phs002545.v1.p1	Immunotherapy
346.0	346.0		2018/03/20	678.0		332.0	./data/phs001498.v1.pht007323.v1.p1.INSIGHT_Microbiome_Pedigree.var_report.xml	0.0	339.0	9.899	332.0			339.0		phs001498.v1.p1	Pediatric Obesity
			2019/05/07				./data/phs001524.v1.pht008555.v1.p1.PC_Rare_Variation_Subject.var_report.xml									phs001524.v1.p1	Prostatic Neoplasms
			2021/04/08				./data/phs002344.v1.pht011120.v1.p1.PAX3_FOXO1_RMS_Subject.var_report.xml									phs002344.v1.p1	Rhabdomyosarcoma
			2018/01/18				./data/phs000819.v1.pht004378.v1.p1.Normal_Human_Tissue_Sequencing_Subject.var_report.xml									phs000819.v1.p1	
			2019/03/11				./data/phs000286.v6.pht008754.v1.p2.incevtchd.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/03/04				./data/phs001892.v1.pht009941.v1.p1.miRNA_Profiling_Sample.var_report.xml									phs001892.v1.p1	
			2019/06/28				./data/phs001851.v1.pht009224.v1.p1.LEAP_Sample_Attributes.var_report.xml									phs001851.v1.p1	Peanut Hypersensitivity
			12/11/2009				./data/phs000171.v1.pht000772.v1.p1.MS_DATA_MHQSELFDEM.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			11/25/2013				./data/phs000682.v1.pht003598.v1.p1.Neuropsychiatric_Neurodevelopmental_Disorders_Sample_Attributes.var_report.xml									phs000682.v1.p1	Psychiatry and Psychology Category
			2018/06/14				./data/phs001238.v2.pht006028.v2.p1.GENOA_Subject.var_report.xml									phs001238.v2.p1	Hypertension
			2018/05/31				./data/phs001316.v1.pht008006.v1.p1.eligibility_form.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			08/20/2013				./data/phs000285.v3.pht001556.v2.p2.A4ABTAPE.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/12/19				./data/phs001937.v1.pht009711.v1.p1.PEPP3_Sample_Attributes.var_report.xml									phs001937.v1.p1	Pre-Eclampsia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000494.v2.p3.simphen095.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/02/08				./data/phs001488.v1.pht007425.v1.p1.uhdr1.var_report.xml									phs001488.v1.p1	Huntington Disease
			2018/07/23				./data/phs001627.v1.pht008188.v1.p1.AML_scDNA_Sample.var_report.xml									phs001627.v1.p1	Leukemia, Myeloid, Acute
			2020/09/18				./data/phs002015.v1.pht010365.v1.p1.AREDS2_ARR.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2017/09/06				./data/phs000554.v1.pht003198.v1.p1.CRPC_Sample_Attributes.var_report.xml									phs000554.v1.p1	Prostatic Neoplasms
			05/24/2016				./data/phs001065.v1.pht005421.v1.p1.mhxhd.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/01/23				./data/phs000287.v7.pht001494.v1.p1.YR8.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
13.0			12/17/2012	26.0			./data/phs000567.v1.pht003080.v1.p1.Solitary_Fibrous_Tumor_Subject_Phenotypes.var_report.xml	0.0			13.0					phs000567.v1.p1	Solitary Fibrous Tumors
			11/25/2016				./data/phs000907.v1.pht004698.v1.p1.Lung_Cancer_Brain_Metastasis_Sample_Attributes.var_report.xml									phs000907.v1.p1	Squamous Cell Carcinoma
			2020/09/18				./data/phs002015.v1.pht010383.v1.p1.AREDS2_HAD.var_report.xml									phs002015.v1.p1	Macular Degeneration
	58.0		2021/06/02	58.0		58.0	./data/phs002419.v1.pht011262.v1.p1.BC_Subject.var_report.xml	0.0	58.0		58.0			58.0		phs002419.v1.p1	Breast Neoplasms
			2019/05/07				./data/phs001719.v1.pht008918.v1.p1.Prediabetes_Sample.var_report.xml									phs001719.v1.p1	Prediabetic State
			11/27/2009				./data/phs000016.v2.pht000053.v2.p2.SDQParent.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			08/20/2013				./data/phs000285.v3.pht001815.v2.p2.F1F09OVA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/12/07				./data/phs001312.v1.pht007199.v1.p1.POAAGG_Subject.var_report.xml									phs001312.v1.p1	Glaucoma, Open-Angle
			01/19/2010				./data/phs000219.v1.pht001070.v1.p1.d_csa05_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2019/08/01				./data/phs000222.v6.pht007354.v1.p2.ROIs_for_sMR_and_diffusion_scalars.var_report.xml									phs000222.v6.p2	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001572.v2.p2.A4F09TOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/16/2016				./data/phs000935.v1.pht004818.v1.p1.CSER_PediSeq_Subject_Phenotypes.var_report.xml									phs000935.v1.p1	Genetic Testing
			2017/10/19				./data/phs001288.v1.pht006779.v1.p1.physical_exam.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2021/04/28				./data/phs002408.v1.pht011162.v1.p1.CTCF_11p15_Sample_Attributes.var_report.xml									phs002408.v1.p1	Beckwith-Wiedemann Syndrome
			09/10/2014				./data/phs000798.v1.pht004024.v1.p1.Genetic_Diagnostic_Testing_Subject.var_report.xml									phs000798.v1.p1	Genetic Testing
			08/05/2016				./data/phs000360.v3.pht003251.v2.p1.MergedSet_Subject.var_report.xml									phs000360.v3.p1	Electronic Health Records
			2018/06/01				./data/phs001538.v1.pht008097.v1.p1.Registry_Dx.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			2020/06/18				./data/phs000280.v7.pht006413.v1.p1.AAT.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/03/28				./data/phs001680.v1.pht008916.v1.p1.T_Cell_States_Melanoma_Sample_Attributes.var_report.xml									phs001680.v1.p1	Immunotherapy
			2018/12/11				./data/phs001750.v1.pht008586.v1.p1.sc_Pulmonary_Fibrosis_Subject.var_report.xml									phs001750.v1.p1	Pulmonary Fibrosis
653.0			2021/07/15	1271.0			./data/phs001600.v2.pht011019.v2.p2.TOPMed_CCDG_CATHGEN_Subject.var_report.xml	0.0			618.0					phs001600.v2.p2	Atrial Fibrillation
			2020/01/23				./data/phs000287.v7.pht001480.v1.p1.YR14ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
238.0	238.0		2018/06/07	456.0		83.0	./data/phs001481.v1.pht008131.v1.p1.IBMFS_Subject_Phenotypes.var_report.xml	0.0	97.0	5.657	83.0			97.0		phs001481.v1.p1	Bone Marrow Failure Syndromes
			2018/05/03				./data/phs001264.v1.pht007899.v1.p1.CD47_Breast_Cancer_Subject.var_report.xml									phs001264.v1.p1	Breast Neoplasms
			06/23/2015				./data/phs000648.v1.pht004580.v1.p1.Pancreatic_Cancer_Sample_Attributes.var_report.xml									phs000648.v1.p1	Pancreatic Neoplasms
			04/16/2012				./data/phs000477.v1.pht002686.v1.p1.Familial_Renal_Disorders_Sample.var_report.xml									phs000477.v1.p1	Hypophosphatemia, Familial
			08/26/2013				./data/phs000362.v1.pht003227.v1.p1.ESP_FamilialAtrialFibrillation_Subject.var_report.xml									phs000362.v1.p1	Atrial Fibrillation
			01/19/2010				./data/phs000219.v1.pht001076.v1.p1.d_csa10.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/06/18				./data/phs000280.v7.pht004236.v2.p1.VENB02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/19				./data/phs000357.v2.pht002329.v2.p1.Systemic_Sclerosis_Subject.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
6.0	6.0		2019/06/13	71.0		5.0	./data/phs001611.v1.pht009160.v1.p1.Organoid_Profiling_PC_Subject_Phenotypes.var_report.xml	0.0	5.5	20.26	5.0			5.5		phs001611.v1.p1	Neoplasms
			2019/02/22				./data/phs001739.v1.pht008795.v1.p1.sPTB_Subject_Phenotypes.var_report.xml									phs001739.v1.p1	Premature Birth
			2020/12/21				./data/phs000007.v32.pht000161.v8.p13.il61_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/18/2016				./data/phs001085.v1.pht005645.v1.p1.Melanesian_Individuals_Subject.var_report.xml									phs001085.v1.p1	
			11/05/2012				./data/phs000561.v1.pht003033.v1.p1.Hypobetalipoproteinemia_Subject.var_report.xml									phs000561.v1.p1	Hypobetalipoproteinemias
24.0	29.0		2021/04/19	53.0		24.0	./data/phs002394.v1.pht011133.v1.p1.PDAC_Subject_Phenotypes.var_report.xml	0.0	26.5	3.536	29.0			26.5		phs002394.v1.p1	pancreatic cancer
			04/15/2014				./data/phs000508.v2.pht002812.v1.p1.Pediatric_Rhabdoid_Cancers_Sample_Attributes.var_report.xml									phs000508.v2.p1	Rhabdoid Tumor
			2020/09/29				./data/phs002225.v1.pht010483.v1.p1.HTAN_MCL_PCAPP_Breast_CA_Sample.var_report.xml									phs002225.v1.p1	Carcinoma, Intraductal, Noninfiltrating
1.0	1.0		2019/05/24	1.0		1.0	./data/phs001830.v1.pht009118.v1.p1.FGFR2_CCA_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs001830.v1.p1	Cholangiocarcinoma
			2018/06/18				./data/phs001594.v1.pht008145.v1.p1.Mucosal_Melanomas_Sample.var_report.xml									phs001594.v1.p1	Melanoma
			01/19/2010				./data/phs000219.v1.pht001064.v1.p1.d_csa01.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			Wed Jan 21 13:20:50 2009				./data/phs000144.v1.pht000726.v1.p1.TSP_ClinPathQA_Data_TumorSamplePheno.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
			2018/08/03				./data/phs000590.v1.pht008265.v1.p1.angiogram_pulmonary.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2020/01/31				./data/phs001940.v2.pht009696.v1.p1.Immune_Checkpoint_NSCLC_Subject.var_report.xml									phs001940.v2.p1	Carcinoma, Non-Small-Cell Lung
			06/12/2017				./data/phs001275.v1.pht006543.v1.p1.Cryptorchid_Testes_Sample_Attributes.var_report.xml									phs001275.v1.p1	Cryptorchidism
			08/09/2013				./data/phs000367.v1.pht003264.v1.p1.IBDGC_Familial_Crohns_Disease_Sample_Attributes.var_report.xml									phs000367.v1.p1	Crohn Disease
			11/08/2013				./data/phs000200.v9.pht002125.v3.p3.f60_nutr_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			12/17/2013				./data/phs000662.v1.pht003559.v1.p1.NCS_AIM_Sample.var_report.xml									phs000662.v1.p1	Population Groups
			2019/01/29				./data/phs001765.v1.pht008663.v1.p1.Parathyroid_Cancer_Subject.var_report.xml									phs001765.v1.p1	Parathyroid Neoplasms
			09/11/2014				./data/phs000790.v1.pht004018.v1.p1.Colorectal_Cancer_Lesions_Sample.var_report.xml									phs000790.v1.p1	Colorectal Neoplasms
			11/04/2014				./data/phs000086.v3.pht000218.v1.p1.DCCT_f045cmb2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			06/12/2017				./data/phs000594.v1.pht006506.v1.p1.HLATyping.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
	732.0		05/05/2015	732.0		732.0	./data/phs000517.v3.pht002915.v2.p1.Multiethnic_Cohort_Study_Subject_Phenotypes.var_report.xml	0.0	732.0		732.0			732.0		phs000517.v3.p1	Breast Neoplasms
			2019/08/01				./data/phs000222.v6.pht002877.v3.p2.Psychiatric_P.var_report.xml									phs000222.v6.p2	Huntington Disease
			03/22/2017				./data/phs001181.v1.pht005772.v1.p1.CLL_Multiple_Cell_Clones_Sample_Attributes.var_report.xml									phs001181.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			04/22/2014				./data/phs000740.v1.pht003818.v1.p1.Waldenstroms_Macroglobulinemia_Sample_Attributes.var_report.xml									phs000740.v1.p1	Waldenstrom Macroglobulinemia
			11/27/2013				./data/phs000504.v2.pht002823.v2.p2.Medulloblastoma_Sample_Attributes.var_report.xml									phs000504.v2.p2	Medulloblastoma
			2020/12/21				./data/phs000007.v32.pht010730.v1.p13.l_telomere_2005_m_1161s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/03/24				./data/phs001641.v1.pht010030.v1.p1.CompletedProcedures.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			05/02/2017				./data/phs001358.v1.pht006337.v1.p1.RareBliss_Sample_Attributes.var_report.xml									phs001358.v1.p1	Bipolar Disorder
			01/02/2013				./data/phs000568.v1.pht003110.v1.p1.Solitary_Fibrous_Tumors_SIGMA_Subject.var_report.xml									phs000568.v1.p1	Sarcoma
			2017/11/13				./data/phs001013.v3.pht005310.v2.p2.HVH_Sample.var_report.xml									phs001013.v3.p2	Cardiovascular Disease
			2020/08/05				./data/phs002052.v1.pht010319.v1.p1.mtDNA_Deletion_POLG_Sample.var_report.xml									phs002052.v1.p1	Mitochondrial Diseases
			10/27/2014				./data/phs000727.v1.pht003865.v1.p1.Alzheimers_Parkinsons_Extracellular_miRNA_Sample_Attributes.var_report.xml									phs000727.v1.p1	Alzheimer Disease
			2020/09/18				./data/phs002015.v1.pht010397.v1.p1.AREDS2_VUF.var_report.xml									phs002015.v1.p1	Macular Degeneration
48.0			06/01/2017	91.0			./data/phs000701.v1.pht005517.v1.p1.InitialEvaluation.var_report.xml	0.0			43.0					phs000701.v1.p1	Angelman Syndrome
			2021/08/27				./data/phs000966.v2.pht011075.v1.p2.Essential_Tremor_Baylor_Subject_Phenotypes.var_report.xml									phs000966.v2.p2	Essential Tremor
			08/19/2016				./data/phs001192.v1.pht005691.v1.p1.Thoracic_PDX_Sample.var_report.xml									phs001192.v1.p1	Lung Neoplasms
			07/12/2017				./data/phs000592.v1.pht006598.v1.p1.registration.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2021/10/06				./data/phs002276.v1.pht011555.v1.p1.GMKF_T_ALL_Sample.var_report.xml									phs002276.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			2020/10/16				./data/phs002245.v1.pht010530.v1.p1.COVID19_Sample.var_report.xml									phs002245.v1.p1	COVID-19
546.0	651.0		08/09/2016	2226.0		526.0	./data/phs001097.v1.pht005616.v1.p1.T2D_GENES_Singapore_Asian_Subject_Phenotypes.var_report.xml	0.0	588.5	88.39	651.0			588.5		phs001097.v1.p1	Diabetes Mellitus, Type 2
			2018/08/02				./data/phs001487.v1.pht007139.v1.p1.CCDG_TAICHI_Sample_Attributes.var_report.xml									phs001487.v1.p1	
			11/08/2013				./data/phs000200.v9.pht001503.v2.p3.outc_bc_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			11/08/2012				./data/phs000540.v1.pht003047.v1.p1.Ehlers_Danlos_Syndrome_Type_VIII_Sample_Attributes.var_report.xml									phs000540.v1.p1	Ehlers-Danlos Syndrome
33.0	125.0		2020/12/15	158.0		33.0	./data/phs001404.v1.pht010788.v1.p1.GBC_Subject_Phenotypes.var_report.xml	0.0	79.0	65.05	125.0			79.0		phs001404.v1.p1	Gallbladder Cancer
			2017/10/02				./data/phs000962.v1.pht006966.v1.p1.CIDR_Brain_Growth_Children_Sample.var_report.xml									phs000962.v1.p1	Cerebral Cortex
			2018/05/31				./data/phs001318.v1.pht008028.v1.p1.eligibility.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			05/08/2017				./data/phs000871.v1.pht004569.v1.p1.Pancreatic_Neuroendocrine_Tumors_Sample.var_report.xml									phs000871.v1.p1	Carcinoma, Neuroendocrine
			2020/04/03	20.0			./data/phs001916.v2.pht009723.v1.p1.PBMCs_Aging_Subject_Phenotypes.var_report.xml	0.0			20.0					phs001916.v2.p1	Healthy Aging
522.0	629.0		09/03/2009	581.0		384.0	./data/phs000166.v2.pht000702.v2.p1.CARE_CData.var_report_2009_09_03.xml	0.0	506.5	85.56	312.0			506.5		phs000166.v2.p1	Asthma
			08/12/2016				./data/phs000888.v1.pht005578.v1.p1.emerge2_appendicitis_med.var_report.xml									phs000888.v1.p1	
			2017/12/12				./data/phs000676.v2.pht003586.v2.p2.Breast_Tissues_Sequence_Analysis_Subject.var_report.xml									phs000676.v2.p2	Breast Neoplasms
37.0	37.0		2021/05/24	71.0		34.0	./data/phs002323.v1.pht010879.v1.p1.Pediatric_Immunotherapy_Subject.var_report.xml	0.0	35.5	2.121	34.0			35.5		phs002323.v1.p1	Immunotherapy
			2020/03/24				./data/phs001641.v1.pht010039.v1.p1.Visits.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2020/12/10				./data/phs002299.v1.pht010774.v1.p1.PETAL_ORCHID_Sample.var_report.xml									phs002299.v1.p1	COVID-19
			06/04/2014				./data/phs000660.v1.pht003508.v1.p1.Chinese_AHC_Subject.var_report.xml									phs000660.v1.p1	Alternating hemiplegia of childhood
			03/22/2017				./data/phs000925.v1.pht005176.v1.p1.PAGE_IPM_BioMe_Biobank_Subject.var_report.xml									phs000925.v1.p1	Cardiovascular Diseases
2788.0			2018/04/05	5196.0			./data/phs001196.v1.pht007727.v1.p1.Schizophrenia_Trios_Taiwanese_Subject_Phenotypes.var_report.xml	0.0			791.0					phs001196.v1.p1	Schizophrenia
			2018/10/02				./data/phs001519.v1.pht008436.v1.p1.Neoantigen_Cancer_Vaccine_GBM_Sample_Attributes.var_report.xml									phs001519.v1.p1	Glioblastoma
			2019/02/21				./data/phs001281.v2.pht006125.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
72.0	85.0		07/09/2015	276.0		72.0	./data/phs000564.v2.pht003057.v2.p1.WGS_NICU_Pedigree.var_report.xml	0.0	78.5	9.192	85.0			78.5		phs000564.v2.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2020/08/24				./data/phs001501.v1.pht007227.v1.p1.Race_Genetics_BetaBlocker_Subject_Phenotypes.var_report.xml									phs001501.v1.p1	Heart Failure
			2020/03/02				./data/phs001870.v1.pht009917.v1.p1.BC_Chinese_Sample.var_report.xml									phs001870.v1.p1	Breast Neoplasms
94.0	9104.0		2020/09/03	922.0		94.0	./data/phs001903.v1.pht009894.v1.p1.OncoArray_CRC_Subject_Phenotypes.var_report.xml	0.0	95.5	94.05	87.0			95.5		phs001903.v1.p1	Colorectal Neoplasms
			11/15/2013				./data/phs000238.v1.pht002006.v1.p1.NEIGHBOR_Glaucoma_Subject.var_report.xml									phs000238.v1.p1	Glaucoma
			2019/06/14				./data/phs000589.v1.pht009171.v1.p1.adverse_event.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2021/07/21				./data/phs002366.v1.pht011346.v1.p1.LC_Asian_Sample_Attributes.var_report.xml									phs002366.v1.p1	Lung Neoplasms
			2021/10/06				./data/phs000218.v24.pht000918.v24.p8.TARGET_Sample.var_report.xml									phs000218.v24.p8	Neoplasms
			2019/10/17				./data/phs001511.v1.pht007293.v1.p1.SEARCH_ProDIGY_Sample.var_report.xml									phs001511.v1.p1	Diabetes Mellitus, Type 2
			03/06/2017				./data/phs000574.v1.pht005872.v1.p1.motorbehavioralassessment.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2019/07/03				./data/phs001850.v1.pht009235.v1.p1.Subtype_SLE_Subject.var_report.xml									phs001850.v1.p1	Lupus Erythematosus, Systemic
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000498.v2.p3.simphen099.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/28/2014				./data/phs000350.v1.pht002200.v1.p1.FHCRC_Prostate_Cancer_Pedigree.var_report.xml									phs000350.v1.p1	Prostatic Neoplasms
			2017/12/04				./data/phs001419.v1.pht007086.v1.p1.concomitant_meds.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2017/12/13				./data/phs001053.v1.pht007231.v1.p1.XFS_Glaucoma_Sample.var_report.xml									phs001053.v1.p1	Glaucoma
761.0	5834.0		11/04/2014	11167.0		5333.0	./data/phs000086.v3.pht000240.v1.p1.DCCT_f0351.var_report.xml	0.0	5584.0	354.3	680.0			5584.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			09/10/2013				./data/phs000601.v1.pht003516.v1.p1.Heritable_Breast_Cancer_Sample_Attributes.var_report.xml									phs000601.v1.p1	Breast Neoplasms
			2020/10/01				./data/phs001881.v1.pht010565.v1.p1.CNV_NDD_Sample_Attributes.var_report.xml									phs001881.v1.p1	Autism Spectrum Disorder
1568.0	2670.0		05/16/2017	4357.0		1687.0	./data/phs001252.v1.pht006404.v1.p1.vdlgctql.var_report.xml	0.0	2179.0	695.1	1028.0			2179.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			05/09/2016				./data/phs001023.v1.pht005462.v1.p1.Male_Infertility_Subject.var_report.xml									phs001023.v1.p1	Azoospermia
			2019/04/23				./data/phs001259.v1.pht006089.v1.p1.VIRGO_AMI_Subject_Phenotypes.var_report.xml									phs001259.v1.p1	Myocardial Infarction
			11/05/2014				./data/phs000209.v13.pht001528.v1.p3.MESA_AirNRIMT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			12/16/2013				./data/phs000633.v1.pht003623.v1.p1.Lung_Microbiome_Inflammation_Subject.var_report.xml									phs000633.v1.p1	Pneumonia
			08/20/2013				./data/phs000285.v3.pht001835.v2.p2.F1F63.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
89.0	875.0		2019/01/10	964.0		89.0	./data/phs001609.v1.pht008141.v1.p1.Lupus_Nephritis_Subject_Phenotypes.var_report.xml	0.0	7.5	8.485	875.0			7.5		phs001609.v1.p1	Lupus Erythematosus, Systemic
7.0	10.0		2018/03/21	17.0		7.0	./data/phs001512.v1.pht007667.v1.p1.IR_Signatures_Subject_Phenotypes.var_report.xml	0.0	8.5	2.121	10.0			8.5		phs001512.v1.p1	Immune System Phenomena
			06/01/2017				./data/phs000701.v1.pht005511.v1.p1.DevelopmentalDataSheet.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/12/21				./data/phs000007.v32.pht000151.v8.p13.eisoform1_4s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/26				./data/phs001630.v1.pht008170.v1.p1.Measles_Immunity_Subject.var_report.xml									phs001630.v1.p1	Measles Vaccine
			07/05/2017				./data/phs000595.v1.pht006638.v1.p1.nasal_nitric_oxide.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			08/29/2016				./data/phs000770.v1.pht003925.v1.p1.HER2_Breast_Cancer_Subject.var_report.xml									phs000770.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001826.v2.p2.F1F51.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/04/04				./data/phs001742.v2.pht008553.v2.p1.Metastasis_TNBC_Sample.var_report.xml									phs001742.v2.p1	Triple Negative Breast Neoplasms
			2021/07/15				./data/phs001547.v2.pht009988.v1.p1.TOPMed_CCDG_GENAF_Sample.var_report.xml									phs001547.v2.p1	Atrial Fibrillation
			2019/03/15				./data/phs001791.v1.pht008853.v1.p1.Brain_Cell_Types_Sample.var_report.xml									phs001791.v1.p1	Cerebral Cortex
235.0	235.0		2021/06/07	416.0		181.0	./data/phs001710.v1.pht011290.v1.p1.TOAA_Subject.var_report.xml	0.0	208.0	38.18	181.0			208.0		phs001710.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000300.v9.p13.echo1_4s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/13				./data/phs001611.v1.pht009159.v1.p1.Organoid_Profiling_PC_Sample.var_report.xml									phs001611.v1.p1	Neoplasms
11.0			2019/05/31	41.0			./data/phs001296.v2.pht006356.v2.p1.demographics.var_report.xml	0.0			30.0					phs001296.v2.p1	Urea Cycle Disorders, Inborn
			08/21/2014				./data/phs000758.v1.pht004002.v1.p1.Congenital_Heart_Defects_Sample_Attributes.var_report.xml									phs000758.v1.p1	Heart Septal Defects
519.0	568.0		08/09/2016	561.0		519.0	./data/phs001096.v1.pht005608.v1.p1.T2D_GENES_KARE_East_Asian_Subject_Phenotypes.var_report.xml	0.0	543.5	67.18	568.0			543.5		phs001096.v1.p1	Diabetes Mellitus, Type 2
			2021/09/23				./data/phs001089.v4.pht005486.v4.p1.CSER_DD_ID_Children_Subject_Phenotypes.var_report.xml									phs001089.v4.p1	Intellectual Disability
			02/03/2014				./data/phs000706.v1.pht003665.v1.p1.RAD50_Hypomorphism_Sample.var_report.xml									phs000706.v1.p1	Ureteral Neoplasms
			08/06/2013				./data/phs000646.v1.pht003437.v1.p1.Breakpoint_Detection_LI_WGS_Sample_Attributes.var_report.xml									phs000646.v1.p1	Chromosome Breakpoints
			05/13/2014				./data/phs000678.v1.pht003566.v1.p1.Young_Onset_Breast_Cancer_Sample_Attributes.var_report.xml									phs000678.v1.p1	Breast Neoplasms
72.0	85.0		07/09/2015	279.0		72.0	./data/phs000564.v2.pht003059.v2.p1.WGS_NICU_Subject_Phenotypes.var_report.xml	0.0	78.5	9.192	85.0			78.5		phs000564.v2.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2018/09/07				./data/phs001502.v1.pht007259.v1.p1.CCDG_UPenn_EOCAD_Sample.var_report.xml									phs001502.v1.p1	Cardiovascular Diseases
71.0	71.0		2018/04/27	76.0		84.0	./data/phs001197.v1.pht007562.v1.p1.Methamphetamine_Dependence_Pedigree.var_report.xml	0.0	97.5	19.09	84.0			97.5		phs001197.v1.p1	Substance-Related Disorders
			2018/05/31				./data/phs001316.v1.pht008003.v1.p1.aprtrs_episode_report.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			08/20/2013				./data/phs000285.v3.pht001586.v2.p2.A4HCY.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000536.v2.p3.simphen137.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			02/07/2014				./data/phs000632.v1.pht003580.v1.p1.ESP_Hematological_Cancers_Sample_Attributes.var_report.xml									phs000632.v1.p1	Hemic and Lymphatic Diseases
			02/27/2014				./data/phs000299.v2.pht001551.v2.p1.Genentech_NSCLC_Subject.var_report.xml									phs000299.v2.p1	Lung Neoplasms
8.0	8.0		2020/11/30	8.0		8.0	./data/phs002295.v1.pht010686.v1.p1.CIMAC_CIDC_NSCLC_Subject.var_report.xml	0.0	8.0					8.0		phs002295.v1.p1	Carcinoma, Non-Small-Cell Lung
			05/24/2016				./data/phs001065.v1.pht005439.v1.p1.vital.var_report.xml									phs001065.v1.p1	Huntington Disease
			09/27/2013				./data/phs000627.v1.pht003531.v1.p1.Hepatocellular_Carcinoma_Driver_Genes_Sample.var_report.xml									phs000627.v1.p1	Carcinoma, Hepatocellular
			11/25/2016				./data/phs000907.v1.pht004695.v1.p1.Lung_Cancer_Brain_Metastasis_Subject.var_report.xml									phs000907.v1.p1	Squamous Cell Carcinoma
			11/05/2014				./data/phs000209.v13.pht002300.v1.p3.MESA_MesaAirNR_LungAirway.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001662.v2.p2.C1F09MOT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/14/2014				./data/phs000708.v1.pht003725.v1.p1.POAT_GEDWR_Subject.var_report.xml									phs000708.v1.p1	Thromboembolism
90.0	909.0		10/11/2012	737.0		992.0	./data/phs000254.v2.pht002226.v2.p1.ESP_LungGO_CF_FEV_Data.var_report.xml	0.0	886.0	93.34	84.0			886.0		phs000254.v2.p1	Cystic Fibrosis
			2020/01/23				./data/phs000287.v7.pht001486.v1.p1.YR17ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
30.0	99.0		03/11/2014	35.0		35.0	./data/phs000410.v1.pht002450.v1.p1.Colorectal_Cancer_Subject_Phenotypes.var_report.xml	0.0	82.0	73.54	99.0			82.0		phs000410.v1.p1	Colorectal Neoplasms
5.0	5.0		2021/07/16	7.0		2.0	./data/phs001602.v2.pht009978.v1.p1.TOPMed_WGS_ChildrensHS_GAP_Subject_Phenotypes.var_report.xml	0.0	3.5	2.121	2.0			3.5		phs001602.v2.p1	Asthma
			04/01/2016				./data/phs000895.v1.pht005070.v1.p1.Periampullary_Tumors_Subject.var_report.xml									phs000895.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000016.v3.p13.ex0_14s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/07/09				./data/phs001544.v2.pht009897.v1.p1.TOPMed_CCDG_MPP_Sample.var_report.xml									phs001544.v2.p1	Atrial Fibrillation
			2021/05/17				./data/phs001134.v1.pht011226.v1.p1.Chernobyl_PTC_Sample.var_report.xml									phs001134.v1.p1	Thyroid Cancer, Papillary
			08/12/2016				./data/phs000888.v1.pht005585.v1.p1.MergedSetII_Phenotype_Marshfield_Glaucoma_OHT.var_report.xml									phs000888.v1.p1	
			08/12/2016				./data/phs000888.v1.pht005590.v1.p1.Geisinger_AAA_Static.var_report.xml									phs000888.v1.p1	
216.0	216.0		2021/06/16	338.0		122.0	./data/phs001402.v3.pht008239.v1.p1.TOPMed_WGS_Mayo_VTE_Subject_Phenotypes.var_report.xml	0.0	169.0	66.47	122.0			169.0		phs001402.v3.p1	Venous Thromboembolism
			08/20/2013				./data/phs000285.v3.pht001810.v2.p2.F1F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001631.v2.p2.B2F18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
122.0	199.0		2021/09/24	321.0		936.0	./data/phs001726.v2.pht009836.v2.p1.TOPMed_WGS_CAMP_Subject_Phenotypes.var_report.xml	0.0	970.0	7.778	936.0			970.0		phs001726.v2.p1	Asthma
			2019/06/03				./data/phs000624.v1.pht009130.v1.p1.LGRC_Sample.var_report.xml									phs000624.v1.p1	Pulmonary Disease, Chronic Obstructive
			2019/01/31				./data/phs001712.v1.pht008673.v1.p1.avid.var_report.xml									phs001712.v1.p1	Vasculitis
			2020/12/21				./data/phs000007.v32.pht001224.v4.p13.ctpaof1_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/10/2016				./data/phs000952.v1.pht005319.v1.p1.Substance_Dependence_EA_AA_Sample.var_report.xml									phs000952.v1.p1	Substance-Related Disorders
			04/05/2017				./data/phs000987.v1.pht004969.v1.p1.WES_P1_22q11_Sample.var_report.xml									phs000987.v1.p1	DiGeorge Syndrome
			2019/07/29				./data/phs001736.v1.pht009330.v1.p1.RCC_European_Sample_Attributes.var_report.xml									phs001736.v1.p1	Carcinoma, Renal Cell
947.0	310.0		08/20/2013	511.0		201.0	./data/phs000285.v3.pht001559.v2.p2.A4F01.var_report.xml	0.0	255.5	77.07	896.0			255.5		phs000285.v3.p2	Cardiovascular Diseases
			06/16/2017				./data/phs001278.v1.pht006280.v1.p1.promis_assessment_adult.var_report.xml									phs001278.v1.p1	Porphyrias
19.0	19.0		2021/09/14	26.0		7.0	./data/phs002545.v1.pht011484.v1.p1.MSS_CRC_PDAC_Subject.var_report.xml	0.0	13.0	8.485	7.0			13.0		phs002545.v1.p1	Immunotherapy
			01/25/2016				./data/phs001058.v1.pht005238.v1.p1.MIGen_BioImage_Sample_Attributes.var_report.xml									phs001058.v1.p1	Myocardial Infarction
			07/09/2013				./data/phs000347.v1.pht003123.v1.p1.ESP_Family_Studies_Aortic_Disease_Subject.var_report.xml									phs000347.v1.p1	Aortic Diseases
54.0	54.0		2019/11/27	91.0		37.0	./data/phs001703.v3.pht008452.v1.p1.DICE_Subject_Phenotypes.var_report.xml	0.0	45.5	12.02	37.0			45.5		phs001703.v3.p1	
70.0	70.0		2021/03/31	75.0		65.0	./data/phs001561.v1.pht010996.v1.p1.CCGO_Pedigree.var_report.xml	0.0	67.5	4.95	65.0			67.5		phs001561.v1.p1	Immunologic Deficiency Syndromes
			08/20/2013				./data/phs000285.v3.pht001632.v2.p2.B2F20.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/05/24				./data/phs000929.v1.pht007984.v1.p1.High_Risk_Breast_Cancer_Sample_Attributes.var_report.xml									phs000929.v1.p1	Breast Neoplasms
			01/06/2015				./data/phs000811.v1.pht004400.v1.p1.Targeted_DNA_NGS_Subject_Phenotypes.var_report.xml									phs000811.v1.p1	Neoplasms
50.0	50.0		05/12/2017	68.0		18.0	./data/phs001256.v2.pht005995.v2.p1.HLHS_Subject_Phenotypes.var_report.xml	0.0	34.0	22.63	18.0			34.0		phs001256.v2.p1	Hypoplastic Left Heart Syndrome
			2017/10/19				./data/phs001288.v1.pht006763.v1.p1.ancestral_orgin.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			11/04/2014				./data/phs000086.v3.pht000329.v1.p1.EDIC_f0044.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/05/15				./data/phs001557.v1.pht007615.v1.p1.MADSEQ_Subject.var_report.xml									phs001557.v1.p1	Hemihyperplasia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000547.v2.p3.simphen148.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/31/2011				./data/phs000374.v1.pht002359.v1.p1.Colorectal_Adenocarcinomas_Sample_Attributes.var_report.xml									phs000374.v1.p1	Colonic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000465.v2.p3.simphen066.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/04/27				./data/phs001197.v1.pht007561.v1.p1.Methamphetamine_Dependence_Subject.var_report.xml									phs001197.v1.p1	Substance-Related Disorders
			01/03/2017				./data/phs001141.v1.pht005600.v1.p1.PROMOTE_Sample.var_report.xml									phs001141.v1.p1	Prostatic Neoplasms, Castration-Resistant
			03/06/2017				./data/phs001248.v1.pht006093.v1.p1.LRTI_Sample.var_report.xml									phs001248.v1.p1	Respiratory Tract Infections
			12/20/2016				./data/phs000768.v2.pht004480.v2.p1.Pediatric_Ewing_Sarcoma_Sample_Attributes.var_report.xml									phs000768.v2.p1	Sarcoma, Ewing
			11/04/2014				./data/phs000086.v3.pht000223.v1.p1.DCCT_f020cmb4.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			08/20/2013				./data/phs000285.v3.pht001644.v2.p2.B2LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht005171.v1.p13.t_pftpstal_ex09_1b_0865s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/03/24				./data/phs000720.v4.pht003881.v2.p1.Pediatric_Rhabdomyosarcoma_Sample_Attributes.var_report.xml									phs000720.v4.p1	Rhabdomyosarcoma
			2020/06/18				./data/phs000280.v7.pht004152.v2.p1.RHXB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			10/06/2011				./data/phs000333.v1.pht002314.v1.p1.FIND_Subject_Phenotypes.var_report.xml									phs000333.v1.p1	Diabetes Mellitus
			2019/11/14				./data/phs001922.v1.pht009619.v1.p1.Chromosome_Errors_Oocytes_Sample_Attributes.var_report.xml									phs001922.v1.p1	Aneuploidy
			2019/03/15				./data/phs001791.v1.pht008855.v1.p1.Brain_Cell_Types_Sample_Attributes.var_report.xml									phs001791.v1.p1	Cerebral Cortex
			2020/01/30				./data/phs001707.v2.pht008605.v2.p1.CTL019_CLL_Subject.var_report.xml									phs001707.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
484.0			04/19/2012	936.0			./data/phs000444.v1.pht002703.v1.p1.Italian_Primary_Biliary_Cirrhosis_Subject_Phenotypes.var_report.xml	0.0			829.0					phs000444.v1.p1	Liver Cirrhosis, Biliary
			2018/03/20				./data/phs001559.v1.pht007662.v1.p1.Oxycodone_Abuse_Sample.var_report.xml									phs001559.v1.p1	Heroin Dependence
			2020/08/26				./data/phs000998.v2.pht005054.v2.p1.iPSC_Pulmonary_Hypertension_Subject.var_report.xml									phs000998.v2.p1	Pulmonary Arterial Hypertension
			2020/07/23				./data/phs001992.v1.pht010283.v1.p1.C4_Imputation_Subject.var_report.xml									phs001992.v1.p1	
			2017/09/22				./data/phs001392.v1.pht006903.v1.p1.pidtc_19175_day100gen.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			08/20/2013				./data/phs000285.v3.pht001741.v2.p2.D1LEPTIN.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/08/13				./data/phs001535.v1.pht008293.v1.p1.DDP_Sample.var_report.xml									phs001535.v1.p1	Diabetes, Gestational
			2021/06/28				./data/phs001514.v2.pht009815.v1.p1.Walk_PHaSST_Sample.var_report.xml									phs001514.v2.p1	Anemia, Sickle Cell
			08/30/2013				./data/phs000657.v1.pht003493.v1.p1.Advanced_Cancers_Sample.var_report.xml									phs000657.v1.p1	Carcinoma
773.0	773.0		2020/03/09	615.0		592.0	./data/phs001266.v2.pht007221.v1.p1.Addiction_Susceptibility_Genes_Pedigree.var_report.xml	0.0	682.5	85.56	592.0			682.5		phs001266.v2.p1	Opioid-Related Disorders
			2021/08/19				./data/phs001662.v2.pht010062.v1.p1.LTRC_R040_subject_parenchymalfindings.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2021/07/16				./data/phs001603.v2.pht009969.v1.p1.TOPMed_WGS_ChildrensHS_IGERA_Sample.var_report.xml									phs001603.v2.p1	Asthma
			2018/07/23				./data/phs000742.v1.pht008121.v1.p1.7_14_AED_Detail.var_report.xml									phs000742.v1.p1	Epilepsy
			2019/10/11				./data/phs000996.v2.pht005751.v2.p1.Neurodevelopmental_Metal_Toxicity_Sample.var_report.xml									phs000996.v2.p1	
			2019/06/05				./data/phs001835.v1.pht009142.v1.p1.Ocular_Melanocytosis_UM_Sample.var_report.xml									phs001835.v1.p1	Uveal melanoma
			06/17/2013				./data/phs000454.v1.pht002649.v1.p1.HIV_Susceptibility_Sample.var_report.xml									phs000454.v1.p1	HIV
631.0	896.0		12/13/2011	1527.0		631.0	./data/phs000404.v1.pht002368.v1.p1.GENEVA_Smoking_Cessation_Subject_Phenotypes_COGEND.var_report.xml	0.0	763.5	187.4	896.0			763.5		phs000404.v1.p1	Smoking Cessation
			2018/04/16				./data/phs001326.v1.pht007825.v1.p1.p6902_17994_day100dat.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
63.0	63.0		05/07/2014	54.0		45.0	./data/phs000738.v1.pht003836.v1.p1.Schizophrenia_Families_Subject_Phenotypes.var_report.xml	0.0	54.0	7.071	45.0			54.0		phs000738.v1.p1	Schizophrenia
			10/15/2012				./data/phs000512.v1.pht002863.v1.p1.Etiology_HDL_Cholesterol_Sample_Attributes.var_report.xml									phs000512.v1.p1	Lipoproteins, HDL
			2020/06/18				./data/phs000280.v7.pht004136.v2.p1.MSRD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/15				./data/phs001404.v1.pht010787.v1.p1.GBC_Sample.var_report.xml									phs001404.v1.p1	Gallbladder Cancer
			06/01/2017				./data/phs000701.v1.pht005523.v1.p1.Registration.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/08/26				./data/phs001831.v1.pht009168.v1.p1.Neuroblastoma_Epigenetics_Sample.var_report.xml									phs001831.v1.p1	Neuroblastoma
			03/01/2016				./data/phs001054.v1.pht005276.v1.p1.Angiocentric_Glioma_Subject.var_report.xml									phs001054.v1.p1	Glioma
			2020/06/18				./data/phs000280.v7.pht006456.v1.p1.NFH.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/10/2014				./data/phs000248.v1.pht003682.v1.p1.HCV_Sample_Attributes.var_report.xml									phs000248.v1.p1	Hepatitis C
			06/25/2015				./data/phs000634.v1.pht003830.v1.p1.Lung_Cancer_Never_Smokers_Sample.var_report.xml									phs000634.v1.p1	Lung Neoplasms
19.0	19.0		2020/01/31	36.0		17.0	./data/phs001940.v2.pht009698.v1.p1.Immune_Checkpoint_NSCLC_Subject_Phenotypes.var_report.xml	0.0	18.0	1.414	17.0			18.0		phs001940.v2.p1	Carcinoma, Non-Small-Cell Lung
			2017/12/04				./data/phs001366.v1.pht006575.v1.p1.SCLC_CTCA_Subject.var_report.xml									phs001366.v1.p1	Small Cell Lung Carcinoma
			12/11/2009				./data/phs000171.v1.pht000749.v1.p1.MS_DATA_ASCT.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			08/20/2013				./data/phs000285.v3.pht001802.v2.p2.E1LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/24				./data/phs001641.v1.pht010037.v1.p1.OrderedProcedures.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2019/12/17				./data/phs001258.v2.pht006678.v2.p1.College_Athletes_Subject_Phenotypes.var_report.xml									phs001258.v2.p1	MicroRNAs
568.0	750.0		2020/02/04	4808.0		568.0	./data/phs001721.v1.pht009719.v1.p1.IBDGC_Repo_IC_Subject_Phenotypes.var_report.xml	0.0	659.0	240.4	750.0			659.0		phs001721.v1.p1	Inflammatory Bowel Disease
			2018/03/26				./data/phs000697.v1.pht007697.v1.p1.infusionrecord.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			06/01/2015				./data/phs000901.v1.pht004673.v1.p1.Parkinson_CSF_Biomarker_Sample.var_report.xml									phs000901.v1.p1	Parkinson Disease
			2018/06/11				./data/phs000220.v2.pht002386.v2.p2.PAGE_MEC_Metabochip_Sample.var_report.xml									phs000220.v2.p2	Neoplasms
			12/07/2015				./data/phs000970.v1.pht005016.v1.p1.Fetal_Methylmercury_Exposure_Subject.var_report.xml									phs000970.v1.p1	Methylmercury Compounds
			2021/05/04				./data/phs002387.v1.pht011176.v1.p1.GBHS_Subject.var_report.xml									phs002387.v1.p1	Breast Neoplasms
			2019/06/06				./data/phs001420.v1.pht009145.v1.p1.GMKF_OFC_Colombian_Sample.var_report.xml									phs001420.v1.p1	Cleft Lip
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000253.v1.p1.DCCT_baseline.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/18/2012				./data/phs000395.v1.pht002362.v1.p1.CIDR_Mammographic_Density_Sample.var_report.xml									phs000395.v1.p1	Breast Neoplasms
			02/10/2014				./data/phs000248.v1.pht001199.v1.p1.HCV_Subject_Phenotypes.var_report.xml									phs000248.v1.p1	Hepatitis C
			2020/09/18				./data/phs002015.v1.pht010370.v1.p1.AREDS2_CNT.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2020/12/15				./data/phs001404.v1.pht010786.v1.p1.GBC_Subject.var_report.xml									phs001404.v1.p1	Gallbladder Cancer
			12/06/2016				./data/phs001203.v1.pht005965.v1.p1.STARNET_Subject.var_report.xml									phs001203.v1.p1	Coronary Artery Disease
			05/24/2012				./data/phs000394.v1.pht002651.v1.p1.APDGC_Subject.var_report.xml									phs000394.v1.p1	Parkinson Disease
			08/12/2016				./data/phs000888.v1.pht005564.v1.p1.13aAtopic_dermatitis_related_conditions.var_report.xml									phs000888.v1.p1	
			2019/02/01				./data/phs001770.v1.pht008684.v1.p1.6408_QOL.var_report.xml									phs001770.v1.p1	Dent Disease
			09/16/2013				./data/phs000328.v2.pht002133.v2.p1.DLBCL_Sample.var_report.xml									phs000328.v2.p1	Lymphoma, Large B-Cell, Diffuse
			2020/12/21				./data/phs000007.v32.pht010740.v1.p13.t_pft_ex01_7_0731s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000100.v8.p13.psych1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003659.v1.p3.MESA_TimeToDiabetes.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			10/24/2012				./data/phs000542.v1.pht003018.v1.p1.Mendelian_Neonatal_Diabetes_Sample_Attributes.var_report.xml									phs000542.v1.p1	Pancreatic beta cell agenesis with neonatal diabetes mellitus
			2020/12/21				./data/phs000007.v32.pht000742.v7.p13.fhslab1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/11/2014				./data/phs000795.v1.pht004016.v1.p1.Gastric_Cancer_Metastasis_Sample_Attributes.var_report.xml									phs000795.v1.p1	Stomach Neoplasms
			08/20/2013				./data/phs000285.v3.pht001625.v2.p2.B2F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
5.0	5.0		02/09/2017	9.0		4.0	./data/phs001082.v1.pht005381.v1.p1.VZV_TCell_Subject_Phenotypes.var_report.xml	0.0	4.5	0.7071	4.0			4.5		phs001082.v1.p1	Herpes Zoster
			2017/11/01				./data/phs001305.v1.pht007105.v1.p1.fluxendpointdataform.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			01/26/2015	1914.0			./data/phs000807.v1.pht004388.v1.p1.CALGB40101_Early_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0			1914.0					phs000807.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht000987.v4.p3.core_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/03/30				./data/phs002311.v1.pht010935.v1.p1.GATA2_Deficiency_Sample_Attributes.var_report.xml									phs002311.v1.p1	Neoplasms
			11/08/2013				./data/phs000200.v9.pht002766.v1.p3.outc_dvt_pe_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			02/05/2015				./data/phs000808.v1.pht004465.v1.p1.diLQTS_Susceptibility_Sample.var_report.xml									phs000808.v1.p1	Long QT Syndrome
			2021/02/10				./data/phs001675.v1.pht010220.v1.p1.OFC_Sample.var_report.xml									phs001675.v1.p1	Cleft Lip
			05/08/2017				./data/phs000871.v1.pht004571.v1.p1.Pancreatic_Neuroendocrine_Tumors_Sample_Attributes.var_report.xml									phs000871.v1.p1	Carcinoma, Neuroendocrine
			11/04/2014				./data/phs000086.v3.pht000344.v1.p1.EDIC_f0914.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/01/23				./data/phs000287.v7.pht001479.v1.p1.YR13PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			03/13/2015				./data/phs000873.v1.pht004557.v1.p1.Bleeding_Disorders_Sample.var_report.xml									phs000873.v1.p1	Thrombocytopenia
			2018/06/14				./data/phs001238.v2.pht006655.v1.p1.GENOA_EuropeanAmerican_Phase1_LabData.var_report.xml									phs001238.v2.p1	Hypertension
5.0	5.0		11/08/2012	8.0		3.0	./data/phs000540.v1.pht003044.v1.p1.Ehlers_Danlos_Syndrome_Type_VIII_Pedigree.var_report.xml	0.0	4.0	1.414	3.0			4.0		phs000540.v1.p1	Ehlers-Danlos Syndrome
			10/24/2016				./data/phs001214.v1.pht005875.v1.p1.Simul_seq_Subject.var_report.xml									phs001214.v1.p1	Esophageal Neoplasms
13.0	13.0		2021/01/26	17.0		4.0	./data/phs001427.v2.pht007486.v1.p1.Melanoma_CPB_Resistance_Subject_Phenotypes.var_report.xml	0.0	8.5	6.364	4.0			8.5		phs001427.v2.p1	Immunotherapy
			05/12/2017				./data/phs001256.v2.pht005994.v1.p1.HLHS_Sample.var_report.xml									phs001256.v2.p1	Hypoplastic Left Heart Syndrome
			04/04/2014				./data/phs000679.v1.pht003656.v1.p1.Anorexia_Nervosa_Sample.var_report.xml									phs000679.v1.p1	Anorexia Nervosa
			2019/07/03				./data/phs001850.v1.pht009236.v1.p1.Subtype_SLE_Sample.var_report.xml									phs001850.v1.p1	Lupus Erythematosus, Systemic
			2020/08/04				./data/phs001793.v1.pht008899.v1.p1.PDGCL_Subject.var_report.xml									phs001793.v1.p1	Glioma
			2021/06/01				./data/phs001143.v4.pht005904.v2.p1.TOPMed_WGS_BAGS_Sample.var_report.xml									phs001143.v4.p1	Asthma
			2020/04/14				./data/phs001947.v1.pht010138.v1.p1.Melanoma_Hu14_18_IL2_Sample_Attributes.var_report.xml									phs001947.v1.p1	Melanoma
96.0	96.0		2018/06/22	9958.0		7.0	./data/phs000298.v4.pht002583.v3.p3.Autism_Sequencing_Collaboration_Pedigree.var_report.xml	85.0	81.0	21.92	947.0			81.0		phs000298.v4.p3	Autistic Disorder
			07/10/2017				./data/phs001202.v1.pht005776.v1.p1.OncoArray_Oral_Pharynx_Cancer_Sample_Attributes.var_report.xml									phs001202.v1.p1	Head and Neck Neoplasms
			2020/03/11				./data/phs001964.v1.pht009963.v1.p1.WHS_Accelerometer_60sec.var_report.xml									phs001964.v1.p1	Physical Activity
			01/11/2016				./data/phs000279.v2.pht001436.v2.p1.ESP_Broad_EOMI_Sample.var_report.xml									phs000279.v2.p1	Myocardial Infarction
			2018/02/08				./data/phs001488.v1.pht007431.v1.p1.uhdr7.var_report.xml									phs001488.v1.p1	Huntington Disease
2.0	4.0		2019/09/18	4.0		4.0	./data/phs001737.v2.pht008561.v2.p1.EEC_Syndrome_Subject_Phenotypes.var_report.xml	0.0	4.667	5.508	1.0			4.0		phs001737.v2.p1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
			02/08/2016				./data/phs000949.v1.pht005224.v1.p1.CIDR_Facial_Variation_Sample.var_report.xml									phs000949.v1.p1	Anthropometry
			11/05/2014				./data/phs000209.v13.pht002193.v1.p3.MESA_AncilMesaAirExposure.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002852.v5.p13.l_isopros_2005_m_0470s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/09/2013				./data/phs000347.v1.pht003126.v1.p1.ESP_Family_Studies_Aortic_Disease_Sample_Attributes.var_report.xml									phs000347.v1.p1	Aortic Diseases
			11/04/2014				./data/phs000086.v3.pht000358.v1.p1.EDIC_f1422.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht001044.v8.p13.vr_fxrev_2018_m_1176s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008758.v1.p2.liverattenuation.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2017/12/08	2.0			./data/phs001279.v1.pht007215.v1.p1.p5904_19462_supplemen.var_report.xml	37.0			2.0					phs001279.v1.p1	Bronchiectasis
			2020/12/21				./data/phs000007.v32.pht009750.v2.p13.l_balip1_ex08_1_0947s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001959.v2.p2.loca.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			10/09/2014				./data/phs000717.v1.pht003810.v1.p1.Circulating_Tumor_Cells_Subject_Phenotypes.var_report.xml									phs000717.v1.p1	Prostatic Neoplasms
			2020/07/24				./data/phs001194.v3.pht005819.v2.p2.CardiacSurgeriesProcedures.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
820.0	820.0		08/26/2013	820.0		820.0	./data/phs000619.v1.pht003354.v1.p1.Autism_Epigenetics_Relatives.var_report.xml	0.0	820.0					820.0		phs000619.v1.p1	Autistic Disorder
			2020/01/10				./data/phs001956.v1.pht009788.v1.p1.sc_Liver_Sample_Attributes.var_report.xml									phs001956.v1.p1	
			03/06/2012				./data/phs000425.v1.pht002502.v1.p1.dbGAP_Sample.var_report.xml									phs000425.v1.p1	Alcoholism
			2020/12/21				./data/phs000007.v32.pht005155.v3.p13.t_ctemphy_2011_m_0954s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/05/07				./data/phs001327.v2.pht011196.v1.p1.surgerysumm.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/12/21				./data/phs000007.v32.pht003902.v5.p13.l_insulin_2011_m_0703s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/08/19				./data/phs000101.v5.pht003749.v2.p1.ALS_Sample_Attributes.var_report.xml									phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2019/10/11				./data/phs001406.v1.pht007744.v1.p1.novelpheds.var_report.xml									phs001406.v1.p1	Cognition
			2021/03/05				./data/phs001504.v2.pht007909.v2.p1.T2D_GENES_Hong_Kong_Sample.var_report.xml									phs001504.v2.p1	Diabetes Mellitus, Type 2
			2018/08/06				./data/phs001655.v1.pht008259.v1.p1.Acne_Skin_Metagenome_Sample_Attributes.var_report.xml									phs001655.v1.p1	Acne Vulgaris
			08/20/2013				./data/phs000285.v3.pht001846.v2.p2.F1INS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			10/24/2012				./data/phs000537.v1.pht003024.v1.p1.Mendelian_fHLH_Sample.var_report.xml									phs000537.v1.p1	Lymphohistiocytosis, Hemophagocytic
			02/03/2012				./data/phs000419.v1.pht002497.v1.p1.Melanoma_SubjectSampleMappingDS_Sample.var_report.xml									phs000419.v1.p1	Melanoma
			2019/12/03				./data/phs001897.v1.pht009542.v1.p1.Peanut_OIT_Subject_Phenotypes.var_report.xml									phs001897.v1.p1	Peanut Hypersensitivity
			08/21/2015				./data/phs000626.v1.pht003431.v1.p1.CD4_Tcells_Healthy_Humans_Sample.var_report.xml									phs000626.v1.p1	Immune System Processes
			2020/03/19				./data/phs001979.v1.pht010002.v1.p1.Skin_SingleCell_Sample_Attributes.var_report.xml									phs001979.v1.p1	Melanoma
			2018/03/20				./data/phs000605.v1.pht007643.v1.p1.volumetric_ct_result.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2021/01/22				./data/phs001962.v1.pht009821.v1.p1.PTCL_Sample_Attributes.var_report.xml									phs001962.v1.p1	Lymphoma, T-Cell, Peripheral
990.0	861.0		2018/05/18	8725.0		990.0	./data/phs001315.v1.pht006193.v1.p1.CIDR_GECCO_Colorectal_Cancer_GxE_Subject_Phenotypes.var_report.xml	0.0	926.0	95.46	710.0			926.0		phs001315.v1.p1	Colorectal Neoplasms
12.0	53.0		04/08/2014	65.0		12.0	./data/phs000552.v2.pht003029.v1.p1.Meningiomas_Subject_Phenotypes.var_report.xml	0.0	32.5	28.99	53.0			32.5		phs000552.v2.p1	Meningioma
6.0			06/12/2017	9.0			./data/phs000594.v1.pht006499.v1.p1.DemographicInformation.var_report.xml	0.0			3.0					phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
77.0	80.0		2018/11/16	75.0		9.0	./data/phs001272.v1.pht007303.v1.p1.Broad_CMG_Subject_Phenotypes.var_report.xml	0.0	78.5	6.364	9.0			78.5		phs001272.v1.p1	Genetic Diseases, Inborn
			11/04/2014				./data/phs000086.v3.pht000250.v1.p1.DCCT_cbl3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			05/12/2017				./data/phs001256.v2.pht005996.v1.p1.HLHS_Sample_Attributes.var_report.xml									phs001256.v2.p1	Hypoplastic Left Heart Syndrome
			2020/01/10				./data/phs001471.v1.pht009807.v1.p1.HHL_Sample_Attributes.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			07/26/2017				./data/phs000852.v1.pht006694.v1.p1.GEDI_SUDs_Sample.var_report.xml									phs000852.v1.p1	Substance-Related Disorders
898.0			11/30/2016	869.0			./data/phs001210.v1.pht005963.v1.p1.Lung_Cancer_Smoking_AA_Subject_Phenotypes.var_report.xml	0.0			972.0					phs001210.v1.p1	Lung Neoplasms
			2020/06/30				./data/phs002045.v1.pht010308.v1.p1.PDAC_Sample.var_report.xml									phs002045.v1.p1	Carcinoma, Pancreatic Ductal
8.0	8.0		2021/03/10	9.0		7.0	./data/phs001485.v2.pht007187.v1.p1.Cell_ID_Subject_Phenotypes.var_report.xml	0.0	7.5	2.121	7.0			7.5		phs001485.v2.p1	Cockayne Syndrome
7.0	8.0		08/04/2014	33.0		7.0	./data/phs000776.v1.pht003949.v1.p1.MCCD_Subject_Phenotypes.var_report.xml	0.0	7.5	13.44	8.0			7.5		phs000776.v1.p1	Urea Cycle Disorders, Inborn
	16.0		09/10/2015	16.0		16.0	./data/phs000967.v1.pht004862.v1.p1.Clear_Cell_Endometrial_Cancer_WES_Subject_Phenotypes.var_report.xml	0.0	16.0		16.0			16.0		phs000967.v1.p1	Endometrial Neoplasms
			2017/12/20				./data/phs000577.v1.pht007284.v1.p1.p5101_16899_qualityof.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			08/20/2013				./data/phs000285.v3.pht001837.v2.p2.F1F65.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/16/2013				./data/phs000690.v1.pht003618.v1.p1.Multiplex_Epilepsy_Families_Subject.var_report.xml									phs000690.v1.p1	Idiopathic generalized epilepsy
			08/20/2013				./data/phs000285.v3.pht001862.v2.p2.F2IGFIL.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/06/09				./data/phs001293.v3.pht008893.v1.p1.TOPMed_WGS_HyperGEN_Subject.var_report.xml									phs001293.v3.p1	Hypertrophy, Left Ventricular
9.0	50.0		2020/08/17	7715.0		79.0	./data/phs000397.v3.pht002410.v3.p3.LLFS_Subject_Phenotypes.var_report.xml	7.0	3858.0	563.6	89.0			3858.0		phs000397.v3.p3	Longevity
			2018/03/23				./data/phs000698.v1.pht007689.v1.p1.inspiratory_site_ctscan_80mas.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
6.0	6.0		2021/08/05	9.0		3.0	./data/phs002499.v1.pht011448.v1.p1.CTCLs_JAK_STAT_Subject_Phenotypes.var_report.xml	0.0	4.5	2.121	3.0			4.5		phs002499.v1.p1	Lymphoma, T-Cell, Cutaneous
15.0	15.0		2020/04/14	23.0		8.0	./data/phs001947.v1.pht010136.v1.p1.Melanoma_Hu14_18_IL2_Subject_Phenotypes.var_report.xml	0.0	11.5	4.95	8.0			11.5		phs001947.v1.p1	Melanoma
			2019/12/26				./data/phs001889.v1.pht009741.v1.p1.ALS_TDP_Sample_Attributes.var_report.xml									phs001889.v1.p1	Amyotrophic Lateral Sclerosis
			11/16/2016				./data/phs001200.v1.pht005928.v1.p1.West_Nile_Virus_NAb_Sample_Attributes.var_report.xml									phs001200.v1.p1	West Nile Fever
			01/26/2015				./data/phs000846.v1.pht004448.v1.p1.Bisulfite_Sequencing_ccf_DNA_Subject.var_report.xml									phs000846.v1.p1	DNA Methylation
			2020/06/18				./data/phs000280.v7.pht001441.v7.p1.ARIC_Sample.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
860.0	860.0		03/21/2014	842.0		756.0	./data/phs000583.v1.pht003294.v1.p1.Type2Diabetes_AsianIndians_Subject_Phenotypes.var_report.xml	0.0	808.0	73.54	756.0			808.0		phs000583.v1.p1	Metabolic Syndrome X
			2019/05/30				./data/phs001222.v1.pht005907.v1.p1.CCDG_T1DGC_Subject.var_report.xml									phs001222.v1.p1	Diabetes Mellitus, Type 1
			03/28/2014				./data/phs000496.v1.pht003166.v1.p1.Late_Onset_Alzheimers_Subject.var_report.xml									phs000496.v1.p1	Alzheimer Disease
			06/03/2015				./data/phs000863.v1.pht004745.v1.p1.RCC_AA_Sample_Attributes.var_report.xml									phs000863.v1.p1	Carcinoma, Renal Cell
			11/13/2015				./data/phs000985.v1.pht005102.v1.p1.PrCa_Risk_SNPs_Sample.var_report.xml									phs000985.v1.p1	
			11/05/2014				./data/phs000209.v13.pht001985.v1.p3.MESA_FamilyAorticValvularCalcium.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/04/24				./data/phs001829.v1.pht010166.v1.p1.Rectal_Chemoradiation_Sample.var_report.xml									phs001829.v1.p1	Rectal Neoplasms
			11/05/2014				./data/phs000209.v13.pht002513.v1.p3.MESA_AncilMesaPentraxinSAP3.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/02/26				./data/phs001754.v4.pht009109.v3.p2.Spit4Science_Sample.var_report.xml									phs001754.v4.p2	
737.0	1628.0		2021/06/08	3209.0		737.0	./data/phs001218.v3.pht005958.v1.p1.TOPMed_WGS_GeneSTAR_Pedigree.var_report.xml	0.0	893.5	33.23	1628.0			893.5		phs001218.v3.p1	Platelet Aggregation
983.0	3307.0		2020/10/27	5931.0		983.0	./data/phs001616.v2.pht010143.v1.p2.eMERGEseq_Case_Control.var_report.xml	0.0	996.7	867.8	929.0			929.0		phs001616.v2.p2	Precision Medicine
501.0		2.0	08/20/2013	480.0	1.719		./data/phs000285.v3.pht001570.v2.p2.A4F09GEN.var_report.xml	0.0		0.4788	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			06/09/2016				./data/phs001041.v1.pht005393.v1.p1.Melanoma_CTLA_4_Blockade_Sample_Attributes.var_report.xml									phs001041.v1.p1	Melanoma
13.0	13.0		2020/12/16	15.0		2.0	./data/phs001800.v2.pht008927.v2.p1.Pediatric_RMC_Subject_Phenotypes.var_report.xml	0.0	7.5	7.778	2.0			7.5		phs001800.v2.p1	SMARCB1 Protein
19.0			06/16/2017	41.0			./data/phs001278.v1.pht006268.v1.p1.disorder_specific_info_pct.var_report.xml	8.0			22.0					phs001278.v1.p1	Porphyrias
			11/04/2014				./data/phs000086.v3.pht000237.v1.p1.DCCT_m9exhpcs.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			03/06/2017				./data/phs001248.v1.pht006094.v1.p1.LRTI_Subject_Phenotypes.var_report.xml									phs001248.v1.p1	Respiratory Tract Infections
			2018/07/23				./data/phs001627.v1.pht008190.v1.p1.AML_scDNA_Sample_Attributes.var_report.xml									phs001627.v1.p1	Leukemia, Myeloid, Acute
			01/15/2016				./data/phs000909.v1.pht004875.v1.p1.NEPC_Sample.var_report.xml									phs000909.v1.p1	Adenocarcinoma
			04/18/2012				./data/phs000369.v1.pht002586.v1.p1.Breast_Carcinoma_Subtypes_Sample.var_report.xml									phs000369.v1.p1	Carcinoma, Ductal, Breast
737.0	737.0		11/19/2013	764.0		63.0	./data/phs000436.v1.pht002833.v1.p1.Autism_Disorders_Pedigree.var_report.xml	0.0	593.0	207.2	63.0			593.0		phs000436.v1.p1	Autistic Disorder
			2017/11/28				./data/phs001482.v1.pht007126.v1.p1.Carrier_Screening_Sample_Attributes.var_report.xml									phs001482.v1.p1	Infertility
			06/25/2015				./data/phs000634.v1.pht003829.v1.p1.Lung_Cancer_Never_Smokers_Subject.var_report.xml									phs000634.v1.p1	Lung Neoplasms
1688.0	1688.0		05/16/2017	2741.0		1053.0	./data/phs001252.v1.pht006368.v1.p1.atsdld78.var_report.xml	0.0	1371.0	449	1053.0			1371.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
79.0			2019/12/10	277.0			./data/phs001913.v1.pht009514.v1.p1.CCDG_eMERGE_Northwestern_Subject_Phenotypes.var_report.xml	0.0			70.0					phs001913.v1.p1	Cardiovascular Diseases
100.0			2019/04/19	298.0			./data/phs001295.v2.pht006238.v2.p1.cmt_disability_survey.var_report.xml	8.0			182.0					phs001295.v2.p1	Charcot-Marie-Tooth Disease
			04/21/2017				./data/phs001344.v1.pht006287.v1.p1.PMDD_Sample_Attributes.var_report.xml									phs001344.v1.p1	Premenstrual Dysphoric Disorder
			2019/03/11				./data/phs000286.v6.pht001966.v2.p2.pdsa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000682.v7.p13.ffreq1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/04				./data/phs001748.v1.pht008575.v1.p1.Histiocytic_Sarcomas_Sample.var_report.xml									phs001748.v1.p1	Histiocytic Sarcoma
			2020/07/24				./data/phs001194.v3.pht005818.v2.p2.FishResults.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			08/29/2016				./data/phs000126.v2.pht005716.v1.p1.CIDR_PD_Sample.var_report.xml									phs000126.v2.p1	Parkinson Disease
			2018/05/10				./data/phs001565.v1.pht007896.v1.p1.Immune_Checkpoint_Blockade_Sample.var_report.xml									phs001565.v1.p1	Neoplasms
			09/09/2013				./data/phs000266.v4.pht001265.v4.p1.HMP_Dermatitis_Immunodeficiency_MRSA_Sample.var_report.xml									phs000266.v4.p1	Dermatitis, Atopic
1258.0	1258.0		05/16/2017	1971.0		713.0	./data/phs001252.v1.pht006385.v1.p1.fv950.var_report.xml	0.0	985.5	385.4	713.0			985.5		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2021/05/20				./data/phs002280.v1.pht010805.v1.p1.scRNA_PBMC_Subject.var_report.xml									phs002280.v1.p1	PBMC &#8211; Peripheral Blood Mononuclear Cells
			02/27/2017				./data/phs000435.v3.pht002522.v3.p1.CLL_Sample.var_report.xml									phs000435.v3.p1	Chronic Lymphocytic Leukemia
			03/11/2014				./data/phs000410.v1.pht002451.v1.p1.Colorectal_Cancer_Sample_Attributes.var_report.xml									phs000410.v1.p1	Colorectal Neoplasms
			2020/12/21				./data/phs000007.v32.pht003903.v4.p13.t_ctairway_2011_m_0851s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/03/30				./data/phs002311.v1.pht010934.v1.p1.GATA2_Deficiency_Subject_Phenotypes.var_report.xml									phs002311.v1.p1	Neoplasms
			2021/05/21				./data/phs001040.v5.pht005204.v3.p1.TOPMed_WGS_WGHS_Sample.var_report.xml									phs001040.v5.p1	Atrial Fibrillation
			03/06/2017				./data/phs000574.v1.pht005866.v1.p1.diagnosticmecp2status.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2021/03/22				./data/phs001375.v2.pht006520.v1.p1.SIGMA_MCDS_Subject.var_report.xml									phs001375.v2.p1	Diabetes Mellitus, Type 2
			2019/08/30				./data/phs001331.v2.pht006935.v2.p1.imd_17919_patientstat.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			2019/11/15				./data/phs000784.v3.pht004286.v1.p1.GenSalt_Subject_Phenotypes.var_report.xml									phs000784.v3.p1	Arterial Pressure, Mean
			03/23/2015				./data/phs000866.v1.pht004618.v1.p1.Bipolar_Disorder_Family_Genomics_Subject.var_report.xml									phs000866.v1.p1	Bipolar Disorder
			2021/06/16				./data/phs002088.v2.pht010650.v1.p1.LINCS_DToxS_Sample.var_report.xml									phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			2021/02/02				./data/phs002204.v1.pht010908.v1.p1.cCREs_Sample.var_report.xml									phs002204.v1.p1	Heart
			2020/12/21				./data/phs000007.v32.pht000307.v9.p13.meno1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/07/23				./data/phs000742.v1.pht008117.v1.p1.7_10_Diagnostic_Interview_Old_Header.var_report.xml									phs000742.v1.p1	Epilepsy
776.0	776.0		2018/03/08	69.0		446.0	./data/phs001494.v1.pht007190.v1.p1.ALIVE_Smokescreen_Pedigree.var_report.xml	0.0	611.0	24.75	446.0			611.0		phs001494.v1.p1	Substance-Related Disorders
			2020/12/21				./data/phs000007.v32.pht000194.v8.p13.brach3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2015				./data/phs000910.v1.pht004729.v1.p1.T1DGC_CNV_Sample_Attributes.var_report.xml									phs000910.v1.p1	Diabetes Mellitus, Type 1
			2019/09/16				./data/phs000979.v3.pht005195.v2.p2.HBCC_Postmortem_Psychiatric_Subject_Phenotypes.var_report.xml									phs000979.v3.p2	Schizophrenia
			05/24/2016				./data/phs001065.v1.pht005400.v1.p1.cag.var_report.xml									phs001065.v1.p1	Huntington Disease
254.0			04/16/2014	382.0			./data/phs000249.v2.pht001879.v2.p1.Brain_QTL_Subject_Phenotypes.var_report.xml	0.0			128.0					phs000249.v2.p1	DNA Methylation
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000514.v2.p3.simphen115.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			05/02/2012				./data/phs000478.v1.pht002655.v1.p1.Strabismus_Subject.var_report.xml									phs000478.v1.p1	Strabismus
			2020/12/21				./data/phs000007.v32.pht000163.v8.p13.lpa1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/19/2016				./data/phs001185.v1.pht005763.v1.p1.Early_Onset_Prostate_Cancer_Sample.var_report.xml									phs001185.v1.p1	Prostatic Neoplasms
			2020/10/21				./data/phs001942.v1.pht010588.v1.p1.Histiocytic_Dendritic_Sarcoma_Sample_Attributes.var_report.xml									phs001942.v1.p1	Histiocytic Sarcoma
			2018/10/11				./data/phs001234.v1.pht006620.v1.p1.ER_Positive_Breast_Tumors_Tamoxifen_Sample_Attributes.var_report.xml									phs001234.v1.p1	Breast Neoplasms
			02/06/2017				./data/phs001075.v1.pht006110.v1.p1.CSER_CanSeq_Subject_Phenotypes.var_report.xml									phs001075.v1.p1	Neoplasms
			2019/03/11				./data/phs000286.v6.pht001976.v2.p2.ssfa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
3.0	3.0		08/04/2015	4.0		1.0	./data/phs000926.v1.pht004867.v1.p1.Crohn_Disease_Childhood_Onset_Subject_Phenotypes.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs000926.v1.p1	Crohn Disease
			2018/04/16				./data/phs001326.v1.pht007827.v1.p1.p6902_18076_12mthimmu.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000557.v2.p3.simphen158.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			01/22/2014				./data/phs000670.v1.pht003554.v1.p1.PGRN_AMPS_Subject.var_report.xml									phs000670.v1.p1	Depressive Disorder, Major
			02/24/2012				./data/phs000001.v3.pht002479.v1.p1.sunlight.var_report.xml									phs000001.v3.p1	Cataract
31.0	85.0		2021/05/18	116.0		31.0	./data/phs002224.v1.pht010845.v1.p1.Crosstalk_Asthma_Subject.var_report.xml	0.0	58.0	38.18	85.0			58.0		phs002224.v1.p1	Asthma
			11/05/2014				./data/phs000209.v13.pht001207.v2.p3.MESA_AncilMesaPericardialFat.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
24.0			2021/08/26	41.0			./data/phs001730.v2.pht010132.v1.p1.TOPMed_WGS_CARE_PACT_Subject_Phenotypes.var_report.xml	0.0			17.0					phs001730.v2.p1	Asthma
			2020/03/31				./data/phs001976.v2.pht009903.v2.p1.Melorheostosis_Sample_Attributes.var_report.xml									phs001976.v2.p1	Melorheostosis
			01/27/2017				./data/phs000428.v2.pht002612.v2.p2.HRS_Subject.var_report.xml									phs000428.v2.p2	Aging
819.0	819.0		2021/08/23	4814.0		767.0	./data/phs001232.v4.pht006076.v4.p2.UDN_Pedigree.var_report.xml	0.0	793.0	94.05	767.0			793.0		phs001232.v4.p2	Rare Diseases
			2020/06/18				./data/phs000280.v7.pht004143.v2.p1.PHEA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001613.v2.p2.B2F09MHM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
4.0	4.0		08/31/2011	9.0		2.0	./data/phs000374.v1.pht002358.v1.p1.Colorectal_Adenocarcinomas_Subject_Phenotypes.var_report.xml	0.0	3.0	1	3.0			3.0		phs000374.v1.p1	Colonic Neoplasms
			09/03/2013				./data/phs000652.v1.pht003456.v1.p1.GliomaScan_Sample.var_report.xml									phs000652.v1.p1	Glioma
22.0	4.0		2019/10/15	5.0		4.0	./data/phs001910.v1.pht009538.v1.p1.PNETs_Subject_Phenotypes.var_report.xml	0.0	4.0	2.121	4.0			4.0		phs001910.v1.p1	Neuroendocrine Tumors
			2019/05/02				./data/phs001378.v1.pht006690.v1.p1.FL_Tumors_Sample.var_report.xml									phs001378.v1.p1	Lymphoma, Follicular
			12/16/2013				./data/phs000690.v1.pht003620.v1.p1.Multiplex_Epilepsy_Families_Sample.var_report.xml									phs000690.v1.p1	Idiopathic generalized epilepsy
			2020/10/09				./data/phs002262.v1.pht010572.v1.p1.HGSOC_Subject.var_report.xml									phs002262.v1.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000546.v2.p3.simphen147.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/03/2015				./data/phs000620.v1.pht003895.v1.p1.MCTFR_Subject_Phenotype_fsiq_data.var_report.xml									phs000620.v1.p1	Substance-Related Disorders
749.0	821.0		2018/05/14	1570.0		749.0	./data/phs001396.v1.pht006737.v1.p1.Pigmentation_Eastern_Southern_African_Subject_Phenotypes.var_report.xml	3.0	785.0	50.91	821.0			785.0		phs001396.v1.p1	Skin Pigmentation
			2019/02/21				./data/phs001281.v2.pht006128.v2.p1.eligibility_form.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2018/10/02				./data/phs001664.v1.pht008438.v1.p1.PDCGC_Sample.var_report.xml									phs001664.v1.p1	Parkinson Disease
			06/12/2014				./data/phs000602.v2.pht003221.v1.p1.DiverseCancers_Sample.var_report.xml									phs000602.v2.p1	Neoplasms
			2018/08/02				./data/phs001487.v1.pht007138.v1.p1.CCDG_TAICHI_Subject_Phenotypes.var_report.xml									phs001487.v1.p1	
			08/20/2013				./data/phs000285.v3.pht001627.v2.p2.B2F12PF.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000259.v1.p1.DCCT_m9exevet.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			11/04/2014				./data/phs000086.v3.pht000627.v1.p1.EDIC_f0952.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht006446.v1.p1.MRD_FINAL.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/31				./data/phs001318.v1.pht008035.v1.p1.assessmentofefficacy.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			08/20/2013				./data/phs000285.v3.pht001831.v2.p2.F1F59.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005428.v1.p1.screen.var_report.xml									phs001065.v1.p1	Huntington Disease
			11/05/2014				./data/phs000209.v13.pht001217.v5.p3.MESA_MesaAfibEvents.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht003156.v1.p1.nih.var_report.xml									phs000343.v3.p1	Stroke
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000541.v2.p3.simphen142.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			06/09/2010				./data/phs000255.v1.pht001252.v1.p1.HMP_Crohns_Risk_Sample.var_report.xml									phs000255.v1.p1	Crohn Disease
			08/20/2013				./data/phs000285.v3.pht001585.v2.p2.A4F25.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			05/12/2017				./data/phs001256.v2.pht005993.v1.p1.HLHS_Subject.var_report.xml									phs001256.v2.p1	Hypoplastic Left Heart Syndrome
			2020/12/10				./data/phs002065.v1.pht010772.v1.p1.Genitourinary_Cancers_Sample_Attributes.var_report.xml									phs002065.v1.p1	Bladder Neoplasms
			05/16/2017				./data/phs001252.v1.pht006406.v1.p1.ECLIPSE_Sample_Attributes.var_report.xml									phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			03/17/2015				./data/phs000884.v1.pht004602.v1.p1.Gut_Microbiome_Controls_Sample_Attributes.var_report.xml									phs000884.v1.p1	Human Microbiome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000435.v2.p3.simphen036.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			05/24/2016				./data/phs001065.v1.pht005419.v1.p1.mhxdxhd3.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/07/22				./data/phs001124.v1.pht009256.v1.p1.Sulfonamide_HS_Sample.var_report.xml									phs001124.v1.p1	Drug Hypersensitivity Syndrome
			2019/03/11				./data/phs000286.v6.pht001967.v2.p2.pfha.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht002767.v1.p3.outc_fracture_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/03/01				./data/phs001003.v2.pht010325.v1.p1.Solid_Tumor_SRA.var_report.xml									phs001003.v2.p1	Melanoma
			12/01/2014				./data/phs000839.v1.pht004392.v1.p1.Bitter_Taste_Blockers_Subject_Phenotypes.var_report.xml									phs000839.v1.p1	Taste Perception
			2018/10/23				./data/phs001692.v1.pht008486.v1.p1.LIFE_Subject_Phenotypes.var_report.xml									phs001692.v1.p1	MicroRNAs
			08/20/2013				./data/phs000285.v3.pht001794.v2.p2.E1F51.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			05/24/2017				./data/phs000576.v1.pht006157.v1.p1.physicalexam.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			09/29/2015				./data/phs000892.v2.pht004629.v2.p2.CPTAC_Sample.var_report.xml									phs000892.v2.p2	
			06/30/2014				./data/phs000757.v1.pht003924.v1.p1.Hereditary_Ataxias_Sample_Attributes.var_report.xml									phs000757.v1.p1	Ataxia
2.0	3.0		2019/03/21	5.0		2.0	./data/phs001235.v1.pht008448.v1.p1.MDA5_Deficiency_Subject_Phenotypes.var_report.xml	0.0	2.5	0.7071	3.0			2.5		phs001235.v1.p1	Immunologic Deficiency Syndromes
			07/30/2015				./data/phs000947.v1.pht004829.v1.p1.SLE_Autoantibodies_Sample_Attributes.var_report.xml									phs000947.v1.p1	Systemic Lupus Erythematosus
			01/19/2010				./data/phs000219.v1.pht001087.v1.p1.d_lab.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/12/21				./data/phs000007.v32.pht009755.v1.p13.l_lipids_ex12_0_0342s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/03/19				./data/phs001990.v1.pht010017.v1.p1.Aneurysmal_SAH_Subject.var_report.xml									phs001990.v1.p1	Subarachnoid Hemorrhage
			05/19/2014				./data/phs000745.v1.pht003850.v1.p1.Alzheimers_Posterior_Cingulate_Astrocytes_Sample_Attributes.var_report.xml									phs000745.v1.p1	Alzheimer Disease
			2018/09/06				./data/phs001505.v1.pht007320.v1.p1.SAB_WES_EA_Subject_Phenotypes.var_report.xml									phs001505.v1.p1	Staphylococcus aureus
			2020/12/21				./data/phs000007.v32.pht010753.v1.p13.vr_ffreq_ex03_7_0973s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000400.v2.p3.simphen001.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/07/10				./data/phs001886.v2.pht009419.v2.p1.Placenta_Term_Preterm_Sample_Attributes.var_report.xml									phs001886.v2.p1	Pregnancy, COVID-19
			2020/12/09				./data/phs002298.v1.pht010760.v1.p1.Skin_Pigmentation_AA_Subject_Phenotypes.var_report.xml									phs002298.v1.p1	Skin Pigmentation (Melanin Index)
			07/09/2013				./data/phs000556.v1.pht003138.v1.p1.ESP_AtypicalCysticFibrosis_Sample.var_report.xml									phs000556.v1.p1	Cystic Fibrosis
			04/11/2014				./data/phs000735.v1.pht003796.v1.p1.Placental_Microbiome_Sample.var_report.xml									phs000735.v1.p1	Bacterial Infections
			03/10/2015				./data/phs000516.v2.pht002829.v2.p1.Pancreatic_Ductal_Adenocarcinoma_Sample.var_report.xml									phs000516.v2.p1	Carcinoma, Pancreatic Ductal
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000580.v2.p3.simphen181.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/09/30				./data/phs001951.v1.pht009784.v1.p1.Relapsed_ALL_Sample_Attributes.var_report.xml									phs001951.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2020/04/17				./data/phs001868.v1.pht009778.v1.p1.CM_Risk_Subject.var_report.xml									phs001868.v1.p1	Melanoma
			2019/06/14				./data/phs000589.v1.pht009183.v1.p1.bvas.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			01/05/2016				./data/phs001028.v1.pht005129.v1.p1.Circulating_Tumor_Cells_MBC_Sample.var_report.xml									phs001028.v1.p1	Breast Neoplasms
316.0	404.0		2017/10/05	720.0		316.0	./data/phs001397.v1.pht006954.v1.p1.GUARDIAN_MACAD_Subject_Phenotypes.var_report.xml	0.0	360.0	62.23	404.0			360.0		phs001397.v1.p1	Coronary Artery Disease
			2017/12/08				./data/phs001279.v1.pht007217.v1.p1.registration.var_report.xml									phs001279.v1.p1	Bronchiectasis
			06/05/2017				./data/phs001265.v1.pht006339.v1.p1.OncoArray_DRIVE_Sample.var_report.xml									phs001265.v1.p1	Breast Neoplasms
			2019/06/11				./data/phs001807.v1.pht008977.v1.p1.InTEAM_Sample.var_report.xml									phs001807.v1.p1	Hepatitis, Alcoholic
			2019/04/23				./data/phs001804.v1.pht008964.v1.p1.GEODB_Sample.var_report.xml									phs001804.v1.p1	Opioid-Related Disorders
			2020/02/13				./data/phs001564.v3.pht007989.v3.p1.Urinary_cfDNA_Subject.var_report.xml									phs001564.v3.p1	Bacteriuria
695.0	2276.0		05/16/2017	3861.0		1585.0	./data/phs001252.v1.pht006394.v1.p1.pleth.var_report.xml	0.0	1931.0	488.6	487.0			1931.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/11/13				./data/phs001584.v2.pht010214.v1.p2.eMERGE_III_HRC_Phecode.var_report.xml									phs001584.v2.p2	
			09/29/2015				./data/phs000892.v2.pht004628.v2.p2.CPTAC_Subject.var_report.xml									phs000892.v2.p2	
			2017/11/30				./data/phs000373.v1.pht007128.v1.p1.MrOS_Sample.var_report.xml									phs000373.v1.p1	Osteoporosis
			2021/03/01				./data/phs002294.v1.pht010811.v1.p1.HGSOC_Sample.var_report.xml									phs002294.v1.p1	Ovarian Neoplasms
			2021/08/13				./data/phs002486.v1.pht011470.v1.p1.Nivolumab_TIL_NSCLC_Sample.var_report.xml									phs002486.v1.p1	Carcinoma, Non-Small-Cell Lung
			12/17/2015				./data/phs000728.v1.pht003766.v1.p1.Lung_Cancer_Smokers_Subject.var_report.xml									phs000728.v1.p1	Lung Neoplasms
			03/04/2011				./data/phs000264.v2.pht001419.v1.p1.HMP_Virome_Febrile_Sample.var_report.xml									phs000264.v2.p1	Virus Diseases
			2020/04/29				./data/phs000185.v7.pht003282.v3.p1.Hutterites_16WGS_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			11/04/2014				./data/phs000086.v3.pht000230.v1.p1.DCCT_cbl2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
481.0	785.0		10/14/2015	3088.0		481.0	./data/phs000903.v1.pht004870.v1.p1.OCD_OCGAS_Pedigree.var_report.xml	0.0	633.0	222	785.0			633.0		phs000903.v1.p1	Obsessive-Compulsive Disorder
			2020/02/18				./data/phs001227.v1.pht005834.v1.p1.WUCADS_Subject_Phenotypes.var_report.xml									phs001227.v1.p1	Coronary Artery Disease
			2017/08/25				./data/phs001407.v1.pht006665.v1.p1.HNPCC_Subject.var_report.xml									phs001407.v1.p1	Lynch syndrome I
			2019/07/01				./data/phs001810.v1.pht009068.v1.p1.COCCaINE_Sample_Attributes.var_report.xml									phs001810.v1.p1	Cocaine
			2020/12/21				./data/phs000007.v32.pht005142.v1.p13.e_exam_ex30_0_0274s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/02/2012				./data/phs000456.v1.pht002642.v1.p1.RACE_Sample.var_report.xml									phs000456.v1.p1	Stroke
			06/16/2017				./data/phs001278.v1.pht006274.v1.p1.p7201_14425_disorders.var_report.xml									phs001278.v1.p1	Porphyrias
			10/27/2014				./data/phs000726.v1.pht003777.v1.p1.Myasthenia_Gravis_Subject.var_report.xml									phs000726.v1.p1	Myasthenia gravis
			06/20/2014				./data/phs000759.v1.pht003911.v1.p1.High_Risk_AML_Subject.var_report.xml									phs000759.v1.p1	Leukemia, Myeloid, Acute
			08/15/2012				./data/phs000514.v1.pht002837.v1.p1.Familial_Coronary_Artery_Disease_Subject.var_report.xml									phs000514.v1.p1	Coronary Artery Disease
	2.0		2020/09/18	2.0		2.0	./data/phs002210.v1.pht010518.v1.p1.Structural_Variants_BC_Subject.var_report.xml	0.0	2.0		2.0			2.0		phs002210.v1.p1	Breast Neoplasms
			2018/05/10				./data/phs001565.v1.pht007898.v1.p1.Immune_Checkpoint_Blockade_Sample_Attributes.var_report.xml									phs001565.v1.p1	Neoplasms
			2021/05/20				./data/phs000997.v5.pht005088.v3.p2.TOPMed_WGS_VAFAR_Sample.var_report.xml									phs000997.v5.p2	Atrial Fibrillation
			2018/04/12				./data/phs001458.v1.pht007782.v1.p1.Cannabis_Stimulant_Dependence_Sample_Attributes.var_report.xml									phs001458.v1.p1	Marijuana Abuse
			2019/03/25				./data/phs001164.v1.pht008870.v1.p1.ASD_ROHs_DNMs_Sample.var_report.xml									phs001164.v1.p1	Autism Spectrum Disorder
			01/22/2014				./data/phs000276.v2.pht003627.v1.p1.NFBC66_Sample_Attributes.var_report.xml									phs000276.v2.p1	Metabolic Syndrome X
			2018/08/28				./data/phs001563.v1.pht008324.v1.p1.Blood_Handling_Sample_Attributes.var_report.xml									phs001563.v1.p1	Cerebral Hemorrhage
			08/21/2014				./data/phs000772.v1.pht003997.v1.p1.GenePARE_Sample_Attributes.var_report.xml									phs000772.v1.p1	Prostatic Neoplasms
			2017/08/16				./data/phs001055.v1.pht005913.v1.p1.DeNovo_Mutation_Rates_Sample.var_report.xml									phs001055.v1.p1	Preterm Birth
			08/20/2013				./data/phs000285.v3.pht001723.v2.p2.D1F44.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			02/08/2016				./data/phs000949.v1.pht005226.v1.p1.CIDR_Facial_Variation_Sample_Attributes.var_report.xml									phs000949.v1.p1	Anthropometry
			11/04/2014				./data/phs000086.v3.pht000271.v1.p1.DCCT_status.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht006466.v1.p1.PSA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			07/15/2015				./data/phs000616.v2.pht003370.v2.p2.VIVA_LA_FAMILIA_Sample.var_report.xml									phs000616.v2.p2	Obesity
			08/28/2015				./data/phs000977.v1.pht004954.v1.p1.Desmoplastic_Melanoma_Subject.var_report.xml									phs000977.v1.p1	Melanoma
			2021/01/28				./data/phs002289.v1.pht010895.v1.p1.YSPORE_SC2_Cell_Attributes.var_report.xml									phs002289.v1.p1	single-cell analysis
			11/15/2011				./data/phs000408.v1.pht002439.v1.p1.eMERGE_Obesity_Sample.var_report.xml									phs000408.v1.p1	Obesity
			09/29/2016				./data/phs001216.v1.pht005788.v1.p1.Asthma_Puerto_Rican_Children_Sample_Attributes.var_report.xml									phs001216.v1.p1	Asthma
34.0	96.0		2019/05/16	96.0		96.0	./data/phs001761.v1.pht009029.v1.p1.MPNs_Chernobyl_Subject_Phenotypes.var_report.xml	1.0	96.0	7.071	96.0			96.0		phs001761.v1.p1	Primary Myelofibrosis
			2018/06/14				./data/phs001238.v2.pht006654.v1.p1.GENOA_EuropeanAmerican_Phase1_FamilyHistory.var_report.xml									phs001238.v2.p1	Hypertension
35.0	47.0		2018/08/06	82.0		35.0	./data/phs001655.v1.pht008258.v1.p1.Acne_Skin_Metagenome_Subject_Phenotypes.var_report.xml	0.0	41.0	8.485	47.0			41.0		phs001655.v1.p1	Acne Vulgaris
			2020/10/27				./data/phs001616.v2.pht008543.v2.p2.eMERGEseq_CSGIndications.var_report.xml									phs001616.v2.p2	Precision Medicine
			08/20/2013				./data/phs000285.v3.pht001676.v2.p2.C1F36.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/15				./data/phs001473.v1.pht009688.v1.p1.Ibrutinib_CLL_Sample.var_report.xml									phs001473.v1.p1	Leukemia, Lymphoid
			04/18/2014				./data/phs000438.v1.pht003319.v1.p1.ACE_Inhibitor_Angioedema_Sample.var_report.xml									phs000438.v1.p1	Angioedema
			2017/09/18				./data/phs001310.v1.pht006866.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			2020/06/18				./data/phs000280.v7.pht004156.v2.p1.RHXCOD42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001742.v2.p2.D1LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000788.v1.p1.MS_Sample.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			10/14/2015				./data/phs000879.v1.pht005033.v1.p1.Relapsed_CLL_Sample.var_report.xml									phs000879.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2021/03/01				./data/phs001003.v2.pht010326.v2.p1.Solid_Tumor_Sample_Attributes.var_report.xml									phs001003.v2.p1	Melanoma
			07/14/2010				./data/phs000204.v1.pht001523.v1.p1.Freeman_Sheldon_Syndrome_Exome_Sample.var_report_2010_07_14.xml									phs000204.v1.p1	Freeman-Sheldon Syndrome
			2021/05/17				./data/phs002383.v1.pht011234.v1.p1.Walk_PhaSST_Sample.var_report.xml									phs002383.v1.p1	Sickle Cell Anemia
			03/15/2016				./data/phs001074.v1.pht005339.v1.p1.GeneSTAR_Platelet_Aggregation_iPS_MKs_Subject.var_report.xml									phs001074.v1.p1	Platelet Aggregation
			2021/06/08				./data/phs001215.v4.pht008632.v2.p2.TOPMed_WGS_SAFHS_Sample_Attributes.var_report.xml									phs001215.v4.p2	Cardiovascular Diseases
			2021/03/01				./data/phs001003.v2.pht010322.v2.p1.Solid_Tumor_Subject.var_report.xml									phs001003.v2.p1	Melanoma
			2020/04/29				./data/phs001573.v1.pht010176.v1.p1.pRCC_Subject.var_report.xml									phs001573.v1.p1	Carcinoma, Renal Cell
			02/27/2014				./data/phs000716.v1.pht003705.v1.p1.Lung_Cancer_Never_Smoking_Asian_Subject.var_report.xml									phs000716.v1.p1	Lung Neoplasms
856.0	2426.0		2017/11/22	4718.0		856.0	./data/phs000313.v4.pht002065.v4.p2.SardiNIA_Pedigree.var_report.xml	0.0	2359.0	94.75	2426.0			2359.0		phs000313.v4.p2	Cardiovascular Diseases
			2020/03/09				./data/phs001135.v2.pht005984.v2.p1.START_Sample.var_report.xml									phs001135.v2.p1	Opioid-Related Disorders
			2020/06/18				./data/phs001787.v1.pht009044.v1.p1.CRC_High_Risk_Families_Sample.var_report.xml									phs001787.v1.p1	Colorectal Neoplasms, Hereditary Nonpolyposis
729.0	788.0		09/14/2015	2847.0		701.0	./data/phs000982.v1.pht004983.v1.p1.PsA_Subject_Phenotypes.var_report.xml	0.0	715.0	92.63	788.0			715.0		phs000982.v1.p1	Arthritis, Psoriatic
			11/20/2013				./data/phs000638.v1.pht003571.v1.p1.ALL_Relapse_Sample_Attributes.var_report.xml									phs000638.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2021/05/05				./data/phs002310.v1.pht011209.v1.p1.InC3_Sample_Attributes.var_report.xml									phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			2020/02/13				./data/phs000960.v2.pht004841.v1.p1.Biliary_Atresia_Subject.var_report.xml									phs000960.v2.p1	Biliary Atresia
			2019/03/19				./data/phs001168.v2.pht007579.v2.p2.GMKF_OFC_Sample.var_report.xml									phs001168.v2.p2	Cleft Lip
			2021/01/15				./data/phs000989.v4.pht005023.v4.p1.Cortical_Neurogenesis_Sample_Attributes.var_report.xml									phs000989.v4.p1	Stem cells, neural
			2019/03/25				./data/phs001164.v1.pht008872.v1.p1.ASD_ROHs_DNMs_Sample_Attributes.var_report.xml									phs001164.v1.p1	Autism Spectrum Disorder
			02/08/2017				./data/phs001187.v1.pht005676.v1.p1.CD8_T_Cell_Differentiation_Aging_Subject.var_report.xml									phs001187.v1.p1	Aging
5.0	7.0		06/04/2014	6.0		5.0	./data/phs000660.v1.pht003511.v1.p1.Chinese_AHC_Subject_Phenotypes.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs000660.v1.p1	Alternating hemiplegia of childhood
			2021/04/06				./data/phs001163.v1.pht011099.v1.p1.Chernobyl_Radiation_Sample_Attributes.var_report.xml									phs001163.v1.p1	
			2019/12/12				./data/phs001866.v1.pht009675.v1.p1.ConvertHER_Sample_Attributes.var_report.xml									phs001866.v1.p1	Breast Neoplasms
			06/15/2017				./data/phs001229.v1.pht006548.v1.p1.Follicular_Lymphoma_Seq_Sample.var_report.xml									phs001229.v1.p1	Lymphoma, Follicular
			2021/01/15				./data/phs002240.v1.pht010863.v1.p1.Sex_Differences_Placentas_Sample.var_report.xml									phs002240.v1.p1	Birth Weight
			2020/06/18				./data/phs000280.v7.pht006448.v1.p1.MRF2.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/12/2014				./data/phs000793.v1.pht004020.v1.p1.AML_Epigenetics_Subject.var_report.xml									phs000793.v1.p1	Leukemia, Myeloid, Acute
			2020/12/21				./data/phs000007.v32.pht005175.v1.p13.vr_mmse_ex32_0_0945s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001843.v2.p2.F1F9PRG2.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			10/17/2011				./data/phs000265.v3.pht001275.v3.p1.HMP_Pediatric_Abdominal_Pain_IBD_Sample_Attributes.var_report.xml									phs000265.v3.p1	Irritable Bowel Syndrome
			2019/05/03				./data/phs000681.v2.pht003871.v1.p1.Diabetes_Prevention_Program_Sample.var_report.xml									phs000681.v2.p1	Diabetes Mellitus, Type 2
			2017/12/20				./data/phs000577.v1.pht007290.v1.p1.registration.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2020/03/02	92.0			./data/phs001870.v1.pht009918.v1.p1.BC_Chinese_Subject_Phenotypes.var_report.xml	0.0			92.0					phs001870.v1.p1	Breast Neoplasms
9.0	9.0		2017/10/03	14.0		5.0	./data/phs001464.v1.pht006971.v1.p1.HLA_Class_I_Antigen_Lung_Cancer_Subject_Phenotypes.var_report.xml	0.0	7.0	2.828	5.0			7.0		phs001464.v1.p1	Carcinoma, Non-Small-Cell Lung
			2020/09/18				./data/phs002015.v1.pht010386.v1.p1.AREDS2_MED.var_report.xml									phs002015.v1.p1	Macular Degeneration
			07/18/2014				./data/phs000775.v1.pht003943.v1.p1.Molecular_Genetics_Schizophrenia_Subject.var_report.xml									phs000775.v1.p1	Schizophrenia
			2019/12/12				./data/phs000785.v1.pht004009.v1.p1.SCC_Sample.var_report.xml									phs000785.v1.p1	Carcinoma, Squamous Cell
			2020/12/21				./data/phs000007.v32.pht002346.v3.p13.t_bmdhs_2011_3_0625s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/24				./data/phs001368.v3.pht007958.v3.p2.TOPMed_WGS_CHS_VTE_Sample.var_report.xml									phs001368.v3.p2	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003377.v1.p3.MESA_AncilMesaEyeRetinalPhotoE5.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
1.0			2019/06/24	76.0			./data/phs001836.v1.pht009220.v1.p1.Neocortical_Development_Sample_Attributes.var_report.xml	0.0			3.0					phs001836.v1.p1	Autism Spectrum Disorder
			2019/04/04				./data/phs001742.v2.pht008554.v2.p1.Metastasis_TNBC_Sample_Attributes.var_report.xml									phs001742.v2.p1	Triple Negative Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht002569.v6.p13.l_sdf1_ex06_1_0640s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/27/2015				./data/phs000170.v2.pht000739.v2.p1.Marshfield_Sample.var_report.xml									phs000170.v2.p1	Cataract
			08/20/2013				./data/phs000285.v3.pht001690.v2.p2.C1F9PRG2.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
9.0	9.0		2020/06/30	15.0		6.0	./data/phs002045.v1.pht010309.v1.p1.PDAC_Subject_Phenotypes.var_report.xml	0.0	7.5	2.121	6.0			7.5		phs002045.v1.p1	Carcinoma, Pancreatic Ductal
77.0	77.0		2020/08/24	62.0		926.0	./data/phs001744.v1.pht008572.v1.p1.CIDR_HCC_Subject_Phenotypes.var_report.xml	0.0	61.0	970.9	926.0			61.0		phs001744.v1.p1	Liver Neoplasms
			08/28/2012				./data/phs000448.v1.pht002510.v1.p1.AJ_SZ_Subject_Phenotypes.var_report.xml									phs000448.v1.p1	Schizophrenia
			2018/10/02				./data/phs001696.v1.pht008430.v1.p1.EAC_Chinese_Sample.var_report.xml									phs001696.v1.p1	Esophageal Neoplasms
			2020/12/21				./data/phs000007.v32.pht005153.v3.p13.t_ctabfat_2011_m_0669s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
573.0			2020/01/07	905.0			./data/phs001741.v1.pht009163.v1.p1.CCDG_TASC_Pedigree.var_report.xml	0.0			34.0					phs001741.v1.p1	Autism Spectrum Disorder
			2020/12/21				./data/phs000007.v32.pht000685.v2.p13.ntx1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
10.0	10.0		2021/08/13	20.0		10.0	./data/phs002486.v1.pht011469.v1.p1.Nivolumab_TIL_NSCLC_Subject.var_report.xml	0.0	10.0	0	10.0			10.0		phs002486.v1.p1	Carcinoma, Non-Small-Cell Lung
			2018/05/15				./data/phs001311.v1.pht007920.v1.p1.ae_mro_review.var_report.xml									phs001311.v1.p1	Myotonia
			08/12/2016				./data/phs000888.v1.pht005563.v1.p1.12aAtopic_dermatitis_meds.var_report.xml									phs000888.v1.p1	
			07/12/2017				./data/phs000592.v1.pht006586.v1.p1.deathrecord.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			11/29/2012				./data/phs000541.v1.pht003048.v1.p1.Mendelian_Muscle_Hypertrophy_Subject.var_report.xml									phs000541.v1.p1	Hypertrophy
			2021/04/28				./data/phs002408.v1.pht011160.v1.p1.CTCF_11p15_Sample.var_report.xml									phs002408.v1.p1	Beckwith-Wiedemann Syndrome
			2018/06/27				./data/phs001006.v1.pht006001.v1.p1.Lobular_Carcinomas_Subject.var_report.xml									phs001006.v1.p1	Carcinoma, Lobular
			2021/03/30				./data/phs001307.v1.pht011047.v1.p1.TGCT_UPenn_Sample.var_report.xml									phs001307.v1.p1	Testicular Germ Cell Tumor
			2019/03/18				./data/phs001796.v1.pht008835.v1.p1.CTS_Nerve_Repair_Sample_Attributes.var_report.xml									phs001796.v1.p1	Carpal Tunnel Syndrome
			2017/12/04				./data/phs001366.v1.pht006576.v1.p1.SCLC_CTCA_Sample.var_report.xml									phs001366.v1.p1	Small Cell Lung Carcinoma
			2017/12/04				./data/phs001419.v1.pht007085.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
130.0	130.0		2019/11/22	242.0		112.0	./data/phs000999.v3.pht005182.v3.p1.CSER_ClinSeq_Cancer_Subject_Phenotypes.var_report.xml	0.0	121.0	12.73	112.0			121.0		phs000999.v3.p1	Colorectal Neoplasms
			2021/01/12				./data/phs001617.v1.pht010620.v1.p1.Growth_Disorders_Subject_Phenotypes.var_report.xml									phs001617.v1.p1	Growth Disorders
			05/09/2016				./data/phs001112.v1.pht005471.v1.p1.ChrX_Mosaicism_Methylation_Sample.var_report.xml									phs001112.v1.p1	Neoplasm
			09/11/2012				./data/phs000535.v1.pht002957.v1.p1.Bladder_Cancer_Subject.var_report.xml									phs000535.v1.p1	Urinary Bladder Neoplasms
			2020/11/13				./data/phs002019.v1.pht010174.v1.p1.SCCIS_Subject_Phenotypes.var_report.xml									phs002019.v1.p1	Carcinoma in Situ
			2021/08/27				./data/phs000966.v2.pht005308.v2.p2.Essential_Tremor_FASET_Sample_Attributes.var_report.xml									phs000966.v2.p2	Essential Tremor
1691.0	8069.0		05/16/2017	13126.0		5057.0	./data/phs001252.v1.pht006382.v1.p1.exacrate.var_report.xml	0.0	6563.0	2130	1055.0			6563.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/02/14				./data/phs000575.v2.pht005896.v2.p1.kbit.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
4.0	4.0		11/16/2016	7.0		3.0	./data/phs001200.v1.pht005927.v1.p1.West_Nile_Virus_NAb_Subject_Phenotypes.var_report.xml	0.0	3.5	0.7071	3.0			3.5		phs001200.v1.p1	West Nile Fever
3747.0	3747.0		2021/03/17	3747.0		3747.0	./data/phs002226.v1.pht011063.v1.p1.MACS_Subject.var_report.xml	0.0	3747.0					3747.0		phs002226.v1.p1	HIV
			2020/01/10				./data/phs001471.v1.pht009805.v1.p1.Subject_Phenotypes_TIME4.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			08/26/2013				./data/phs000656.v1.pht003483.v1.p1.Influenza_Vaccination_B_cell_Recall_SampleAttributesDS.var_report.xml									phs000656.v1.p1	Influenza Vaccines
			08/20/2015				./data/phs000910.v1.pht004725.v1.p1.T1DGC_CNV_Subject.var_report.xml									phs000910.v1.p1	Diabetes Mellitus, Type 1
			2021/01/27				./data/phs002313.v1.pht010819.v1.p1.AAOV_Sample.var_report.xml									phs002313.v1.p1	Cancer
			04/16/2013				./data/phs000145.v4.pht000660.v2.p2.POPRES_PC_Scores.var_report.xml									phs000145.v4.p2	Normalcy
			2021/05/07				./data/phs000946.v5.pht004973.v3.p1.TOPMed_WGS_Boston_EO_COPD_Sample.var_report.xml									phs000946.v5.p1	Chronic Obstructive Pulmonary Disease
			06/01/2015				./data/phs000912.v1.pht004731.v1.p1.Breast_Cancer_Latina_Sample.var_report.xml									phs000912.v1.p1	Breast Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000566.v2.p3.simphen167.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
917.0	917.0		2019/11/15	1776.0		859.0	./data/phs000784.v3.pht004284.v1.p1.GenSalt_Pedigree.var_report.xml	0.0	888.0	41.01	859.0			888.0		phs000784.v3.p1	Arterial Pressure, Mean
			2019/03/25				./data/phs001747.v1.pht008642.v1.p1.CAREGIVER_Subject.var_report.xml									phs001747.v1.p1	Coronary Disease
			11/04/2014				./data/phs000086.v3.pht000336.v1.p1.EDIC_f0602.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
87.0	99.0		2019/08/18	186.0		87.0	./data/phs001201.v2.pht007557.v2.p1.SubjectClinicalVariables.var_report.xml	0.0	93.0	8.485	99.0			93.0		phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2019/05/07				./data/phs001524.v1.pht008557.v1.p1.PC_Rare_Variation_Subject_Phenotypes.var_report.xml									phs001524.v1.p1	Prostatic Neoplasms
			07/25/2014				./data/phs000779.v1.pht003964.v1.p1.OFCCR_SNP_CpG_Sample_Attributes.var_report.xml									phs000779.v1.p1	Colorectal Neoplasms
			2018/09/06				./data/phs001505.v1.pht007319.v1.p1.SAB_WES_EA_Sample.var_report.xml									phs001505.v1.p1	Staphylococcus aureus
			02/21/2012				./data/phs000400.v1.pht002534.v1.p1.ESP_CHS_Subject.var_report.xml									phs000400.v1.p1	Cardiovascular Diseases
			08/21/2014				./data/phs000772.v1.pht003996.v1.p1.GenePARE_Subject_Phenotypes.var_report.xml									phs000772.v1.p1	Prostatic Neoplasms
310.0	3183.0		09/03/2009	5667.0		2484.0	./data/phs000166.v2.pht000705.v2.p1.ACRN_LData.var_report_2009_09_03.xml	0.0	2834.0	494.3	411.0			2834.0		phs000166.v2.p1	Asthma
4.0	4.0		09/10/2012	8.0		4.0	./data/phs000434.v1.pht002606.v1.p1.Atypical_Werner_Syndrome_Subject_Phenotypes.var_report.xml	0.0	4.0	0	4.0			4.0		phs000434.v1.p1	Werner Syndrome
			2017/12/04				./data/phs001419.v1.pht007088.v1.p1.eligibility.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2021/02/02				./data/phs002327.v1.pht010917.v1.p1.ATR_Stress_Tumors_Subject_Phenotypes.var_report.xml									phs002327.v1.p1	Small Cell Lung Carcinoma
65.0	81.0		2020/01/23	5.0		92.0	./data/phs000287.v7.pht001475.v1.p1.YR11.var_report.xml	26.0	79.5	96.87	94.0			79.5		phs000287.v7.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000261.v1.p1.DCCT_cbl8.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			08/06/2010				./data/phs000182.v2.pht000795.v1.p1.AMD_MMAP_Phenotype.var_report.xml									phs000182.v2.p1	Macular Degeneration
			2018/09/19				./data/phs001581.v1.pht008381.v1.p1.HNSCC_Cell_Lines_Subject.var_report.xml									phs001581.v1.p1	Head and Neck Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000596.v2.p3.simphen197.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/06/08				./data/phs001217.v3.pht007761.v1.p1.TOPMed_WGS_GenSalt_Subject.var_report.xml									phs001217.v3.p1	Arterial Pressure, Mean
			2020/07/20				./data/phs002025.v1.pht010236.v1.p1.TB_3q23_Peruvians_Sample.var_report.xml									phs002025.v1.p1	Tuberculosis, Pulmonary
			11/04/2014				./data/phs000086.v3.pht000272.v1.p1.DCCT_f083cmb2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/01/23				./data/phs000287.v7.pht001492.v1.p1.YR6.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2019/10/29				./data/phs001924.v1.pht009573.v1.p1.Cholangiocarcinoma_Subject.var_report.xml									phs001924.v1.p1	Cholangiocarcinoma
			2019/10/01				./data/phs001416.v2.pht009014.v1.p1.TOPMed_WGS_MESA_Sample.var_report.xml									phs001416.v2.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001822.v2.p2.F1F18R.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/17/2017				./data/phs000816.v2.pht004344.v2.p1.X_Chromosome_Inactivation_Sample_Attributes.var_report.xml									phs000816.v2.p1	X Chromosome Inactivation
			2020/12/21				./data/phs000007.v32.pht009754.v2.p13.l_igfbp_ex01_3b_0469s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008719.v1.p2.abbb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/04/16				./data/phs001289.v1.pht007791.v1.p1.eligibility.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			07/27/2017				./data/phs000247.v5.pht001288.v5.p3.HMP_Neonatal_Enterocolitis_Sample_Attributes.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			2020/02/03				./data/phs000815.v2.pht006791.v2.p1.Human_Leukocytes_Sample.var_report.xml									phs000815.v2.p1	
			2018/08/03				./data/phs000590.v1.pht008266.v1.p1.angiogram_rightupperextremity.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
21.0	21.0		2018/12/11	39.0		18.0	./data/phs001750.v1.pht008588.v1.p1.sc_Pulmonary_Fibrosis_Subject_Phenotypes.var_report.xml	0.0	19.5	2.121	18.0			19.5		phs001750.v1.p1	Pulmonary Fibrosis
			2018/09/26				./data/phs001410.v1.pht008423.v1.p1.GMKF_AIS_Subject_Phenotypes.var_report.xml									phs001410.v1.p1	Scoliosis
			2018/09/14				./data/phs001658.v1.pht008343.v1.p1.Adrenocortical_Carcinoma_Sample.var_report.xml									phs001658.v1.p1	Adrenocortical Carcinoma
			2017/12/20				./data/phs000577.v1.pht007278.v1.p1.neuropsychformd.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			08/27/2013				./data/phs000650.v1.pht003486.v1.p1.PediGFR_CKiD_Subject_Phenotypes.var_report.xml									phs000650.v1.p1	Kidney Diseases
914.0	123.0		2019/04/25	2058.0		914.0	./data/phs001673.v1.pht008512.v1.p1.ADAGESIII_Subject_Phenotypes.var_report.xml	0.0	940.0	48.08	123.0			940.0		phs001673.v1.p1	Glaucoma
			12/07/2015				./data/phs000482.v1.pht002884.v1.p1.Sporadic_Autism_Sample_Attributes.var_report.xml									phs000482.v1.p1	Autistic Disorder
			2018/03/06				./data/phs000603.v1.pht007545.v1.p1.amerelatedbaselinemedicalhxform.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			08/20/2013				./data/phs000285.v3.pht001638.v2.p2.B2F34.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/04/2014				./data/phs000734.v1.pht003770.v1.p1.Osteosarcoma_Risk_Sample.var_report.xml									phs000734.v1.p1	Osteosarcoma
			2018/02/08				./data/phs001488.v1.pht007382.v1.p1.concl.var_report.xml									phs001488.v1.p1	Huntington Disease
			2021/09/29				./data/phs001608.v2.pht011585.v1.p1.OMG_SCD_medicationData.var_report.xml									phs001608.v2.p1	Anemia, Sickle Cell
			2018/04/16				./data/phs001326.v1.pht007818.v1.p1.pidtc_17995_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2018/03/09				./data/phs000606.v1.pht007575.v1.p1.lab_preoperative.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
9.0	9.0		2017/09/27	9.0		9.0	./data/phs000747.v2.pht003845.v2.p1.IBBE_Sporadic_ALS_Subject_Phenotypes.var_report.xml	0.0	9.0					9.0		phs000747.v2.p1	Amyotrophic Lateral Sclerosis
	695.0		11/16/2011	1345.0		650.0	./data/phs000096.v4.pht001880.v1.p1.HAPO_AfroCarib_Phenotypes.var_report.xml	0.0	672.5	31.82	1344.0			672.5		phs000096.v4.p1	Pregnancy Complications
			07/21/2009				./data/phs000142.v1.pht000639.v1.p1.MyopiaGlaucoma_Subject.var_report_2009_07_21.xml									phs000142.v1.p1	Eye Diseases
			2020/07/17				./data/phs001995.v1.pht009992.v1.p1.Himba_Sample.var_report.xml									phs001995.v1.p1	Sex
			03/31/2015				./data/phs000832.v1.pht004424.v1.p1.Amphetamine_Sensitivity_Sample.var_report.xml									phs000832.v1.p1	Dextroamphetamine
			2020/12/21				./data/phs000007.v32.pht000387.v4.p13.liverct1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006457.v1.p1.NHX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/03/2009				./data/phs000166.v2.pht000706.v1.p1.CAMP_CARE_ACRN_Subject.var_report_2009_09_03.xml									phs000166.v2.p1	Asthma
			05/08/2012				./data/phs000443.v1.pht002533.v1.p1.Prostate_Cancer_PCAT1_Sample_Attributes.var_report.xml									phs000443.v1.p1	Prostatic Neoplasms
			2021/01/28				./data/phs002289.v1.pht010892.v1.p1.YSPORE_SC2_Sample.var_report.xml									phs002289.v1.p1	single-cell analysis
			07/27/2012				./data/phs000297.v1.pht002392.v1.p1.Resistant_HTN_Sample.var_report.xml									phs000297.v1.p1	Hypertension
			2018/03/23				./data/phs000698.v1.pht007687.v1.p1.ae_mro_review.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			2021/08/13				./data/phs001442.v3.pht008328.v3.p2.TEDDY_Cohort_Sample.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
989.0	989.0		2021/06/01	679.0		866.0	./data/phs001143.v4.pht005903.v1.p1.TOPMed_WGS_BAGS_Pedigree.var_report.xml	0.0	927.5	86.97	866.0			927.5		phs001143.v4.p1	Asthma
			2019/08/30				./data/phs001331.v2.pht006928.v2.p1.p6501_13994_researchs.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			2020/10/16				./data/phs002269.v1.pht010581.v1.p1.Tumor_Neoantigens_Sample.var_report.xml									phs002269.v1.p1	Antigens, Neoplasm
222.0			2021/06/28	290.0			./data/phs001598.v2.pht009997.v1.p1.TOPMed_CCDG_JHU_AF_Subject_Phenotypes.var_report.xml	0.0			68.0					phs001598.v2.p1	Atrial Fibrillation
			05/09/2016				./data/phs001101.v1.pht005368.v1.p1.MIGen_MDC_Sample_Attributes.var_report.xml									phs001101.v1.p1	Myocardial Infarction
			2020/02/14				./data/phs000575.v2.pht005901.v2.p1.registration.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			01/26/2015				./data/phs000837.v1.pht004440.v1.p1.22q11DS_Sample.var_report.xml									phs000837.v1.p1	Tetralogy of Fallot
			08/06/2013				./data/phs000646.v1.pht003435.v1.p1.Breakpoint_Detection_LI_WGS_Sample.var_report.xml									phs000646.v1.p1	Chromosome Breakpoints
			03/06/2017				./data/phs001248.v1.pht006095.v1.p1.LRTI_Sample_Attributes.var_report.xml									phs001248.v1.p1	Respiratory Tract Infections
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000539.v2.p3.simphen140.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/09/13				./data/phs002487.v1.pht011543.v1.p1.Schizophrenia_Antipsychotics_Subject_Phenotypes.var_report.xml									phs002487.v1.p1	Schizophrenic Disorders
			2021/03/01				./data/phs001003.v2.pht010323.v2.p1.Solid_Tumor_Sample.var_report.xml									phs001003.v2.p1	Melanoma
			2019/04/04				./data/phs001803.v1.pht008937.v1.p1.Dystonias_Subject.var_report.xml									phs001803.v1.p1	Cervical Dystonia
			11/04/2014				./data/phs000086.v3.pht000343.v1.p1.EDIC_f0913.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
2.0	2.0		2019/11/22	3.0		2.0	./data/phs001325.v3.pht006352.v2.p1.iPSCORE_WGS_Subject_Phenotypes.var_report.xml	0.0	2.0	24.04	152.0			2.0		phs001325.v3.p1	Heart Diseases
			10/15/2015				./data/phs000870.v1.pht004548.v1.p1.Alternative_Splicing_Sample.var_report.xml									phs000870.v1.p1	
			05/17/2017				./data/phs001328.v1.pht006309.v1.p1.ldn_14090_mri.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			2019/03/19				./data/phs001168.v2.pht007580.v2.p2.GMKF_OFC_Subject_Phenotypes.var_report.xml									phs001168.v2.p2	Cleft Lip
			06/01/2017				./data/phs000701.v1.pht005522.v1.p1.PhysicalExam.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2018/09/07				./data/phs001551.v1.pht008347.v1.p1.CURE_EGI_Sample.var_report.xml									phs001551.v1.p1	Epilepsy
			2019/09/19				./data/phs001877.v1.pht009482.v1.p1.Mycosis_Fungoides_Sample.var_report.xml									phs001877.v1.p1	Mycosis Fungoides
152.0			2019/03/11	302.0			./data/phs001717.v1.pht008580.v1.p1.Placental_Regulation_Subject_Phenotypes.var_report.xml	0.0			150.0					phs001717.v1.p1	Control Groups
			2017/12/20				./data/phs000577.v1.pht007287.v1.p1.physical_examination_form.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2020/04/02				./data/phs000277.v2.pht002795.v2.p1.Heroin_Dependence_Subject.var_report.xml									phs000277.v2.p1	Heroin Dependence
			2020/12/21				./data/phs000007.v32.pht007773.v2.p13.vr_dgai2010_ex07_1_1108s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht002719.v1.p1.dct.var_report.xml									phs000343.v3.p1	Stroke
			2019/07/29				./data/phs001799.v1.pht008876.v1.p1.Neutrophilic_Leukemias_Subject.var_report.xml									phs001799.v1.p1	Leukemia
			07/09/2012				./data/phs000511.v1.pht002819.v1.p1.Hypertriglyceridemia_I_III_V_Sample_Attributes.var_report.xml									phs000511.v1.p1	Hypertriglyceridemia
			2021/04/07				./data/phs001349.v2.pht010330.v1.p1.TGCT_Sample_Attributes.var_report.xml									phs001349.v2.p1	Testicular Germ Cell Tumor
			08/20/2013				./data/phs000285.v3.pht001845.v2.p2.F1GLU.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/07/26				./data/phs001852.v1.pht009279.v1.p1.Height_Jewish_Sample_Attributes.var_report.xml									phs001852.v1.p1	Body Height
			2020/04/29				./data/phs000185.v7.pht010105.v1.p1.Hutterites_3Gen_WGS_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			2018/05/22				./data/phs001314.v1.pht007996.v1.p1.GSD_5611_Subject.var_report.xml									phs001314.v1.p1	Steroid 21-Hydroxylase
			2019/11/19				./data/phs000572.v8.pht003454.v5.p4.ConnectingFamilySubjectPhenotypes_y1.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			2017/12/04				./data/phs001419.v1.pht007084.v1.p1.chqqol.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/12/21				./data/phs000007.v32.pht006007.v1.p13.e_exam_ex31_0_0738s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
26.0	26.0		09/24/2013	42.0		16.0	./data/phs000364.v2.pht002262.v2.p1.ChronicLymphocyticLeukemia_Subject_Phenotypes.var_report.xml	1.0	21.0	7.071	16.0			21.0		phs000364.v2.p1	Chronic Lymphocytic Leukemia
			11/05/2014				./data/phs000209.v13.pht003373.v1.p3.MESA_AncilMesaAbdBodyCompCT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/07/24				./data/phs001194.v3.pht005815.v2.p2.OtherGeneticTestResults.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2020/12/21				./data/phs000007.v32.pht004813.v2.p13.e_exam_ex01_7_0020s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/04/25				./data/phs000899.v1.pht008945.v1.p1.AmBiGen_Sample_Attributes.var_report.xml									phs000899.v1.p1	Bipolar Disorder
828.0	865.0		2018/07/23	7870.0		828.0	./data/phs000742.v1.pht008106.v1.p1.EPGP_Pedigree.var_report.xml	0.0	846.5	297	865.0			846.5		phs000742.v1.p1	Epilepsy
1168.0	1786.0		10/21/2015	2969.0		15.0	./data/phs000813.v1.pht004304.v1.p1.Nicotine_Dependence_Genomic_Regions_Subject_Phenotypes.var_report.xml	0.0	989.7	898.9	1786.0			1168.0		phs000813.v1.p1	Tobacco Use Disorder
			11/04/2014				./data/phs000086.v3.pht000265.v1.p1.DCCT_f013cmb3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			11/04/2014				./data/phs000086.v3.pht000242.v1.p1.DCCT_f003cmb2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			05/09/2016				./data/phs001112.v1.pht005470.v1.p1.ChrX_Mosaicism_Methylation_Subject.var_report.xml									phs001112.v1.p1	Neoplasm
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000406.v2.p3.simphen007.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			10/07/2016				./data/phs000497.v3.pht002712.v3.p2.Hirschsprung_Disease_Sample.var_report.xml									phs000497.v3.p2	Disease, Hirschsprung
			12/11/2009				./data/phs000171.v1.pht000765.v1.p1.MS_DATA_MHQCOVER.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			10/07/2011				./data/phs000368.v1.pht002291.v1.p1.NU_PCOS_Subject.var_report.xml									phs000368.v1.p1	Polycystic Ovary Syndrome
			2019/03/11				./data/phs000286.v6.pht001982.v2.p2.wsia.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001454.v1.p1.BONE_DENSITY_FOLLOWUP.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001755.v2.p2.E1ECHY05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			09/27/2010				./data/phs000245.v1.pht001913.v1.p1.Triple_Negative_Breast_Cancer_Subject.var_report_2010_09_27.xml									phs000245.v1.p1	Breast Neoplasms
1505.0	500000.0		05/16/2017	799267.0		300000.0	./data/phs001252.v1.pht006402.v1.p1.vdawall.var_report.xml	0.0	400000.0	140000	990.0			400000.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2021/04/06				./data/phs001163.v1.pht011097.v1.p1.Chernobyl_Radiation_Sample.var_report.xml									phs001163.v1.p1	
			2020/06/18				./data/phs000280.v7.pht006464.v1.p1.PHX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/10/04				./data/phs000920.v5.pht004900.v5.p3.TOPMed_WGS_GALAII_Sample_Attributes.var_report.xml									phs000920.v5.p3	Lung Diseases
			09/28/2012				./data/phs000549.v1.pht002991.v1.p1.AML_Clonal_Evolution_Sample.var_report.xml									phs000549.v1.p1	Leukemia, Myeloid, Acute
			2021/07/22				./data/phs001605.v2.pht010082.v2.p1.TOPMed_WGS_CHIRAH_Sample_Attributes.var_report.xml									phs001605.v2.p1	Asthma
			10/24/2013				./data/phs000618.v1.pht003304.v1.p1.Hypertriglyceridemia_Mexican_Sample_Attributes.var_report.xml									phs000618.v1.p1	Hypertriglyceridemia
			2019/12/10				./data/phs001913.v1.pht009512.v1.p1.CCDG_eMERGE_Northwestern_Subject.var_report.xml									phs001913.v1.p1	Cardiovascular Diseases
			2019/05/30				./data/phs001222.v1.pht005909.v1.p1.CCDG_T1DGC_Subject_Phenotypes.var_report.xml									phs001222.v1.p1	Diabetes Mellitus, Type 1
			08/20/2013				./data/phs000285.v3.pht001700.v2.p2.CENTER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/05/11				./data/phs000954.v4.pht006299.v2.p2.TOPMed_WGS_CFS_Sample_Attributes.var_report.xml									phs000954.v4.p2	Sleep Apnea Syndromes
			2018/04/16				./data/phs001326.v1.pht007812.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			05/08/2017				./data/phs001320.v1.pht006288.v1.p1.Placentation_Pregnancy_CVS_Subject.var_report.xml									phs001320.v1.p1	Pre-eclampsia
			04/16/2012				./data/phs000475.v1.pht002689.v1.p1.Inherited_Reproductive_Disorders_Subject.var_report.xml									phs000475.v1.p1	Hypogonadism 
			2019/08/10				./data/phs001876.v1.pht009387.v1.p1.BSRC_ASD_CNV_Subject.var_report.xml									phs001876.v1.p1	Autism Spectrum Disorder
82.0	82.0		2021/07/13	88.0		63.0	./data/phs002481.v1.pht011371.v1.p1.SCA_Subject.var_report.xml	0.0	72.5	14.14	63.0			72.5		phs002481.v1.p1	Aneuploidy
			07/09/2013				./data/phs000556.v1.pht003139.v1.p1.ESP_AtypicalCysticFibrosis_Subject_Phenotypes.var_report.xml									phs000556.v1.p1	Cystic Fibrosis
7.0	7.0		03/24/2015	24.0		6.0	./data/phs000872.v1.pht004574.v1.p1.Autism_Postmortem_Brain_Subject_Phenotypes.var_report.xml	0.0	6.0	8.485	6.0			6.0		phs000872.v1.p1	Autistic Disorder
			2018/05/15				./data/phs001309.v1.pht007912.v1.p1.RLD_5706_Subject.var_report.xml									phs001309.v1.p1	Pulmonary Alveolar Proteinosis
			2019/05/07				./data/phs001409.v1.pht006799.v1.p1.Uterine_Fibroids_AA_EA_Sample.var_report.xml									phs001409.v1.p1	Leiomyoma
			2021/01/07				./data/phs002083.v1.pht010656.v1.p1.TS_ccRCC_Subject_Phenotypes.var_report.xml									phs002083.v1.p1	Carcinoma, Renal Cell
			12/17/2012				./data/phs000567.v1.pht003079.v1.p1.Solitary_Fibrous_Tumor_Sample.var_report.xml									phs000567.v1.p1	Solitary Fibrous Tumors
			2017/11/14				./data/phs001241.v1.pht005922.v1.p1.Metastatic_Melanomas_Sample.var_report.xml									phs001241.v1.p1	Melanoma
			2020/01/07				./data/phs001941.v1.pht009745.v1.p1.Otitis_Media_Sample_Attributes.var_report.xml									phs001941.v1.p1	Otitis Media
996.0			02/20/2015	173.0			./data/phs000431.v2.pht004307.v1.p1.IGAN2.var_report.xml	0.0			94.0					phs000431.v2.p1	Glomerulonephritis, IGA
			2019/10/10				./data/phs001273.v3.pht006174.v2.p2.OncoArray_Lung_Cancer_Sample_Attributes.var_report.xml									phs001273.v3.p2	Lung Neoplasms
135.0			2020/02/14	490.0			./data/phs000575.v2.pht005884.v2.p1.bascform.var_report.xml	19.0			155.0					phs000575.v2.p1	Prader-Willi Syndrome
			06/27/2017				./data/phs001389.v1.pht006602.v1.p1.GBM_Tumors_Sample.var_report.xml									phs001389.v1.p1	Glioblastoma
			06/30/2014				./data/phs000757.v1.pht003920.v1.p1.Hereditary_Ataxias_Subject.var_report.xml									phs000757.v1.p1	Ataxia
3314.0	4943.0		12/17/2014	8257.0		3314.0	./data/phs000486.v1.pht002803.v1.p1.GODOT_Pedigree.var_report.xml	0.0	4129.0	1152	4943.0			4129.0		phs000486.v1.p1	Depressive Disorder, Major
			2019/04/09				./data/phs001802.v1.pht008959.v1.p1.Lymphatic_Anomalies_CAG_Sample.var_report.xml									phs001802.v1.p1	Lymphatic Diseases
533.0	761.0		2018/06/13	2587.0		533.0	./data/phs001490.v1.pht008137.v1.p1.T2D_GENES_BioMe_Subject_Phenotypes.var_report.xml	0.0	647.0	323.1	761.0			647.0		phs001490.v1.p1	Diabetes Mellitus, Type 2
			2020/12/21				./data/phs000007.v32.pht002153.v1.p13.ffreq0_22s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001796.v2.p2.E1F9PRG1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
320.0	320.0		05/12/2015	555.0		235.0	./data/phs000894.v1.pht004660.v1.p1.Acute_Kidney_Injury_Vancomycin_Subject_Phenotypes.var_report.xml	0.0	277.5	60.1	235.0			277.5		phs000894.v1.p1	Acute Kidney Injury
4.0	4.0		2021/02/04	8.0		4.0	./data/phs002333.v1.pht010919.v1.p1.Chronic_Rhinosinusitis_Subject.var_report.xml	0.0	4.0	0	4.0			4.0		phs002333.v1.p1	Paranasal Sinus Diseases
			2018/12/28				./data/phs001663.v1.pht008403.v1.p1.GBM_POLE_Deficiency_Sample_Attributes.var_report.xml									phs001663.v1.p1	Glioblastoma
			05/16/2017				./data/phs001252.v1.pht006366.v1.p1.ECLIPSE_Subject.var_report.xml									phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/12/21				./data/phs000007.v32.pht003463.v4.p13.vr_crdstrex_ex02_3_0821s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/02				./data/phs000962.v1.pht006968.v1.p1.CIDR_Brain_Growth_Children_Sample_Attributes.var_report.xml									phs000962.v1.p1	Cerebral Cortex
			11/08/2013				./data/phs000200.v9.pht002124.v1.p3.outc_self_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
7.0	7.0		2021/07/07	13.0		6.0	./data/phs002436.v1.pht011377.v1.p1.TIL_Infusion_Subject_Phenotypes.var_report.xml	0.0	6.5	0.7071	6.0			6.5		phs002436.v1.p1	Melanoma
			2018/02/15				./data/phs001496.v1.pht007339.v1.p1.Warfarin_Caribbean_Hispanics_Sample.var_report.xml									phs001496.v1.p1	Warfarin Sensitivity
			11/16/2015				./data/phs000896.v1.pht005126.v1.p1.LGG_Probiotics_Metagenome_Sample_Attributes.var_report.xml									phs000896.v1.p1	Human Microbiome
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000282.v1.p1.DCCT_f002cmb4.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/04/14				./data/phs001570.v2.pht007870.v2.p1.CALGB_40601_Sample_Attributes.var_report.xml									phs001570.v2.p1	Neoplasms
1915.0			2018/04/05	3813.0			./data/phs001522.v1.pht007729.v1.p1.cDNMs_Pedigree.var_report.xml	0.0			1898.0					phs001522.v1.p1	
	6.0		2017/08/14	6.0		6.0	./data/phs000803.v2.pht004566.v2.p1.Colon_Cancer_Subject_Phenotypes.var_report.xml	0.0	6.0		6.0			6.0		phs000803.v2.p1	Colonic Neoplasms
109.0			2021/07/22	292.0			./data/phs001605.v2.pht010081.v1.p1.TOPMed_WGS_CHIRAH_Subject_Phenotypes.var_report.xml	0.0			183.0					phs001605.v2.p1	Asthma
9.0	9.0		2017/10/02	306.0		77.0	./data/phs000962.v1.pht006965.v1.p1.CIDR_Brain_Growth_Children_Pedigree.var_report.xml	0.0	81.0	5.657	77.0			81.0		phs000962.v1.p1	Cerebral Cortex
			2021/02/11				./data/phs001140.v1.pht010944.v1.p1.ALCHEMIST_Subject.var_report.xml									phs001140.v1.p1	
			2020/02/04				./data/phs001721.v1.pht009720.v1.p1.IBDGC_Repo_IC_Sample_Attributes.var_report.xml									phs001721.v1.p1	Inflammatory Bowel Disease
			08/20/2013				./data/phs000285.v3.pht001564.v2.p2.A4F06BH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/08/17				./data/phs000397.v3.pht002409.v3.p3.LLFS_Sample.var_report.xml									phs000397.v3.p3	Longevity
128.0	140.0		2018/08/19	268.0		128.0	./data/phs000101.v5.pht000187.v1.p1.ALS_First_Stage_Controls.var_report.xml	0.0	134.0	8.485	140.0			134.0		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			01/05/2016				./data/phs000917.v1.pht004738.v1.p1.MIGen_Exome_PROMIS_Subject.var_report.xml									phs000917.v1.p1	Coronary Artery Disease
			05/24/2016				./data/phs001065.v1.pht005417.v1.p1.mhxdxhd1.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/06/02				./data/phs001841.v1.pht009904.v1.p1.CADD_GADD_Subject.var_report.xml									phs001841.v1.p1	Opioid-Related Disorders
			07/14/2010				./data/phs000244.v1.pht001521.v1.p1.Miller_Syndrome_Exome_Sample.var_report_2010_07_14.xml									phs000244.v1.p1	Genee-Wiedemann Syndrome
			2019/08/27				./data/phs001845.v1.pht009406.v1.p1.SDS_Subject.var_report.xml									phs001845.v1.p1	Shwachman syndrome [Supplementary Concept]
			12/06/2012				./data/phs000565.v1.pht003074.v1.p1.RHD_Subject.var_report.xml									phs000565.v1.p1	Congenital Abnormalities
			2020/06/29				./data/phs001180.v2.pht006988.v1.p1.GALAII_Subject.var_report.xml									phs001180.v2.p1	Lung Diseases
			2017/08/18				./data/phs001363.v1.pht006517.v1.p1.P100_Sample.var_report.xml									phs001363.v1.p1	Health
4.0	4.0		2018/01/30	8.0		4.0	./data/phs000904.v1.pht004689.v1.p1.Familial_Adenomatous_Polyposis_Subject_Phenotypes.var_report.xml	0.0	4.0	0.7071	4.0			4.0		phs000904.v1.p1	Familial Adenomatous Polyposis
			2018/01/08				./data/phs001291.v1.pht007328.v1.p1.Neoadjuvant_Trastuzumab_BC_Sample.var_report.xml									phs001291.v1.p1	Breast Neoplasms
			2018/03/15				./data/phs001516.v1.pht007491.v1.p1.PheRS_eMERGE_Subject.var_report.xml									phs001516.v1.p1	Genetic Diseases, Inborn
			2021/08/20				./data/phs001939.v2.pht009667.v2.p1.CMI_MPCproject_Sample_Attributes.var_report.xml									phs001939.v2.p1	Prostatic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000513.v2.p3.simphen114.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004161.v2.p1.RPAA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
8.0			2018/10/29	88.0			./data/phs001626.v1.pht008477.v1.p1.IBDMDB_Subject_Phenotypes.var_report.xml	0.0			64.0					phs001626.v1.p1	Inflammatory Bowel Diseases
			2020/11/10				./data/phs002172.v1.pht010662.v1.p1.GMKF_Microtia_Hispanic_Subject.var_report.xml									phs002172.v1.p1	Congenital Microtia
			2018/09/11				./data/phs000653.v3.pht003465.v3.p1.Epi4K_Sample.var_report.xml									phs000653.v3.p1	Epilepsy
			2018/06/21				./data/phs001470.v1.pht008165.v1.p1.CIDR_SWAN_Subject.var_report.xml									phs001470.v1.p1	Menopause
			10/05/2015				./data/phs000983.v1.pht005004.v1.p1.Rheumatoid_Arthritis_Therapy_Subject.var_report.xml									phs000983.v1.p1	Arthritis, Rheumatoid
			04/16/2014				./data/phs000249.v2.pht001878.v2.p1.Brain_QTL_GEO.var_report.xml									phs000249.v2.p1	DNA Methylation
			11/05/2014				./data/phs000209.v13.pht002195.v2.p3.MESA_Exam1ECGContiWaveform.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000099.v8.p13.act1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/19/2015				./data/phs000869.v1.pht004607.v1.p1.BEAGESS_Subject.var_report.xml									phs000869.v1.p1	Esophageal Neoplasms
			09/29/2016				./data/phs001216.v1.pht005786.v1.p1.Asthma_Puerto_Rican_Children_Sample.var_report.xml									phs001216.v1.p1	Asthma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000488.v2.p3.simphen089.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
5.0	3.0		2021/06/16	405.0		5.0	./data/phs001412.v3.pht006746.v1.p1.TOPMed_WGS_DHS_Subject_Phenotypes.var_report.xml	0.0	3.0	9.899	3.0			3.0		phs001412.v3.p1	Cardiovascular Disease
298.0	380.0		2020/07/17	678.0		298.0	./data/phs001995.v1.pht010398.v1.p1.Himba_Pedigree.var_report.xml	0.0	339.0	57.98	380.0			339.0		phs001995.v1.p1	Sex
			01/19/2010				./data/phs000219.v1.pht001053.v1.p1.d_barthel.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2019/05/07				./data/phs001719.v1.pht008919.v1.p1.Prediabetes_Subject_Phenotypes.var_report.xml									phs001719.v1.p1	Prediabetic State
			05/09/2016				./data/phs001023.v1.pht005465.v1.p1.Male_Infertility_Sample_Attributes.var_report.xml									phs001023.v1.p1	Azoospermia
			2020/12/21				./data/phs000007.v32.pht004802.v3.p13.l_fhslab_ex09_1b_0658s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001809.v2.p2.F1F05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
104.0	104.0		2021/06/11	181.0		77.0	./data/phs002208.v1.pht010498.v1.p1.BAL_HCT_Subject.var_report.xml	0.0	90.5	19.09	77.0			90.5		phs002208.v1.p1	Hematopoietic Stem Cell Transplantation
468.0			2021/08/18	640.0			./data/phs001725.v2.pht010094.v1.p1.TOPMed_CCDG_GGAF_Subject_Phenotypes.var_report.xml	0.0			172.0					phs001725.v2.p1	Atrial Fibrillation
			2018/03/23				./data/phs000698.v1.pht007681.v1.p1.ats_questionnaire.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			05/17/2017				./data/phs001328.v1.pht006303.v1.p1.LDN_6703_Subject.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			2019/10/30				./data/phs001907.v1.pht009582.v1.p1.CPTAC_MiProt_Sample.var_report.xml									phs001907.v1.p1	
			2019/12/11				./data/phs001906.v1.pht009660.v1.p1.GISTs_Sample.var_report.xml									phs001906.v1.p1	Gastrointestinal Stromal Tumors
			09/15/2011				./data/phs000345.v1.pht002375.v1.p1.IBD_UC_Sample.var_report.xml									phs000345.v1.p1	Colitis, Ulcerative
			09/27/2013				./data/phs000627.v1.pht003530.v1.p1.Hepatocellular_Carcinoma_Driver_Genes_Subject.var_report.xml									phs000627.v1.p1	Carcinoma, Hepatocellular
			2019/10/15				./data/phs001910.v1.pht009539.v1.p1.PNETs_Sample_Attributes.var_report.xml									phs001910.v1.p1	Neuroendocrine Tumors
			10/05/2011				./data/phs000396.v1.pht002390.v1.p1.DCEG_Reference_Sample.var_report.xml									phs000396.v1.p1	
			2018/03/06				./data/phs000603.v1.pht007546.v1.p1.baselinemedicalhistoryform.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			12/06/2016				./data/phs001193.v1.pht005973.v1.p1.Colorectal_Cancer_Hispanic_Subject.var_report.xml									phs001193.v1.p1	Colorectal Neoplasms
93.0	93.0		2021/03/10	550.0		92.0	./data/phs001619.v3.pht008175.v3.p1.IRD_Pedigree.var_report.xml	0.0	89.0	9.899	85.0			89.0		phs001619.v3.p1	Retinal Degeneration
			11/28/2011				./data/phs000385.v1.pht002342.v1.p1.Epigenetic_Colorectal_Cancer_Sample_Attributes.var_report.xml									phs000385.v1.p1	Colorectal Neoplasms
			2017/10/20				./data/phs001156.v2.pht007048.v1.p1.EVE_Subject.var_report.xml									phs001156.v2.p1	Asthma
18.0			2020/12/18	65.0			./data/phs001073.v2.pht005955.v2.p1.Epigenetics_Malnutrition_Subject_Phenotypes.var_report.xml	13.0			47.0					phs001073.v2.p1	Stunting
			07/24/2017	2392.0			./data/phs001088.v1.pht006670.v1.p1.DRIVE_SBCGS_Subject_Phenotypes.var_report.xml	0.0			2392.0					phs001088.v1.p1	Breast Neoplasms
			2020/01/07				./data/phs001518.v1.pht007331.v1.p1.TRIUMPH_Subject.var_report.xml									phs001518.v1.p1	Myocardial Infarction
			07/26/2017				./data/phs000852.v1.pht006693.v1.p1.GEDI_SUDs_Subject.var_report.xml									phs000852.v1.p1	Substance-Related Disorders
			11/13/2015				./data/phs000730.v1.pht005061.v1.p1.Brain_Metastasis_Sample_Attributes.var_report.xml									phs000730.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht004803.v4.p13.l_hormthp_ex01_3b_0751s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/11				./data/phs001706.v1.pht008455.v1.p1.MCD_Subject.var_report.xml									phs001706.v1.p1	Castleman Disease
			08/20/2013				./data/phs000285.v3.pht001875.v2.p2.B2F09MAS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
52.0	60.0		08/08/2011	536.0		9.0	./data/phs000353.v1.pht002255.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_114.var_report.xml	0.0	39.67	86.33	65.0			50.0		phs000353.v1.p1	Premature Birth
			05/24/2016				./data/phs001065.v1.pht005399.v1.p1.blind.var_report.xml									phs001065.v1.p1	Huntington Disease
			11/30/2015				./data/phs000260.v4.pht001256.v4.p2.HMP_Foregut_Esophageal_Adenocarcinoma_Subject.var_report.xml									phs000260.v4.p2	Esophageal Adenocarcinoma
			2021/09/16				./data/phs001813.v2.pht009036.v2.p1.PC_Integrative_Tissue_Analysis_Sample.var_report.xml									phs001813.v2.p1	Prostatic Neoplasms
			02/27/2015				./data/phs000170.v2.pht000738.v2.p1.Marshfield_Subject.var_report.xml									phs000170.v2.p1	Cataract
638.0	677.0		05/26/2011	2597.0		638.0	./data/phs000289.v2.pht001886.v2.p1.Venous_Thrombosis_Subject_Phenotypes.var_report.xml	0.0	655.0	33.23	677.0			655.0		phs000289.v2.p1	Venous Thrombosis
			11/05/2014				./data/phs000209.v13.pht003605.v1.p3.MESA_AncilMesaNeighborFoodExam1.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht004804.v3.p13.l_insulin_ex01_72_0937s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006432.v1.p1.DLC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
33.0			2018/08/03	69.0			./data/phs000590.v1.pht008273.v1.p1.demographic_form.var_report.xml	0.0			36.0					phs000590.v1.p1	Polyarteritis Nodosa
			12/01/2014				./data/phs000839.v1.pht004390.v1.p1.Bitter_Taste_Blockers_Subject.var_report.xml									phs000839.v1.p1	Taste Perception
5660.0	5660.0		2021/09/27	292.0		4987.0	./data/phs000951.v5.pht005050.v5.p5.TOPMed_WGS_COPDGene_Subject.var_report.xml	0.0	5324.0	475.9	4987.0			5324.0		phs000951.v5.p5	Pulmonary Disease, Chronic Obstructive
			2018/05/17				./data/phs001596.v1.pht007965.v1.p1.Acral_Melanoma_Sample.var_report.xml									phs001596.v1.p1	Melanoma
			10/18/2016	6830.0			./data/phs000669.v1.pht003732.v1.p1.AMBER_Subject_Phenotypes.var_report.xml	0.0			6830.0					phs000669.v1.p1	Breast Neoplasms
371.0	381.0		08/05/2010	716.0		3.0	./data/phs000269.v1.pht001498.v1.p1.Chromosomal_Aberration_CNV_Sample_Data.var_report_2010_08_05.xml	0.0	238.7	205.6	323.0			332.0		phs000269.v1.p1	Chromosome Disorders
			2019/01/29				./data/phs001298.v1.pht008649.v1.p1.Psoriasis_European_Sample_Attributes.var_report.xml									phs001298.v1.p1	Psoriasis
			07/26/2016				./data/phs000916.v1.pht004737.v1.p1.MIGen_Exome_Munich_MI_Sample_Attributes.var_report.xml									phs000916.v1.p1	Coronary Artery Disease
			2019/05/15				./data/phs001825.v1.pht009047.v1.p1.5UTR_Mutations_PC_Subject.var_report.xml									phs001825.v1.p1	Prostatic Neoplasms
			2019/11/27				./data/phs001703.v3.pht008450.v1.p1.DICE_Subject.var_report.xml									phs001703.v3.p1	
			2017/08/22				./data/phs001209.v1.pht006802.v1.p1.MIDCIRS_Subject.var_report.xml									phs001209.v1.p1	Malaria
			2018/02/08				./data/phs001488.v1.pht007407.v1.p1.mhxdxhd2.var_report.xml									phs001488.v1.p1	Huntington Disease
			04/24/2014				./data/phs000709.v1.pht003812.v1.p1.Fibrolamellar_Hepatocellular_Carcinoma_Subject.var_report.xml									phs000709.v1.p1	Fibrolamellar hepatocellular carcinoma
			11/07/2014				./data/phs000809.v1.pht004347.v1.p1.Glycosylation_Congenital_Disorder_Sample.var_report.xml									phs000809.v1.p1	Congenital Disorders of Glycosylation
			08/20/2013				./data/phs000285.v3.pht001773.v2.p2.E1F09MOT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
8.0	9.0		01/02/2013	17.0		8.0	./data/phs000568.v1.pht003112.v1.p1.Solitary_Fibrous_Tumors_SIGMA_Subject_Phenotypes.var_report.xml	0.0	8.5	0.7071	9.0			8.5		phs000568.v1.p1	Sarcoma
			2020/10/02				./data/phs002244.v1.pht010551.v1.p1.NSCLC_Pembrolizumab_Sample.var_report.xml									phs002244.v1.p1	Carcinoma, Non-Small-Cell Lung
			02/27/2017				./data/phs000435.v3.pht002524.v3.p1.CLL_Sample_Attributes.var_report.xml									phs000435.v3.p1	Chronic Lymphocytic Leukemia
	75.0		05/08/2017	8.0		50.0	./data/phs001343.v1.pht006348.v1.p1.hESCs_Sample_Attributes.var_report.xml	0.0	62.5	17.68				62.5		phs001343.v1.p1	Human Embryonic Stem Cells
			07/09/2013				./data/phs000621.v1.pht003329.v1.p1.Chronic_Lymphocytic_Leukemia_Trial_Sample.var_report.xml									phs000621.v1.p1	Leukemia, Lymphoid
			2018/02/08				./data/phs001488.v1.pht007378.v1.p1.bpseries.var_report.xml									phs001488.v1.p1	Huntington Disease
			11/04/2014				./data/phs000086.v3.pht000324.v1.p1.EDIC_cbldata.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/01/07				./data/phs002083.v1.pht010655.v1.p1.TS_ccRCC_Sample.var_report.xml									phs002083.v1.p1	Carcinoma, Renal Cell
			10/16/2014				./data/phs000376.v1.pht002306.v1.p1.CIDR_PD_Exome_Subject.var_report.xml									phs000376.v1.p1	Parkinson Disease
			08/20/2013				./data/phs000285.v3.pht001616.v2.p2.B2F09NER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
421.0	437.0		09/28/2016	858.0		421.0	./data/phs001095.v1.pht005620.v1.p1.T2D_GENES_Ashkenazi_Subject_Phenotypes.var_report.xml	0.0	429.0	32.53	437.0			429.0		phs001095.v1.p1	Diabetes Mellitus, Type 2
			2020/09/18				./data/phs002015.v1.pht010396.v1.p1.AREDS2_VIS.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/06/01				./data/phs001538.v1.pht008091.v1.p1.Registry_GenTests.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			02/25/2011				./data/phs000143.v1.pht000646.v1.p1.T2D_Starr_Sample.var_report_2011_02_25.xml									phs000143.v1.p1	Diabetes Mellitus, Type 2
			2017/08/17				./data/phs001399.v1.pht006734.v1.p1.Neoadjuvant_Adjuvant_Therapies_GEO.var_report.xml									phs001399.v1.p1	Prostatic Neoplasms
			2019/03/28				./data/phs001680.v1.pht008913.v1.p1.T_Cell_States_Melanoma_Sample.var_report.xml									phs001680.v1.p1	Immunotherapy
			2021/07/29				./data/phs001607.v3.pht010150.v3.p2.TOPMed_WGS_IPF_Sample.var_report.xml									phs001607.v3.p2	Idiopathic Pulmonary Fibrosis
			2019/04/10				./data/phs001048.v2.pht005658.v2.p1.FUSION_Tissue_Biopsy_Subject.var_report.xml									phs001048.v2.p1	Diabetes Mellitus, Type 2
			2021/10/06				./data/phs001486.v3.pht008701.v3.p3.HCMI_Sample.var_report.xml									phs001486.v3.p3	Neoplasms
			07/25/2014				./data/phs000622.v1.pht003954.v1.p1.Pheno_Anthropometric.var_report.xml									phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			03/12/2013				./data/phs000343.v3.pht002723.v1.p1.endcor.var_report.xml									phs000343.v3.p1	Stroke
			11/04/2013				./data/phs000579.v1.pht003278.v1.p1.SmallBowelNeuroendocrineTumors_Sample.var_report.xml									phs000579.v1.p1	Intestinal Neoplasms
			2021/04/09				./data/phs002292.v1.pht011107.v1.p1.Neocortical_Neurons_Subject_Phenotypes.var_report.xml									phs002292.v1.p1	Neocortex
			2020/12/21				./data/phs000007.v32.pht010738.v1.p13.t_pettau_2020_3_1286s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/01/26				./data/phs001417.v1.pht007365.v1.p1.Metastatic_Tumors_cfDNA_Sample.var_report.xml									phs001417.v1.p1	Neoplasms
5.0	5.0		2019/03/28	7.0		2.0	./data/phs001797.v1.pht008891.v1.p1.mUC_Subject_Phenotypes.var_report.xml	0.0	3.5	2.121	2.0			3.5		phs001797.v1.p1	Urogenital Neoplasms
			2020/11/09				./data/phs000976.v2.pht005685.v2.p1.CIDR_COGA_AA_Family_Sample.var_report.xml									phs000976.v2.p1	Alcoholism
			2020/12/21				./data/phs000007.v32.pht003459.v3.p13.t_ctlung_2011_m_0829s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			Wed Nov 26 07:46:15 2008				./data/phs000017.v3.pht000367.v1.p1.GAIN_AA_DIGS4.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			05/24/2016				./data/phs001065.v1.pht005405.v1.p1.demo.var_report.xml									phs001065.v1.p1	Huntington Disease
			12/11/2009				./data/phs000171.v1.pht000783.v1.p1.MS_DATA_PASAT.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/12/21				./data/phs000007.v32.pht004367.v1.p13.t_mrbrput_2005_1_0904s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/13/2015				./data/phs000415.v1.pht002413.v1.p1.CIDR_Tourette_Syndrome_Sample.var_report.xml									phs000415.v1.p1	Tourette Syndrome
			2021/09/14				./data/phs002121.v1.pht011550.v1.p1.Hematological_Transcriptomic_Subject_Phenotypes.var_report.xml									phs002121.v1.p1	Myeloproliferative Neoplasms
850.0	2005.0		11/05/2014	3735.0		850.0	./data/phs000209.v13.pht001109.v1.p3.MESA_Pedigree.var_report.xml	0.0	1868.0	53.03	2005.0			1868.0		phs000209.v13.p3	Cardiovascular Diseases
			2019/12/06				./data/phs001875.v1.pht009651.v1.p1.Venetoclax_Resistance_Sample.var_report.xml									phs001875.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			09/10/2012				./data/phs000434.v1.pht002605.v1.p1.Atypical_Werner_Syndrome_Sample.var_report.xml									phs000434.v1.p1	Werner Syndrome
			2020/03/04				./data/phs001969.v1.pht009934.v1.p1.CGD_TCL_Subject.var_report.xml									phs001969.v1.p1	Lymphoma, T-Cell, Cutaneous
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000461.v2.p3.simphen062.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
1273.0	3819.0		05/16/2017	6294.0		2475.0	./data/phs001252.v1.pht006374.v1.p1.bonedx.var_report.xml	0.0	3147.0	950.4	825.0			3147.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2018/04/16				./data/phs001289.v1.pht007784.v1.p1.adverse_event.var_report.xml									phs001289.v1.p1	Andersen Syndrome
8.0	10.0		03/07/2016	18.0		8.0	./data/phs001084.v1.pht005328.v1.p1.Colorectal_Tumors_Primary_Metastatic_Subject_Phenotypes.var_report.xml	0.0	9.0	1.414	10.0			9.0		phs001084.v1.p1	Colorectal Neoplasms
			03/16/2015				./data/phs000868.v1.pht004588.v1.p1.Pediatric_Neuroblastoma_Sample.var_report.xml									phs000868.v1.p1	Neuroblastoma
			2020/11/24				./data/phs001700.v1.pht008500.v1.p1.Moyamoya_Subject.var_report.xml									phs001700.v1.p1	Moyamoya Disease
			2021/08/19				./data/phs001662.v2.pht010060.v1.p1.LTRC_R040_subject_medical_history.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
31.0	31.0		2021/09/20	62.0		31.0	./data/phs002407.v1.pht011355.v1.p1.MMRd_MMRp_CRC_Subject.var_report.xml	0.0	31.0	0	31.0			31.0		phs002407.v1.p1	Colorectal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001746.v2.p2.D2F06V.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/15/2012				./data/phs000514.v1.pht002838.v1.p1.Familial_Coronary_Artery_Disease_Sample.var_report.xml									phs000514.v1.p1	Coronary Artery Disease
			2018/05/31				./data/phs001318.v1.pht008024.v1.p1.12_lead_ekg.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2019/11/14				./data/phs001865.v1.pht009610.v1.p1.AAMP_Sample.var_report.xml									phs001865.v1.p1	
			2019/09/19				./data/phs001879.v1.pht009458.v1.p1.Kidney_Transplant_Recipients_Sample_Attributes.var_report.xml									phs001879.v1.p1	Urinary Tract Infections
			2020/12/21				./data/phs000007.v32.pht000392.v7.p13.eye1_1991s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
6600.0	6600.0		08/15/2016	6245.0		5780.0	./data/phs000473.v2.pht002600.v2.p2.Schizophrenia_Swedish_Subject_Phenotypes.var_report.xml	0.0	6190.0	84.15	5780.0			6190.0		phs000473.v2.p2	Schizophrenia
			04/16/2013				./data/phs000145.v4.pht002999.v1.p2.PORPES_Sample_Attributes.var_report.xml									phs000145.v4.p2	Normalcy
802.0	802.0		11/27/2009	924.0		122.0	./data/phs000016.v2.pht000049.v2.p2.Diagnosis.var_report_2009_11_27.xml	0.0	462.0	480.8	122.0			462.0		phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			2020/11/02				./data/phs002046.v1.pht010624.v1.p1.GTP_Sample.var_report.xml									phs002046.v1.p1	Stress Disorders, Post-Traumatic
			2018/04/30				./data/phs001555.v1.pht007879.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001555.v1.p1	Pompe Disease
			2021/08/13				./data/phs002405.v1.pht011236.v1.p1.PPGL_Sample.var_report.xml									phs002405.v1.p1	Paraganglioma
			03/17/2017				./data/phs001121.v1.pht005708.v1.p1.Rare_Cancers_Subject.var_report.xml									phs001121.v1.p1	Sarcoma
			2018/06/30				./data/phs001620.v1.pht008179.v1.p1.GUARDD_AA_Subject.var_report.xml									phs001620.v1.p1	Apolipoprotein L1
			2020/12/21				./data/phs000007.v32.pht000686.v7.p13.vitk1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/07/26				./data/phs000588.v1.pht009296.v1.p1.followup_comorbidity_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2018/11/30				./data/phs001578.v1.pht007875.v1.p1.Preterm_Infant_Microbiome_Sample.var_report.xml									phs001578.v1.p1	Microbiota
			2020/02/13				./data/phs001975.v1.pht009882.v1.p1.SDV_iPSCs_Sample.var_report.xml									phs001975.v1.p1	
			2021/05/25				./data/phs001945.v1.pht010486.v1.p1.CIDR_ACCME_Subject.var_report.xml									phs001945.v1.p1	Uterine Cervical Neoplasms
			07/09/2013				./data/phs000556.v1.pht003136.v1.p1.ESP_AtypicalCysticFibrosis_Subject.var_report.xml									phs000556.v1.p1	Cystic Fibrosis
			08/20/2013				./data/phs000285.v3.pht001648.v2.p2.C1APOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
82.0	82.0		2020/12/30	118.0		36.0	./data/phs002290.v1.pht010821.v1.p1.cfDNA_Metastasis_Subject.var_report.xml	0.0	59.0	32.53	36.0			59.0		phs002290.v1.p1	Cell-Free Nucleic Acids
			2017/12/12				./data/phs000295.v2.pht001530.v1.p1.Kabuki_Subject.var_report.xml									phs000295.v2.p1	Kabuki syndrome
			2020/09/18				./data/phs002015.v1.pht010375.v1.p1.AREDS2_DCR.var_report.xml									phs002015.v1.p1	Macular Degeneration
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000515.v2.p3.simphen116.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/28/2011				./data/phs000274.v1.pht001278.v1.p1.CIDR_Celiac_Subject_Phenotypes.var_report.xml									phs000274.v1.p1	Celiac Disease
			2020/05/26				./data/phs001820.v1.pht010243.v1.p1.Oncologic_Hematologic_Sample_Attributes.var_report.xml									phs001820.v1.p1	Neoplasms
			2017/08/09				./data/phs001425.v1.pht006757.v1.p1.Melanoma_Immune_Checkpoint_Sample_Attributes.var_report.xml									phs001425.v1.p1	Melanoma
			2018/02/08				./data/phs001488.v1.pht007392.v1.p1.drugret.var_report.xml									phs001488.v1.p1	Huntington Disease
236.0	239.0		2018/04/23	475.0		236.0	./data/phs001219.v1.pht007860.v1.p1.LPD_Subject_Phenotypes.var_report.xml	0.0	237.5	2.121	239.0			237.5		phs001219.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
87.0	87.0		2018/03/09	469.0		87.0	./data/phs000783.v2.pht004281.v2.p1.CDH_Subject_Phenotypes.var_report.xml	0.0	98.33	89.29	87.0			87.0		phs000783.v2.p1	Hernias, Diaphragmatic, Congenital
			2019/10/30				./data/phs001907.v1.pht009581.v1.p1.CPTAC_MiProt_Subject.var_report.xml									phs001907.v1.p1	
			2018/03/23				./data/phs000698.v1.pht007686.v1.p1.adverse_event.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			2021/07/16				./data/phs001602.v2.pht009979.v1.p1.TOPMed_WGS_ChildrensHS_GAP_Sample_Attributes.var_report.xml									phs001602.v2.p1	Asthma
			2018/02/08				./data/phs001488.v1.pht007419.v1.p1.screen.var_report.xml									phs001488.v1.p1	Huntington Disease
			2017/12/12				./data/phs000676.v2.pht003590.v2.p2.Breast_Tissues_Sequence_Analysis_Sample_Attributes.var_report.xml									phs000676.v2.p2	Breast Neoplasms
			2018/05/15				./data/phs001309.v1.pht007916.v1.p1.eligibility_form.var_report.xml									phs001309.v1.p1	Pulmonary Alveolar Proteinosis
			2019/02/06				./data/phs001745.v1.pht008599.v1.p1.Lung_eQTL_Sample.var_report.xml									phs001745.v1.p1	Smoking
38.0	38.0		2020/10/21	66.0		13.0	./data/phs002067.v1.pht010410.v1.p1.TLE_Subject_Phenotypes.var_report.xml	0.0	22.0	8.888	27.0			27.0		phs002067.v1.p1	Epilepsy, Temporal Lobe
			03/13/2014				./data/phs000715.v1.pht003744.v1.p1.Multiple_Sclerosis_Brains_Sample.var_report.xml									phs000715.v1.p1	Multiple Sclerosis, Chronic Progressive
			2020/02/04				./data/phs001723.v1.pht009726.v1.p1.IBDGC_Repo_EC_Sample.var_report.xml									phs001723.v1.p1	Inflammatory Bowel Disease
			2019/07/26				./data/phs001705.v1.pht009271.v1.p1.EMBLEM_Subject.var_report.xml									phs001705.v1.p1	Burkitt Lymphoma
			05/11/2012				./data/phs000291.v2.pht002269.v1.p1.LHS_COPD_Subject.var_report.xml									phs000291.v2.p1	Pulmonary Disease, Chronic Obstructive
			2018/03/09				./data/phs000783.v2.pht004282.v2.p1.CDH_Sample_Attributes.var_report.xml									phs000783.v2.p1	Hernias, Diaphragmatic, Congenital
			2021/07/13				./data/phs002481.v1.pht011372.v1.p1.SCA_Sample.var_report.xml									phs002481.v1.p1	Aneuploidy
			2019/07/31				./data/phs001872.v1.pht009363.v1.p1.CEPH_Utah_Subject.var_report.xml									phs001872.v1.p1	Population Groups
862.0	99.0		Thu Nov 13 11:10:50 2008	711.0		904.0	./data/phs000125.v1.pht000647.v1.p1.COGA_Pedigree.var_report_2008_11_13.xml	0.0	972.5	96.87	99.0			972.5		phs000125.v1.p1	Alcoholism
8.0	15.0		2020/07/10	23.0		8.0	./data/phs002022.v1.pht010183.v1.p1.pPCL_Subject_Phenotypes.var_report.xml	0.0	11.5	4.95	15.0			11.5		phs002022.v1.p1	Leukemia, Plasma Cell
			11/04/2014				./data/phs000086.v3.pht000255.v1.p1.DCCT_m9exall.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/04/25				./data/phs000899.v1.pht008941.v1.p1.AmBiGen_Subject.var_report.xml									phs000899.v1.p1	Bipolar Disorder
			09/29/2014				./data/phs000797.v1.pht004266.v1.p1.CTLA4_Haploinsufficiency_Subject.var_report.xml									phs000797.v1.p1	Autoimmune enteropathy
	20.0		2021/01/27	20.0		20.0	./data/phs002313.v1.pht010818.v1.p1.AAOV_Subject.var_report.xml	0.0	20.0		20.0			20.0		phs002313.v1.p1	Cancer
			2020/08/26				./data/phs000998.v2.pht005057.v2.p1.iPSC_Pulmonary_Hypertension_Sample_Attributes.var_report.xml									phs000998.v2.p1	Pulmonary Arterial Hypertension
			2021/07/21				./data/phs002446.v1.pht011405.v1.p1.SjS_Transcriptional_Sample_Attributes.var_report.xml									phs002446.v1.p1	Sjogren's Syndrome
			2021/05/18				./data/phs002385.v1.pht011244.v1.p1.CIBMTR_HCTforSCD_Sample.var_report.xml									phs002385.v1.p1	Sickle Cell Disease
			07/08/2016				./data/phs001166.v1.pht005631.v1.p1.T2D_Seq_GWAS_Starr_County_Cohort_Subject.var_report.xml									phs001166.v1.p1	Diabetes Mellitus, Type 2
			03/06/2017				./data/phs000574.v1.pht005870.v1.p1.measurements.var_report.xml									phs000574.v1.p1	Rett Syndrome
			04/15/2014				./data/phs000719.v1.pht003736.v1.p1.PNTM_Sample.var_report.xml									phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
			11/21/2016				./data/phs001251.v1.pht005949.v1.p1.UC_WES_Sample.var_report.xml									phs001251.v1.p1	Colitis, Ulcerative
1540.0	1540.0		03/10/2016	2872.0		1332.0	./data/phs000952.v1.pht005320.v1.p1.Substance_Dependence_EA_AA_Subject_Phenotypes.var_report.xml	0.0	1436.0	147.1	1332.0			1436.0		phs000952.v1.p1	Substance-Related Disorders
			2020/03/12				./data/phs000673.v4.pht003661.v4.p1.CSER_Sample.var_report.xml									phs000673.v4.p1	Neoplasms
			05/09/2016				./data/phs001063.v1.pht005289.v1.p1.HER2_Positive_Breast_Cancer_Subject.var_report.xml									phs001063.v1.p1	Breast Neoplasms
			11/04/2014				./data/phs000086.v3.pht000327.v1.p1.EDIC_f0042.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			10/18/2016				./data/phs001205.v1.pht005853.v1.p1.Neural_Stem_Cell_Lineages_Sample_Attributes.var_report.xml									phs001205.v1.p1	Neural Stem Cells
			2021/01/15				./data/phs000989.v4.pht005021.v4.p1.Cortical_Neurogenesis_Sample.var_report.xml									phs000989.v4.p1	Stem cells, neural
3.0	3.0		05/12/2017	5.0		2.0	./data/phs001091.v1.pht006065.v1.p1.CLL_Clonal_Evolution_Subject_Phenotypes.var_report.xml	0.0	2.5	0.7071	2.0			2.5		phs001091.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2021/08/11				./data/phs002480.v1.pht011396.v1.p1.Glomerular_Disorders_Sample_Attributes.var_report.xml									phs002480.v1.p1	Glomerulonephritis
459.0	484.0		2021/07/29	943.0		459.0	./data/phs001599.v1.pht011433.v1.p1.TOPMed_WGS_Boston_Brazil_SCD_Subject.var_report.xml	0.0	471.5	17.68	484.0			471.5		phs001599.v1.p1	Anemia, Sickle Cell
			12/11/2009				./data/phs000171.v1.pht000767.v1.p1.MS_DATA_MHQGPRDEM.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/12/21				./data/phs000007.v32.pht005161.v3.p13.t_ctthrcac_2011_m_0682s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000531.v2.p3.simphen132.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/11/27				./data/phs000510.v1.pht010697.v1.p1.SOF_Subject_Phenotypes.var_report.xml									phs000510.v1.p1	Osteoporosis
664.0	712.0		02/25/2011	990.0		664.0	./data/phs000143.v1.pht000644.v1.p1.T2D_Starr_Data.var_report_2011_02_25.xml	0.0	990.0	461	712.0			990.0		phs000143.v1.p1	Diabetes Mellitus, Type 2
	12.0		2020/03/04	12.0		12.0	./data/phs001892.v1.pht009942.v1.p1.miRNA_Profiling_Subject_Phenotypes.var_report.xml	0.0	12.0		12.0			12.0		phs001892.v1.p1	
			2021/05/18				./data/phs002224.v1.pht010846.v1.p1.Crosstalk_Asthma_Sample.var_report.xml									phs002224.v1.p1	Asthma
			2020/12/21				./data/phs000007.v32.pht000203.v8.p13.laba1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/09/11				./data/phs001887.v1.pht009433.v1.p1.Sperm_Donors_Sample.var_report.xml									phs001887.v1.p1	Spermatozoa
184.0	184.0		2020/01/02	286.0		102.0	./data/phs001895.v2.pht009444.v2.p1.Lung_Cancer_EA_AA_Subject_Phenotypes.var_report.xml	0.0	143.0	57.98	102.0			143.0		phs001895.v2.p1	Lung Neoplasms
			08/20/2013				./data/phs000285.v3.pht001565.v2.p2.A4F06FG.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/08/09				./data/phs001847.v1.pht009382.v1.p1.AML_Sample_Attributes.var_report.xml									phs001847.v1.p1	Leukemia, Myeloid, Acute
			2018/03/06				./data/phs000603.v1.pht007550.v1.p1.laboratoryinvestigationform.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			2018/04/16				./data/phs001289.v1.pht007783.v1.p1.CINCH_5301_Subject.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			2018/04/16				./data/phs001326.v1.pht007820.v1.p1.p6902_17366_timetoeve.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2018/05/17				./data/phs001313.v1.pht007975.v1.p1.eligibilityform.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2020/11/27				./data/phs000510.v1.pht010695.v1.p1.SOF_Subject.var_report.xml									phs000510.v1.p1	Osteoporosis
			12/16/2013				./data/phs000690.v1.pht003621.v1.p1.Multiplex_Epilepsy_Families_Subject_Phenotypes.var_report.xml									phs000690.v1.p1	Idiopathic generalized epilepsy
			2020/06/18				./data/phs000280.v7.pht006416.v4.p1.afucomposite28ps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/08/20				./data/phs002557.v1.pht011481.v1.p1.PID_LRBA_Sample.var_report.xml									phs002557.v1.p1	LRBA protein, human
			2018/11/16				./data/phs001272.v1.pht007302.v1.p1.Broad_CMG_Sample.var_report.xml									phs001272.v1.p1	Genetic Diseases, Inborn
			08/12/2016				./data/phs000888.v1.pht005569.v1.p1.18aGERD_other_conditions.var_report.xml									phs000888.v1.p1	
			2017/10/19				./data/phs001288.v1.pht006773.v1.p1.interval_hx.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2021/08/10				./data/phs001467.v2.pht009730.v2.p2.TOPMed_WGS_SAPPHIRE_Sample.var_report.xml									phs001467.v2.p2	Asthma
2.0	6.0		03/13/2015	8.0		2.0	./data/phs000873.v1.pht004558.v1.p1.Bleeding_Disorders_Subject_Phenotypes.var_report.xml	0.0	4.0	2.828	6.0			4.0		phs000873.v1.p1	Thrombocytopenia
			2021/07/16				./data/phs001602.v2.pht009976.v1.p1.TOPMed_WGS_ChildrensHS_GAP_Subject.var_report.xml									phs001602.v2.p1	Asthma
			2019/08/18				./data/phs001201.v2.pht007555.v2.p1.AsPIRES_HINT_Sample.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2019/01/15				./data/phs001175.v2.pht007755.v2.p2.CTSP_Subject.var_report.xml									phs001175.v2.p2	Breast
42.0	42.0		10/07/2016	42.0		42.0	./data/phs001223.v1.pht005801.v1.p1.AR_Prostate_Cancer_Subject_Phenotypes.var_report.xml	0.0	42.0					42.0		phs001223.v1.p1	Prostatic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000576.v2.p3.simphen177.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			06/12/2017				./data/phs001371.v1.pht006545.v1.p1.TNF_RA_FLS_Sample.var_report.xml									phs001371.v1.p1	Arthritis, Rheumatoid
			01/19/2010				./data/phs000219.v1.pht001094.v1.p1.d_mri_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			08/04/2015				./data/phs000926.v1.pht004868.v1.p1.Crohn_Disease_Childhood_Onset_Sample_Attributes.var_report.xml									phs000926.v1.p1	Crohn Disease
			11/05/2014				./data/phs000209.v13.pht003379.v1.p3.MESA_AncilMesaSleepPolysomnography.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			01/06/2015				./data/phs000811.v1.pht004399.v1.p1.Targeted_DNA_NGS_Sample.var_report.xml									phs000811.v1.p1	Neoplasms
			03/06/2017				./data/phs000574.v1.pht005867.v1.p1.ekg.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2019/08/30				./data/phs001331.v2.pht006923.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			04/20/2012				./data/phs000390.v1.pht002328.v1.p1.Female_Osteoporosis_Risk_Genes_Sample_Attributes.var_report.xml									phs000390.v1.p1	Osteoporosis
748.0	2240.0		06/01/2010	2988.0		748.0	./data/phs000138.v2.pht000618.v1.p1.Bone_Fragility_Pedigree.var_report_2010_06_01.xml	0.0	1494.0	1055	2240.0			1494.0		phs000138.v2.p1	Osteoporosis
			2018/09/19				./data/phs000257.v3.pht001249.v3.p1.HMP_Gut_Crohns_Function_Sample.var_report.xml									phs000257.v3.p1	Crohn Disease
			2020/04/23				./data/phs000640.v9.pht003439.v9.p1.HeLaCell_Sample.var_report.xml									phs000640.v9.p1	Uterine Cervical Neoplasms
			11/04/2014				./data/phs000086.v3.pht000235.v1.p1.DCCT_f0361.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht000366.v7.p13.renin1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
21.0	21.0		2020/08/04	33.0		12.0	./data/phs001793.v1.pht008901.v1.p1.PDGCL_Subject_Phenotypes.var_report.xml	0.0	16.5	6.364	12.0			16.5		phs001793.v1.p1	Glioma
			2020/01/23				./data/phs000287.v7.pht001483.v1.p1.YR15PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			02/08/2017				./data/phs001276.v1.pht006123.v1.p1.Interneuron_Development_Sample_Attributes.var_report.xml									phs001276.v1.p1	Growth and Development
			11/08/2013				./data/phs000200.v9.pht003418.v1.p3.spec_draws_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			07/15/2013				./data/phs000608.v1.pht003342.v1.p1.Schizophrenia_Methylation_Subject.var_report.xml									phs000608.v1.p1	Schizophrenia
			05/24/2016				./data/phs001065.v1.pht005409.v1.p1.drugdis.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/04/03				./data/phs001916.v2.pht009722.v2.p1.PBMCs_Aging_Sample.var_report.xml									phs001916.v2.p1	Healthy Aging
			2018/03/06				./data/phs000603.v1.pht007548.v1.p1.eligibility.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			2020/05/26				./data/phs001820.v1.pht010239.v1.p1.Oncologic_Hematologic_Subject.var_report.xml									phs001820.v1.p1	Neoplasms
			08/20/2013				./data/phs000285.v3.pht001608.v2.p2.B2F09HYS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/11/05				./data/phs001632.v1.pht008532.v1.p1.Multiple_Myeloma_AA_Sample.var_report.xml									phs001632.v1.p1	Multiple Myeloma
			2018/05/01				./data/phs000607.v3.pht003443.v2.p2.Neurodevelopmental_Genomics_Sample.var_report.xml									phs000607.v3.p2	Mental Processes
			2017/12/04				./data/phs001419.v1.pht007096.v1.p1.physician_examination.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2019/06/14				./data/phs000589.v1.pht009188.v1.p1.followup_comorbidity_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
	23.0		2018/09/17	23.0		23.0	./data/phs001685.v1.pht008371.v1.p1.OVCA_Organoids_Subject_Phenotypes.var_report.xml	0.0	23.0		23.0			23.0		phs001685.v1.p1	Ovarian Neoplasms
			04/07/2017				./data/phs001174.v1.pht006240.v1.p1.Primary_Ovarian_Insufficiency_Subject.var_report.xml									phs001174.v1.p1	Infertility, Female
301.0	595.0		06/27/2011	896.0		301.0	./data/phs000344.v1.pht002170.v1.p1.Finnish_ALS_Subject_Phenotypes.var_report.xml	0.0	448.0	3.536	595.0			448.0		phs000344.v1.p1	Amyotrophic Lateral Sclerosis
			10/24/2013				./data/phs000563.v1.pht003083.v1.p1.NF1_Pilocytic_Astrocytoma_Sample.var_report.xml									phs000563.v1.p1	Pilocytic Astrocytoma
			2020/01/07				./data/phs001941.v1.pht009743.v1.p1.Otitis_Media_Sample.var_report.xml									phs001941.v1.p1	Otitis Media
			05/13/2015				./data/phs000769.v1.pht004004.v1.p1.LHMP_Sample.var_report.xml									phs000769.v1.p1	HIV
2408.0	2643.0		2021/05/07	5051.0		2408.0	./data/phs001327.v2.pht011194.v1.p1.sparticip.var_report.xml	0.0	2526.0	166.2	2643.0			2526.0		phs001327.v2.p1	Neoplasm
			2019/09/11				./data/phs001437.v1.pht006806.v1.p1.PPTC_Subject.var_report.xml									phs001437.v1.p1	Leukemia, Lymphoid
			04/18/2012				./data/phs000369.v1.pht002588.v1.p1.Breast_Carcinoma_Subtypes_Sample_Attributes.var_report.xml									phs000369.v1.p1	Carcinoma, Ductal, Breast
			2018/09/17				./data/phs001685.v1.pht008372.v1.p1.OVCA_Organoids_Sample_Attributes.var_report.xml									phs001685.v1.p1	Ovarian Neoplasms
			03/15/2016				./data/phs000337.v1.pht005334.v1.p1.Developmental_Disabilities_Subject.var_report.xml									phs000337.v1.p1	Intellectual Disability
			11/05/2014				./data/phs000209.v13.pht001209.v2.p3.MESA_AncilMesaSphingomyelin.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/08/19				./data/phs001662.v2.pht010061.v1.p1.LTRC_R040_subject_medications.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			08/23/2011				./data/phs000290.v1.pht002276.v1.p1.PAH_Sample_Attributes.var_report.xml									phs000290.v1.p1	Hypertension, Pulmonary
			2017/12/13				./data/phs001053.v1.pht007232.v1.p1.XFS_Glaucoma_Subject_Phenotypes.var_report.xml									phs001053.v1.p1	Glaucoma
51.0	55.0		2018/01/18	4.0		51.0	./data/phs000382.v3.pht002323.v3.p1.CIDR_Joubert_Syndrome_Subject_Phenotypes.var_report.xml	0.0	53.0	2.828	55.0			53.0		phs000382.v3.p1	Joubert syndrome 1
			2020/08/05				./data/phs002052.v1.pht010318.v1.p1.mtDNA_Deletion_POLG_Subject.var_report.xml									phs002052.v1.p1	Mitochondrial Diseases
			04/17/2017				./data/phs001157.v1.pht005806.v1.p1.WLS_Aging_Sample_Attributes.var_report.xml									phs001157.v1.p1	
			08/17/2010				./data/phs000294.v1.pht001533.v1.p1.MIGen_Subject.var_report_2010_08_17.xml									phs000294.v1.p1	Myocardial Infarction
			12/10/2014				./data/phs000848.v1.pht004412.v1.p1.Autosomal_Recessive_TPP2_Mutations_Sample_Attributes.var_report.xml									phs000848.v1.p1	Immunologic Deficiency Syndromes
			2019/07/19				./data/phs001230.v1.pht009241.v1.p1.Estonian_Biobank_Subject_Phenotypes.var_report.xml									phs001230.v1.p1	Population Groups
			2018/06/14				./data/phs001238.v2.pht006044.v1.p1.GENOA_AfricanAmerican_Phase2_Brain.var_report.xml									phs001238.v2.p1	Hypertension
			2020/11/04	1089.0			./data/phs002062.v1.pht010639.v1.p1.BC_TDLUs_Subject_Phenotypes.var_report.xml	0.0			1089.0					phs002062.v1.p1	Breast Neoplasms
			01/19/2010				./data/phs000219.v1.pht001079.v1.p1.d_drs_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000559.v2.p3.simphen160.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/02/27				./data/phs001064.v1.pht006835.v1.p1.PC_SRC_Bladder_Sample_Attributes.var_report.xml									phs001064.v1.p1	Carcinoma, Signet Ring Cell
611.0	611.0		2019/08/10	648.0		73.0	./data/phs001876.v1.pht009389.v1.p1.BSRC_ASD_CNV_Subject_Phenotypes.var_report.xml	0.0	508.0	157	73.0			508.0		phs001876.v1.p1	Autism Spectrum Disorder
			2019/03/01				./data/phs001775.v1.pht008807.v1.p1.Multiplex_AD_Families_Subject.var_report.xml									phs001775.v1.p1	Alcoholism
			08/29/2016				./data/phs001199.v1.pht005707.v1.p1.TIGER_LC_OncoVar_Sample_Attributes.var_report.xml									phs001199.v1.p1	Carcinoma, Hepatocellular
113.0	138.0		09/03/2014	251.0		113.0	./data/phs000750.v1.pht003936.v1.p1.GOAL_Subject_Phenotypes.var_report.xml	0.0	125.5	17.68	138.0			125.5		phs000750.v1.p1	Population Groups
			2019/08/18				./data/phs001201.v2.pht007558.v1.p1.SubjectPathogensVariables.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			08/20/2013				./data/phs000285.v3.pht001702.v2.p2.CFLWUPT1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/06/09				./data/phs001395.v2.pht006625.v1.p1.TOPMed_WGS_HCHS_SOL_Subject.var_report.xml									phs001395.v2.p1	Cardiovascular Diseases
			2018/06/13				./data/phs001490.v1.pht008138.v1.p1.T2D_GENES_BioMe_Sample_Attributes.var_report.xml									phs001490.v1.p1	Diabetes Mellitus, Type 2
			2020/06/09				./data/phs002036.v1.pht010274.v1.p1.Chromoanasynthesis_JBS_Subject.var_report.xml									phs002036.v1.p1	Jacobsen Distal 11q Deletion Syndrome
			2020/12/21				./data/phs000007.v32.pht000389.v12.p13.vr_cvdproc_2019_a_1218s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001103.v1.p1.d_terfd_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/09/02				./data/phs002006.v2.pht010163.v2.p1.Segmental_Overgrowth_Subject_Phenotypes.var_report.xml									phs002006.v2.p1	Proteus Syndrome
			04/04/2012				./data/phs000433.v1.pht002433.v1.p1.SIGNET_Subject.var_report.xml									phs000433.v1.p1	Type 2 Diabetes Mellitus
925.0	931.0		05/21/2013	845.0		925.0	./data/phs000421.v1.pht003235.v1.p1.FuchsEndothelialCornealDystrophy_Subject_Phenotypes.var_report.xml	0.0	938.0	86.27	931.0			938.0		phs000421.v1.p1	Fuchs&#39; Endothelial Dystrophy
			11/04/2014				./data/phs000086.v3.pht000220.v1.p1.DCCT_ms12expt.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/11/08				./data/phs001332.v2.pht007462.v2.p1.deathrecord.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			08/12/2016				./data/phs000888.v1.pht005583.v1.p1.emerge2_obesity_med.var_report.xml									phs000888.v1.p1	
			2018/02/12				./data/phs001525.v1.pht007476.v1.p1.XDP_Sample.var_report.xml									phs001525.v1.p1	X-Linked Dystonia Parkinsonism
			11/05/2014				./data/phs000209.v13.pht002297.v2.p3.MESA_AncilMesaLungAirway.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/02/04				./data/phs001748.v1.pht008577.v1.p1.Histiocytic_Sarcomas_Sample_Attributes.var_report.xml									phs001748.v1.p1	Histiocytic Sarcoma
			2020/03/09				./data/phs001491.v2.pht007253.v2.p1.CIDR_Tooth_Disorders_Sample.var_report.xml									phs001491.v2.p1	Amelogenesis Imperfecta
			05/13/2014				./data/phs000678.v1.pht003564.v1.p1.Young_Onset_Breast_Cancer_Sample.var_report.xml									phs000678.v1.p1	Breast Neoplasms
			2021/01/13				./data/phs001480.v1.pht010833.v1.p1.PRO_CIPN_Sample_Attributes.var_report.xml									phs001480.v1.p1	Peripheral Nervous System Diseases/drug effects
			2020/02/04				./data/phs001721.v1.pht009718.v1.p1.IBDGC_Repo_IC_Sample.var_report.xml									phs001721.v1.p1	Inflammatory Bowel Disease
118.0			2021/05/20	173.0			./data/phs000997.v5.pht005688.v3.p2.TOPMed_WGS_VAFAR_Subject_Phenotypes.var_report.xml	0.0			55.0					phs000997.v5.p2	Atrial Fibrillation
22.0	45.0		02/11/2016	79.0		6.0	./data/phs000536.v2.pht002949.v2.p1.Retrotransposition_Colorectal_Tumors_Subject_Phenotypes.var_report.xml	0.0	8.667	2.309	6.0			22.0		phs000536.v2.p1	Colonic Neoplasms
18.0	47.0		2020/12/18	65.0		18.0	./data/phs001073.v2.pht005953.v2.p1.Epigenetics_Malnutrition_Pedigree.var_report.xml	0.0	32.5	20.51	47.0			32.5		phs001073.v2.p1	Stunting
			2020/06/18				./data/phs000280.v7.pht009474.v1.p1.GNCps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/19/2011				./data/phs000387.v1.pht002445.v1.p1.eMERGE_GeM_AAA_Sample_Attributes.var_report.xml									phs000387.v1.p1	Abdominal Aortic Aneurysms
			05/12/2017				./data/phs001091.v1.pht006066.v1.p1.CLL_Clonal_Evolution_Sample_Attributes.var_report.xml									phs001091.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
1341.0	3856.0		05/16/2017	7310.0		3454.0	./data/phs001252.v1.pht006384.v1.p1.famrcnd.var_report.xml	0.0	3655.0	284.3	941.0			3655.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2019/06/14				./data/phs000589.v1.pht009184.v1.p1.change_of_information_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2019/08/01				./data/phs000222.v6.pht003450.v2.p2.lh_aparc_area.var_report.xml									phs000222.v6.p2	Huntington Disease
			11/15/2012				./data/phs000405.v1.pht003065.v1.p1.Mendelian_Malignant_Hyperthermia_Sample_Attributes.var_report.xml									phs000405.v1.p1	Malignant Hyperthermia
1985.0	2429.0		2021/10/04	4860.0		49.0	./data/phs000920.v5.pht004897.v5.p3.TOPMed_WGS_GALAII_Subject.var_report.xml	0.0	1620.0	1361	1992.0			2382.0		phs000920.v5.p3	Lung Diseases
6.0	7.0		2018/07/18	49.0		6.0	./data/phs001618.v1.pht008227.v1.p1.TIL_NSCLC_Subject_Phenotypes.var_report.xml	0.0	6.5	1.414	7.0			6.5		phs001618.v1.p1	Neoplasms
1.0	4.0		07/28/2014	5.0		1.0	./data/phs000778.v1.pht003969.v1.p1.Vesicoureteral_Reflux_Subject_Phenotypes.var_report.xml	0.0	2.5	2.121	4.0			2.5		phs000778.v1.p1	Vesico-Ureteral Reflux
			11/04/2014				./data/phs000086.v3.pht000216.v1.p1.DCCT_f0051.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			02/01/2016				./data/phs001021.v1.pht005264.v1.p1.CHDWB_Rare_Regulatory_Variants_Subject.var_report.xml									phs001021.v1.p1	Wellness Center
			03/15/2016				./data/phs001074.v1.pht005341.v1.p1.GeneSTAR_Platelet_Aggregation_iPS_MKs_Sample.var_report.xml									phs001074.v1.p1	Platelet Aggregation
			01/16/2015				./data/phs000763.v1.pht004254.v1.p1.COGA_Family_GWAS_Sample.var_report.xml									phs000763.v1.p1	Alcoholism
			05/12/2015				./data/phs000894.v1.pht004659.v1.p1.Acute_Kidney_Injury_Vancomycin_Sample.var_report.xml									phs000894.v1.p1	Acute Kidney Injury
			2019/03/11				./data/phs000286.v6.pht001964.v3.p2.msra.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			11/06/2015				./data/phs001025.v1.pht005083.v1.p1.SLE_Amerindian_Hispanics_Subject.var_report.xml									phs001025.v1.p1	Lupus Erythematosus, Systemic
			2018/08/19				./data/phs001647.v1.pht008200.v1.p1.Impulsivity_Addiction_Sample.var_report.xml									phs001647.v1.p1	Impulsive Behavior
			2020/12/21				./data/phs000007.v32.pht000205.v8.p13.lipids1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/22				./data/phs002212.v1.pht010984.v1.p1.ZRSR2_MDS_Sample.var_report.xml									phs002212.v1.p1	Myelodysplastic Syndromes
			2018/03/20	103.0			./data/phs000605.v1.pht007630.v1.p1.demographics.var_report.xml	0.0			103.0					phs000605.v1.p1	Lymphangioleiomyomatosis
			2021/05/07				./data/phs001327.v2.pht011185.v1.p1.chronicconditionsumm.var_report.xml									phs001327.v2.p1	Neoplasm
			2021/02/08				./data/phs001422.v2.pht006760.v2.p1.GETHIN_Subject_Phenotypes.var_report.xml									phs001422.v2.p1	Insulinoma
			03/17/2015				./data/phs000884.v1.pht004600.v1.p1.Gut_Microbiome_Controls_Sample.var_report.xml									phs000884.v1.p1	Human Microbiome
			11/08/2013				./data/phs000200.v9.pht000996.v4.p3.f149_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
49.0			2017/10/11	94.0			./data/phs000578.v1.pht007008.v1.p1.demographics.var_report.xml	0.0			45.0					phs000578.v1.p1	Nondystrophic myotonia
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001645.v2.p2.B2REF.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			2019/02/05				./data/phs000748.v7.pht003890.v7.p4.MMRF_Sample_Attributes.var_report.xml									phs000748.v7.p4	Multiple Myeloma
			2017/09/22				./data/phs001392.v1.pht006904.v1.p1.pidtc_19292_day0erttr.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			08/20/2013				./data/phs000285.v3.pht001747.v2.p2.D2F22.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/08/06				./data/phs001580.v1.pht008291.v1.p1.HCC_Sample_Attributes.var_report.xml									phs001580.v1.p1	Thyroid cancer, Hurthle cell
			2020/04/27				./data/phs002002.v1.pht010190.v1.p1.ILCs_HNSCC_Sample.var_report.xml									phs002002.v1.p1	Squamous Cell Carcinoma of the Head and Neck
			2019/06/03				./data/phs001292.v2.pht007855.v2.p1.sleep_disorder_breathing.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			2021/09/23				./data/phs001468.v3.pht009555.v1.p1.TOPMed_WGS_REDSIII_Brazil_SCD_Sample_Attributes.var_report.xml									phs001468.v3.p1	Sickle Cell Anemia
2252.0	2252.0		12/15/2009	2252.0		2252.0	./data/phs000207.v1.pht001105.v1.p1.CGEMS_Prostate_Data.var_report.xml	0.0	2252.0					2252.0		phs000207.v1.p1	Prostatic Neoplasms
1401.0	199.0		2021/09/24	321.0		936.0	./data/phs001726.v2.pht009834.v2.p1.TOPMed_WGS_CAMP_Subject.var_report.xml	0.0	970.0	54.45	936.0			970.0		phs001726.v2.p1	Asthma
			2020/06/18				./data/phs000280.v7.pht006433.v1.p1.DLR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/21/2016				./data/phs000341.v2.pht003171.v1.p1.Hypodiploid_ALL_GEO.var_report.xml									phs000341.v2.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2021/06/09				./data/phs001293.v3.pht008895.v1.p1.TOPMed_WGS_HyperGEN_Sample.var_report.xml									phs001293.v3.p1	Hypertrophy, Left Ventricular
			11/28/2011				./data/phs000274.v1.pht001276.v1.p1.CIDR_Celiac_Subject.var_report.xml									phs000274.v1.p1	Celiac Disease
			2017/10/02				./data/phs000962.v1.pht006964.v1.p1.CIDR_Brain_Growth_Children_Subject.var_report.xml									phs000962.v1.p1	Cerebral Cortex
			01/18/2013				./data/phs000550.v1.pht003127.v1.p1.Pancreatic_Adenocarcinoma_Subject.var_report.xml									phs000550.v1.p1	Pancreatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001577.v2.p2.A4F14.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/08/19				./data/phs002075.v1.pht010458.v1.p1.Chorioamniotic_Membranes_Sample.var_report.xml									phs002075.v1.p1	Placenta Previa
			02/18/2015				./data/phs000509.v1.pht004315.v1.p1.Hepatocellular_Carcinoma_Sequencing_Sample_Attributes.var_report.xml									phs000509.v1.p1	Carcinoma, Hepatocellular
81.0	81.0		2019/04/25	5.0		80.0	./data/phs000899.v1.pht008942.v1.p1.AmBiGen_Pedigree.var_report.xml	0.0	80.5	2.121	80.0			80.5		phs000899.v1.p1	Bipolar Disorder
			2018/05/07				./data/phs000490.v1.pht002963.v1.p1.eMERGE_Complex_Pediatric_Disorders_Sample.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			2018/04/12				./data/phs001411.v1.pht007725.v1.p1.ACCORD_Sample.var_report.xml									phs001411.v1.p1	Diabetes Mellitus, Type 2
84.0	84.0		08/13/2015	54.0		73.0	./data/phs000831.v1.pht004907.v1.p1.Sporadic_ALS_Subject_Phenotypes.var_report.xml	0.0	78.5	7.778	73.0			78.5		phs000831.v1.p1	Amyotrophic Lateral Sclerosis
			2019/08/01				./data/phs001828.v1.pht009370.v1.p1.CKD_Sample_Attributes.var_report.xml									phs001828.v1.p1	Renal Insufficiency, Chronic
			2018/03/23				./data/phs000698.v1.pht007677.v1.p1.inspiratory_ctscan_20mas.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
676.0	718.0		12/02/2016	1394.0		676.0	./data/phs000847.v2.pht005718.v1.p1.T2D_GENES_SAMAFS_Pedigree.var_report.xml	0.0	697.0	29.7	718.0			697.0		phs000847.v2.p1	Diabetes Mellitus, Type 2
			07/19/2012				./data/phs000494.v1.pht002800.v1.p1.eMERGE_Pediatric_CCHMC_Sample.var_report.xml									phs000494.v1.p1	Child Health
9.0	49.0		2019/06/24	95.0		9.0	./data/phs001795.v1.pht008950.v1.p1.CM1_Pedigree.var_report.xml	0.0	47.5	6.364	49.0			47.5		phs001795.v1.p1	Arnold-Chiari Malformation
			06/22/2016				./data/phs001012.v1.pht005551.v1.p1.Diabetes_Heart_Study_EA_Sample_Attributes.var_report.xml									phs001012.v1.p1	Cardiovascular Diseases
21.0	25.0		10/28/2011	46.0		21.0	./data/phs000352.v1.pht002286.v1.p1.Retinoblastoma_Subject_Phenotypes.var_report.xml	0.0	23.0	2.828	25.0			23.0		phs000352.v1.p1	Retinoblastoma
			2021/07/07				./data/phs002436.v1.pht011376.v1.p1.TIL_Infusion_Sample.var_report.xml									phs002436.v1.p1	Melanoma
3.0	11.0		2020/05/06	14.0		3.0	./data/phs002023.v1.pht010197.v1.p1.CRPM_Subject_Phenotypes.var_report.xml	0.0	7.0	5.657	11.0			7.0		phs002023.v1.p1	Peritoneal Neoplasms
6.0	6.0		2018/02/27	7.0		6.0	./data/phs001206.v1.pht007343.v1.p1.BSP_AA_Pedigree.var_report.xml	0.0	6.0	0.7071	6.0			6.0		phs001206.v1.p1	Blepharospasm
			2018/05/15				./data/phs001309.v1.pht007914.v1.p1.registration.var_report.xml									phs001309.v1.p1	Pulmonary Alveolar Proteinosis
			2021/02/03				./data/phs001018.v1.pht010911.v1.p1.Clinical_Renal_Tumors_Subject.var_report.xml									phs001018.v1.p1	
			02/24/2012				./data/phs000001.v3.pht000370.v2.p1.adverse.var_report.xml									phs000001.v3.p1	Cataract
			2017/12/08				./data/phs001279.v1.pht007203.v1.p1.GDMCC_5904_Subject.var_report.xml									phs001279.v1.p1	Bronchiectasis
			2019/03/11				./data/phs000286.v6.pht001945.v2.p2.cena.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			05/07/2013				./data/phs000462.v1.pht002542.v1.p1.T2D_GENES_Sample.var_report.xml									phs000462.v1.p1	Diabetes Mellitus, Type 2
			09/16/2009				./data/phs000211.v1.pht000913.v1.p1.NIGMS_Variation_Panels_Subject.var_report_2009_09_16.xml									phs000211.v1.p1	Normalcy
			07/12/2017				./data/phs000592.v1.pht006593.v1.p1.interimmedicalhistory.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
454.0	454.0		2019/10/22	824.0		370.0	./data/phs001917.v1.pht009550.v1.p1.Methylation_PC_Subject_Phenotypes.var_report.xml	0.0	412.0	59.4	370.0			412.0		phs001917.v1.p1	Pancreatic Neoplasms
			06/28/2017				./data/phs001338.v1.pht006364.v1.p1.Tibetan_High_Altitude_Adaptation_Subject_Phenotypes.var_report.xml									phs001338.v1.p1	
			2017/12/08				./data/phs001279.v1.pht007205.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001279.v1.p1	Bronchiectasis
			2018/05/07				./data/phs000490.v1.pht002967.v1.p1.GERD_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			09/19/2016				./data/phs001185.v1.pht005764.v1.p1.Early_Onset_Prostate_Cancer_Subject_Phenotypes.var_report.xml									phs001185.v1.p1	Prostatic Neoplasms
29.0	29.0		2020/01/21	39.0		2.0	./data/phs001282.v2.pht006098.v2.p1.Endemic_Burkitt_Lymphoma_Subject_Phenotypes.var_report.xml	0.0	13.0	14.18	8.0			8.0		phs001282.v2.p1	Burkitt Lymphoma
9.0	9.0		2017/11/30	18.0		9.0	./data/phs001474.v1.pht007153.v1.p1.Metastasis_HNSCC_Subject_Phenotypes.var_report.xml	0.0	9.0	0	9.0			9.0		phs001474.v1.p1	Carcinoma, Squamous Cell
			2020/12/21				./data/phs000007.v32.pht002151.v1.p13.ffreq0_20s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/10/27				./data/phs001616.v2.pht008546.v2.p2.eMERGEseq_Sample_Attributes.var_report.xml									phs001616.v2.p2	Precision Medicine
			2019/10/29				./data/phs001465.v1.pht006958.v1.p1.Localized_Prostate_Cancer_Subject_Phenotypes.var_report.xml									phs001465.v1.p1	Prostate Neoplasm
			2019/04/04				./data/phs001768.v1.pht008693.v1.p1.Methylmercury_Pregnancy_Subject_Phenotypes.var_report.xml									phs001768.v1.p1	
			2018/06/18				./data/phs001586.v1.pht008149.v1.p1.RICHS_Sample.var_report.xml									phs001586.v1.p1	Child Health
			08/20/2013				./data/phs000285.v3.pht001817.v2.p2.F1F09TOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			02/02/2012				./data/phs000417.v2.pht002397.v2.p1.Brain_Cloud_Sample.var_report.xml									phs000417.v2.p1	Aging
			2017/10/11				./data/phs000578.v1.pht007021.v1.p1.sf10_for_age5.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
5.0	5.0		2019/08/27	8.0		3.0	./data/phs001845.v1.pht009408.v1.p1.SDS_Subject_Phenotypes.var_report.xml	0.0	4.0	1.414	3.0			4.0		phs001845.v1.p1	Shwachman syndrome [Supplementary Concept]
			08/20/2013				./data/phs000285.v3.pht001574.v2.p2.A4F11.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/07/21				./data/phs002464.v1.pht011334.v1.p1.Familial_AF_Sample.var_report.xml									phs002464.v1.p1	Atrial Fibrillation
			2017/08/31				./data/phs000939.v2.pht004787.v2.p1.Lymphoma_Oncogene_Dysregulation_Subject.var_report.xml									phs000939.v2.p1	Lymphoma, B-Cell
			2020/12/21				./data/phs000007.v32.pht001892.v5.p13.t_bmdhs_2010_3_0626s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000784.v1.p1.MS_DATA_PREGNANCY.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2021/01/26				./data/phs002068.v1.pht010872.v1.p1.SALSA_SGC_Sample.var_report.xml									phs002068.v1.p1	Amyotrophic Lateral Sclerosis
70.0			2020/03/13	127.0			./data/phs000521.v2.pht007039.v2.p1.demographics.var_report.xml	3.0			57.0					phs000521.v2.p1	Ataxia
			2020/12/10				./data/phs002065.v1.pht010770.v1.p1.Genitourinary_Cancers_Sample.var_report.xml									phs002065.v1.p1	Bladder Neoplasms
			12/03/2013				./data/phs000631.v1.pht003599.v1.p1.ARDSNet_iSPAAR_Subject.var_report.xml									phs000631.v1.p1	Respiration Disorders
			07/06/2016				./data/phs000743.v1.pht004820.v1.p1.METSIM_Subject.var_report.xml									phs000743.v1.p1	Metabolic Syndrome X
			2020/12/21				./data/phs000007.v32.pht003097.v6.p13.t_ecgpwm_2005_m_0718s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002146.v7.p13.l_rbp4_2005_m_0547s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
616.0	616.0		08/29/2016	895.0		432.0	./data/phs000126.v2.pht000365.v2.p1.CIDR_PD_Pedigree.var_report.xml	0.0	524.0	8.485	532.0			524.0		phs000126.v2.p1	Parkinson Disease
			06/16/2017				./data/phs001278.v1.pht006279.v1.p1.porphyria_specific_lab_tests.var_report.xml									phs001278.v1.p1	Porphyrias
			2020/12/21				./data/phs000007.v32.pht000025.v4.p13.ex0_23s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/23				./data/phs000698.v1.pht007669.v1.p1.RLD_5701_Subject.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			2018/05/31				./data/phs001316.v1.pht008013.v1.p1.registration.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			06/03/2015				./data/phs000863.v1.pht004743.v1.p1.RCC_AA_Sample.var_report.xml									phs000863.v1.p1	Carcinoma, Renal Cell
			2020/01/23				./data/phs000287.v7.pht001487.v1.p1.YR17PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008738.v1.p2.bcfv.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			01/03/2017				./data/phs001141.v1.pht005602.v1.p1.PROMOTE_Sample_Attributes.var_report.xml									phs001141.v1.p1	Prostatic Neoplasms, Castration-Resistant
2.0	2.0		10/24/2016	2.0		2.0	./data/phs001214.v1.pht005877.v1.p1.Simul_seq_Subject_Phenotypes.var_report.xml	0.0	2.0					2.0		phs001214.v1.p1	Esophageal Neoplasms
			2019/10/15				./data/phs000256.v4.pht002179.v3.p3.HMP_Vaginal_Microbiome_Sample_Attributes.var_report.xml									phs000256.v4.p3	Microbiomes, Human
			2020/12/21				./data/phs000007.v32.pht000106.v8.p13.pft1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/17				./data/phs001661.v3.pht010561.v1.p1.TOPMed_WGS_GCPD_A_Sample_Attributes.var_report.xml									phs001661.v3.p1	Asthma
			2020/01/16				./data/phs001960.v1.pht009825.v1.p1.Osteoporosis_Risk_Sample_Attributes.var_report.xml									phs001960.v1.p1	Osteoporosis
			2019/11/08				./data/phs001332.v2.pht007459.v2.p1.p7301_12575_timedtest.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			03/29/2017				./data/phs001319.v1.pht006208.v1.p1.GICC_Subject.var_report.xml									phs001319.v1.p1	Glioma
2.0			2018/05/31	3.0			./data/phs001316.v1.pht008005.v1.p1.demographics.var_report.xml	0.0			1.0					phs001316.v1.p1	Andersen Syndrome
			2018/11/15				./data/phs001418.v1.pht007238.v1.p1.CD_Sample_Attributes.var_report.xml									phs001418.v1.p1	Crohn Disease
			02/12/2014				./data/phs000461.v1.pht003685.v1.p1.GLAUGEN_POAG_Methylation_Sample.var_report.xml									phs000461.v1.p1	Glaucoma, Open-Angle
			2019/01/29				./data/phs001765.v1.pht008666.v1.p1.Parathyroid_Cancer_Sample_Attributes.var_report.xml									phs001765.v1.p1	Parathyroid Neoplasms
			2020/04/29				./data/phs000185.v7.pht003276.v5.p1.Hutterites_Sample.var_report.xml									phs000185.v7.p1	Prospective
			10/15/2015				./data/phs000870.v1.pht004547.v1.p1.Alternative_Splicing_Subject.var_report.xml									phs000870.v1.p1	
			08/12/2016				./data/phs000888.v1.pht005562.v1.p1.11aAtopic_dermatitis_Labs.var_report.xml									phs000888.v1.p1	
			2021/04/08				./data/phs001590.v2.pht007894.v2.p1.NESARCIII_Sample_Attributes.var_report.xml									phs001590.v2.p1	Alcoholism
			11/29/2012				./data/phs000541.v1.pht003049.v1.p1.Mendelian_Muscle_Hypertrophy_Sample.var_report.xml									phs000541.v1.p1	Hypertrophy
			2017/09/27				./data/phs001071.v1.pht005344.v1.p1.CIDR_HD_Onset_Age_Subject.var_report.xml									phs001071.v1.p1	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht000907.v7.p13.imtcarotid1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/09				./data/phs000606.v1.pht007574.v1.p1.eligibilityform.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000306.v9.p13.mcp3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/03				./data/phs001814.v1.pht009008.v1.p1.Heterotaxy_Sample_Attributes.var_report.xml									phs001814.v1.p1	Heterotaxy Syndrome
			05/09/2016				./data/phs001043.v1.pht005316.v1.p1.Adjuvant_Aromatase_Inhibitors_Breast_Cancer_Sample_Attributes.var_report.xml									phs001043.v1.p1	Neoplasm
287.0			07/05/2017	617.0			./data/phs000595.v1.pht006632.v1.p1.demographics_and_referral.var_report.xml	0.0			330.0					phs000595.v1.p1	Primary ciliary dyskinesia
			2021/06/01				./data/phs001189.v4.pht005978.v2.p1.TOPMed_WGS_CCAF_Sample.var_report.xml									phs001189.v4.p1	Atrial Fibrillation
8.0			2019/06/19	91.0			./data/phs001776.v1.pht009210.v1.p1.LTG_Pancreas_QTL_Subject_Phenotypes.var_report.xml	0.0			8.0					phs001776.v1.p1	Pancreas
			04/25/2014				./data/phs000587.v1.pht003518.v1.p1.ESP_Family_Studies_MLD_Sample.var_report.xml									phs000587.v1.p1	Hyperlipoproteinemia Type II
			04/18/2014				./data/phs000438.v1.pht003320.v1.p1.ACE_Inhibitor_Angioedema_Subject_Phenotypes.var_report.xml									phs000438.v1.p1	Angioedema
			2019/10/17				./data/phs001511.v1.pht007292.v1.p1.SEARCH_ProDIGY_Subject.var_report.xml									phs001511.v1.p1	Diabetes Mellitus, Type 2
			2019/09/18				./data/phs001737.v2.pht008559.v2.p1.EEC_Syndrome_Subject.var_report.xml									phs001737.v2.p1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
25.0	25.0		2020/10/16	37.0		12.0	./data/phs002269.v1.pht010580.v1.p1.Tumor_Neoantigens_Subject.var_report.xml	0.0	18.5	9.192	12.0			18.5		phs002269.v1.p1	Antigens, Neoplasm
			2020/07/10				./data/phs002055.v1.pht010343.v1.p1.GTAC_ALS_FTD_Subject.var_report.xml									phs002055.v1.p1	Amyotrophic Lateral Sclerosis
			2018/05/16				./data/phs001592.v1.pht007979.v1.p1.CCDG_ATVB_Sample_Attributes.var_report.xml									phs001592.v1.p1	Atherosclerosis
			02/11/2016				./data/phs000536.v2.pht002951.v2.p1.Retrotransposition_Colorectal_Tumors_Sample_Attributes.var_report.xml									phs000536.v2.p1	Colonic Neoplasms
5.0	7.0		07/21/2010	6.0		5.0	./data/phs000239.v2.pht001220.v1.p1.MS_MZTwins_Pedigree.var_report_2010_07_21.xml	0.0	6.0	1.414	7.0			6.0		phs000239.v2.p1	Multiple Sclerosis
			08/01/2016				./data/phs000744.v4.pht003978.v4.p2.Y_CMG_Sample.var_report.xml									phs000744.v4.p2	Familial Idiopathic Pulmonary Fibrosis
			2020/06/18				./data/phs000280.v7.pht004237.v2.p1.VENC04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
40.0	40.0		2018/10/22	82.0		7.0	./data/phs001550.v2.pht007506.v1.p1.Melanocytic_Neoplasms_Subject_Phenotypes.var_report.xml	0.0	27.33	17.79	35.0			35.0		phs001550.v2.p1	Melanoma
			2020/10/29				./data/phs002270.v1.pht010599.v1.p1.Recurrent_GBM_Sample_Attributes.var_report.xml									phs002270.v1.p1	Glioblastoma
			2020/04/23				./data/phs000640.v9.pht003438.v4.p1.HeLaCell_Subject.var_report.xml									phs000640.v9.p1	Uterine Cervical Neoplasms
			2018/06/14				./data/phs001238.v2.pht006037.v1.p1.GENOA_AfricanAmerican_JacksonCAC_Medications.var_report.xml									phs001238.v2.p1	Hypertension
			2018/04/16				./data/phs001326.v1.pht007811.v1.p1.pidtc_19175_day100gen.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000475.v2.p3.simphen076.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/01/31				./data/phs001934.v1.pht009774.v1.p1.Immune_Aging_Subject.var_report.xml									phs001934.v1.p1	
836.0			2021/03/24	780.0			./data/phs000711.v7.pht003721.v7.p2.BH_CMG_Pedigree.var_report.xml	0.0			816.0					phs000711.v7.p2	Mendelian Conditions
			01/19/2010				./data/phs000219.v1.pht001090.v1.p1.d_meal_info_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
383.0	793.0		05/16/2017	1268.0		475.0	./data/phs001252.v1.pht006392.v1.p1.nssputum.var_report.xml	0.0	634.0	224.9	250.0			634.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
199.0			01/13/2012	982.0			./data/phs000380.v1.pht002458.v1.p1.EMERGE_GWASOM_Phenotype.var_report.xml	0.0			783.0					phs000380.v1.p1	Obesity
1.0	3.0		02/08/2017	4.0		1.0	./data/phs001276.v1.pht006122.v1.p1.Interneuron_Development_Subject_Phenotypes.var_report.xml	0.0	2.0	1.414				2.0		phs001276.v1.p1	Growth and Development
4620.0	4611.0		08/17/2010	6042.0		7.0	./data/phs000294.v1.pht001536.v1.p1.MIGen_Subject_Phenotypes.var_report_2010_08_17.xml	0.0	989.0	2355	755.0			751.0		phs000294.v1.p1	Myocardial Infarction
			11/04/2014				./data/phs000086.v3.pht000624.v1.p1.EDIC_f0022.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			03/01/2016				./data/phs000942.v1.pht004835.v1.p1.Cancer_Genetics_Clinic_Sample.var_report.xml									phs000942.v1.p1	Neoplasms
			08/20/2013				./data/phs000285.v3.pht001786.v2.p2.E1F29.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/08/26				./data/phs001958.v1.pht009931.v1.p1.caQTL_Sample.var_report.xml									phs001958.v1.p1	Mental Disorders
			2021/05/24				./data/phs000922.v2.pht004925.v2.p1.CLL8_Cohort_Sample.var_report.xml									phs000922.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
4.0	4.0		04/16/2012	4.0		4.0	./data/phs000485.v1.pht002679.v1.p1.Congenital_Diaphragmatic_Hernia_Subject_Phenotypes.var_report.xml	0.0	4.0					4.0		phs000485.v1.p1	Congenital diaphragmatic hernia
			2020/02/27				./data/phs000452.v3.pht002589.v3.p1.MelanomaCIP_Subject.var_report.xml									phs000452.v3.p1	Melanoma
820.0	820.0		08/26/2013	820.0		820.0	./data/phs000619.v1.pht003353.v1.p1.Autism_Epigenetics_Subject_Phenotypes.var_report.xml	0.0	820.0					820.0		phs000619.v1.p1	Autistic Disorder
3.0	3.0		11/04/2013	51.0		8.0	./data/phs000579.v1.pht003279.v1.p1.SmallBowelNeuroendocrineTumors_Subject_Phenotypes.var_report.xml	0.0	9.0	1.414	8.0			9.0		phs000579.v1.p1	Intestinal Neoplasms
			07/27/2017	248.0			./data/phs000596.v1.pht006707.v1.p1.cfq_children_ages_6to11.var_report.xml	1.0								phs000596.v1.p1	Primary ciliary dyskinesia
			03/29/2017				./data/phs000707.v2.pht003714.v2.p1.Hereditary_Neurological_Disorders_Subject.var_report.xml									phs000707.v2.p1	Nervous System Diseases
			2019/03/11				./data/phs000286.v6.pht008740.v1.p2.cbfa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/01/31				./data/phs001940.v2.pht009699.v2.p1.Immune_Checkpoint_NSCLC_Sample_Attributes.var_report.xml									phs001940.v2.p1	Carcinoma, Non-Small-Cell Lung
			11/05/2014				./data/phs000209.v13.pht002106.v3.p3.MESA_AncilMesaStressCortisolLong.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000224.v1.p1.DCCT_m9exmorb.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			01/13/2014				./data/phs000658.v1.pht003497.v1.p1.MDD2000AFFY_Sample.var_report.xml									phs000658.v1.p1	Depressive Disorder, Major
			2018/05/24				./data/phs000929.v1.pht007981.v1.p1.High_Risk_Breast_Cancer_Subject.var_report.xml									phs000929.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001782.v2.p2.E1F12PF8.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/07/30				./data/phs001714.v1.pht010432.v1.p1.GMKF_Osteosarcoma_Subject.var_report.xml									phs001714.v1.p1	Osteosarcoma
			2020/06/18				./data/phs000280.v7.pht004084.v2.p1.ESMB07.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000036.v10.p13.ex1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/11/22				./data/phs000313.v4.pht002395.v3.p2.SardiNIA_Sample_Attributes.var_report.xml									phs000313.v4.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht010755.v1.p13.vr_meds_ex03_3b_1071s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/02/19				./data/phs001853.v1.pht009813.v1.p1.GI_Malignancies_Sample_Attributes.var_report.xml									phs001853.v1.p1	Colorectal Neoplasms
			06/01/2017				./data/phs000701.v1.pht005519.v1.p1.LabTesting.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/06/18				./data/phs000280.v7.pht006467.v1.p1.PULB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/04/15				./data/phs001894.v1.pht009521.v1.p1.CCDG_HMCA_Subject.var_report.xml									phs001894.v1.p1	Autism Spectrum Disorder
			2019/10/08				./data/phs000224.v3.pht004624.v2.p2.VitGene_Vitiligo_Sample_Attributes.var_report.xml									phs000224.v3.p2	Vitiligo
			06/01/2010				./data/phs000138.v2.pht000642.v2.p1.Bone_Fragility_Sample.var_report_2010_06_01.xml									phs000138.v2.p1	Osteoporosis
3.0			2018/01/29	5.0			./data/phs001245.v1.pht005932.v1.p1.CD70_Subject_Phenotypes.var_report.xml	0.0			2.0					phs001245.v1.p1	Immunologic Deficiency Syndromes
			2020/07/10				./data/phs001886.v2.pht009417.v2.p1.Placenta_Term_Preterm_Sample.var_report.xml									phs001886.v2.p1	Pregnancy, COVID-19
			2017/09/22				./data/phs001394.v1.pht006948.v1.p1.GUARDIAN_HTN_IR_Sample.var_report.xml									phs001394.v1.p1	Hypertension
			2018/08/03				./data/phs000590.v1.pht008286.v1.p1.unscheduled_visit_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2019/09/06				./data/phs001885.v1.pht009428.v1.p1.ECAC_European_Subject.var_report.xml									phs001885.v1.p1	Endometrial Neoplasms
			2020/06/18				./data/phs000280.v7.pht006412.v1.p1.AAO.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/03/24				./data/phs001641.v1.pht010036.v1.p1.Medications.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2021/04/09				./data/phs002316.v1.pht011110.v1.p1.TEA_seq_Sample.var_report.xml									phs002316.v1.p1	
			11/05/2012				./data/phs000561.v1.pht003034.v1.p1.Hypobetalipoproteinemia_Sample.var_report.xml									phs000561.v1.p1	Hypobetalipoproteinemias
			2020/06/18				./data/phs000280.v7.pht004191.v2.p1.RTAWM42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
372.0	465.0		2021/08/06	837.0		372.0	./data/phs001783.v2.pht008819.v2.p1.Clinical_Specimens_Subject.var_report.xml	0.0	418.5	65.76	465.0			418.5		phs001783.v2.p1	Neoplasms
			2020/01/10				./data/phs001471.v1.pht009803.v1.p1.Subject_Phenotypes_TIME2.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			2021/08/18				./data/phs001725.v2.pht010093.v1.p1.TOPMed_CCDG_GGAF_Sample.var_report.xml									phs001725.v2.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004188.v2.p1.RTAWM03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/07				./data/phs001502.v1.pht007258.v1.p1.CCDG_UPenn_EOCAD_Subject.var_report.xml									phs001502.v1.p1	Cardiovascular Diseases
2.0			2020/01/21	9.0			./data/phs001936.v1.pht009648.v1.p1.Gastric_Cancer_BDI_Subject_Phenotypes.var_report.xml	0.0			7.0					phs001936.v1.p1	Gastrointestinal Neoplasms
72.0	72.0		2017/10/25	48.0		9.0	./data/phs000771.v2.pht003983.v2.p1.Bladder_Cancer_Chemotherapy_Response_Subject_Phenotypes.var_report.xml	0.0	9.5	7.778	9.0			9.5		phs000771.v2.p1	Urinary Bladder Neoplasms
			11/18/2016				./data/phs001224.v1.pht005942.v1.p1.Platinum_Genomes_Sample_Attributes.var_report.xml									phs001224.v1.p1	Computational Biology
			2017/08/17				./data/phs001022.v1.pht005441.v1.p1.PsychENCODE_ASD_Sample.var_report.xml									phs001022.v1.p1	Autistic Disorder
			2020/06/30				./data/phs002049.v1.pht010295.v1.p1.Myeloid_Malignancies_Subject.var_report.xml									phs002049.v1.p1	Acute Myeloid Leukemia
8.0			2018/05/10	8.0			./data/phs001565.v1.pht007897.v1.p1.Immune_Checkpoint_Blockade_Subject_Phenotypes.var_report.xml	0.0			8.0					phs001565.v1.p1	Neoplasms
			08/09/2016				./data/phs001097.v1.pht005615.v1.p1.T2D_GENES_Singapore_Asian_Sample.var_report.xml									phs001097.v1.p1	Diabetes Mellitus, Type 2
984.0	984.0		02/08/2017	824.0		906.0	./data/phs001271.v1.pht006118.v1.p1.KIDRISK_Subject_Phenotypes.var_report.xml	0.0	904.5	92.63	906.0			904.5		phs001271.v1.p1	Carcinoma, Renal Cell
			2019/12/16				./data/phs001188.v2.pht006301.v2.p1.FUSION_Islet_Subject_Phenotypes.var_report.xml									phs001188.v2.p1	Diabetes Mellitus, Type 2
			2017/09/12				./data/phs001403.v1.pht006844.v1.p1.NF1_PN_Sample_Attributes.var_report.xml									phs001403.v1.p1	Neurofibromatosis Type I
			2017/12/29				./data/phs000774.v2.pht004699.v1.p1.CCDG_OFCs_Subject.var_report.xml									phs000774.v2.p1	Cleft Lip
			2019/03/27				./data/phs001286.v1.pht007890.v1.p1.PLCO_Sample_Attributes.var_report.xml									phs001286.v1.p1	Neoplasms
919.0	919.0		2021/03/30	919.0		919.0	./data/phs001307.v1.pht011048.v1.p1.TGCT_UPenn_Subject_Phenotypes.var_report.xml	0.0	919.0					919.0		phs001307.v1.p1	Testicular Germ Cell Tumor
			2020/06/18				./data/phs000280.v7.pht004038.v3.p1.ATRFIB21.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/08/26				./data/phs001837.v1.pht009315.v1.p1.NAFLD_Microbiome_Sample_Attributes.var_report.xml									phs001837.v1.p1	Non-alcoholic Fatty Liver Disease
			2019/04/10				./data/phs001653.v1.pht008706.v1.p1.Holoprosencephaly_Sample_Attributes.var_report.xml									phs001653.v1.p1	Holoprosencephaly
			2021/07/09				./data/phs001544.v2.pht009896.v1.p1.TOPMed_CCDG_MPP_Subject.var_report.xml									phs001544.v2.p1	Atrial Fibrillation
			2019/02/05				./data/phs001158.v2.pht005592.v2.p1.Human_Dorsal_Root_Ganglion_Subject.var_report.xml									phs001158.v2.p1	Chronic Pain
9.0	35.0		2019/06/24	62.0		9.0	./data/phs001795.v1.pht008952.v1.p1.CM1_Subject_Phenotypes.var_report.xml	0.0	31.0	6.364	35.0			31.0		phs001795.v1.p1	Arnold-Chiari Malformation
19.0	19.0		2020/04/06	38.0		19.0	./data/phs002003.v1.pht010108.v1.p1.Single_Cell_Atlas_Subject_Phenotypes.var_report.xml	0.0	19.0	0	19.0			19.0		phs002003.v1.p1	Human Development
5.0	5.0		05/02/2017	9.0		4.0	./data/phs001358.v1.pht006334.v1.p1.RareBliss_Pedigree.var_report.xml	0.0	4.5	9.899	4.0			4.5		phs001358.v1.p1	Bipolar Disorder
			12/11/2009				./data/phs000181.v1.pht000806.v1.p1.OZALC_Subject.var_report_2009_12_11.xml									phs000181.v1.p1	Alcohol-Related Disorders
			11/08/2013				./data/phs000200.v9.pht002771.v1.p3.outc_strk_carotid_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			09/10/2014				./data/phs000798.v1.pht004026.v1.p1.Genetic_Diagnostic_Testing_Sample_Attributes.var_report.xml									phs000798.v1.p1	Genetic Testing
211.0			2021/06/28	50.0			./data/phs001514.v2.pht009816.v1.p1.Walk_PHaSST_Subject_Phenotypes.var_report.xml	0.0			31.0					phs001514.v2.p1	Anemia, Sickle Cell
232.0			2021/05/04	415.0			./data/phs002317.v1.pht011163.v1.p1.ALL_Bone_Toxicities_Subject.var_report.xml	0.0			183.0					phs002317.v1.p1	Fractures, Bone
			07/12/2017				./data/phs000592.v1.pht006599.v1.p1.sf_36.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			07/27/2017				./data/phs000247.v5.pht003420.v1.p3.HMP_Neonatal_Enterocolitis_GenBank.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			2021/09/21				./data/phs002330.v1.pht011570.v1.p1.GMKF_INCLUDE_Sample.var_report.xml									phs002330.v1.p1	Down Syndrome
			05/12/2017				./data/phs001091.v1.pht006064.v1.p1.CLL_Clonal_Evolution_Sample.var_report.xml									phs001091.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
8.0	34.0		2017/12/04	42.0		8.0	./data/phs001385.v1.pht007165.v1.p1.Gallbladder_Cancer_Chileans_Subject_Phenotypes.var_report.xml	0.0	94.5	99.7	34.0			94.5		phs001385.v1.p1	Gallbladder Neoplasms
			06/01/2017				./data/phs000701.v1.pht005513.v1.p1.DietHistory.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/12/21				./data/phs000007.v32.pht000673.v8.p13.t_pat_2005_m_0259s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/03/2014				./data/phs000706.v1.pht003664.v1.p1.RAD50_Hypomorphism_Subject.var_report.xml									phs000706.v1.p1	Ureteral Neoplasms
2.0	2.0		05/19/2016	3.0		1.0	./data/phs001115.v1.pht005481.v1.p1.Melanoma_Genetic_Analysis_Subject_Phenotypes.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs001115.v1.p1	Melanoma, Cutaneous Malignant
			08/01/2016				./data/phs000744.v4.pht003977.v4.p2.Y_CMG_Pedigree.var_report.xml									phs000744.v4.p2	Familial Idiopathic Pulmonary Fibrosis
			2020/03/19				./data/phs001982.v1.pht010004.v1.p1.MFS_UPS_Sample.var_report.xml									phs001982.v1.p1	Sarcoma, Soft Tissue
			2020/06/18				./data/phs000280.v7.pht006477.v1.p1.REX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/08/26				./data/phs001729.v2.pht010126.v1.p1.TOPMed_WGS_CARE_CLIC_Subject.var_report.xml									phs001729.v2.p1	Asthma
			08/20/2013				./data/phs000285.v3.pht001727.v2.p2.D1F9MBCA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			02/08/2017				./data/phs001187.v1.pht005677.v1.p1.CD8_T_Cell_Differentiation_Aging_Sample.var_report.xml									phs001187.v1.p1	Aging
			06/09/2010				./data/phs000255.v1.pht001255.v1.p1.HMP_Crohns_Risk_Sample_Attributes.var_report.xml									phs000255.v1.p1	Crohn Disease
			2020/07/06				./data/phs001955.v1.pht009792.v1.p1.REDS_III_RBCOmics_Subject.var_report.xml									phs001955.v1.p1	
			2018/09/19				./data/phs001684.v1.pht008389.v1.p1.Pulmonary_Fluid_Immunocompromised_Subject.var_report.xml									phs001684.v1.p1	Immunocompromised Host
			02/27/2014				./data/phs000299.v2.pht001552.v2.p1.Genentech_NSCLC_Sample.var_report.xml									phs000299.v2.p1	Lung Neoplasms
			2019/03/11				./data/phs000286.v6.pht008782.v1.p2.sbpb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			02/24/2012				./data/phs000001.v3.pht000381.v2.p1.nsaids.var_report.xml									phs000001.v3.p1	Cataract
92.0	67.0		2017/12/13	4.0		92.0	./data/phs001053.v1.pht007230.v1.p1.XFS_Glaucoma_Pedigree.var_report.xml	0.0	50.0	24.04	67.0			50.0		phs001053.v1.p1	Glaucoma
			05/24/2012				./data/phs000394.v1.pht002654.v1.p1.APDGC_Sample_Attributes.var_report.xml									phs000394.v1.p1	Parkinson Disease
			08/11/2015				./data/phs000941.v1.pht004901.v1.p1.Melanoma_Metastasis_Subject.var_report.xml									phs000941.v1.p1	Melanoma
			08/12/2016				./data/phs000888.v1.pht004677.v1.p1.eMERGE_Imputed_Sample.var_report.xml									phs000888.v1.p1	
5547.0	5547.0		03/19/2015	6923.0		1376.0	./data/phs000869.v1.pht004610.v1.p1.BEAGESS_Subject_Phenotypes.var_report.xml	0.0	3462.0	2949	1376.0			3462.0		phs000869.v1.p1	Esophageal Neoplasms
			04/24/2012				./data/phs000447.v1.pht002582.v1.p1.Prostate_CIP_Sample_Attributes.var_report.xml									phs000447.v1.p1	Prostatic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000413.v2.p3.simphen014.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/10/11				./data/phs000996.v2.pht005750.v1.p1.Neurodevelopmental_Metal_Toxicity_Subject.var_report.xml									phs000996.v2.p1	
469.0			2021/10/04	674.0			./data/phs001542.v2.pht009644.v2.p1.TOPMed_WGS_GALAI_Subject_Phenotypes.var_report.xml	20.0			535.0					phs001542.v2.p1	
			08/20/2013				./data/phs000285.v3.pht001709.v2.p2.D1F05A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
8.0	8.0		2021/04/06	62.0		7.0	./data/phs002389.v1.pht011091.v1.p1.HTN_microRNAs_Subject.var_report.xml	0.0	7.5	11.31	7.0			7.5		phs002389.v1.p1	Hypertension
			03/10/2016				./data/phs000952.v1.pht005321.v1.p1.Substance_Dependence_EA_AA_Sample_Attributes.var_report.xml									phs000952.v1.p1	Substance-Related Disorders
			12/11/2009				./data/phs000171.v1.pht000769.v1.p1.MS_DATA_MHQMEDHIS2.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			04/15/2014				./data/phs000719.v1.pht003807.v1.p1.PNTM_Mycos_SRA.var_report.xml									phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
			2020/02/06				./data/phs001430.v2.pht008066.v2.p1.p7001_19378_developme.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			03/07/2011				./data/phs000252.v2.pht001270.v2.p1.HMP_Gut_Crohns_Diet_CaFE1_Subject_Phenotypes.var_report.xml									phs000252.v2.p1	Crohn Disease
			2020/12/09				./data/phs001857.v1.pht010767.v1.p1.MD_Ashkenazi_Subject_Phenotypes.var_report.xml									phs001857.v1.p1	Mammographic Breast Density
			2018/04/23				./data/phs001219.v1.pht007859.v1.p1.LPD_Sample.var_report.xml									phs001219.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
	29.0		2019/12/12	29.0		29.0	./data/phs001883.v1.pht009682.v1.p1.S0800_BC_Subject_Phenotypes.var_report.xml	0.0	29.0		29.0			29.0		phs001883.v1.p1	Breast Neoplasms
			09/21/2016				./data/phs000984.v1.pht005009.v1.p1.T2DM_Metformin_Sample.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
			2017/09/11				./data/phs000472.v2.pht006830.v1.p1.BRC77_Pre_Post_Subject_Phenotypes.var_report.xml									phs000472.v2.p1	Breast Neoplasms
			2021/03/18				./data/phs001489.v2.pht008585.v2.p2.CCDG_Epi25_Sample_Attributes.var_report.xml									phs001489.v2.p2	Epilepsy
			2019/01/17				./data/phs001769.v1.pht008627.v1.p1.6104_Study_Data_Clinical.var_report.xml									phs001769.v1.p1	Pure Autonomic Failure
			10/27/2014				./data/phs000726.v1.pht003778.v1.p1.Myasthenia_Gravis_Sample.var_report.xml									phs000726.v1.p1	Myasthenia gravis
11.0	13.0		2021/02/02	24.0		11.0	./data/phs002327.v1.pht010915.v1.p1.ATR_Stress_Tumors_Subject.var_report.xml	0.0	12.0	1.414	13.0			12.0		phs002327.v1.p1	Small Cell Lung Carcinoma
			2018/06/30				./data/phs001643.v1.pht008194.v1.p1.Chordoma_Sample_Attributes.var_report.xml									phs001643.v1.p1	Chordoma
			03/24/2017				./data/phs001257.v2.pht005999.v1.p1.Anti_CTLA_4_Subject_Phenotypes.var_report.xml									phs001257.v2.p1	Melanoma
			05/09/2016				./data/phs001063.v1.pht005292.v1.p1.HER2_Positive_Breast_Cancer_Sample_Attributes.var_report.xml									phs001063.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001824.v2.p2.F1F36.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/05				./data/phs001959.v1.pht009790.v1.p1.CLL_SF3B1_Sample.var_report.xml									phs001959.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
236.0	239.0		2018/04/23	475.0		236.0	./data/phs001219.v1.pht007858.v1.p1.LPD_Pedigree.var_report.xml	0.0	237.5	2.121	239.0			237.5		phs001219.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			08/04/2014				./data/phs000776.v1.pht003948.v1.p1.MCCD_Sample.var_report.xml									phs000776.v1.p1	Urea Cycle Disorders, Inborn
885.0	885.0		2020/04/02	963.0		896.0	./data/phs000277.v2.pht002797.v2.p1.Heroin_Dependence_Subject_Phenotypes.var_report.xml	0.0	737.0	70	896.0			737.0		phs000277.v2.p1	Heroin Dependence
			2021/04/28				./data/phs002393.v1.pht011137.v1.p1.ABCA4_Sample.var_report.xml									phs002393.v1.p1	Retina
			2018/10/02				./data/phs001519.v1.pht008435.v1.p1.Neoantigen_Cancer_Vaccine_GBM_Subject_Phenotypes.var_report.xml									phs001519.v1.p1	Glioblastoma
			08/02/2012				./data/phs000502.v1.pht002815.v1.p1.Splenic_Marginal_Zone_Lymphoma_Sample_Attributes.var_report.xml									phs000502.v1.p1	Lymphoma, Non-Hodgkin
			2020/07/24				./data/phs001194.v3.pht005817.v2.p2.GeneticTesting.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2021/06/23				./data/phs001027.v4.pht005216.v3.p1.Epigenetics_AML_Subject_Phenotypes.var_report.xml									phs001027.v4.p1	Acute Myeloid Leukemia
			12/16/2014				./data/phs000018.v2.pht004356.v1.p1.GoKinD_GAIN_Sample.var_report.xml									phs000018.v2.p1	Diabetic Nephropathies
	1.0		07/22/2013	1.0		1.0	./data/phs000614.v1.pht003290.v1.p1.PLGGs_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs000614.v1.p1	Astrocytoma
			2021/07/15				./data/phs001547.v2.pht009990.v1.p1.TOPMed_CCDG_GENAF_Sample_Attributes.var_report.xml									phs001547.v2.p1	Atrial Fibrillation
			2020/06/02				./data/phs002030.v1.pht010262.v1.p1.MEIs_Transcriptome_Subject.var_report.xml									phs002030.v1.p1	Reference Values
26.0	26.0		2019/01/29	40.0		1.0	./data/phs001765.v1.pht008665.v1.p1.Parathyroid_Cancer_Subject_Phenotypes.var_report.xml	0.0	13.33	12.5	13.0			13.0		phs001765.v1.p1	Parathyroid Neoplasms
			2020/12/21				./data/phs000007.v32.pht000684.v7.p13.l_srankl_ex07_1b_1044s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/01/22				./data/phs001962.v1.pht009819.v1.p1.PTCL_Sample.var_report.xml									phs001962.v1.p1	Lymphoma, T-Cell, Peripheral
			2020/07/07				./data/phs001938.v2.pht009637.v2.p1.ADT_PC_Sample_Attributes.var_report.xml									phs001938.v2.p1	Prostatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001828.v2.p2.F1F56.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/09/14				./data/phs002187.v1.pht011547.v1.p1.GMKF_Myeloid_Malignancies_Sample.var_report.xml									phs002187.v1.p1	Leukemia, Myeloid, Acute
			2019/08/30				./data/phs001331.v2.pht006926.v2.p1.bl_visit_chart_abstraction.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
	452.0		11/16/2011	889.0		437.0	./data/phs000096.v4.pht001426.v1.p1.HAPO_Hispanic_Phenotypes.var_report.xml	0.0	444.5	10.61	889.0			444.5		phs000096.v4.p1	Pregnancy Complications
86.0	85.0		2020/05/15	66.0		86.0	./data/phs001860.v1.pht009451.v1.p1.Autoinflammatory_Disorders_Pedigree.var_report.xml	0.0	70.0	24.04	85.0			70.0		phs001860.v1.p1	Hereditary Autoinflammatory Diseases
			05/17/2016				./data/phs000796.v1.pht005383.v1.p1.OPPERA_Chronic_TMJD_Subject.var_report.xml									phs000796.v1.p1	Temporomandibular Joint Disorders
69.0			04/14/2014	92.0			./data/phs000370.v2.pht002383.v1.p1.Head_Neck_Squamous_Cell_Carcinoma_Subject_Phenotypes.var_report.xml	0.0			23.0					phs000370.v2.p1	Head and Neck Neoplasms
			2019/10/30				./data/phs001921.v1.pht009584.v1.p1.DNA_Methylation_PC_Subject.var_report.xml									phs001921.v1.p1	Prostatic Neoplasms
			2020/06/18				./data/phs000280.v7.pht004153.v2.p1.RHXC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
56.0	56.0		03/15/2016	94.0		8.0	./data/phs000337.v1.pht005335.v1.p1.Developmental_Disabilities_Pedigree.var_report.xml	0.0	8.0	9.192	8.0			8.0		phs000337.v1.p1	Intellectual Disability
			08/20/2013				./data/phs000285.v3.pht001688.v2.p2.C1F43.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
233.0	544.0		2021/02/23	780.0		3.0	./data/phs002230.v1.pht010964.v1.p1.TSP_Hypertension_Subject_Phenotypes.var_report.xml	0.0	260.0	271.5	544.0			233.0		phs002230.v1.p1	Hypertension
			2018/11/13				./data/phs001523.v1.pht007515.v1.p1.MOMS_PI_Sample_Attributes.var_report.xml									phs001523.v1.p1	Pregnancy
			02/25/2011				./data/phs000143.v1.pht000645.v1.p1.T2D_Starr_Subject.var_report_2011_02_25.xml									phs000143.v1.p1	Diabetes Mellitus, Type 2
41.0	6.0		07/26/2017	8.0		33.0	./data/phs001357.v1.pht006699.v1.p1.TSC_Subject_Phenotypes.var_report.xml	0.0	4.0	8.485	6.0			4.0		phs001357.v1.p1	Tuberous Sclerosis
			2018/10/02				./data/phs001696.v1.pht008429.v1.p1.EAC_Chinese_Subject.var_report.xml									phs001696.v1.p1	Esophageal Neoplasms
			2018/07/23				./data/phs000742.v1.pht008122.v1.p1.7_15_MRI.var_report.xml									phs000742.v1.p1	Epilepsy
			2020/06/18				./data/phs000280.v7.pht006479.v1.p1.RSE.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/03/2011				./data/phs000240.v1.pht002279.v1.p1.CIDR_QT_Glaucoma_Sample.var_report.xml									phs000240.v1.p1	Glaucoma, Open-Angle
			2020/02/28				./data/phs001109.v3.pht005445.v2.p2.Addictive_Diseases_Subject.var_report.xml									phs001109.v3.p2	Substance-Related Disorders
			2020/06/18				./data/phs000280.v7.pht004082.v2.p1.ESHB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/26/2015				./data/phs000807.v1.pht004387.v1.p1.CALGB40101_Early_Breast_Cancer_Sample.var_report.xml									phs000807.v1.p1	Breast Neoplasms
			12/11/2009				./data/phs000171.v1.pht000773.v1.p1.MS_DATA_MHQSUBTYPE.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
85.0	748.0		2018/09/19	833.0		85.0	./data/phs000357.v2.pht002333.v1.p1.Systemic_Sclerosis_Demographics.var_report.xml	0.0	416.5	468.8	748.0			416.5		phs000357.v2.p1	Systemic Sclerosis
			04/24/2014				./data/phs000709.v1.pht003813.v1.p1.Fibrolamellar_Hepatocellular_Carcinoma_Sample.var_report.xml									phs000709.v1.p1	Fibrolamellar hepatocellular carcinoma
			11/08/2013				./data/phs000200.v9.pht002750.v2.p3.f153_barriers_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/03/23				./data/phs000698.v1.pht007688.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			08/05/2016				./data/phs000360.v3.pht003254.v3.p1.MergedSet_Lab.var_report.xml									phs000360.v3.p1	Electronic Health Records
			03/22/2013				./data/phs000327.v1.pht003009.v1.p1.ESP_HeartGO_SWISS_Subject.var_report.xml									phs000327.v1.p1	Stroke
			2020/02/03				./data/phs000815.v2.pht008404.v1.p1.Human_Leukocytes_GEO.var_report.xml									phs000815.v2.p1	
			Wed Jan 21 13:20:41 2009				./data/phs000144.v1.pht000723.v1.p1.TSP_Sample.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
			12/17/2014				./data/phs000799.v1.pht004294.v1.p1.SBCGS_Breast_Cancer_Chinese_Sample.var_report.xml									phs000799.v1.p1	Breast Neoplasms
			2019/12/17				./data/phs001258.v2.pht006679.v2.p1.College_Athletes_Sample_Attributes.var_report.xml									phs001258.v2.p1	MicroRNAs
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000572.v2.p3.simphen173.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/04/16				./data/phs001326.v1.pht007826.v1.p1.pidtc_19171_day100ert.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
47.0			08/16/2013	106.0			./data/phs000623.v1.pht003338.v1.p1.Rare_Mendelian_Disease_Plain_Subject_Phenotypes.var_report.xml	0.0			59.0					phs000623.v1.p1	Developmental Disabilities
			08/20/2013				./data/phs000285.v3.pht001849.v2.p2.F1MICRO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/08/03				./data/phs000590.v1.pht008272.v1.p1.death_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2021/01/26				./data/phs002068.v1.pht010871.v1.p1.SALSA_SGC_Subject.var_report.xml									phs002068.v1.p1	Amyotrophic Lateral Sclerosis
700.0		1.0	04/22/2009	1385.0	1.495		./data/phs000167.v1.pht000715.v1.p1.nonGAIN_Schizophrenia_controls_main.var_report_2009_04_22.xml	0.0		0.5002	685.0	1.0			2.0	phs000167.v1.p1	Schizophrenia
			05/04/2011				./data/phs000361.v1.pht002222.v1.p1.CGEMS_UpperGastrointestinalCancers_Sample.var_report.xml									phs000361.v1.p1	Intestinal Neoplasms
			2020/06/18				./data/phs000280.v7.pht004107.v2.p1.HMTA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/24/2010				./data/phs000140.v1.pht000655.v1.p1.T2D_Sample.var_report_2010_11_24.xml									phs000140.v1.p1	Diabetes Mellitus, Type 2
			08/20/2013				./data/phs000285.v3.pht001618.v2.p2.B2F09PER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/07/26				./data/phs000588.v1.pht009305.v1.p1.patientglobalassessment.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			11/12/2013				./data/phs000600.v1.pht003238.v1.p1.Cervical_Cancer_Sample.var_report.xml									phs000600.v1.p1	Uterine Cervical Neoplasms
			Wed Jan 21 13:20:42 2009				./data/phs000144.v1.pht000724.v1.p1.TSP_TraceID.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
			10/24/2013				./data/phs000563.v1.pht003082.v1.p1.NF1_Pilocytic_Astrocytoma_Subject.var_report.xml									phs000563.v1.p1	Pilocytic Astrocytoma
			04/15/2014				./data/phs000508.v2.pht002810.v1.p1.Pediatric_Rhabdoid_Cancers_Sample.var_report.xml									phs000508.v2.p1	Rhabdoid Tumor
			10/12/2010				./data/phs000203.v1.pht000882.v1.p1.eMERGE_PAD_Subject.var_report_2010_10_12.xml									phs000203.v1.p1	Peripheral Vascular Diseases
			2020/06/18				./data/phs000280.v7.pht004054.v5.p1.CIFIPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht010727.v1.p13.l_prothf_ex07_1_1148s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/05/15				./data/phs001825.v1.pht009050.v1.p1.5UTR_Mutations_PC_Sample_Attributes.var_report.xml									phs001825.v1.p1	Prostatic Neoplasms
			2017/11/13				./data/phs001013.v3.pht005309.v3.p2.HVH_Subject.var_report.xml									phs001013.v3.p2	Cardiovascular Disease
			2019/03/11				./data/phs000286.v6.pht001948.v2.p2.csta.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			05/17/2017				./data/phs001328.v1.pht006319.v1.p1.medical_history.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
671.0	671.0		01/15/2016	2054.0		723.0	./data/phs000883.v1.pht004597.v1.p1.MIGen_PROCARDIS_Subject_Phenotypes.var_report.xml	0.0	515.0	429.9	723.0			515.0		phs000883.v1.p1	Coronary Artery Disease
			2020/12/21				./data/phs000007.v32.pht000208.v5.p13.telomere1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/09/2016				./data/phs001041.v1.pht005390.v1.p1.Melanoma_CTLA_4_Blockade_Subject.var_report.xml									phs001041.v1.p1	Melanoma
			2019/10/17				./data/phs001511.v1.pht007295.v1.p1.SEARCH_ProDIGY_Sample_Attributes.var_report.xml									phs001511.v1.p1	Diabetes Mellitus, Type 2
			08/20/2013				./data/phs000285.v3.pht001708.v2.p2.D1F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/09/20				./data/phs002407.v1.pht011358.v1.p1.MMRd_MMRp_CRC_Sample_Attributes.var_report.xml									phs002407.v1.p1	Colorectal Neoplasms
			05/30/2014				./data/phs000751.v1.pht003866.v1.p1.Fibrosing_Interstitial_Lung_Disease_Subject.var_report.xml									phs000751.v1.p1	Lung Diseases, Interstitial
	19.0		08/25/2016	19.0		19.0	./data/phs001153.v1.pht005696.v1.p1.Endometrioid_Endometrial_Carcinoma_Subject_Phenotypes.var_report.xml	0.0	19.0		19.0			19.0		phs001153.v1.p1	Endometrial Neoplasms
			01/13/2014				./data/phs000658.v1.pht003499.v1.p1.MDD2000AFFY_Sample_Attributes.var_report.xml									phs000658.v1.p1	Depressive Disorder, Major
			2021/01/27				./data/phs000584.v1.pht010795.v1.p1.CIDR_Longevity_Subject.var_report.xml									phs000584.v1.p1	Longevity
			2018/05/18				./data/phs001315.v1.pht006192.v1.p1.CIDR_GECCO_Colorectal_Cancer_GxE_Sample.var_report.xml									phs001315.v1.p1	Colorectal Neoplasms
774.0	2131.0		03/24/2015	4011.0		774.0	./data/phs000196.v3.pht000875.v2.p1.NGRC_Data.var_report.xml	0.0	999.0	495.7	656.0			999.0		phs000196.v3.p1	Parkinson Disease
			01/07/2016				./data/phs000814.v1.pht004582.v1.p1.MIGen_Exome_Italian_ATVB_Sample.var_report.xml									phs000814.v1.p1	Coronary Artery Disease
			08/09/2013				./data/phs000367.v1.pht003262.v1.p1.IBDGC_Familial_Crohns_Disease_Sample.var_report.xml									phs000367.v1.p1	Crohn Disease
			11/05/2014				./data/phs000209.v13.pht004317.v1.p3.MESA_exam5dietnutrients.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			03/21/2017				./data/phs000228.v4.pht001187.v3.p1.EMMES_HMP_DCM.var_report.xml									phs000228.v4.p1	Metagenomics
			2020/04/14				./data/phs001994.v1.pht010011.v1.p1.Tobacco_HNSCC_Sample_Attributes.var_report.xml									phs001994.v1.p1	Squamous Cell Carcinoma of Head and Neck
			2019/11/20				./data/phs000921.v4.pht004882.v3.p1.TOPMed_WGS_SAGE_Sample.var_report.xml									phs000921.v4.p1	Lung Diseases
30.0			2018/06/01	46.0			./data/phs001342.v1.pht008051.v1.p1.Statin_Induced_Myopathy_Subject_Phenotypes.var_report.xml	0.0			3.0					phs001342.v1.p1	Myopathy
1.0	5.0		09/28/2012	6.0		1.0	./data/phs000549.v1.pht002992.v1.p1.AML_Clonal_Evolution_Subject_Phenotypes.var_report.xml	0.0	3.0	2.828	5.0			3.0		phs000549.v1.p1	Leukemia, Myeloid, Acute
30.0	66.0		2021/01/15	96.0		30.0	./data/phs002240.v1.pht010862.v1.p1.Sex_Differences_Placentas_Pedigree.var_report.xml	0.0	48.0	25.46	66.0			48.0		phs002240.v1.p1	Birth Weight
			2017/09/22				./data/phs001392.v1.pht006888.v1.p1.immune_status.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2018/08/13				./data/phs001659.v1.pht008304.v1.p1.SGDs_NIPD_Sample_Attributes.var_report.xml									phs001659.v1.p1	
84.0			2020/02/14	574.0			./data/phs000575.v2.pht005895.v2.p1.familyhistory.var_report.xml	679.0			6.0					phs000575.v2.p1	Prader-Willi Syndrome
			2018/02/08				./data/phs001488.v1.pht007426.v1.p1.uhdr2.var_report.xml									phs001488.v1.p1	Huntington Disease
			04/23/2014				./data/phs000378.v1.pht002319.v1.p1.CIDR_Dementia_Repeated_Data.var_report.xml									phs000378.v1.p1	Alzheimer Disease
			2017/11/22				./data/phs000313.v4.pht002066.v4.p2.SardiNIA_Sample.var_report.xml									phs000313.v4.p2	Cardiovascular Diseases
			2021/07/15				./data/phs001547.v2.pht009987.v1.p1.TOPMed_CCDG_GENAF_Subject.var_report.xml									phs001547.v2.p1	Atrial Fibrillation
			07/12/2017				./data/phs000592.v1.pht006595.v1.p1.mdsclassification.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2017/10/19				./data/phs001288.v1.pht006782.v1.p1.rd_8444_1qualityoflif.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2018/03/30				./data/phs001108.v1.pht007718.v1.p1.neuropsychological_testing.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
			03/12/2013				./data/phs000343.v3.pht002718.v1.p1.cti.var_report.xml									phs000343.v3.p1	Stroke
			03/31/2015				./data/phs000832.v1.pht004423.v1.p1.Amphetamine_Sensitivity_Subject.var_report.xml									phs000832.v1.p1	Dextroamphetamine
			05/19/2016				./data/phs000617.v1.pht005476.v1.p1.diLQTS_European_Sample.var_report.xml									phs000617.v1.p1	Long QT Syndrome
			09/10/2014				./data/phs000798.v1.pht004025.v1.p1.Genetic_Diagnostic_Testing_Sample.var_report.xml									phs000798.v1.p1	Genetic Testing
			05/24/2017				./data/phs000576.v1.pht006156.v1.p1.pedigreeverificationform.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			08/20/2013				./data/phs000285.v3.pht001868.v2.p2.PACKYEARSY0.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/05/03				./data/phs000681.v2.pht003870.v1.p1.Diabetes_Prevention_Program_Subject.var_report.xml									phs000681.v2.p1	Diabetes Mellitus, Type 2
			2020/02/04				./data/phs001723.v1.pht009728.v1.p1.IBDGC_Repo_EC_Sample_Attributes.var_report.xml									phs001723.v1.p1	Inflammatory Bowel Disease
			2018/03/20				./data/phs000605.v1.pht007641.v1.p1.st_georges_resp_quest.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/05/06				./data/phs002023.v1.pht010194.v1.p1.CRPM_Subject.var_report.xml									phs002023.v1.p1	Peritoneal Neoplasms
			2018/06/13				./data/phs001521.v1.pht007723.v1.p1.Microbiota_S_Typhi_Sample_Attributes.var_report.xml									phs001521.v1.p1	Microbiota
			2019/06/03				./data/phs001292.v2.pht007849.v2.p1.cleveland_adol_sleepiness.var_report.xml									phs001292.v2.p1	Angelman Syndrome
2.0	4.0		11/07/2012	6.0		2.0	./data/phs000538.v1.pht003041.v1.p1.Mendelian_Familial_Hyperlipidemia_Subject_Phenotypes.var_report.xml	0.0	3.0	1.414	4.0			3.0		phs000538.v1.p1	Hyperlipidemia, Familial Combined
			Wed Nov 26 07:50:34 2008				./data/phs000017.v3.pht000697.v1.p1.EA_DIGS4_Diagnosis.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			11/08/2013				./data/phs000200.v9.pht001014.v4.p3.f48_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/05/05				./data/phs002310.v1.pht011206.v1.p1.InC3_Sample.var_report.xml									phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			02/27/2017				./data/phs000435.v3.pht002521.v3.p1.CLL_Subject.var_report.xml									phs000435.v3.p1	Chronic Lymphocytic Leukemia
			2020/12/21				./data/phs000007.v32.pht004812.v3.p13.t_physactf_ex09_1b_0833s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/11/05				./data/phs000507.v2.pht002928.v2.p2.BEN_Sample.var_report.xml									phs000507.v2.p2	Neutropenia
			2021/09/08				./data/phs001497.v2.pht007241.v2.p1.Adult_Glioma_Subject_Phenotypes.var_report.xml									phs001497.v2.p1	
			12/26/2012				./data/phs000562.v1.pht003104.v1.p1.Burkitt_Lymphoma_Subject.var_report.xml									phs000562.v1.p1	Burkitt Lymphoma
			2019/11/08				./data/phs001332.v2.pht007444.v2.p1.p7301_12683_ageatonse.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			04/23/2010				./data/phs000187.v1.pht000815.v1.p1.Melanoma_Subject.var_report_2010_04_23.xml									phs000187.v1.p1	Melanoma
			08/24/2009				./data/phs000091.v2.pht000115.v2.p1.Type2Diabetes_NHS_HPFS_Phenotype.var_report_2009_08_24.xml									phs000091.v2.p1	Diabetes Mellitus, Type 2
			11/08/2013				./data/phs000200.v9.pht002764.v1.p3.outc_death_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
304.0	628.0		2021/08/10	932.0		304.0	./data/phs001467.v2.pht009729.v2.p2.TOPMed_WGS_SAPPHIRE_Subject.var_report.xml	0.0	466.0	802.6	628.0			466.0		phs001467.v2.p2	Asthma
			2018/03/09				./data/phs001554.v1.pht007608.v1.p1.GECCO_CRC_Susceptibility_Sample.var_report.xml									phs001554.v1.p1	Colorectal Neoplasms
			2021/09/27				./data/phs000951.v5.pht005052.v5.p5.TOPMed_WGS_COPDGene_Sample_Attributes.var_report.xml									phs000951.v5.p5	Pulmonary Disease, Chronic Obstructive
			2017/09/22				./data/phs001392.v1.pht006895.v1.p1.pidtc_17365_timetoeve.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2019/03/20				./data/phs001715.v1.pht008840.v1.p1.VCRC_5515_Subject.var_report.xml									phs001715.v1.p1	Vasculitis
			03/24/2017				./data/phs001257.v2.pht005997.v1.p1.Anti_CTLA_4_Subject.var_report.xml									phs001257.v2.p1	Melanoma
2.0	2.0		2020/06/02	3.0		1.0	./data/phs002040.v1.pht010258.v1.p1.IL37_IBD_Pedigree.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs002040.v1.p1	Inflammatory Bowel Diseases
			Mon Jun 16 14:32:00 2008				./data/phs000102.v1.pht000283.v1.p1.stroke_case.var_report_2008_08_12.xml									phs000102.v1.p1	Cerebrovascular Disorders
			2021/05/20				./data/phs002280.v1.pht010806.v1.p1.scRNA_PBMC_Sample.var_report.xml									phs002280.v1.p1	PBMC &#8211; Peripheral Blood Mononuclear Cells
	57.0		2018/11/05	57.0		57.0	./data/phs001690.v1.pht008367.v1.p1.EC_SCNA_Subject_Phenotypes.var_report.xml	0.0	57.0		57.0			57.0		phs001690.v1.p1	Endometrial Neoplasms
			2021/10/06				./data/phs000218.v24.pht000917.v23.p8.TARGET_Subject.var_report.xml									phs000218.v24.p8	Neoplasms
			2019/06/24				./data/phs001784.v1.pht009003.v1.p1.HCC_Imaging_Sample_Attributes.var_report.xml									phs001784.v1.p1	Carcinoma, Hepatocellular
1.0	2.0		12/10/2014	3.0		1.0	./data/phs000848.v1.pht004409.v1.p1.Autosomal_Recessive_TPP2_Mutations_Pedigree.var_report.xml	0.0	1.5	0.7071	2.0			1.5		phs000848.v1.p1	Immunologic Deficiency Syndromes
			11/08/2013				./data/phs000200.v9.pht001001.v4.p3.f32_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/12/21				./data/phs000007.v32.pht006012.v4.p13.l_fibrin_ex01_3b_1020s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
778.0	706.0		2021/06/01	681.0		317.0	./data/phs001143.v4.pht005905.v3.p1.TOPMed_WGS_BAGS_Subject_Phenotypes.var_report.xml	0.0	509.0	33.23	749.0			629.0		phs001143.v4.p1	Asthma
			2019/11/22				./data/phs000999.v3.pht005180.v3.p1.CSER_ClinSeq_Cancer_Subject.var_report.xml									phs000999.v3.p1	Colorectal Neoplasms
			2018/03/27				./data/phs001566.v1.pht007707.v1.p1.MBC_NF1_Subject.var_report.xml									phs001566.v1.p1	Neurofibromatosis 1
			10/28/2013				./data/phs000598.v2.pht003322.v2.p2.EsophagealAdenocarcinoma_Subject.var_report.xml									phs000598.v2.p2	Esophageal Neoplasms
			2020/09/18				./data/phs002210.v1.pht010520.v1.p1.Structural_Variants_BC_Subject_Phenotypes.var_report.xml									phs002210.v1.p1	Breast Neoplasms
3.0	3.0		01/26/2015	6.0		3.0	./data/phs000837.v1.pht004439.v1.p1.22q11DS_Pedigree.var_report.xml	0.0	3.0	0	3.0			3.0		phs000837.v1.p1	Tetralogy of Fallot
31.0			03/06/2017	2504.0			./data/phs000574.v1.pht005874.v1.p1.sf_36.var_report.xml	18.0			857.0					phs000574.v1.p1	Rett Syndrome
			2017/08/24				./data/phs001433.v1.pht006813.v1.p1.HB_Wnt_Bcatenin_Sample_Attributes.var_report.xml									phs001433.v1.p1	Hepatoblastoma
			2021/05/24				./data/phs002323.v1.pht010882.v1.p1.scATACSeq_Sample_Attributes.var_report.xml									phs002323.v1.p1	Immunotherapy
			2020/07/15				./data/phs001683.v2.pht008865.v2.p1.CSER_Pediatric_Cancer_Care_Subject.var_report.xml									phs001683.v2.p1	Genes, Neoplasm
			2018/08/13				./data/phs001247.v1.pht008299.v1.p1.Symptoms.var_report.xml									phs001247.v1.p1	Cranial Nerve Diseases
11.0			2021/08/26	19.0			./data/phs001729.v2.pht010128.v1.p1.TOPMed_WGS_CARE_CLIC_Subject_Phenotypes.var_report.xml	0.0			8.0					phs001729.v2.p1	Asthma
			2020/02/27				./data/phs001774.v1.pht008806.v1.p1.AVSD_Sample_Attributes.var_report.xml									phs001774.v1.p1	Complete atrioventricular septal defect
			2018/05/31				./data/phs001318.v1.pht008017.v1.p1.enrollmentmedicalillness.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
1956.0	1956.0		2020/06/26	2676.0		720.0	./data/phs001630.v1.pht008172.v1.p1.Measles_Immunity_Subject_Phenotypes.var_report.xml	0.0	1338.0	874	720.0			1338.0		phs001630.v1.p1	Measles Vaccine
			2020/12/21				./data/phs000007.v32.pht003906.v7.p13.t_mricbi_2013_a_0959s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/30				./data/phs002457.v1.pht011518.v1.p1.TNBC_BrM_Sample_Attributes.var_report.xml									phs002457.v1.p1	Triple Negative Breast Neoplasms
			2020/06/26				./data/phs001630.v1.pht008173.v1.p1.Measles_Immunity_Sample_Attributes.var_report.xml									phs001630.v1.p1	Measles Vaccine
			2019/11/15				./data/phs000700.v2.pht003649.v2.p1.Roadmap_Epigenomics_Broad_Sample.var_report.xml									phs000700.v2.p1	Nervous System Diseases
			2018/04/05				./data/phs001196.v1.pht005700.v1.p1.Schizophrenia_Trios_Taiwanese_Sample.var_report.xml									phs001196.v1.p1	Schizophrenia
			02/01/2016				./data/phs001021.v1.pht005265.v1.p1.CHDWB_Rare_Regulatory_Variants_Sample.var_report.xml									phs001021.v1.p1	Wellness Center
807.0	807.0		2021/01/26	859.0		637.0	./data/phs002068.v1.pht010873.v1.p1.SALSA_SGC_Subject_Phenotypes.var_report.xml	0.0	722.0	20.51	637.0			722.0		phs002068.v1.p1	Amyotrophic Lateral Sclerosis
			2019/07/26				./data/phs000588.v1.pht009285.v1.p1.angiogram_leftlowerextremity.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2021/03/11				./data/phs001818.v3.pht009021.v3.p1.sc_GI_Cancer_Sample.var_report.xml									phs001818.v3.p1	Stomach Neoplasms
			2020/12/21				./data/phs000007.v32.pht000011.v3.p13.ex0_9s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009174.v1.p1.angiogram_cerebral.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2019/03/11				./data/phs000286.v6.pht001963.v2.p2.mhxa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht004810.v3.p13.vr_meds_ex09_1b_0879s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/15/2011				./data/phs000345.v1.pht002374.v1.p1.IBD_UC_Subject.var_report.xml									phs000345.v1.p1	Colitis, Ulcerative
			04/12/2010				./data/phs000094.v1.pht001135.v1.p1.Oral_Clefts_Affected_Child_Phenotype.var_report_2010_04_12.xml									phs000094.v1.p1	Cleft Palate
			2019/03/11				./data/phs000286.v6.pht001971.v2.p2.rhxa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006475.v1.p1.RETV0.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht008053.v2.p1.STAIR_7001_Subject.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2019/05/13				./data/phs001811.v1.pht009063.v1.p1.Early_Lung_ADC_Sample_Attributes.var_report.xml									phs001811.v1.p1	Adenocarcinoma of Lung
			12/03/2013				./data/phs000551.v1.pht003061.v1.p1.CATHGEN_Subject.var_report.xml									phs000551.v1.p1	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000775.v1.p1.MS_DATA_MSFC1.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
330.0	472.0		2021/07/02	802.0		330.0	./data/phs001782.v2.pht008797.v2.p1.LOI_Stunting_Malian_Subject.var_report.xml	0.0	401.0	100.4	472.0			401.0		phs001782.v2.p1	Growth
			05/21/2010				./data/phs000261.v1.pht001230.v1.p1.HMP_Bacterial_Vaginosis_Sample.var_report.xml									phs000261.v1.p1	Vaginosis, Bacterial
			01/05/2016				./data/phs000917.v1.pht004739.v1.p1.MIGen_Exome_PROMIS_Sample.var_report.xml									phs000917.v1.p1	Coronary Artery Disease
9.0	5072.0		2020/07/24	9677.0		9.0	./data/phs001194.v3.pht005813.v2.p2.PCGC_Cohort_Pedigree.var_report.xml	0.0	4839.0	333	4605.0			4839.0		phs001194.v3.p2	Heart Defects, Congenital
			2021/03/22				./data/phs002188.v1.pht011034.v1.p1.Lymphoma_Sample_Attributes.var_report.xml									phs002188.v1.p1	Lymphoma
			2020/06/18				./data/phs000280.v7.pht006484.v1.p1.TIC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/10/16				./data/phs001704.v1.pht008460.v1.p1.CLL_Enhancer_Mapping_Subject.var_report.xml									phs001704.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2017/10/26				./data/phs001277.v1.pht006853.v1.p1.iPSCs_Subject.var_report.xml									phs001277.v1.p1	Platelet Disorder, Familial, with Associated Myeloid Malignancy
			2020/06/18				./data/phs000280.v7.pht004158.v2.p1.RIPA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001739.v2.p2.D1HEMO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/09/2016				./data/phs000655.v3.pht003491.v3.p1.Inherited_Muscle_Disease_Sample_Attributes.var_report.xml									phs000655.v3.p1	Muscular Dystrophies
668.0	774.0		10/25/2010	1442.0		668.0	./data/phs000021.v3.pht000068.v1.p2.EA_GAIN_phenotype_controls_main.var_report_2010_10_25.xml	0.0	721.0	74.95	774.0			721.0		phs000021.v3.p2	Schizophrenia
763.0	763.0		05/23/2011	613.0		620.0	./data/phs000358.v1.pht002243.v1.p1.PUWMa_Subject_Phenotypes.var_report.xml	0.0	691.5	14.85	620.0			691.5		phs000358.v1.p1	Attention Deficit Hyperactivity Disorder
2769.0	2769.0		07/25/2014	4391.0		1622.0	./data/phs000335.v3.pht002117.v2.p2.LHS_COPD_Phenotypes.var_report.xml	0.0	2196.0	811.1	1622.0			2196.0		phs000335.v3.p2	COPD
			2020/11/20				./data/phs002255.v1.pht010674.v1.p1.Language_Impairment_Sample.var_report.xml									phs002255.v1.p1	Language Development
			11/21/2016				./data/phs000341.v2.pht002673.v2.p1.Hypodiploid_ALL_Sample.var_report.xml									phs000341.v2.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			11/08/2013				./data/phs000200.v9.pht003419.v1.p3.spec_results_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/06/06				./data/phs001420.v1.pht009144.v1.p1.GMKF_OFC_Colombian_Subject.var_report.xml									phs001420.v1.p1	Cleft Lip
			04/21/2017				./data/phs001344.v1.pht006284.v1.p1.PMDD_Subject.var_report.xml									phs001344.v1.p1	Premenstrual Dysphoric Disorder
			2021/06/24				./data/phs001446.v2.pht009627.v1.p1.TOPMed_WGS_SARP_Sample.var_report.xml									phs001446.v2.p1	Asthma
			03/21/2017				./data/phs000228.v4.pht002158.v1.p1.EMMES_HMP_DEM_ENR.var_report.xml									phs000228.v4.p1	Metagenomics
2788.0			2018/04/05	5196.0			./data/phs001196.v1.pht005699.v1.p1.Schizophrenia_Trios_Taiwanese_Pedigree.var_report.xml	0.0			791.0					phs001196.v1.p1	Schizophrenia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000480.v2.p3.simphen081.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
32.0	67.0		2018/06/01	99.0		32.0	./data/phs001046.v1.pht005296.v1.p1.risk_extremes_pheno.var_report.xml	0.0	49.5	9.899	67.0			49.5		phs001046.v1.p1	Macular Degeneration
10.0	17.0		01/13/2014	27.0		10.0	./data/phs000666.v1.pht003574.v1.p1.Elderly_Influenza_Vaccine_Subject_Phenotypes.var_report.xml	0.0	13.5	4.95	17.0			13.5		phs000666.v1.p1	Influenza Vaccines
			02/21/2012				./data/phs000398.v1.pht002466.v1.p1.ESP_ARIC_LDLandEOMI_Sample.var_report.xml									phs000398.v1.p1	Cardiovascular Diseases
			2018/12/06				./data/phs001688.v1.pht008593.v1.p1.Psoriasis_Secukinumab_Sample_Attributes.var_report.xml									phs001688.v1.p1	Psoriasis
			2019/08/06				./data/phs001701.v1.pht009375.v1.p1.INGENIOUS_Subject.var_report.xml									phs001701.v1.p1	Metabolism
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000577.v2.p3.simphen178.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/09/19				./data/phs001879.v1.pht009456.v1.p1.Kidney_Transplant_Recipients_Sample.var_report.xml									phs001879.v1.p1	Urinary Tract Infections
199.0	199.0		03/31/2015	381.0		182.0	./data/phs000832.v1.pht004425.v1.p1.Amphetamine_Sensitivity_Subject_Phenotypes.var_report.xml	0.0	190.5	12.02	182.0			190.5		phs000832.v1.p1	Dextroamphetamine
			2019/03/11				./data/phs000286.v6.pht001940.v2.p2.antv.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/11/17				./data/phs002197.v1.pht010610.v1.p1.Taupathy_Subject_Phenotypes.var_report.xml									phs002197.v1.p1	Pick Disease of the Brain
			2020/03/09				./data/phs001266.v2.pht007224.v1.p1.Addiction_Susceptibility_Genes_Sample_Attributes.var_report.xml									phs001266.v2.p1	Opioid-Related Disorders
			2019/03/11				./data/phs000286.v6.pht001923.v2.p2.abha.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			12/19/2011				./data/phs000381.v1.pht002421.v1.p1.GeM_Controls_Sample.var_report.xml									phs000381.v1.p1	Normalcy
			08/20/2013				./data/phs000285.v3.pht001595.v2.p2.AFLWUPT1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/05/2017				./data/phs000595.v1.pht006640.v1.p1.physician_examination.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2021/08/19				./data/phs001662.v2.pht010057.v1.p1.LTRC_R040_subject_demographics.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/02/04				./data/phs001721.v1.pht009717.v1.p1.IBDGC_Repo_IC_Subject.var_report.xml									phs001721.v1.p1	Inflammatory Bowel Disease
			02/24/2011				./data/phs000268.v1.pht002165.v1.p1.CEPH_FamilyPanels_Sample.var_report_2011_02_24.xml									phs000268.v1.p1	Cell Line
			05/24/2017				./data/phs000576.v1.pht006140.v1.p1.bsiquestionnaire.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2020/03/09				./data/phs001135.v2.pht005986.v1.p1.START_Sample_Attributes.var_report.xml									phs001135.v2.p1	Opioid-Related Disorders
			2020/01/07				./data/phs001941.v1.pht009742.v1.p1.Otitis_Media_Subject.var_report.xml									phs001941.v1.p1	Otitis Media
3.0	3.0		2021/08/20	4.0		2.0	./data/phs002557.v1.pht011480.v1.p1.PID_LRBA_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs002557.v1.p1	LRBA protein, human
901.0	901.0		12/06/2016	950.0		70.0	./data/phs001193.v1.pht005975.v1.p1.Colorectal_Cancer_Hispanic_Subject_Phenotypes.var_report.xml	0.0	92.0	58.69	70.0			92.0		phs001193.v1.p1	Colorectal Neoplasms
			2020/06/02				./data/phs002040.v1.pht010259.v1.p1.IL37_IBD_Sample.var_report.xml									phs002040.v1.p1	Inflammatory Bowel Diseases
			2020/04/29				./data/phs000185.v7.pht008409.v1.p1.Hutterites_FcgammaRIIA_Variant_Effects_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			2020/01/10				./data/phs000791.v2.pht005322.v1.p1.Roadmap_Epigenomics_UCSF_GEO.var_report.xml									phs000791.v2.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht002343.v5.p13.l_mtbllipi1_ex05_1_0617s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/11/06				./data/phs000288.v2.pht002516.v2.p2.Ciliopathies_Exome_Subject.var_report.xml									phs000288.v2.p2	Congenital Abnormalities
49.0	81.0		2021/08/24	4877.0		49.0	./data/phs001368.v3.pht007957.v3.p2.TOPMed_WGS_CHS_VTE_Subject.var_report.xml	0.0	65.0	524	81.0			65.0		phs001368.v3.p2	Cardiovascular Diseases
852.0	852.0		11/10/2015	5870.0		7.0	./data/phs000936.v1.pht004891.v1.p1.GOESP_Broad_EOMI_ExomeChip_Subject_Phenotypes.var_report.xml	0.0	509.0	517.6	670.0			509.0		phs000936.v1.p1	
			12/12/2014				./data/phs000699.v1.pht004385.v1.p1.Osteosarcoma_Genomics_Sample_Attributes.var_report.xml									phs000699.v1.p1	Osteosarcoma
			08/25/2016				./data/phs001153.v1.pht005694.v1.p1.Endometrioid_Endometrial_Carcinoma_Subject.var_report.xml									phs001153.v1.p1	Endometrial Neoplasms
	4594.0		2019/05/07	4594.0		4594.0	./data/phs001409.v1.pht006800.v1.p1.Uterine_Fibroids_AA_EA_Subject_Phenotypes.var_report.xml	0.0	4594.0		4594.0			4594.0		phs001409.v1.p1	Leiomyoma
8.0	8.0		2019/06/11	6.0		3.0	./data/phs001807.v1.pht008979.v1.p1.InTEAM_Meth_Subject_Phenotypes.var_report.xml	0.0	5.5	3.536	3.0			5.5		phs001807.v1.p1	Hepatitis, Alcoholic
			06/12/2017				./data/phs000594.v1.pht006494.v1.p1.BoneMarrowBiopsy_Differential.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			11/05/2014				./data/phs000209.v13.pht002105.v3.p3.MESA_AncilMesaStressCortisol.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
2090.0	2440.0		2021/09/13	4530.0		2090.0	./data/phs000095.v4.pht001210.v3.p2.GENEVA_DentalCaries_Subject_Phenotypes.var_report.xml	0.0	2265.0	247.5	2440.0			2265.0		phs000095.v4.p2	Dental Caries
78.0	78.0		2019/08/26	87.0		46.0	./data/phs001837.v1.pht009314.v1.p1.NAFLD_Microbiome_Subject_Phenotypes.var_report.xml	0.0	62.0	25.46	46.0			62.0		phs001837.v1.p1	Non-alcoholic Fatty Liver Disease
			08/20/2013				./data/phs000285.v3.pht001803.v2.p2.E1MICRO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/08/30				./data/phs001331.v2.pht006929.v2.p1.registration.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
30.0	44.0		05/26/2016	74.0		30.0	./data/phs000886.v1.pht004647.v1.p1.Asthma_MZ_Twins_Pedigree.var_report.xml	0.0	37.0	9.899	44.0			37.0		phs000886.v1.p1	Asthma
2.0	207.0		2019/10/07	385.0		2.0	./data/phs000924.v4.pht006321.v1.p1.iPSCORE_Pedigree.var_report.xml	0.0	2.0	24.04	207.0			2.0		phs000924.v4.p1	Heart Diseases
			2019/01/31				./data/phs001712.v1.pht008672.v1.p1.angiogram_aortaandbranches.var_report.xml									phs001712.v1.p1	Vasculitis
			2017/09/22				./data/phs001392.v1.pht006902.v1.p1.pidtc_17968_commentfo.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
64.0	64.0		2021/02/22	61.0		51.0	./data/phs001812.v1.pht009106.v1.p1.Pediatric_Obesity_Asthma_Subject_Phenotypes.var_report.xml	0.0	57.5	9.192	51.0			57.5		phs001812.v1.p1	Asthma
			2019/12/26				./data/phs001949.v1.pht009704.v1.p1.P3DT_Subject.var_report.xml									phs001949.v1.p1	Diabetes Mellitus, Type 1
			2018/07/23				./data/phs000742.v1.pht008111.v1.p1.7_4_Demographics_Old.var_report.xml									phs000742.v1.p1	Epilepsy
			2018/11/13				./data/phs001523.v1.pht007513.v1.p1.phenotype_followUpSurvey.var_report.xml									phs001523.v1.p1	Pregnancy
			2020/05/05				./data/phs001360.v1.pht006295.v1.p1.CLEAR_Subject_Phenotypes.var_report.xml									phs001360.v1.p1	Arthritis, Rheumatoid
			2020/10/29				./data/phs002270.v1.pht010597.v1.p1.Recurrent_GBM_Sample.var_report.xml									phs002270.v1.p1	Glioblastoma
			05/24/2016				./data/phs001065.v1.pht005406.v1.p1.dnacon.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/06/24				./data/phs001836.v1.pht009218.v1.p1.Neocortical_Development_Sample.var_report.xml									phs001836.v1.p1	Autism Spectrum Disorder
			03/29/2017				./data/phs000707.v2.pht003715.v2.p1.Hereditary_Neurological_Disorders_Sample.var_report.xml									phs000707.v2.p1	Nervous System Diseases
			2018/07/23				./data/phs000742.v1.pht008118.v1.p1.7_11_Diagnostic_Interview_Old_Other_Events.var_report.xml									phs000742.v1.p1	Epilepsy
372.0	372.0		2020/07/15	735.0		363.0	./data/phs001683.v2.pht008911.v2.p1.CSER_Pediatric_Cancer_Care_Pedigree.var_report.xml	0.0	367.5	6.364	363.0			367.5		phs001683.v2.p1	Genes, Neoplasm
			2020/07/16				./data/phs001778.v1.pht009831.v1.p1.MDS_huM_Sample.var_report.xml									phs001778.v1.p1	Myelodysplastic Syndromes
			2019/06/14				./data/phs000589.v1.pht009196.v1.p1.protocol_termination.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			08/20/2013				./data/phs000285.v3.pht001743.v2.p2.D1PROINS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/07/2011				./data/phs000252.v2.pht001267.v2.p1.HMP_Gut_Crohns_Diet_Subject.var_report.xml									phs000252.v2.p1	Crohn Disease
			2019/07/29				./data/phs001855.v1.pht009247.v1.p1.STRRIDE_Subject.var_report.xml									phs001855.v1.p1	Exercise
698.0	698.0		2019/10/11	1385.0		687.0	./data/phs000996.v2.pht005752.v1.p1.Neurodevelopmental_Metal_Toxicity_Subject_Phenotypes.var_report.xml	0.0	692.5	7.778	687.0			692.5		phs000996.v2.p1	
894.0	894.0		02/18/2016	993.0		99.0	./data/phs001057.v1.pht005301.v1.p1.Smallpox_Vaccine_Immune_Response_Subject_Phenotypes.var_report.xml	0.0	496.5	562.1	99.0			496.5		phs001057.v1.p1	Smallpox Vaccine
748.0	748.0		09/20/2010	2493.0		550.0	./data/phs000272.v1.pht001912.v1.p1.Behcets_Disease_Turk_Gender.var_report_2010_09_20.xml	0.0	639.0	81.32	550.0			639.0		phs000272.v1.p1	Behcet Syndrome
138.0	138.0		08/29/2016	197.0		59.0	./data/phs001199.v1.pht005706.v1.p1.TIGER_LC_OncoVar_Subject_Phenotypes.var_report.xml	0.0	98.5	55.86	59.0			98.5		phs001199.v1.p1	Carcinoma, Hepatocellular
			2021/09/28				./data/phs002001.v1.pht010099.v1.p1.Osimertinib_EGFR_LC_Sample_Attributes.var_report.xml									phs002001.v1.p1	Lung Neoplasms
			2019/03/22				./data/phs000842.v2.pht004403.v2.p1.PediGFR_Sample.var_report.xml									phs000842.v2.p1	Kidney Diseases
			2020/12/21				./data/phs000007.v32.pht002150.v5.p13.vr_ffreq_ex01_3_0587s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/09/17				./data/phs001154.v1.pht008376.v1.p1.CNV_Developmental_Disorders_Sample_Attributes.var_report.xml									phs001154.v1.p1	Developmental Disabilities
			2020/06/18				./data/phs000280.v7.pht006449.v1.p1.MRM_FINAL.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
90.0	858.0		2020/12/21	977.0		8.0	./data/phs000007.v32.pht000391.v2.p13.eye0_1989s.var_report.xml	2.0	66.0	410.4	602.0			61.5		phs000007.v32.p13	Cardiovascular Diseases
			2018/10/24				./data/phs001695.v1.pht008497.v1.p1.UCSF_CRH_Sample.var_report.xml									phs001695.v1.p1	MicroRNAs
			2017/10/11				./data/phs000578.v1.pht007002.v1.p1.CINCH_5303_Subject.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			03/12/2013				./data/phs000343.v3.pht002726.v1.p1.elc.var_report.xml									phs000343.v3.p1	Stroke
			08/20/2014				./data/phs000777.v1.pht003975.v1.p1.FSGS_CKD_Sample_Attributes.var_report.xml									phs000777.v1.p1	Glomerulosclerosis, Focal Segmental
			2020/12/21				./data/phs000007.v32.pht003629.v3.p13.t_ctinlngab_2011_m_0835s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/06/07				./data/phs001481.v1.pht008132.v1.p1.IBMFS_Sample_Attributes.var_report.xml									phs001481.v1.p1	Bone Marrow Failure Syndromes
			2021/06/09				./data/phs001345.v3.pht008603.v1.p1.TOPMed_WGS_GENOA_Sample.var_report.xml									phs001345.v3.p1	Hypertension
			02/23/2017				./data/phs001253.v1.pht006166.v1.p1.Efavirenz_CNS_Symptoms_Subject_Genotypes.var_report.xml									phs001253.v1.p1	Central Nervous System Diseases
			2018/05/29				./data/phs000234.v2.pht007980.v1.p2.Dementia_Sample_Attributes.var_report.xml									phs000234.v2.p2	Dementia
			11/04/2014				./data/phs000086.v3.pht000228.v1.p1.DCCT_f0971.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/05/04				./data/phs002387.v1.pht011177.v1.p1.GBHS_Sample.var_report.xml									phs002387.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht004815.v1.p13.e_exam_ex03_7_0426s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/07/17				./data/phs000481.v3.pht002661.v3.p2.Cholesterol_and_Pharmacogenetics_Subject_Phenotypes.var_report.xml									phs000481.v3.p2	Hypercholesterolemia
174.0			2017/12/20	515.0			./data/phs000577.v1.pht007270.v1.p1.enrollment_demographics.var_report.xml	217.0			341.0					phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2018/03/26				./data/phs000697.v1.pht007699.v1.p1.laboratory.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2020/02/06				./data/phs001430.v2.pht008085.v2.p1.diet_history.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			10/27/2014	3.0			./data/phs000628.v1.pht003506.v1.p1.Metastatic_Cervical_Carcinoma_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000628.v1.p1	Uterine Cervical Neoplasms
			2019/03/27				./data/phs001286.v1.pht007887.v1.p1.PLCO_Subject.var_report.xml									phs001286.v1.p1	Neoplasms
			2018/10/22				./data/phs001674.v1.pht008470.v1.p1.BC_Paired_Tumor_Sample_Attributes.var_report.xml									phs001674.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht002893.v6.p13.l_mcp1_2008_m_0432s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002147.v2.p13.t_ctspdsc_2005_m_0586s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008768.v1.p2.msrb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
4.0	6.0		2017/09/27	48.0		8.0	./data/phs001071.v1.pht005345.v1.p1.CIDR_HD_Onset_Age_Pedigree.var_report.xml	0.0	9.5	3.536	8.0			9.5		phs001071.v1.p1	Huntington Disease
			2021/01/12				./data/phs001697.v1.pht010579.v1.p1.EAGLE_Never_Smokers_Sample_Attributes.var_report.xml									phs001697.v1.p1	Lung Neoplasms
			05/09/2016				./data/phs001101.v1.pht005365.v1.p1.MIGen_MDC_Subject.var_report.xml									phs001101.v1.p1	Myocardial Infarction
			2019/10/11				./data/phs001380.v1.pht009232.v1.p1.TS_GWAS2_Sample_Attributes.var_report.xml									phs001380.v1.p1	Tourette Syndrome
			08/20/2013				./data/phs000285.v3.pht001583.v2.p2.A4F20.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/10/02				./data/phs001901.v1.pht009499.v1.p1.CCDG_Coronary_Subject.var_report.xml									phs001901.v1.p1	Myocardial Infarction
			2021/01/21				./data/phs002291.v1.pht010802.v1.p1.HSPCs_Aging_MBM_Subject_Phenotypes.var_report.xml									phs002291.v1.p1	Multiple Myeloma
			05/24/2016				./data/phs001065.v1.pht005394.v1.p1.2CARE_HD_CoQ_Subject.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/07/26				./data/phs000588.v1.pht009297.v1.p1.fu_medical_history_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
538.0	538.0		2018/09/11	676.0		476.0	./data/phs000653.v3.pht003478.v3.p1.Epi4K_Pedigree.var_report.xml	0.0	507.0	43.84	476.0			507.0		phs000653.v3.p1	Epilepsy
			08/20/2013				./data/phs000285.v3.pht001785.v2.p2.E1F20.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/24/2017				./data/phs001076.v1.pht005361.v1.p1.IBD_Exome_Subject.var_report.xml									phs001076.v1.p1	Inflammatory Bowel Diseases
			2018/02/08				./data/phs001488.v1.pht007387.v1.p1.digspan.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht002888.v6.p13.l_crp_2008_m_0477s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/01/28				./data/phs002089.v1.pht010497.v1.p1.dMMR_Tumors_Sample_Attributes.var_report.xml									phs002089.v1.p1	Small Cell Lung Carcinoma
52.0	338.0		2020/10/16	585.0		52.0	./data/phs002245.v1.pht010531.v1.p1.COVID19_Subject_Phenotypes.var_report.xml	0.0	95.0	60.81	246.0			95.0		phs002245.v1.p1	COVID-19
			2020/06/18				./data/phs000280.v7.pht006431.v1.p1.DERV.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/07/29				./data/phs001624.v2.pht008232.v2.p2.TOPMed_CCDG_BioVU_Sample_Attributes.var_report.xml									phs001624.v2.p2	Atrial Fibrillation
1.0	3.0		2020/11/20	4.0		2.0	./data/phs002255.v1.pht010673.v1.p1.Language_Impairment_Pedigree.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs002255.v1.p1	Language Development
			2019/09/16				./data/phs001718.v1.pht009425.v1.p1.C9ORF72_Sample.var_report.xml									phs001718.v1.p1	Amyotrophic Lateral Sclerosis
134.0	165.0		2019/06/14	299.0		134.0	./data/phs001833.v1.pht009152.v1.p1.MS_Severity_Subject_Phenotypes.var_report.xml	0.0	149.5	21.92	165.0			149.5		phs001833.v1.p1	Multiple Sclerosis
			2021/03/24				./data/phs002341.v1.pht011058.v1.p1.Dermal_Fibroblasts_Pluripotency_Sample.var_report.xml									phs002341.v1.p1	Fibroblast-Derived Induced Pluripotent Stem Cells
			11/08/2013				./data/phs000200.v9.pht001011.v4.p3.f43_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/04/23				./data/phs001804.v1.pht008962.v1.p1.GEODB_Subject.var_report.xml									phs001804.v1.p1	Opioid-Related Disorders
			2018/02/12				./data/phs001525.v1.pht007479.v1.p1.XDP_RNA_Sample_Attributes.var_report.xml									phs001525.v1.p1	X-Linked Dystonia Parkinsonism
			07/26/2010				./data/phs000283.v1.pht001537.v1.p1.MESA_CARe_Subject.var_report_2010_07_26.xml									phs000283.v1.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008747.v1.p2.ecgb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			10/25/2011				./data/phs000406.v1.pht002402.v1.p1.Spatiotemporal_Transcriptome_Brain_Subject.var_report.xml									phs000406.v1.p1	Aging
			2020/01/23				./data/phs000287.v7.pht001447.v4.p1.CHS_Subject.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2018/10/02				./data/phs001519.v1.pht008433.v1.p1.Neoantigen_Cancer_Vaccine_GBM_Subject.var_report.xml									phs001519.v1.p1	Glioblastoma
			2020/06/18				./data/phs000280.v7.pht004069.v2.p1.DTIB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000910.v8.p13.t_pftdiff_ex08_1_0454s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001028.v3.p3.outc_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2017/11/06				./data/phs001391.v1.pht007078.v1.p1.OncoArray_Prostate_Cancer_Subject.var_report.xml									phs001391.v1.p1	Prostatic Neoplasms
			2021/08/16				./data/phs001806.v1.pht011473.v1.p1.GMKF_Nonsyndromic_Craniosynostosis_Subject.var_report.xml									phs001806.v1.p1	Craniosynostoses
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000458.v2.p3.simphen059.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			10/21/2015				./data/phs000813.v1.pht004305.v1.p1.Nicotine_Dependence_Genomic_Regions_Sample_Attributes.var_report.xml									phs000813.v1.p1	Tobacco Use Disorder
			2018/05/16				./data/phs001592.v1.pht007976.v1.p1.CCDG_ATVB_Subject.var_report.xml									phs001592.v1.p1	Atherosclerosis
			2018/09/17				./data/phs001154.v1.pht008374.v1.p1.CNV_Developmental_Disorders_Sample.var_report.xml									phs001154.v1.p1	Developmental Disabilities
			2017/10/11				./data/phs000578.v1.pht007014.v1.p1.physical_exam.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
4.0	4.0		12/31/2012	6.0		2.0	./data/phs000500.v1.pht003115.v1.p1.Fetal_Genome_Pedigree.var_report.xml	0.0	3.0	1.414	2.0			3.0		phs000500.v1.p1	Prenatal Care
			2020/03/09				./data/phs001299.v2.pht007623.v1.p1.Nicotine_Addiction_Sample_Attributes.var_report.xml									phs001299.v2.p1	Behavior, Addictive
			05/01/2017				./data/phs000722.v2.pht003897.v2.p2.Colon_CIP_Subject.var_report.xml									phs000722.v2.p2	Colorectal Neoplasms
			07/12/2017				./data/phs000592.v1.pht006589.v1.p1.eligibility.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2020/03/19				./data/phs001990.v1.pht010019.v1.p1.Aneurysmal_SAH_Subject_Phenotypes.var_report.xml									phs001990.v1.p1	Subarachnoid Hemorrhage
913.0	988.0		11/13/2015	1901.0		913.0	./data/phs001008.v1.pht005108.v1.p1.IRAS_Family_Study_Pedigree.var_report.xml	0.0	950.5	53.03	988.0			950.5		phs001008.v1.p1	Insulin Resistance
			08/05/2016				./data/phs000923.v1.pht005495.v1.p1.Germ_Cell_Tumors_Sample_Attributes.var_report.xml									phs000923.v1.p1	Male Germ Cell Tumor
			2018/11/19				./data/phs000915.v2.pht004947.v2.p2.mCRPC_SU2C_Sample_Attributes.var_report.xml									phs000915.v2.p2	Prostatic Neoplasms
			2019/03/11				./data/phs000286.v6.pht001970.v2.p2.rcpa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000139.v5.p13.abdomct1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/13				./data/phs002487.v1.pht011544.v1.p1.Schizophrenia_Antipsychotics_GEO.var_report.xml									phs002487.v1.p1	Schizophrenic Disorders
981.0			2019/11/20	769.0			./data/phs000921.v4.pht004883.v3.p1.TOPMed_WGS_SAGE_Subject_Phenotypes.var_report.xml	0.0			671.0					phs000921.v4.p1	Lung Diseases
			01/18/2013				./data/phs000550.v1.pht003128.v1.p1.Pancreatic_Adenocarcinoma_Sample.var_report.xml									phs000550.v1.p1	Pancreatic Neoplasms
			2017/09/22				./data/phs001392.v1.pht006909.v1.p1.treatment_assessment.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2018/04/16				./data/phs001326.v1.pht007803.v1.p1.p6902_17417_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
7980.0	7980.0		07/16/2015	7111.0		7899.0	./data/phs000153.v9.pht000835.v8.p8.shareped_Pedigree.var_report.xml	0.0	7940.0	57.28	7899.0			7940.0		phs000153.v9.p8	Social Behavior
			08/14/2014				./data/phs000615.v1.pht003305.v1.p1.IschemicStroke_Subject.var_report.xml									phs000615.v1.p1	Cerebral infarction
17.0	19.0		2019/08/01	36.0		17.0	./data/phs001786.v1.pht008838.v1.p1.SU2C_GEMM_Subject_Phenotypes.var_report.xml	0.0	18.0	1.414	19.0			18.0		phs001786.v1.p1	Melanoma
			2020/06/16				./data/phs001738.v1.pht010290.v1.p1.GMKF_SJFAMILY_HM_Sample.var_report.xml									phs001738.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2019/11/08				./data/phs001332.v2.pht007449.v2.p1.p7301_12627_phq9.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
36.0	53.0		2020/01/10	89.0		36.0	./data/phs001954.v1.pht009798.v1.p1.ICPC_LUAD_Taiwan_Subject_Phenotypes.var_report.xml	0.0	44.5	12.02	53.0			44.5		phs001954.v1.p1	Adenocarcinoma of Lung
			2017/12/08				./data/phs001279.v1.pht007208.v1.p1.eligibility.var_report.xml									phs001279.v1.p1	Bronchiectasis
			08/17/2012				./data/phs000518.v1.pht002850.v1.p1.ESP_Family_Studies_IB_Sample_Attributes.var_report.xml									phs000518.v1.p1	Bronchiectasis
28.0	28.0		2020/03/11	39.0		11.0	./data/phs001919.v1.pht009593.v1.p1.Melanoma_Anti_PD_1_Subject_Phenotypes.var_report.xml	0.0	19.5	12.02	11.0			19.5		phs001919.v1.p1	Melanoma
			2020/11/24				./data/phs001700.v1.pht008503.v1.p1.Moyamoya_Sample_Attributes.var_report.xml									phs001700.v1.p1	Moyamoya Disease
			2018/05/16				./data/phs001592.v1.pht007978.v1.p1.CCDG_ATVB_Subject_Phenotypes.var_report.xml									phs001592.v1.p1	Atherosclerosis
			2020/03/24				./data/phs001641.v1.pht010024.v1.p1.MeTree_FHH_Subject.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2018/04/12				./data/phs001457.v1.pht007055.v1.p1.AMP_RA_Sample_Attributes.var_report.xml									phs001457.v1.p1	Arthritis, Rheumatoid
			2018/10/22				./data/phs001666.v1.pht008467.v1.p1.Alisertib_PC_Sample_Attributes.var_report.xml									phs001666.v1.p1	Adenocarcinoma
			11/28/2011				./data/phs000385.v1.pht002339.v1.p1.Epigenetic_Colorectal_Cancer_Subject.var_report.xml									phs000385.v1.p1	Colorectal Neoplasms
			2020/02/14				./data/phs000575.v2.pht005889.v2.p1.deathrecord.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			2018/10/24				./data/phs001694.v1.pht008493.v1.p1.HIV_CSF_Sample.var_report.xml									phs001694.v1.p1	MicroRNAs
			2020/01/23				./data/phs000287.v7.pht001484.v1.p1.YR16ANNUAL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/03/11				./data/phs001964.v1.pht009962.v1.p1.WHS_Accelerometer_15sec.var_report.xml									phs001964.v1.p1	Physical Activity
			08/20/2013				./data/phs000285.v3.pht001686.v2.p2.C1F42B.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/10/29				./data/phs001626.v1.pht008476.v1.p1.IBDMDB_Sample.var_report.xml									phs001626.v1.p1	Inflammatory Bowel Diseases
			2017/10/19				./data/phs001288.v1.pht006785.v1.p1.surgery_procedure.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/09/19				./data/phs001877.v1.pht009484.v1.p1.Mycosis_Fungoides_Sample_Attributes.var_report.xml									phs001877.v1.p1	Mycosis Fungoides
			2021/06/28				./data/phs001514.v2.pht009817.v1.p1.Walk_PHaSST_Sample_Attributes.var_report.xml									phs001514.v2.p1	Anemia, Sickle Cell
			07/18/2012				./data/phs000513.v1.pht002824.v1.p1.MAST_Kinase_Notch_Gene_Breast_Cancer_Subject.var_report.xml									phs000513.v1.p1	Breast Neoplasms
			2018/11/15				./data/phs001418.v1.pht007236.v1.p1.CD_Sample.var_report.xml									phs001418.v1.p1	Crohn Disease
			2021/06/07				./data/phs000971.v3.pht004917.v3.p1.ClinSeq_Sample.var_report.xml									phs000971.v3.p1	Atherosclerosis
			04/12/2010				./data/phs000094.v1.pht001138.v1.p1.Oral_Clefts_Sample.var_report_2010_04_12.xml									phs000094.v1.p1	Cleft Palate
			2019/02/21				./data/phs001281.v2.pht006134.v2.p1.rankin_scale_score.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2017/09/22				./data/phs001394.v1.pht006946.v1.p1.GUARDIAN_HTN_IR_Subject.var_report.xml									phs001394.v1.p1	Hypertension
88.0			04/01/2016	160.0			./data/phs000895.v1.pht005072.v1.p1.Periampullary_Tumors_Subject_Phenotypes.var_report.xml	0.0			72.0					phs000895.v1.p1	
			2019/11/27				./data/phs001884.v1.pht009639.v1.p1.Giftedness_Saudi_Arabia_Sample.var_report.xml									phs001884.v1.p1	Intelligence
			03/21/2017				./data/phs000228.v4.pht001193.v3.p1.EMMES_HMP_GTV.var_report.xml									phs000228.v4.p1	Metagenomics
			2017/12/04				./data/phs000906.v1.pht007150.v1.p1.eMERGE_PGx_Sample_Attributes.var_report.xml									phs000906.v1.p1	Pharmacogenetics
			2018/05/07				./data/phs000490.v1.pht002964.v1.p1.Asthma_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			2021/02/03				./data/phs001018.v1.pht010914.v1.p1.Clinical_Renal_Tumors_Sample_Attributes.var_report.xml									phs001018.v1.p1	
14.0	14.0		11/05/2014	27.0		13.0	./data/phs000209.v13.pht001111.v4.p3.MESA_AirNRExamMain.var_report.xml	0.0	13.5	15.56	136.0			13.5		phs000209.v13.p3	Cardiovascular Diseases
			05/26/2016				./data/phs000886.v1.pht004646.v1.p1.Asthma_MZ_Twins_Subject.var_report.xml									phs000886.v1.p1	Asthma
			2017/10/03				./data/phs001464.v1.pht006970.v1.p1.HLA_Class_I_Antigen_Lung_Cancer_Sample.var_report.xml									phs001464.v1.p1	Carcinoma, Non-Small-Cell Lung
			2020/12/21				./data/phs000007.v32.pht006015.v4.p13.t_doppvasc_2008_m_0756s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
16.0	16.0		07/08/2011	25.0		9.0	./data/phs000273.v1.pht001433.v1.p1.LINE1_Retrotransposon_Pedigree.var_report.xml	0.0	12.5	4.95	9.0			12.5		phs000273.v1.p1	Normalcy
			2020/12/21				./data/phs000007.v32.pht000744.v5.p13.vr_soepedvt_2012_m_0766s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/15/2012				./data/phs000479.v1.pht002666.v1.p1.SCID_Exome_Subject_Phenotypes.var_report.xml									phs000479.v1.p1	Severe Combined Immunodeficiency
			2019/08/01				./data/phs000222.v6.pht007352.v1.p2.Concomitant_Meds.var_report.xml									phs000222.v6.p2	Huntington Disease
			2021/03/01				./data/phs001003.v2.pht010324.v2.p1.Solid_Tumor_Subject_Phenotypes.var_report.xml									phs001003.v2.p1	Melanoma
			11/08/2013				./data/phs000200.v9.pht003414.v1.p3.outc_self_x2_src_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
636.0	670.0		12/11/2009	920.0		636.0	./data/phs000171.v1.pht000766.v1.p1.MS_DATA_MHQDEM.var_report_2009_12_11.xml	0.0	960.0	458.2	670.0			960.0		phs000171.v1.p1	Multiple Sclerosis
			06/01/2017				./data/phs000701.v1.pht005509.v1.p1.ClinicalSeverityScale.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/12/21				./data/phs000007.v32.pht000018.v4.p13.ex0_16s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/05/2017				./data/phs001260.v1.pht006051.v1.p1.Antibiotic_Resistance_Subject.var_report.xml									phs001260.v1.p1	Diarrhea
			2019/07/01				./data/phs001810.v1.pht009064.v1.p1.COCCaINE_Subject.var_report.xml									phs001810.v1.p1	Cocaine
			04/11/2017				./data/phs000897.v1.pht004640.v1.p1.Early_Stage_Ovarian_Cancer_Sample_Attributes.var_report.xml									phs000897.v1.p1	Cystadenocarcinoma, Serous
			2020/12/14				./data/phs001984.v1.pht010785.v1.p1.MN_Sample_Attributes.var_report.xml									phs001984.v1.p1	Glomerulonephritis, Membranous
			2020/01/23				./data/phs000287.v7.pht001472.v1.p1.ULTRAY11.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000584.v2.p3.simphen185.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2017/09/22				./data/phs001392.v1.pht006882.v1.p1.PIDTC_6901_Subject.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			07/27/2012				./data/phs000297.v1.pht002391.v1.p1.Resistant_HTN_Subject.var_report.xml									phs000297.v1.p1	Hypertension
			2020/09/02				./data/phs002006.v2.pht010162.v2.p1.Segmental_Overgrowth_Sample.var_report.xml									phs002006.v2.p1	Proteus Syndrome
420.0	436.0		07/19/2012	856.0		420.0	./data/phs000494.v1.pht002799.v1.p1.eMERGE_Pediatric_CCHMC_Pedigree.var_report.xml	0.0	428.0	381.8	436.0			428.0		phs000494.v1.p1	Child Health
			05/20/2015				./data/phs000898.v1.pht004642.v1.p1.Colorectal_Cancer_Mb_Scale_Haplotypes_Sample.var_report.xml									phs000898.v1.p1	Colorectal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001816.v2.p2.F1F09TB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/16/2013				./data/phs000145.v4.pht002998.v2.p2.POPRES_v3_Subject_Phenotypes.var_report.xml									phs000145.v4.p2	Normalcy
			10/05/2010				./data/phs000188.v1.pht000978.v1.p1.QRS_BMI.var_report_2010_10_05.xml									phs000188.v1.p1	Heart Conduction System
			08/12/2016				./data/phs000888.v1.pht005587.v1.p1.Geisinger_AAA_BMI.var_report.xml									phs000888.v1.p1	
			2020/11/03				./data/phs002279.v1.pht010631.v1.p1.GIMs_Spermatids_Subject_Phenotypes.var_report.xml									phs002279.v1.p1	Germ Cells
			10/21/2015				./data/phs001002.v1.pht005045.v1.p1.CALGB90401_Prostate_Cancer_Sample_Attributes.var_report.xml									phs001002.v1.p1	Prostatic Neoplasms
			11/05/2014				./data/phs000209.v13.pht002197.v1.p3.MESA_MesaFamily_EyeRefraction.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht003412.v1.p3.outc_fracture_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			03/20/2013				./data/phs000573.v1.pht003213.v1.p1.DiffuseLargeBCellLymphoma_Subject.var_report.xml									phs000573.v1.p1	Lymphoma, Large B-Cell, Diffuse
22.0	22.0		2021/06/16	40.0		18.0	./data/phs002088.v2.pht010651.v1.p1.LINCS_DToxS_Subject_Phenotypes.var_report.xml	0.0	20.0	2.828	18.0			20.0		phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			10/07/2016				./data/phs000497.v3.pht002711.v3.p2.Hirschsprung_Disease_Subject.var_report.xml									phs000497.v3.p2	Disease, Hirschsprung
			2021/03/25				./data/phs002235.v1.pht011081.v1.p1.GMbC_Microbiome_Subject_Phenotypes.var_report.xml									phs002235.v1.p1	Gastrointestinal Microbiome
			08/17/2012				./data/phs000359.v1.pht002901.v1.p1.Hereditary_Spastic_Paraparesis_Subject.var_report.xml									phs000359.v1.p1	Hereditary Spastic Paraplegias
			2018/05/01				./data/phs001568.v1.pht007872.v1.p1.CLL_Sample.var_report.xml									phs001568.v1.p1	Leukemia, Lymphoid
			2017/12/20				./data/phs000577.v1.pht007273.v1.p1.medicalanddevelopmentalhistory.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			02/13/2015				./data/phs000867.v1.pht004481.v1.p1.FUSION_Cohort_Subject.var_report.xml									phs000867.v1.p1	Diabetes Mellitus, Type 2
			2019/08/10				./data/phs001876.v1.pht009390.v1.p1.BSRC_ASD_CNV_Sample_Attributes.var_report.xml									phs001876.v1.p1	Autism Spectrum Disorder
516.0	516.0		07/26/2016	799.0		283.0	./data/phs000916.v1.pht004736.v1.p1.MIGen_Exome_Munich_MI_Subject_Phenotypes.var_report.xml	0.0	399.5	84.85	283.0			399.5		phs000916.v1.p1	Coronary Artery Disease
			03/12/2013				./data/phs000343.v3.pht002715.v1.p1.alldti.var_report.xml									phs000343.v3.p1	Stroke
			2017/11/30				./data/phs001341.v1.pht006245.v1.p1.PhLiPS_Sample.var_report.xml									phs001341.v1.p1	Lipids
			2018/08/03				./data/phs000590.v1.pht008282.v1.p1.protocol_termination.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			05/23/2014				./data/phs000612.v1.pht003528.v1.p1.Adenoid_Cystic_Carcinoma_Subject_Phenotypes.var_report.xml									phs000612.v1.p1	Cancer
			06/01/2015				./data/phs000901.v1.pht004672.v1.p1.Parkinson_CSF_Biomarker_Subject.var_report.xml									phs000901.v1.p1	Parkinson Disease
			01/21/2016				./data/phs000991.v1.pht005255.v1.p1.VESPA_Cohort_Subject.var_report.xml									phs000991.v1.p1	Dose-Response Relationship, Drug
			11/08/2013				./data/phs000200.v9.pht001986.v2.p3.spec_draws_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/02/05				./data/phs002319.v1.pht010924.v1.p1.INVEST_Sample.var_report.xml									phs002319.v1.p1	Heart Disease
			2020/08/06				./data/phs001571.v1.pht009505.v1.p1.IBD_AA_Sample.var_report.xml									phs001571.v1.p1	Crohn Disease
			2017/11/01				./data/phs001305.v1.pht007108.v1.p1.nutrient_data_form.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
4.0			06/16/2017	11.0			./data/phs001278.v1.pht006283.v1.p1.sociodemographics.var_report.xml	185.0			7.0					phs001278.v1.p1	Porphyrias
			08/05/2010				./data/phs000269.v1.pht001496.v1.p1.Chromosomal_Aberration_Subject.var_report_2010_08_05.xml									phs000269.v1.p1	Chromosome Disorders
			2018/03/23				./data/phs000698.v1.pht007685.v1.p1.st_georges_resp_quest.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			2018/05/31				./data/phs001318.v1.pht008029.v1.p1.azacitidinedosage.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			11/04/2014				./data/phs000086.v3.pht000279.v1.p1.DCCT_ms2exprt.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			09/14/2015				./data/phs000982.v1.pht004982.v1.p1.PsA_Sample.var_report.xml									phs000982.v1.p1	Arthritis, Psoriatic
			03/06/2012				./data/phs000425.v1.pht002501.v1.p1.dbGAP_Subject.var_report.xml									phs000425.v1.p1	Alcoholism
			2021/08/13				./data/phs002405.v1.pht011237.v1.p1.PPGL_Subject_Phenotypes.var_report.xml									phs002405.v1.p1	Paraganglioma
			2020/08/05				./data/phs002053.v1.pht010448.v1.p1.Pazopanib_RCC_Subject_Phenotypes.var_report.xml									phs002053.v1.p1	Carcinoma, Renal Cell
			2020/12/21				./data/phs000007.v32.pht006025.v1.p13.vr_vte_2014_a_0913s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002892.v6.p13.l_lppla2_2008_m_0440s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/10/2014				./data/phs000689.v1.pht003681.v1.p1.Peripheral_T_Cell_Lymphomas_Sample_Attributes.var_report.xml									phs000689.v1.p1	Lymphoma, T-Cell, Peripheral
			2018/04/16				./data/phs001289.v1.pht007793.v1.p1.muscletestingform.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			09/04/2015				./data/phs000953.v1.pht004964.v1.p1.Microdissected_Pancreatic_Cancer_Subject.var_report.xml									phs000953.v1.p1	Pancreatic Neoplasms
			2018/07/23				./data/phs000742.v1.pht008113.v1.p1.7_6_Elig_Affected.var_report.xml									phs000742.v1.p1	Epilepsy
848.0	469.0		2017/10/05	821.0		848.0	./data/phs001397.v1.pht006952.v1.p1.GUARDIAN_MACAD_Pedigree.var_report.xml	0.0	410.5	82.73	469.0			410.5		phs001397.v1.p1	Coronary Artery Disease
			11/08/2013				./data/phs000200.v9.pht001508.v2.p3.outc_death_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/12/21				./data/phs000007.v32.pht010733.v1.p13.t_echodop_ex01_3b_0989s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht004801.v2.p13.l_fhslab_ex01_7_0270s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004067.v2.p1.DSRA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001641.v2.p2.B2F9PRG3.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004073.v2.p1.ECGE04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/10/11				./data/phs001706.v1.pht008457.v1.p1.MCD_Sample.var_report.xml									phs001706.v1.p1	Castleman Disease
			2019/10/08				./data/phs001911.v1.pht009516.v1.p1.RADseq_Subject.var_report.xml									phs001911.v1.p1	Ataxia Telangiectasia
			01/15/2016				./data/phs000806.v1.pht004773.v1.p1.MIGen_Ottawa_Heart_Sample_Attributes.var_report.xml									phs000806.v1.p1	
			2021/03/23				./data/phs001122.v1.pht008641.v1.p1.Neonatal_Brain_Sample_Attributes.var_report.xml									phs001122.v1.p1	Brain
			05/08/2017				./data/phs000871.v1.pht004568.v1.p1.Pancreatic_Neuroendocrine_Tumors_Subject.var_report.xml									phs000871.v1.p1	Carcinoma, Neuroendocrine
			11/16/2015				./data/phs001026.v1.pht005120.v1.p1.CSER_BASIC3_Sample.var_report.xml									phs001026.v1.p1	Genes, Neoplasm
			2018/02/27				./data/phs001206.v1.pht007346.v1.p1.BSP_AA_SRA.var_report.xml									phs001206.v1.p1	Blepharospasm
			2020/08/24				./data/phs001744.v1.pht008570.v1.p1.CIDR_HCC_Subject.var_report.xml									phs001744.v1.p1	Liver Neoplasms
			11/05/2014				./data/phs000209.v13.pht003608.v1.p3.MESA_AncilMesaNeighborFoodExam4.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
859.0			2019/05/03	2535.0			./data/phs000681.v2.pht003872.v2.p1.Diabetes_Prevention_Program_Subject_Phenotypes.var_report.xml	0.0			1676.0					phs000681.v2.p1	Diabetes Mellitus, Type 2
			2020/01/02				./data/phs001895.v2.pht009443.v2.p1.Lung_Cancer_EA_AA_Sample.var_report.xml									phs001895.v2.p1	Lung Neoplasms
43.0			2021/08/26	89.0			./data/phs001732.v2.pht010141.v1.p1.TOPMed_WGS_CARE_TREXA_Subject_Phenotypes.var_report.xml	0.0			46.0					phs001732.v2.p1	Asthma
			2020/12/21				./data/phs000007.v32.pht003633.v4.p13.t_pftpstalb_2011_m_0647s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/14/2015				./data/phs000828.v1.pht004329.v1.p1.Fibrolamellar_HCC_Genomic_Analysis_Sample_Attributes.var_report.xml									phs000828.v1.p1	Fibrolamellar hepatocellular carcinoma
			2021/09/16				./data/phs001813.v2.pht009039.v2.p1.PC_Integrative_Tissue_Analysis_Sample_Attributes.var_report.xml									phs001813.v2.p1	Prostatic Neoplasms
			11/04/2014				./data/phs000086.v3.pht000341.v1.p1.EDIC_f0902.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			08/20/2013				./data/phs000285.v3.pht001679.v2.p2.C1F39.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
97.0	41.0		12/16/2013	56.0		97.0	./data/phs000690.v1.pht003619.v1.p1.Multiplex_Epilepsy_Families_Pedigree.var_report.xml	0.0	7.0	7.071	41.0			7.0		phs000690.v1.p1	Idiopathic generalized epilepsy
			2018/03/23				./data/phs000698.v1.pht007680.v1.p1.exacerbation_questionnaire.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
5.0			2020/01/10	30.0			./data/phs001834.v1.pht009422.v1.p1.Fuchs_Corneal_Dystrophy_Subject_Phenotypes.var_report.xml	0.0			9.0					phs001834.v1.p1	Fuchs&#39; Endothelial Dystrophy
49.0	52.0		2018/09/07	64.0		49.0	./data/phs001551.v1.pht008346.v1.p1.CURE_EGI_Pedigree.var_report.xml	0.0	50.5	2.121	52.0			50.5		phs001551.v1.p1	Epilepsy
			2018/09/06				./data/phs001505.v1.pht007318.v1.p1.SAB_WES_EA_Subject.var_report.xml									phs001505.v1.p1	Staphylococcus aureus
			2018/07/18				./data/phs001645.v1.pht008212.v1.p1.Cutaneous_DLBCL_Sample_Attributes.var_report.xml									phs001645.v1.p1	Lymphoma, Large B-Cell, Diffuse
			11/05/2014				./data/phs000209.v13.pht003088.v1.p3.MESA_AncilMesaLungA1AT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			05/07/2014				./data/phs000738.v1.pht003833.v1.p1.Schizophrenia_Families_Subject.var_report.xml									phs000738.v1.p1	Schizophrenia
			2021/05/20				./data/phs000972.v5.pht005681.v2.p1.TOPMed_WGS_Samoans_Adiposity_Sample_Attributes.var_report.xml									phs000972.v5.p1	Obesity
			2018/05/31				./data/phs001316.v1.pht008004.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			2018/02/08				./data/phs001488.v1.pht007415.v1.p1.peneuro.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004154.v2.p1.RHXCOD05.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002424.v6.p13.l_antibod_ex05_1_0582s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001987.v2.p3.spec_results_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			07/03/2014				./data/phs000767.v1.pht003930.v1.p1.UCSD_CLL_Sample.var_report.xml									phs000767.v1.p1	Chronic Lymphocytic Leukemia
			2021/07/21				./data/phs002471.v1.pht011412.v1.p1.AATD_iPSCs_Subject_Phenotypes.var_report.xml									phs002471.v1.p1	alpha 1-Antitrypsin Deficiency
			06/14/2016				./data/phs001127.v1.pht005526.v1.p1.Endometrial_Cancer_Primaries_Metastases_Sample.var_report.xml									phs001127.v1.p1	Endometrial Neoplasms
			2018/10/29				./data/phs001626.v1.pht008478.v1.p1.IBDMDB_Sample_Attributes.var_report.xml									phs001626.v1.p1	Inflammatory Bowel Diseases
			08/20/2013				./data/phs000285.v3.pht001680.v2.p2.C1F40.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001448.v7.p1.CHS_Sample.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
72.0	72.0		05/08/2012	72.0		72.0	./data/phs000443.v1.pht002532.v1.p1.Prostate_Cancer_PCAT1P_Subject_Phenotypes.var_report.xml	0.0	72.0					72.0		phs000443.v1.p1	Prostatic Neoplasms
1691.0	1691.0		05/16/2017	2746.0		1055.0	./data/phs001252.v1.pht006381.v1.p1.disdur.var_report.xml	0.0	1373.0	449.7	1055.0			1373.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2021/07/13				./data/phs001798.v2.pht008947.v2.p2.23andMe_AfAmSeq_Sample.var_report.xml									phs001798.v2.p2	
234.0			02/21/2012	595.0			./data/phs000398.v1.pht002467.v1.p1.HeartGO_ARIC_LDLandEOMI_PhenotypeDataFile.var_report.xml	0.0			361.0					phs000398.v1.p1	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010362.v1.p1.AREDS2_ADV.var_report.xml									phs002015.v1.p1	Macular Degeneration
			08/21/2015				./data/phs000830.v1.pht004923.v1.p1.cSCC_XPC_Mutation_Rates_Sample_Attributes.var_report.xml									phs000830.v1.p1	Xeroderma Pigmentosum, Complementation Group C
181.0	181.0		2021/04/06	348.0		167.0	./data/phs001163.v1.pht011095.v1.p1.Chernobyl_Radiation_Subject.var_report.xml	0.0	174.0	9.899	167.0			174.0		phs001163.v1.p1	
			10/25/2011				./data/phs000406.v1.pht002404.v1.p1.Spatiotemporal_Transcriptome_Brain_GEO.var_report.xml									phs000406.v1.p1	Aging
			2018/02/08				./data/phs001488.v1.pht007396.v1.p1.hdcag.var_report.xml									phs001488.v1.p1	Huntington Disease
			08/20/2015				./data/phs000910.v1.pht004726.v1.p1.T1DGC_CNV_Pedigree.var_report.xml									phs000910.v1.p1	Diabetes Mellitus, Type 1
			08/20/2013				./data/phs000285.v3.pht001776.v2.p2.E1F09TB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
819.0	819.0		2021/08/23	4239.0		767.0	./data/phs001232.v4.pht006079.v4.p2.UDN_Subject_Phenotypes.var_report.xml	0.0	793.0	94.05	767.0			793.0		phs001232.v4.p2	Rare Diseases
			2020/03/13				./data/phs000521.v2.pht007041.v2.p1.ea_genetic_data_form.var_report.xml									phs000521.v2.p1	Ataxia
			01/19/2016				./data/phs000908.v1.pht004708.v1.p1.PD_Rare_Variants_Subject_Phenotypes.var_report.xml									phs000908.v1.p1	
			2017/08/25				./data/phs001079.v2.pht005359.v2.p1.Malignant_Glioblastoma_Sample.var_report.xml									phs001079.v2.p1	Glioblastoma
			2019/10/28				./data/phs001880.v1.pht009563.v1.p1.CCDG_Emory_Sample_Attributes.var_report.xml									phs001880.v1.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht006022.v1.p13.vr_meno_ex03_7_0916s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002853.v6.p13.l_isopros_2008_m_0512s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/28/2016				./data/phs001009.v1.pht005351.v1.p1.RBEL_Asthma_Determinants_Sample.var_report.xml									phs001009.v1.p1	Asthma
			2018/12/10				./data/phs001720.v1.pht008595.v1.p1.Kidney_On_A_Chip_Sample.var_report.xml									phs001720.v1.p1	Podocytes
			05/14/2013				./data/phs000422.v1.pht003224.v1.p1.LungGO_SevereAsthma_Sample.var_report.xml									phs000422.v1.p1	Asthma
			09/03/2009				./data/phs000166.v2.pht000727.v1.p1.CAMP_CARE_ACRN_Sample.var_report_2009_09_03.xml									phs000166.v2.p1	Asthma
			2020/10/01				./data/phs001881.v1.pht010562.v1.p1.CNV_NDD_Subject.var_report.xml									phs001881.v1.p1	Autism Spectrum Disorder
			08/20/2013				./data/phs000285.v3.pht001622.v2.p2.B2F09TUM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			06/01/2017				./data/phs000701.v1.pht005514.v1.p1.DoseLog.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2018/06/21				./data/phs001470.v1.pht008169.v1.p1.CIDR_SWAN_Sample_Attributes.var_report.xml									phs001470.v1.p1	Menopause
			11/14/2016				./data/phs000827.v3.pht004470.v3.p1.CSER_NCGENES_Sample.var_report.xml									phs000827.v3.p1	Genetic Diseases, Inborn
91.0	91.0		11/25/2013	859.0		59.0	./data/phs000682.v1.pht003595.v1.p1.Neuropsychiatric_Neurodevelopmental_Disorders_Pedigree.var_report.xml	0.0	81.0	38.89	59.0			81.0		phs000682.v1.p1	Psychiatry and Psychology Category
			07/22/2013				./data/phs000614.v1.pht003289.v1.p1.PLGGs_GEO.var_report.xml									phs000614.v1.p1	Astrocytoma
			04/22/2009				./data/phs000167.v1.pht000714.v1.p1.nonGAIN_Schizophrenia_cases.var_report_2009_04_22.xml									phs000167.v1.p1	Schizophrenia
			2018/05/29				./data/phs000234.v2.pht001153.v2.p2.Dementia_Sample.var_report.xml									phs000234.v2.p2	Dementia
			2020/09/18				./data/phs002015.v1.pht010369.v1.p1.AREDS2_CLO.var_report.xml									phs002015.v1.p1	Macular Degeneration
			01/19/2010				./data/phs000219.v1.pht001086.v1.p1.d_img_consent.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/02/06				./data/phs001430.v2.pht008081.v2.p1.registration.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2017/12/20				./data/phs000577.v1.pht007286.v1.p1.pedsql4_core_parent_child_5_7.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			06/01/2015				./data/phs000346.v2.pht002184.v2.p2.CGEMS_BladderCancer_Sample.var_report.xml									phs000346.v2.p2	Urinary Bladder Neoplasms
			2018/03/08				./data/phs001494.v1.pht007189.v1.p1.ALIVE_Smokescreen_Subject.var_report.xml									phs001494.v1.p1	Substance-Related Disorders
			07/08/2011				./data/phs000273.v1.pht001432.v1.p1.LINE1_Retrotransposon_Subject.var_report.xml									phs000273.v1.p1	Normalcy
			2017/09/22				./data/phs001392.v1.pht006892.v1.p1.pedsql_infant.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			02/05/2016				./data/phs000944.v1.pht004845.v1.p1.eMERGE_PhaseIII_Partners_Biobank_Sample.var_report.xml									phs000944.v1.p1	Hypercholesterolemia
425.0			2019/08/06	1309.0			./data/phs001701.v1.pht009377.v1.p1.INGENIOUS_Subject_Phenotypes.var_report.xml	0.0			884.0					phs001701.v1.p1	Metabolism
			2020/01/23				./data/phs000287.v7.pht001462.v1.p1.CYST_C_YR5.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/11/19				./data/phs002050.v1.pht010360.v1.p1.OICR_CRC_Sample_Attributes.var_report.xml									phs002050.v1.p1	Colorectal Neoplasms
745.0	745.0		11/19/2013	781.0		64.0	./data/phs000436.v1.pht002835.v1.p1.Autism_Disorders_Subject_Phenotypes.var_report.xml	0.0	601.0	3.536	64.0			601.0		phs000436.v1.p1	Autistic Disorder
2826.0	20135.0		11/05/2014	51104.0		11533.0	./data/phs000209.v13.pht001117.v3.p3.MESA_Exam2FamilyHx.var_report.xml	92.0	17035.0	4777	3044.0			19436.0		phs000209.v13.p3	Cardiovascular Diseases
			2020/07/20				./data/phs002025.v1.pht010235.v1.p1.TB_3q23_Peruvians_Subject.var_report.xml									phs002025.v1.p1	Tuberculosis, Pulmonary
9.0	20.0		2020/08/26	34.0		9.0	./data/phs000998.v2.pht005056.v2.p1.iPSC_Pulmonary_Hypertension_Subject_Phenotypes.var_report.xml	0.0	9.5	4.243	20.0			9.5		phs000998.v2.p1	Pulmonary Arterial Hypertension
			05/24/2016				./data/phs001065.v1.pht005423.v1.p1.mort.var_report.xml									phs001065.v1.p1	Huntington Disease
			03/28/2014				./data/phs000350.v1.pht002199.v1.p1.FHCRC_Prostate_Cancer_Subject.var_report.xml									phs000350.v1.p1	Prostatic Neoplasms
27.0	27.0		2019/10/11	44.0		26.0	./data/phs001380.v1.pht009233.v1.p1.TS_Trios_ExomeSeq_Subject_Phenotypes.var_report.xml	0.0	73.0	7.071	26.0			73.0		phs001380.v1.p1	Tourette Syndrome
2.0	2.0		2018/10/30	3.0		1.0	./data/phs001724.v1.pht008505.v1.p1.Pain_Resilience_Pedigree.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs001724.v1.p1	Erythromelalgia
			2020/06/16				./data/phs001738.v1.pht010289.v1.p1.GMKF_SJFAMILY_HM_Subject.var_report.xml									phs001738.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2019/01/31				./data/phs001712.v1.pht008675.v1.p1.css_baseline_med_hx_form.var_report.xml									phs001712.v1.p1	Vasculitis
47.0	75.0		2019/07/22	99.0		8.0	./data/phs001124.v1.pht009257.v1.p1.Sulfonamide_HS_Subject_Phenotypes.var_report.xml	0.0	99.0	75.82	75.0			47.0		phs001124.v1.p1	Drug Hypersensitivity Syndrome
			01/26/2015	1.0			./data/phs000856.v1.pht004459.v1.p1.Chromothripsis_WHIM_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000856.v1.p1	WHIM syndrome
			2020/06/18				./data/phs000280.v7.pht006454.v1.p1.MSRCOD51.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
7.0			05/24/2017	54.0			./data/phs000576.v1.pht006151.v1.p1.fullpedigree.var_report.xml	96.0			9.0					phs000576.v1.p1	Angelman Syndrome
			05/21/2010				./data/phs000261.v1.pht001232.v1.p1.HMP_Bacterial_Vaginosis_Subject_Time_Varying_Phenotype.var_report.xml									phs000261.v1.p1	Vaginosis, Bacterial
			2021/08/19				./data/phs001662.v2.pht010065.v1.p1.LTRC_R040_subject_cardio_pulm_exer_test.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			08/02/2012				./data/phs000502.v1.pht002813.v1.p1.Splenic_Marginal_Zone_Lymphoma_Subject.var_report.xml									phs000502.v1.p1	Lymphoma, Non-Hodgkin
			06/15/2017				./data/phs001376.v1.pht006554.v1.p1.CD55_Deficiency_Subject_Phenotypes.var_report.xml									phs001376.v1.p1	Protein-Losing Enteropathies
			2019/07/16				./data/phs001826.v1.pht009140.v1.p1.IHS_Depression_Sample_Attributes.var_report.xml									phs001826.v1.p1	Depression
			11/08/2013				./data/phs000200.v9.pht002759.v1.p3.outc_cancer_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/02/27				./data/phs001469.v1.pht007168.v1.p1.DM_Anti_PD1_Sample.var_report.xml									phs001469.v1.p1	Immunotherapy
			09/04/2015				./data/phs000953.v1.pht004965.v1.p1.Microdissected_Pancreatic_Cancer_Sample.var_report.xml									phs000953.v1.p1	Pancreatic Neoplasms
			11/05/2014				./data/phs000209.v13.pht004322.v1.p3.MESA_AncilMesaNeighborSESExam2.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			05/24/2017				./data/phs000576.v1.pht006147.v1.p1.eegcharacteristics.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			03/06/2017				./data/phs000574.v1.pht005868.v1.p1.eligibility.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2018/06/14				./data/phs001238.v2.pht006038.v1.p1.GENOA_AfricanAmerican_JacksonCAC_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2021/05/07				./data/phs001327.v2.pht011182.v1.p1.chemodrug_yn.var_report.xml									phs001327.v2.p1	Neoplasm
			10/25/2010				./data/phs000021.v3.pht000287.v1.p2.AA_GAIN_phenotype_controls_questionnaire.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
			2020/06/18				./data/phs000280.v7.pht004170.v2.p1.RTABM34.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/05/20				./data/phs000993.v5.pht005014.v3.p2.TOPMed_WGS_HVH_Sample.var_report.xml									phs000993.v5.p2	Cardiovascular Disease
			12/11/2009				./data/phs000171.v1.pht000751.v1.p1.MS_DATA_EDSS.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			05/24/2017				./data/phs000576.v1.pht006145.v1.p1.developmentalhistory.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2018/03/20				./data/phs001559.v1.pht007660.v1.p1.Oxycodone_Abuse_Subject.var_report.xml									phs001559.v1.p1	Heroin Dependence
			03/14/2012				./data/phs000223.v1.pht002620.v1.p1.PAGE_ARIC_Sample.var_report.xml									phs000223.v1.p1	Cardiovascular Diseases
990.0	990.0		2019/10/10	983.0		96.0	./data/phs001273.v3.pht006173.v2.p2.OncoArray_Lung_Cancer_Subject_Phenotypes.var_report.xml	0.0	972.5	9.192	955.0			972.5		phs001273.v3.p2	Lung Neoplasms
			11/15/2011				./data/phs000408.v1.pht002441.v1.p1.eMERGE_Obesity_Sample_Attributes.var_report.xml									phs000408.v1.p1	Obesity
			05/09/2016				./data/phs001063.v1.pht005290.v1.p1.HER2_Positive_Breast_Cancer_Sample.var_report.xml									phs001063.v1.p1	Breast Neoplasms
			2018/05/31				./data/phs001318.v1.pht008027.v1.p1.adverse_event.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2021/09/29				./data/phs001608.v2.pht009736.v1.p1.TOPMed_WGS_OMG_SCD_Sample_Attributes.var_report.xml									phs001608.v2.p1	Anemia, Sickle Cell
			2021/08/19				./data/phs001662.v2.pht010066.v1.p1.LTRC_R040_subject_central_pathology.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
664.0	904.0		01/19/2010	2885.0		625.0	./data/phs000219.v1.pht001065.v1.p1.d_csa02.var_report_2010_01_19.xml	0.0	764.5	475.9	560.0			764.5		phs000219.v1.p1	Alzheimer Disease
101.0			2021/03/17	101.0			./data/phs001648.v2.pht008909.v1.p1.mCRPC_Subject_Phenotypes.var_report.xml	0.0								phs001648.v2.p1	Prostatic Neoplasms, Castration-Resistant
			2019/11/13				./data/phs001612.v1.pht009497.v1.p1.TOPMed_WGS_CARDIA_Sample.var_report.xml									phs001612.v1.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001859.v2.p2.F2HCY.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/12				./data/phs001722.v1.pht009885.v1.p1.mCRC_Subject.var_report.xml									phs001722.v1.p1	Neoplasms
			2018/11/21				./data/phs001746.v1.pht008569.v1.p1.GTEx_WGBS_Sample_Attributes.var_report.xml									phs001746.v1.p1	Reference Values
			2018/03/23				./data/phs000698.v1.pht007674.v1.p1.pulmonary_function_testing.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			02/06/2017				./data/phs001075.v1.pht006108.v1.p1.CSER_CanSeq_Subject.var_report.xml									phs001075.v1.p1	Neoplasms
			11/30/2015				./data/phs000260.v4.pht001259.v4.p2.HMP_Foregut_Esophageal_Adenocarcinoma_Sample_Attributes.var_report.xml									phs000260.v4.p2	Esophageal Adenocarcinoma
			2019/10/18				./data/phs001237.v2.pht005989.v2.p1.TOPMed_WGS_WHI_Sample_Attributes.var_report.xml									phs001237.v2.p1	Stroke
486.0	486.0		02/23/2017	563.0		77.0	./data/phs001253.v1.pht006165.v1.p1.Efavirenz_CNS_Symptoms_Subject_Phenotypes.var_report.xml	0.0	281.5	289.2	77.0			281.5		phs001253.v1.p1	Central Nervous System Diseases
			05/08/2017				./data/phs001362.v1.pht006345.v1.p1.Gastric_Cancer_Metastases_Sample_Attributes.var_report.xml									phs001362.v1.p1	Stomach Neoplasms
			10/21/2013				./data/phs000637.v1.pht003537.v1.p1.ALL_Methotrexate_Clearance_Sample_Attributes.var_report.xml									phs000637.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			2020/12/21				./data/phs000007.v32.pht010751.v1.p13.vr_ffreq_ex01_2_0984s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/10/16				./data/phs001373.v2.pht006702.v2.p2.Human_Microglia_Sample.var_report.xml									phs001373.v2.p2	Epilepsy
			10/27/2014				./data/phs000726.v1.pht003780.v1.p1.Myasthenia_Gravis_Sample_Attributes.var_report.xml									phs000726.v1.p1	Myasthenia gravis
627.0	706.0		05/02/2017	2322.0		524.0	./data/phs001358.v1.pht006336.v1.p1.RareBliss_Subject_Phenotypes.var_report.xml	0.0	585.5	97.58	706.0			585.5		phs001358.v1.p1	Bipolar Disorder
			02/11/2016				./data/phs000536.v2.pht002948.v2.p1.Retrotransposition_Colorectal_Tumors_Sample.var_report.xml									phs000536.v2.p1	Colonic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000595.v2.p3.simphen196.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004214.v2.p1.UBMEBF4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/12/10				./data/phs001621.v1.pht008152.v1.p1.Platinum_Study_Subject.var_report.xml									phs001621.v1.p1	
			06/29/2015				./data/phs000838.v1.pht004796.v1.p1.Ghana_Prostate_Study_Subject.var_report.xml									phs000838.v1.p1	Prostatic Neoplasms
53.0	53.0		04/12/2012	91.0		38.0	./data/phs000442.v1.pht002489.v1.p1.Resistant_Hypertension_AA_Subject_Phenotypes.var_report.xml	0.0	45.5	10.61	38.0			45.5		phs000442.v1.p1	Hypertension
			2019/08/07				./data/phs001823.v1.pht009056.v1.p1.Lung_Cancer_Cell_Lines_Subject.var_report.xml									phs001823.v1.p1	Carcinoma, Non-Small-Cell Lung
			04/21/2011				./data/phs000336.v1.pht002218.v1.p1.CGEMS_Lung_Cancer_Subject.var_report.xml									phs000336.v1.p1	Lung Neoplasms
			2019/07/26				./data/phs000588.v1.pht009293.v1.p1.change_of_information_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			07/06/2011				./data/phs000250.v1.pht002187.v1.p1.CALGB_80303_Sample.var_report.xml									phs000250.v1.p1	Pancreatic Neoplasms
			2020/09/28				./data/phs002254.v1.pht010541.v1.p1.CF_Nasal_Epithelium_Subject_Phenotypes.var_report.xml									phs002254.v1.p1	Cystic Fibrosis
			2020/01/21				./data/phs001282.v2.pht006096.v2.p1.Endemic_Burkitt_Lymphoma_Subject.var_report.xml									phs001282.v2.p1	Burkitt Lymphoma
			12/11/2009				./data/phs000171.v1.pht000752.v1.p1.MS_DATA_ELIG.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000472.v2.p3.simphen073.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/07/26				./data/phs000588.v1.pht009290.v1.p1.baseline_comordity_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			06/09/2016				./data/phs000955.v1.pht005450.v1.p1.GeCKO_OAI_Sample.var_report.xml									phs000955.v1.p1	Osteoarthritis
			2018/03/23				./data/phs000698.v1.pht007670.v1.p1.lab_form.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			11/28/2011				./data/phs000385.v1.pht002447.v1.p1.Epigenetic_Colorectal_Cancer_GEO.var_report.xml									phs000385.v1.p1	Colorectal Neoplasms
			2017/09/18				./data/phs001310.v1.pht006872.v1.p1.registration.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
4065.0	4866.0		2018/07/18	8943.0		77.0	./data/phs001588.v1.pht007962.v1.p1.Low_LDL_EHRs_Subject_Phenotypes.var_report.xml	0.0	2981.0	2602	4866.0			4065.0		phs001588.v1.p1	Diabetes Mellitus, Type 2
			09/19/2016				./data/phs001185.v1.pht005765.v1.p1.Early_Onset_Prostate_Cancer_Sample_Attributes.var_report.xml									phs001185.v1.p1	Prostatic Neoplasms
			06/13/2016				./data/phs000205.v6.pht001430.v6.p2.ISCA_Sample.var_report.xml									phs000205.v6.p2	Developmental Disabilities
			11/08/2013				./data/phs000200.v9.pht000984.v4.p3.bmdspine_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/20/2013				./data/phs000285.v3.pht001617.v2.p2.B2F09OTH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/01/17				./data/phs001769.v1.pht008626.v1.p1.6104_Study_Data_Visit.var_report.xml									phs001769.v1.p1	Pure Autonomic Failure
			06/20/2013				./data/phs000430.v1.pht003053.v1.p1.HALT_C_Sample.var_report.xml									phs000430.v1.p1	Hepatitis C
3.0	3.0		08/04/2015	4.0		1.0	./data/phs000926.v1.pht004865.v1.p1.Crohn_Disease_Childhood_Onset_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs000926.v1.p1	Crohn Disease
			2018/02/28				./data/phs001001.v1.pht005654.v1.p1.MGH_AF_Sample.var_report.xml									phs001001.v1.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004108.v2.p1.HMTB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000160.v3.p13.psipi_2003s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/03				./data/phs001292.v2.pht007848.v2.p1.child_sleep_habits.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			09/11/2012				./data/phs000535.v1.pht002959.v1.p1.Bladder_Cancer_Subject_Phenotypes.var_report.xml									phs000535.v1.p1	Urinary Bladder Neoplasms
			2018/02/08				./data/phs001488.v1.pht007409.v1.p1.mhxgen.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/09/18				./data/phs002217.v1.pht010536.v1.p1.MELAS_Sample_Attributes.var_report.xml									phs002217.v1.p1	MELAS Syndrome
			2017/08/09				./data/phs001425.v1.pht006755.v1.p1.Melanoma_Immune_Checkpoint_Sample.var_report.xml									phs001425.v1.p1	Melanoma
			05/02/2011				./data/phs000310.v1.pht002095.v1.p1.NonETS_Fusions_Subject.var_report.xml									phs000310.v1.p1	Prostatic Neoplasms
			2019/08/30				./data/phs001331.v2.pht006925.v2.p1.imd_13174_medications.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			04/24/2012				./data/phs000447.v1.pht002580.v1.p1.Prostate_CIP_Sample.var_report.xml									phs000447.v1.p1	Prostatic Neoplasms
			09/19/2011				./data/phs000389.v1.pht002377.v1.p1.GoKinD_GENIE_Subject.var_report.xml									phs000389.v1.p1	Diabetes Mellitus, Type 1
			2020/12/21				./data/phs000007.v32.pht003462.v4.p13.vr_ceradstr_ex02_3_0807s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004202.v2.p1.TIAC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			10/05/2015				./data/phs000969.v1.pht004931.v1.p1.Sensorineural_Hearing_Loss_Subject_Phenotypes.var_report.xml									phs000969.v1.p1	Bilateral deafness
			07/25/2013				./data/phs000293.v1.pht003365.v1.p1.Familial_Intracranial_Aneurysm_Sample.var_report.xml									phs000293.v1.p1	Intracranial Aneurysm
			01/19/2010				./data/phs000219.v1.pht001074.v1.p1.d_csa08_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
51.0	51.0		2019/07/26	88.0		37.0	./data/phs001852.v1.pht009278.v1.p1.Height_Jewish_Subject_Phenotypes.var_report.xml	0.0	44.0	9.899	37.0			44.0		phs001852.v1.p1	Body Height
6.0	8.0		2018/01/30	8.0		6.0	./data/phs000904.v1.pht004687.v1.p1.Familial_Adenomatous_Polyposis_Pedigree.var_report.xml	0.0	7.0	1.414	8.0			7.0		phs000904.v1.p1	Familial Adenomatous Polyposis
			03/24/2015				./data/phs000196.v3.pht004623.v1.p1.NGRC_Sample_Attributes.var_report.xml									phs000196.v3.p1	Parkinson Disease
			03/03/2015				./data/phs000620.v1.pht003891.v1.p1.MCTFR_Substance_Abuse_Subject.var_report.xml									phs000620.v1.p1	Substance-Related Disorders
33.0	61.0		2018/06/01	94.0		33.0	./data/phs001046.v1.pht005297.v1.p1.exome_chip_pheno.var_report.xml	0.0	47.0	96.87	61.0			47.0		phs001046.v1.p1	Macular Degeneration
101.0			2020/08/26	189.0			./data/phs001831.v1.pht009915.v1.p1.Neuroblastoma_Epigenetics_Subject_Phenotypes.var_report.xml	0.0			88.0					phs001831.v1.p1	Neuroblastoma
4.0	8.0		2018/04/12	55.0		3.0	./data/phs001457.v1.pht007054.v1.p1.AMP_RA_Subject_Phenotypes.var_report.xml	0.0	5.0	2.646	8.0			4.0		phs001457.v1.p1	Arthritis, Rheumatoid
			11/26/2013				./data/phs000458.v1.pht003592.v1.p1.POA_Glaucoma_Methylation_Sample.var_report.xml									phs000458.v1.p1	Glaucoma, Open-Angle
			2019/09/11				./data/phs001437.v1.pht006808.v1.p1.PPTC_Subject_Phenotypes.var_report.xml									phs001437.v1.p1	Leukemia, Lymphoid
			01/13/2016				./data/phs000928.v1.pht004940.v1.p1.LGG_Probiotics_Transcriptome_Sample_Attributes.var_report.xml									phs000928.v1.p1	Volunteers, Human
714.0	799.0		07/15/2010	941.0		804.0	./data/phs000292.v1.pht001527.v1.p1.GEOS_Subject_Phenotypes.var_report_2010_07_15.xml	0.0	931.0	94.05	804.0			931.0		phs000292.v1.p1	Stroke
			08/20/2013				./data/phs000285.v3.pht001751.v2.p2.E1APOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
116.0			2017/12/04	261.0			./data/phs001419.v1.pht007099.v1.p1.sf_36.var_report.xml	8.0			127.0					phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/06/18				./data/phs000280.v7.pht004077.v2.p1.ECGMD41.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/09/29				./data/phs002415.v1.pht011586.v1.p1.BABY_HUG_Subject.var_report.xml									phs002415.v1.p1	Sickle Cell Anemia
			2018/09/17				./data/phs001677.v1.pht008377.v1.p1.AIS_1000_Exomes_Subject.var_report.xml									phs001677.v1.p1	Scoliosis
3928.0			2018/05/07	7430.0			./data/phs000490.v1.pht002962.v1.p1.eMERGE_Complex_Pediatric_Disorders_Pedigree.var_report.xml	0.0			3501.0					phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			2019/03/11				./data/phs000286.v6.pht008750.v1.p2.ftrd.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
59.0			10/15/2012	97.0			./data/phs000512.v1.pht002862.v1.p1.Etiology_HDL_Cholesterol_Subject_Phenotypes.var_report.xml	0.0			38.0					phs000512.v1.p1	Lipoproteins, HDL
			08/20/2013				./data/phs000285.v3.pht001670.v2.p2.C1F18A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht008077.v2.p1.p7001_16297_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2021/08/26				./data/phs001730.v2.pht010130.v1.p1.TOPMed_WGS_CARE_PACT_Subject.var_report.xml									phs001730.v2.p1	Asthma
			2020/05/15				./data/phs001860.v1.pht009452.v1.p1.Autoinflammatory_Disorders_Sample.var_report.xml									phs001860.v1.p1	Hereditary Autoinflammatory Diseases
			04/05/2017				./data/phs000927.v1.pht004753.v1.p1.CSER_Carrier_Testing_Subject_Phenotypes.var_report.xml									phs000927.v1.p1	
30.0	30.0		06/17/2013	54.0		24.0	./data/phs000454.v1.pht003326.v1.p1.HIV_Susceptibility_Pedigree.var_report.xml	0.0	27.0	4.243	24.0			27.0		phs000454.v1.p1	HIV
265.0			2021/07/08	350.0			./data/phs001543.v2.pht009913.v1.p1.AFLMU_Subject_Phenotypes.var_report.xml	0.0			84.0					phs001543.v2.p1	Atrial Fibrillation
			03/06/2017				./data/phs001248.v1.pht006092.v1.p1.LRTI_Subject.var_report.xml									phs001248.v1.p1	Respiratory Tract Infections
			12/18/2014				./data/phs000794.v1.pht004311.v1.p1.Longitudinal_CLL_Sample_Attributes.var_report.xml									phs000794.v1.p1	Chronic Lymphocytic Leukemia
			2020/06/18				./data/phs000280.v7.pht004122.v2.p1.LIPB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/08/18				./data/phs001049.v1.pht005230.v1.p1.Relapsed_SCLC_Sample_Attributes.var_report.xml									phs001049.v1.p1	Small Cell Lung Carcinoma
			01/09/2017				./data/phs001244.v1.pht006057.v1.p1.NPC_WES_Subject_Phenotypes.var_report.xml									phs001244.v1.p1	Nasopharyngeal Neoplasms
			04/11/2014				./data/phs000735.v1.pht003798.v1.p1.Placental_Microbiome_Sample_Attributes.var_report.xml									phs000735.v1.p1	Bacterial Infections
149.0	149.0		07/09/2013	215.0		66.0	./data/phs000621.v1.pht003330.v1.p1.Chronic_Lymphocytic_Leukemia_Trial_Subject_Phenotypes.var_report.xml	0.0	107.5	58.69	66.0			107.5		phs000621.v1.p1	Leukemia, Lymphoid
			05/01/2017				./data/phs000722.v2.pht003898.v2.p2.Colon_CIP_Sample.var_report.xml									phs000722.v2.p2	Colorectal Neoplasms
			03/06/2017				./data/phs000574.v1.pht005873.v1.p1.registration.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2017/09/27				./data/phs001071.v1.pht005346.v1.p1.CIDR_HD_Onset_Age_Sample.var_report.xml									phs001071.v1.p1	Huntington Disease
			12/31/2012				./data/phs000500.v1.pht003114.v1.p1.Fetal_Genome_Subject.var_report.xml									phs000500.v1.p1	Prenatal Care
			2018/11/05				./data/phs000507.v2.pht008526.v1.p2.BEN_Sample_Attributes.var_report.xml									phs000507.v2.p2	Neutropenia
			2018/10/24				./data/phs001695.v1.pht008496.v1.p1.UCSF_CRH_Subject.var_report.xml									phs001695.v1.p1	MicroRNAs
			2018/06/14				./data/phs001238.v2.pht006034.v1.p1.GENOA_AfricanAmerican_JacksonCAC_Exam.var_report.xml									phs001238.v2.p1	Hypertension
			08/20/2013				./data/phs000285.v3.pht001629.v2.p2.B2F16.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
3.0	3.0		2019/10/07	6.0		3.0	./data/phs001854.v1.pht009253.v1.p1.BRAF_PA_Subject_Phenotypes.var_report.xml	0.0	3.0	0	3.0			3.0		phs001854.v1.p1	Astrocytoma
			2020/07/14				./data/phs001816.v1.pht009125.v1.p1.ASD_CRISPR_Sample.var_report.xml									phs001816.v1.p1	Autism Spectrum Disorder
			2018/02/27				./data/phs001447.v1.pht007468.v1.p1.MCRPCS_Subject.var_report.xml									phs001447.v1.p1	Prostatic Neoplasms
			2020/08/05				./data/phs001815.v1.pht009009.v1.p1.MHGRID_Subject.var_report.xml									phs001815.v1.p1	Hypertension
			08/13/2015				./data/phs000831.v1.pht004906.v1.p1.Sporadic_ALS_Sample.var_report.xml									phs000831.v1.p1	Amyotrophic Lateral Sclerosis
			10/28/2013				./data/phs000598.v2.pht003325.v2.p2.EsophagealAdenocarcinoma_Sample_Attributes.var_report.xml									phs000598.v2.p2	Esophageal Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000538.v2.p3.simphen139.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/09/16				./data/phs000979.v3.pht005196.v3.p2.HBCC_Postmortem_Psychiatric_Sample_Attributes.var_report.xml									phs000979.v3.p2	Schizophrenia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000583.v2.p3.simphen184.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/01/10				./data/phs001493.v2.pht007299.v2.p1.RCC_Immune_Checkpoint_Sample_Attributes.var_report.xml									phs001493.v2.p1	Carcinoma, Renal Cell
			08/12/2016				./data/phs000888.v1.pht005577.v1.p1.emerge2_appendicitis_historydisease.var_report.xml									phs000888.v1.p1	
			2020/12/21				./data/phs000007.v32.pht002568.v7.p13.l_rbcfa_2008_m_0420s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010374.v1.p1.AREDS2_DAD.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/05/29				./data/phs000234.v2.pht001151.v2.p2.Dementia_Phenotype_Data_BMI.var_report.xml									phs000234.v2.p2	Dementia
			03/31/2017				./data/phs000558.v1.pht006231.v1.p1.NEIGHBOR_POAG_Sample_Attributes.var_report.xml									phs000558.v1.p1	Glaucoma
			2019/08/29				./data/phs001333.v2.pht006529.v2.p1.participant_medical_history.var_report.xml									phs001333.v2.p1	Fabry Disease
			08/20/2013				./data/phs000285.v3.pht001653.v2.p2.C1F03A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/05/27				./data/phs002034.v1.pht010254.v1.p1.Glioma_Grade_Sample.var_report.xml									phs002034.v1.p1	Glioma
			2019/08/01				./data/phs000222.v6.pht002872.v3.p2.Cognitive.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/06/11				./data/phs002000.v1.pht010121.v1.p1.HC_Mongolian_Sample_Attributes.var_report.xml									phs002000.v1.p1	Carcinoma, Hepatocellular
			2019/06/14				./data/phs000589.v1.pht009194.v1.p1.lvvid_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2019/10/22				./data/phs001917.v1.pht009548.v1.p1.Methylation_PC_Subject.var_report.xml									phs001917.v1.p1	Pancreatic Neoplasms
109.0			2021/07/22	292.0			./data/phs001605.v2.pht010079.v2.p1.TOPMed_WGS_CHIRAH_Subject.var_report.xml	0.0			183.0					phs001605.v2.p1	Asthma
			10/09/2009				./data/phs000093.v2.pht000699.v2.p2.PLCO_Eagle_Sample.var_report_2009_10_09.xml									phs000093.v2.p2	Lung Neoplasms
4901.0	4901.0		03/02/2016	7880.0		2979.0	./data/phs000267.v5.pht002303.v2.p2.Autism_Genome_Project_Pedigree.var_report.xml	0.0	3940.0	1359	2979.0			3940.0		phs000267.v5.p2	Autistic Disorder
			2020/12/21				./data/phs000007.v32.pht000105.v8.p13.pft1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/11/22				./data/phs001325.v3.pht006351.v2.p1.iPSCORE_WGS_Sample.var_report.xml									phs001325.v3.p1	Heart Diseases
			2018/04/16				./data/phs001289.v1.pht007790.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			11/04/2014				./data/phs000086.v3.pht000625.v1.p1.EDIC_f0705.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/07/07				./data/phs002436.v1.pht011378.v1.p1.TIL_Infusion_Sample_Attributes.var_report.xml									phs002436.v1.p1	Melanoma
			09/10/2015				./data/phs000967.v1.pht004860.v1.p1.Clear_Cell_Endometrial_Cancer_WES_Subject.var_report.xml									phs000967.v1.p1	Endometrial Neoplasms
7925.0	9027.0		10/19/2016	7463.0		7925.0	./data/phs001039.v1.pht005848.v1.p1.IAMDGC_Exome_Chip_Subject_Phenotypes.var_report.xml	0.0	9556.0	3585	9027.0			9556.0		phs001039.v1.p1	Macular Degeneration
			08/20/2013				./data/phs000285.v3.pht001674.v2.p2.C1F31B.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/10/09				./data/phs002262.v1.pht010575.v1.p1.HGSOC_Sample_Attributes.var_report.xml									phs002262.v1.p1	
833.0	833.0		08/01/2016	414.0		196.0	./data/phs000744.v4.pht003979.v4.p2.Y_CMG_Subject_Phenotypes.var_report.xml	0.0	474.0	543.6	851.0			432.5		phs000744.v4.p2	Familial Idiopathic Pulmonary Fibrosis
	6.0		2020/07/10	12.0		3.0	./data/phs001886.v2.pht009418.v2.p1.Placenta_Term_Preterm_Subject_Phenotypes.var_report.xml	0.0	4.0	1.732	12.0			3.0		phs001886.v2.p1	Pregnancy, COVID-19
			2020/09/03				./data/phs001903.v1.pht009895.v1.p1.OncoArray_CRC_Sample_Attributes.var_report.xml									phs001903.v1.p1	Colorectal Neoplasms
			11/04/2014				./data/phs000086.v3.pht000354.v1.p1.EDIC_f0954.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht000193.v8.p13.l_aldost_ex06_1b_0046s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/31				./data/phs000663.v3.pht003550.v3.p3.DILIN_Subject.var_report.xml									phs000663.v3.p3	Drug-Induced Liver Injury
			2019/03/20				./data/phs001715.v1.pht008846.v1.p1.registration.var_report.xml									phs001715.v1.p1	Vasculitis
			12/15/2009				./data/phs000207.v1.pht001107.v1.p1.CGEMS_Prostate_Sample.var_report.xml									phs000207.v1.p1	Prostatic Neoplasms
			2019/07/26				./data/phs000588.v1.pht009306.v1.p1.protocol_termination.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			10/25/2016				./data/phs000488.v2.pht002911.v2.p1.LUAD_CIP_Subject_Phenotypes.var_report.xml									phs000488.v2.p1	Carcinoma, Non-Small-Cell Lung
			2017/10/11				./data/phs000578.v1.pht007022.v1.p1.short_exercise_test.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			2020/07/24				./data/phs001194.v3.pht005830.v2.p2.PaternalDemographics.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
8.0	8.0		04/06/2016	88.0		7.0	./data/phs001080.v1.pht005372.v1.p1.Hereditary_Spastic_Paraplegia_Subject_Phenotypes.var_report.xml	0.0	7.5	14.85	7.0			7.5		phs001080.v1.p1	Spastic Paraplegia, Hereditary
			2018/05/15				./data/phs001311.v1.pht007927.v1.p1.laboratory_form.var_report.xml									phs001311.v1.p1	Myotonia
21.0	21.0		2020/07/24	34.0		7.0	./data/phs002063.v1.pht010406.v1.p1.PD_Immunity_Subject_Phenotypes.var_report.xml	0.0	9.0	5.657	7.0			9.0		phs002063.v1.p1	Parkinson Disease
78.0	78.0		2018/08/19	141.0		63.0	./data/phs000101.v5.pht002167.v1.p1.ALS_Third_Stage_Cases.var_report.xml	0.0	70.5	10.61	63.0			70.5		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2020/12/21				./data/phs000007.v32.pht000604.v5.p13.knoa1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			04/16/2013				./data/phs000145.v4.pht000659.v2.p2.POPRES_v1_v2_Subject_Phenotypes.var_report.xml									phs000145.v4.p2	Normalcy
			2019/05/07				./data/phs001524.v1.pht008558.v1.p1.PC_Rare_Variation_Sample_Attributes.var_report.xml									phs001524.v1.p1	Prostatic Neoplasms
995.0	9.0		2020/01/23	71.0		8.0	./data/phs000287.v7.pht001495.v1.p1.YR9.var_report.xml	61.0	8.5	7.071	93.0			8.5		phs000287.v7.p1	Cardiovascular Diseases
			08/13/2015				./data/phs000415.v1.pht002415.v1.p1.CIDR_Tourette_Syndrome_Sample_Attributes.var_report.xml									phs000415.v1.p1	Tourette Syndrome
13.0	13.0		2017/08/31	20.0		7.0	./data/phs000939.v2.pht004789.v2.p1.Lymphoma_Oncogene_Dysregulation_Subject_Phenotypes.var_report.xml	0.0	10.0	4.243	7.0			10.0		phs000939.v2.p1	Lymphoma, B-Cell
12416.0	12416.0		2021/08/13	24577.0		12161.0	./data/phs001442.v3.pht008326.v3.p2.TEDDY_Cohort_Subject.var_report.xml	0.0	12289.0	180.3	12161.0			12289.0		phs001442.v3.p2	Diabetes Mellitus, Type 1
			2021/07/07				./data/phs001472.v2.pht007116.v1.p1.TOPMed_WGS_ECLIPSE_Subject.var_report.xml									phs001472.v2.p1	Pulmonary Disease, Chronic Obstructive
6.0	14.0		02/08/2016	28.0		6.0	./data/phs000949.v1.pht005223.v1.p1.CIDR_Facial_Variation_Pedigree.var_report.xml	0.0	8.0	2.828	14.0			8.0		phs000949.v1.p1	Anthropometry
			2019/05/30				./data/phs000424.v8.pht002741.v8.p2.GTEx_Sample.var_report.xml									phs000424.v8.p2	Reference Values
			2018/05/31				./data/phs001318.v1.pht008030.v1.p1.transfusionrecord.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2021/02/04				./data/phs002333.v1.pht010920.v1.p1.Chronic_Rhinosinusitis_Sample.var_report.xml									phs002333.v1.p1	Paranasal Sinus Diseases
			03/01/2016				./data/phs000942.v1.pht004834.v1.p1.Cancer_Genetics_Clinic_Subject.var_report.xml									phs000942.v1.p1	Neoplasms
			2018/09/17				./data/phs001687.v1.pht008358.v1.p1.WABCS_Sample.var_report.xml									phs001687.v1.p1	Breast Neoplasms
			2017/10/13				./data/phs001212.v1.pht006565.v1.p1.Globin_Sickle_Cell_iPSC_Sample_Attributes.var_report.xml									phs001212.v1.p1	Anemia, Sickle Cell
			2019/03/11				./data/phs000286.v6.pht008743.v1.p2.censustract.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			04/17/2017				./data/phs001157.v1.pht005804.v1.p1.WLS_Aging_Sample.var_report.xml									phs001157.v1.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000408.v2.p3.simphen009.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/08/2013				./data/phs000200.v9.pht002765.v1.p3.outc_death_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
30.0	39.0		2020/09/04	69.0		30.0	./data/phs001993.v1.pht010086.v1.p1.NF1_AtypicalNeurofibromas_Subject_Phenotypes.var_report.xml	0.0	34.5	6.364	39.0			34.5		phs001993.v1.p1	Neurofibromatosis 1
			02/08/2017				./data/phs001271.v1.pht006119.v1.p1.KIDRISK_Sample_Attributes.var_report.xml									phs001271.v1.p1	Carcinoma, Renal Cell
			2018/03/20				./data/phs000605.v1.pht007635.v1.p1.initial_medical_history_form.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2019/03/19				./data/phs001168.v2.pht007577.v2.p2.GMKF_OFC_Subject.var_report.xml									phs001168.v2.p2	Cleft Lip
5.0	7.0		04/10/2014	12.0		5.0	./data/phs000306.v4.pht001909.v1.p1.MEC_Prostate_Cancer_Pedigree.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs000306.v4.p1	Prostatic Neoplasms
			2018/02/08				./data/phs001488.v1.pht007394.v1.p1.ethra.var_report.xml									phs001488.v1.p1	Huntington Disease
8.0	8.0		2018/04/30	7.0		4.0	./data/phs001322.v2.pht006331.v2.p1.ALS4_Subject_Phenotypes.var_report.xml	0.0	6.0	2.828	4.0			6.0		phs001322.v2.p1	Amyotrophic Lateral Sclerosis 4, Juvenile
			2019/07/26				./data/phs000588.v1.pht009298.v1.p1.fu_vasculitis_meds_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/07/17				./data/phs000480.v1.pht002904.v1.p1.FBCS_Subject.var_report.xml									phs000480.v1.p1	Breast Neoplasms
			08/31/2012				./data/phs000451.v1.pht002602.v1.p1.NECS_Subject.var_report.xml									phs000451.v1.p1	Centenarian
	1493.0		06/01/2010	1493.0		1493.0	./data/phs000138.v2.pht000617.v1.p1.Bone_Fragility_Data.var_report_2010_06_01.xml	0.0	1493.0		1493.0			1493.0		phs000138.v2.p1	Osteoporosis
			2018/09/19				./data/phs000357.v2.pht002330.v2.p1.Systemic_Sclerosis_Sample.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
			2018/07/06				./data/phs000416.v2.pht002747.v2.p1.GOCHA_Subject_Phenotypes.var_report.xml									phs000416.v2.p1	Intracranial Hemorrhage
9054.0			06/01/2015	5947.0			./data/phs000346.v2.pht002185.v2.p2.CGEMS_BladderCancer_Data.var_report.xml	0.0			986.0					phs000346.v2.p2	Urinary Bladder Neoplasms
10464.0			2019/03/27	13155.0			./data/phs001286.v1.pht007889.v1.p1.PLCO_Subject_Phenotypes.var_report.xml	0.0			2691.0					phs001286.v1.p1	Neoplasms
			2019/11/08				./data/phs001332.v2.pht007456.v2.p1.p7301_12624_physician.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			03/24/2017				./data/phs001257.v2.pht005998.v2.p1.Anti_CTLA_4_Sample.var_report.xml									phs001257.v2.p1	Melanoma
			05/07/2013				./data/phs000462.v1.pht002845.v1.p1.T2D_GENES_Sample_Attributes.var_report.xml									phs000462.v1.p1	Diabetes Mellitus, Type 2
			2017/10/05				./data/phs001454.v1.pht006980.v1.p1.Cross_BETRNet_Admixture_Subject.var_report.xml									phs001454.v1.p1	Adenocarcinoma Of Esophagus
			02/18/2015				./data/phs000857.v1.pht004488.v1.p1.ER_Positive_Breast_Cancer_Sample.var_report.xml									phs000857.v1.p1	Breast Neoplasms
			2018/06/01				./data/phs001538.v1.pht008090.v1.p1.Registry_GenTestMutations.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			09/08/2016				./data/phs000893.v1.pht005500.v1.p1.Endometrial_Cancer_E2C2_Subject.var_report.xml									phs000893.v1.p1	Carcinoma, Endometrioid
79.0	48.0		2021/07/02	48.0		79.0	./data/phs001017.v1.pht005074.v1.p1.Breast_Cancer_Susceptibility_Subject.var_report.xml	0.0	879.5	1132	48.0			879.5		phs001017.v1.p1	Breast Neoplasms
4.0	10.0		2019/04/19	14.0		4.0	./data/phs001808.v1.pht008974.v1.p1.B_Lymphocytes_Aging_Subject_Phenotypes.var_report.xml	0.0	7.0	4.243	10.0			7.0		phs001808.v1.p1	Aging
			2020/03/24				./data/phs001641.v1.pht010031.v1.p1.Diagnoses.var_report.xml									phs001641.v1.p1	Progressive Patient Care
4.0	4.0		2021/04/28	7.0		3.0	./data/phs002408.v1.pht011159.v1.p1.CTCF_11p15_Subject.var_report.xml	0.0	3.5	0.7071	3.0			3.5		phs002408.v1.p1	Beckwith-Wiedemann Syndrome
623.0	623.0		2020/02/28	925.0		674.0	./data/phs001109.v3.pht005447.v2.p2.Addictive_Diseases_Subject_Phenotypes.var_report.xml	0.0	897.5	89.1	674.0			897.5		phs001109.v3.p2	Substance-Related Disorders
			2020/07/21				./data/phs001011.v2.pht005531.v1.p1.eMERGE_CCHMC_IIIA_Sample.var_report.xml									phs001011.v2.p1	
			02/25/2016				./data/phs001014.v1.pht005112.v1.p1.IRAS_Classic_Subject.var_report.xml									phs001014.v1.p1	Insulin Resistance
			09/11/2012				./data/phs000535.v1.pht002960.v1.p1.Bladder_Cancer_Sample_Attributes.var_report.xml									phs000535.v1.p1	Urinary Bladder Neoplasms
			2021/03/17				./data/phs002364.v1.pht011041.v1.p1.HIV_cART_Sample.var_report.xml									phs002364.v1.p1	HIV
			11/08/2013				./data/phs000200.v9.pht001008.v4.p3.f40_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
22.0	22.0		2021/05/27	38.0		16.0	./data/phs002433.v1.pht011259.v1.p1.NP_RNAseq_SARS_CoV2_Subject_Phenotypes.var_report.xml	0.0	19.0	4.243	16.0			19.0		phs002433.v1.p1	COVID-19
			02/21/2012				./data/phs000400.v1.pht002535.v1.p1.ESP_CHS_Sample.var_report.xml									phs000400.v1.p1	Cardiovascular Diseases
			2019/06/19				./data/phs001776.v1.pht009208.v1.p1.LTG_Pancreas_QTL_Subject.var_report.xml									phs001776.v1.p1	Pancreas
			2018/04/12				./data/phs001458.v1.pht007778.v1.p1.Cannabis_Stimulant_Dependence_Subject.var_report.xml									phs001458.v1.p1	Marijuana Abuse
			08/20/2013				./data/phs000285.v3.pht001799.v2.p2.E1GLU.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/11/13				./data/phs001612.v1.pht009496.v1.p1.TOPMed_WGS_CARDIA_Subject.var_report.xml									phs001612.v1.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000473.v2.p3.simphen074.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
23.0	438.0		2019/03/27	814.0		376.0	./data/phs001670.v1.pht008881.v1.p1.DeKAF_Tac_AA_EA_Subject_Phenotypes.var_report.xml	0.0	407.0	43.84	25.0			407.0		phs001670.v1.p1	Tacrolimus
			2019/03/25				./data/phs001734.v1.pht008824.v1.p1.Drug_Abuse_ADHD_Sample.var_report.xml									phs001734.v1.p1	Attention Deficit Disorder with Hyperactivity
1401.0	199.0		2021/09/24	321.0		936.0	./data/phs001726.v2.pht011573.v1.p1.TOPMed_WGS_CAMP_Pedigree.var_report.xml	0.0	970.0	54.45	936.0			970.0		phs001726.v2.p1	Asthma
			05/24/2012				./data/phs000394.v1.pht002652.v1.p1.APDGC_Sample.var_report.xml									phs000394.v1.p1	Parkinson Disease
			2019/07/26				./data/phs000588.v1.pht009286.v1.p1.angiogram_leftupperextremity.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
18.0	22.0		2021/01/07	40.0		18.0	./data/phs002073.v1.pht010828.v1.p1.Infant_Immunity_Subject_Phenotypes.var_report.xml	0.0	20.0	2.828	22.0			20.0		phs002073.v1.p1	Breast Feeding
			01/07/2014				./data/phs000611.v1.pht003502.v1.p1.Breast_Cancer_Xenotransplants_Subject_Phenotypes.var_report.xml									phs000611.v1.p1	Breast Neoplasms
			2017/10/19				./data/phs001288.v1.pht006781.v1.p1.qol.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			07/26/2016				./data/phs000916.v1.pht004734.v1.p1.MIGen_Exome_Munich_MI_Subject.var_report.xml									phs000916.v1.p1	Coronary Artery Disease
1.0	1.0		2021/06/07	2.0		1.0	./data/phs002440.v1.pht011282.v1.p1.ALS_NMJ_Subject.var_report.xml	0.0	1.0	0	1.0			1.0		phs002440.v1.p1	Amyotrophic Lateral Sclerosis
			2020/12/22				./data/phs002301.v1.pht010817.v1.p1.Skull_Based_Chordoma_Sample_Attributes.var_report.xml									phs002301.v1.p1	chordoma
			2017/10/19				./data/phs001288.v1.pht006777.v1.p1.neurodev_wisc_iv.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			10/24/2012				./data/phs000537.v1.pht003023.v1.p1.Mendelian_fHLH_Subject.var_report.xml									phs000537.v1.p1	Lymphohistiocytosis, Hemophagocytic
			2017/09/06				./data/phs001261.v1.pht006112.v1.p1.Palindromic_Gene_Amplification_Subject.var_report.xml									phs001261.v1.p1	Breast Neoplasms
663.0	810.0		2018/09/26	3507.0		663.0	./data/phs000284.v2.pht001900.v2.p1.CFS_CARe_Pedigree.var_report.xml	0.0	736.5	105.4	810.0			736.5		phs000284.v2.p1	Sleep Apnea Syndromes
			2019/01/31				./data/phs001712.v1.pht008680.v1.p1.pan_baseline_med_hx_form.var_report.xml									phs001712.v1.p1	Vasculitis
			2020/01/10				./data/phs001834.v1.pht009423.v1.p1.Fuchs_Corneal_Dystrophy_Sample_Attributes.var_report.xml									phs001834.v1.p1	Fuchs&#39; Endothelial Dystrophy
			07/15/2015				./data/phs000616.v2.pht003368.v2.p2.VIVA_LA_FAMILIA_Subject.var_report.xml									phs000616.v2.p2	Obesity
503.0			2020/07/24	967.0			./data/phs001194.v3.pht005831.v2.p2.KaryotypeFormula.var_report.xml	0.0			463.0					phs001194.v3.p2	Heart Defects, Congenital
20.0	20.0		2017/08/02	31.0		11.0	./data/phs001384.v1.pht006741.v1.p1.Polyp_To_Cancer_Subject_Phenotypes.var_report.xml	0.0	15.5	6.364	11.0			15.5		phs001384.v1.p1	Colorectal Neoplasms
			2020/02/27				./data/phs001213.v2.pht005838.v2.p1.Heroin_Dependence_China_Sample.var_report.xml									phs001213.v2.p1	Drug Dependence
			10/27/2014				./data/phs000812.v1.pht004301.v1.p1.Breast_Prostate_Cancer_Sample_Attributes.var_report.xml									phs000812.v1.p1	Prostatic Neoplasms
			06/13/2016				./data/phs000205.v6.pht003014.v2.p2.ISCA_Sample_Attributes.var_report.xml									phs000205.v6.p2	Developmental Disabilities
			11/08/2013				./data/phs000200.v9.pht003402.v1.p3.outc_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			06/16/2017				./data/phs001278.v1.pht006275.v1.p1.p7201_14426_disorders.var_report.xml									phs001278.v1.p1	Porphyrias
			04/08/2014				./data/phs000729.v1.pht003773.v1.p1.Follicular_Lymphoma_Subject.var_report.xml									phs000729.v1.p1	Lymphoma, Follicular
430.0	9408.0		2020/12/21	2032.0		820.0	./data/phs000007.v32.pht004374.v6.p13.vr_np_2018_a_1185s.var_report.xml	0.0	8291.0	277.2	606.0			8291.0		phs000007.v32.p13	Cardiovascular Diseases
33.0	33.0		2018/02/12	62.0		29.0	./data/phs001525.v1.pht007477.v1.p1.XDP_Subject_Phenotypes.var_report.xml	0.0	31.0	2.828	29.0			31.0		phs001525.v1.p1	X-Linked Dystonia Parkinsonism
			2020/02/19				./data/phs001221.v1.pht007160.v1.p1.Prostate_Cancer_GWAS_PC.var_report.xml									phs001221.v1.p1	Prostatic Neoplasms
871.0	930.0		04/04/2012	94.0		96.0	./data/phs000433.v1.pht002434.v1.p1.SIGNET_Pedigree.var_report.xml	0.0	99.0	7.778	930.0			99.0		phs000433.v1.p1	Type 2 Diabetes Mellitus
			2019/07/19				./data/phs001230.v1.pht009240.v1.p1.Estonian_Biobank_Sample.var_report.xml									phs001230.v1.p1	Population Groups
6.0	6.0		2021/06/03	10.0		4.0	./data/phs001961.v1.pht011029.v1.p1.LungMAP_Subject_Phenotypes.var_report.xml	0.0	5.0	1.414	4.0			5.0		phs001961.v1.p1	Lung
			05/24/2016				./data/phs001065.v1.pht005424.v1.p1.pecn.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/02/06				./data/phs001430.v2.pht008078.v2.p1.brain_imaging_assessment.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2020/06/18				./data/phs000280.v7.pht006482.v1.p1.SMF.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/03/02				./data/phs001900.v1.pht009630.v1.p1.ASD_SCZ_Development_Subject.var_report.xml									phs001900.v1.p1	Autism Spectrum Disorder
			2018/02/08				./data/phs001488.v1.pht007390.v1.p1.drgdsc.var_report.xml									phs001488.v1.p1	Huntington Disease
			04/12/2012				./data/phs000442.v1.pht002487.v1.p1.Resistant_Hypertension_AA_Subject.var_report.xml									phs000442.v1.p1	Hypertension
			2020/04/14				./data/phs001947.v1.pht010134.v1.p1.Melanoma_Hu14_18_IL2_Subject.var_report.xml									phs001947.v1.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht000832.v7.p13.pft1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/13/2014				./data/phs000625.v1.pht003854.v1.p1.Cleft_Lip_Palate_Subject_Phenotypes.var_report.xml									phs000625.v1.p1	Orofacial Cleft, Nonsyndromic
			2018/07/23				./data/phs000742.v1.pht008123.v1.p1.7_16_EEG.var_report.xml									phs000742.v1.p1	Epilepsy
			2020/02/06				./data/phs001430.v2.pht008065.v2.p1.p7001_18443_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			02/01/2016				./data/phs001021.v1.pht005267.v1.p1.CHDWB_Rare_Regulatory_Variants_Sample_Attributes.var_report.xml									phs001021.v1.p1	Wellness Center
			08/05/2016				./data/phs000923.v1.pht005493.v1.p1.Germ_Cell_Tumors_Sample.var_report.xml									phs000923.v1.p1	Male Germ Cell Tumor
			11/16/2012				./data/phs000391.v1.pht002995.v1.p1.PAPI_Sample.var_report.xml									phs000391.v1.p1	Platelets
			2018/08/03				./data/phs000590.v1.pht008287.v1.p1.vdi.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			06/15/2017				./data/phs001376.v1.pht006551.v1.p1.CD55_Deficiency_Subject.var_report.xml									phs001376.v1.p1	Protein-Losing Enteropathies
			03/01/2012				./data/phs000401.v1.pht002475.v1.p1.ESP_FHS_LDLandEOMI_Sample.var_report.xml									phs000401.v1.p1	Cardiovascular Diseases
			2019/08/30				./data/phs001331.v2.pht006919.v2.p1.cGVHD_6501_Subject.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			10/24/2012				./data/phs000542.v1.pht003016.v1.p1.Mendelian_Neonatal_Diabetes_Sample.var_report.xml									phs000542.v1.p1	Pancreatic beta cell agenesis with neonatal diabetes mellitus
			08/20/2014				./data/phs000777.v1.pht003973.v1.p1.FSGS_CKD_Sample.var_report.xml									phs000777.v1.p1	Glomerulosclerosis, Focal Segmental
			2019/12/09				./data/phs001842.v1.pht009246.v1.p1.Sjogrens_Syndrome_Sample_Attributes.var_report.xml									phs001842.v1.p1	Sjogren&#39;s Syndrome
			2019/06/14				./data/phs000589.v1.pht009175.v1.p1.angiogram_coronary.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
	24.0		2018/06/27	24.0		24.0	./data/phs001006.v1.pht006003.v1.p1.Lobular_Carcinomas_Subject_Phenotypes.var_report.xml	0.0	24.0		24.0			24.0		phs001006.v1.p1	Carcinoma, Lobular
			2018/08/03				./data/phs000590.v1.pht008283.v1.p1.registration.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2021/03/17				./data/phs002364.v1.pht011042.v1.p1.HIV_cART_Sample_Attributes.var_report.xml									phs002364.v1.p1	HIV
815.0	839.0		01/29/2015	970.0		815.0	./data/phs000737.v1.pht004444.v1.p1.Metabolic_Syndrome_Hvar_Islanders_Pedigree.var_report.xml	0.0	827.0	83.44	839.0			827.0		phs000737.v1.p1	Metabolic Syndrome X
			2018/08/06				./data/phs001580.v1.pht008289.v1.p1.HCC_Sample.var_report.xml									phs001580.v1.p1	Thyroid cancer, Hurthle cell
169.0	169.0		2019/07/25	323.0		154.0	./data/phs001045.v1.pht009261.v1.p1.MECC_Ashkenazi_Subject_Phenotypes.var_report.xml	0.0	161.5	10.61	154.0			161.5		phs001045.v1.p1	Colorectal Neoplasms
			2018/09/26				./data/phs001410.v1.pht008424.v1.p1.GMKF_AIS_Sample_Attributes.var_report.xml									phs001410.v1.p1	Scoliosis
			2019/09/27				./data/phs001576.v2.pht008215.v2.p2.P6705_ANTHROPOMETRIC_DATA.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			09/16/2009				./data/phs000211.v1.pht000914.v1.p1.NIGMS_Variation_Panels_Sample.var_report_2009_09_16.xml									phs000211.v1.p1	Normalcy
			2018/08/19				./data/phs001647.v1.pht008201.v1.p1.Impulsivity_Addiction_Subject_Phenotypes.var_report.xml									phs001647.v1.p1	Impulsive Behavior
			2020/12/21				./data/phs000007.v32.pht001894.v6.p13.qctvfx_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/14/2015				./data/phs000828.v1.pht004327.v1.p1.Fibrolamellar_HCC_Genomic_Analysis_Subject.var_report.xml									phs000828.v1.p1	Fibrolamellar hepatocellular carcinoma
2.0	6.0		03/28/2016	8.0		4.0	./data/phs001009.v1.pht005350.v1.p1.RBEL_Asthma_Determinants_Pedigree.var_report.xml	0.0	4.0	2.828	6.0			4.0		phs001009.v1.p1	Asthma
			2021/04/27				./data/phs001908.v2.pht009533.v2.p1.Spatiotemporal_Cerebellum_Subject_Phenotypes.var_report.xml									phs001908.v2.p1	Neural Stem Cells
415.0			2019/10/11	932.0			./data/phs001406.v1.pht007746.v1.p1.cantabds.var_report.xml	0.0			517.0					phs001406.v1.p1	Cognition
			2017/12/20				./data/phs000577.v1.pht007283.v1.p1.p5101_16898_neuropsyc.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2019/07/25				./data/phs001045.v1.pht009260.v1.p1.MECC_Ashkenazi_Sample.var_report.xml									phs001045.v1.p1	Colorectal Neoplasms
			2021/09/22				./data/phs001211.v4.pht005755.v4.p3.TOPMed_WGS_ARIC_Sample.var_report.xml									phs001211.v4.p3	Cardiovascular Diseases
			2020/11/19				./data/phs002202.v1.pht010549.v1.p1.Heterochromatin_Structure_Sample_Attributes.var_report.xml									phs002202.v1.p1	Healthy Volunteers
			2019/11/15				./data/phs000784.v3.pht004283.v1.p1.GenSalt_Subject.var_report.xml									phs000784.v3.p1	Arterial Pressure, Mean
1.0	6.0		2021/06/09	7.0		1.0	./data/phs002448.v1.pht011298.v1.p1.BC_CDK4_6_Subject.var_report.xml	0.0	3.5	3.536	6.0			3.5		phs002448.v1.p1	Immunologic Memory
			04/01/2016				./data/phs000895.v1.pht005073.v1.p1.Periampullary_Tumors_Sample_Attributes.var_report.xml									phs000895.v1.p1	
			2017/09/22				./data/phs001392.v1.pht006907.v1.p1.registration.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
7.0	7.0		05/26/2011	7.0		6.0	./data/phs000289.v2.pht001884.v1.p1.Venous_Thrombosis_Pedigree.var_report.xml	0.0	6.5	2.121	6.0			6.5		phs000289.v2.p1	Venous Thrombosis
			2019/09/26				./data/phs000974.v4.pht004910.v4.p3.TOPMed_WGS_FHS_Sample.var_report.xml									phs000974.v4.p3	Cardiovascular Diseases
5.0	5.0		2021/02/11	8.0		3.0	./data/phs001711.v1.pht008529.v1.p1.GI_Carcinomas_Subject_Phenotypes.var_report.xml	0.0	4.0	1.414	3.0			4.0		phs001711.v1.p1	Gastrointestinal Neoplasms
			2018/05/15				./data/phs001311.v1.pht007926.v1.p1.needle_emg.var_report.xml									phs001311.v1.p1	Myotonia
			2019/12/16				./data/phs000959.v1.pht009701.v1.p1.SCZ_Xhosa_Sample.var_report.xml									phs000959.v1.p1	Schizophrenia
			2020/12/21				./data/phs000007.v32.pht002143.v7.p13.l_leptinr_2005_m_0568s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
12416.0	12416.0		2021/08/13	24577.0		12161.0	./data/phs001442.v3.pht008327.v3.p2.TEDDY_Cohort_Pedigree.var_report.xml	0.0	12289.0	180.3	12161.0			12289.0		phs001442.v3.p2	Diabetes Mellitus, Type 1
			2020/09/28				./data/phs001459.v1.pht007310.v1.p1.AMP_SLE_Sample.var_report.xml									phs001459.v1.p1	Lupus Erythematosus, Systemic
5431.0			2020/04/24	9201.0			./data/phs001676.v1.pht009438.v1.p1.CCDG_Autism_SSC_Subject_Phenotypes.var_report.xml	0.0			3770.0					phs001676.v1.p1	Autism Spectrum Disorder
			2021/08/11				./data/phs002480.v1.pht011394.v1.p1.Glomerular_Disorders_Sample.var_report.xml									phs002480.v1.p1	Glomerulonephritis
			12/06/2016				./data/phs001203.v1.pht005966.v1.p1.STARNET_Sample.var_report.xml									phs001203.v1.p1	Coronary Artery Disease
			2021/08/13				./data/phs001442.v3.pht010303.v1.p2.TEDDY_Cohort_maskid_mapping.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			08/15/2012				./data/phs000479.v1.pht002667.v1.p1.SCID_Exome_Sample_Attributes.var_report.xml									phs000479.v1.p1	Severe Combined Immunodeficiency
			08/20/2013				./data/phs000285.v3.pht001821.v2.p2.F1F18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/19				./data/phs001288.v1.pht006776.v1.p1.neurodev_wais_iii.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			12/31/2012				./data/phs000500.v1.pht003116.v1.p1.Fetal_Genome_Sample.var_report.xml									phs000500.v1.p1	Prenatal Care
3.0	7.0		2017/10/04	10.0		3.0	./data/phs001270.v1.pht006252.v1.p1.SACDS_IGHNSS_Subject_Phenotypes.var_report.xml	0.0	5.0	2.828	7.0			5.0		phs001270.v1.p1	Sleep Wake Disorders
			06/01/2017				./data/phs000701.v1.pht005516.v1.p1.Eligibility.var_report.xml									phs000701.v1.p1	Angelman Syndrome
1.0	5.0		2021/08/20	6.0		1.0	./data/phs002508.v1.pht011500.v1.p1.HVP_scRNA_HepB_Subject.var_report.xml	0.0	3.0	2.828	5.0			3.0		phs002508.v1.p1	Vaccines
568.0	568.0		2021/05/07	2192.0		555.0	./data/phs000956.v5.pht005768.v2.p1.TOPMed_WGS_Amish_Pedigree.var_report.xml	0.0	561.5	9.192	555.0			561.5		phs000956.v5.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001974.v2.p2.sbpa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/09/17				./data/phs002222.v1.pht010526.v1.p1.Tcells_CNS_Sample.var_report.xml									phs002222.v1.p1	Multiple Sclerosis
539.0	839.0		02/27/2015	3964.0		539.0	./data/phs000170.v2.pht000981.v1.p1.Marshfield_Pedigree.var_report.xml	0.0	689.0	492.1	839.0			689.0		phs000170.v2.p1	Cataract
			2019/03/11				./data/phs000286.v6.pht008783.v1.p2.sbpc.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht003417.v1.p3.spec_case_control_types_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2017/09/25				./data/phs001348.v2.pht006236.v2.p1.Gene_Discovery_WGMS_Sample_Attributes.var_report.xml									phs001348.v2.p1	
			2017/10/05				./data/phs001397.v1.pht006955.v1.p1.GUARDIAN_MACAD_Sample_Attributes.var_report.xml									phs001397.v1.p1	Coronary Artery Disease
			2021/04/07				./data/phs002377.v1.pht011115.v1.p1.Ipilimumab_Nivolumab_HCT_Sample_Attributes.var_report.xml									phs002377.v1.p1	Hematologic Malignancy
2021.0	2021.0		2020/06/26	2805.0		784.0	./data/phs001630.v1.pht010193.v1.p1.Measles_Immunity_Pedigree.var_report.xml	0.0	1403.0	874.7	784.0			1403.0		phs001630.v1.p1	Measles Vaccine
			2020/10/21				./data/phs002067.v1.pht010409.v1.p1.TLE_Sample.var_report.xml									phs002067.v1.p1	Epilepsy, Temporal Lobe
			2020/09/18				./data/phs002217.v1.pht010534.v1.p1.MELAS_Sample.var_report.xml									phs002217.v1.p1	MELAS Syndrome
			03/28/2014				./data/phs000350.v1.pht002202.v1.p1.FHCRC_Prostate_Cancer_Subject_Phenotypes.var_report.xml									phs000350.v1.p1	Prostatic Neoplasms
875.0	980.0		08/27/2012	9381.0		875.0	./data/phs000168.v2.pht000709.v2.p2.LOAD610K_Pedigree.var_report.xml	0.0	86.0	84.85	980.0			86.0		phs000168.v2.p2	Alzheimer Disease
			2020/12/21				./data/phs000007.v32.pht000906.v7.p13.ctpericard3_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009199.v1.p1.tobacco_alcohol_drug_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/29/2012				./data/phs000539.v1.pht003020.v1.p1.Mendelian_Hyperinsulinism_Sample.var_report.xml									phs000539.v1.p1	Hyperinsulinism, Congenital
			2018/03/26				./data/phs000697.v1.pht007704.v1.p1.registration.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000486.v2.p3.simphen087.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004114.v2.p1.HPCA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			03/22/2017				./data/phs001181.v1.pht005769.v1.p1.CLL_Multiple_Cell_Clones_Subject.var_report.xml									phs001181.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			07/29/2013				./data/phs000505.v2.pht002973.v2.p1.Glioblastoma_Stem_Cell_Lines_Sample_Attributes.var_report.xml									phs000505.v2.p1	Glioblastoma
			2019/03/11				./data/phs000286.v6.pht001926.v2.p2.adra.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/08/01				./data/phs000222.v6.pht003453.v2.p2.wm_parc.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/03/11				./data/phs001964.v1.pht009961.v1.p1.WHS_Accelerometer_Smoking_Pub.var_report.xml									phs001964.v1.p1	Physical Activity
			2019/07/16				./data/phs001826.v1.pht009137.v1.p1.IHS_Depression_Subject.var_report.xml									phs001826.v1.p1	Depression
			2020/12/21				./data/phs000007.v32.pht005159.v4.p13.t_cttac_2005_m_0013s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
925.0	925.0		2020/12/18	2037.0		953.0	./data/phs002059.v1.pht010422.v1.p1.CIDR_CHD_Pedigree.var_report.xml	0.0	906.0	92.63	953.0			906.0		phs002059.v1.p1	Heart Defects, Congenital
			2021/08/11				./data/phs002056.v1.pht010451.v1.p1.CIDR_PC_AS_Sample.var_report.xml									phs002056.v1.p1	Prostatic Neoplasms
			01/19/2010				./data/phs000219.v1.pht001050.v1.p1.d_alzhist.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/01/16				./data/phs001386.v2.pht007155.v1.p1.Brotman_cross_VLY.var_report.xml									phs001386.v2.p1	Smoking
			04/29/2014				./data/phs000630.v1.pht003382.v1.p1.NIMH_Controls_Sample.var_report.xml									phs000630.v1.p1	Normalcy
			2019/05/01				./data/phs001753.v1.pht009016.v1.p1.Nama_Pigmentation_Subject.var_report.xml									phs001753.v1.p1	Skin Pigmentation
973.0	990.0		Mon Oct 27 17:24:36 2008	995.0		973.0	./data/phs000130.v1.pht000398.v1.p1.IBD_phenotype.var_report_2008_11_06.xml	0.0	981.5	9.899	990.0			981.5		phs000130.v1.p1	Crohn Disease
23.0			2020/05/27	42.0			./data/phs002034.v1.pht010255.v1.p1.Glioma_Grade_Subject_Phenotypes.var_report.xml	0.0			16.0					phs002034.v1.p1	Glioma
			08/20/2013				./data/phs000285.v3.pht001678.v2.p2.C1F38.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/02/19				./data/phs001649.v1.pht008515.v1.p1.CEDAR_Sample.var_report.xml									phs001649.v1.p1	Substance-Related Disorders
293.0			2021/06/01	363.0			./data/phs001189.v4.pht005979.v2.p1.TOPMed_WGS_CCAF_Subject_Phenotypes.var_report.xml	0.0			70.0					phs001189.v4.p1	Atrial Fibrillation
			2018/03/09				./data/phs000933.v2.pht004774.v2.p1.Melanoma_WES_Subject.var_report.xml									phs000933.v2.p1	Melanoma
			05/24/2017				./data/phs000574.v1.pht005855.v1.p1.adverse_event.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2020/03/09				./data/phs001491.v2.pht007255.v2.p1.CIDR_Tooth_Disorders_Sample_Attributes.var_report.xml									phs001491.v2.p1	Amelogenesis Imperfecta
			08/20/2013				./data/phs000285.v3.pht001560.v2.p2.A4F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/19/2015				./data/phs000885.v1.pht004603.v1.p1.HCC_CAGE_Profiling_ncRNAs_Subject.var_report.xml									phs000885.v1.p1	Carcinoma, Hepatocellular
			2020/09/18				./data/phs001182.v2.pht005723.v2.p1.Somatic_Mutation_Load_Clone_Cells_Sample_Attributes.var_report.xml									phs001182.v2.p1	Clonal Evolution
63.0	63.0		2021/09/14	99.0		57.0	./data/phs002121.v1.pht011548.v1.p1.Hematological_Transcriptomic_Subject.var_report.xml	0.0	60.0	7.778	57.0			60.0		phs002121.v1.p1	Myeloproliferative Neoplasms
	1.0		2018/03/27	1.0		1.0	./data/phs001566.v1.pht007709.v1.p1.MBC_NF1_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs001566.v1.p1	Neurofibromatosis 1
			2018/09/21				./data/phs001552.v1.pht008396.v1.p1.T2D_GENES_PROMIS_Sample_Attributes.var_report.xml									phs001552.v1.p1	Diabetes Mellitus, Type 2
			2019/03/11				./data/phs000286.v6.pht001965.v2.p2.paca.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
867.0			05/13/2011	4735.0			./data/phs000351.v1.pht002206.v1.p1.CGEMS_RenalCellCarcinoma_Data.var_report.xml	0.0			785.0					phs000351.v1.p1	Carcinoma, Renal Cell
			2017/09/18				./data/phs001310.v1.pht006864.v1.p1.GDMCC_5903_Subject.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
16.0	16.0		2018/07/18	25.0		9.0	./data/phs001645.v1.pht008211.v1.p1.Cutaneous_DLBCL_Subject_Phenotypes.var_report.xml	0.0	12.5	4.95	9.0			12.5		phs001645.v1.p1	Lymphoma, Large B-Cell, Diffuse
			05/24/2017				./data/phs000576.v1.pht006148.v1.p1.eligibility.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2020/03/19				./data/phs001979.v1.pht010000.v1.p1.Skin_SingleCell_Sample.var_report.xml									phs001979.v1.p1	Melanoma
			2020/02/04				./data/phs001723.v1.pht009725.v1.p1.IBDGC_Repo_EC_Subject.var_report.xml									phs001723.v1.p1	Inflammatory Bowel Disease
722.0	722.0		2019/12/16	728.0		678.0	./data/phs001932.v1.pht009656.v1.p1.MGS_European_Subject_Phenotypes.var_report.xml	0.0	700.0	8.485	69.0			700.0		phs001932.v1.p1	Schizophrenia
12.0	870.0		2018/01/04	882.0		864.0	./data/phs001503.v1.pht007314.v1.p1.WIHS_Pedigree.var_report.xml	0.0	864.0	606.7	870.0			864.0		phs001503.v1.p1	HIV
2.0			2018/03/06	4.0			./data/phs000603.v1.pht007549.v1.p1.familyhxandrelativeenrollment.var_report.xml	8.0			2.0					phs000603.v1.p1	Apparent mineralocorticoid excess
			02/23/2017				./data/phs001253.v1.pht006167.v1.p1.Efavirenz_CNS_Symptoms_Sample_Attributes.var_report.xml									phs001253.v1.p1	Central Nervous System Diseases
			2018/09/07				./data/phs001502.v1.pht007260.v1.p1.CCDG_UPenn_EOCAD_Subject_Phenotypes.var_report.xml									phs001502.v1.p1	Cardiovascular Diseases
			2021/05/28				./data/phs002259.v1.pht011025.v1.p1.CD4T_European_Subject_Phenotypes.var_report.xml									phs002259.v1.p1	RNA-Seq
			2018/02/08				./data/phs001488.v1.pht007429.v1.p1.uhdr5.var_report.xml									phs001488.v1.p1	Huntington Disease
			10/25/2012				./data/phs000445.v1.pht002505.v1.p1.HIV_Sample.var_report.xml									phs000445.v1.p1	HIV
			07/21/2010				./data/phs000239.v2.pht001223.v2.p1.MS_MZTwins_Sample_Attributes.var_report_2010_07_21.xml									phs000239.v2.p1	Multiple Sclerosis
			2018/08/18				./data/phs001049.v1.pht005227.v1.p1.Relapsed_SCLC_Subject.var_report.xml									phs001049.v1.p1	Small Cell Lung Carcinoma
			02/18/2016				./data/phs000932.v1.pht004888.v1.p1.COLO_Sample_Attributes.var_report.xml									phs000932.v1.p1	Melanoma
			06/12/2017				./data/phs000594.v1.pht006492.v1.p1.adverse_event.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2020/02/06				./data/phs001935.v1.pht009768.v1.p1.GAPPS_Sample.var_report.xml									phs001935.v1.p1	Stomach Neoplasms
			11/27/2009				./data/phs000016.v2.pht000052.v2.p2.PACS.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			2020/12/21				./data/phs000007.v32.pht005162.v3.p13.t_ctthrmvc_2011_m_0684s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008773.v1.p2.nbhdstores.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
821.0	821.0		01/15/2016	987.0		653.0	./data/phs000806.v1.pht004772.v1.p1.MIGen_Ottawa_Heart_Subject_Phenotypes.var_report.xml	0.0	984.0	468.1	653.0			984.0		phs000806.v1.p1	
			02/09/2017				./data/phs001082.v1.pht005382.v1.p1.VZV_TCell_Sample_Attributes.var_report.xml									phs001082.v1.p1	Herpes Zoster
632.0	971.0		2021/03/05	3296.0		632.0	./data/phs001388.v2.pht006878.v2.p1.SIGMA_DMS_Subject_Phenotypes.var_report.xml	0.0	863.0	591.1	971.0			863.0		phs001388.v2.p1	Diabetes Mellitus, Type 2
			11/05/2014				./data/phs000209.v13.pht003378.v1.p3.MESA_AncilMesaRenalFunction.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/09/18				./data/phs001737.v2.pht008560.v2.p1.EEC_Syndrome_Sample.var_report.xml									phs001737.v2.p1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
			2019/12/06				./data/phs000159.v9.pht000817.v6.p5.AML_Subject_Phenotypes.var_report.xml									phs000159.v9.p5	Leukemia, Myeloid, Acute
			08/12/2016				./data/phs000888.v1.pht005557.v1.p1.06aAsthma_hx_asthma_exacerbation.var_report.xml									phs000888.v1.p1	
			04/20/2016				./data/phs000914.v1.pht005251.v1.p1.Samoans_Adiposity_Subject.var_report.xml									phs000914.v1.p1	Obesity
			11/04/2014				./data/phs000086.v3.pht000347.v1.p1.EDIC_f0924.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht004146.v2.p1.PHXB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/03/30				./data/phs001108.v1.pht007717.v1.p1.registration.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
5233.0	5558.0		05/06/2016	5571.0		5233.0	./data/phs000911.v1.pht004978.v1.p1.T1DGC_ImmunoChip_Subject_Phenotypes_ASP.var_report.xml	0.0	5396.0	345.1	5558.0			5396.0		phs000911.v1.p1	Diabetes Mellitus, Type 1
			10/22/2013				./data/phs000664.v1.pht003542.v1.p1.Genomic_Variations_Multi_Ethnic_Malaysia_Subject.var_report.xml									phs000664.v1.p1	Population Groups
			2020/12/21				./data/phs000007.v32.pht000606.v5.p13.t_mrcdefat_2005_1b_0906s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000453.v2.p3.simphen054.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/02/03				./data/phs000815.v2.pht009851.v1.p1.R01CA208756_Sample_Attributes.var_report.xml									phs000815.v2.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000524.v2.p3.simphen125.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			04/24/2012				./data/phs000491.v1.pht002700.v1.p1.Renal_Cell_Carcinoma_Sample_Attributes.var_report.xml									phs000491.v1.p1	Carcinoma, Renal Cell
			2019/03/11				./data/phs000286.v6.pht001972.v2.p2.rhxacodes.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/06/27				./data/phs001006.v1.pht006004.v1.p1.Lobular_Carcinomas_Sample_Attributes.var_report.xml									phs001006.v1.p1	Carcinoma, Lobular
			2020/06/02				./data/phs001841.v1.pht009906.v1.p1.CADD_GADD_Sample.var_report.xml									phs001841.v1.p1	Opioid-Related Disorders
			2018/04/16				./data/phs001326.v1.pht007816.v1.p1.pidtc_18010_day100chi.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			04/10/2014				./data/phs000340.v3.pht002207.v2.p1.ETP_T_ALL_Subject.var_report.xml									phs000340.v3.p1	Leukemia, T-cell
19.0			04/15/2014	35.0			./data/phs000508.v2.pht002811.v1.p1.Pediatric_Rhabdoid_Cancers_Subject_Phenotypes.var_report.xml	0.0			16.0					phs000508.v2.p1	Rhabdoid Tumor
2720.0	2747.0		2021/06/10	5467.0		2720.0	./data/phs001387.v3.pht008968.v2.p1.TOPMed_WGS_THRV_Pedigree.var_report.xml	0.0	2734.0	26.16	2747.0			2734.0		phs001387.v3.p1	Blood Pressure
			2020/06/18				./data/phs000280.v7.pht004032.v2.p1.ANTA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/26/2013				./data/phs000553.v1.pht003133.v1.p1.Rare_Pediatric_Phenotypes_Sample.var_report.xml									phs000553.v1.p1	Mendelian
			12/11/2009				./data/phs000171.v1.pht000756.v1.p1.MS_DATA_FAMSGEN.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			06/14/2017				./data/phs001297.v1.pht006200.v1.p1.PROP_LymphocyticMarkers_Sample.var_report.xml									phs001297.v1.p1	Premature Infant
			03/07/2016				./data/phs000961.v1.pht005330.v1.p1.eMERGE_III_Columbia_GENIE_Subject.var_report.xml									phs000961.v1.p1	
			11/08/2013				./data/phs000200.v9.pht001004.v4.p3.f35_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/20/2013				./data/phs000285.v3.pht001827.v2.p2.F1F55.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001489.v1.p1.YR4.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000433.v2.p3.simphen034.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
692.0	1360.0		2018/06/30	2052.0		692.0	./data/phs001620.v1.pht008181.v1.p1.GUARDD_AA_Subject_Phenotypes.var_report.xml	0.0	1026.0	472.3	1360.0			1026.0		phs001620.v1.p1	Apolipoprotein L1
			2018/02/08				./data/phs001488.v1.pht007374.v1.p1.CREST_E_HD_Subject.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/06/03				./data/phs001292.v2.pht007854.v2.p1.registration.var_report.xml									phs001292.v2.p1	Angelman Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000491.v2.p3.simphen092.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			09/26/2013				./data/phs000519.v1.pht003246.v1.p1.MelanomaRisk_Subject.var_report.xml									phs000519.v1.p1	Melanoma
			03/02/2016				./data/phs000267.v5.pht002302.v2.p2.Autism_Genome_Project_Subject.var_report.xml									phs000267.v5.p2	Autistic Disorder
			2019/03/11				./data/phs000286.v6.pht001922.v2.p2.abda.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
19.0	19.0		2017/08/17	19.0		19.0	./data/phs001399.v1.pht006682.v1.p1.Neoadjuvant_Adjuvant_Therapies_Subject_Phenotypes.var_report.xml	0.0	19.0					19.0		phs001399.v1.p1	Prostatic Neoplasms
737.0	2365.0		2021/06/08	3985.0		1620.0	./data/phs001218.v3.pht007766.v1.p1.TOPMed_WGS_GeneSTAR_Subject_Phenotypes.var_report.xml	0.0	1993.0	526.8	1050.0			1993.0		phs001218.v3.p1	Platelet Aggregation
			2018/12/14				./data/phs001439.v1.pht006816.v1.p1.POP_Subject_Phenotypes.var_report.xml									phs001439.v1.p1	Pelvic Organ Prolapse
			2018/02/08				./data/phs001488.v1.pht007377.v1.p1.blind.var_report.xml									phs001488.v1.p1	Huntington Disease
6.0	6.0		11/07/2014	8.0		2.0	./data/phs000809.v1.pht004346.v1.p1.Glycosylation_Congenital_Disorder_Pedigree.var_report.xml	0.0	4.0	2.828	2.0			4.0		phs000809.v1.p1	Congenital Disorders of Glycosylation
			2019/12/16				./data/phs001932.v1.pht009655.v1.p1.MGS_European_Sample.var_report.xml									phs001932.v1.p1	Schizophrenia
161.0	161.0		2018/03/20	190.0		29.0	./data/phs001559.v1.pht007663.v1.p1.Oxycodone_Abuse_Subject_Phenotypes.var_report.xml	0.0	95.0	93.34	29.0			95.0		phs001559.v1.p1	Heroin Dependence
			12/11/2009				./data/phs000171.v1.pht000785.v1.p1.MS_DATA_RELAPSE.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
2691.0	2937.0		11/05/2014	5628.0		2691.0	./data/phs000209.v13.pht001119.v8.p3.MESA_Exam3Main.var_report.xml	99.0	2814.0	36.77	2937.0			2814.0		phs000209.v13.p3	Cardiovascular Diseases
345.0	345.0		2019/06/03	622.0		277.0	./data/phs000624.v1.pht009131.v1.p1.LGRC_Subject_Phenotypes.var_report.xml	0.0	311.0	48.08	277.0			311.0		phs000624.v1.p1	Pulmonary Disease, Chronic Obstructive
			11/07/2014				./data/phs000809.v1.pht004349.v1.p1.Glycosylation_Congenital_Disorder_Sample_Attributes.var_report.xml									phs000809.v1.p1	Congenital Disorders of Glycosylation
			2020/02/06				./data/phs001430.v2.pht009849.v1.p1.p7001_16343_cerebrosp.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			05/24/2016				./data/phs001065.v1.pht005398.v1.p1.autopsy.var_report.xml									phs001065.v1.p1	Huntington Disease
			2018/09/14				./data/phs001078.v1.pht005724.v1.p1.GECCO_Subject.var_report.xml									phs001078.v1.p1	Colorectal Neoplasms
			2018/07/09				./data/phs001650.v1.pht008204.v1.p1.LCL_Expansions_Sample.var_report.xml									phs001650.v1.p1	Control Groups
8.0	28.0		2020/02/27	50.0		8.0	./data/phs001774.v1.pht008805.v1.p1.AVSD_Subject_Phenotypes.var_report.xml	0.0	25.0	4.95	28.0			25.0		phs001774.v1.p1	Complete atrioventricular septal defect
			08/29/2016				./data/phs001199.v1.pht005705.v1.p1.TIGER_LC_OncoVar_Sample.var_report.xml									phs001199.v1.p1	Carcinoma, Hepatocellular
			2019/12/12				./data/phs001930.v1.pht009671.v1.p1.Vit_E_NAFLD_Sample_Attributes.var_report.xml									phs001930.v1.p1	Non-alcoholic Fatty Liver Disease
			05/13/2015				./data/phs000769.v1.pht004003.v1.p1.LHMP_Subject.var_report.xml									phs000769.v1.p1	HIV
			11/04/2014				./data/phs000086.v3.pht000244.v1.p1.DCCT_f0882.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht003098.v6.p13.vr_meds_2011_m_0675s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000009.v2.p13.ex0_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000231.v1.p1.DCCT_ms5exprt.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht004144.v2.p1.PHEB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/04/2013				./data/phs000581.v1.pht003203.v1.p1.ESP_Dilated_Cardiomyopathy_Subject.var_report.xml									phs000581.v1.p1	Cardiomyopathy, Dilated
			2018/11/05				./data/phs000507.v2.pht002929.v2.p2.BEN_Subject_Phenotypes.var_report.xml									phs000507.v2.p2	Neutropenia
			06/13/2014				./data/phs000625.v1.pht003853.v1.p1.Cleft_Lip_Palate_Sample.var_report.xml									phs000625.v1.p1	Orofacial Cleft, Nonsyndromic
			2019/06/14				./data/phs000589.v1.pht009180.v1.p1.angiogram_rightupperextremity.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/12/15				./data/phs001473.v1.pht009690.v1.p1.Ibrutinib_CLL_Sample_Attributes.var_report.xml									phs001473.v1.p1	Leukemia, Lymphoid
35.0			2019/09/27	52.0			./data/phs001576.v2.pht008218.v2.p2.P6705_DEMOGRAPHICS.var_report.xml	0.0			17.0					phs001576.v2.p2	Mucopolysaccharidoses
			11/08/2013				./data/phs000200.v9.pht000991.v4.p3.f144_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/04/19				./data/phs002394.v1.pht011134.v1.p1.PDAC_GEO.var_report.xml									phs002394.v1.p1	pancreatic cancer
			2020/03/09				./data/phs001266.v2.pht007222.v2.p1.Addiction_Susceptibility_Genes_Sample.var_report.xml									phs001266.v2.p1	Opioid-Related Disorders
			11/05/2014				./data/phs000209.v13.pht001114.v2.p3.MESA_AncilMesaLungSpirometry.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/01/26				./data/phs001451.v3.pht007134.v3.p1.Melanoma_Neoantigen_Vaccine_Sample_Attributes.var_report.xml									phs001451.v3.p1	Melanoma
			2017/09/27				./data/phs000747.v2.pht003844.v2.p1.IBBE_Sporadic_ALS_Sample.var_report.xml									phs000747.v2.p1	Amyotrophic Lateral Sclerosis
			2018/02/08				./data/phs001488.v1.pht007416.v1.p1.pregnanc.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/02/14				./data/phs000575.v2.pht005899.v2.p1.physicalexam.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			2021/03/09				./data/phs002348.v1.pht011050.v1.p1.MSH_Subject.var_report.xml									phs002348.v1.p1	Sickle Cell Disease
			2017/10/19				./data/phs001288.v1.pht006770.v1.p1.hxandphysical.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2020/12/21				./data/phs000007.v32.pht004814.v1.p13.e_exam_ex02_7_0003s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/08/25				./data/phs001321.v1.pht006198.v1.p1.OncoArray_CIMBA_Sample_Attributes.var_report.xml									phs001321.v1.p1	Breast Neoplasms
			04/22/2009				./data/phs000167.v1.pht000717.v1.p1.nonGAIN_Schizophrenia_Subject.var_report_2009_04_22.xml									phs000167.v1.p1	Schizophrenia
			02/24/2012				./data/phs000001.v3.pht000374.v2.p1.followup.var_report.xml									phs000001.v3.p1	Cataract
			01/26/2015				./data/phs000856.v1.pht004457.v1.p1.Chromothripsis_WHIM_Subject.var_report.xml									phs000856.v1.p1	WHIM syndrome
			03/04/2011				./data/phs000264.v2.pht001421.v1.p1.HMP_Virome_Febrile_Sample_Attributes.var_report.xml									phs000264.v2.p1	Virus Diseases
			2018/06/07				./data/phs001479.v1.pht008104.v1.p1.STAT5B_Sample_Attributes.var_report.xml									phs001479.v1.p1	Lymphadenopathy
			2018/03/20				./data/phs000605.v1.pht007631.v1.p1.dyspnea_qol_fatigue_vas_scale.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/12/21				./data/phs000007.v32.pht000094.v3.p13.icd0_19s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/15/2017				./data/phs001376.v1.pht006553.v1.p1.CD55_Deficiency_Sample.var_report.xml									phs001376.v1.p1	Protein-Losing Enteropathies
			2019/08/01				./data/phs000222.v6.pht009347.v1.p2.Functional_C.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004162.v2.p1.RPAB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/14				./data/phs001238.v2.pht006662.v1.p1.GENOA_EuropeanAmerican_Phase2_Medications.var_report.xml									phs001238.v2.p1	Hypertension
			04/24/2014				./data/phs000709.v1.pht003814.v1.p1.Fibrolamellar_Hepatocellular_Carcinoma_Sample_Attributes.var_report.xml									phs000709.v1.p1	Fibrolamellar hepatocellular carcinoma
			12/13/2011				./data/phs000404.v1.pht002365.v1.p1.GENEVA_Smoking_Cessation_Subject.var_report.xml									phs000404.v1.p1	Smoking Cessation
			02/03/2012				./data/phs000419.v1.pht002496.v1.p1.Melanoma_SubjectDS_Subject.var_report.xml									phs000419.v1.p1	Melanoma
			08/20/2013				./data/phs000285.v3.pht001805.v2.p2.E1RENALD.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/05/07				./data/phs000956.v5.pht005001.v3.p1.TOPMed_WGS_Amish_Sample.var_report.xml									phs000956.v5.p1	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001046.v1.p1.GenADA_Subject.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
1.0			2019/05/07	5.0			./data/phs001329.v2.pht007179.v2.p1.demographics.var_report.xml	0.0			4.0					phs001329.v2.p1	Mucolipidosis IV
			2017/10/24				./data/phs001352.v1.pht007066.v1.p1.Travelers_Diarrhea_Subject_Phenotypes.var_report.xml									phs001352.v1.p1	Diarrhea
			2021/02/12				./data/phs002334.v1.pht010959.v1.p1.EGFR_Driven_LUAD_Subject_Phenotypes.var_report.xml									phs002334.v1.p1	Adenocarcinoma, Lung
			2021/02/17				./data/phs001287.v9.pht006104.v9.p5.CPTAC_3_Subject.var_report.xml									phs001287.v9.p5	Neoplasms
			03/26/2015				./data/phs000766.v1.pht003938.v1.p1.GEI_Psoriasis_Subject.var_report.xml									phs000766.v1.p1	Psoriasis
			2020/01/10				./data/phs001471.v1.pht009806.v1.p1.Subject_Phenotypes_TIME5.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			04/13/2015				./data/phs000874.v1.pht004655.v1.p1.GERFHS_Sample.var_report.xml									phs000874.v1.p1	Intracerebral Hemorrhage
			2018/12/27				./data/phs000756.v1.pht007372.v1.p1.FINRISK_Sample.var_report.xml									phs000756.v1.p1	
			2017/09/18				./data/phs001310.v1.pht006869.v1.p1.lab_form.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
17.0	17.0		2019/10/23	29.0		12.0	./data/phs001176.v3.pht005797.v2.p1.GxE_Complex_Traits_Subject_Phenotypes.var_report.xml	0.0	14.5	3.536	12.0			14.5		phs001176.v3.p1	Gene-Environment Interaction
13.0	9.0		08/26/2013	30.0		3.0	./data/phs000362.v1.pht003228.v1.p1.ESP_FamilialAtrialFibrillation_Pedigree.var_report.xml	0.0	6.0	7.071	2.0			6.0		phs000362.v1.p1	Atrial Fibrillation
			2018/04/05				./data/phs001522.v1.pht007731.v1.p1.cDNMs_Subject_Phenotypes.var_report.xml									phs001522.v1.p1	
			2020/02/19				./data/phs001221.v1.pht007159.v1.p1.Prostate_Cancer_GWAS_Sample.var_report.xml									phs001221.v1.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht000145.v5.p13.ct1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/12/29				./data/phs000774.v2.pht004703.v1.p1.CCDG_OFCs_Sample_Attributes.var_report.xml									phs000774.v2.p1	Cleft Lip
			11/05/2014				./data/phs000209.v13.pht003606.v1.p3.MESA_AncilMesaNeighborFoodExam2.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008742.v1.p2.cenc.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/09/21				./data/phs002493.v1.pht011464.v1.p1.Neurogenesis_eQTL_sQTL_Sample_Attributes.var_report.xml									phs002493.v1.p1	RNA-seq
			07/21/2015				./data/phs000938.v1.pht004786.v1.p1.WES_HybCapture_vs_Amplicon_Sample_Attributes.var_report.xml									phs000938.v1.p1	
			06/22/2016				./data/phs001146.v1.pht005543.v1.p1.Endometrial_Cells_eQTL_Subject.var_report.xml									phs001146.v1.p1	Fertility
			08/20/2013				./data/phs000285.v3.pht001813.v2.p2.F1F09BCP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/11/22				./data/phs000999.v3.pht005183.v3.p1.CSER_ClinSeq_Cancer_Sample_Attributes.var_report.xml									phs000999.v3.p1	Colorectal Neoplasms
			05/24/2016				./data/phs001065.v1.pht005403.v1.p1.coq10.var_report.xml									phs001065.v1.p1	Huntington Disease
			2017/11/06				./data/phs001441.v1.pht007113.v1.p1.SAB_AA_Sample.var_report.xml									phs001441.v1.p1	Staphylococcus aureus
170.0			2020/02/14	646.0			./data/phs000575.v2.pht005891.v2.p1.dexa.var_report.xml	8.0			208.0					phs000575.v2.p1	Prader-Willi Syndrome
			2017/10/19				./data/phs001463.v1.pht007057.v1.p1.Differential_Transcription_Brain_Sample.var_report.xml									phs001463.v1.p1	Brain
681.0	681.0		2019/12/16	788.0		87.0	./data/phs000959.v1.pht009702.v1.p1.SCZ_Xhosa_Subject_Phenotypes.var_report.xml	0.0	768.5	812.5	87.0			768.5		phs000959.v1.p1	Schizophrenia
			2019/06/24				./data/phs001795.v1.pht008951.v1.p1.CM1_Sample.var_report.xml									phs001795.v1.p1	Arnold-Chiari Malformation
			08/20/2013				./data/phs000285.v3.pht001579.v2.p2.A4F16.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/10/2010				./data/phs000305.v1.pht001916.v1.p1.NSABP_Subject.var_report_2010_11_10.xml									phs000305.v1.p1	Breast Neoplasms
			2018/05/03				./data/phs001264.v1.pht007902.v1.p1.CD47_Breast_Cancer_Sample_Attributes.var_report.xml									phs001264.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht006013.v4.p13.l_proapt2_ex05_1_1113s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/28/2016				./data/phs001095.v1.pht005619.v1.p1.T2D_GENES_Ashkenazi_Sample.var_report.xml									phs001095.v1.p1	Diabetes Mellitus, Type 2
			2019/03/11				./data/phs000286.v6.pht008744.v1.p2.choa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/05/05				./data/phs001360.v1.pht006293.v1.p1.CLEAR_Subject.var_report.xml									phs001360.v1.p1	Arthritis, Rheumatoid
			08/20/2014				./data/phs000777.v1.pht003971.v1.p1.FSGS_CKD_Subject.var_report.xml									phs000777.v1.p1	Glomerulosclerosis, Focal Segmental
			08/15/2012				./data/phs000479.v1.pht002887.v1.p1.SCID_Exome_GEO.var_report.xml									phs000479.v1.p1	Severe Combined Immunodeficiency
			2020/12/21				./data/phs000007.v32.pht000029.v3.p13.ex0_27s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000182.v15.p13.Framingham_Subject.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/24/2016				./data/phs001159.v1.pht005596.v1.p1.Lung_Adenocarcinoma_Tumor_Heterogeneity_Subject.var_report.xml									phs001159.v1.p1	Adenocarcinoma of lung
116.0			05/24/2017	244.0			./data/phs000576.v1.pht006152.v1.p1.initialevaluation.var_report.xml	0.0			128.0					phs000576.v1.p1	Angelman Syndrome
543.0			2019/08/30	905.0			./data/phs001331.v2.pht006924.v2.p1.demographics.var_report.xml	0.0			362.0					phs001331.v2.p1	Graft vs Host Disease
			03/21/2014				./data/phs000583.v1.pht003292.v1.p1.Type2Diabetes_AsianIndians_Subject.var_report.xml									phs000583.v1.p1	Metabolic Syndrome X
			2017/09/18				./data/phs001310.v1.pht006875.v1.p1.wisconsin_cough_score.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			2021/03/24				./data/phs000711.v7.pht003720.v6.p2.BH_CMG_Subject.var_report.xml									phs000711.v7.p2	Mendelian Conditions
59.0	59.0		04/22/2009	55.0		9.0	./data/phs000167.v1.pht000718.v1.p1.nonGAIN_Schizophrenia_Pedigree.var_report_2009_04_22.xml	0.0	9.5	6.364	9.0			9.5		phs000167.v1.p1	Schizophrenia
			09/19/2011				./data/phs000389.v1.pht002379.v1.p1.GoKinD_GENIE_Phenotype.var_report.xml									phs000389.v1.p1	Diabetes Mellitus, Type 1
5653.0	6272.0		2017/12/29	11925.0		5653.0	./data/phs000774.v2.pht004702.v2.p1.CCDG_OFCs_Subject_Phenotypes.var_report.xml	0.0	5963.0	437.7	6272.0			5963.0		phs000774.v2.p1	Cleft Lip
			2020/12/21				./data/phs000007.v32.pht006011.v1.p13.l_fhslab_ex03_7_0267s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/16				./data/phs001960.v1.pht009822.v1.p1.Osteoporosis_Risk_Subject.var_report.xml									phs001960.v1.p1	Osteoporosis
			2018/04/16				./data/phs001326.v1.pht007823.v1.p1.pidtc_17560_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			11/08/2013				./data/phs000200.v9.pht002748.v2.p3.f150_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/02/01				./data/phs001770.v1.pht008687.v1.p1.registration.var_report.xml									phs001770.v1.p1	Dent Disease
			03/17/2017				./data/phs001121.v1.pht005711.v1.p1.Rare_Cancers_Sample_Attributes.var_report.xml									phs001121.v1.p1	Sarcoma
			2018/04/20				./data/phs001572.v1.pht007842.v1.p1.PD_1_Immunotherapy_Sample_Attributes.var_report.xml									phs001572.v1.p1	Neoplasms
			2021/03/09				./data/phs001374.v2.pht008335.v2.p1.APOLLO_RePOP_Sample.var_report.xml									phs001374.v2.p1	Neoplasms
			2018/12/10				./data/phs001621.v1.pht008155.v1.p1.Platinum_Study_Sample_Attributes.var_report.xml									phs001621.v1.p1	
			2017/11/01				./data/phs000833.v7.pht004359.v7.p1.SCAPT_allCenters_Sample.var_report.xml									phs000833.v7.p1	
			2018/05/17				./data/phs001596.v1.pht007964.v1.p1.Acral_Melanoma_Subject.var_report.xml									phs001596.v1.p1	Melanoma
			2019/11/12				./data/phs001575.v2.pht008208.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2020/11/04				./data/phs002062.v1.pht010640.v1.p1.BC_TDLUs_Sample_Attributes.var_report.xml									phs002062.v1.p1	Breast Neoplasms
			2021/01/28				./data/phs002289.v1.pht010894.v1.p1.YSPORE_SC2_Sample_Attributes.var_report.xml									phs002289.v1.p1	single-cell analysis
			08/20/2013				./data/phs000285.v3.pht001759.v2.p2.E1F05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht002098.v2.p3.MESA_AncilMesaCotinine.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
7.0	8.0		11/16/2012	15.0		7.0	./data/phs000413.v2.pht003037.v1.p1.AML_FABM7_Subject_Phenotypes.var_report.xml	0.0	7.5	0.7071	8.0			7.5		phs000413.v2.p1	Acute Megakaryoblastic Leukemia
			2020/12/21				./data/phs000007.v32.pht005389.v4.p13.l_fructo_2005_m_0383s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000275.v1.p1.DCCT_diethist.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/05/15				./data/phs001311.v1.pht007924.v1.p1.physical_and_myotonia_exam.var_report.xml									phs001311.v1.p1	Myotonia
			10/16/2012				./data/phs000443.v1.pht002530.v1.p1.Prostate_Cancer_PCAT1_Subject.var_report.xml									phs000443.v1.p1	Prostatic Neoplasms
			08/12/2016				./data/phs000888.v1.pht005553.v1.p1.02aADHD_hx_meds.var_report.xml									phs000888.v1.p1	
			Tue Nov 18 09:14:40 2008				./data/phs000088.v1.pht000713.v1.p1.GOKIND_NIDDK_Sample.var_report_2008_11_20.xml									phs000088.v1.p1	Diabetic Nephropathies
25.0			06/15/2017	39.0			./data/phs001229.v1.pht006549.v1.p1.Follicular_Lymphoma_Seq_Subject_Phenotypes.var_report.xml	0.0			14.0					phs001229.v1.p1	Lymphoma, Follicular
			03/03/2011				./data/phs000259.v2.pht001244.v2.p1.HMP_Urethral_Males_Sample.var_report.xml									phs000259.v2.p1	Urethritis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000544.v2.p3.simphen145.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
9.0	9.0		2021/07/16	56.0		7.0	./data/phs001604.v2.pht009985.v1.p1.TOPMed_WGS_ChildrensHS_MetaAir_Subject_Phenotypes.var_report.xml	0.0	8.0	1.414	7.0			8.0		phs001604.v2.p1	Asthma
	624.0		2020/11/27	624.0		624.0	./data/phs002060.v1.pht010591.v1.p1.CALGB_40502_Subject_Phenotypes.var_report.xml	0.0	624.0		624.0			624.0		phs002060.v1.p1	Peripheral Nervous System Diseases
			2020/07/21				./data/phs001011.v2.pht005529.v1.p1.eMERGE_CCHMC_IIIA_Subject.var_report.xml									phs001011.v2.p1	
			2020/04/14				./data/phs001570.v2.pht007869.v2.p1.CALGB_40601_Subject_Phenotypes.var_report.xml									phs001570.v2.p1	Neoplasms
			2019/03/11				./data/phs000286.v6.pht008764.v1.p2.mhxb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001649.v2.p2.C1BIOIMP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/04/20				./data/phs001572.v1.pht007839.v1.p1.PD_1_Immunotherapy_Subject.var_report.xml									phs001572.v1.p1	Neoplasms
9.0	9.0		10/25/2013	10.0		1.0	./data/phs000671.v1.pht003548.v1.p1.Hairy_Cell_Leukemia_Subject_Phenotypes.var_report.xml	0.0	5.0	5.657	1.0			5.0		phs000671.v1.p1	Leukemia, Hairy Cell
			06/29/2015				./data/phs000838.v1.pht004797.v1.p1.Ghana_Prostate_Study_Sample.var_report.xml									phs000838.v1.p1	Prostatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001729.v2.p2.D1F9MHBA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			09/30/2016				./data/phs001015.v1.pht005777.v1.p1.Chronic_Fatigue_Syndrome_Subject.var_report.xml									phs001015.v1.p1	Fatigue Syndrome, Chronic
			2018/09/19				./data/phs001684.v1.pht008392.v1.p1.Pulmonary_Fluid_Immunocompromised_Sample_Attributes.var_report.xml									phs001684.v1.p1	Immunocompromised Host
			04/04/2012				./data/phs000433.v1.pht002437.v1.p1.SIGNET_Sample_Attributes.var_report.xml									phs000433.v1.p1	Type 2 Diabetes Mellitus
			2020/02/06				./data/phs001430.v2.pht008067.v2.p1.p7001_18442_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2018/10/15				./data/phs001106.v1.pht008459.v1.p1.Genomics_HCC_Subject_Phenotypes.var_report.xml									phs001106.v1.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000414.v2.p3.simphen015.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
932.0			06/29/2015	932.0			./data/phs000838.v1.pht004798.v1.p1.Ghana_Prostate_Study_Subject_Phenotypes.var_report.xml	0.0								phs000838.v1.p1	Prostatic Neoplasms
			2019/05/31				./data/phs001296.v2.pht006360.v2.p1.p5107_13422_pregnancy.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			11/04/2014				./data/phs000086.v3.pht000267.v1.p1.DCCT_f049cmb2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
2.0	2.0		2019/03/15	2.0		2.0	./data/phs001791.v1.pht008854.v1.p1.Brain_Cell_Types_Subject_Phenotypes.var_report.xml	0.0	2.0					2.0		phs001791.v1.p1	Cerebral Cortex
			11/04/2014				./data/phs000086.v3.pht000346.v1.p1.EDIC_f0923.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/04/04				./data/phs001527.v1.pht007520.v1.p1.Oral_Microbiome_EAC_Sample_Attributes.var_report.xml									phs001527.v1.p1	Esophageal Neoplasms
			04/16/2012				./data/phs000485.v1.pht002677.v1.p1.Congenital_Diaphragmatic_Hernia_Subject.var_report.xml									phs000485.v1.p1	Congenital diaphragmatic hernia
			2018/04/20				./data/phs001556.v1.pht007846.v1.p1.BRAINcode_Sample_Attributes.var_report.xml									phs001556.v1.p1	Parkinson Disease
			2020/09/18				./data/phs002015.v1.pht010384.v1.p1.AREDS2_HDA.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/05/31				./data/phs001318.v1.pht008016.v1.p1.BMF_5405_Subject.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
1691.0	1691.0		05/16/2017	2746.0		1055.0	./data/phs001252.v1.pht006372.v1.p1.blcovars.var_report.xml	0.0	1373.0	449.7	1055.0			1373.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/12/21				./data/phs000007.v32.pht000085.v8.p13.fib1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001557.v2.p2.A4CHEM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001470.v1.p1.MRI2RECS.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht008054.v2.p1.ohsu_lab_results.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
6666.0	6737.0		2020/07/06	13403.0		6666.0	./data/phs001955.v1.pht009794.v1.p1.REDS_III_RBCOmics_Subject_Phenotypes.var_report.xml	0.0	6702.0	50.2	6737.0			6702.0		phs001955.v1.p1	
69.0	69.0		06/30/2014	54.0		58.0	./data/phs000757.v1.pht003921.v1.p1.Hereditary_Ataxias_Pedigree.var_report.xml	0.0	63.5	9.192	58.0			63.5		phs000757.v1.p1	Ataxia
350.0	350.0		12/07/2015	617.0		56.0	./data/phs000482.v1.pht002882.v1.p1.Sporadic_Autism_Pedigree.var_report.xml	0.0	94.5	58.69	56.0			94.5		phs000482.v1.p1	Autistic Disorder
			2021/01/08				./data/phs000649.v2.pht003759.v2.p2.PEAR_Sample.var_report.xml									phs000649.v2.p2	Hypertension
			11/08/2013				./data/phs000200.v9.pht001003.v4.p3.f34_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			03/12/2013				./data/phs000343.v3.pht002721.v1.p1.fdsadd.var_report.xml									phs000343.v3.p1	Stroke
92.0	99.0		08/08/2011	50.0		92.0	./data/phs000353.v1.pht002256.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_115.var_report.xml	0.0	95.5	4.95	99.0			95.5		phs000353.v1.p1	Premature Birth
			2019/08/10				./data/phs001657.v1.pht009393.v1.p1.AML_Sample_Attributes.var_report.xml									phs001657.v1.p1	Leukemia, Myeloid, Acute
			2018/06/01				./data/phs001317.v1.pht008040.v1.p1.GSD_5610_Subject.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
2077.0	2077.0		03/10/2016	3797.0		1720.0	./data/phs000952.v1.pht005318.v1.p1.Substance_Dependence_EA_AA_Pedigree.var_report.xml	0.0	1899.0	252.4	1720.0			1899.0		phs000952.v1.p1	Substance-Related Disorders
			2018/04/12				./data/phs001411.v1.pht007724.v1.p1.ACCORD_Subject.var_report.xml									phs001411.v1.p1	Diabetes Mellitus, Type 2
			01/19/2010				./data/phs000219.v1.pht001077.v1.p1.d_depression_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			04/10/2015				./data/phs000900.v1.pht004653.v1.p1.DIPG_Sample_Attributes.var_report.xml									phs000900.v1.p1	Glioma
			07/08/2011				./data/phs000273.v1.pht001434.v1.p1.LINE1_Retrotransposon_Sample.var_report.xml									phs000273.v1.p1	Normalcy
			2019/06/24				./data/phs001795.v1.pht008953.v1.p1.CM1_Sample_Attributes.var_report.xml									phs001795.v1.p1	Arnold-Chiari Malformation
			2019/03/11				./data/phs001757.v1.pht008667.v1.p1.Odorant_Receptors_Subject.var_report.xml									phs001757.v1.p1	Smell
			2020/02/06				./data/phs001430.v2.pht008074.v2.p1.vineland_adaptive_behaviorscale.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			10/14/2015				./data/phs000903.v1.pht004871.v1.p1.OCD_OCGAS_Sample.var_report.xml									phs000903.v1.p1	Obsessive-Compulsive Disorder
			2020/06/18				./data/phs000280.v7.pht004109.v2.p1.HMTCV301.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
4037.0	4037.0		2021/09/29	7093.0		3056.0	./data/phs002506.v1.pht011537.v1.p1.Drug_Outcome_SNVs_Subject.var_report.xml	0.0	3547.0	693.7	3056.0			3547.0		phs002506.v1.p1	Pharmacology
1.0	199.0		2019/09/27	200.0		1.0	./data/phs001709.v1.pht009494.v1.p1.CMI_MBC_Subject_Phenotypes.var_report.xml	0.0	100.0	140	199.0			100.0		phs001709.v1.p1	Breast Neoplasms
			10/13/2009				./data/phs000210.v1.pht000901.v1.p1.MA27_Sample.var_report_2009_10_13.xml									phs000210.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht006458.v1.p1.NPI.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/27/2014				./data/phs000674.v1.pht003636.v1.p1.GERA_Subject.var_report.xml									phs000674.v1.p1	Aging
			06/01/2017				./data/phs000701.v1.pht005505.v1.p1.ARP_5204_Angelman_Syndrome_Subject.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			03/12/2013				./data/phs000343.v3.pht003160.v1.p1.vit.var_report.xml									phs000343.v3.p1	Stroke
			07/15/2013				./data/phs000608.v1.pht003345.v1.p1.Schizophrenia_Methylation_Sample_Attributes.var_report.xml									phs000608.v1.p1	Schizophrenia
			08/20/2013				./data/phs000285.v3.pht001766.v2.p2.E1F09MAP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
9.0	9.0		11/18/2016	17.0		8.0	./data/phs001224.v1.pht005941.v1.p1.Platinum_Genomes_Subject_Phenotypes.var_report.xml	0.0	8.5	0.7071	8.0			8.5		phs001224.v1.p1	Computational Biology
			06/20/2014				./data/phs000439.v1.pht002931.v1.p1.PGRN_RIKEN_Rate_Ctrl_Sample.var_report.xml									phs000439.v1.p1	Atrial Fibrillation
			2017/08/09				./data/phs000694.v3.pht003754.v3.p2.Clinical_Cancer_Sequencing_Subject.var_report.xml									phs000694.v3.p2	Neoplasms
			2017/10/19				./data/phs001288.v1.pht006778.v1.p1.neurodev_wppsi_iii.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
42.0	42.0		2021/09/13	58.0		8.0	./data/phs002487.v1.pht011541.v1.p1.Schizophrenia_Antipsychotics_Subject.var_report.xml	0.0	29.0	9.192	8.0			29.0		phs002487.v1.p1	Schizophrenic Disorders
			08/20/2013				./data/phs000285.v3.pht001838.v2.p2.F1F66.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			01/05/2015				./data/phs000817.v1.pht004413.v1.p1.Varicella_Zoster_Vaccine_Subject.var_report.xml									phs000817.v1.p1	Varicella Vaccine
			2017/12/20				./data/phs000577.v1.pht007265.v1.p1.baselineassessmentform.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			06/01/2015				./data/phs000346.v2.pht004007.v1.p2.CGEMS_BladderCancer_Sample_Attributes.var_report.xml									phs000346.v2.p2	Urinary Bladder Neoplasms
	81.0		01/06/2010	81.0		81.0	./data/phs000202.v1.pht000878.v1.p1.OMRF_SLEGEN_Data.var_report_2010_01_06.xml	0.0	81.0		81.0			81.0		phs000202.v1.p1	Lupus Erythematosus, Systemic
			Wed Nov 26 07:45:57 2008				./data/phs000017.v3.pht000317.v1.p1.DIGS4_DiagnosisPage1.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			07/25/2014				./data/phs000622.v1.pht003951.v1.p1.FaceBase_Orofacial_Shape_Africans_Subject.var_report.xml									phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
40.0	54.0		06/14/2010	94.0		40.0	./data/phs000263.v1.pht001233.v1.p1.HMP_Skin_Acne_Subject_Phenotypes.var_report.xml	0.0	47.0	9.899	54.0			47.0		phs000263.v1.p1	Acne Vulgaris
			2020/09/28				./data/phs002254.v1.pht010542.v1.p1.CF_Nasal_Epithelium_Sample_Attributes.var_report.xml									phs002254.v1.p1	Cystic Fibrosis
			2021/07/21				./data/phs002366.v1.pht011344.v1.p1.LC_Asian_Sample.var_report.xml									phs002366.v1.p1	Lung Neoplasms
			2017/12/20				./data/phs000577.v1.pht007262.v1.p1.UCDC_5101_Subject.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			09/04/2015				./data/phs000953.v1.pht004966.v1.p1.Microdissected_Pancreatic_Cancer_Sample_Attributes.var_report.xml									phs000953.v1.p1	Pancreatic Neoplasms
			2020/06/18				./data/phs000280.v7.pht004151.v2.p1.RHXA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/12/17				./data/phs001943.v1.pht009716.v1.p1.UM_Sample_Attributes.var_report.xml									phs001943.v1.p1	Uveal melanoma
2.0	3.0		2019/03/21	5.0		2.0	./data/phs001235.v1.pht008446.v1.p1.MDA5_Deficiency_Pedigree.var_report.xml	0.0	2.5	0.7071	3.0			2.5		phs001235.v1.p1	Immunologic Deficiency Syndromes
			11/08/2013				./data/phs000200.v9.pht001020.v4.p3.f81_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
15.0			2019/02/21	40.0			./data/phs001281.v2.pht006126.v2.p1.demographics.var_report.xml	0.0			25.0					phs001281.v2.p1	Sturge-Weber Syndrome
			2020/06/02				./data/phs001841.v1.pht009907.v1.p1.CADD_GADD_Subject_Phenotypes.var_report.xml									phs001841.v1.p1	Opioid-Related Disorders
			2021/01/26				./data/phs001451.v3.pht007133.v3.p1.Melanoma_Neoantigen_Vaccine_Subject_Phenotypes.var_report.xml									phs001451.v3.p1	Melanoma
			2017/09/22				./data/phs001392.v1.pht006887.v1.p1.health_assessment.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2018/09/14				./data/phs001078.v1.pht005725.v1.p1.GECCO_Sample.var_report.xml									phs001078.v1.p1	Colorectal Neoplasms
			05/11/2012				./data/phs000414.v1.pht002731.v1.p1.Core_Binding_Factor_AML_Sample_Attributes.var_report.xml									phs000414.v1.p1	Leukemia, Myeloid, Acute
			2020/06/18				./data/phs000280.v7.pht004080.v2.p1.ERHA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
8.0	8.0		2021/03/10	9.0		7.0	./data/phs001485.v2.pht007185.v1.p1.Cell_ID_PedigreeDS_Pedigree.var_report.xml	0.0	7.5	2.121	7.0			7.5		phs001485.v2.p1	Cockayne Syndrome
			11/04/2014				./data/phs000086.v3.pht001146.v1.p1.d_eSelectin.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht004168.v2.p1.RTABM03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/10/19				./data/phs001463.v1.pht007056.v1.p1.Differential_Transcription_Brain_Subject.var_report.xml									phs001463.v1.p1	Brain
			2020/07/30				./data/phs001714.v1.pht010433.v1.p1.GMKF_Osteosarcoma_Sample.var_report.xml									phs001714.v1.p1	Osteosarcoma
1584.0			07/25/2014	3557.0			./data/phs000622.v1.pht003955.v1.p1.Pheno_Demographic.var_report.xml	0.0			1973.0					phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2017/08/25				./data/phs001079.v2.pht005358.v1.p1.Malignant_Glioblastoma_Subject.var_report.xml									phs001079.v2.p1	Glioblastoma
			2020/12/21				./data/phs000007.v32.pht002854.v4.p13.t_ctlung_2005_m_0696s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/30/2013				./data/phs000659.v1.pht003522.v1.p1.Ileal_Pouch_Microbiome_Sample.var_report.xml									phs000659.v1.p1	Inflammatory Bowel Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000402.v2.p3.simphen003.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/16/2016				./data/phs000973.v1.pht004987.v1.p1.JMML_Subject.var_report.xml									phs000973.v1.p1	Leukemia, Myelomonocytic, Juvenile
			05/24/2016				./data/phs001065.v1.pht005433.v1.p1.uhdr4.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/06/11				./data/phs002000.v1.pht010118.v1.p1.HC_Mongolian_Subject.var_report.xml									phs002000.v1.p1	Carcinoma, Hepatocellular
			08/20/2013				./data/phs000285.v3.pht001647.v2.p2.BFLWUPT1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht009473.v1.p1.GNBps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			04/20/2016				./data/phs000914.v1.pht005252.v1.p1.Samoans_Adiposity_Sample.var_report.xml									phs000914.v1.p1	Obesity
			2020/09/08				./data/phs001110.v3.pht006515.v2.p1.GMKF_CDH_Sample_Attributes.var_report.xml									phs001110.v3.p1	Hernias, Diaphragmatic, Congenital
			2019/11/27				./data/phs001177.v2.pht005665.v2.p1.Familial_Melanoma_Sample.var_report.xml									phs001177.v2.p1	Melanoma, Cutaneous Malignant
			2019/01/29				./data/phs001298.v1.pht008646.v1.p1.Psoriasis_European_Subject.var_report.xml									phs001298.v1.p1	Psoriasis
1.0			10/18/2016	2.0			./data/phs001205.v1.pht005852.v1.p1.Neural_Stem_Cell_Lineages_Subject_Phenotypes.var_report.xml	0.0								phs001205.v1.p1	Neural Stem Cells
			2017/08/17				./data/phs001399.v1.pht006681.v1.p1.Neoadjuvant_Adjuvant_Therapies_Sample.var_report.xml									phs001399.v1.p1	Prostatic Neoplasms
14.0	14.0		2020/12/10	24.0		10.0	./data/phs002071.v1.pht010454.v1.p1.PDA_Subject.var_report.xml	1.0	12.0	2.828	10.0			12.0		phs002071.v1.p1	Carcinoma, Pancreatic Ductal
			01/12/2015				./data/phs000853.v1.pht004427.v1.p1.Normative_Aging_Study_Subject.var_report.xml									phs000853.v1.p1	Mortality
			2020/09/18				./data/phs002015.v1.pht010373.v1.p1.AREDS2_CTS.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2019/01/10				./data/phs001609.v1.pht008142.v1.p1.Lupus_Nephritis_Sample_Attributes.var_report.xml									phs001609.v1.p1	Lupus Erythematosus, Systemic
			2020/06/18				./data/phs000280.v7.pht004140.v2.p1.NUTV3X.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/07				./data/phs001577.v1.pht008353.v1.p1.mCRPC_Sample_Attributes.var_report.xml									phs001577.v1.p1	Prostatic Neoplasms, Castration-Resistant
			07/12/2017				./data/phs000592.v1.pht006592.v1.p1.hlatyping.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2019/03/25				./data/phs001734.v1.pht008826.v1.p1.Drug_Abuse_ADHD_Sample_Attributes.var_report.xml									phs001734.v1.p1	Attention Deficit Disorder with Hyperactivity
			05/09/2016	33.0			./data/phs001112.v1.pht005472.v1.p1.ChrX_Mosaicism_Methylation_Subject_Phenotypes.var_report.xml	0.0			33.0					phs001112.v1.p1	Neoplasm
			2020/01/07				./data/phs001518.v1.pht007334.v1.p1.TRIUMPH_Sample_Attributes.var_report.xml									phs001518.v1.p1	Myocardial Infarction
			11/14/2016				./data/phs000741.v2.pht003919.v2.p1.GOLDN_Lipid_Lowering_Sample_Attributes.var_report.xml									phs000741.v2.p1	Metabolomics
23.0			10/16/2014	44.0			./data/phs000376.v1.pht002309.v1.p1.CIDR_PD_Exome_Subject_Phenotypes.var_report.xml	0.0			21.0					phs000376.v1.p1	Parkinson Disease
			08/12/2016				./data/phs000888.v1.pht005584.v1.p1.MergedSetII_Phenotype_Marshfield_AMD.var_report.xml									phs000888.v1.p1	
			2020/09/18				./data/phs002015.v1.pht010395.v1.p1.AREDS2_STA.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/05/01				./data/phs000607.v3.pht003446.v2.p2.Parameters_n1601.var_report.xml									phs000607.v3.p2	Mental Processes
			2018/03/09				./data/phs000606.v1.pht007573.v1.p1.deathrecord.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2018/05/10				./data/phs001565.v1.pht007895.v1.p1.Immune_Checkpoint_Blockade_Subject.var_report.xml									phs001565.v1.p1	Neoplasms
6402.0	6402.0		2021/09/09	9104.0		2702.0	./data/phs001515.v2.pht009564.v2.p2.TOPMed_WGS_MLOF_Subject.var_report.xml	0.0	4552.0	2616	2702.0			4552.0		phs001515.v2.p2	Hemophilia
			04/14/2011				./data/phs000258.v2.pht001241.v2.p1.HMP_Gut_Obesity_Sample.var_report.xml									phs000258.v2.p1	Obesity
			2021/08/10				./data/phs001467.v2.pht009731.v2.p2.TOPMed_WGS_SAPPHIRE_Subject_Phenotypes.var_report.xml									phs001467.v2.p2	Asthma
			2020/12/21				./data/phs000007.v32.pht000687.v7.p13.fibringam1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/09/2015				./data/phs000937.v1.pht005192.v1.p1.Antisense_Expression_Cancers_Sample_Attributes.var_report.xml									phs000937.v1.p1	Neoplasms
			2019/03/28				./data/phs000645.v5.pht003740.v2.p1.Intellectual_Disabilities_Subject.var_report.xml									phs000645.v5.p1	Dubowitz Syndrome
			03/23/2016				./data/phs000822.v1.pht005132.v1.p1.Breast_Cancer_Predisposing_Mutations_Subject.var_report.xml									phs000822.v1.p1	Breast Neoplasms
757.0	922.0		03/28/2014	968.0		774.0	./data/phs000496.v1.pht003167.v1.p1.Late_Onset_Alzheimers_Pedigree.var_report.xml	0.0	838.5	710.6	922.0			838.5		phs000496.v1.p1	Alzheimer Disease
915.0	799.0		2020/11/02	345.0		915.0	./data/phs001899.v2.pht009571.v2.p1.CSI_Subject_Phenotypes.var_report.xml	0.0	970.0	77.78	799.0			970.0		phs001899.v2.p1	Immunologic Deficiency Syndromes
			2021/03/25				./data/phs002061.v1.pht010836.v1.p1.Zidovudine_Children_Subject_Phenotypes.var_report.xml									phs002061.v1.p1	HIV
			08/20/2013				./data/phs000285.v3.pht001710.v2.p2.D1F06AC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
5.0	5.0		2019/03/28	7.0		8.0	./data/phs001680.v1.pht008915.v1.p1.T_Cell_States_Melanoma_Subject_Phenotypes.var_report.xml	0.0	3.5	8.485	8.0			3.5		phs001680.v1.p1	Immunotherapy
			2018/09/11				./data/phs000653.v3.pht003464.v3.p1.Epi4K_Subject.var_report.xml									phs000653.v3.p1	Epilepsy
			2020/12/21				./data/phs000007.v32.pht000609.v5.p13.oss_1995s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/10				./data/phs001169.v2.pht006184.v2.p1.EAGLE_Lung_Adenocarcinoma_Sample.var_report.xml									phs001169.v2.p1	Adenocarcinoma of lung
16.0	5.0		2018/10/16	5.0		7.0	./data/phs001704.v1.pht008462.v1.p1.CLL_Enhancer_Mapping_Subject_Phenotypes.var_report.xml	0.0	9.333	6.364	7.0			7.0		phs001704.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2020/07/10				./data/phs002022.v1.pht010181.v1.p1.pPCL_Sample.var_report.xml									phs002022.v1.p1	Leukemia, Plasma Cell
			2019/12/17				./data/phs001258.v2.pht006677.v2.p1.College_Athletes_Sample.var_report.xml									phs001258.v2.p1	MicroRNAs
			08/20/2013				./data/phs000285.v3.pht001682.v2.p2.C1F41AU.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004037.v3.p1.ATRFIB11.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/11/22				./data/phs000313.v4.pht002064.v4.p2.SardiNIA_Subject.var_report.xml									phs000313.v4.p2	Cardiovascular Diseases
			07/05/2017				./data/phs000595.v1.pht006630.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2019/05/09				./data/phs001284.v1.pht009034.v1.p1.WM_LPL_Sample_Attributes.var_report.xml									phs001284.v1.p1	Waldenstrom Macroglobulinemia
			2018/06/21				./data/phs001470.v1.pht008166.v1.p1.CIDR_SWAN_Sample.var_report.xml									phs001470.v1.p1	Menopause
			2019/09/18				./data/phs001737.v2.pht009326.v1.p1.EEC_Syndrome_Sample_Pooling.var_report.xml									phs001737.v2.p1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
24.0	3.0		2019/03/01	5.0		2.0	./data/phs001775.v1.pht008809.v1.p1.Multiplex_AD_Families_Subject_Phenotypes.var_report.xml	0.0	20.0	6.364	3.0			20.0		phs001775.v1.p1	Alcoholism
			2018/02/08				./data/phs001488.v1.pht007412.v1.p1.mri.var_report.xml									phs001488.v1.p1	Huntington Disease
79.0			05/02/2012	90.0			./data/phs000456.v1.pht002645.v1.p1.RACE_Controls_2_Subject_Phenotypes.var_report.xml	0.0			11.0					phs000456.v1.p1	Stroke
			03/12/2013				./data/phs000343.v3.pht003154.v1.p1.neu.var_report.xml									phs000343.v3.p1	Stroke
			2020/12/21				./data/phs000007.v32.pht000074.v13.p13.ex3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/06/14				./data/phs001238.v2.pht006033.v1.p1.GENOA_AfricanAmerican_CKD_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			05/11/2012				./data/phs000291.v2.pht002273.v1.p1.LHS_COPD_Subject_Phenotypes_Longitudinal_Measures.var_report.xml									phs000291.v2.p1	Pulmonary Disease, Chronic Obstructive
			11/30/2015				./data/phs000975.v1.pht004935.v1.p1.NHS_Mammographic_Density_Subject_Phenotypes.var_report.xml									phs000975.v1.p1	Mammographic density
			12/11/2009				./data/phs000171.v1.pht000759.v1.p1.MS_DATA_FAMSTHK.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/06/18				./data/phs000280.v7.pht004050.v5.p1.CEVTPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/21				./data/phs001198.v1.pht007862.v1.p1.Methamphetamine_Abstinence_Subject.var_report.xml									phs001198.v1.p1	Substance-Related Disorders
706.0	763.0		2020/12/14	611.0		388.0	./data/phs001984.v1.pht010784.v1.p1.MN_Subject_Phenotypes.var_report.xml	0.0	619.0	76.03	388.0			706.0		phs001984.v1.p1	Glomerulonephritis, Membranous
			08/03/2011				./data/phs000240.v1.pht002278.v1.p1.CIDR_QT_Glaucoma_Subject.var_report.xml									phs000240.v1.p1	Glaucoma, Open-Angle
			06/09/2010				./data/phs000255.v1.pht001417.v1.p1.HMP_Crohns_Risk_TraceID.var_report.xml									phs000255.v1.p1	Crohn Disease
			2018/05/15				./data/phs001557.v1.pht007616.v1.p1.MADSEQ_Sample.var_report.xml									phs001557.v1.p1	Hemihyperplasia
			2020/12/21				./data/phs000007.v32.pht000015.v3.p13.ex0_13s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001092.v1.p1.d_mhqhome.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			08/15/2016				./data/phs000473.v2.pht002599.v2.p2.Schizophrenia_Swedish_Sample.var_report.xml									phs000473.v2.p2	Schizophrenia
			10/11/2012				./data/phs000254.v2.pht002225.v2.p1.ESP_LungGO_CF_Sample.var_report.xml									phs000254.v2.p1	Cystic Fibrosis
			2020/02/06				./data/phs001430.v2.pht008075.v2.p1.p7001_16313_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			06/04/2013				./data/phs000581.v1.pht003205.v1.p1.ESP_Dilated_Cardiomyopathy_Sample.var_report.xml									phs000581.v1.p1	Cardiomyopathy, Dilated
			2019/08/01				./data/phs000222.v6.pht003451.v2.p2.rh_aparc_a2009s_area.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht000304.v8.p13.lppla2a3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/07/2011				./data/phs000252.v2.pht001268.v2.p1.HMP_Gut_Crohns_Diet_Sample.var_report.xml									phs000252.v2.p1	Crohn Disease
			04/08/2014				./data/phs000487.v2.pht002923.v1.p1.Prostate_Cancer_Risk_Subject.var_report.xml									phs000487.v2.p1	Prostatic Neoplasms
43.0	43.0		2017/09/19	82.0		39.0	./data/phs001426.v1.pht006915.v1.p1.T1DGC_RNASeq_Pedigree.var_report.xml	0.0	41.0	2.828	39.0			41.0		phs001426.v1.p1	Diabetes Mellitus, Type 1
2.0	2.0		2021/02/02	4.0		2.0	./data/phs002204.v1.pht010907.v1.p1.cCREs_Subject.var_report.xml	0.0	2.0	0	2.0			2.0		phs002204.v1.p1	Heart
			08/20/2013				./data/phs000285.v3.pht001594.v2.p2.AFLWUP1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000394.v9.p13.wktest1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/28/2016				./data/phs001009.v1.pht005349.v1.p1.RBEL_Asthma_Determinants_Subject.var_report.xml									phs001009.v1.p1	Asthma
			05/26/2016				./data/phs000886.v1.pht004649.v1.p1.Asthma_MZ_Twins_Subject_Phenotypes.var_report.xml									phs000886.v1.p1	Asthma
			09/02/2016				./data/phs001033.v1.pht005200.v1.p1.PAGE_Global_Reference_Panel_Subject.var_report.xml									phs001033.v1.p1	Population
			2019/10/10				./data/phs001273.v3.pht006172.v3.p2.OncoArray_Lung_Cancer_Sample.var_report.xml									phs001273.v3.p2	Lung Neoplasms
			2018/06/14				./data/phs001238.v2.pht006045.v1.p1.GENOA_AfricanAmerican_Phase2_ECHO.var_report.xml									phs001238.v2.p1	Hypertension
4.0	4.0		07/14/2010	6.0		2.0	./data/phs000244.v1.pht001520.v1.p1.Miller_Syndrome_Exome_Pedigree.var_report_2010_07_14.xml	0.0	3.0	1.414	2.0			3.0		phs000244.v1.p1	Genee-Wiedemann Syndrome
81.0	94.0		2017/11/06	565.0		81.0	./data/phs001441.v1.pht007114.v1.p1.SAB_AA_Subject_Phenotypes.var_report.xml	0.0	87.5	9.192	94.0			87.5		phs001441.v1.p1	Staphylococcus aureus
			02/09/2017				./data/phs001082.v1.pht005379.v1.p1.VZV_TCell_Sample.var_report.xml									phs001082.v1.p1	Herpes Zoster
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000445.v2.p3.simphen046.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000424.v2.p3.simphen025.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht006451.v1.p1.MRS.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/01				./data/phs001342.v1.pht008052.v1.p1.Statin_Induced_Myopathy_Sample_Attributes.var_report.xml									phs001342.v1.p1	Myopathy
1686.0	210000.0		05/16/2017	342425.0		130000.0	./data/phs001252.v1.pht006387.v1.p1.lab.var_report.xml	0.0	170000.0	55776	1052.0			170000.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/01/16				./data/phs001386.v2.pht007156.v1.p1.Smoking_Vaginal_Microbiome_SRA.var_report.xml									phs001386.v2.p1	Smoking
			12/10/2014				./data/phs000848.v1.pht004408.v1.p1.Autosomal_Recessive_TPP2_Mutations_Subject.var_report.xml									phs000848.v1.p1	Immunologic Deficiency Syndromes
			2018/06/20				./data/phs001629.v1.pht008160.v1.p1.BRAF_V600E_Subject.var_report.xml									phs001629.v1.p1	Ganglioglioma
559.0	13049.0		2020/03/24	25303.0		12254.0	./data/phs001641.v1.pht010025.v1.p1.FamilyHistory.var_report.xml	0.0	12652.0	562.1	1278.0			12652.0		phs001641.v1.p1	Progressive Patient Care
			2019/10/28				./data/phs001880.v1.pht009561.v1.p1.CCDG_Emory_Sample.var_report.xml									phs001880.v1.p1	Cardiovascular Diseases
			2020/09/18				./data/phs001182.v2.pht005720.v2.p1.Somatic_Mutation_Load_Clone_Cells_Subject.var_report.xml									phs001182.v2.p1	Clonal Evolution
			07/24/2017				./data/phs001088.v1.pht006668.v1.p1.DRIVE_SBCGS_Subject.var_report.xml									phs001088.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001584.v2.p2.A4F21.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
624.0	510.0		2019/05/21	3179.0		624.0	./data/phs001090.v1.pht009054.v1.p1.CIDR_OFC_African_Subject_Phenotypes.var_report.xml	0.0	510.0	644.2	510.0			510.0		phs001090.v1.p1	Cleft Lip
			2018/03/06				./data/phs000603.v1.pht007544.v1.p1.GSD_5601_Subject.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			2020/06/18				./data/phs000280.v7.pht004230.v2.p1.UDTB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/01/17				./data/phs001769.v1.pht008625.v1.p1.ARD_6104_Subject.var_report.xml									phs001769.v1.p1	Pure Autonomic Failure
431.0	617.0		05/07/2013	727.0		431.0	./data/phs000462.v1.pht002844.v1.p1.T2D_GENES_Subject_Phenotypes.var_report.xml	0.0	524.0	94.05	617.0			524.0		phs000462.v1.p1	Diabetes Mellitus, Type 2
			08/04/2014				./data/phs000776.v1.pht003950.v1.p1.MCCD_Sample_Attributes.var_report.xml									phs000776.v1.p1	Urea Cycle Disorders, Inborn
365.0	8394.0		05/16/2017	12795.0		4401.0	./data/phs001252.v1.pht006399.v1.p1.sputum.var_report.xml	0.0	6398.0	2823	221.0			6398.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2017/08/09				./data/phs000694.v3.pht003756.v3.p2.Clinical_Cancer_Sequencing_Subject_Phenotypes.var_report.xml									phs000694.v3.p2	Neoplasms
1090.0	1090.0		05/30/2014	1616.0		526.0	./data/phs000751.v1.pht003868.v1.p1.Fibrosing_Interstitial_Lung_Disease_Subject_Phenotypes.var_report.xml	0.0	808.0	398.8	526.0			808.0		phs000751.v1.p1	Lung Diseases, Interstitial
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000437.v2.p3.simphen038.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/02/11				./data/phs001780.v1.pht008713.v1.p1.African_Demographic_Subject_Phenotypes.var_report.xml									phs001780.v1.p1	
			2017/10/25				./data/phs000771.v2.pht003982.v2.p1.Bladder_Cancer_Chemotherapy_Response_Sample.var_report.xml									phs000771.v2.p1	Urinary Bladder Neoplasms
			11/04/2014				./data/phs000086.v3.pht000330.v1.p1.EDIC_f0302.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			08/20/2013				./data/phs000285.v3.pht001871.v2.p2.YM106.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht005144.v4.p13.l_mtbnegam1_ex01_3_0956s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
123.0	123.0		2020/03/02	219.0		96.0	./data/phs001900.v1.pht009632.v1.p1.ASD_SCZ_Development_Subject_Phenotypes.var_report.xml	0.0	109.5	19.09	96.0			109.5		phs001900.v1.p1	Autism Spectrum Disorder
			2021/01/12				./data/phs001697.v1.pht010577.v1.p1.EAGLE_Never_Smokers_Sample.var_report.xml									phs001697.v1.p1	Lung Neoplasms
			2018/06/01				./data/phs001317.v1.pht008043.v1.p1.medicalformforphysicians.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
			2018/08/03				./data/phs000590.v1.pht008278.v1.p1.hospitalization_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			05/19/2016				./data/phs000617.v1.pht005475.v1.p1.diLQTS_European_Subject.var_report.xml									phs000617.v1.p1	Long QT Syndrome
			2019/01/31				./data/phs001712.v1.pht008678.v1.p1.lvv_baseline_med_hx_form.var_report.xml									phs001712.v1.p1	Vasculitis
			2018/10/29				./data/phs001678.v1.pht008471.v1.p1.scTCR_Subject.var_report.xml									phs001678.v1.p1	Humans
			2018/05/15				./data/phs001311.v1.pht007917.v1.p1.CINCH_5306_Subject.var_report.xml									phs001311.v1.p1	Myotonia
			2019/06/14				./data/phs000589.v1.pht009178.v1.p1.angiogram_pulmonary.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/05/2014				./data/phs000209.v13.pht003375.v1.p3.MESA_AncilMesaApolipoproteinA1.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000027.v3.p13.ex0_25s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/01/2017				./data/phs000701.v1.pht005524.v1.p1.TreatmentTable.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2021/08/30				./data/phs000235.v17.pht001133.v17.p4.CGCI_Sample.var_report.xml									phs000235.v17.p4	Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000582.v2.p3.simphen183.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
278.0	77243.0		05/24/2016	153377.0		76134.0	./data/phs001065.v1.pht005438.v1.p1.urmclab.var_report.xml	0.0	76689.0	784.2	285.0			76689.0		phs001065.v1.p1	Huntington Disease
			2019/09/19				./data/phs001879.v1.pht009457.v1.p1.Kidney_Transplant_Recipients_Subject_Phenotypes.var_report.xml									phs001879.v1.p1	Urinary Tract Infections
			06/16/2017				./data/phs001278.v1.pht006271.v1.p1.medical_history.var_report.xml									phs001278.v1.p1	Porphyrias
			2017/10/13				./data/phs001212.v1.pht006564.v1.p1.Globin_Sickle_Cell_iPSC_Subject_Phenotypes.var_report.xml									phs001212.v1.p1	Anemia, Sickle Cell
7.0	36.0		2019/10/08	55.0		7.0	./data/phs001911.v1.pht009517.v1.p1.RADseq_Pedigree.var_report.xml	0.0	18.33	16.07	12.0			12.0		phs001911.v1.p1	Ataxia Telangiectasia
			2020/07/29				./data/phs002007.v1.pht010170.v1.p1.Innate_Tcells_Sample.var_report.xml									phs002007.v1.p1	Lymphocyte Subsets
			01/27/2014				./data/phs000674.v1.pht003638.v1.p1.GERA_Sample.var_report.xml									phs000674.v1.p1	Aging
			2021/09/13				./data/phs002487.v1.pht011542.v1.p1.Schizophrenia_Antipsychotics_Sample.var_report.xml									phs002487.v1.p1	Schizophrenic Disorders
			2019/03/11				./data/phs000286.v6.pht001960.v2.p2.locaspot.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/10/21				./data/phs001138.v4.pht007077.v2.p2.GMKF_CHD_PCGC_Sample_Attributes.var_report.xml									phs001138.v4.p2	Heart Defects, Congenital
29.0	29.0		12/12/2014	58.0		29.0	./data/phs000699.v1.pht004384.v1.p1.Osteosarcoma_Genomics_Subject_Phenotypes.var_report.xml	0.0	29.0	0	29.0			29.0		phs000699.v1.p1	Osteosarcoma
			2018/10/11				./data/phs001234.v1.pht006618.v1.p1.ER_Positive_Breast_Tumors_Tamoxifen_Sample.var_report.xml									phs001234.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001790.v2.p2.E1F46.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007808.v1.p1.p6902_18349_6mthphysi.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			07/12/2017				./data/phs000592.v1.pht006594.v1.p1.lowgradelymphomapanel.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2018/06/01				./data/phs001317.v1.pht008041.v1.p1.eligibilityform.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
3664.0	6253.0		2021/02/26	9917.0		3664.0	./data/phs001754.v4.pht009108.v2.p2.Spit4Science_Subject.var_report.xml	0.0	4959.0	502	6253.0			4959.0		phs001754.v4.p2	
			2018/09/07				./data/phs001551.v1.pht008348.v1.p1.CURE_EGI_Subject_Phenotypes.var_report.xml									phs001551.v1.p1	Epilepsy
			2019/05/07				./data/phs001329.v2.pht007183.v2.p1.neurological_exam.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
1691.0	1691.0		05/16/2017	2746.0		1055.0	./data/phs001252.v1.pht006380.v1.p1.death.var_report.xml	0.0	1373.0	449.7	1055.0			1373.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			11/05/2014				./data/phs000209.v13.pht002388.v1.p3.MESA_AncilMesaCG.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
77.0	80.0		2018/11/16	75.0		9.0	./data/phs001272.v1.pht007301.v1.p1.Broad_CMG_Pedigree.var_report.xml	0.0	78.5	6.364	9.0			78.5		phs001272.v1.p1	Genetic Diseases, Inborn
			11/04/2014				./data/phs000086.v3.pht000274.v1.p1.DCCT_f010cmb3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/22/2013				./data/phs000614.v1.pht003287.v1.p1.PLGGs_Subject.var_report.xml									phs000614.v1.p1	Astrocytoma
			2018/12/31				./data/phs001758.v1.pht008612.v1.p1.FNMTC_Sample_Attributes.var_report.xml									phs001758.v1.p1	Thyroid Cancer, Papillary
			2020/06/18				./data/phs000280.v7.pht004206.v2.p1.TOTNUTX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/04/23				./data/phs000179.v6.pht002238.v6.p2.COPDGene_Sample.var_report.xml									phs000179.v6.p2	Pulmonary Disease, Chronic Obstructive
72.0			2021/06/02	209.0			./data/phs002428.v1.pht011266.v1.p1.hTERT_Tandem_Repeats_Subject.var_report.xml	0.0			137.0					phs002428.v1.p1	Centenarian
			11/08/2013				./data/phs000200.v9.pht003410.v1.p3.outc_dvt_pe_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
42.0	42.0		03/31/2016	57.0		15.0	./data/phs001072.v1.pht005356.v1.p1.Relapsed_Pediatric_ALL_Subject_Phenotypes.var_report.xml	0.0	28.5	19.09	15.0			28.5		phs001072.v1.p1	Leukemia, Lymphoid
			2017/11/30				./data/phs000373.v1.pht007130.v1.p1.MrOS_Sample_Attributes.var_report.xml									phs000373.v1.p1	Osteoporosis
			2020/04/06				./data/phs002003.v1.pht010107.v1.p1.Single_Cell_Atlas_Sample.var_report.xml									phs002003.v1.p1	Human Development
			08/20/2013				./data/phs000285.v3.pht001681.v2.p2.C1F41.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/24/2017				./data/phs001076.v1.pht005362.v1.p1.IBD_Exome_Sample.var_report.xml									phs001076.v1.p1	Inflammatory Bowel Diseases
			04/10/2014				./data/phs000306.v4.pht001910.v3.p1.MEC_Prostate_Cancer_Sample.var_report.xml									phs000306.v4.p1	Prostatic Neoplasms
945.0	740.0		2018/05/03	2190.0		945.0	./data/phs000304.v3.pht001905.v1.p1.GABC_Pedigree.var_report.xml	0.0	589.5	212.8	740.0			589.5		phs000304.v3.p1	von Willebrand Disease
			12/03/2012				./data/phs000548.v1.pht003072.v1.p1.HV2_Cohort_Subject_Phenotypes.var_report.xml									phs000548.v1.p1	Aspirin
7.0	17.0		08/17/2012	24.0		7.0	./data/phs000518.v1.pht002849.v1.p1.ESP_Family_Studies_IB_Subject_Phenotypes.var_report.xml	0.0	12.0	7.071	17.0			12.0		phs000518.v1.p1	Bronchiectasis
			08/26/2013				./data/phs000656.v1.pht003480.v1.p1.Influenza_Vaccination_B_cell_Recall_Subject.var_report.xml									phs000656.v1.p1	Influenza Vaccines
			2019/06/13				./data/phs001840.v1.pht009147.v1.p1.PDAC_CAFs_Sample.var_report.xml									phs001840.v1.p1	Carcinoma, Pancreatic Ductal
			10/15/2015				./data/phs000870.v1.pht004550.v1.p1.Alternative_Splicing_Sample_Attributes.var_report.xml									phs000870.v1.p1	
1.0	4.0		06/26/2013	6.0		3.0	./data/phs000553.v1.pht003134.v1.p1.Rare_Pediatric_Phenotypes_Subject_Phenotypes.var_report.xml	0.0	3.0	1.732	4.0			3.0		phs000553.v1.p1	Mendelian
			2018/02/08				./data/phs001488.v1.pht007420.v1.p1.sig.var_report.xml									phs001488.v1.p1	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001689.v2.p2.C1F9PRG1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/05				./data/phs002328.v1.pht010856.v1.p1.EPIPARK_HBS2_Sample_Attributes.var_report.xml									phs002328.v1.p1	Parkinson Disease
			12/19/2011				./data/phs000381.v1.pht002423.v1.p1.GeM_Controls_Sample_Attributes.var_report.xml									phs000381.v1.p1	Normalcy
			2020/04/17				./data/phs001868.v1.pht009779.v1.p1.CM_Risk_Sample.var_report.xml									phs001868.v1.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht001227.v6.p13.ctkidney3_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
983.0	3307.0		2020/10/27	5931.0		983.0	./data/phs001616.v2.pht008544.v2.p2.eMERGEseq_Demographics.var_report.xml	0.0	996.7	866.3	929.0			929.0		phs001616.v2.p2	Precision Medicine
			2018/05/31				./data/phs001318.v1.pht008021.v1.p1.p5405_16929_efficacyi.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			02/20/2015				./data/phs000431.v2.pht002482.v2.p1.IGAN_Subject.var_report.xml									phs000431.v2.p1	Glomerulonephritis, IGA
			2018/11/26				./data/phs001686.v1.pht008566.v1.p1.IL17_PD_Sample_Attributes.var_report.xml									phs001686.v1.p1	Parkinson Disease
			2021/08/26				./data/phs001730.v2.pht010131.v1.p1.TOPMed_WGS_CARE_PACT_Sample.var_report.xml									phs001730.v2.p1	Asthma
			04/05/2017				./data/phs000927.v1.pht004751.v1.p1.CSER_Carrier_Testing_Subject.var_report.xml									phs000927.v1.p1	
471.0	471.0		11/13/2015	471.0		471.0	./data/phs000985.v1.pht005103.v1.p1.PrCa_Risk_SNPs_Subject_Phenotypes.var_report.xml	0.0	471.0					471.0		phs000985.v1.p1	
			11/25/2016				./data/phs000907.v1.pht004696.v1.p1.Lung_Cancer_Brain_Metastasis_Sample.var_report.xml									phs000907.v1.p1	Squamous Cell Carcinoma
			2020/12/21				./data/phs000007.v32.pht007770.v3.p13.vr_dgai2010_ex01_3_1078s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002144.v6.p13.l_opg_2005_m_0462s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/05/2016				./data/phs000360.v3.pht003252.v2.p1.MergedSet_Sample.var_report.xml									phs000360.v3.p1	Electronic Health Records
148.0	184.0		2019/03/11	332.0		148.0	./data/phs001757.v1.pht008669.v1.p1.Odorant_Receptors_Subject_Phenotypes.var_report.xml	0.0	166.0	25.46	184.0			166.0		phs001757.v1.p1	Smell
			08/20/2013				./data/phs000285.v3.pht001847.v2.p2.F1ISOP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/07/25				./data/phs001864.v1.pht009265.v1.p1.MAPK_HCL_SH_Subject_Phenotypes.var_report.xml									phs001864.v1.p1	histiocytosis
			2019/02/19				./data/phs001649.v1.pht008514.v1.p1.CEDAR_Subject.var_report.xml									phs001649.v1.p1	Substance-Related Disorders
			2019/05/31				./data/phs001296.v2.pht006354.v2.p1.UCDC_5107_Subject.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			03/21/2017				./data/phs000228.v4.pht001185.v4.p1.EMMES_HMP_Sample.var_report.xml									phs000228.v4.p1	Metagenomics
			2021/03/18				./data/phs001489.v2.pht008583.v2.p2.CCDG_Epi25_Sample.var_report.xml									phs001489.v2.p2	Epilepsy
			08/19/2016				./data/phs001192.v1.pht005692.v1.p1.Thoracic_PDX_Sample_Attributes.var_report.xml									phs001192.v1.p1	Lung Neoplasms
			08/29/2016				./data/phs000882.v1.pht005712.v1.p1.PEGASUS_EA_Subject.var_report.xml									phs000882.v1.p1	Prostatic Neoplasms
			07/29/2013				./data/phs000505.v2.pht002807.v2.p1.Glioblastoma_Stem_Cell_Lines_Subject.var_report.xml									phs000505.v2.p1	Glioblastoma
			2017/09/25				./data/phs001348.v2.pht006234.v2.p1.Gene_Discovery_WGMS_Sample.var_report.xml									phs001348.v2.p1	
			11/19/2013				./data/phs000436.v1.pht002836.v1.p1.Autism_Disorders_Sample_Attributes.var_report.xml									phs000436.v1.p1	Autistic Disorder
3.0	9.0		2017/12/04	12.0		3.0	./data/phs001366.v1.pht006577.v1.p1.SCLC_CTCA_Subject_Phenotypes.var_report.xml	0.0	6.0	4.243	9.0			6.0		phs001366.v1.p1	Small Cell Lung Carcinoma
			10/13/2009				./data/phs000210.v1.pht000898.v1.p1.MA27_Clinical_Data.var_report_2009_10_13.xml									phs000210.v1.p1	Breast Neoplasms
			2018/12/11				./data/phs001750.v1.pht008587.v1.p1.sc_Pulmonary_Fibrosis_Sample.var_report.xml									phs001750.v1.p1	Pulmonary Fibrosis
75.0	75.0		08/08/2011	134.0		59.0	./data/phs000353.v1.pht002254.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_113.var_report.xml	0.0	67.0	11.31	59.0			67.0		phs000353.v1.p1	Premature Birth
			12/27/2012				./data/phs000524.v1.pht002917.v1.p1.CRIC_Sample.var_report.xml									phs000524.v1.p1	Chronic Renal Insufficiency
			2020/12/21				./data/phs000007.v32.pht000095.v8.p13.lppla2m1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/10/2009				./data/phs000090.v1.pht001035.v1.p1.ARIC_CARE_Subject.var_report_2009_12_10.xml									phs000090.v1.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006444.v1.p1.LIP.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/10/22				./data/phs001917.v1.pht009549.v1.p1.Methylation_PC_Sample.var_report.xml									phs001917.v1.p1	Pancreatic Neoplasms
28.0	28.0		05/02/2011	28.0		28.0	./data/phs000310.v1.pht002097.v1.p1.NonETS_Fusions_Subject_Phenotypes.var_report.xml	0.0	28.0					28.0		phs000310.v1.p1	Prostatic Neoplasms
			09/27/2013				./data/phs000627.v1.pht003532.v1.p1.Hepatocellular_Carcinoma_Driver_Genes_Sample_Attributes.var_report.xml									phs000627.v1.p1	Carcinoma, Hepatocellular
			2020/02/06				./data/phs001430.v2.pht008056.v2.p1.concomitant_medications.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2018/05/15				./data/phs001309.v1.pht007913.v1.p1.case_report_form.var_report.xml									phs001309.v1.p1	Pulmonary Alveolar Proteinosis
			08/24/2009				./data/phs000091.v2.pht000800.v2.p1.Type2Diabetes_NHS_HPFS_Sample.var_report_2009_08_24.xml									phs000091.v2.p1	Diabetes Mellitus, Type 2
			11/08/2013				./data/phs000200.v9.pht002123.v1.p3.outc_self_ct_os_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			12/16/2013				./data/phs000559.v1.pht003615.v1.p1.PAGE_EAGLE_BioVU_Cancer_Sample.var_report.xml									phs000559.v1.p1	Neoplasms
			01/02/2013				./data/phs000568.v1.pht003111.v1.p1.Solitary_Fibrous_Tumors_SIGMA_Sample.var_report.xml									phs000568.v1.p1	Sarcoma
			2019/03/25				./data/phs001781.v1.pht008860.v1.p1.SCC_Sample.var_report.xml									phs001781.v1.p1	Carcinoma, Non-Small-Cell Lung
			2020/11/24				./data/phs001963.v1.pht009829.v1.p1.DEMENTIA_SEQ_Sample_Attributes.var_report.xml									phs001963.v1.p1	Lewy Body Disease
			2019/10/18				./data/phs001237.v2.pht005987.v1.p1.TOPMed_WGS_WHI_Subject.var_report.xml									phs001237.v2.p1	Stroke
			2017/12/04				./data/phs001419.v1.pht007098.v1.p1.registration.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			12/17/2013				./data/phs000662.v1.pht003558.v1.p1.NCS_AIM_Subject.var_report.xml									phs000662.v1.p1	Population Groups
			2017/08/18				./data/phs001363.v1.pht006516.v1.p1.P100_Subject.var_report.xml									phs001363.v1.p1	Health
			2020/05/01				./data/phs001890.v1.pht009546.v1.p1.CIViC_smMIPs_Subject_Phenotypes.var_report.xml									phs001890.v1.p1	
			07/15/2015				./data/phs000616.v2.pht003372.v2.p2.VIVA_LA_FAMILIA_Sample_Attributes.var_report.xml									phs000616.v2.p2	Obesity
			2017/11/28				./data/phs001482.v1.pht007125.v1.p1.Carrier_Screening_Subject_Phenotypes.var_report.xml									phs001482.v1.p1	Infertility
			12/09/2016				./data/phs000655.v3.pht003488.v3.p1.Inherited_Muscle_Disease_Subject.var_report.xml									phs000655.v3.p1	Muscular Dystrophies
			06/13/2014				./data/phs000625.v1.pht003851.v1.p1.Cleft_Lip_Palate_Subject.var_report.xml									phs000625.v1.p1	Orofacial Cleft, Nonsyndromic
2110.0	2345.0		11/05/2014	4455.0		2110.0	./data/phs000209.v13.pht003091.v3.p3.MESA_Exam5Main.var_report.xml	237.0	2228.0	21.21	2345.0			2228.0		phs000209.v13.p3	Cardiovascular Diseases
			2017/12/08				./data/phs001279.v1.pht007214.v1.p1.nasal_nitric_oxide.var_report.xml									phs001279.v1.p1	Bronchiectasis
68.0	285.0		2020/12/21	494.0		68.0	./data/phs000007.v32.pht009761.v1.p13.vr_wkthru_ex04_7_0917s.var_report.xml	0.0	88.0	53.74	285.0			88.0		phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002851.v7.p13.l_igf1_ex07_1_0629s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/07/26				./data/phs000588.v1.pht009307.v1.p1.registration.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/12/21				./data/phs000007.v32.pht000169.v7.p13.t_bmd_ex07_1_0104s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/09				./data/phs001515.v2.pht009566.v2.p2.TOPMed_WGS_MLOF_Subject_Phenotypes.var_report.xml									phs001515.v2.p2	Hemophilia
			05/08/2015				./data/phs000864.v1.pht004493.v1.p1.Combat_Stress_Predictors_Sample.var_report.xml									phs000864.v1.p1	Stress Disorders, Post-Traumatic
			2021/03/05				./data/phs001504.v2.pht007908.v1.p1.T2D_GENES_Hong_Kong_Subject.var_report.xml									phs001504.v2.p1	Diabetes Mellitus, Type 2
			2020/06/15				./data/phs002008.v1.pht010203.v1.p1.Orofacial_Enhancers_Sample_Attributes.var_report.xml									phs002008.v1.p1	Embryonic and Fetal Development
			2019/09/18				./data/phs001737.v2.pht008562.v2.p1.EEC_Syndrome_Sample_Attributes.var_report.xml									phs001737.v2.p1	Ectrodactyly, Ectodermal Dysplasia, and Cleft Lip-Palate Syndrome 3
154.0	184.0		2020/08/20	338.0		154.0	./data/phs002069.v1.pht010469.v1.p1.BAVM_Hemorrhage_Subject.var_report.xml	0.0	169.0	21.21	184.0			169.0		phs002069.v1.p1	Intracranial Arteriovenous Malformations
			12/19/2014				./data/phs000348.v2.pht002229.v2.p1.Myeloma_Sample.var_report.xml									phs000348.v2.p1	Multiple Myeloma
			2019/08/09				./data/phs001847.v1.pht009380.v1.p1.AML_Sample.var_report.xml									phs001847.v1.p1	Leukemia, Myeloid, Acute
			Mon Oct 27 17:24:54 2008				./data/phs000130.v1.pht000652.v1.p1.IBD_Sample.var_report_2008_11_06.xml									phs000130.v1.p1	Crohn Disease
			11/13/2015				./data/phs000820.v1.pht004333.v1.p1.Lone_Atrial_Fibrillation_Sample_Attributes.var_report.xml									phs000820.v1.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht006426.v1.p1.CES.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/09/08				./data/phs001497.v2.pht007240.v2.p1.Adult_Glioma_Sample.var_report.xml									phs001497.v2.p1	
			2020/12/21				./data/phs000007.v32.pht009751.v2.p13.l_balip1is_ex08_1_1172s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/10/2009				./data/phs000090.v1.pht001036.v1.p1.ARIC_CARE_Sample.var_report_2009_12_10.xml									phs000090.v1.p1	Cardiovascular Diseases
			2020/07/24				./data/phs002063.v1.pht010405.v1.p1.PD_Immunity_Sample.var_report.xml									phs002063.v1.p1	Parkinson Disease
6.0	7.0		06/27/2017	13.0		6.0	./data/phs001389.v1.pht006603.v1.p1.GBM_Tumors_Subject_Phenotypes.var_report.xml	0.0	6.5	0.7071	7.0			6.5		phs001389.v1.p1	Glioblastoma
			11/05/2014				./data/phs000209.v13.pht002298.v1.p3.MESA_AncilMesaRVFunction.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/06/28				./data/phs001851.v1.pht009222.v1.p1.LEAP_Subject.var_report.xml									phs001851.v1.p1	Peanut Hypersensitivity
			2018/10/24				./data/phs001693.v1.pht008490.v1.p1.Maternal_Fetal_IR_Subject_Phenotypes.var_report.xml									phs001693.v1.p1	MicroRNAs
			2020/02/06				./data/phs001430.v2.pht009847.v1.p1.adverse_event.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
86.0	85.0		2020/05/15	66.0		86.0	./data/phs001860.v1.pht009453.v1.p1.Autoinflammatory_Disorders_Subject_Phenotypes.var_report.xml	0.0	70.0	24.04	85.0			70.0		phs001860.v1.p1	Hereditary Autoinflammatory Diseases
			2017/11/30				./data/phs001341.v1.pht006863.v1.p1.PhLiPS_Sample_Attributes.var_report.xml									phs001341.v1.p1	Lipids
			10/27/2014				./data/phs000628.v1.pht003504.v1.p1.Metastatic_Cervical_Carcinoma_Subject.var_report.xml									phs000628.v1.p1	Uterine Cervical Neoplasms
			2019/11/08				./data/phs001332.v2.pht007446.v2.p1.p7301_12572_therapyre.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2018/05/29				./data/phs000234.v2.pht001152.v2.p2.Dementia_Subject.var_report.xml									phs000234.v2.p2	Dementia
			2020/06/18				./data/phs000280.v7.pht004196.v2.p1.SESA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001696.v2.p2.C1LPA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/11/05				./data/phs001690.v1.pht008368.v1.p1.EC_SCNA_Sample_Attributes.var_report.xml									phs001690.v1.p1	Endometrial Neoplasms
			05/02/2014				./data/phs000739.v1.pht003826.v1.p1.Ameloblastoma_Mutations_Sample.var_report.xml									phs000739.v1.p1	Ameloblastoma
			2017/12/29				./data/phs000950.v1.pht005969.v1.p1.SEER_Ovarian_FFPE_Sample.var_report.xml									phs000950.v1.p1	Neoplasms
			2020/06/18				./data/phs000280.v7.pht004127.v2.p1.MPRA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000510.v2.p3.simphen111.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
416.0	565.0		03/15/2012	981.0		416.0	./data/phs000440.v1.pht002494.v1.p1.MARAZITA_Guatemala_DentalCaries_PhenotypeDS.var_report.xml	0.0	490.5	105.4	565.0			490.5		phs000440.v1.p1	Dental Caries
688.0	990.0		2021/06/08	557.0		688.0	./data/phs001215.v4.pht008631.v2.p2.TOPMed_WGS_SAFHS_Subject_Phenotypes.var_report.xml	5.0	839.0	85.56	990.0			839.0		phs001215.v4.p2	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008790.v1.p2.tobb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/08/06				./data/phs001580.v1.pht008288.v1.p1.HCC_Subject.var_report.xml									phs001580.v1.p1	Thyroid cancer, Hurthle cell
			03/12/2013				./data/phs000343.v3.pht003157.v1.p1.vdl.var_report.xml									phs000343.v3.p1	Stroke
195.0	195.0		2018/04/20	312.0		117.0	./data/phs001572.v1.pht007841.v1.p1.PD_1_Immunotherapy_Subject_Phenotypes.var_report.xml	0.0	156.0	55.15	117.0			156.0		phs001572.v1.p1	Neoplasms
			2020/11/24				./data/phs001963.v1.pht009826.v1.p1.DEMENTIA_SEQ_Subject.var_report.xml									phs001963.v1.p1	Lewy Body Disease
			06/20/2013				./data/phs000430.v1.pht003052.v1.p1.HALT_C_Subject.var_report.xml									phs000430.v1.p1	Hepatitis C
			2018/02/08	88.0			./data/phs001531.v1.pht007441.v1.p1.Turner_Syndrome_BAV_Subject_Phenotypes.var_report.xml	0.0			88.0					phs001531.v1.p1	Turner Syndrome
			2020/08/06				./data/phs001571.v1.pht009503.v1.p1.IBD_AA_Subject.var_report.xml									phs001571.v1.p1	Crohn Disease
			11/08/2013				./data/phs000200.v9.pht002772.v1.p3.outc_strk_carotid_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/09/19				./data/phs000357.v2.pht002334.v1.p1.Systemic_Sclerosis_Pulmonary_Attributes.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
			2021/01/12				./data/phs001617.v1.pht010617.v1.p1.Growth_Disorders_Subject.var_report.xml									phs001617.v1.p1	Growth Disorders
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000523.v2.p3.simphen124.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/07/09				./data/phs001207.v3.pht005794.v3.p1.TOPMed_WGS_AA_Sarcoidosis_Sample_Attributes.var_report.xml									phs001207.v3.p1	Sarcoidosis
			2021/04/28				./data/phs001500.v2.pht007257.v1.p1.Melanocyte_QTL_GEO.var_report.xml									phs001500.v2.p1	Melanocytes
			2020/06/18				./data/phs000280.v7.pht006489.v2.p1.WMRN.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/27/2014				./data/phs000299.v2.pht001882.v2.p1.Genentech_NSCLC_Sample_Attributes.var_report.xml									phs000299.v2.p1	Lung Neoplasms
2.0	2.0		2020/06/02	3.0		1.0	./data/phs002040.v1.pht010260.v1.p1.IL37_IBD_Subject_Phenotypes.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs002040.v1.p1	Inflammatory Bowel Diseases
			2020/01/10				./data/phs000791.v2.pht004591.v2.p1.Roadmap_Epigenomics_UCSF_Subject.var_report.xml									phs000791.v2.p1	Neoplasms
			08/20/2013				./data/phs000285.v3.pht001740.v2.p2.D1INS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/12/13				./data/phs001053.v1.pht007233.v1.p1.XFS_Glaucoma_Sample_Attributes.var_report.xml									phs001053.v1.p1	Glaucoma
22.0	22.0		2021/06/16	40.0		18.0	./data/phs002088.v2.pht010649.v1.p1.LINCS_DToxS_Subject.var_report.xml	0.0	20.0	2.828	18.0			20.0		phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			2018/08/18				./data/phs001549.v1.pht008253.v1.p1.EWS_European_Sample_Attributes.var_report.xml									phs001549.v1.p1	Sarcoma, Ewing
			2019/08/18				./data/phs001201.v2.pht007559.v1.p1.Microbiome.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2018/05/31				./data/phs001316.v1.pht008007.v1.p1.p5305_12378_day1form.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			2020/12/21				./data/phs000007.v32.pht002899.v6.p13.l_tnfr_2008_m_0513s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
991.0	991.0		2021/09/28	4369.0		910.0	./data/phs000988.v5.pht005245.v5.p1.TOPMed_WGS_Asthma_Costa_Rica_Subject.var_report.xml	0.0	950.5	9.192	910.0			950.5		phs000988.v5.p1	Asthma
			05/12/2017				./data/phs001091.v1.pht006063.v1.p1.CLL_Clonal_Evolution_Subject.var_report.xml									phs001091.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			05/26/2015				./data/phs000851.v1.pht004683.v1.p1.Breast_Cancer_AA_Sample.var_report.xml									phs000851.v1.p1	Breast Neoplasms
			2018/05/31				./data/phs001318.v1.pht008020.v1.p1.treatmenttable.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
70.0	70.0		06/12/2017	70.0		70.0	./data/phs001275.v1.pht006542.v1.p1.Cryptorchid_Testes_Subject_Phenotypes.var_report.xml	0.0	70.0					70.0		phs001275.v1.p1	Cryptorchidism
			2020/06/18				./data/phs000280.v7.pht006434.v1.p1.DRD.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/18				./data/phs001594.v1.pht008147.v1.p1.Mucosal_Melanomas_Sample_Attributes.var_report.xml									phs001594.v1.p1	Melanoma
			2020/06/18				./data/phs000280.v7.pht006430.v1.p1.DCM.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			04/21/2017				./data/phs001344.v1.pht006285.v1.p1.PMDD_Sample.var_report.xml									phs001344.v1.p1	Premenstrual Dysphoric Disorder
25.0	59.0		05/19/2016	84.0		69.0	./data/phs000617.v1.pht005477.v1.p1.diLQTS_European_Subject_Phenotypes.var_report.xml	0.0	42.0	48.08	69.0			42.0		phs000617.v1.p1	Long QT Syndrome
			02/04/2016				./data/phs001066.v1.pht005283.v1.p1.ALL_Sample_Attributes.var_report.xml									phs001066.v1.p1	Neoplasms
16.0	16.0		04/25/2014	29.0		13.0	./data/phs000587.v1.pht003519.v1.p1.ESP_Family_Studies_MLD_Subject_Phenotypes.var_report.xml	0.0	14.5	2.121	13.0			14.5		phs000587.v1.p1	Hyperlipoproteinemia Type II
			07/26/2010				./data/phs000283.v1.pht001538.v1.p1.MESA_CARe_Sample.var_report_2010_07_26.xml									phs000283.v1.p1	Cardiovascular Diseases
			2017/12/20				./data/phs000577.v1.pht007280.v1.p1.neuropsychformf.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			12/09/2015				./data/phs000937.v1.pht005190.v1.p1.Antisense_Expression_Cancers_Sample.var_report.xml									phs000937.v1.p1	Neoplasms
8.0	8.0		2021/03/30	8.0		8.0	./data/phs001988.v1.pht010927.v1.p1.mCRPC_Subject.var_report.xml	0.0	8.0					8.0		phs001988.v1.p1	Prostatic Neoplasms
			11/05/2014				./data/phs000209.v13.pht002140.v2.p3.MESA_AncilMesaBNP.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			12/13/2011				./data/phs000426.v1.pht002455.v1.p1.4a_dbGaP_SampleAttributesDS.var_report.xml									phs000426.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			11/13/2015				./data/phs001008.v1.pht005111.v1.p1.IRAS_Family_Study_Sample_Attributes.var_report.xml									phs001008.v1.p1	Insulin Resistance
			01/02/2013				./data/phs000568.v1.pht003113.v1.p1.Solitary_Fibrous_Tumors_SIGMA_Sample_Attributes.var_report.xml									phs000568.v1.p1	Sarcoma
			2019/04/25				./data/phs001673.v1.pht008511.v1.p1.ADAGESIII_Sample.var_report.xml									phs001673.v1.p1	Glaucoma
			07/10/2017				./data/phs001202.v1.pht005774.v1.p1.OncoArray_Oral_Pharynx_Cancer_Sample.var_report.xml									phs001202.v1.p1	Head and Neck Neoplasms
			03/21/2014				./data/phs000583.v1.pht003293.v1.p1.Type2Diabetes_AsianIndians_Sample.var_report.xml									phs000583.v1.p1	Metabolic Syndrome X
			2020/06/18				./data/phs000280.v7.pht004165.v2.p1.RTABF25.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000776.v1.p1.MS_DATA_MSFC2.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
370.0	609.0		10/25/2010	979.0		370.0	./data/phs000021.v3.pht000288.v1.p2.AA_GAIN_phenotype_controls_main.var_report_2010_10_25.xml	0.0	489.5	169	609.0			489.5		phs000021.v3.p2	Schizophrenia
			2019/10/29				./data/phs001924.v1.pht009574.v1.p1.Cholangiocarcinoma_Sample.var_report.xml									phs001924.v1.p1	Cholangiocarcinoma
			2021/05/13				./data/phs001423.v3.pht008551.v1.p2.TIC_Genetics_Array_Sample_Attributes.var_report.xml									phs001423.v3.p2	Tourette Disorder
			2018/03/08				./data/phs001494.v1.pht007191.v1.p1.ALIVE_Smokescreen_Sample.var_report.xml									phs001494.v1.p1	Substance-Related Disorders
			2021/06/11				./data/phs002208.v1.pht010499.v1.p1.BAL_HCT_Sample.var_report.xml									phs002208.v1.p1	Hematopoietic Stem Cell Transplantation
			2018/06/14				./data/phs001238.v2.pht006659.v1.p1.GENOA_EuropeanAmerican_Phase2_Exam.var_report.xml									phs001238.v2.p1	Hypertension
5.0			2018/03/06	15.0			./data/phs000603.v1.pht007547.v1.p1.demographicandregistrationform.var_report.xml	0.0			10.0					phs000603.v1.p1	Apparent mineralocorticoid excess
3.0			2019/02/21	19.0			./data/phs001281.v2.pht006129.v2.p1.erhardt.var_report.xml	0.0			7.0					phs001281.v2.p1	Sturge-Weber Syndrome
			08/20/2013				./data/phs000285.v3.pht001666.v2.p2.C1F11.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001588.v2.p2.A4LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
827.0	827.0		2018/08/19	773.0		629.0	./data/phs000101.v5.pht001147.v1.p1.ALS_Follow_Up_Cases_Controls.var_report.xml	0.0	728.0	74.25	629.0			728.0		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2018/06/14				./data/phs001238.v2.pht006663.v1.p1.GENOA_EuropeanAmerican_Phase2_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2020/01/10				./data/phs001471.v1.pht009804.v1.p1.Subject_Phenotypes_TIME3.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000349.v1.p1.EDIC_f0933.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
537.0	537.0		09/27/2010	988.0		471.0	./data/phs000103.v1.pht001888.v1.p1.Preterm_Delivery_Pedigree.var_report_2010_09_27.xml	0.0	503.5	82.73	471.0			503.5		phs000103.v1.p1	Premature Birth
			03/06/2017				./data/phs000574.v1.pht005858.v1.p1.clinicalassessment.var_report.xml									phs000574.v1.p1	Rett Syndrome
196.0	196.0		07/06/2011	351.0		155.0	./data/phs000250.v1.pht002188.v1.p1.CALGB_80303_Subject_Phenotypes.var_report.xml	0.0	175.5	28.99	155.0			175.5		phs000250.v1.p1	Pancreatic Neoplasms
			2020/02/03				./data/phs001931.v1.pht009679.v1.p1.CMI_ASCproject_Sample_Attributes.var_report.xml									phs001931.v1.p1	Sarcoma
			2019/06/04				./data/phs001817.v1.pht009133.v1.p1.GeneScreen_Subject.var_report.xml									phs001817.v1.p1	Genetics, Population
			08/27/2012				./data/phs000168.v2.pht000708.v2.p2.LOAD610K_Subject.var_report.xml									phs000168.v2.p2	Alzheimer Disease
			11/08/2013				./data/phs000200.v9.pht003405.v1.p3.outc_cardio_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
5418.0	5814.0		2020/04/17	6442.0		2998.0	./data/phs001868.v1.pht009780.v1.p1.CM_Risk_Subject_Phenotypes.var_report.xml	0.0	3745.0	3247	5814.0			5418.0		phs001868.v1.p1	Melanoma
			11/02/2015				./data/phs000994.v1.pht005062.v1.p1.CTCL_Sezary_Syndrome_Subject.var_report.xml									phs000994.v1.p1	Sezary Syndrome
			08/30/2013				./data/phs000657.v1.pht003495.v1.p1.Advanced_Cancers_Sample_Attributes.var_report.xml									phs000657.v1.p1	Carcinoma
			2018/08/03				./data/phs000590.v1.pht008270.v1.p1.bvas.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
1.0	1.0		2021/01/28	1.0		1.0	./data/phs002089.v1.pht010496.v1.p1.dMMR_Tumors_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs002089.v1.p1	Small Cell Lung Carcinoma
991.0	991.0		2021/09/28	4369.0		910.0	./data/phs000988.v5.pht005246.v4.p1.TOPMed_WGS_Asthma_Costa_Rica_Pedigree.var_report.xml	0.0	950.5	9.192	910.0			950.5		phs000988.v5.p1	Asthma
18.0	18.0		10/18/2012	36.0		18.0	./data/phs000547.v1.pht003005.v1.p1.GARNET_SUCCESS_Pedigree.var_report.xml	0.0	18.0	0	18.0			18.0		phs000547.v1.p1	Breast Neoplasms
			2021/05/11				./data/phs002340.v1.pht010939.v1.p1.scAtlas_Gynecological_Malignancies_Sample_Attributes.var_report.xml									phs002340.v1.p1	Carcinoma, Ovarian Epithelial
			05/31/2017				./data/phs001030.v1.pht005091.v1.p1.Viral_Respiratory_Pathogens_Genetics_Sample.var_report.xml									phs001030.v1.p1	Influenza, Human
3202.0			2020/07/29	6069.0			./data/phs001290.v1.pht010334.v1.p1.CIDR_CRC_Survival_Subject_Phenotypes.var_report.xml	8.0			2867.0					phs001290.v1.p1	Colorectal Neoplasms
			2020/09/08				./data/phs001110.v3.pht006511.v3.p1.GMKF_CDH_Subject.var_report.xml									phs001110.v3.p1	Hernias, Diaphragmatic, Congenital
			2020/12/21				./data/phs000007.v32.pht006024.v4.p13.vr_svstktia_2018_a_1270s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
915.0	799.0		2020/11/02	345.0		915.0	./data/phs001899.v2.pht009569.v2.p1.CSI_Pedigree.var_report.xml	0.0	970.0	77.78	799.0			970.0		phs001899.v2.p1	Immunologic Deficiency Syndromes
7.0	8.0		2021/03/11	15.0		7.0	./data/phs001818.v3.pht009316.v2.p1.sc_GI_Cancer_Subject_Phenotypes.var_report.xml	0.0	7.5	0.7071	8.0			7.5		phs001818.v3.p1	Stomach Neoplasms
			2017/11/01				./data/phs001305.v1.pht007107.v1.p1.missedoralmedicationlog.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			01/05/2017				./data/phs001260.v1.pht006053.v1.p1.Antibiotic_Resistance_Subject_Phenotypes.var_report.xml									phs001260.v1.p1	Diarrhea
			2018/04/16				./data/phs001289.v1.pht007788.v1.p1.baselineinformation.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			2020/03/09				./data/phs001491.v2.pht007251.v2.p1.CIDR_Tooth_Disorders_Subject.var_report.xml									phs001491.v2.p1	Amelogenesis Imperfecta
			03/29/2017				./data/phs001319.v1.pht006211.v1.p1.GICC_Sample_Attributes.var_report.xml									phs001319.v1.p1	Glioma
			08/20/2013				./data/phs000285.v3.pht001603.v2.p2.B2F09CHL.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000786.v1.p1.MS_DATA_VITAL.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			12/27/2012				./data/phs000522.v1.pht002879.v1.p1.Hyperdiploid_Pediatric_ALL_Sample.var_report.xml									phs000522.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			2020/06/18				./data/phs000280.v7.pht006440.v4.p1.HFCCHIPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			04/29/2015				./data/phs000710.v1.pht003985.v1.p1.Cloud_Testing_Subject.var_report.xml									phs000710.v1.p1	Test study for cloud access
			2019/04/23				./data/phs001804.v1.pht008965.v1.p1.GEODB_Subject_Phenotypes.var_report.xml									phs001804.v1.p1	Opioid-Related Disorders
			2018/05/07				./data/phs000490.v1.pht002961.v1.p1.eMERGE_Complex_Pediatric_Disorders_Subject.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			08/20/2013				./data/phs000285.v3.pht001712.v2.p2.D1F06FG.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/06/16				./data/phs001402.v3.pht008237.v2.p1.TOPMed_WGS_Mayo_VTE_Subject.var_report.xml									phs001402.v3.p1	Venous Thromboembolism
			2019/06/14				./data/phs000589.v1.pht009173.v1.p1.angiogram_celiacmesentericrenal.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			08/12/2016				./data/phs000888.v1.pht005565.v1.p1.14aGERD_hx.var_report.xml									phs000888.v1.p1	
			2019/07/26				./data/phs000588.v1.pht009311.v1.p1.vdi.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/03/04				./data/phs001969.v1.pht009937.v1.p1.CGD_TCL_Sample_Attributes.var_report.xml									phs001969.v1.p1	Lymphoma, T-Cell, Cutaneous
			10/27/2014				./data/phs000812.v1.pht004300.v1.p1.Prostate_Subject_Phenotypes.var_report.xml									phs000812.v1.p1	Prostatic Neoplasms
			01/19/2010				./data/phs000219.v1.pht001080.v1.p1.d_drug.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			06/05/2017				./data/phs001265.v1.pht006338.v1.p1.OncoArray_DRIVE_Subject.var_report.xml									phs001265.v1.p1	Breast Neoplasms
			2021/09/29				./data/phs002415.v1.pht011587.v1.p1.BABY_HUG_Sample.var_report.xml									phs002415.v1.p1	Sickle Cell Anemia
470.0	470.0		05/16/2017	757.0		287.0	./data/phs001252.v1.pht006390.v1.p1.ns_brcon.var_report.xml	0.0	378.5	129.4	287.0			378.5		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/03/11				./data/phs001964.v1.pht009959.v1.p1.WHS_Accelerometer_Subject.var_report.xml									phs001964.v1.p1	Physical Activity
4620.0	4611.0		08/17/2010	6042.0		7.0	./data/phs000294.v1.pht001534.v1.p1.MIGen_Pedigree.var_report_2010_08_17.xml	0.0	989.0	2355	755.0			751.0		phs000294.v1.p1	Myocardial Infarction
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000450.v2.p3.simphen051.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/07/10				./data/phs002022.v1.pht010184.v1.p1.pPCL_Sample_Attributes.var_report.xml									phs002022.v1.p1	Leukemia, Plasma Cell
			11/05/2014				./data/phs000209.v13.pht001108.v4.p3.MESA_Subject.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
901.0	894.0		2018/05/29	988.0		901.0	./data/phs000234.v2.pht001150.v2.p2.Dementia_Phenotype_Data.var_report.xml	0.0	864.0	83.44	894.0			864.0		phs000234.v2.p2	Dementia
360.0	360.0		2020/11/19	715.0		355.0	./data/phs002050.v1.pht010359.v1.p1.OICR_CRC_Subject_Phenotypes.var_report.xml	0.0	357.5	6.364	355.0			357.5		phs002050.v1.p1	Colorectal Neoplasms
			04/13/2015				./data/phs000874.v1.pht004656.v1.p1.GERFHS_Subject_Phenotypes.var_report.xml									phs000874.v1.p1	Intracerebral Hemorrhage
			2020/07/17				./data/phs000481.v3.pht003164.v3.p2.Cholesterol_and_Pharmacogenetics_Sample_Attributes.var_report.xml									phs000481.v3.p2	Hypercholesterolemia
			2020/06/18				./data/phs000280.v7.pht004044.v5.p1.CCEAPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/07/18				./data/phs001651.v1.pht008234.v1.p1.Lung_SQCC_AppKY_Sample.var_report.xml									phs001651.v1.p1	Lung Neoplasms
23.0	23.0		2020/10/02	33.0		10.0	./data/phs002244.v1.pht010550.v1.p1.NSCLC_Pembrolizumab_Subject.var_report.xml	0.0	16.5	9.192	10.0			16.5		phs002244.v1.p1	Carcinoma, Non-Small-Cell Lung
			06/09/2016				./data/phs000955.v1.pht005451.v1.p1.GeCKO_OAI_Subject_Phenotypes.var_report.xml									phs000955.v1.p1	Osteoarthritis
			01/13/2016				./data/phs000928.v1.pht004937.v1.p1.LGG_Probiotics_Transcriptome_Subject.var_report.xml									phs000928.v1.p1	Volunteers, Human
1691.0	5954.0		05/16/2017	9705.0		3751.0	./data/phs001252.v1.pht006386.v1.p1.index.var_report.xml	0.0	4853.0	1558	1055.0			4853.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2019/08/26				./data/phs001837.v1.pht009313.v1.p1.NAFLD_Microbiome_Sample.var_report.xml									phs001837.v1.p1	Non-alcoholic Fatty Liver Disease
			2020/03/03				./data/phs001987.v1.pht009928.v1.p1.GMKF_Enchondromatoses_Subject.var_report.xml									phs001987.v1.p1	Enchondromatosis
569.0	827.0		2021/07/09	812.0		569.0	./data/phs001207.v3.pht005791.v3.p1.TOPMed_WGS_AA_Sarcoidosis_Pedigree.var_report.xml	0.0	698.0	76.37	827.0			698.0		phs001207.v3.p1	Sarcoidosis
			07/30/2015				./data/phs000947.v1.pht004826.v1.p1.SLE_Autoantibodies_Subject.var_report.xml									phs000947.v1.p1	Systemic Lupus Erythematosus
			08/20/2013				./data/phs000285.v3.pht001623.v2.p2.B2F09ULC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
41.0	67.0		2021/03/30	108.0		41.0	./data/phs002311.v1.pht010931.v1.p1.GATA2_Deficiency_Subject.var_report.xml	0.0	54.0	18.38	67.0			54.0		phs002311.v1.p1	Neoplasms
15.0	15.0		08/26/2013	28.0		13.0	./data/phs000656.v1.pht003482.v1.p1.Influenza_Vaccination_B_cell_Recall_Subject_Phenotypes.var_report.xml	0.0	14.0	1.414	13.0			14.0		phs000656.v1.p1	Influenza Vaccines
			11/30/2015				./data/phs001007.v1.pht005067.v1.p1.HNSCC_Metastasis_Recurrence_Sample.var_report.xml									phs001007.v1.p1	Carcinoma, squamous cell of head and neck
			08/01/2016				./data/phs000744.v4.pht003976.v4.p2.Y_CMG_Subject.var_report.xml									phs000744.v4.p2	Familial Idiopathic Pulmonary Fibrosis
			2020/05/05				./data/phs001360.v1.pht006296.v1.p1.CLEAR_Sample_Attributes.var_report.xml									phs001360.v1.p1	Arthritis, Rheumatoid
			08/20/2013				./data/phs000285.v3.pht001832.v2.p2.F1F60.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/05				./data/phs002328.v1.pht010855.v1.p1.EPIPARK_HBS2_Subject_Phenotypes.var_report.xml									phs002328.v1.p1	Parkinson Disease
64.0	68.0		2021/09/24	71.0		7.0	./data/phs001927.v1.pht011578.v1.p1.TOPMed_WGS_SPIROMICS_Subject.var_report.xml	0.0	768.7	663.8	964.0			964.0		phs001927.v1.p1	Pulmonary Disease, Chronic Obstructive
			2018/10/16				./data/phs001704.v1.pht008463.v1.p1.CLL_Enhancer_Mapping_Sample_Attributes.var_report.xml									phs001704.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			05/23/2014				./data/phs000612.v1.pht003526.v1.p1.Adenoid_Cystic_Carcinoma_Subject.var_report.xml									phs000612.v1.p1	Cancer
			03/31/2016				./data/phs001072.v1.pht005357.v1.p1.Relapsed_Pediatric_ALL_Sample_Attributes.var_report.xml									phs001072.v1.p1	Leukemia, Lymphoid
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000429.v2.p3.simphen030.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/11/13				./data/phs001523.v1.pht008454.v1.p1.MOMS_PI_SRA.var_report.xml									phs001523.v1.p1	Pregnancy
			2021/08/23				./data/phs001232.v4.pht006080.v4.p2.UDN_Sample_Attributes.var_report.xml									phs001232.v4.p2	Rare Diseases
			2020/04/29				./data/phs001573.v1.pht010179.v1.p1.pRCC_Sample_Attributes.var_report.xml									phs001573.v1.p1	Carcinoma, Renal Cell
			05/09/2016				./data/phs001023.v1.pht005463.v1.p1.Male_Infertility_Sample.var_report.xml									phs001023.v1.p1	Azoospermia
			2018/08/03				./data/phs000590.v1.pht008274.v1.p1.eligibility_checklist.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2020/02/06				./data/phs001430.v2.pht008062.v2.p1.p7001_16145_audiology.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
891.0	89.0		Wed Nov 19 17:39:49 2008	4121.0		762.0	./data/phs000092.v1.pht000116.v1.p1.AlcoholDepAdd_Data.var_report_2008_11_26.xml	0.0	982.5	808.1	91.0			982.5		phs000092.v1.p1	Alcoholism
			10/18/2016				./data/phs000669.v1.pht003730.v1.p1.AMBER_Subject.var_report.xml									phs000669.v1.p1	Breast Neoplasms
			2017/09/22				./data/phs001377.v1.pht006945.v1.p1.Cocaine_Nicotine_Addiction_Sample_Attributes.var_report.xml									phs001377.v1.p1	Cocaine-Related Disorders
152.0	152.0		11/21/2016	241.0		89.0	./data/phs000341.v2.pht003165.v1.p1.Hypodiploid_ALL_Subject_Phenotypes.var_report.xml	0.0	120.5	44.55	89.0			120.5		phs000341.v2.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2021/03/17				./data/phs002048.v2.pht010315.v2.p1.SLE_Sample.var_report.xml									phs002048.v2.p1	Lupus Erythematosus, Systemic
876.0	980.0		08/27/2012	779.0		876.0	./data/phs000168.v2.pht000707.v2.p2.LOAD610K_Subject_Phenotypes.var_report.xml	0.0	86.0	948.9	980.0			86.0		phs000168.v2.p2	Alzheimer Disease
5031.0	7019.0		2021/08/08	12050.0		5031.0	./data/phs001644.v2.pht009944.v2.p2.TOPMed_CCDG_BioME_Subject.var_report.xml	0.0	6025.0	1406	7019.0			6025.0		phs001644.v2.p2	Coronary Artery Disease
			09/11/2014				./data/phs000790.v1.pht004017.v1.p1.Colorectal_Cancer_Lesions_Subject.var_report.xml									phs000790.v1.p1	Colorectal Neoplasms
			2021/08/19				./data/phs001662.v2.pht010074.v1.p1.LTRC_R040_subject_symptom_quest.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2021/07/21				./data/phs002471.v1.pht011413.v1.p1.AATD_iPSCs_Sample_Attributes.var_report.xml									phs002471.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/08/18				./data/phs001201.v2.pht008325.v1.p1.RSVClinicalVariablesSeverity.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			08/20/2013				./data/phs000285.v3.pht001598.v2.p2.B2F04.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/22/2016				./data/phs001152.v1.pht005535.v1.p1.Endometrial_Carcinosarcomas_Sample.var_report.xml									phs001152.v1.p1	Endometrial Neoplasms
			2020/10/01				./data/phs001881.v1.pht010563.v1.p1.CNV_NDD_Sample.var_report.xml									phs001881.v1.p1	Autism Spectrum Disorder
			2021/01/08				./data/phs002309.v1.pht010839.v1.p1.Melanoma_Associated_Vitiligo_Sample.var_report.xml									phs002309.v1.p1	Melanoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000598.v2.p3.simphen199.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/08/03				./data/phs000590.v1.pht008263.v1.p1.angiogram_cerebral.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2019/11/08				./data/phs001330.v2.pht007535.v2.p1.risk_room.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			03/24/2015				./data/phs000196.v3.pht000877.v2.p1.NGRC_Sample.var_report.xml									phs000196.v3.p1	Parkinson Disease
			04/23/2014				./data/phs000378.v1.pht002317.v1.p1.CIDR_Dementia_Sample.var_report.xml									phs000378.v1.p1	Alzheimer Disease
			2019/10/22				./data/phs001917.v1.pht009551.v1.p1.Methylation_PC_Sample_Attributes.var_report.xml									phs001917.v1.p1	Pancreatic Neoplasms
			2019/08/05				./data/phs001867.v1.pht009352.v1.p1.Aging_Cells_Sample.var_report.xml									phs001867.v1.p1	Hutchinson-Gilford Progeria Syndrome
			02/03/2012				./data/phs000419.v1.pht002499.v1.p1.Melanoma_SampleAttributesDS.var_report.xml									phs000419.v1.p1	Melanoma
			2017/12/29				./data/phs001347.v2.pht006795.v2.p1.PRISM_Sample.var_report.xml									phs001347.v2.p1	Infant, Premature
			05/26/2016				./data/phs001107.v1.pht005489.v1.p1.VHL_Renal_Tumors_Sample.var_report.xml									phs001107.v1.p1	von Hippel-Lindau Disease
			08/31/2012				./data/phs000451.v1.pht002603.v1.p1.NECS_Sample.var_report.xml									phs000451.v1.p1	Centenarian
			2020/03/04				./data/phs001892.v1.pht009940.v1.p1.miRNA_Profiling_Subject.var_report.xml									phs001892.v1.p1	
			2020/01/23				./data/phs000287.v7.pht001474.v1.p1.YR10.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2019/11/08				./data/phs001332.v2.pht007448.v2.p1.p7301_12574_functiona.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
8.0	13.0		2020/09/18	21.0		8.0	./data/phs001182.v2.pht005722.v2.p1.Somatic_Mutation_Load_Clone_Cells_Subject_Phenotypes.var_report.xml	0.0	10.5	3.536	13.0			10.5		phs001182.v2.p1	Clonal Evolution
49.0			2020/02/13	98.0			./data/phs001564.v3.pht007991.v3.p1.Urinary_cfDNA_Subject_Phenotypes.var_report.xml	0.0			41.0					phs001564.v3.p1	Bacteriuria
			2021/07/02				./data/phs001782.v2.pht008800.v2.p1.LOI_Stunting_Malian_Subject_Phenotypes.var_report.xml									phs001782.v2.p1	Growth
			2020/12/21				./data/phs000007.v32.pht000023.v4.p13.ex0_21s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/05/15				./data/phs001825.v1.pht009049.v1.p1.5UTR_Mutations_PC_Subject_Phenotypes.var_report.xml									phs001825.v1.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht000020.v3.p13.ex0_18s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/10				./data/phs001424.v1.pht006999.v1.p1.Glioblastoma_Phylogeny_Sample.var_report.xml									phs001424.v1.p1	Glioblastoma
			01/15/2016				./data/phs000883.v1.pht004595.v1.p1.MIGen_PROCARDIS_Subject.var_report.xml									phs000883.v1.p1	Coronary Artery Disease
			2018/08/03				./data/phs000590.v1.pht008267.v1.p1.avid.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
33235.0	47667.0		01/27/2014	80915.0		47.0	./data/phs000674.v1.pht003637.v1.p1.GERA_Pedigree.var_report.xml	0.0	26972.0	24414	47680.0			33201.0		phs000674.v1.p1	Aging
			2020/09/18				./data/phs002015.v1.pht010371.v1.p1.AREDS2_COR.var_report.xml									phs002015.v1.p1	Macular Degeneration
			05/20/2015				./data/phs000180.v3.pht000790.v2.p2.T1DGC_Subject.var_report.xml									phs000180.v3.p2	Diabetes Mellitus, Type 1
			2020/03/19				./data/phs001970.v1.pht010021.v1.p1.DNAMethylation_RMS_Subject.var_report.xml									phs001970.v1.p1	Rhabdomyosarcoma
70.0	70.0		2020/09/28	134.0		64.0	./data/phs002254.v1.pht010539.v1.p1.CF_Nasal_Epithelium_Subject.var_report.xml	0.0	67.0	4.243	64.0			67.0		phs002254.v1.p1	Cystic Fibrosis
			03/01/2016				./data/phs001054.v1.pht005279.v1.p1.Angiocentric_Glioma_Sample_Attributes.var_report.xml									phs001054.v1.p1	Glioma
			2021/05/18				./data/phs002224.v1.pht010847.v1.p1.Crosstalk_Asthma_Subject_Phenotypes.var_report.xml									phs002224.v1.p1	Asthma
			2020/06/18				./data/phs000280.v7.pht004226.v2.p1.UBMGWF01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
46.0	57.0		2020/04/29	103.0		46.0	./data/phs000185.v7.pht008408.v1.p1.Hutterites_FcgammaRIIA_Variant_Effects_Subject_Phenotypes.var_report.xml	0.0	51.5	7.778	57.0			51.5		phs000185.v7.p1	Prospective
			03/12/2013				./data/phs000343.v3.pht003161.v1.p1.vml.var_report.xml									phs000343.v3.p1	Stroke
			11/08/2013				./data/phs000200.v9.pht001506.v2.p3.outc_cardio_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/20/2013				./data/phs000285.v3.pht001703.v2.p2.D1APOE.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
1691.0	12549.0		05/16/2017	20306.0		7757.0	./data/phs001252.v1.pht006400.v1.p1.status.var_report.xml	0.0	10153.0	3388	1055.0			10153.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2018/10/02				./data/phs001664.v1.pht008439.v1.p1.PDCGC_Subject_Phenotypes.var_report.xml									phs001664.v1.p1	Parkinson Disease
			12/01/2015				./data/phs000571.v3.pht003182.v3.p2.FishResults.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2017/12/08				./data/phs001279.v1.pht007219.v1.p1.spirometry.var_report.xml									phs001279.v1.p1	Bronchiectasis
			06/20/2012				./data/phs000455.v1.pht002578.v1.p1.Developmental_Brain_Disorders_Sample_Attributes.var_report.xml									phs000455.v1.p1	Brain Diseases
			2019/03/11				./data/phs000286.v6.pht008762.v1.p2.medcodesV2.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/04/04				./data/phs001527.v1.pht007517.v1.p1.Oral_Microbiome_EAC_Subject.var_report.xml									phs001527.v1.p1	Esophageal Neoplasms
43.0	43.0		2021/05/21	57.0		698.0	./data/phs002331.v1.pht011100.v1.p1.DASH_Subject.var_report.xml	0.0	28.5	895.9	698.0			28.5		phs002331.v1.p1	Drug Users
			04/22/2009				./data/phs000167.v1.pht000719.v1.p1.nonGAIN_Schizophrenia_Sample.var_report_2009_04_22.xml									phs000167.v1.p1	Schizophrenia
			11/08/2013				./data/phs000200.v9.pht001511.v2.p3.outc_fracture_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			02/02/2016				./data/phs001067.v1.pht005285.v1.p1.Meningitis_Encephalitis_Sample.var_report.xml									phs001067.v1.p1	Encephalitis
85.0	769.0		2018/03/09	965.0		90.0	./data/phs001554.v1.pht007609.v1.p1.GECCO_CRC_Susceptibility_Subject_Phenotypes.var_report.xml	0.0	963.5	73.54	90.0			963.5		phs001554.v1.p1	Colorectal Neoplasms
			07/12/2017				./data/phs000592.v1.pht006584.v1.p1.bonemarrowtransplant.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2020/12/21				./data/phs000007.v32.pht002152.v1.p13.ffreq0_21s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/28	1.0			./data/phs000645.v5.pht004704.v1.p1.Intellectual_Disabilities_Subject_Phenotypes.var_report.xml	3.0			1.0					phs000645.v5.p1	Dubowitz Syndrome
			01/26/2015				./data/phs000837.v1.pht004442.v1.p1.22q11DS_Sample_Attributes.var_report.xml									phs000837.v1.p1	Tetralogy of Fallot
			07/25/2013				./data/phs000293.v1.pht003367.v1.p1.Familial_Intracranial_Aneurysm_Sample_Attributes.var_report.xml									phs000293.v1.p1	Intracranial Aneurysm
			11/16/2016				./data/phs001200.v1.pht005926.v1.p1.West_Nile_Virus_NAb_Sample.var_report.xml									phs001200.v1.p1	West Nile Fever
			2017/10/20				./data/phs001156.v2.pht007049.v1.p1.EVE_Sample.var_report.xml									phs001156.v2.p1	Asthma
			2017/07/28				./data/phs001179.v1.pht005668.v1.p1.FM_AD_Subject.var_report.xml									phs001179.v1.p1	Neoplasms
64.0			2017/10/19	2.0			./data/phs001288.v1.pht006766.v1.p1.demographics.var_report.xml	13.0			43.0					phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			08/20/2013				./data/phs000285.v3.pht001707.v2.p2.D1F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000234.v1.p1.DCCT_m9excaif.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/04/14				./data/phs001994.v1.pht010008.v1.p1.Tobacco_HNSCC_Subject.var_report.xml									phs001994.v1.p1	Squamous Cell Carcinoma of Head and Neck
			2018/10/22				./data/phs001674.v1.pht008468.v1.p1.BC_Paired_Tumor_Subject.var_report.xml									phs001674.v1.p1	Breast Neoplasms
			10/25/2013				./data/phs000671.v1.pht003546.v1.p1.Hairy_Cell_Leukemia_Subject.var_report.xml									phs000671.v1.p1	Leukemia, Hairy Cell
			12/06/2016				./data/phs001193.v1.pht005976.v1.p1.Colorectal_Cancer_Hispanic_Sample_Attributes.var_report.xml									phs001193.v1.p1	Colorectal Neoplasms
6.0	7.0		2021/03/24	804.0		6.0	./data/phs000720.v4.pht003878.v2.p1.Pediatric_Rhabdomyosarcoma_Subject.var_report.xml	3.0	6.5	153.4	7.0			6.5		phs000720.v4.p1	Rhabdomyosarcoma
			03/01/2012				./data/phs000401.v1.pht002474.v1.p1.ESP_FHS_Subject.var_report.xml									phs000401.v1.p1	Cardiovascular Diseases
641.0			11/07/2014	1366.0			./data/phs000821.v1.pht004339.v1.p1.DNA_Methylation_Age_Scottish_Subject_Phenotypes.var_report.xml	0.0			725.0					phs000821.v1.p1	Mortality
			2020/07/15				./data/phs001683.v2.pht008866.v2.p1.CSER_Pediatric_Cancer_Care_Sample.var_report.xml									phs001683.v2.p1	Genes, Neoplasm
			2021/06/09				./data/phs002448.v1.pht011301.v1.p1.BC_CDK4_6_Sample_Attributes.var_report.xml									phs002448.v1.p1	Immunologic Memory
			08/20/2013				./data/phs000285.v3.pht001812.v2.p2.F1F09ASP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/17				./data/phs002226.v1.pht011066.v1.p1.MACS_Sample_Attributes.var_report.xml									phs002226.v1.p1	HIV
30.0	66.0		2021/01/15	96.0		30.0	./data/phs002240.v1.pht010861.v1.p1.Sex_Differences_Placentas_Subject.var_report.xml	0.0	48.0	25.46	66.0			48.0		phs002240.v1.p1	Birth Weight
			10/07/2016				./data/phs000497.v3.pht002714.v3.p2.Hirschsprung_Disease_Sample_Attributes.var_report.xml									phs000497.v3.p2	Disease, Hirschsprung
			2021/07/13				./data/phs001545.v2.pht009967.v1.p1.TOPMed_CCDG_INSPIRE_AF_Sample_Attributes.var_report.xml									phs001545.v2.p1	Atrial Fibrillation
			07/09/2012				./data/phs000511.v1.pht002817.v1.p1.Hypertriglyceridemia_I_III_V_Sample.var_report.xml									phs000511.v1.p1	Hypertriglyceridemia
			2021/05/07				./data/phs001327.v2.pht006559.v2.p1.CCSS_Sample.var_report.xml									phs001327.v2.p1	Neoplasm
			10/24/2012				./data/phs000542.v1.pht003015.v1.p1.Mendelian_Neonatal_Diabetes_Subject.var_report.xml									phs000542.v1.p1	Pancreatic beta cell agenesis with neonatal diabetes mellitus
			11/04/2014				./data/phs000086.v3.pht000359.v1.p1.EDIC_f1442.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/10/04				./data/phs000920.v5.pht004898.v5.p3.TOPMed_WGS_GALAII_Sample.var_report.xml									phs000920.v5.p3	Lung Diseases
			2020/06/18				./data/phs000280.v7.pht004195.v2.p1.SBPD04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/24/2017				./data/phs000576.v1.pht006146.v1.p1.diethistory.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2019/10/11				./data/phs001406.v1.pht007747.v1.p1.attix_test_retestds.var_report.xml									phs001406.v1.p1	Cognition
			05/09/2016				./data/phs001043.v1.pht005315.v1.p1.Adjuvant_Aromatase_Inhibitors_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs001043.v1.p1	Neoplasm
			2019/03/11				./data/phs000286.v6.pht008753.v1.p2.hhxa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			10/12/2010				./data/phs000203.v1.pht000883.v1.p1.eMERGE_PAD_Sample.var_report_2010_10_12.xml									phs000203.v1.p1	Peripheral Vascular Diseases
			2021/03/18				./data/phs002361.v1.pht011070.v1.p1.Pneumococcal_Vaccines_Elderly_Sample_Attributes.var_report.xml									phs002361.v1.p1	
			2020/06/18				./data/phs000280.v7.pht006415.v1.p1.ABI_DERV.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000101.v8.p13.pft1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/02/06				./data/phs001745.v1.pht008601.v1.p1.Lung_eQTL_Sample_Attributes.var_report.xml									phs001745.v1.p1	Smoking
22.0	29.0		06/04/2013	51.0		22.0	./data/phs000581.v1.pht003206.v1.p1.ESP_Dilated_Cardiomyopathy_Subject_Phenotypes.var_report.xml	0.0	25.5	4.95	29.0			25.5		phs000581.v1.p1	Cardiomyopathy, Dilated
			2020/12/21				./data/phs000007.v32.pht000175.v8.p13.tnfr1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/05/20				./data/phs001032.v6.pht005100.v2.p2.TOPMed_WGS_VUH_AF_Sample_Attributes.var_report.xml									phs001032.v6.p2	Atrial Fibrillation
35.0	794.0		08/20/2013	837.0		9.0	./data/phs000285.v3.pht001762.v2.p2.E1F08CP.var_report.xml	324.0	47.67	76.54	39.0			6.0		phs000285.v3.p2	Cardiovascular Diseases
			2019/05/21				./data/phs001090.v1.pht009053.v1.p1.CIDR_OFC_African_Sample.var_report.xml									phs001090.v1.p1	Cleft Lip
			2017/10/10				./data/phs001424.v1.pht006998.v1.p1.Glioblastoma_Phylogeny_Subject.var_report.xml									phs001424.v1.p1	Glioblastoma
1.0			2018/06/20	1.0			./data/phs001629.v1.pht008162.v1.p1.BRAF_V600E_Subject_Phenotypes.var_report.xml	0.0								phs001629.v1.p1	Ganglioglioma
			2018/04/12				./data/phs001458.v1.pht007780.v1.p1.Cannabis_Stimulant_Dependence_Sample.var_report.xml									phs001458.v1.p1	Marijuana Abuse
			11/08/2013				./data/phs000200.v9.pht002761.v1.p3.outc_cardio_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			10/16/2014				./data/phs000713.v1.pht004274.v1.p1.GDNF_Anxiety_Depression_Sample_Attributes.var_report.xml									phs000713.v1.p1	Anxiety
			07/25/2014				./data/phs000622.v1.pht003953.v1.p1.Denver_PCScores_Age_noSchool.var_report.xml									phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2020/12/18				./data/phs001073.v2.pht005952.v2.p1.Epigenetics_Malnutrition_Subject.var_report.xml									phs001073.v2.p1	Stunting
			10/05/2015				./data/phs000983.v1.pht005007.v1.p1.Rheumatoid_Arthritis_Therapy_Sample_Attributes.var_report.xml									phs000983.v1.p1	Arthritis, Rheumatoid
			2018/08/03				./data/phs000590.v1.pht008264.v1.p1.angiogram_coronary.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			02/13/2015				./data/phs000867.v1.pht004482.v1.p1.FUSION_Cohort_Sample.var_report.xml									phs000867.v1.p1	Diabetes Mellitus, Type 2
			2021/05/11				./data/phs002340.v1.pht010937.v1.p1.scAtlas_Gynecological_Malignancies_Sample.var_report.xml									phs002340.v1.p1	Carcinoma, Ovarian Epithelial
			2019/04/19				./data/phs001808.v1.pht008972.v1.p1.B_Lymphocytes_Aging_Subject.var_report.xml									phs001808.v1.p1	Aging
			2020/07/17				./data/phs000480.v1.pht002907.v1.p1.FBCS_Subject_Phenotypes.var_report.xml									phs000480.v1.p1	Breast Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000504.v2.p3.simphen105.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			02/21/2012				./data/phs000398.v1.pht002465.v1.p1.ESP_ARIC_Subject.var_report.xml									phs000398.v1.p1	Cardiovascular Diseases
			2020/06/18				./data/phs001787.v1.pht009045.v1.p1.CRC_High_Risk_Families_Subject_Phenotypes.var_report.xml									phs001787.v1.p1	Colorectal Neoplasms, Hereditary Nonpolyposis
			02/23/2016				./data/phs001038.v1.pht005208.v1.p1.Melanoma_DNMTi_Immunotherapy_Subject_Phenotypes.var_report.xml									phs001038.v1.p1	Melanoma
			08/20/2013				./data/phs000285.v3.pht001654.v2.p2.C1F05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/13/2015				./data/phs000985.v1.pht005104.v1.p1.PrCa_Risk_SNPs_Sample_Attributes.var_report.xml									phs000985.v1.p1	
515.0	814.0		2021/02/23	780.0		3.0	./data/phs002230.v1.pht010962.v1.p1.TSP_Hypertension_Pedigree.var_report.xml	0.0	444.0	410.1	814.0			515.0		phs002230.v1.p1	Hypertension
			2020/12/18				./data/phs001073.v2.pht005956.v2.p1.Epigenetics_Malnutrition_Sample_Attributes.var_report.xml									phs001073.v2.p1	Stunting
			10/17/2011				./data/phs000265.v3.pht001272.v3.p1.HMP_Pediatric_Abdominal_Pain_IBD_Subject.var_report.xml									phs000265.v3.p1	Irritable Bowel Syndrome
			07/31/2015				./data/phs000957.v1.pht004852.v1.p1.eMERGE_III_MyCode_Subject.var_report.xml									phs000957.v1.p1	Aortic Aneurysm, Abdominal
12.0	12.0		04/14/2014	20.0		8.0	./data/phs000732.v1.pht003801.v1.p1.L1_Retrotransposon_Asian_Subject_Phenotypes.var_report.xml	0.0	10.0	2.828	8.0			10.0		phs000732.v1.p1	Molecular Structure
			2020/12/21				./data/phs000007.v32.pht010742.v1.p13.t_pftprealb_ex03_7_0817s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/22/2016				./data/phs001146.v1.pht005546.v1.p1.Endometrial_Cells_eQTL_Sample_Attributes.var_report.xml									phs001146.v1.p1	Fertility
			2017/09/22				./data/phs001392.v1.pht006908.v1.p1.scid_early_life.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2019/02/05				./data/phs000748.v7.pht003889.v7.p4.MMRF_Sample.var_report.xml									phs000748.v7.p4	Multiple Myeloma
			2020/06/18				./data/phs000280.v7.pht004123.v2.p1.LIPC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004142.v2.p1.PFTA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
87.0	87.0		2018/03/09	469.0		87.0	./data/phs000783.v2.pht006292.v1.p1.CDH_Pedigree.var_report.xml	0.0	98.33	89.29	87.0			87.0		phs000783.v2.p1	Hernias, Diaphragmatic, Congenital
			2020/06/18				./data/phs000280.v7.pht004176.v2.p1.RTASBM33.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
6.0	7.0		2019/08/05	13.0		6.0	./data/phs001867.v1.pht009353.v1.p1.Aging_Cells_Subject_Phenotypes.var_report.xml	0.0	6.5	0.7071	7.0			6.5		phs001867.v1.p1	Hutchinson-Gilford Progeria Syndrome
			2019/01/07				./data/phs001733.v1.pht008617.v1.p1.Early_Onset_PTD_Sample.var_report.xml									phs001733.v1.p1	Dystonia
			11/16/2015				./data/phs000980.v1.pht004961.v1.p1.NSCLC_Pembrolizumab_Subject.var_report.xml									phs000980.v1.p1	Carcinoma, Non-Small-Cell Lung
5.0	7.0		2021/09/30	7.0		5.0	./data/phs002614.v1.pht011588.v1.p1.BWS_HB_Subject.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs002614.v1.p1	Beckwith-Wiedemann Syndrome
			2021/01/13				./data/phs001480.v1.pht010832.v1.p1.PRO_CIPN_Subject_Phenotypes.var_report.xml									phs001480.v1.p1	Peripheral Nervous System Diseases/drug effects
			2018/04/16				./data/phs001326.v1.pht007822.v1.p1.pidtc_19188_day100tre.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2018/08/13				./data/phs001247.v1.pht008301.v1.p1.GMKF_CCDD_Sample_Attributes.var_report.xml									phs001247.v1.p1	Cranial Nerve Diseases
			2019/05/07				./data/phs001409.v1.pht006801.v1.p1.Uterine_Fibroids_AA_EA_Sample_Attributes.var_report.xml									phs001409.v1.p1	Leiomyoma
			11/05/2014				./data/phs000209.v13.pht001123.v7.p3.MESA_ThruYear2011Events.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004064.v2.p1.DERIVE37.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/04/28				./data/phs001500.v2.pht007245.v2.p1.Melanocyte_QTL_Sample.var_report.xml									phs001500.v2.p1	Melanocytes
			2020/06/18				./data/phs000280.v7.pht004189.v2.p1.RTAWM25.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
3437.0	367.0		2021/08/03	7022.0		3437.0	./data/phs001591.v1.pht009692.v1.p1.CIDR_COHRA_Pedigree.var_report.xml	0.0	3511.0	962.4	367.0			3511.0		phs001591.v1.p1	Dental Caries
			2021/05/13				./data/phs001423.v3.pht006985.v3.p2.TIC_Genetics_Sample.var_report.xml									phs001423.v3.p2	Tourette Disorder
			10/09/2014				./data/phs000717.v1.pht003808.v1.p1.Circulating_Tumor_Cells_Subject.var_report.xml									phs000717.v1.p1	Prostatic Neoplasms
			2018/06/07				./data/phs001479.v1.pht008103.v1.p1.STAT5B_Subject_Phenotypes.var_report.xml									phs001479.v1.p1	Lymphadenopathy
			2020/06/18				./data/phs000280.v7.pht004036.v2.p1.ANUT2.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/17/2017				./data/phs001328.v1.pht006311.v1.p1.treatment_history.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			08/20/2013				./data/phs000285.v3.pht001611.v2.p2.B2F09MBC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/07/23				./data/phs000742.v1.pht008119.v1.p1.7_12_Final_DX.var_report.xml									phs000742.v1.p1	Epilepsy
			2017/12/12				./data/phs001405.v1.pht006826.v1.p1.GSK1120212_TNBC_Kinome_Subject.var_report.xml									phs001405.v1.p1	Triple Negative Breast Neoplasms
			07/21/2015				./data/phs000938.v1.pht004783.v1.p1.WES_HybCapture_vs_Amplicon_Subject.var_report.xml									phs000938.v1.p1	
			11/14/2016				./data/phs000741.v2.pht003917.v2.p1.GOLDN_Lipid_Lowering_Sample.var_report.xml									phs000741.v2.p1	Metabolomics
85.0	177.0		2019/06/04	262.0		85.0	./data/phs001817.v1.pht009135.v1.p1.GeneScreen_Subject_Phenotypes.var_report.xml	0.0	131.0	65.05	177.0			131.0		phs001817.v1.p1	Genetics, Population
8.0			06/20/2014	18.0			./data/phs000759.v1.pht003913.v1.p1.High_Risk_AML_Subject_Phenotypes.var_report.xml	0.0			10.0					phs000759.v1.p1	Leukemia, Myeloid, Acute
			04/09/2014				./data/phs000201.v2.pht000886.v1.p1.AML_Subject.var_report.xml									phs000201.v2.p1	Leukemia, Myeloid, Acute
			2020/09/18				./data/phs002015.v1.pht010385.v1.p1.AREDS2_HSP.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2021/07/21				./data/phs002446.v1.pht011404.v1.p1.SjS_Transcriptional_Subject_Phenotypes.var_report.xml									phs002446.v1.p1	Sjogren's Syndrome
			2019/11/27				./data/phs001884.v1.pht009638.v1.p1.Giftedness_Saudi_Arabia_Subject.var_report.xml									phs001884.v1.p1	Intelligence
			2020/12/21				./data/phs000007.v32.pht000674.v7.p13.platagg1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/09/18				./data/phs001182.v2.pht005721.v2.p1.Somatic_Mutation_Load_Clone_Cells_Sample.var_report.xml									phs001182.v2.p1	Clonal Evolution
			2019/11/14				./data/phs001337.v1.pht009621.v1.p1.AACR_GENIE_Sample.var_report.xml									phs001337.v1.p1	Neoplasms
			07/14/2014				./data/phs000708.v1.pht003728.v1.p1.POAT_GEDWR_Sample_Attributes.var_report.xml									phs000708.v1.p1	Thromboembolism
			2020/12/21				./data/phs000007.v32.pht000168.v3.p13.bmd0_2009s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/05				./data/phs001660.v1.pht008414.v1.p1.Paclitaxel_Cohort_LUPG_Sample_Attributes.var_report.xml									phs001660.v1.p1	Paclitaxel
			2017/12/08				./data/phs001279.v1.pht007210.v1.p1.final_diagnosis.var_report.xml									phs001279.v1.p1	Bronchiectasis
			2019/03/25				./data/phs001734.v1.pht008823.v1.p1.Drug_Abuse_ADHD_Subject.var_report.xml									phs001734.v1.p1	Attention Deficit Disorder with Hyperactivity
			2019/08/01				./data/phs000222.v6.pht006857.v2.p2.SBM_sMRI.var_report.xml									phs000222.v6.p2	Huntington Disease
			05/11/2012				./data/phs000414.v1.pht002729.v1.p1.Core_Binding_Factor_AML_Subject.var_report.xml									phs000414.v1.p1	Leukemia, Myeloid, Acute
			2018/07/18				./data/phs001615.v1.pht008244.v1.p1.RA_FLS_Sample_Attributes.var_report.xml									phs001615.v1.p1	Arthritis, Rheumatoid
			2019/09/27				./data/phs001576.v2.pht008213.v1.p2.LDN_6705_Subject.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			03/24/2015				./data/phs000872.v1.pht004572.v1.p1.Autism_Postmortem_Brain_Subject.var_report.xml									phs000872.v1.p1	Autistic Disorder
			2021/03/31				./data/phs002365.v1.pht011089.v1.p1.BWS_Subject_Phenotypes.var_report.xml									phs002365.v1.p1	Beckwith-Wiedemann Syndrome
991.0	991.0		Thu Nov 20 13:23:05 2008	939.0		976.0	./data/phs000139.v1.pht000622.v1.p1.TRIOS_IMSGC_Pedigree.var_report_2008_11_26.xml	0.0	983.5	6.364	976.0			983.5		phs000139.v1.p1	Multiple Sclerosis
98.0	97.0		05/17/2016	880.0		9.0	./data/phs000796.v1.pht005386.v1.p1.OPPERA_Chronic_TMJD_Subject_Phenotypes.var_report.xml	871.0	566.8	985.7	79.0			83.0		phs000796.v1.p1	Temporomandibular Joint Disorders
			2018/05/15	2.0			./data/phs001557.v1.pht007617.v1.p1.MADSEQ_Subject_Phenotypes.var_report.xml	0.0			2.0					phs001557.v1.p1	Hemihyperplasia
431.0	811.0		2019/10/11	2918.0		4.0	./data/phs001406.v1.pht007745.v1.p1.surveyds.var_report.xml	1673.0	972.7	895.2	813.0			430.0		phs001406.v1.p1	Cognition
			08/20/2013				./data/phs000285.v3.pht001836.v2.p2.F1F64.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/09/26				./data/phs000974.v4.pht004909.v3.p3.TOPMed_WGS_FHS_Subject.var_report.xml									phs000974.v4.p3	Cardiovascular Diseases
			06/16/2017				./data/phs001278.v1.pht006269.v1.p1.family_history.var_report.xml									phs001278.v1.p1	Porphyrias
			11/27/2009				./data/phs000016.v2.pht000051.v2.p2.ConnersTeacher.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			09/24/2013				./data/phs000364.v2.pht002261.v2.p1.ChronicLymphocyticLeukemia_Sample.var_report.xml									phs000364.v2.p1	Chronic Lymphocytic Leukemia
			2020/12/21				./data/phs000007.v32.pht000602.v3.p13.echo0_20s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/08				./data/phs001218.v3.pht005959.v1.p1.TOPMed_WGS_GeneSTAR_Sample.var_report.xml									phs001218.v3.p1	Platelet Aggregation
			2021/01/06				./data/phs001383.v1.pht010792.v1.p1.Moebius_Syndrome_Sample.var_report.xml									phs001383.v1.p1	Mobius Syndrome
			2017/12/04				./data/phs000906.v1.pht007145.v1.p1.eMERGE_PGx_Sample.var_report.xml									phs000906.v1.p1	Pharmacogenetics
9873.0	12975.0	4.0	2021/04/08	22848.0	4.586	9873.0	./data/phs001590.v2.pht007893.v2.p1.NESARCIII_Subject_Phenotypes.var_report.xml	0.0	11424.0	2193	12975.0	4.0		11424.0	5.0	phs001590.v2.p1	Alcoholism
			03/21/2012				./data/phs000402.v1.pht002537.v1.p1.ESP_HeartGO_JHS_Subject.var_report_2012_03_21.xml									phs000402.v1.p1	Cardiovascular Diseases
10.0	10.0		2020/04/24	17.0		7.0	./data/phs001829.v1.pht010167.v1.p1.Rectal_Chemoradiation_Subject_Phenotypes.var_report.xml	0.0	8.5	2.121	7.0			8.5		phs001829.v1.p1	Rectal Neoplasms
42.0			10/28/2013	78.0			./data/phs000598.v2.pht003324.v2.p2.EsophagealAdenocarcinoma_Subject_Phenotypes.var_report.xml	0.0			9.0					phs000598.v2.p2	Esophageal Neoplasms
			2020/12/21				./data/phs000007.v32.pht000080.v8.p13.crp1_2s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/12/2017				./data/phs000592.v1.pht006588.v1.p1.diagnosisspecificlaboratory.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2018/11/07				./data/phs001691.v1.pht008535.v1.p1.HTX_Subject.var_report.xml									phs001691.v1.p1	Heterotaxy Syndrome
			04/01/2010				./data/phs000089.v3.pht000802.v2.p2.ParkinsonsDisease_Sample.var_report_2010_04_01.xml									phs000089.v3.p2	Parkinson Disease
962.0	4028.0		2020/11/02	5387.0		27.0	./data/phs002046.v1.pht010625.v1.p1.GTP_aam_Subject_Phenotypes.var_report.xml	0.0	515.3	599.4	4028.0			962.0		phs002046.v1.p1	Stress Disorders, Post-Traumatic
3546.0	3831.0		03/03/2015	7377.0		3546.0	./data/phs000620.v1.pht003892.v1.p1.MCTFR_Substance_Abuse_Pedigree.var_report.xml	0.0	3689.0	363.5	3831.0			3689.0		phs000620.v1.p1	Substance-Related Disorders
			04/24/2012				./data/phs000491.v1.pht002706.v1.p1.Renal_Cell_Carcinoma_GEO.var_report.xml									phs000491.v1.p1	Carcinoma, Renal Cell
			05/19/2016				./data/phs001115.v1.pht005480.v1.p1.Melanoma_Genetic_Analysis_Sample.var_report.xml									phs001115.v1.p1	Melanoma, Cutaneous Malignant
			2020/06/18				./data/phs000280.v7.pht004150.v2.p1.REXB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/23/2011				./data/phs000358.v1.pht002242.v1.p1.PUWMa_Sample.var_report.xml									phs000358.v1.p1	Attention Deficit Hyperactivity Disorder
			01/19/2010				./data/phs000219.v1.pht001096.v1.p1.d_npi_q_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
24.0	29.0		2021/04/19	53.0		24.0	./data/phs002394.v1.pht011131.v1.p1.PDAC_Subject.var_report.xml	0.0	26.5	3.536	29.0			26.5		phs002394.v1.p1	pancreatic cancer
			08/20/2013				./data/phs000285.v3.pht001621.v2.p2.B2F09TOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
55.0	55.0		2021/06/25	99.0		44.0	./data/phs001466.v2.pht009579.v1.p1.TOPMed_WGS_PharmHU_Subject_Phenotypes.var_report.xml	5.0	49.5	9.192	44.0			49.5		phs001466.v2.p1	Sickle Cell Anemia
			09/28/2012				./data/phs000275.v1.pht002970.v1.p1.BWH_MS_Subject.var_report.xml									phs000275.v1.p1	Multiple Sclerosis
			2018/05/14				./data/phs001396.v1.pht006735.v1.p1.Pigmentation_Eastern_Southern_African_Subject.var_report.xml									phs001396.v1.p1	Skin Pigmentation
			2019/06/04				./data/phs001817.v1.pht009136.v1.p1.GeneScreen_Sample_Attributes.var_report.xml									phs001817.v1.p1	Genetics, Population
			2018/02/08				./data/phs001488.v1.pht007391.v1.p1.drugdis.var_report.xml									phs001488.v1.p1	Huntington Disease
			03/06/2017				./data/phs000574.v1.pht005871.v1.p1.medicationlog.var_report.xml									phs000574.v1.p1	Rett Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000522.v2.p3.simphen123.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2017/10/11				./data/phs000578.v1.pht007024.v1.p1.symptoms.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			12/18/2013				./data/phs000677.v1.pht003581.v1.p1.APOBEC_Cytidine_Deaminase_Subject.var_report.xml									phs000677.v1.p1	Neoplasms
			2018/06/07				./data/phs001481.v1.pht008130.v1.p1.IBMFS_Sample.var_report.xml									phs001481.v1.p1	Bone Marrow Failure Syndromes
766.0	881.0		2021/08/27	1655.0		12.0	./data/phs000966.v2.pht005304.v2.p2.Essential_Tremor_Subject.var_report.xml	0.0	551.7	471.1	884.0			762.0		phs000966.v2.p2	Essential Tremor
			2018/04/16				./data/phs001326.v1.pht007813.v1.p1.p6902_19358_dliworksh.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			01/19/2010				./data/phs000219.v1.pht001089.v1.p1.d_lmt_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			05/24/2017				./data/phs000576.v1.pht006143.v1.p1.deathrecord.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2018/03/06				./data/phs000603.v1.pht007551.v1.p1.physicalexaminationform.var_report.xml									phs000603.v1.p1	Apparent mineralocorticoid excess
			2019/01/29				./data/phs001767.v1.pht008659.v1.p1.GC_miRNA_Korean_Subject.var_report.xml									phs001767.v1.p1	Circulating MicroRNA
			2019/04/23				./data/phs001259.v1.pht006088.v1.p1.VIRGO_AMI_Sample.var_report.xml									phs001259.v1.p1	Myocardial Infarction
			08/20/2013				./data/phs000285.v3.pht001705.v2.p2.D1CRP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht003634.v2.p13.t_pftpstalb_ex08_1b_0760s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/10				./data/phs001954.v1.pht009799.v1.p1.ICPC_LUAD_Taiwan_Sample_Attributes.var_report.xml									phs001954.v1.p1	Adenocarcinoma of Lung
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000555.v2.p3.simphen156.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
8.0	8.0		2020/01/10	15.0		7.0	./data/phs001956.v1.pht009787.v1.p1.sc_Liver_Subject_Phenotypes.var_report.xml	0.0	7.5	0.7071	7.0			7.5		phs001956.v1.p1	
9.0	9.0		2021/01/28	13.0		4.0	./data/phs002289.v1.pht010893.v1.p1.YSPORE_SC2_Subject_Phenotypes.var_report.xml	0.0	6.5	3.536	4.0			6.5		phs002289.v1.p1	single-cell analysis
			2020/03/12				./data/phs000673.v4.pht003663.v4.p1.CSER_Sample_Attributes.var_report.xml									phs000673.v4.p1	Neoplasms
			03/21/2017				./data/phs000228.v4.pht002156.v1.p1.EMMES_HMP_DSU.var_report.xml									phs000228.v4.p1	Metagenomics
			2020/03/24				./data/phs001641.v1.pht010035.v1.p1.LabResults.var_report.xml									phs001641.v1.p1	Progressive Patient Care
1.0			02/04/2016	1.0			./data/phs001066.v1.pht005282.v1.p1.ALL_Subject_Phenotypes.var_report.xml	0.0								phs001066.v1.p1	Neoplasms
			2020/07/29				./data/phs002007.v1.pht010171.v1.p1.Innate_Tcells_Sample_Attributes.var_report.xml									phs002007.v1.p1	Lymphocyte Subsets
147.0			2017/12/29	267.0			./data/phs001347.v2.pht006796.v2.p1.PRISM_Subject_Phenotypes.var_report.xml	0.0			120.0					phs001347.v2.p1	Infant, Premature
			2020/08/05				./data/phs002053.v1.pht010446.v1.p1.Pazopanib_RCC_Subject.var_report.xml									phs002053.v1.p1	Carcinoma, Renal Cell
			12/16/2013				./data/phs000559.v1.pht003617.v1.p1.PAGE_EAGLE_BioVU_Cancer_Sample_Attributes.var_report.xml									phs000559.v1.p1	Neoplasms
1.0			02/18/2016	1.0			./data/phs000932.v1.pht004887.v1.p1.COLO_Subject_Phenotypes.var_report.xml	0.0								phs000932.v1.p1	Melanoma
			2021/07/16				./data/phs001603.v2.pht009971.v1.p1.TOPMed_WGS_ChildrensHS_IGERA_Sample_Attributes.var_report.xml									phs001603.v2.p1	Asthma
			2021/05/27				./data/phs002433.v1.pht011260.v1.p1.NP_RNAseq_SARS_CoV2_Sample_Attributes.var_report.xml									phs002433.v1.p1	COVID-19
			2020/06/18				./data/phs000280.v7.pht004066.v2.p1.DHSA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/08/14				./data/phs000803.v2.pht004567.v2.p1.Colon_Cancer_Sample_Attributes.var_report.xml									phs000803.v2.p1	Colonic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001563.v2.p2.A4F05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
89.0	89.0		2021/08/30	113.0		24.0	./data/phs001933.v1.pht011511.v1.p1.TOPMed_CCDG_UCSF_AF_Subject.var_report.xml	0.0	56.5	45.96	24.0			56.5		phs001933.v1.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004049.v5.p1.CDTHPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
81.0	88.0		12/13/2011	57.0		81.0	./data/phs000404.v1.pht002366.v1.p1.GENEVA_Smoking_Cessation_Pedigree.var_report.xml	0.0	9.0	4.95	88.0			9.0		phs000404.v1.p1	Smoking Cessation
			2020/02/06				./data/phs001430.v2.pht009848.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2020/06/18				./data/phs000280.v7.pht004210.v2.p1.UBMDBM02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000405.v2.p3.simphen006.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/18/2011				./data/phs000226.v2.pht002290.v1.p1.STAMPEED_CHS_Subject_Gender.var_report.xml									phs000226.v2.p1	Cardiovascular Diseases
			2017/10/03				./data/phs001382.v1.pht006973.v1.p1.VCRC_5531_Subject.var_report.xml									phs001382.v1.p1	Vasculitis
			2021/01/06				./data/phs002252.v1.pht010671.v1.p1.RCC_Sample_Attributes.var_report.xml									phs002252.v1.p1	Carcinoma, Renal Cell
7.0	901.0		2021/07/20	902.0		7.0	./data/phs001882.v1.pht010490.v1.p1.OncoArray_FOCI_Subject.var_report.xml	248.0	897.5	927.7	901.0			897.5		phs001882.v1.p1	Carcinoma, Ovarian Epithelial
			2020/06/18				./data/phs000280.v7.pht006435.v1.p1.ECA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000562.v2.p3.simphen163.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht009476.v1.p1.GNEps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			03/07/2016				./data/phs000961.v1.pht005331.v1.p1.eMERGE_III_Columbia_GENIE_Sample.var_report.xml									phs000961.v1.p1	
			08/29/2016				./data/phs000126.v2.pht000321.v2.p1.CIDR_PD_Case.var_report.xml									phs000126.v2.p1	Parkinson Disease
			2021/03/05				./data/phs002328.v1.pht010854.v1.p1.EPIPARK_HBS2_Sample.var_report.xml									phs002328.v1.p1	Parkinson Disease
			2019/07/26				./data/phs000588.v1.pht009299.v1.p1.gca_eligibility_checklist.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2019/09/16				./data/phs001534.v1.pht008518.v1.p1.Pathways_Subject.var_report.xml									phs001534.v1.p1	Breast Neoplasms
			05/12/2015				./data/phs000894.v1.pht004661.v1.p1.Acute_Kidney_Injury_Vancomycin_Sample_Attributes.var_report.xml									phs000894.v1.p1	Acute Kidney Injury
			06/17/2013				./data/phs000454.v1.pht003327.v1.p1.HIV_Susceptibility_Sample_Attributes.var_report.xml									phs000454.v1.p1	HIV
			2018/02/08				./data/phs001488.v1.pht007397.v1.p1.htd.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/09/27				./data/phs001576.v2.pht008217.v2.p2.P6705_DATE_OF_VISIT.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			06/12/2017				./data/phs000594.v1.pht006510.v1.p1.TreatmentTable.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2019/10/11				./data/phs001406.v1.pht007742.v1.p1.DCC_Sample.var_report.xml									phs001406.v1.p1	Cognition
			06/01/2017				./data/phs000701.v1.pht005518.v1.p1.InterimMedicalHistory.var_report.xml									phs000701.v1.p1	Angelman Syndrome
5.0	5.0		2018/03/27	7.0		3.0	./data/phs001195.v1.pht006859.v1.p1.Atomoxetine_Methamphetamine_Pedigree.var_report.xml	0.0	6.5	4.95	3.0			6.5		phs001195.v1.p1	Sex/Gender Identity
			04/10/2014				./data/phs000340.v3.pht002208.v2.p1.ETP_T_ALL_Sample.var_report.xml									phs000340.v3.p1	Leukemia, T-cell
			2020/12/21				./data/phs000007.v32.pht000041.v8.p13.vr_diab_ex09_1_1002s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001866.v2.p2.LTSMK.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/16/2013				./data/phs000559.v1.pht003614.v1.p1.PAGE_EAGLE_BioVU_Cancer_Subject.var_report.xml									phs000559.v1.p1	Neoplasms
			2019/08/10				./data/phs001208.v2.pht008656.v1.p1.COGA_SmokeScreen_Sample.var_report.xml									phs001208.v2.p1	Alcoholism
3272.0	3764.0		2019/08/10	7036.0		703.0	./data/phs001208.v2.pht008657.v1.p1.COGA_SmokeScreen_Subject_Phenotypes.var_report.xml	0.0	912.5	649.1	703.0			912.5		phs001208.v2.p1	Alcoholism
			2020/09/18				./data/phs002015.v1.pht010363.v1.p1.AREDS2_AER.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/02/08				./data/phs001488.v1.pht007405.v1.p1.mhcam.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht006442.v1.p1.incafps11.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
149.0	149.0		2019/06/03	279.0		130.0	./data/phs001814.v1.pht009006.v1.p1.Heterotaxy_Demographics.var_report.xml	0.0	139.5	13.44	130.0			139.5		phs001814.v1.p1	Heterotaxy Syndrome
			2020/01/21				./data/phs001936.v1.pht009649.v1.p1.Gastric_Cancer_BDI_Sample_Attributes.var_report.xml									phs001936.v1.p1	Gastrointestinal Neoplasms
			02/01/2016				./data/phs000332.v3.pht003739.v2.p2.CIDR_Preterm_Birth_Boston_Sample_Attributes.var_report.xml									phs000332.v3.p2	Infant, Premature
			2019/03/05				./data/phs001788.v1.pht008814.v1.p1.CNICS_Subject.var_report.xml									phs001788.v1.p1	HIV Infections
			2018/03/23				./data/phs000698.v1.pht007676.v1.p1.expiratory_ctscan_80mas.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000438.v2.p3.simphen039.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
9.0			2020/03/13	50.0			./data/phs000521.v2.pht007040.v2.p1.ea_family_history.var_report.xml	91.0			5.0					phs000521.v2.p1	Ataxia
			2018/06/14				./data/phs001238.v2.pht006036.v1.p1.GENOA_AfricanAmerican_JacksonCAC_LabData.var_report.xml									phs001238.v2.p1	Hypertension
			2018/10/29				./data/phs001678.v1.pht008473.v1.p1.scTCR_Subject_Phenotypes.var_report.xml									phs001678.v1.p1	Humans
			01/19/2010				./data/phs000219.v1.pht001082.v1.p1.d_fam_ad_hist.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2018/09/07				./data/phs001577.v1.pht008352.v1.p1.mCRPC_Subject_Phenotypes.var_report.xml									phs001577.v1.p1	Prostatic Neoplasms, Castration-Resistant
			10/14/2015				./data/phs000879.v1.pht005032.v1.p1.Relapsed_CLL_Subject.var_report.xml									phs000879.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2018/06/07				./data/phs001481.v1.pht008128.v1.p1.IBMFS_Subject.var_report.xml									phs001481.v1.p1	Bone Marrow Failure Syndromes
			2020/11/02				./data/phs002046.v1.pht010628.v1.p1.GTP_aam_Sample_Attributes.var_report.xml									phs002046.v1.p1	Stress Disorders, Post-Traumatic
			2021/03/30				./data/phs002146.v1.pht011085.v1.p1.Chromatin_Transcriptional_Regulation_Sample.var_report.xml									phs002146.v1.p1	
3988.0	3988.0		04/12/2010	7479.0		3491.0	./data/phs000094.v1.pht001137.v1.p1.Oral_Clefts_Pedigree.var_report_2010_04_12.xml	0.0	3740.0	351.4	3491.0			3740.0		phs000094.v1.p1	Cleft Palate
			2020/12/21				./data/phs000007.v32.pht000198.v8.p13.hemostatic1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
15.0	22.0		2018/05/17	37.0		15.0	./data/phs001596.v1.pht007966.v1.p1.Acral_Melanoma_Subject_Phenotypes.var_report.xml	0.0	18.5	4.95	22.0			18.5		phs001596.v1.p1	Melanoma
			2020/06/02				./data/phs001841.v1.pht009908.v1.p1.CADD_GADD_Sample_Attributes.var_report.xml									phs001841.v1.p1	Opioid-Related Disorders
			10/05/2015				./data/phs000969.v1.pht004932.v1.p1.Sensorineural_Hearing_Loss_Sample_Attributes.var_report.xml									phs000969.v1.p1	Bilateral deafness
			2020/01/30				./data/phs001698.v1.pht009601.v1.p1.BPH_Subject.var_report.xml									phs001698.v1.p1	Prostatic Hyperplasia
			2020/02/14				./data/phs000575.v2.pht005894.v2.p1.eligibility.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			07/12/2017				./data/phs000592.v1.pht006596.v1.p1.pastmedicalhistory.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			12/01/2015				./data/phs000571.v3.pht003176.v3.p2.CardiacAbnormalities.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000526.v2.p3.simphen127.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/04/16				./data/phs001326.v1.pht007821.v1.p1.eligibility_form.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/12/21				./data/phs000007.v32.pht000171.v8.p13.psel1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht007767.v1.p13.nsrrid_fhsdbgapid_link_shareid.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/04/20				./data/phs001556.v1.pht007843.v1.p1.BRAINcode_Subject.var_report.xml									phs001556.v1.p1	Parkinson Disease
			03/15/2016				./data/phs001074.v1.pht005343.v1.p1.GeneSTAR_Platelet_Aggregation_iPS_MKs_Sample_Attributes.var_report.xml									phs001074.v1.p1	Platelet Aggregation
			01/05/2016				./data/phs001028.v1.pht005131.v1.p1.Circulating_Tumor_Cells_MBC_Sample_Attributes.var_report.xml									phs001028.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001771.v2.p2.E1F09MHM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007427.v1.p1.uhdr3.var_report.xml									phs001488.v1.p1	Huntington Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000574.v2.p3.simphen175.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
9.0	9.0		04/10/2014	9.0		9.0	./data/phs000306.v4.pht002081.v1.p1.MEC_Prostate_Cancer_AA_Subject_Phenotypes.var_report.xml	0.0	9.0					9.0		phs000306.v4.p1	Prostatic Neoplasms
			2021/05/12				./data/phs000964.v5.pht004838.v1.p1.TOPMed_WGS_JHS_Subject.var_report.xml									phs000964.v5.p1	Cardiovascular Diseases
			08/27/2013				./data/phs000650.v1.pht003487.v1.p1.PediGFR_CKiD_Sample_Attributes.var_report.xml									phs000650.v1.p1	Kidney Diseases
16.0			2018/04/16	29.0			./data/phs001289.v1.pht007794.v1.p1.demographics.var_report.xml	0.0			13.0					phs001289.v1.p1	Andersen Syndrome
			2020/11/02				./data/phs002046.v1.pht010622.v1.p1.GTP_Subject.var_report.xml									phs002046.v1.p1	Stress Disorders, Post-Traumatic
905.0	347.0		08/20/2013	494.0		8.0	./data/phs000285.v3.pht001668.v2.p2.C1F13.var_report.xml	0.0	952.7	949	849.0			944.0		phs000285.v3.p2	Cardiovascular Diseases
40.0	40.0		07/09/2013	75.0		35.0	./data/phs000546.v1.pht003143.v1.p1.ESP_ISGS_Subject_Phenotypes.var_report.xml	0.0	37.5	3.536	35.0			37.5		phs000546.v1.p1	Stroke
			2020/12/21				./data/phs000007.v32.pht010744.v1.p13.t_tonla_ex02_3b_1235s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/05				./data/phs001835.v1.pht009141.v1.p1.Ocular_Melanocytosis_UM_Subject.var_report.xml									phs001835.v1.p1	Uveal melanoma
			2018/03/30				./data/phs001108.v1.pht007711.v1.p1.UCDC_5104_Subject.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
1.0	1.0		2021/03/11	2.0		1.0	./data/phs002368.v1.pht011043.v1.p1.CaBagE_Subject.var_report.xml	0.0	1.0	0	1.0			1.0		phs002368.v1.p1	Amyotrophic Lateral Sclerosis
			2020/06/18				./data/phs000280.v7.pht006485.v1.p1.UC7155VTE.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/10				./data/phs002037.v1.pht010266.v1.p1.Mg_Deficiency_CRC_Sample.var_report.xml									phs002037.v1.p1	Magnesium Deficiency
			2019/03/11				./data/phs000286.v6.pht001969.v2.p2.pula.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/03/25				./data/phs002235.v1.pht010956.v1.p1.GMbC_Microbiome_Sample_Attributes.var_report.xml									phs002235.v1.p1	Gastrointestinal Microbiome
			2018/02/27				./data/phs001064.v1.pht006833.v1.p1.PC_SRC_Bladder_Sample.var_report.xml									phs001064.v1.p1	Carcinoma, Signet Ring Cell
			07/27/2012				./data/phs000297.v1.pht002394.v1.p1.Resistant_HTN_Weight_Height_BMI.var_report.xml									phs000297.v1.p1	Hypertension
89.0	9.0		2020/01/23	9.0		78.0	./data/phs000287.v7.pht001490.v1.p1.YR5NEW.var_report.xml	7.0	8.5	93.34	99.0			8.5		phs000287.v7.p1	Cardiovascular Diseases
	8.0		11/16/2011	13.0		5.0	./data/phs000096.v4.pht001427.v1.p1.HAPO_Minimal_European_Phenotypes.var_report.xml	0.0	6.5	2.121	13.0			6.5		phs000096.v4.p1	Pregnancy Complications
			06/24/2010				./data/phs000282.v1.pht001442.v1.p1.Framingham_CARe_Subject.var_report_2010_06_24.xml									phs000282.v1.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001714.v2.p2.D1F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/09/27				./data/phs001576.v2.pht008220.v2.p2.P6705_LABORATORY_DATA.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			2020/06/18				./data/phs000280.v7.pht006463.v1.p1.PFX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/15				./data/phs001311.v1.pht007921.v1.p1.mexelitine_medication_log.var_report.xml									phs001311.v1.p1	Myotonia
			2019/10/29				./data/phs001465.v1.pht006959.v1.p1.Localized_Prostate_Cancer_Sample_Attributes.var_report.xml									phs001465.v1.p1	Prostate Neoplasm
			07/14/2014				./data/phs000714.v1.pht003753.v1.p1.Spontaneous_Preterm_Birth_Sample_Attributes.var_report.xml									phs000714.v1.p1	Premature Birth
			2019/11/19				./data/phs000572.v8.pht003392.v7.p4.ADSP_Sample.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			2018/08/18				./data/phs001049.v1.pht005228.v1.p1.Relapsed_SCLC_Sample.var_report.xml									phs001049.v1.p1	Small Cell Lung Carcinoma
			08/06/2010				./data/phs000182.v2.pht000796.v1.p1.AMD_MMAP_Subject.var_report_2010_08_06.xml									phs000182.v2.p1	Macular Degeneration
			2018/11/07				./data/phs001691.v1.pht008536.v1.p1.HTX_Sample.var_report.xml									phs001691.v1.p1	Heterotaxy Syndrome
			2017/08/02				./data/phs001384.v1.pht006740.v1.p1.Polyp_To_Cancer_Sample.var_report.xml									phs001384.v1.p1	Colorectal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001852.v2.p2.F2CATECH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			09/27/2010				./data/phs000245.v1.pht001919.v1.p1.Triple_Negative_Breast_Cancer_Sample_Attributes.var_report_2010_09_27.xml									phs000245.v1.p1	Breast Neoplasms
			10/24/2013				./data/phs000618.v1.pht003303.v1.p1.Hypertriglyceridemia_Mexican_Subject_Phenotypes.var_report.xml									phs000618.v1.p1	Hypertriglyceridemia
			08/21/2014				./data/phs000758.v1.pht004000.v1.p1.Congenital_Heart_Defects_Sample.var_report.xml									phs000758.v1.p1	Heart Septal Defects
			2019/07/29				./data/phs001799.v1.pht008877.v1.p1.Neutrophilic_Leukemias_Sample.var_report.xml									phs001799.v1.p1	Leukemia
1.0	1.0		08/21/2015	2.0		1.0	./data/phs000626.v1.pht003432.v1.p1.CD4_Tcells_Healthy_Humans_Subject_Phenotypes.var_report.xml	0.0	1.0	0	1.0			1.0		phs000626.v1.p1	Immune System Processes
			2020/12/18				./data/phs002059.v1.pht010427.v1.p1.CIDR_CHD_Sample_Attributes.var_report.xml									phs002059.v1.p1	Heart Defects, Congenital
			2020/05/26				./data/phs002020.v1.pht010228.v1.p1.ROP_Sample.var_report.xml									phs002020.v1.p1	Retinopathy of Prematurity
			11/04/2014				./data/phs000086.v3.pht000222.v1.p1.DCCT_f023a_sc.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/09/2013				./data/phs000347.v1.pht003124.v1.p1.ESP_Family_Studies_Aortic_Disease_Sample.var_report.xml									phs000347.v1.p1	Aortic Diseases
3903.0	3903.0		2019/03/05	4761.0		858.0	./data/phs001788.v1.pht008817.v1.p1.CNICS_Subject_Phenotypes.var_report.xml	0.0	2381.0	2153	858.0			2381.0		phs001788.v1.p1	HIV Infections
10.0	10.0		08/21/2013	15.0		5.0	./data/phs000641.v1.pht003475.v1.p1.Combined_Immunodeficiency_Multiple_Intestinal_Atresias_Pedigree.var_report.xml	0.0	7.5	3.536	5.0			7.5		phs000641.v1.p1	Immunological Deficiency Syndrome
			2018/09/19				./data/phs001581.v1.pht008382.v1.p1.HNSCC_Cell_Lines_Sample.var_report.xml									phs001581.v1.p1	Head and Neck Neoplasms
			12/07/2015				./data/phs000482.v1.pht002881.v1.p1.Sporadic_Autism_Subject.var_report.xml									phs000482.v1.p1	Autistic Disorder
			2021/03/05				./data/phs001388.v2.pht006880.v1.p1.SIGMA_DMS_Sample_Attributes.var_report.xml									phs001388.v2.p1	Diabetes Mellitus, Type 2
			2021/03/31				./data/phs002365.v1.pht011090.v1.p1.BWS_Sample_Attributes.var_report.xml									phs002365.v1.p1	Beckwith-Wiedemann Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000422.v2.p3.simphen023.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/02/2015				./data/phs000994.v1.pht005065.v1.p1.CTCL_Sezary_Syndrome_Sample_Attributes.var_report.xml									phs000994.v1.p1	Sezary Syndrome
			08/20/2013				./data/phs000285.v3.pht001606.v2.p2.B2F09HBP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			02/18/2016				./data/phs000932.v1.pht004885.v1.p1.COLO_Subject.var_report.xml									phs000932.v1.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht000826.v7.p13.sflt3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/10/30				./data/phs001921.v1.pht009587.v1.p1.DNA_Methylation_PC_Sample_Attributes.var_report.xml									phs001921.v1.p1	Prostatic Neoplasms
			2019/09/16				./data/phs001123.v2.pht006059.v2.p1.CAAPA_Subject.var_report.xml									phs001123.v2.p1	Asthma
			2020/12/21				./data/phs000007.v32.pht005168.v1.p13.t_pftdiff_ex09_1b_0866s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/11/06				./data/phs001441.v1.pht007115.v1.p1.SAB_AA_Sample_Attributes.var_report.xml									phs001441.v1.p1	Staphylococcus aureus
			2020/11/02				./data/phs002046.v1.pht010627.v1.p1.GTP_eur_Sample_Attributes.var_report.xml									phs002046.v1.p1	Stress Disorders, Post-Traumatic
			2021/07/02				./data/phs001017.v1.pht005075.v1.p1.Breast_Cancer_Susceptibility_Sample.var_report.xml									phs001017.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004046.v5.p1.CCELPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/25/2015				./data/phs000712.v1.pht003713.v1.p1.UIC_ACE_Sample_Attributes.var_report.xml									phs000712.v1.p1	Autistic Disorder
9873.0	12975.0		2021/04/08	22848.0		9873.0	./data/phs001590.v2.pht007891.v2.p1.NESARCIII_Subject.var_report.xml	0.0	11424.0	2193	12975.0			11424.0		phs001590.v2.p1	Alcoholism
			2021/09/16				./data/phs001813.v2.pht009037.v2.p1.PC_Integrative_Tissue_Analysis_GEO.var_report.xml									phs001813.v2.p1	Prostatic Neoplasms
			2021/07/08				./data/phs001543.v2.pht009914.v1.p1.AFLMU_Sample_Attributes.var_report.xml									phs001543.v2.p1	Atrial Fibrillation
			2021/08/13				./data/phs001442.v3.pht010300.v1.p2.TEDDY_Cohort_casecntrl_ialist3.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			2018/06/11				./data/phs000220.v2.pht002385.v2.p2.PAGE_MEC_Metabochip_Subject.var_report.xml									phs000220.v2.p2	Neoplasms
			2020/02/19				./data/phs001853.v1.pht009811.v1.p1.GI_Malignancies_Sample.var_report.xml									phs001853.v1.p1	Colorectal Neoplasms
			01/14/2016				./data/phs001050.v1.pht005231.v1.p1.BEAUTY_Subject.var_report.xml									phs001050.v1.p1	Breast Neoplasms
			2019/08/30				./data/phs001331.v2.pht006922.v2.p1.fu_visit_chart_abstraction.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			2018/05/18				./data/phs001315.v1.pht006191.v1.p1.CIDR_GECCO_Colorectal_Cancer_GxE_Subject.var_report.xml									phs001315.v1.p1	Colorectal Neoplasms
			2021/06/07				./data/phs000971.v3.pht004916.v2.p1.ClinSeq_Subject.var_report.xml									phs000971.v3.p1	Atherosclerosis
			2020/10/29				./data/phs000450.v4.pht002529.v3.p1.DLBCL_Subject.var_report.xml									phs000450.v4.p1	Hodgkin Disease
			2017/08/25				./data/phs001079.v2.pht005360.v2.p1.Malignant_Glioblastoma_Sample_Attributes.var_report.xml									phs001079.v2.p1	Glioblastoma
			06/19/2017				./data/phs001381.v1.pht006566.v1.p1.Gut_Microbiome_Colorectal_Polyps_Subject.var_report.xml									phs001381.v1.p1	Colonic Polyps
			2020/12/21				./data/phs000007.v32.pht000032.v8.p13.ex1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/04/12				./data/phs001457.v1.pht007053.v1.p1.AMP_RA_Sample.var_report.xml									phs001457.v1.p1	Arthritis, Rheumatoid
			04/16/2014				./data/phs000249.v2.pht003650.v1.p1.Brain_QTL_Sample_Attributes.var_report.xml									phs000249.v2.p1	DNA Methylation
			11/26/2013				./data/phs000597.v1.pht003199.v1.p1.DNA_Methylation_Prostate_Cancer_Subject.var_report.xml									phs000597.v1.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht010739.v1.p13.t_pettauc_2020_3_1285s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000277.v1.p1.DCCT_m9exhpra.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/01				./data/phs002105.v1.pht010706.v1.p1.Opioid_Pharmacogenomics_Children_Sample.var_report.xml									phs002105.v1.p1	Opioid-Related Disorders
			2017/08/16				./data/phs001055.v1.pht005915.v1.p1.DeNovo_Mutation_Rates_Sample_Attributes.var_report.xml									phs001055.v1.p1	Preterm Birth
7.0	9.0		2021/08/13	16.0		7.0	./data/phs002405.v1.pht011235.v1.p1.PPGL_Subject.var_report.xml	0.0	8.0	1.414	9.0			8.0		phs002405.v1.p1	Paraganglioma
			2021/07/19				./data/phs001606.v2.pht010089.v1.p1.TOPMed_WGS_EGCUT_Sample.var_report.xml									phs001606.v2.p1	Atrial Fibrillation
			06/15/2017				./data/phs001229.v1.pht006547.v1.p1.Follicular_Lymphoma_Seq_Subject.var_report.xml									phs001229.v1.p1	Lymphoma, Follicular
			2018/04/30				./data/phs001322.v2.pht006330.v2.p1.ALS4_Sample.var_report.xml									phs001322.v2.p1	Amyotrophic Lateral Sclerosis 4, Juvenile
608.0			09/26/2013	3912.0			./data/phs000519.v1.pht003248.v1.p1.MelanomaRisk_Subject_Phenotypes.var_report.xml	0.0			787.0					phs000519.v1.p1	Melanoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000478.v2.p3.simphen079.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/04/25				./data/phs000899.v1.pht008943.v1.p1.AmBiGen_Sample.var_report.xml									phs000899.v1.p1	Bipolar Disorder
			2020/12/21				./data/phs000007.v32.pht002348.v2.p13.t_eegshhs_1998_1_0616s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006460.v1.p1.NTR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001830.v2.p2.F1F58.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/05/31				./data/phs001316.v1.pht008002.v1.p1.adverse_event.var_report.xml									phs001316.v1.p1	Andersen Syndrome
96.0	96.0		2018/06/22	9958.0		7.0	./data/phs000298.v4.pht002283.v3.p3.Autism_Sequencing_Collaboration_Subject_Phenotypes.var_report.xml	85.0	81.0	21.92	947.0			81.0		phs000298.v4.p3	Autistic Disorder
			10/24/2016				./data/phs001214.v1.pht005876.v1.p1.Simul_seq_Sample.var_report.xml									phs001214.v1.p1	Esophageal Neoplasms
			11/28/2011				./data/phs000274.v1.pht001277.v1.p1.CIDR_Celiac_Sample.var_report.xml									phs000274.v1.p1	Celiac Disease
			2019/07/22				./data/phs001124.v1.pht009258.v1.p1.Sulfonamide_HS_Sample_Attributes.var_report.xml									phs001124.v1.p1	Drug Hypersensitivity Syndrome
			02/07/2014				./data/phs000632.v1.pht003579.v1.p1.ESP_Hematological_Cancers_Subject_Phenotypes.var_report.xml									phs000632.v1.p1	Hemic and Lymphatic Diseases
			2018/03/09				./data/phs001554.v1.pht007610.v1.p1.GECCO_CRC_Susceptibility_Sample_Attributes.var_report.xml									phs001554.v1.p1	Colorectal Neoplasms
	11215.0	20.0	2021/05/25	11215.0	20.26	11215.0	./data/phs001945.v1.pht010488.v1.p1.CIDR_ACCME_Subject_Phenotypes.var_report.xml	0.0	11215.0	4.035	11215.0	9.0		11215.0	78.0	phs001945.v1.p1	Uterine Cervical Neoplasms
869.0	1239.0		2021/01/27	2108.0		869.0	./data/phs000584.v1.pht010798.v1.p1.CIDR_Longevity_Subject_Phenotypes.var_report.xml	0.0	1054.0	261.6	1239.0			1054.0		phs000584.v1.p1	Longevity
171.0			2018/04/16	227.0			./data/phs001326.v1.pht007829.v1.p1.demographics.var_report.xml	0.0			56.0					phs001326.v1.p1	Severe Combined Immunodeficiency
			2019/05/01				./data/phs001753.v1.pht009017.v1.p1.Nama_Pigmentation_Sample.var_report.xml									phs001753.v1.p1	Skin Pigmentation
			05/21/2013				./data/phs000421.v1.pht003232.v1.p1.FuchsEndothelialCornealDystrophy_Subject.var_report.xml									phs000421.v1.p1	Fuchs&#39; Endothelial Dystrophy
			03/07/2016				./data/phs000961.v1.pht005333.v1.p1.eMERGE_III_Columbia_GENIE_Sample_Attributes.var_report.xml									phs000961.v1.p1	
			11/04/2014				./data/phs000086.v3.pht000332.v1.p1.EDIC_f0422.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
196.0			2019/02/01	356.0			./data/phs001770.v1.pht008685.v1.p1.demographics.var_report.xml	0.0			160.0					phs001770.v1.p1	Dent Disease
			2020/02/18				./data/phs001227.v1.pht005835.v1.p1.WUCADS_Sample_Attributes.var_report.xml									phs001227.v1.p1	Coronary Artery Disease
			2020/12/21				./data/phs000007.v32.pht002142.v7.p13.l_leptin_2005_m_0559s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/22				./data/phs001377.v1.pht006943.v1.p1.Cocaine_Nicotine_Addiction_Sample.var_report.xml									phs001377.v1.p1	Cocaine-Related Disorders
			08/21/2015				./data/phs000626.v1.pht003433.v1.p1.CD4_Tcells_Healthy_Humans_Sample_Attributes.var_report.xml									phs000626.v1.p1	Immune System Processes
			2018/04/05				./data/phs001553.v1.pht007734.v1.p1.eligibility.var_report.xml									phs001553.v1.p1	Charcot-Marie-Tooth Disease
			08/11/2011				./data/phs000365.v1.pht002268.v1.p1.XMEN_Disease_Sample_Attributes.var_report.xml									phs000365.v1.p1	Immune System Diseases
1408.0	4615.0		05/16/2017	7063.0		2448.0	./data/phs001252.v1.pht006397.v1.p1.sixmwlk.var_report.xml	0.0	3532.0	1532	753.0			3532.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
5.0	7.0		2021/04/27	12.0		5.0	./data/phs001908.v2.pht009531.v2.p1.Spatiotemporal_Cerebellum_Subject.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs001908.v2.p1	Neural Stem Cells
			2017/09/22				./data/phs001392.v1.pht006890.v1.p1.p6901_16207_labresult.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			08/20/2013				./data/phs000285.v3.pht001750.v2.p2.DFLWUPT1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004088.v2.p1.ETLC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/05/2016				./data/phs000944.v1.pht004847.v1.p1.eMERGE_PhaseIII_Partners_Biobank_Sample_Attributes.var_report.xml									phs000944.v1.p1	Hypercholesterolemia
			02/10/2014				./data/phs000689.v1.pht003680.v1.p1.Peripheral_T_Cell_Lymphomas_Sample.var_report.xml									phs000689.v1.p1	Lymphoma, T-Cell, Peripheral
			07/30/2015				./data/phs000947.v1.pht004827.v1.p1.SLE_Autoantibodies_Sample.var_report.xml									phs000947.v1.p1	Systemic Lupus Erythematosus
306.0	306.0		2020/09/08	594.0		90.0	./data/phs001110.v3.pht006514.v2.p1.GMKF_CDH_Subject_Phenotypes.var_report.xml	0.0	99.0	12.73	90.0			99.0		phs001110.v3.p1	Hernias, Diaphragmatic, Congenital
			10/21/2015				./data/phs000789.v1.pht004290.v1.p1.CSGNM_Sample.var_report.xml									phs000789.v1.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000567.v2.p3.simphen168.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			02/27/2014				./data/phs000299.v2.pht001881.v2.p1.Genentech_NSCLC_GEO.var_report.xml									phs000299.v2.p1	Lung Neoplasms
			10/31/2014				./data/phs000543.v1.pht002936.v1.p1.PPB_Subject.var_report.xml									phs000543.v1.p1	Pleuropulmonary blastoma [Supplementary Concept]
			2020/12/21				./data/phs000007.v32.pht006021.v1.p13.vr_meno_ex02_72_0720s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/05/15				./data/phs001311.v1.pht007923.v1.p1.mexelitine_short_excercise.var_report.xml									phs001311.v1.p1	Myotonia
			03/19/2015				./data/phs000869.v1.pht004609.v1.p1.BEAGESS_Sample.var_report.xml									phs000869.v1.p1	Esophageal Neoplasms
			03/22/2013				./data/phs000327.v1.pht003013.v1.p1.ESP_HeartGO_SWISS_Sample_Attributes.var_report.xml									phs000327.v1.p1	Stroke
			11/02/2015				./data/phs000994.v1.pht005063.v1.p1.CTCL_Sezary_Syndrome_Sample.var_report.xml									phs000994.v1.p1	Sezary Syndrome
			11/27/2009				./data/phs000016.v2.pht001037.v1.p2.IMAGE_Subject.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			11/04/2014				./data/phs000086.v3.pht000353.v1.p1.EDIC_f0944.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			12/18/2013				./data/phs000677.v1.pht003583.v1.p1.APOBEC_Cytidine_Deaminase_Sample_Attributes.var_report.xml									phs000677.v1.p1	Neoplasms
			Wed Nov 26 07:41:22 2008				./data/phs000017.v3.pht000058.v1.p1.EA_DIGS4_Data.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
4.0	4.0		2019/05/02	6.0		4.0	./data/phs001378.v1.pht006691.v1.p1.FL_Tumors_Subject_Phenotypes.var_report.xml	0.0	4.0	1.414	2.0			4.0		phs001378.v1.p1	Lymphoma, Follicular
			2020/07/10				./data/phs000723.v1.pht005213.v1.p1.Cervical_Adenocarcinoma_Chinese_Sample_Attributes.var_report.xml									phs000723.v1.p1	Uterine Cervical Neoplasms
			2019/08/01				./data/phs001871.v1.pht009362.v1.p1.CCDG_CCC_AA_Sample_Attributes.var_report.xml									phs001871.v1.p1	Cardiovascular Diseases
7.0	7.0		10/15/2012	20.0		3.0	./data/phs000445.v1.pht002506.v1.p1.HIV_SubjectPhenotypesDS.var_report.xml	0.0	5.0	9.899	3.0			5.0		phs000445.v1.p1	HIV
			2017/12/20				./data/phs000577.v1.pht007276.v1.p1.neuropsychformb.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000540.v2.p3.simphen141.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
8.0	2681.0		12/01/2015	5063.0		8.0	./data/phs000571.v3.pht003174.v3.p2.PCGC_Pedigree.var_report.xml	0.0	9.0	212.8	2382.0			9.0		phs000571.v3.p2	Heart Defects, Congenital
98.0	360.0		04/24/2017	712.0		98.0	./data/phs001076.v1.pht005363.v1.p1.IBD_Exome_Subject_Phenotypes.var_report.xml	3.0	343.5	25.46	360.0			343.5		phs001076.v1.p1	Inflammatory Bowel Diseases
			2018/01/18				./data/phs000382.v3.pht002324.v3.p1.CIDR_Joubert_Syndrome_Sample_Attributes.var_report.xml									phs000382.v3.p1	Joubert syndrome 1
37.0	37.0		07/03/2014	49.0		2.0	./data/phs000767.v1.pht003931.v1.p1.UCSD_CLL_Subject_Phenotypes.var_report.xml	0.0	24.5	17.68	12.0			24.5		phs000767.v1.p1	Chronic Lymphocytic Leukemia
2.0			08/06/2013	3.0			./data/phs000646.v1.pht003436.v1.p1.Breakpoint_Detection_LI_WGS_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000646.v1.p1	Chromosome Breakpoints
			11/08/2013				./data/phs000200.v9.pht001518.v3.p3.fust_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			03/31/2017				./data/phs000558.v1.pht006229.v1.p1.NEIGHBOR_POAG_Sample.var_report.xml									phs000558.v1.p1	Glaucoma
2.0	8.0		2018/12/31	10.0		2.0	./data/phs001758.v1.pht008609.v1.p1.FNMTC_Pedigree.var_report.xml	0.0	5.0	4.243	8.0			5.0		phs001758.v1.p1	Thyroid Cancer, Papillary
			04/11/2011				./data/phs000100.v3.pht001125.v1.p1.FUSION_Subject.var_report.xml									phs000100.v3.p1	Diabetes Mellitus, Type 2
90.0	90.0		08/13/2015	94.0		76.0	./data/phs000415.v1.pht002412.v1.p1.CIDR_Tourette_Syndrome_Pedigree.var_report.xml	0.0	83.0	9.899	76.0			83.0		phs000415.v1.p1	Tourette Syndrome
			02/07/2014				./data/phs000632.v1.pht003576.v1.p1.ESP_Hematological_Cancers_Subject.var_report.xml									phs000632.v1.p1	Hemic and Lymphatic Diseases
			2017/08/09				./data/phs001425.v1.pht006756.v1.p1.Melanoma_Immune_Checkpoint_Subject_Phenotypes.var_report.xml									phs001425.v1.p1	Melanoma
			2021/06/07				./data/phs002440.v1.pht011285.v1.p1.ALS_NMJ_Sample_Attributes.var_report.xml									phs002440.v1.p1	Amyotrophic Lateral Sclerosis
			11/04/2014				./data/phs000086.v3.pht000266.v1.p1.DCCT_cbl4.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			12/09/2016				./data/phs000655.v3.pht004377.v2.p1.MacArthur_SubjectPhenotypes.var_report.xml									phs000655.v3.p1	Muscular Dystrophies
810.0	922.0		04/18/2011	978.0		810.0	./data/phs000237.v1.pht002162.v1.p1.NU_VU_T2D_Subject_Phenotypes.var_report.xml	0.0	996.5	98.29	922.0			996.5		phs000237.v1.p1	Diabetes Mellitus, Type 2
			2020/06/18				./data/phs000280.v7.pht004102.v5.p1.HFCHFAPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/19				./data/phs000257.v3.pht003093.v1.p1.HMP_Gut_Crohns_Function_Sample_Attributes.var_report.xml									phs000257.v3.p1	Crohn Disease
			2020/06/18				./data/phs000280.v7.pht004085.v2.p1.ESMC03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/01/18				./data/phs001513.v1.pht007357.v1.p1.Chemo_Resistance_T_ALL_Sample.var_report.xml									phs001513.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			2021/05/20				./data/phs002280.v1.pht010807.v1.p1.scRNA_PBMC_GEO.var_report.xml									phs002280.v1.p1	PBMC &#8211; Peripheral Blood Mononuclear Cells
			11/04/2014				./data/phs000086.v3.pht000628.v1.p1.EDIC_f0953.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/25/2014				./data/phs000622.v1.pht003952.v1.p1.FaceBase_Orofacial_Shape_Africans_Sample.var_report.xml									phs000622.v1.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			03/23/2015				./data/phs000866.v1.pht004622.v1.p1.Bipolar_Disorder_Family_Genomics_Sample_Attributes.var_report.xml									phs000866.v1.p1	Bipolar Disorder
			2021/02/26				./data/phs001754.v4.pht009110.v3.p2.Spit4Science_Subject_Phenotypes.var_report.xml									phs001754.v4.p2	
601.0			05/09/2016	601.0			./data/phs001023.v1.pht005464.v1.p1.Male_Infertility_Subject_Phenotypes.var_report.xml	0.0								phs001023.v1.p1	Azoospermia
91.0	91.0		2018/08/13	899.0		90.0	./data/phs001247.v1.pht008300.v1.p1.GMKF_CCDD_Subject_Phenotypes.var_report.xml	0.0	90.5	3.536	90.0			90.5		phs001247.v1.p1	Cranial Nerve Diseases
			2019/02/11				./data/phs001780.v1.pht008714.v1.p1.African_Demographic_Sample_Attributes.var_report.xml									phs001780.v1.p1	
			2017/08/09				./data/phs000694.v3.pht003757.v3.p2.Clinical_Cancer_Sequencing_Sample_Attributes.var_report.xml									phs000694.v3.p2	Neoplasms
			2020/12/15				./data/phs001473.v1.pht009687.v1.p1.Ibrutinib_CLL_Subject.var_report.xml									phs001473.v1.p1	Leukemia, Lymphoid
44.0	65.0		2018/06/01	7.0		44.0	./data/phs001046.v1.pht005295.v1.p1.progression_treatment_extremes_pheno.var_report.xml	0.0	54.5	14.85	65.0			54.5		phs001046.v1.p1	Macular Degeneration
			2018/03/20				./data/phs000605.v1.pht007627.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2018/09/21				./data/phs001552.v1.pht008393.v1.p1.T2D_GENES_PROMIS_Subject.var_report.xml									phs001552.v1.p1	Diabetes Mellitus, Type 2
			2020/12/21				./data/phs000007.v32.pht000740.v10.p13.vr_birthyr_2020_a_1246s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/12/06				./data/phs001875.v1.pht009653.v1.p1.Venetoclax_Resistance_Sample_Attributes.var_report.xml									phs001875.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2019/03/25				./data/phs001415.v1.pht006687.v1.p1.CIDR_GECCO_CRC_Sample_Attributes.var_report.xml									phs001415.v1.p1	
			2018/05/21				./data/phs001198.v1.pht007866.v1.p1.Methamphetamine_Abstinence_Sample_Attributes.var_report.xml									phs001198.v1.p1	Substance-Related Disorders
			2018/06/14				./data/phs001238.v2.pht006039.v1.p1.GENOA_AfricanAmerican_Phase1_Exam.var_report.xml									phs001238.v2.p1	Hypertension
			04/18/2014				./data/phs000438.v1.pht003321.v1.p1.ACE_Inhibitor_Angioedema_Sample_Attributes.var_report.xml									phs000438.v1.p1	Angioedema
			08/20/2013				./data/phs000285.v3.pht001597.v2.p2.B2F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/08/18				./data/phs001475.v1.pht007582.v1.p1.Infection_Malnutrition_Bangladesh_Subject.var_report.xml									phs001475.v1.p1	Sprue, Tropical
			2021/09/28				./data/phs000988.v5.pht005247.v5.p1.TOPMed_WGS_Asthma_Costa_Rica_Sample.var_report.xml									phs000988.v5.p1	Asthma
			2019/03/28				./data/phs001346.v1.pht006255.v1.p1.CPS_Immunization_P_Falciparum_Sample.var_report.xml									phs001346.v1.p1	Malaria
5.0	5.0		2021/03/22	10.0		5.0	./data/phs002188.v1.pht011031.v1.p1.Lymphoma_Subject.var_report.xml	0.0	5.0	0	5.0			5.0		phs002188.v1.p1	Lymphoma
			05/16/2013				./data/phs000582.v1.pht003245.v1.p1.ESP_FamilialInterstitialPneumonia_Sample_Attributes.var_report.xml									phs000582.v1.p1	Idiopathic Pulmonary Fibrosis
			07/14/2010				./data/phs000204.v1.pht001522.v1.p1.Freeman_Sheldon_Syndrome_Exome_Subject.var_report_2010_07_14.xml									phs000204.v1.p1	Freeman-Sheldon Syndrome
			2019/03/18				./data/phs001796.v1.pht008833.v1.p1.CTS_Nerve_Repair_Sample.var_report.xml									phs001796.v1.p1	Carpal Tunnel Syndrome
			10/07/2016				./data/phs001223.v1.pht005802.v1.p1.AR_Prostate_Cancer_Sample_Attributes.var_report.xml									phs001223.v1.p1	Prostatic Neoplasms
			12/19/2011				./data/phs000381.v1.pht002420.v1.p1.GeM_Controls_Subject.var_report.xml									phs000381.v1.p1	Normalcy
			03/12/2013				./data/phs000343.v3.pht003162.v1.p1.mfo.var_report.xml									phs000343.v3.p1	Stroke
878.0	797.0		05/17/2016	3104.0		878.0	./data/phs000796.v1.pht005385.v1.p1.OPPERA_Chronic_TMJD_Summary_Phenotypes.var_report.xml	0.0	505.5	650.5	797.0			505.5		phs000796.v1.p1	Temporomandibular Joint Disorders
2.0	2.0		08/11/2011	3.0		2.0	./data/phs000365.v1.pht002267.v1.p1.XMEN_Disease_Subject_Phenotypes.var_report.xml	0.0	2.0	0.7071	1.0			2.0		phs000365.v1.p1	Immune System Diseases
15.0	26.0		2018/08/06	41.0		15.0	./data/phs001580.v1.pht008290.v1.p1.HCC_Subject_Phenotypes.var_report.xml	0.0	20.5	7.778	26.0			20.5		phs001580.v1.p1	Thyroid cancer, Hurthle cell
			09/20/2016				./data/phs000801.v2.pht004612.v2.p1.NHL_Subject.var_report.xml									phs000801.v2.p1	Lymphoma, Non-Hodgkin
			10/11/2012				./data/phs000254.v2.pht002224.v2.p1.ESP_LungGO_CF_Subject.var_report.xml									phs000254.v2.p1	Cystic Fibrosis
			01/15/2016				./data/phs000909.v1.pht005250.v1.p1.NEPC_Subject_Phenotypes.var_report.xml									phs000909.v1.p1	Adenocarcinoma
			04/23/2014				./data/phs000378.v1.pht002320.v1.p1.CIDR_Dementia_Sample_Attributes.var_report.xml									phs000378.v1.p1	Alzheimer Disease
85.0	98.0		02/24/2011	184.0		86.0	./data/phs000268.v1.pht002166.v1.p1.CEPH_FamilyPanels_Sample_Phenotypes.var_report_2011_02_24.xml	0.0	92.0	8.485	96.0			92.0		phs000268.v1.p1	Cell Line
			2019/03/27				./data/phs001670.v1.pht008880.v1.p1.DeKAF_Tac_AA_EA_Sample.var_report.xml									phs001670.v1.p1	Tacrolimus
			08/20/2013				./data/phs000285.v3.pht001732.v2.p2.D1F9PRG1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000553.v2.p3.simphen154.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
7980.0	7980.0		04/29/2016	6981.0		7897.0	./data/phs000128.v3.pht000601.v3.p3.share_ped_Pedigree.var_report.xml	0.0	7939.0	6.364	7897.0			7939.0		phs000128.v3.p3	Coronary Disease
			11/04/2014				./data/phs000086.v3.pht000626.v1.p1.EDIC_f0904.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht000294.v2.p13.hsa0_24s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005580.v1.p1.emerge2_autism_historydisease.var_report.xml									phs000888.v1.p1	
			2017/11/09				./data/phs001400.v1.pht006825.v1.p1.Mega_Haplotypes_CRC_Sample_Attributes.var_report.xml									phs001400.v1.p1	Cancer, Colorectal
			11/08/2013				./data/phs000200.v9.pht003416.v1.p3.outc_strk_carotid_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/05/27				./data/phs002034.v1.pht010253.v1.p1.Glioma_Grade_Subject.var_report.xml									phs002034.v1.p1	Glioma
			10/12/2010				./data/phs000203.v1.pht000881.v1.p1.eMERGE_PAD_Phenotype.var_report_2010_10_12.xml									phs000203.v1.p1	Peripheral Vascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000483.v2.p3.simphen084.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/04/02				./data/phs000277.v2.pht002796.v2.p1.Heroin_Dependence_Sample.var_report.xml									phs000277.v2.p1	Heroin Dependence
			2020/06/10				./data/phs002039.v1.pht010273.v1.p1.IAV_IBV_Sample_Attributes.var_report.xml									phs002039.v1.p1	Influenza, Human
			2021/05/10				./data/phs002176.v2.pht010949.v2.p1.PD1_PDL1_SCLC_Sample_Attributes.var_report.xml									phs002176.v2.p1	Small Cell Lung Carcinoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000427.v2.p3.simphen028.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2017/09/27				./data/phs001071.v1.pht005348.v1.p1.CIDR_HD_Onset_Age_Sample_Attributes.var_report.xml									phs001071.v1.p1	Huntington Disease
			2018/05/31				./data/phs001318.v1.pht008019.v1.p1.generallaboratory.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			07/27/2017				./data/phs000596.v1.pht006709.v1.p1.cfq_parent_cg_childrn_age_6to13.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			11/05/2014				./data/phs000209.v13.pht001206.v2.p3.MESA_AncilMesaFMD.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/08/30				./data/phs002457.v1.pht011517.v1.p1.TNBC_BrM_Subject_Phenotypes.var_report.xml									phs002457.v1.p1	Triple Negative Breast Neoplasms
387.0	413.0		12/03/2013	638.0		225.0	./data/phs000551.v1.pht003063.v1.p1.CATHGEN_Subject_Phenotypes.var_report.xml	0.0	319.0	132.9	207.0			319.0		phs000551.v1.p1	Cardiovascular Diseases
	11.0		2021/06/02	11.0		11.0	./data/phs002421.v1.pht011270.v1.p1.ALT_nonMYCN_NBL_Subject.var_report.xml	0.0	11.0					11.0		phs002421.v1.p1	Neuroblastoma
			2020/03/13				./data/phs000521.v2.pht007035.v2.p1.ae_mro_review.var_report.xml									phs000521.v2.p1	Ataxia
			08/20/2013				./data/phs000285.v3.pht001763.v2.p2.E1F09ANG.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/09/2013				./data/phs000546.v1.pht003141.v1.p1.ESP_ISGS_Subject.var_report.xml									phs000546.v1.p1	Stroke
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000565.v2.p3.simphen166.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/01/23				./data/phs000287.v7.pht001466.v2.p1.CHS_Event16.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001088.v1.p1.d_last_meal.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
856.0	1249.0		2017/11/22	2105.0		856.0	./data/phs000313.v4.pht002067.v4.p2.SardiNIA_SubjectPhenotypes.var_report.xml	0.0	1053.0	277.9	1249.0			1053.0		phs000313.v4.p2	Cardiovascular Diseases
			01/16/2015				./data/phs000763.v1.pht004256.v1.p1.COGA_Family_GWAS_Sample_Attributes.var_report.xml									phs000763.v1.p1	Alcoholism
			2021/05/24				./data/phs000922.v2.pht004926.v2.p1.CLL8_Cohort_Subject_Phenotypes.var_report.xml									phs000922.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2020/11/10				./data/phs002161.v1.pht010659.v1.p1.GMKF_EA_TEF_Sample.var_report.xml									phs002161.v1.p1	Tracheoesophageal Fistula
	12.0		2020/08/19	12.0		12.0	./data/phs002075.v1.pht010459.v1.p1.Chorioamniotic_Membranes_Subject_Phenotypes.var_report.xml	0.0	12.0		12.0			12.0		phs002075.v1.p1	Placenta Previa
			2021/08/19				./data/phs001662.v2.pht010053.v2.p1.LTRC_Sample.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			07/25/2014				./data/phs000335.v3.pht003965.v1.p2.LHS_COPD_Sample_Attributes.var_report.xml									phs000335.v3.p2	COPD
			2018/04/16				./data/phs001326.v1.pht007802.v1.p1.pidtc_19292_day0erttr.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			05/11/2012				./data/phs000291.v2.pht002271.v1.p1.LHS_COPD_Sample_Attributes.var_report.xml									phs000291.v2.p1	Pulmonary Disease, Chronic Obstructive
			07/27/2017				./data/phs000596.v1.pht006711.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			2020/12/21				./data/phs000007.v32.pht003316.v9.p13.vr_survcvd_2018_a_1267s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/02/2016				./data/phs001033.v1.pht005201.v1.p1.PAGE_Global_Reference_Panel_Sample.var_report.xml									phs001033.v1.p1	Population
			2019/04/09				./data/phs001805.v1.pht008955.v1.p1.Neoantigens_NSCLC_Sample.var_report.xml									phs001805.v1.p1	Adenocarcinoma of Lung
			2017/09/11				./data/phs000472.v2.pht002593.v2.p1.BRC77_Subject.var_report.xml									phs000472.v2.p1	Breast Neoplasms
			2021/07/13				./data/phs002481.v1.pht011373.v1.p1.SCA_Subject_Phenotypes.var_report.xml									phs002481.v1.p1	Aneuploidy
3.0	3.0		2018/11/26	6.0		3.0	./data/phs001686.v1.pht008565.v1.p1.IL17_PD_Subject_Phenotypes.var_report.xml	0.0	3.0	0.7071	3.0			3.0		phs001686.v1.p1	Parkinson Disease
			2019/05/24				./data/phs001830.v1.pht009116.v1.p1.FGFR2_CCA_Subject.var_report.xml									phs001830.v1.p1	Cholangiocarcinoma
			09/15/2016				./data/phs001044.v1.pht005272.v1.p1.Breast_Cancer_Risk_Pathways_Subject.var_report.xml									phs001044.v1.p1	Breast Neoplasms
			08/20/2013				./data/phs000285.v3.pht001713.v2.p2.D1F06MJ.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			09/10/2015				./data/phs000967.v1.pht004861.v1.p1.Clear_Cell_Endometrial_Cancer_WES_Sample.var_report.xml									phs000967.v1.p1	Endometrial Neoplasms
6.0	6.0		2020/10/27	6.0		6.0	./data/phs001616.v2.pht008540.v2.p2.eMERGEseq_Pedigree.var_report.xml	0.0	6.0	2.828	6.0			6.0		phs001616.v2.p2	Precision Medicine
			03/03/2011				./data/phs000259.v2.pht001243.v2.p1.HMP_Urethral_Males_Subject.var_report.xml									phs000259.v2.p1	Urethritis
			08/29/2016				./data/phs000882.v1.pht005715.v1.p1.PEGASUS_EA_Sample_Attributes.var_report.xml									phs000882.v1.p1	Prostatic Neoplasms
			06/09/2016				./data/phs000955.v1.pht005452.v1.p1.GeCKO_OAI_Sample_Attributes.var_report.xml									phs000955.v1.p1	Osteoarthritis
			01/19/2010				./data/phs000219.v1.pht001058.v1.p1.d_bnefin_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			11/05/2014				./data/phs000209.v13.pht001203.v2.p3.MESA_AncilMesaAorticValvularCalcium.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2017/12/08				./data/phs001279.v1.pht007216.v1.p1.physician_examination.var_report.xml									phs001279.v1.p1	Bronchiectasis
			05/11/2016				./data/phs000963.v1.pht004856.v1.p1.Statins_CV_Subject.var_report.xml									phs000963.v1.p1	Myocardial Revascularization
			2019/03/28				./data/phs001743.v1.pht008924.v1.p1.Urothelial_Cancer_Sample_Attributes.var_report.xml									phs001743.v1.p1	Urologic Neoplasms
			02/24/2012				./data/phs000001.v3.pht002478.v1.p1.AREDS_Sample.var_report.xml									phs000001.v3.p1	Cataract
			2021/01/15				./data/phs002240.v1.pht010865.v1.p1.Sex_Differences_Placentas_Sample_Attributes.var_report.xml									phs002240.v1.p1	Birth Weight
			02/24/2012				./data/phs000001.v3.pht000375.v2.p1.fundus.var_report.xml									phs000001.v3.p1	Cataract
7.0	17.0		08/17/2012	24.0		7.0	./data/phs000518.v1.pht002847.v1.p1.ESP_Family_Studies_IB_Pedigree.var_report.xml	0.0	12.0	7.071	17.0			12.0		phs000518.v1.p1	Bronchiectasis
			2020/12/21				./data/phs000007.v32.pht004363.v4.p13.l_uralcrea_ex07_1b_0380s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000516.v2.p3.simphen117.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004094.v2.p1.FTRD04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005435.v1.p1.uhdr6.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/05/30				./data/phs001222.v1.pht005910.v1.p1.CCDG_T1DGC_Sample_Attributes.var_report.xml									phs001222.v1.p1	Diabetes Mellitus, Type 1
			12/09/2015				./data/phs000937.v1.pht005189.v1.p1.Antisense_Expression_Cancers_Subject.var_report.xml									phs000937.v1.p1	Neoplasms
			2021/05/27				./data/phs002433.v1.pht011258.v1.p1.NP_RNAseq_SARS_CoV2_Sample.var_report.xml									phs002433.v1.p1	COVID-19
			02/24/2012				./data/phs000001.v3.pht000378.v2.p1.hospitalization.var_report.xml									phs000001.v3.p1	Cataract
			2020/12/21				./data/phs000007.v32.pht000013.v3.p13.ex0_11s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1.0			11/04/2015	3.0			./data/phs001016.v1.pht005081.v1.p1.Radial_Glial_Diversity_Subject_Phenotypes.var_report.xml	0.0								phs001016.v1.p1	Neuroglia
			2018/05/17				./data/phs001313.v1.pht007971.v1.p1.adverse_event.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			03/27/2012				./data/phs000331.v1.pht002094.v1.p1.PGRN_RIKEN_Subject_Phenotypes.var_report.xml									phs000331.v1.p1	Long QT Syndrome
			2018/03/20				./data/phs000605.v1.pht007629.v1.p1.DeathRecord.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/03/24				./data/phs001641.v1.pht010028.v1.p1.12MonthPost.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			06/20/2012				./data/phs000455.v1.pht002576.v1.p1.Developmental_Brain_Disorders_Sample.var_report.xml									phs000455.v1.p1	Brain Diseases
			11/18/2016				./data/phs001243.v1.pht005935.v1.p1.BRCA1_Carrier_Sample.var_report.xml									phs001243.v1.p1	Breast Neoplasms
			06/28/2017				./data/phs001303.v1.pht006611.v1.p1.TGCT_Subject.var_report.xml									phs001303.v1.p1	Germinoma
			12/18/2014				./data/phs000841.v1.pht004422.v1.p1.Endometrial_Tumors_Sample_Attributes.var_report.xml									phs000841.v1.p1	Endometrial Carcinomas
904.0	2163.0		07/25/2013	3877.0		904.0	./data/phs000293.v1.pht003364.v1.p1.Familial_Intracranial_Aneurysm_Pedigree.var_report.xml	0.0	1939.0	494.3	2163.0			1939.0		phs000293.v1.p1	Intracranial Aneurysm
			2018/08/03				./data/phs000590.v1.pht008277.v1.p1.fu_vasculitis_meds_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2020/12/21				./data/phs000007.v32.pht000748.v7.p13.t_pat_ex08_1b_0230s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/30/2015				./data/phs000975.v1.pht004933.v1.p1.NHS_Mammographic_Density_Subject.var_report.xml									phs000975.v1.p1	Mammographic density
			04/11/2017				./data/phs000897.v1.pht004637.v1.p1.Early_Stage_Ovarian_Cancer_Subject.var_report.xml									phs000897.v1.p1	Cystadenocarcinoma, Serous
			2018/02/08				./data/phs001488.v1.pht007393.v1.p1.ekg.var_report.xml									phs001488.v1.p1	Huntington Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000556.v2.p3.simphen157.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/10/31				./data/phs001654.v1.pht008442.v1.p1.NSAID_BE_Sample.var_report.xml									phs001654.v1.p1	Barrett Esophagus
			03/12/2013				./data/phs000343.v3.pht003155.v1.p1.ros.var_report.xml									phs000343.v3.p1	Stroke
			2021/06/01				./data/phs001143.v4.pht005906.v1.p1.TOPMed_WGS_BAGS_Sample_Attributes.var_report.xml									phs001143.v4.p1	Asthma
			2019/06/24				./data/phs001848.v1.pht009207.v1.p1.PIK3CG_Sample_Attributes.var_report.xml									phs001848.v1.p1	Immune System Diseases
8.0	8.0		2020/02/04	3.0		8.0	./data/phs001507.v1.pht008698.v1.p1.ET_Turkish_Subject_Phenotypes.var_report.xml	0.0	8.0	2.121	8.0			8.0		phs001507.v1.p1	Essential Tremor
			2018/02/08				./data/phs001488.v1.pht007424.v1.p1.trlab.var_report.xml									phs001488.v1.p1	Huntington Disease
			11/04/2014				./data/phs000086.v3.pht000258.v1.p1.DCCT_f046cmb2.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/05/01				./data/phs001890.v1.pht009545.v1.p1.CIViC_smMIPs_Sample.var_report.xml									phs001890.v1.p1	
			03/12/2013				./data/phs000343.v3.pht002717.v1.p1.cor.var_report.xml									phs000343.v3.p1	Stroke
			11/04/2013				./data/phs000579.v1.pht003280.v1.p1.SmallBowelNeuroendocrineTumors_Sample_Attributes.var_report.xml									phs000579.v1.p1	Intestinal Neoplasms
			2020/12/21				./data/phs000007.v32.pht000030.v9.p13.ex1_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
129.0	137.0		Mon Jun 16 14:31:57 2008	266.0		129.0	./data/phs000102.v1.pht000189.v1.p1.cde_ctl.var_report_2008_08_12.xml	0.0	133.0	5.657	137.0			133.0		phs000102.v1.p1	Cerebrovascular Disorders
			04/09/2014				./data/phs000201.v2.pht000885.v1.p1.AML_Data.var_report.xml									phs000201.v2.p1	Leukemia, Myeloid, Acute
			2017/10/11				./data/phs000578.v1.pht007003.v1.p1.adverse_event.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
40.0			2017/12/20	540.0			./data/phs000577.v1.pht007291.v1.p1.sf_36.var_report.xml	11.0			159.0					phs000577.v1.p1	Urea Cycle Disorders, Inborn
			10/11/2012				./data/phs000254.v2.pht003002.v1.p1.ESP_LungGO_CF_Sample_Attributes.var_report.xml									phs000254.v2.p1	Cystic Fibrosis
			2021/05/07				./data/phs001327.v2.pht011183.v1.p1.chemogroups.var_report.xml									phs001327.v2.p1	Neoplasm
			2019/03/25				./data/phs001747.v1.pht008643.v1.p1.CAREGIVER_Sample.var_report.xml									phs001747.v1.p1	Coronary Disease
58.0	636.0		02/24/2012	975.0		58.0	./data/phs000001.v3.pht000001.v2.p1.genspecphenotype.var_report.xml	0.0	85.0	89.8	636.0			85.0		phs000001.v3.p1	Cataract
			2018/03/09				./data/phs000606.v1.pht007568.v1.p1.crf_dayofsurgery.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2018/12/31				./data/phs001758.v1.pht008608.v1.p1.FNMTC_Subject.var_report.xml									phs001758.v1.p1	Thyroid Cancer, Papillary
			03/18/2010				./data/phs000207.v1.pht001106.v1.p1.CGEMS_Prostate_Subject.var_report.xml									phs000207.v1.p1	Prostatic Neoplasms
2.0	2.0		10/24/2012	4.0		2.0	./data/phs000537.v1.pht003025.v1.p1.Mendelian_fHLH_Subject_Phenotypes.var_report.xml	0.0	2.0	0	2.0			2.0		phs000537.v1.p1	Lymphohistiocytosis, Hemophagocytic
			2018/01/26				./data/phs001417.v1.pht007367.v1.p1.Metastatic_Tumors_cfDNA_Sample_Attributes.var_report.xml									phs001417.v1.p1	Neoplasms
			2019/10/08				./data/phs001911.v1.pht009520.v1.p1.RADseq_Sample_Attributes.var_report.xml									phs001911.v1.p1	Ataxia Telangiectasia
			08/14/2014				./data/phs000615.v1.pht003306.v1.p1.IschemicStroke_Sample.var_report.xml									phs000615.v1.p1	Cerebral infarction
40.0	1824.0		10/05/2010	3021.0		40.0	./data/phs000188.v1.pht000977.v1.p1.QRS_Phenotype.var_report_2010_10_05.xml	0.0	74.0	48.08	1824.0			74.0		phs000188.v1.p1	Heart Conduction System
			2018/02/08				./data/phs001488.v1.pht007379.v1.p1.cgassess.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004130.v2.p1.MSRB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			10/25/2016				./data/phs000371.v2.pht002989.v1.p1.Huntingtons_Disease_Sample_Attributes.var_report.xml									phs000371.v2.p1	Huntington Disease
			2021/07/02				./data/phs001017.v1.pht005076.v1.p1.Breast_Cancer_Susceptibility_Subject_Phenotypes.var_report.xml									phs001017.v1.p1	Breast Neoplasms
			01/19/2010				./data/phs000219.v1.pht001049.v1.p1.d_addiag.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			02/09/2011				./data/phs000330.v1.pht002110.v1.p1.Prostate_Cancer_Characterization_Subject.var_report_2011_02_09.xml									phs000330.v1.p1	Prostatic Neoplasms
			2019/11/08				./data/phs001330.v2.pht007539.v2.p1.registration.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			2020/01/23				./data/phs000287.v7.pht001467.v1.p1.ICD9.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2017/09/22				./data/phs001392.v1.pht006894.v1.p1.pidtc_15773_ndvinelan.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
316.0			2021/07/13	476.0			./data/phs001545.v2.pht009966.v1.p1.TOPMed_CCDG_INSPIRE_AF_Subject_Phenotypes.var_report.xml	0.0			152.0					phs001545.v2.p1	Atrial Fibrillation
			11/04/2014				./data/phs000086.v3.pht000214.v1.p1.DCCT_f0034.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/02/05				./data/phs000748.v7.pht003887.v7.p4.MMRF_Subject.var_report.xml									phs000748.v7.p4	Multiple Myeloma
482.0	482.0		06/10/2015	764.0		282.0	./data/phs000545.v1.pht003764.v1.p1.Chemotherapy_Induced_Mucositis_Subject_Phenotypes.var_report.xml	0.0	382.0	141.4	282.0			382.0		phs000545.v1.p1	Multiple Myeloma
			10/15/2012				./data/phs000445.v1.pht002504.v1.p1.HIV_Subject.var_report.xml									phs000445.v1.p1	HIV
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000455.v2.p3.simphen056.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			06/05/2014				./data/phs000753.v1.pht003877.v1.p1.Lung_Cancer_High_Density_SNP_Sample_Attributes.var_report.xml									phs000753.v1.p1	Lung Neoplasms
			12/02/2015				./data/phs000810.v1.pht004714.v1.p1.HCHS_SOL_Cohort_Sample.var_report.xml									phs000810.v1.p1	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht001110.v8.p3.MESA_Sample.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
7.0	14.0		2017/09/12	21.0		7.0	./data/phs001403.v1.pht006843.v1.p1.NF1_PN_Subject_Phenotypes.var_report.xml	0.0	10.5	4.95	14.0			10.5		phs001403.v1.p1	Neurofibromatosis Type I
			06/12/2017				./data/phs000594.v1.pht006493.v1.p1.AE_MRO_Review.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
3.0	5.0		11/29/2012	8.0		3.0	./data/phs000539.v1.pht003021.v1.p1.Mendelian_Hyperinsulinism_Subject_Phenotypes.var_report.xml	0.0	4.0	1.414	5.0			4.0		phs000539.v1.p1	Hyperinsulinism, Congenital
			2019/08/09				./data/phs001847.v1.pht009379.v1.p1.AML_Subject.var_report.xml									phs001847.v1.p1	Leukemia, Myeloid, Acute
			11/05/2014				./data/phs000209.v13.pht002301.v1.p3.MESA_MesaFamily_LungAirway.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/01/31				./data/phs001712.v1.pht008677.v1.p1.eligibility.var_report.xml									phs001712.v1.p1	Vasculitis
			2021/02/11				./data/phs001711.v1.pht008528.v1.p1.GI_Carcinomas_Sample.var_report.xml									phs001711.v1.p1	Gastrointestinal Neoplasms
			12/01/2015				./data/phs000571.v3.pht003192.v3.p2.Genotype_SampleFileMapping.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2021/07/14				./data/phs002484.v1.pht011400.v1.p1.Aging_Lungs_Sample_Attributes.var_report.xml									phs002484.v1.p1	Lung
			2018/03/08				./data/phs001494.v1.pht007193.v1.p1.ALIVE_Smokescreen_Sample_Attributes.var_report.xml									phs001494.v1.p1	Substance-Related Disorders
45.0			2017/10/11	191.0			./data/phs000578.v1.pht007020.v1.p1.sf_36.var_report.xml	2.0			42.0					phs000578.v1.p1	Nondystrophic myotonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000579.v2.p3.simphen180.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/12/21				./data/phs000007.v32.pht005165.v4.p13.t_mrtbss_2014_m_0961s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001839.v2.p2.F1F67.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
4.0		0.0	2019/02/21	21.0	0.4286		./data/phs001281.v2.pht006133.v2.p1.pedi.var_report.xml	0.0		0.5071	7.0	0.0			1.0	phs001281.v2.p1	Sturge-Weber Syndrome
			2020/01/23				./data/phs000287.v7.pht003697.v2.p1.SHHS1_ecg.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001829.v2.p2.F1F57.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/06/19				./data/phs001776.v1.pht009211.v1.p1.LTG_Pancreas_QTL_Sample_Attributes.var_report.xml									phs001776.v1.p1	Pancreas
			2020/12/21				./data/phs000007.v32.pht006017.v2.p13.t_xrhand_2001_m_0982s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/26				./data/phs001730.v2.pht010133.v1.p1.TOPMed_WGS_CARE_PACT_Sample_Attributes.var_report.xml									phs001730.v2.p1	Asthma
81.0	91.0		2020/01/31	172.0		81.0	./data/phs001934.v1.pht009776.v1.p1.Immune_Aging_Subject_Phenotypes.var_report.xml	0.0	86.0	7.071	91.0			86.0		phs001934.v1.p1	
5.0	5.0		2020/03/19	7.0		2.0	./data/phs001979.v1.pht010001.v1.p1.Skin_SingleCell_Subject_Phenotypes.var_report.xml	0.0	3.5	2.121	2.0			3.5		phs001979.v1.p1	Melanoma
47.0			2021/06/23	65.0			./data/phs001434.v2.pht009858.v1.p1.TOPMed_WGS_miRhythm_Subject_Phenotypes.var_report.xml	0.0			18.0					phs001434.v2.p1	Atrial Fibrillation
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000233.v1.p1.DCCT_master.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/05/15				./data/phs001484.v1.pht007737.v1.p1.ATV_Bilirubin_Subject.var_report.xml									phs001484.v1.p1	Drug-Related Side Effects and Adverse Reactions
			06/20/2013				./data/phs000430.v1.pht003055.v1.p1.HALT_C_Sample_Attributes.var_report.xml									phs000430.v1.p1	Hepatitis C
70.0	76.0		10/07/2016	416.0		88.0	./data/phs000497.v3.pht002713.v3.p2.Hirschsprung_Disease_Subject_Phenotypes.var_report.xml	0.0	73.0	66.47	88.0			73.0		phs000497.v3.p2	Disease, Hirschsprung
			2020/08/17				./data/phs000397.v3.pht003356.v3.p3.LLFS_Sample_Attributes.var_report.xml									phs000397.v3.p3	Longevity
			2020/06/02				./data/phs001339.v1.pht006786.v1.p1.22q11_2_Deletion_Syndrome_Subject.var_report.xml									phs001339.v1.p1	DiGeorge Syndrome
56.0	59.0		11/05/2014	950.0		56.0	./data/phs000209.v13.pht004326.v1.p3.MESA_AncilMesaStressWave1.var_report.xml	0.0	57.5	26.87	59.0			57.5		phs000209.v13.p3	Cardiovascular Diseases
			02/25/2016				./data/phs001014.v1.pht005115.v1.p1.IRAS_Classic_Sample_Attributes.var_report.xml									phs001014.v1.p1	Insulin Resistance
			12/18/2014				./data/phs000841.v1.pht004419.v1.p1.Endometrial_Tumors_Subject.var_report.xml									phs000841.v1.p1	Endometrial Carcinomas
			03/16/2016				./data/phs001000.v1.pht005031.v1.p1.MIGen_Leicester_Sample_Attributes.var_report.xml									phs001000.v1.p1	Myocardial Infarction
			2020/06/18				./data/phs000280.v7.pht006487.v1.p1.UPR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010391.v1.p1.AREDS2_RCF.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2019/11/25				./data/phs001541.v1.pht008305.v1.p1.ANGI_Subject.var_report.xml									phs001541.v1.p1	Anorexia Nervosa
			05/26/2011				./data/phs000289.v2.pht001883.v1.p1.Venous_Thrombosis_Subject.var_report.xml									phs000289.v2.p1	Venous Thrombosis
			11/16/2011				./data/phs000096.v4.pht001424.v4.p1.HAPO_Sample.var_report.xml									phs000096.v4.p1	Pregnancy Complications
			2018/01/30				./data/phs000904.v1.pht004688.v1.p1.Familial_Adenomatous_Polyposis_Sample.var_report.xml									phs000904.v1.p1	Familial Adenomatous Polyposis
			2019/08/06				./data/phs001701.v1.pht009378.v1.p1.INGENIOUS_Sample_Attributes.var_report.xml									phs001701.v1.p1	Metabolism
			2018/10/02				./data/phs001699.v1.pht008400.v1.p1.BC_Epigenetic_Heritability_Sample_Attributes.var_report.xml									phs001699.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000083.v8.p13.carotid1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010389.v1.p1.AREDS2_OPR_RE.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/06/14				./data/phs001238.v2.pht006040.v1.p1.GENOA_AfricanAmerican_Phase1_FamilyHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2019/03/11				./data/phs000286.v6.pht008771.v1.p2.nbhdconditions.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			09/09/2013				./data/phs000266.v4.pht002360.v3.p1.HMP_Dermatitis_Immunodeficiency_MRSA_Sample_Attributes.var_report.xml									phs000266.v4.p1	Dermatitis, Atopic
			2021/03/24				./data/phs002386.v1.pht011083.v1.p1.STOPII_Sample.var_report.xml									phs002386.v1.p1	
6.0	36.0		2019/10/08	53.0		6.0	./data/phs001911.v1.pht009519.v1.p1.RADseq_Subject_Phenotypes.var_report.xml	0.0	17.67	16.07	11.0			11.0		phs001911.v1.p1	Ataxia Telangiectasia
			2021/06/16				./data/phs001412.v3.pht006745.v1.p1.TOPMed_WGS_DHS_Sample.var_report.xml									phs001412.v3.p1	Cardiovascular Disease
	1.0		02/03/2012	1.0		1.0	./data/phs000419.v1.pht002498.v1.p1.Melanoma_SubjectPhenotypesDS.var_report.xml	0.0	1.0		1.0			1.0		phs000419.v1.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht000305.v8.p13.lppla2m3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht003399.v1.p3.fust_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			10/27/2014				./data/phs000628.v1.pht003507.v1.p1.Metastatic_Cervical_Carcinoma_Sample_Attributes.var_report.xml									phs000628.v1.p1	Uterine Cervical Neoplasms
			06/01/2017				./data/phs000701.v1.pht005521.v1.p1.ParentQuest.var_report.xml									phs000701.v1.p1	Angelman Syndrome
7.0	5.0		2020/09/28	8.0		7.0	./data/phs001459.v1.pht007311.v1.p1.AMP_SLE_Subject_Phenotypes.var_report.xml	0.0	4.0	15.56	5.0			4.0		phs001459.v1.p1	Lupus Erythematosus, Systemic
85.0	85.0		2019/10/11	72.0		566.0	./data/phs001380.v1.pht009231.v1.p1.TS_GWAS2_Subject_Phenotypes.var_report.xml	0.0	896.5	688.7	566.0			896.5		phs001380.v1.p1	Tourette Syndrome
			2021/10/04				./data/phs001542.v2.pht009645.v2.p1.TOPMed_WGS_GALAI_Sample_Attributes.var_report.xml									phs001542.v2.p1	
			01/23/2017				./data/phs001246.v1.pht006085.v1.p1.Arhinia_Subject_Phenotypes.var_report.xml									phs001246.v1.p1	Arhinia, choanal atresia, and microphthalmia
			Thu Nov 20 13:23:14 2008				./data/phs000139.v1.pht000643.v1.p1.TRIOS_IMSGC_Sample.var_report_2008_11_26.xml									phs000139.v1.p1	Multiple Sclerosis
			10/25/2011				./data/phs000406.v1.pht002403.v1.p1.Spatiotemporal_Transcriptome_Brain_Sample.var_report.xml									phs000406.v1.p1	Aging
			07/12/2017				./data/phs000592.v1.pht006579.v1.p1.BMF_5401_Subject.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2020/07/24				./data/phs001194.v3.pht005812.v3.p2.PCGC_Cohort_Subject.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			05/20/2015				./data/phs000898.v1.pht004644.v1.p1.Colorectal_Cancer_Mb_Scale_Haplotypes_Sample_Attributes.var_report.xml									phs000898.v1.p1	Colorectal Neoplasms
761.0			10/21/2015	761.0			./data/phs001002.v1.pht005044.v1.p1.CALGB90401_Prostate_Cancer_Subject_Phenotypes.var_report.xml	0.0								phs001002.v1.p1	Prostatic Neoplasms
			2019/07/26				./data/phs000588.v1.pht009303.v1.p1.lvv_physical_exam.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2018/11/19				./data/phs001178.v1.pht008547.v1.p1.GMKF_DSD_Subject.var_report.xml									phs001178.v1.p1	Disorders of Sex Development
			2020/12/21				./data/phs000007.v32.pht004365.v5.p13.t_mrbrwmh_2017_a_1188s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/01/2017				./data/phs000701.v1.pht005520.v1.p1.NeurologicalAssessment.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2020/12/21				./data/phs000007.v32.pht000077.v8.p13.ankle1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/28				./data/phs001346.v1.pht006257.v1.p1.CPS_Immunization_P_Falciparum_Sample_Attributes.var_report.xml									phs001346.v1.p1	Malaria
878.0	878.0		07/17/2012	988.0		838.0	./data/phs000314.v1.pht002071.v1.p1.CIDR_Clubfoot_Subject_Phenotypes.var_report.xml	0.0	858.0	28.28	838.0			858.0		phs000314.v1.p1	Clubfoot
			2020/11/24				./data/phs001700.v1.pht008501.v1.p1.Moyamoya_Sample.var_report.xml									phs001700.v1.p1	Moyamoya Disease
			03/07/2016				./data/phs001083.v1.pht005325.v1.p1.SCLC_Chinese_Sample_Attributes.var_report.xml									phs001083.v1.p1	Small Cell Lung Carcinoma
			2019/05/07				./data/phs001329.v2.pht007173.v2.p1.physical_exam.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/08/26				./data/phs001958.v1.pht009939.v1.p1.caQTL_Sample_Attributes.var_report.xml									phs001958.v1.p1	Mental Disorders
			2021/06/23				./data/phs001434.v2.pht009856.v1.p1.TOPMed_WGS_miRhythm_Subject.var_report.xml									phs001434.v2.p1	Atrial Fibrillation
79.0			2019/10/28	429.0			./data/phs001880.v1.pht009562.v1.p1.CCDG_Emory_Subject_Phenotypes.var_report.xml	0.0			235.0					phs001880.v1.p1	Cardiovascular Diseases
			2021/10/04				./data/phs002238.v1.pht011520.v1.p1.Beat_Childhood_Cancer_Sample.var_report.xml									phs002238.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht005164.v3.p13.t_ctvasclng_2011_m_0952s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/28				./data/phs002001.v1.pht010096.v1.p1.Osimertinib_EGFR_LC_Subject.var_report.xml									phs002001.v1.p1	Lung Neoplasms
			2019/06/13				./data/phs001611.v1.pht009158.v1.p1.Organoid_Profiling_PC_Subject.var_report.xml									phs001611.v1.p1	Neoplasms
			06/12/2017				./data/phs000594.v1.pht006507.v1.p1.PastMedicalHistory.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2021/08/06				./data/phs001783.v2.pht008820.v2.p1.Clinical_Specimens_Sample.var_report.xml									phs001783.v2.p1	Neoplasms
			05/17/2017				./data/phs001328.v1.pht006316.v1.p1.diagnosis.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			07/28/2014				./data/phs000778.v1.pht003970.v1.p1.Vesicoureteral_Reflux_Sample_Attributes.var_report.xml									phs000778.v1.p1	Vesico-Ureteral Reflux
			2019/01/29				./data/phs001767.v1.pht008661.v1.p1.GC_miRNA_Korean_Subject_Phenotypes.var_report.xml									phs001767.v1.p1	Circulating MicroRNA
			11/22/2013				./data/phs000460.v1.pht002547.v1.p1.Recurrent_Nephrolithiasis_Subject.var_report.xml									phs000460.v1.p1	Nephrolithiasis
			2021/07/16				./data/phs001604.v2.pht009986.v1.p1.TOPMed_WGS_ChildrensHS_MetaAir_Sample_Attributes.var_report.xml									phs001604.v2.p1	Asthma
			2020/12/21				./data/phs000007.v32.pht003910.v6.p13.vr_npdates_2019_a_1249s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2.0	4.0		09/01/2015	6.0		2.0	./data/phs000858.v1.pht004461.v1.p1.IVF_Blastocyst_Biopsies_Pedigree.var_report.xml	0.0	3.0	1.414	4.0			3.0		phs000858.v1.p1	Fertilization in Vitro
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000401.v2.p3.simphen002.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/08/10				./data/phs001208.v2.pht008658.v1.p1.COGA_SmokeScreen_Sample_Attributes.var_report.xml									phs001208.v2.p1	Alcoholism
			2018/05/31				./data/phs001318.v1.pht008034.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2020/06/18				./data/phs000280.v7.pht004171.v2.p1.RTABM42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/02/18				./data/phs001227.v1.pht005832.v1.p1.WUCADS_Subject.var_report.xml									phs001227.v1.p1	Coronary Artery Disease
			04/21/2011				./data/phs000336.v1.pht002220.v1.p1.CGEMS_Lung_Cancer_Subject_Phenotypes.var_report.xml									phs000336.v1.p1	Lung Neoplasms
			2020/11/03				./data/phs002279.v1.pht010630.v1.p1.GIMs_Spermatids_Sample.var_report.xml									phs002279.v1.p1	Germ Cells
			05/24/2017				./data/phs000576.v1.pht006139.v1.p1.ARP_5203_Angelman_Syndrome_Subject.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2020/02/03				./data/phs001931.v1.pht009676.v1.p1.CMI_ASCproject_Subject.var_report.xml									phs001931.v1.p1	Sarcoma
73.0	73.0		10/27/2014	76.0		96.0	./data/phs000727.v1.pht003864.v1.p1.Alzheimers_Parkinsons_Extracellular_miRNA_Subject_Phenotypes.var_report.xml	0.0	68.0	7.071	95.0			68.0		phs000727.v1.p1	Alzheimer Disease
			2020/02/06				./data/phs001430.v2.pht008068.v2.p1.laboratory_results.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			08/20/2013				./data/phs000285.v3.pht001730.v2.p2.D1F9MHMA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004112.v2.p1.HPAA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/09/16				./data/phs001813.v2.pht009038.v2.p1.PC_Integrative_Tissue_Analysis_Subject_Phenotypes.var_report.xml									phs001813.v2.p1	Prostatic Neoplasms
			11/26/2013				./data/phs000458.v1.pht003593.v1.p1.POA_Glaucoma_Methylation_Sample_Attributes.var_report.xml									phs000458.v1.p1	Glaucoma, Open-Angle
68.0	70.0		2021/04/28	69.0		68.0	./data/phs002393.v1.pht011136.v1.p1.ABCA4_Subject.var_report.xml	0.0	69.0	7.778	70.0			69.0		phs002393.v1.p1	Retina
			2020/12/21				./data/phs000007.v32.pht000693.v6.p13.vr_meno_ex02_3_0653s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/10				./data/phs002065.v1.pht010771.v1.p1.Genitourinary_Cancers_Subject_Phenotypes.var_report.xml									phs002065.v1.p1	Bladder Neoplasms
			05/19/2016				./data/phs000617.v1.pht005478.v1.p1.diLQTS_European_Sample_Attributes.var_report.xml									phs000617.v1.p1	Long QT Syndrome
115.0	405.0		03/15/2016	750.0		345.0	./data/phs001074.v1.pht005342.v1.p1.GeneSTAR_Platelet_Aggregation_iPS_MKs_Subject_Phenotypes.var_report.xml	0.0	375.0	42.43	135.0			375.0		phs001074.v1.p1	Platelet Aggregation
			2021/03/25				./data/phs002235.v1.pht010955.v1.p1.GMbC_Microbiome_Sample.var_report.xml									phs002235.v1.p1	Gastrointestinal Microbiome
			02/20/2015				./data/phs000431.v2.pht002485.v2.p1.IGAN_Sample_Attributes.var_report.xml									phs000431.v2.p1	Glomerulonephritis, IGA
			2019/10/16				./data/phs001373.v2.pht006701.v2.p2.Human_Microglia_Subject.var_report.xml									phs001373.v2.p2	Epilepsy
			10/28/2011				./data/phs000352.v1.pht002354.v1.p1.Retinoblastoma_GEO.var_report.xml									phs000352.v1.p1	Retinoblastoma
			2018/04/16				./data/phs001326.v1.pht007801.v1.p1.pidtc_17365_timetoeve.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
991.0	991.0		10/12/2010	3385.0		658.0	./data/phs000203.v1.pht001988.v1.p1.eMERGE_PAD_Pedigree.var_report_2010_10_12.xml	0.0	844.0	570.6	658.0			844.0		phs000203.v1.p1	Peripheral Vascular Diseases
			2020/06/18				./data/phs000280.v7.pht004145.v2.p1.PHXA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004229.v2.p1.UDTA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/08/29				./data/phs001333.v2.pht006526.v2.p1.eligibility.var_report.xml									phs001333.v2.p1	Fabry Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000537.v2.p3.simphen138.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/06/10				./data/phs001387.v3.pht008971.v2.p1.TOPMed_WGS_THRV_Sample_Attributes.var_report.xml									phs001387.v3.p1	Blood Pressure
			02/18/2015				./data/phs000509.v1.pht004313.v1.p1.Hepatocellular_Carcinoma_Sequencing_Sample.var_report.xml									phs000509.v1.p1	Carcinoma, Hepatocellular
6.0	6.0		2021/08/18	8.0		2.0	./data/phs002315.v1.pht011314.v1.p1.Integrated_Multimodal_Single_Cell_Subject.var_report.xml	1.0	4.0	2.828	2.0			4.0		phs002315.v1.p1	Single-Cell Analysis
			2020/09/22				./data/phs002211.v1.pht010537.v1.p1.Time_Invariant_Subject_Phenotypes.var_report.xml									phs002211.v1.p1	Bacterial Vaginosis
			2019/12/09				./data/phs001842.v1.pht009243.v1.p1.Sjogrens_Syndrome_Subject.var_report.xml									phs001842.v1.p1	Sjogren&#39;s Syndrome
			2018/04/04				./data/phs001455.v1.pht007757.v1.p1.Dystonia_CIZ1_Subject.var_report.xml									phs001455.v1.p1	Dystonia
			2020/06/18				./data/phs000280.v7.pht006419.v1.p1.ANT.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/03				./data/phs001961.v1.pht011030.v1.p1.LungMAP_Sample_Attributes.var_report.xml									phs001961.v1.p1	Lung
			06/12/2017				./data/phs000594.v1.pht006495.v1.p1.ConclusionofStudyParticipation.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2020/12/21				./data/phs000007.v32.pht005170.v3.p13.t_pftprealb_2005_m_0759s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004043.v2.p1.BPUB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
1.0	3.0		09/21/2016	4.0		2.0	./data/phs000984.v1.pht005767.v1.p1.T2DM_Metformin_Pedigree.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs000984.v1.p1	Diabetes Mellitus, Type 2
			2020/12/21				./data/phs000007.v32.pht000089.v7.p13.hearo1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007401.v1.p1.inexca.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/10/08				./data/phs001911.v1.pht009518.v1.p1.RADseq_Sample.var_report.xml									phs001911.v1.p1	Ataxia Telangiectasia
			08/20/2013				./data/phs000285.v3.pht001619.v2.p2.B2F09SIC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004183.v2.p1.RTASWM42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/08/31				./data/phs000663.v3.pht003551.v3.p3.DILIN_Sample.var_report.xml									phs000663.v3.p3	Drug-Induced Liver Injury
	24.0		2020/12/02	24.0		24.0	./data/phs002287.v1.pht010710.v1.p1.ER_Positive_BC_Subject.var_report.xml	0.0	24.0					24.0		phs002287.v1.p1	Breast Neoplasms
			2020/12/21				./data/phs000007.v32.pht000031.v9.p13.ex1_2s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/17/2017				./data/phs001328.v1.pht006307.v1.p1.concomitant_meds.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			2020/06/18				./data/phs000280.v7.pht004110.v2.p1.HMTCV401.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/02/13				./data/phs000960.v2.pht004842.v2.p1.Biliary_Atresia_Sample.var_report.xml									phs000960.v2.p1	Biliary Atresia
			02/24/2012				./data/phs000001.v3.pht000371.v2.p1.amdlensphenotype.var_report.xml									phs000001.v3.p1	Cataract
8.0	8.0		08/21/2014	28.0		7.0	./data/phs000758.v1.pht004001.v1.p1.Congenital_Heart_Defects_Subject_Phenotypes.var_report.xml	0.0	7.0	1.414	7.0			7.0		phs000758.v1.p1	Heart Septal Defects
			2021/05/07				./data/phs001327.v2.pht006561.v2.p1.CCSS_Sample_Attributes.var_report.xml									phs001327.v2.p1	Neoplasm
			2018/03/23				./data/phs000698.v1.pht007672.v1.p1.fu_physical_exam.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
837.0	837.0		2019/07/01	884.0		724.0	./data/phs001810.v1.pht009065.v1.p1.COCCaINE_Pedigree.var_report.xml	0.0	780.5	81.32	724.0			780.5		phs001810.v1.p1	Cocaine
28.0	52.0		2019/03/18	80.0		28.0	./data/phs001585.v1.pht008828.v1.p1.FALS_Pedigree.var_report.xml	0.0	40.0	70.71	52.0			40.0		phs001585.v1.p1	Amyotrophic Lateral Sclerosis
			06/09/2016				./data/phs001041.v1.pht005392.v1.p1.Melanoma_CTLA_4_Blockade_Subject_Phenotypes.var_report.xml									phs001041.v1.p1	Melanoma
	60.0		2021/02/19	60.0		60.0	./data/phs002273.v1.pht010904.v1.p1.Urine_cfDNA_Subject.var_report.xml	0.0	60.0					60.0		phs002273.v1.p1	Cell-Free Nucleic Acids
			02/10/2014				./data/phs000248.v1.pht001200.v1.p1.HCV_Subject.var_report.xml									phs000248.v1.p1	Hepatitis C
			2020/02/14				./data/phs000575.v2.pht005883.v2.p1.ARP_5202_PWS_EMO_Subject.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			2020/12/21				./data/phs000007.v32.pht002233.v6.p13.l_gdf15_ex06_1_0533s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/12/03				./data/phs001897.v1.pht009540.v1.p1.Peanut_OIT_Subject.var_report.xml									phs001897.v1.p1	Peanut Hypersensitivity
			2020/12/21				./data/phs000007.v32.pht003309.v5.p13.l_bamyl_2001_m_0740s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/04/29				./data/phs001573.v1.pht010178.v1.p1.pRCC_Subject_Phenotypes.var_report.xml									phs001573.v1.p1	Carcinoma, Renal Cell
			2020/06/15				./data/phs002008.v1.pht010200.v1.p1.Orofacial_Enhancers_Sample.var_report.xml									phs002008.v1.p1	Embryonic and Fetal Development
			2020/06/18				./data/phs000280.v7.pht004086.v2.p1.ETLA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/14/2017				./data/phs001297.v1.pht006201.v1.p1.PROP_LymphocyticMarkers_Subject_Phenotypes.var_report.xml									phs001297.v1.p1	Premature Infant
			2021/05/07				./data/phs001327.v2.pht011187.v1.p1.mortality.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/06/18				./data/phs000280.v7.pht004218.v2.p1.UBMF04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000525.v2.p3.simphen126.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/20/2013				./data/phs000285.v3.pht001867.v2.p2.MORBID06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
5.0			2018/04/16	9.0			./data/phs001289.v1.pht007792.v1.p1.familyhistory.var_report.xml	28.0			4.0					phs001289.v1.p1	Andersen Syndrome
			2019/03/20				./data/phs001715.v1.pht008847.v1.p1.study_visit_form.var_report.xml									phs001715.v1.p1	Vasculitis
			10/07/2011				./data/phs000368.v1.pht002294.v1.p1.NU_PCOS_Subject_Phenotypes.var_report.xml									phs000368.v1.p1	Polycystic Ovary Syndrome
587.0	619.0		01/06/2010	664.0		587.0	./data/phs000088.v1.pht000072.v1.p1.GOKIND_NIDDK_Phenotype.var_report_2010_01_06.xml	0.0	603.0	22.63	619.0			603.0		phs000088.v1.p1	Diabetic Nephropathies
			11/08/2013				./data/phs000200.v9.pht000995.v4.p3.f148_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/28/2015				./data/phs000977.v1.pht004956.v1.p1.Desmoplastic_Melanoma_Sample_Attributes.var_report.xml									phs000977.v1.p1	Melanoma
			2019/09/27				./data/phs001648.v2.pht008908.v2.p1.mCRPC_Sample.var_report.xml									phs001648.v2.p1	Prostatic Neoplasms, Castration-Resistant
			06/22/2017				./data/phs001250.v1.pht006327.v1.p1.Primary_Breast_Cancers_Subject_Phenotypes.var_report.xml									phs001250.v1.p1	Breast Neoplasms
			11/04/2014				./data/phs000086.v3.pht000225.v1.p1.DCCT_dtfamcls.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht010745.v1.p13.t_tonla_ex08_1b_1232s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/04/14				./data/phs001947.v1.pht010137.v1.p1.Melanoma_Hu14_18_IL2_GEO.var_report.xml									phs001947.v1.p1	Melanoma
24.0			2019/09/19	31.0			./data/phs001877.v1.pht009483.v1.p1.Mycosis_Fungoides_Subject_Phenotypes.var_report.xml	0.0			7.0					phs001877.v1.p1	Mycosis Fungoides
106.0	106.0		2021/04/28	106.0		106.0	./data/phs001500.v2.pht007244.v2.p1.Melanocyte_QTL_Subject.var_report.xml	0.0	106.0					106.0		phs001500.v2.p1	Melanocytes
			2017/09/11				./data/phs000472.v2.pht002596.v2.p1.BRC77_Sample_Attributes.var_report.xml									phs000472.v2.p1	Breast Neoplasms
			05/13/2015				./data/phs000769.v1.pht004006.v1.p1.LHMP_Sample_Attributes.var_report.xml									phs000769.v1.p1	HIV
			2020/12/21				./data/phs000007.v32.pht000113.v8.p13.vitd1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001800.v2.p2.E1INS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002567.v4.p13.l_mtbllipi2_ex05_1_0661s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005418.v1.p1.mhxdxhd2.var_report.xml									phs001065.v1.p1	Huntington Disease
			12/17/2014				./data/phs000486.v1.pht002805.v1.p1.GODOT_Subject_Phenotypes.var_report.xml									phs000486.v1.p1	Depressive Disorder, Major
			08/20/2013				./data/phs000285.v3.pht001701.v2.p2.CFLWUP1A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/10/11				./data/phs001380.v1.pht009234.v1.p1.TS_Trios_ExomeSeq_Sample_Attributes.var_report.xml									phs001380.v1.p1	Tourette Syndrome
			07/27/2017				./data/phs000596.v1.pht006710.v1.p1.complete_med_hx.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			03/12/2013				./data/phs000343.v3.pht003158.v1.p1.vcf.var_report.xml									phs000343.v3.p1	Stroke
			2020/06/18				./data/phs000280.v7.pht004081.v2.p1.ESHA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/04/16				./data/phs001289.v1.pht007786.v1.p1.atsbaseline_yearlyinvestresults.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			2017/12/20				./data/phs000577.v1.pht007279.v1.p1.neuropsychforme.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			12/13/2011				./data/phs000404.v1.pht002367.v1.p1.GENEVA_Smoking_Cessation_Sample.var_report.xml									phs000404.v1.p1	Smoking Cessation
			03/06/2017				./data/phs000574.v1.pht005860.v1.p1.clinicalseverityscale.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2017/09/22				./data/phs001392.v1.pht006884.v1.p1.deathrecord.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2017/12/04				./data/phs000906.v1.pht007144.v1.p1.eMERGE_PGx_Subject.var_report.xml									phs000906.v1.p1	Pharmacogenetics
			2019/10/11				./data/phs001406.v1.pht007748.v1.p1.attixds.var_report.xml									phs001406.v1.p1	Cognition
40.0	40.0		10/16/2014	77.0		37.0	./data/phs000376.v1.pht002307.v1.p1.CIDR_PD_Exome_Pedigree.var_report.xml	0.0	38.5	2.121	37.0			38.5		phs000376.v1.p1	Parkinson Disease
7440.0			08/29/2016	7440.0			./data/phs000882.v1.pht005714.v1.p1.PEGASUS_EA_Subject_Phenotypes.var_report.xml	0.0								phs000882.v1.p1	Prostatic Neoplasms
			2020/06/18				./data/phs000280.v7.pht004063.v2.p1.DERIVE13.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/08/03				./data/phs000590.v1.pht008281.v1.p1.patientglobalassessment.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2020/05/15				./data/phs001860.v1.pht009454.v1.p1.Autoinflammatory_Disorders_Sample_Attributes.var_report.xml									phs001860.v1.p1	Hereditary Autoinflammatory Diseases
			2020/12/21				./data/phs000007.v32.pht002891.v6.p13.l_il6_2008_m_0433s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/10				./data/phs000791.v2.pht004592.v2.p1.Roadmap_Epigenomics_UCSF_Sample.var_report.xml									phs000791.v2.p1	Neoplasms
			07/03/2014				./data/phs000767.v1.pht003932.v1.p1.UCSD_CLL_Sample_Attributes.var_report.xml									phs000767.v1.p1	Chronic Lymphocytic Leukemia
			07/27/2017				./data/phs000247.v5.pht001284.v4.p3.HMP_Neonatal_Enterocolitis_Pedigree.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			2021/05/12				./data/phs000964.v5.pht004839.v3.p1.TOPMed_WGS_JHS_Sample.var_report.xml									phs000964.v5.p1	Cardiovascular Diseases
			2020/04/30				./data/phs001517.v2.pht007481.v2.p2.GHIRD_Sample.var_report.xml									phs001517.v2.p2	Retinitis Pigmentosa
			2019/08/01				./data/phs001740.v1.pht008620.v1.p1.CCDG_SAGE_Subject.var_report.xml									phs001740.v1.p1	Autism Spectrum Disorder
			2019/08/01				./data/phs000222.v6.pht007350.v1.p2.8oHdG.var_report.xml									phs000222.v6.p2	Huntington Disease
633.0	633.0		05/24/2012	977.0		344.0	./data/phs000394.v1.pht002653.v1.p1.APDGC_Subject_Phenotypes.var_report.xml	0.0	488.5	204.4	344.0			488.5		phs000394.v1.p1	Parkinson Disease
			2020/12/21				./data/phs000007.v32.pht005166.v3.p13.t_pftdiff_2005_m_0762s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/19/2014				./data/phs000348.v2.pht002228.v2.p1.Myeloma_Subject.var_report.xml									phs000348.v2.p1	Multiple Myeloma
			08/20/2013				./data/phs000285.v3.pht001801.v2.p2.E1LEPTIN.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/18/2015				./data/phs000586.v1.pht004831.v1.p1.Alopecia_Areata_Sample.var_report.xml									phs000586.v1.p1	Alopecia Areata
			09/10/2012				./data/phs000434.v1.pht002607.v1.p1.Atypical_Werner_Syndrome_Sample_Attributes.var_report.xml									phs000434.v1.p1	Werner Syndrome
			10/05/2011				./data/phs000396.v1.pht002389.v1.p1.DCEG_Reference_Subject.var_report.xml									phs000396.v1.p1	
			2018/01/04				./data/phs001503.v1.pht007313.v1.p1.WIHS_Subject.var_report.xml									phs001503.v1.p1	HIV
			2018/10/23				./data/phs001692.v1.pht008484.v1.p1.LIFE_Subject.var_report.xml									phs001692.v1.p1	MicroRNAs
			08/20/2013				./data/phs000285.v3.pht001820.v2.p2.F1F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/05/06				./data/phs002023.v1.pht010198.v1.p1.CRPM_Sample_Attributes.var_report.xml									phs002023.v1.p1	Peritoneal Neoplasms
			2018/03/20				./data/phs001559.v1.pht007664.v1.p1.Oxycodone_Abuse_Sample_Attributes.var_report.xml									phs001559.v1.p1	Heroin Dependence
			2020/08/24				./data/phs001744.v1.pht008571.v1.p1.CIDR_HCC_Sample.var_report.xml									phs001744.v1.p1	Liver Neoplasms
			11/05/2014				./data/phs000209.v13.pht002514.v1.p3.MESA_AncilMesaVitaminD.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004174.v2.p1.RTASBF42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/13/2011				./data/phs000426.v1.pht002452.v1.p1.5a_dbGap_SubjectConsent_Subject.var_report.xml									phs000426.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			08/20/2013				./data/phs000285.v3.pht001605.v2.p2.B2F09GAL.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/17/2012				./data/phs000314.v1.pht002068.v1.p1.CIDR_Clubfoot_Subject.var_report.xml									phs000314.v1.p1	Clubfoot
			09/19/2011				./data/phs000389.v1.pht002378.v1.p1.GoKinD_GENIE_Sample.var_report.xml									phs000389.v1.p1	Diabetes Mellitus, Type 1
			11/07/2014				./data/phs000809.v1.pht004345.v1.p1.Glycosylation_Congenital_Disorder_Subject.var_report.xml									phs000809.v1.p1	Congenital Disorders of Glycosylation
			01/19/2010				./data/phs000219.v1.pht001063.v1.p1.d_contact.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			06/14/2010				./data/phs000263.v1.pht001236.v1.p1.HMP_Skin_Acne_Sample.var_report.xml									phs000263.v1.p1	Acne Vulgaris
			2019/08/30				./data/phs001331.v2.pht006930.v2.p1.pulmonary_function_testing.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			08/27/2013				./data/phs000650.v1.pht003485.v1.p1.PediGFR_CKiD_Sample.var_report.xml									phs000650.v1.p1	Kidney Diseases
			2020/01/23				./data/phs000287.v7.pht001477.v1.p1.YR12PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/07/21				./data/phs002471.v1.pht011411.v1.p1.AATD_iPSCs_Sample.var_report.xml									phs002471.v1.p1	alpha 1-Antitrypsin Deficiency
5.0			2017/11/01	12.0			./data/phs001305.v1.pht007104.v1.p1.demographics.var_report.xml	0.0			7.0					phs001305.v1.p1	Urea Cycle Disorders, Inborn
			03/22/2017				./data/phs001181.v1.pht005770.v1.p1.CLL_Multiple_Cell_Clones_Sample.var_report.xml									phs001181.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2017/11/28				./data/phs001482.v1.pht007123.v1.p1.Carrier_Screening_Subject.var_report.xml									phs001482.v1.p1	Infertility
50.0	50.0		2020/12/22	80.0		30.0	./data/phs002301.v1.pht010816.v1.p1.Skull_Based_Chordoma_Subject_Phenotypes.var_report.xml	0.0	40.0	14.14	30.0			40.0		phs002301.v1.p1	chordoma
			2018/01/04				./data/phs001503.v1.pht007315.v1.p1.WIHS_Sample.var_report.xml									phs001503.v1.p1	HIV
			2020/12/21				./data/phs000007.v32.pht000196.v6.p13.t_mrcdlvh_2006_1b_0907s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/11				./data/phs000578.v1.pht007016.v1.p1.quantitative_testing.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			08/20/2013				./data/phs000285.v3.pht001783.v2.p2.E1F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/05				./data/phs001959.v1.pht009789.v1.p1.CLL_SF3B1_Subject.var_report.xml									phs001959.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2019/06/03				./data/phs001292.v2.pht009127.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001292.v2.p1	Angelman Syndrome
119.0	119.0		09/03/2010	221.0		102.0	./data/phs000127.v2.pht000649.v1.p1.IrishALS_Cases_Data.var_report_2010_09_03.xml	0.0	110.5	12.02	102.0			110.5		phs000127.v2.p1	Amyotrophic Lateral Sclerosis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000535.v2.p3.simphen136.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			06/01/2015				./data/phs000346.v2.pht002183.v2.p2.CGEMS_BladderCancer_Subject.var_report.xml									phs000346.v2.p2	Urinary Bladder Neoplasms
			2019/11/08				./data/phs001330.v2.pht007537.v2.p1.cognitive.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			11/04/2014				./data/phs000086.v3.pht000736.v2.p1.DCCT_EDIC_Sample.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/27/2017				./data/phs000596.v1.pht006718.v1.p1.spirometry.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			06/28/2017				./data/phs001303.v1.pht006614.v1.p1.TGCT_Sample_Attributes.var_report.xml									phs001303.v1.p1	Germinoma
			2020/03/13				./data/phs000521.v2.pht007033.v2.p1.CINCH_5302_Subject.var_report.xml									phs000521.v2.p1	Ataxia
			2021/05/07				./data/phs001327.v2.pht011184.v1.p1.chroniccondition.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/05/15				./data/phs001860.v1.pht009450.v1.p1.Autoinflammatory_Disorders_Subject.var_report.xml									phs001860.v1.p1	Hereditary Autoinflammatory Diseases
			2021/02/26				./data/phs001120.v2.pht005807.v2.p2.ELLIPSE_Subject.var_report.xml									phs001120.v2.p2	Prostatic Neoplasms
			03/15/2012				./data/phs000440.v1.pht002493.v1.p1.Marazita_Guatemala_SampleSubjectMappingDS_Sample.var_report.xml									phs000440.v1.p1	Dental Caries
			2020/11/24				./data/phs001963.v1.pht009827.v1.p1.DEMENTIA_SEQ_Sample.var_report.xml									phs001963.v1.p1	Lewy Body Disease
			2019/03/11				./data/phs000286.v6.pht008767.v1.p2.mribV3.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002155.v6.p13.l_fetuina_2005_m_0435s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
793.0			2019/03/11	878.0			./data/phs000286.v6.pht008729.v1.p2.analysis1.var_report.xml	0.0			511.0					phs000286.v6.p2	Cardiovascular Diseases
			05/07/2014				./data/phs000738.v1.pht003835.v1.p1.Schizophrenia_Families_Sample.var_report.xml									phs000738.v1.p1	Schizophrenia
			03/23/2015				./data/phs000866.v1.pht004620.v1.p1.Bipolar_Disorder_Family_Genomics_Sample.var_report.xml									phs000866.v1.p1	Bipolar Disorder
			2020/03/02				./data/phs001870.v1.pht009916.v1.p1.BC_Chinese_Subject.var_report.xml									phs001870.v1.p1	Breast Neoplasms
			09/02/2015				./data/phs000851.v1.pht004682.v1.p1.Breast_Cancer_AA_Subject.var_report.xml									phs000851.v1.p1	Breast Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000497.v2.p3.simphen098.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004239.v2.p1.VITNUT01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
	11.0		2021/05/11	11.0		11.0	./data/phs002340.v1.pht010936.v1.p1.scAtlas_Gynecological_Malignancies_Subject.var_report.xml	0.0	11.0		11.0			11.0		phs002340.v1.p1	Carcinoma, Ovarian Epithelial
			08/20/2013				./data/phs000285.v3.pht001566.v2.p2.A4F06MJ.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/19	0.0			./data/phs001288.v1.pht006769.v1.p1.final_status.var_report.xml	7.0								phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			08/22/2012				./data/phs000495.v1.pht002864.v1.p1.TGP_Subject.var_report.xml									phs000495.v1.p1	Non-Neoplastic Pediatric Disorder
			2017/11/01				./data/phs000833.v7.pht004360.v6.p1.SCAPT_allCenters_Subject_Phenotypes.var_report.xml									phs000833.v7.p1	
			2020/12/21				./data/phs000007.v32.pht010748.v1.p13.vr_cmrdate_2006_1b_0777s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/23/2016				./data/phs000822.v1.pht005133.v1.p1.Breast_Cancer_Predisposing_Mutations_Sample.var_report.xml									phs000822.v1.p1	Breast Neoplasms
			2017/11/01				./data/phs001305.v1.pht007100.v1.p1.UCDC_5102_Subject.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			10/15/2012				./data/phs000512.v1.pht002861.v1.p1.Etiology_HDL_Cholesterol_Sample.var_report.xml									phs000512.v1.p1	Lipoproteins, HDL
			2019/10/30				./data/phs001921.v1.pht009585.v1.p1.DNA_Methylation_PC_Sample.var_report.xml									phs001921.v1.p1	Prostatic Neoplasms
			11/08/2013				./data/phs000200.v9.pht003406.v1.p3.outc_cardio_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2017/10/11				./data/phs000578.v1.pht007015.v1.p1.prolonged_excercise_test.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			02/04/2016				./data/phs001066.v1.pht005281.v1.p1.ALL_Sample.var_report.xml									phs001066.v1.p1	Neoplasms
6.0	6.0		2021/02/08	12.0		6.0	./data/phs002335.v1.pht010940.v1.p1.CLL_Subject.var_report.xml	0.0	6.0	0	6.0			6.0		phs002335.v1.p1	Leukemia
9.0			11/26/2013	9.0			./data/phs000597.v1.pht003201.v1.p1.DNA_Methylation_Prostate_Cancer_Subject_Phenotypes.var_report.xml	0.0								phs000597.v1.p1	Prostatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001633.v2.p2.B2F28.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/16/2013				./data/phs000633.v1.pht003624.v1.p1.Lung_Microbiome_Inflammation_Sample.var_report.xml									phs000633.v1.p1	Pneumonia
			06/23/2015				./data/phs000648.v1.pht004578.v1.p1.Pancreatic_Cancer_Sample.var_report.xml									phs000648.v1.p1	Pancreatic Neoplasms
18.0	18.0		2019/10/16	33.0		15.0	./data/phs001373.v2.pht006703.v2.p2.Human_Microglia_Subject_Phenotypes.var_report.xml	0.0	16.5	2.121	15.0			16.5		phs001373.v2.p2	Epilepsy
			2019/04/04				./data/phs001768.v1.pht008691.v1.p1.Methylmercury_Pregnancy_Subject.var_report.xml									phs001768.v1.p1	
			2018/08/13				./data/phs001659.v1.pht008303.v1.p1.SGDs_NIPD_Sample.var_report.xml									phs001659.v1.p1	
			2018/09/17				./data/phs001685.v1.pht008370.v1.p1.OVCA_Organoids_Sample.var_report.xml									phs001685.v1.p1	Ovarian Neoplasms
7.0	7.0		2019/12/26	6.0		6.0	./data/phs001889.v1.pht009740.v1.p1.ALS_TDP_Subject_Phenotypes.var_report.xml	0.0	6.5	4.041	7.0			7.0		phs001889.v1.p1	Amyotrophic Lateral Sclerosis
			2021/06/23				./data/phs001027.v4.pht005652.v1.p1.Epigenetics_AML_GEO.var_report.xml									phs001027.v4.p1	Acute Myeloid Leukemia
			2021/05/24				./data/phs002323.v1.pht010881.v1.p1.Pediatric_Immunotherapy_Subject_Phenotypes.var_report.xml									phs002323.v1.p1	Immunotherapy
			09/06/2016				./data/phs000804.v1.pht005374.v1.p1.Ewing_Sarcoma_Subject.var_report.xml									phs000804.v1.p1	Sarcoma, Ewing
			2021/09/24				./data/phs001927.v1.pht011580.v1.p1.TOPMed_WGS_SPIROMICS_Sample_Attributes.var_report.xml									phs001927.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/06/18				./data/phs000280.v7.pht004233.v2.p1.V3ECG.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/11/19				./data/phs001178.v1.pht008550.v1.p1.GMKF_DSD_Sample_Attributes.var_report.xml									phs001178.v1.p1	Disorders of Sex Development
			03/17/2015				./data/phs000884.v1.pht004599.v1.p1.Gut_Microbiome_Controls_Subject.var_report.xml									phs000884.v1.p1	Human Microbiome
			2021/04/16				./data/phs002398.v1.pht011124.v1.p1.PrCa_Sample.var_report.xml									phs002398.v1.p1	Prostatic Neoplasms
			2020/10/27				./data/phs001925.v1.pht010569.v1.p1.MSI_H_Cancers_Sample.var_report.xml									phs001925.v1.p1	Microsatellite Instability
7.0	8.0		2018/11/05	81.0		7.0	./data/phs001632.v1.pht008533.v1.p1.Multiple_Myeloma_AA_Subject_Phenotypes.var_report.xml	0.0	9.0	79.2	8.0			9.0		phs001632.v1.p1	Multiple Myeloma
			2020/12/21				./data/phs000007.v32.pht005151.v1.p13.t_bmdhs_ex02_2_0992s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
212.0	338.0		2019/10/17	550.0		212.0	./data/phs001511.v1.pht007294.v1.p1.SEARCH_ProDIGY_Subject_Phenotypes.var_report.xml	0.0	275.0	89.1	338.0			275.0		phs001511.v1.p1	Diabetes Mellitus, Type 2
			06/19/2017				./data/phs001381.v1.pht006567.v1.p1.Gut_Microbiome_Colorectal_Polyps_Sample.var_report.xml									phs001381.v1.p1	Colonic Polyps
			2018/03/26				./data/phs000697.v1.pht007705.v1.p1.bonemarrowbiopsy_aspiration.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2020/07/24				./data/phs001194.v3.pht005825.v2.p2.MutationResults.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			12/13/2011				./data/phs000426.v1.pht002453.v1.p1.6a_dbGaP_SubjectSampleMappingDS_Sample.var_report.xml									phs000426.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2021/02/04				./data/phs001748.v1.pht008574.v1.p1.Histiocytic_Sarcomas_Subject.var_report.xml									phs001748.v1.p1	Histiocytic Sarcoma
			2020/12/21				./data/phs000007.v32.pht009758.v2.p13.q_cesd_2009_m_0570s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/04/2014				./data/phs000776.v1.pht003947.v1.p1.MCCD_Subject.var_report.xml									phs000776.v1.p1	Urea Cycle Disorders, Inborn
			2020/12/21				./data/phs000007.v32.pht000110.v9.p13.sawin1_3s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/11/19				./data/phs000572.v8.pht005179.v1.p4.CaseControlEnrichedPhenotypesWES_y1.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			09/24/2013				./data/phs000364.v2.pht002263.v2.p1.ChronicLymphocyticLeukemia_Sample_Attributes.var_report.xml									phs000364.v2.p1	Chronic Lymphocytic Leukemia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000470.v2.p3.simphen071.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
15.0			2017/12/08	38.0			./data/phs001279.v1.pht007209.v1.p1.family_history_form.var_report.xml	38.0			23.0					phs001279.v1.p1	Bronchiectasis
419.0	605.0		11/13/2015	1024.0		419.0	./data/phs001008.v1.pht005110.v1.p1.IRAS_Family_Study_Subject_Phenotypes.var_report.xml	0.0	512.0	131.5	605.0			512.0		phs001008.v1.p1	Insulin Resistance
			2020/12/21				./data/phs000007.v32.pht000301.v9.p13.echo1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001869.v2.p2.Y1MORB06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/27/2017				./data/phs000596.v1.pht006715.v1.p1.nasal_nitric_oxide.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			2020/11/13				./data/phs002019.v1.pht010175.v1.p1.SCCIS_Sample_Attributes.var_report.xml									phs002019.v1.p1	Carcinoma in Situ
112.0	112.0		09/03/2010	211.0		99.0	./data/phs000127.v2.pht000648.v1.p1.IrishALS_Controls_Data.var_report_2010_09_03.xml	0.0	105.5	9.192	99.0			105.5		phs000127.v2.p1	Amyotrophic Lateral Sclerosis
			2020/06/25				./data/phs001779.v1.pht010204.v1.p1.CIDR_NIA_Ehlers_Danlos_Subject.var_report.xml									phs001779.v1.p1	Ehlers-Danlos syndrome type 3
			11/26/2013				./data/phs000458.v1.pht003591.v1.p1.POA_Glaucoma_Methylation_Subject.var_report.xml									phs000458.v1.p1	Glaucoma, Open-Angle
36.0	36.0		2021/03/24	72.0		36.0	./data/phs002341.v1.pht011057.v1.p1.Dermal_Fibroblasts_Pluripotency_Subject.var_report.xml	0.0	36.0	0	36.0			36.0		phs002341.v1.p1	Fibroblast-Derived Induced Pluripotent Stem Cells
972.0	972.0		2020/11/24	6907.0		948.0	./data/phs001963.v1.pht009828.v1.p1.DEMENTIA_SEQ_Subject_Phenotypes.var_report.xml	0.0	960.0	1989	948.0			960.0		phs001963.v1.p1	Lewy Body Disease
			2018/09/11				./data/phs000653.v3.pht008354.v1.p1.Epi4K_Subject_Phenotypes.var_report.xml									phs000653.v3.p1	Epilepsy
			2017/09/06				./data/phs000554.v1.pht003195.v1.p1.CRPC_Sample.var_report.xml									phs000554.v1.p1	Prostatic Neoplasms
			06/14/2017				./data/phs001365.v1.pht006408.v1.p1.NAC_Bevacizumab_Sample.var_report.xml									phs001365.v1.p1	Breast Neoplasms
67.0	578.0		11/05/2014	851.0		42.0	./data/phs000209.v13.pht001120.v10.p3.MESA_Exam4Main.var_report.xml	924.0	77.5	50.2	88.0			77.5		phs000209.v13.p3	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005581.v1.p1.emerge2_obesity_bmi.var_report.xml									phs000888.v1.p1	
			2018/02/27				./data/phs001539.v1.pht007524.v1.p1.MAGNet_Sample_Attributes.var_report.xml									phs001539.v1.p1	Atrial Fibrillation
			11/16/2016				./data/phs000935.v1.pht004817.v1.p1.CSER_PediSeq_Sample.var_report.xml									phs000935.v1.p1	Genetic Testing
			2020/09/18				./data/phs001087.v3.pht005759.v3.p1.UC_Sample.var_report.xml									phs001087.v3.p1	Carcinoma, Transitional Cell
			2018/02/20				./data/phs001528.v1.pht007361.v1.p1.SCCOHT_Sample.var_report.xml									phs001528.v1.p1	Ovarian Neoplasms
			07/27/2017				./data/phs000596.v1.pht006719.v1.p1.volumetric_chest_ct.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
679.0	764.0		2021/01/27	950.0		679.0	./data/phs000584.v1.pht010796.v1.p1.CIDR_Longevity_Pedigree.var_report.xml	0.0	721.5	60.1	764.0			721.5		phs000584.v1.p1	Longevity
			07/18/2014				./data/phs000775.v1.pht003946.v1.p1.Molecular_Genetics_Schizophrenia_Sample_Attributes.var_report.xml									phs000775.v1.p1	Schizophrenia
			2021/02/12				./data/phs001771.v1.pht008718.v1.p1.IGNITE_Sample_Attributes.var_report.xml									phs001771.v1.p1	Diabetes Mellitus
			06/20/2014				./data/phs000759.v1.pht003914.v1.p1.High_Risk_AML_Sample_Attributes.var_report.xml									phs000759.v1.p1	Leukemia, Myeloid, Acute
			10/18/2016				./data/phs001205.v1.pht005851.v1.p1.Neural_Stem_Cell_Lineages_Sample.var_report.xml									phs001205.v1.p1	Neural Stem Cells
			06/12/2017				./data/phs000594.v1.pht006501.v1.p1.DrugLog.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000530.v2.p3.simphen131.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/20/2013				./data/phs000285.v3.pht001825.v2.p2.F1F48.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			01/21/2016				./data/phs000991.v1.pht005256.v1.p1.VESPA_Cohort_Sample.var_report.xml									phs000991.v1.p1	Dose-Response Relationship, Drug
959.0	889.0		2020/01/23	91.0		897.0	./data/phs000287.v7.pht001450.v1.p1.BASE1.var_report.xml	95.0	825.5	8.485	938.0			825.5		phs000287.v7.p1	Cardiovascular Diseases
72.0	628.0		06/22/2016	983.0		72.0	./data/phs001012.v1.pht005550.v1.p1.Diabetes_Heart_Study_EA_Subject_Phenotypes.var_report.xml	0.0	96.5	341.3	628.0			96.5		phs001012.v1.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001656.v2.p2.C1F08.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/05/15				./data/phs001484.v1.pht007738.v1.p1.ATV_Bilirubin_Sample.var_report.xml									phs001484.v1.p1	Drug-Related Side Effects and Adverse Reactions
			2018/12/27				./data/phs000756.v1.pht007373.v1.p1.FINRISK_Sample_Attributes.var_report.xml									phs000756.v1.p1	
	14.0		08/22/2016	14.0		14.0	./data/phs001152.v1.pht005536.v1.p1.Endometrial_Carcinosarcomas_Subject_Phenotypes.var_report.xml	0.0	14.0		14.0			14.0		phs001152.v1.p1	Endometrial Neoplasms
133.0	133.0		2018/08/19	247.0		114.0	./data/phs000101.v5.pht003748.v1.p1.ALS_Subject_Phenotypes.var_report.xml	0.0	123.5	13.44	114.0			123.5		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2019/07/26				./data/phs000588.v1.pht009282.v1.p1.angiogram_celiacmesentericrenal.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2019/03/11				./data/phs000286.v6.pht001958.v2.p2.isla.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/07/06				./data/phs000416.v2.pht002745.v2.p1.GOCHA_Subject.var_report.xml									phs000416.v2.p1	Intracranial Hemorrhage
			2021/05/12				./data/phs000964.v5.pht004840.v2.p1.TOPMed_WGS_JHS_Sample_Attributes.var_report.xml									phs000964.v5.p1	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001081.v1.p1.d_elig2_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/03/24				./data/phs000720.v4.pht003880.v2.p1.Pediatric_Rhabdomyosarcoma_Subject_Phenotypes.var_report.xml									phs000720.v4.p1	Rhabdomyosarcoma
			11/16/2015				./data/phs001026.v1.pht005119.v1.p1.CSER_BASIC3_Subject.var_report.xml									phs001026.v1.p1	Genes, Neoplasm
			11/04/2014				./data/phs000086.v3.pht000339.v1.p1.EDIC_f0703.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			09/11/2014				./data/phs000795.v1.pht004014.v1.p1.Gastric_Cancer_Metastasis_Sample.var_report.xml									phs000795.v1.p1	Stomach Neoplasms
			2017/08/31				./data/phs000939.v2.pht004790.v2.p1.Lymphoma_Oncogene_Dysregulation_Sample_Attributes.var_report.xml									phs000939.v2.p1	Lymphoma, B-Cell
			2021/06/07				./data/phs001998.v1.pht010503.v1.p1.CLL_allo_HSCT_Sample.var_report.xml									phs001998.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2021/08/17				./data/phs001661.v3.pht010559.v1.p1.TOPMed_WGS_GCPD_A_Sample.var_report.xml									phs001661.v3.p1	Asthma
			2020/06/18				./data/phs000280.v7.pht004101.v5.p1.HFCHDXPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/02/13				./data/phs001975.v1.pht009881.v1.p1.SDV_iPSCs_Subject.var_report.xml									phs001975.v1.p1	
			04/24/2012				./data/phs000491.v1.pht002698.v1.p1.Renal_Cell_Carcinoma_Sample.var_report.xml									phs000491.v1.p1	Carcinoma, Renal Cell
			2018/10/19				./data/phs000492.v3.pht002710.v3.p2.Developmental_Brain_Disorders_Sample_Attributes.var_report.xml									phs000492.v3.p2	Microcephaly
			2019/03/05				./data/phs001788.v1.pht008816.v1.p1.CNICS_Sample.var_report.xml									phs001788.v1.p1	HIV Infections
			03/12/2013				./data/phs000343.v3.pht003147.v1.p1.medcod.var_report.xml									phs000343.v3.p1	Stroke
			2020/02/06				./data/phs001430.v2.pht008071.v2.p1.p7001_15783_previsit1.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2020/12/21				./data/phs000007.v32.pht002894.v1.p13.l_mtblcmhi2_ex05_1_0708s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/14/2010				./data/phs000263.v1.pht001235.v1.p1.HMP_Skin_Acne_Subject.var_report.xml									phs000263.v1.p1	Acne Vulgaris
			08/20/2013				./data/phs000285.v3.pht001767.v2.p2.E1F09MAS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/25				./data/phs001777.v1.pht008857.v1.p1.SCO_Syndrome_Sample.var_report.xml									phs001777.v1.p1	Sertoli Cell-Only Syndrome
			02/24/2012				./data/phs000001.v3.pht000382.v2.p1.vfq.var_report.xml									phs000001.v3.p1	Cataract
			2019/12/26				./data/phs001862.v1.pht009747.v1.p1.PBB_Sample.var_report.xml									phs001862.v1.p1	Endocrine Disruptors
			2021/05/18				./data/phs002385.v1.pht011243.v1.p1.CIBMTR_HCTforSCD_Subject.var_report.xml									phs002385.v1.p1	Sickle Cell Disease
			2019/09/16				./data/phs001718.v1.pht009427.v1.p1.C9ORF72_Sample_Attributes.var_report.xml									phs001718.v1.p1	Amyotrophic Lateral Sclerosis
55.0	55.0		08/05/2016	55.0		55.0	./data/phs000923.v1.pht005494.v1.p1.Germ_Cell_Tumors_Subject_Phenotypes.var_report.xml	0.0	55.0					55.0		phs000923.v1.p1	Male Germ Cell Tumor
			2018/02/08				./data/phs001488.v1.pht007404.v1.p1.lineornt.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004041.v2.p1.BPU01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/07/2012				./data/phs000538.v1.pht003039.v1.p1.Mendelian_Familial_Hyperlipidemia_Subject.var_report.xml									phs000538.v1.p1	Hyperlipidemia, Familial Combined
			02/06/2017				./data/phs001075.v1.pht006109.v1.p1.CSER_CanSeq_Sample.var_report.xml									phs001075.v1.p1	Neoplasms
			12/06/2012				./data/phs000565.v1.pht003077.v1.p1.RHD_Sample_Attributes.var_report.xml									phs000565.v1.p1	Congenital Abnormalities
			11/30/2015				./data/phs000260.v4.pht001257.v4.p2.HMP_Foregut_Esophageal_Adenocarcinoma_Sample.var_report.xml									phs000260.v4.p2	Esophageal Adenocarcinoma
			2020/12/21				./data/phs000007.v32.pht010747.v1.p13.t_tonla_ex28_0_1230s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/22/2017				./data/phs001250.v1.pht006328.v1.p1.Primary_Breast_Cancers_Sample_Attributes.var_report.xml									phs001250.v1.p1	Breast Neoplasms
			2019/08/10				./data/phs001657.v1.pht009391.v1.p1.AML_Subject.var_report.xml									phs001657.v1.p1	Leukemia, Myeloid, Acute
			2017/11/01				./data/phs001305.v1.pht007101.v1.p1.adverse_event.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			05/24/2016				./data/phs001065.v1.pht005412.v1.p1.incident.var_report.xml									phs001065.v1.p1	Huntington Disease
			05/14/2013				./data/phs000609.v1.pht003283.v1.p1.AutismGeneExpression_Subject.var_report.xml									phs000609.v1.p1	Autism
			2020/03/26				./data/phs001929.v1.pht010012.v1.p1.Neurogenetics_OCD_Subject.var_report.xml									phs001929.v1.p1	Obsessive-Compulsive Disorder
			08/17/2012				./data/phs000518.v1.pht002846.v1.p1.ESP_Family_Studies_IB_Subject.var_report.xml									phs000518.v1.p1	Bronchiectasis
			2021/08/23				./data/phs001232.v4.pht006077.v4.p2.UDN_Sample.var_report.xml									phs001232.v4.p2	Rare Diseases
312.0	588.0		03/29/2017	900.0		312.0	./data/phs001191.v1.pht006226.v1.p1.eMERGE_NUgene_WGS_Subject_Phenotypes.var_report.xml	0.0	450.0	195.2	588.0			450.0		phs001191.v1.p1	Healthy Volunteers
			2018/06/14				./data/phs001238.v2.pht006031.v1.p1.GENOA_AfricanAmerican_CKD_Labs.var_report.xml									phs001238.v2.p1	Hypertension
			04/06/2016				./data/phs001080.v1.pht005369.v1.p1.Hereditary_Spastic_Paraplegia_Subject.var_report.xml									phs001080.v1.p1	Spastic Paraplegia, Hereditary
			2020/06/18				./data/phs000280.v7.pht006411.v1.p1.AAA_DERV.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/09				./data/phs002298.v1.pht010761.v1.p1.Skin_Pigmentation_AA_Sample_Attributes.var_report.xml									phs002298.v1.p1	Skin Pigmentation (Melanin Index)
5.0			2021/07/14	6.0			./data/phs001546.v2.pht009974.v1.p1.TOPMed_WGS_DECAF_Subject_Phenotypes.var_report.xml	0.0			1.0					phs001546.v2.p1	Atrial Fibrillation
			2021/07/14				./data/phs001546.v2.pht009973.v1.p1.TOPMed_WGS_DECAF_Sample.var_report.xml									phs001546.v2.p1	Atrial Fibrillation
			2018/09/17				./data/phs001687.v1.pht008359.v1.p1.WABCS_Subject_Phenotypes.var_report.xml									phs001687.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht003395.v1.p3.ext_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/03/11				./data/phs000286.v6.pht008733.v1.p2.asn0027_bnp.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			03/08/2011				./data/phs000124.v2.pht002172.v1.p1.COG_Neuroblastoma_Sample.var_report_2011_03_08.xml									phs000124.v2.p1	Neuroblastoma
			03/16/2016				./data/phs001000.v1.pht005029.v1.p1.MIGen_Leicester_Sample.var_report.xml									phs001000.v1.p1	Myocardial Infarction
			09/26/2013				./data/phs000519.v1.pht003249.v1.p1.MelanomaRisk_Sample_Attributes.var_report.xml									phs000519.v1.p1	Melanoma
			2019/08/30				./data/phs001331.v2.pht009413.v1.p1.adverse_event.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			08/20/2013				./data/phs000285.v3.pht001863.v2.p2.F2UCORT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004211.v2.p1.UBMDWF02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
1.0	3.0		06/28/2013	4.0		1.0	./data/phs000563.v1.pht003084.v1.p1.NF1_Pilocytic_Astrocytoma_Subject_Phenotypes.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs000563.v1.p1	Pilocytic Astrocytoma
			08/20/2013				./data/phs000285.v3.pht001721.v2.p2.D1F21.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
	753.0		11/16/2011	1507.0		1.0	./data/phs000096.v4.pht001550.v1.p1.HAPO_European_Phenotypes.var_report.xml	0.0	502.3	434.2	1507.0			753.0		phs000096.v4.p1	Pregnancy Complications
			2018/04/20				./data/phs001231.v2.pht006182.v2.p1.NeuroLINCS_ALS_SMA_Sample_Attributes.var_report.xml									phs001231.v2.p1	Amyotrophic Lateral Sclerosis
			2020/11/02				./data/phs001899.v2.pht009572.v2.p1.CSI_Sample_Attributes.var_report.xml									phs001899.v2.p1	Immunologic Deficiency Syndromes
			2018/11/13				./data/phs001523.v1.pht007508.v1.p1.MOMS_PI_Subject.var_report.xml									phs001523.v1.p1	Pregnancy
			2020/06/18				./data/phs000280.v7.pht004056.v2.p1.CNFB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/12/20				./data/phs000577.v1.pht007281.v1.p1.nutrientdataform.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			08/12/2016				./data/phs000888.v1.pht005556.v1.p1.05aAsthma_hx_asthma_allergy.var_report.xml									phs000888.v1.p1	
1745.0	1745.0		2021/06/08	3352.0		1607.0	./data/phs001217.v3.pht007762.v1.p1.TOPMed_WGS_GenSalt_Pedigree.var_report.xml	0.0	1676.0	97.58	1607.0			1676.0		phs001217.v3.p1	Arterial Pressure, Mean
			05/11/2016				./data/phs000963.v1.pht004859.v1.p1.Statins_CV_Sample_Attributes.var_report.xml									phs000963.v1.p1	Myocardial Revascularization
3570.0	3570.0		11/09/2016	7012.0		3442.0	./data/phs001037.v1.pht005917.v1.p1.TEDDY_Pedigree.var_report.xml	0.0	3506.0	90.51	3442.0			3506.0		phs001037.v1.p1	Diabetes Mellitus, Type 1
1379.0	1379.0		03/12/2013	2164.0		785.0	./data/phs000343.v3.pht002215.v1.p1.DERIV.var_report.xml	0.0	1082.0	420	785.0			1082.0		phs000343.v3.p1	Stroke
			2021/04/08				./data/phs002344.v1.pht011121.v1.p1.PAX3_FOXO1_RMS_Sample.var_report.xml									phs002344.v1.p1	Rhabdomyosarcoma
			2019/07/29				./data/phs001855.v1.pht009248.v1.p1.STRRIDE_Sample.var_report.xml									phs001855.v1.p1	Exercise
922.0	63.0		01/06/2010	2026.0		922.0	./data/phs000199.v1.pht000892.v1.p1.CHOP_CNV_Pedigree.var_report_2010_01_06.xml	0.0	52.5	14.85	63.0			52.5		phs000199.v1.p1	Normalcy
			01/13/2014				./data/phs000666.v1.pht003575.v1.p1.Elderly_Influenza_Vaccine_Sample_Attributes.var_report.xml									phs000666.v1.p1	Influenza Vaccines
			07/24/2017				./data/phs001088.v1.pht006671.v1.p1.DRIVE_SBCGS_Sample_Attributes.var_report.xml									phs001088.v1.p1	Breast Neoplasms
			2017/08/16				./data/phs001055.v1.pht005914.v1.p1.DeNovo_Mutation_Rates_Subject_Phenotypes.var_report.xml									phs001055.v1.p1	Preterm Birth
			08/20/2013				./data/phs000285.v3.pht001673.v2.p2.C1F31AC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
673.0	694.0		2020/03/09	437.0		673.0	./data/phs001299.v2.pht007622.v1.p1.Nicotine_Addiction_Subject_Phenotypes.var_report.xml	0.0	683.5	48.08	694.0			683.5		phs001299.v2.p1	Behavior, Addictive
			2019/05/07				./data/phs001329.v2.pht007174.v2.p1.vabs.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			08/20/2013				./data/phs000285.v3.pht001699.v2.p2.CARE_ICAM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/03/26				./data/phs000697.v1.pht007696.v1.p1.concomitantmedications.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			07/18/2014				./data/phs000733.v1.pht003819.v1.p1.Familial_Prostate_Cancer_Subject.var_report.xml									phs000733.v1.p1	Prostate cancer, familial
			2020/08/05				./data/phs001856.v1.pht009598.v1.p1.CORECT_Axiom_Sample.var_report.xml									phs001856.v1.p1	Colorectal Neoplasms
			2021/07/19				./data/phs001606.v2.pht010088.v1.p1.TOPMed_WGS_EGCUT_Subject.var_report.xml									phs001606.v2.p1	Atrial Fibrillation
			08/08/2011				./data/phs000353.v1.pht002248.v1.p1.Preterm_Birth_AA_Subject.var_report.xml									phs000353.v1.p1	Premature Birth
			2018/09/19				./data/phs000257.v3.pht001250.v2.p1.HMP_Gut_Crohns_Function_Subject_Phenotypes.var_report.xml									phs000257.v3.p1	Crohn Disease
			01/26/2015				./data/phs000837.v1.pht004441.v1.p1.22q11DS_Subject_Phenotypes.var_report.xml									phs000837.v1.p1	Tetralogy of Fallot
			08/28/2015				./data/phs000977.v1.pht004955.v1.p1.Desmoplastic_Melanoma_Sample.var_report.xml									phs000977.v1.p1	Melanoma
			03/10/2015				./data/phs000855.v1.pht004554.v1.p1.Lung_Cancer_Resistance_Sample_Attributes.var_report.xml									phs000855.v1.p1	Carcinoma
			2018/01/11				./data/phs001421.v1.pht007028.v1.p1.Uveal_Melanoma_Pathogenesis_Sample_Attributes.var_report.xml									phs001421.v1.p1	Uveal melanoma
			2018/09/26				./data/phs001130.v1.pht008415.v1.p1.NIDDM_Athero_Hispanic_Subject.var_report.xml									phs001130.v1.p1	Diabetes Mellitus, Type 2
			2018/10/05				./data/phs001660.v1.pht008411.v1.p1.Paclitaxel_Cohort_LUPG_Subject.var_report.xml									phs001660.v1.p1	Paclitaxel
			03/24/2017				./data/phs001336.v1.pht006205.v1.p1.ECLS_HCT_GVHD_Sample.var_report.xml									phs001336.v1.p1	Bone Marrow Transplantation
			2021/09/23				./data/phs001468.v3.pht009553.v1.p1.TOPMed_WGS_REDSIII_Brazil_SCD_Sample.var_report.xml									phs001468.v3.p1	Sickle Cell Anemia
			2018/10/02				./data/phs001519.v1.pht008434.v1.p1.Neoantigen_Cancer_Vaccine_GBM_Sample.var_report.xml									phs001519.v1.p1	Glioblastoma
			10/09/2014				./data/phs000717.v1.pht003811.v1.p1.Circulating_Tumor_Cells_Sample_Attributes.var_report.xml									phs000717.v1.p1	Prostatic Neoplasms
			2019/10/11				./data/phs000996.v2.pht005753.v1.p1.Neurodevelopmental_Metal_Toxicity_Sample_Attributes.var_report.xml									phs000996.v2.p1	
			10/15/2012				./data/phs000512.v1.pht002860.v1.p1.Etiology_HDL_Cholesterol_Subject.var_report.xml									phs000512.v1.p1	Lipoproteins, HDL
			2019/12/06				./data/phs001875.v1.pht009650.v1.p1.Venetoclax_Resistance_Subject.var_report.xml									phs001875.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
330.0	330.0		2017/09/22	380.0		50.0	./data/phs001377.v1.pht006944.v1.p1.Cocaine_Nicotine_Addiction_Subject_Phenotypes.var_report.xml	0.0	79.0	80.61	50.0			79.0		phs001377.v1.p1	Cocaine-Related Disorders
			2020/05/27				./data/phs002034.v1.pht010256.v1.p1.Glioma_Grade_Sample_Attributes.var_report.xml									phs002034.v1.p1	Glioma
			2018/08/28				./data/phs001563.v1.pht008322.v1.p1.Blood_Handling_Subject.var_report.xml									phs001563.v1.p1	Cerebral Hemorrhage
			2018/12/06				./data/phs001688.v1.pht008591.v1.p1.Psoriasis_Secukinumab_Sample.var_report.xml									phs001688.v1.p1	Psoriasis
894.0		2.0	08/20/2013	456.0	1.607		./data/phs000285.v3.pht001626.v2.p2.B2F12.var_report.xml	0.0		0.4975	859.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht006009.v4.p13.l_bdnf_ex02_3b_0878s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/04/05				./data/phs001196.v1.pht005701.v1.p1.Schizophrenia_Trios_Taiwanese_Sample_Attributes.var_report.xml									phs001196.v1.p1	Schizophrenia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000528.v2.p3.simphen129.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/05/05				./data/phs002310.v1.pht011208.v1.p1.InC3_Drug_History.var_report.xml									phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			2020/09/15				./data/phs002234.v1.pht010515.v1.p1.Xq28_Deletion_HH_Sample.var_report.xml									phs002234.v1.p1	Hypogonadism
	1.0		01/11/2017	1.0		1.0	./data/phs001242.v1.pht006073.v1.p1.Enhancers_Misregulate_Oncogenes_Sample_Attributes.var_report.xml	0.0	1.0					1.0		phs001242.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			2018/11/05				./data/phs001690.v1.pht008365.v1.p1.EC_SCNA_Subject.var_report.xml									phs001690.v1.p1	Endometrial Neoplasms
			2020/12/21				./data/phs000007.v32.pht003631.v5.p13.t_pftdiff_2011_m_0648s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht009479.v2.p1.MCUps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
49.0	49.0		2021/07/14	86.0		37.0	./data/phs002484.v1.pht011398.v1.p1.Aging_Lungs_Subject.var_report.xml	0.0	43.0	8.485	37.0			43.0		phs002484.v1.p1	Lung
			10/21/2013				./data/phs000637.v1.pht003535.v1.p1.ALL_Methotrexate_Clearance_Sample.var_report.xml									phs000637.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			2020/12/02				./data/phs002287.v1.pht010714.v1.p1.ER_Positive_BC_Sample_Attributes.var_report.xml									phs002287.v1.p1	Breast Neoplasms
			Thu Jan 17 21:45:42 2008				./data/phs000019.v1.pht000181.v1.p1.GAIN_control_institution.var_report_2008_08_12.xml									phs000019.v1.p1	Psoriasis
			2020/12/21				./data/phs000007.v32.pht003904.v5.p13.vr_ctdates_2011_m_0715s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001091.v1.p1.d_mhqcountry_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			08/12/2016				./data/phs000888.v1.pht005571.v1.p1.ACEiCough.var_report.xml									phs000888.v1.p1	
			2019/03/11				./data/phs000286.v6.pht008769.v1.p2.msrc.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			04/14/2014				./data/phs000370.v2.pht002382.v2.p1.Head_Neck_Squamous_Cell_Carcinoma_Sample.var_report.xml									phs000370.v2.p1	Head and Neck Neoplasms
908.0	908.0		07/06/2016	538.0		85.0	./data/phs001093.v1.pht005612.v1.p1.T2D_GENES_UK_South_Asian_Subject_Phenotypes.var_report.xml	0.0	534.0	528.9	85.0			534.0		phs001093.v1.p1	Diabetes Mellitus, Type 2
			2019/06/14				./data/phs000589.v1.pht009182.v1.p1.baseline_vasculitis_med_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/07/21				./data/phs002035.v1.pht010415.v1.p1.PCD_Sample_Attributes.var_report.xml									phs002035.v1.p1	Ciliary Motility Disorders
			2020/01/23				./data/phs000287.v7.pht001453.v1.p1.BONE_DENSITY_BASE_YR7.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/01/31				./data/phs001934.v1.pht009775.v1.p1.Immune_Aging_Sample.var_report.xml									phs001934.v1.p1	
			10/25/2013				./data/phs000671.v1.pht003549.v1.p1.Hairy_Cell_Leukemia_Sample_Attributes.var_report.xml									phs000671.v1.p1	Leukemia, Hairy Cell
1670.0	5754.0		05/16/2017	9361.0		3607.0	./data/phs001252.v1.pht006396.v1.p1.sgrqcomp.var_report.xml	0.0	4681.0	1518	1043.0			4681.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2017/09/22				./data/phs001392.v1.pht006901.v1.p1.pidtc_17826_baselinea.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
64.0	92.0		04/14/2011	599.0		89.0	./data/phs000258.v2.pht001242.v2.p1.HMP_Gut_Obesity_Sample_Attributes.var_report.xml	0.0	90.5	2.121	61.0			90.5		phs000258.v2.p1	Obesity
2119.0	2450.0		2020/12/21	4569.0		2119.0	./data/phs000007.v32.pht006026.v4.p13.vr_wkthru_ex02_3b_0464s.var_report.xml	0.0	2285.0	29.7	2450.0			2285.0		phs000007.v32.p13	Cardiovascular Diseases
			2018/11/13				./data/phs001523.v1.pht007512.v1.p1.phenotype_healthHistorySurvey.var_report.xml									phs001523.v1.p1	Pregnancy
			2019/09/16				./data/phs001123.v2.pht006062.v2.p1.CAAPA_Sample_Attributes.var_report.xml									phs001123.v2.p1	Asthma
			2019/09/27				./data/phs001576.v2.pht008222.v2.p2.P6705_ADAPTIVEQOL_FCAB.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			11/15/2012				./data/phs000405.v1.pht002609.v1.p1.Mendelian_Malignant_Hyperthermia_Sample.var_report.xml									phs000405.v1.p1	Malignant Hyperthermia
848.0	848.0		05/02/2011	711.0		72.0	./data/phs000349.v1.pht002191.v1.p1.SEA_Phase2_Subject_Phenotypes.var_report.xml	0.0	534.0	444.1	72.0			534.0		phs000349.v1.p1	Atherosclerosis
894.0	894.0		2021/04/07	9225.0		561.0	./data/phs001349.v2.pht010329.v1.p1.TGCT_Subject_Phenotypes.var_report.xml	0.0	561.0	6773	515.0			561.0		phs001349.v2.p1	Testicular Germ Cell Tumor
743.0	743.0		12/19/2011	1231.0		488.0	./data/phs000381.v1.pht002422.v1.p1.GeM_Controls_Subject_Phenotypes.var_report.xml	0.0	615.5	180.3	488.0			615.5		phs000381.v1.p1	Normalcy
			2018/03/27				./data/phs001195.v1.pht006858.v1.p1.Atomoxetine_Methamphetamine_Subject.var_report.xml									phs001195.v1.p1	Sex/Gender Identity
			2021/08/30				./data/phs001933.v1.pht011512.v1.p1.TOPMed_CCDG_UCSF_AF_Sample.var_report.xml									phs001933.v1.p1	Atrial Fibrillation
			06/30/2014				./data/phs000757.v1.pht003922.v1.p1.Hereditary_Ataxias_Sample.var_report.xml									phs000757.v1.p1	Ataxia
			2020/12/18				./data/phs002059.v1.pht010424.v1.p1.DemographicsDS.var_report.xml									phs002059.v1.p1	Heart Defects, Congenital
			2017/12/04				./data/phs000906.v1.pht007146.v1.p1.BMI_ALL.var_report.xml									phs000906.v1.p1	Pharmacogenetics
			2020/06/18				./data/phs000280.v7.pht004095.v2.p1.GTAA04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2171.0	2171.0		05/20/2015	4069.0		3.0	./data/phs000180.v3.pht000789.v2.p2.T1DGC_Subject_Phenotypes.var_report.xml	0.0	1356.0	1180	1895.0			1895.0		phs000180.v3.p2	Diabetes Mellitus, Type 1
	23.0		2021/03/01	23.0		23.0	./data/phs002294.v1.pht010810.v1.p1.HGSOC_Subject.var_report.xml	0.0	23.0		23.0			23.0		phs002294.v1.p1	Ovarian Neoplasms
			2020/12/21				./data/phs000007.v32.pht004375.v2.p13.vr_npka_1978_0_0872s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/17/2017				./data/phs001328.v1.pht006305.v1.p1.cognitive_4to6.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			06/01/2015				./data/phs000912.v1.pht004733.v1.p1.Breast_Cancer_Latina_Sample_Attributes.var_report.xml									phs000912.v1.p1	Breast Neoplasms
			2019/08/05				./data/phs001867.v1.pht009354.v1.p1.Aging_Cells_Sample_Attributes.var_report.xml									phs001867.v1.p1	Hutchinson-Gilford Progeria Syndrome
			2021/09/14				./data/phs002545.v1.pht011556.v1.p1.MSS_CRC_PDAC_GEO.var_report.xml									phs002545.v1.p1	Immunotherapy
			2018/11/19				./data/phs001178.v1.pht008549.v1.p1.GMKF_DSD_Sample.var_report.xml									phs001178.v1.p1	Disorders of Sex Development
			05/30/2014				./data/phs000751.v1.pht003867.v1.p1.Fibrosing_Interstitial_Lung_Disease_Sample.var_report.xml									phs000751.v1.p1	Lung Diseases, Interstitial
			11/13/2015				./data/phs001008.v1.pht005107.v1.p1.IRAS_Family_Study_Subject.var_report.xml									phs001008.v1.p1	Insulin Resistance
			2019/10/31				./data/phs001623.v2.pht008362.v2.p1.HNSCC_Sample.var_report.xml									phs001623.v2.p1	Carcinoma, squamous cell of head and neck
			2021/08/11				./data/phs002056.v1.pht010452.v1.p1.CIDR_PC_AS_Subject_Phenotypes.var_report.xml									phs002056.v1.p1	Prostatic Neoplasms
23.0			2020/10/02	33.0			./data/phs002244.v1.pht010552.v1.p1.NSCLC_Pembrolizumab_Subject_Phenotypes.var_report.xml	0.0			10.0					phs002244.v1.p1	Carcinoma, Non-Small-Cell Lung
			11/08/2013				./data/phs000200.v9.pht002120.v3.p3.f85_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/06/21				./data/phs001470.v1.pht008168.v1.p1.CIDR_SWAN_Phenotypes_Long.var_report.xml									phs001470.v1.p1	Menopause
			2019/06/19				./data/phs001776.v1.pht009209.v1.p1.LTG_Pancreas_QTL_Sample.var_report.xml									phs001776.v1.p1	Pancreas
			2020/07/16				./data/phs001778.v1.pht009833.v1.p1.MDS_huM_Sample_Attributes.var_report.xml									phs001778.v1.p1	Myelodysplastic Syndromes
			09/29/2014				./data/phs000797.v1.pht004268.v1.p1.CTLA4_Haploinsufficiency_Sample.var_report.xml									phs000797.v1.p1	Autoimmune enteropathy
			2020/12/21				./data/phs000007.v32.pht000010.v3.p13.ex0_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/08/2011				./data/phs000124.v2.pht002171.v1.p1.COG_Neuroblastoma_Subject.var_report_2011_03_08.xml									phs000124.v2.p1	Neuroblastoma
			05/01/2017				./data/phs000722.v2.pht003900.v2.p2.Colon_CIP_Sample_Attributes.var_report.xml									phs000722.v2.p2	Colorectal Neoplasms
			2021/06/07				./data/phs001998.v1.pht010502.v1.p1.CLL_allo_HSCT_Subject.var_report.xml									phs001998.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2017/09/22				./data/phs001392.v1.pht006891.v1.p1.p6901_19430_immunerec.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2019/03/11				./data/phs000286.v6.pht008732.v1.p2.asn0006_hearing.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			05/08/2012				./data/phs000443.v1.pht002531.v1.p1.Prostate_Cancer_PCAT1_Sample.var_report.xml									phs000443.v1.p1	Prostatic Neoplasms
			05/24/2017				./data/phs000574.v1.pht005854.v1.p1.ARP_5201_Rett_Syndrome_Subject.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2020/06/18				./data/phs000280.v7.pht004199.v2.p1.STROKE32.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/19/2014				./data/phs000745.v1.pht003848.v1.p1.Alzheimers_Posterior_Cingulate_Astrocytes_Sample.var_report.xml									phs000745.v1.p1	Alzheimer Disease
			2018/09/19				./data/phs000357.v2.pht002331.v2.p1.Systemic_Sclerosis_Lab_Results.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
			2020/06/18				./data/phs000280.v7.pht004200.v2.p1.STROKE41.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/11/14				./data/phs001922.v1.pht009617.v1.p1.Chromosome_Errors_Oocytes_Sample.var_report.xml									phs001922.v1.p1	Aneuploidy
			06/12/2017				./data/phs000594.v1.pht006505.v1.p1.GeneralLab.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2020/12/21				./data/phs000007.v32.pht005150.v3.p13.t_aabp_ex09_1b_0948s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/06				./data/phs001783.v2.pht008822.v2.p1.Clinical_Specimens_Sample_Attributes.var_report.xml									phs001783.v2.p1	Neoplasms
126.0			2017/12/04	5.0			./data/phs001419.v1.pht007194.v1.p1.p6601_cmtpeds.var_report.xml	0.0			4.0					phs001419.v1.p1	Charcot-Marie-Tooth Disease
			11/15/2013				./data/phs000238.v1.pht002007.v1.p1.NEIGHBOR_Glaucoma_Sample.var_report.xml									phs000238.v1.p1	Glaucoma
			05/08/2017	1.0			./data/phs001362.v1.pht006344.v1.p1.Gastric_Cancer_Metastases_Subject_Phenotypes.var_report.xml	0.0			1.0					phs001362.v1.p1	Stomach Neoplasms
34.0			2018/05/15	225.0			./data/phs001311.v1.pht007928.v1.p1.sf_36.var_report.xml	1.0			26.0					phs001311.v1.p1	Myotonia
			2021/09/24				./data/phs002346.v1.pht011577.v1.p1.EAGLE_Immune_Related_Sample_Attributes.var_report.xml									phs002346.v1.p1	Lung Neoplasms
560.0	560.0		05/16/2017	946.0		386.0	./data/phs001252.v1.pht006376.v1.p1.ca_calc.var_report.xml	0.0	473.0	123	386.0			473.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/12/21				./data/phs000007.v32.pht000028.v3.p13.ex0_26s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/26				./data/phs001729.v2.pht010127.v1.p1.TOPMed_WGS_CARE_CLIC_Sample.var_report.xml									phs001729.v2.p1	Asthma
			06/25/2013				./data/phs000354.v1.pht003350.v1.p1.ESP_Family_Studies_PAH_Sample_Attributes.var_report.xml									phs000354.v1.p1	Hypertension, Pulmonary
			12/03/2012				./data/phs000548.v1.pht003070.v1.p1.asa2_Sample.var_report.xml									phs000548.v1.p1	Aspirin
10.0	10.0		03/29/2017	18.0		8.0	./data/phs000707.v2.pht003716.v2.p1.Hereditary_Neurological_Disorders_Subject_Phenotypes.var_report.xml	0.0	9.0	1.414	8.0			9.0		phs000707.v2.p1	Nervous System Diseases
			2018/04/23				./data/phs000179.v6.pht002259.v3.p2.COPDGene_Subject_Images.var_report.xml									phs000179.v6.p2	Pulmonary Disease, Chronic Obstructive
7.0	8.0		2018/10/19	76.0		9.0	./data/phs000492.v3.pht006605.v2.p2.Developmental_Brain_Disorders_Pedigree.var_report.xml	0.0	9.5	7	9.0			9.5		phs000492.v3.p2	Microcephaly
			03/03/2015				./data/phs000620.v1.pht003893.v1.p1.MCTFR_Substance_Abuse_Sample.var_report.xml									phs000620.v1.p1	Substance-Related Disorders
			2020/09/22				./data/phs002211.v1.pht010524.v1.p1.GALE_Sample_Attributes.var_report.xml									phs002211.v1.p1	Bacterial Vaginosis
			03/19/2015				./data/phs000869.v1.pht004611.v1.p1.BEAGESS_Sample_Attributes.var_report.xml									phs000869.v1.p1	Esophageal Neoplasms
156.0			2021/07/29	289.0			./data/phs001624.v2.pht008229.v2.p2.TOPMed_CCDG_BioVU_Subject.var_report.xml	0.0			739.0					phs001624.v2.p2	Atrial Fibrillation
71.0			09/09/2013	114.0			./data/phs000266.v4.pht001266.v4.p1.HMP_Dermatitis_Immunodeficiency_MRSA_Subject_Phenotypes.var_report.xml	0.0			43.0					phs000266.v4.p1	Dermatitis, Atopic
			04/23/2014				./data/phs000378.v1.pht002316.v1.p1.CIDR_Dementia_Subject.var_report.xml									phs000378.v1.p1	Alzheimer Disease
			11/21/2016				./data/phs001251.v1.pht005951.v1.p1.UC_WES_Sample_Attributes.var_report.xml									phs001251.v1.p1	Colitis, Ulcerative
			08/20/2013				./data/phs000285.v3.pht001643.v2.p2.B2LEPTIN.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/10/21				./data/phs001942.v1.pht010586.v1.p1.Histiocytic_Dendritic_Sarcoma_Sample.var_report.xml									phs001942.v1.p1	Histiocytic Sarcoma
			2018/08/02				./data/phs001487.v1.pht007137.v1.p1.CCDG_TAICHI_Sample.var_report.xml									phs001487.v1.p1	
			2019/03/11				./data/phs000286.v6.pht008720.v1.p2.adrb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/12/14				./data/phs001439.v1.pht006817.v1.p1.POP_Sample_Attributes.var_report.xml									phs001439.v1.p1	Pelvic Organ Prolapse
			2018/04/16				./data/phs001326.v1.pht007809.v1.p1.pidtc_19287_day100tre.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
85.0	85.0		2019/04/25	5.0		81.0	./data/phs000899.v1.pht008944.v1.p1.AmBiGen_Subject_Phenotypes.var_report.xml	0.0	83.0	2.828	81.0			83.0		phs000899.v1.p1	Bipolar Disorder
7.0	7.0		2021/07/07	13.0		6.0	./data/phs002436.v1.pht011375.v1.p1.TIL_Infusion_Subject.var_report.xml	0.0	6.5	0.7071	6.0			6.5		phs002436.v1.p1	Melanoma
			03/21/2017				./data/phs000228.v4.pht001184.v3.p1.EMMES_HMP_Subject.var_report.xml									phs000228.v4.p1	Metagenomics
			08/21/2013				./data/phs000641.v1.pht003476.v1.p1.Combined_Immunodeficiency_Multiple_Intestinal_Atresias_Sample.var_report.xml									phs000641.v1.p1	Immunological Deficiency Syndrome
			02/20/2015				./data/phs000431.v2.pht002483.v2.p1.IGAN_Sample.var_report.xml									phs000431.v2.p1	Glomerulonephritis, IGA
			09/16/2013				./data/phs000328.v2.pht002132.v2.p1.DLBCL_Subject.var_report.xml									phs000328.v2.p1	Lymphoma, Large B-Cell, Diffuse
			2019/12/12	166.0			./data/phs001866.v1.pht009674.v1.p1.ConvertHER_Subject_Phenotypes.var_report.xml	0.0			166.0					phs001866.v1.p1	Breast Neoplasms
			2019/06/03				./data/phs001814.v1.pht009005.v1.p1.Heterotaxy_Sample.var_report.xml									phs001814.v1.p1	Heterotaxy Syndrome
			2018/10/31				./data/phs001654.v1.pht008443.v1.p1.NSAID_BE_Subject_Phenotypes.var_report.xml									phs001654.v1.p1	Barrett Esophagus
			2020/12/21				./data/phs000007.v32.pht002564.v6.p13.l_gal3_ex06_1_0623s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001806.v2.p2.EFLWUP1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/12/12				./data/phs001883.v1.pht009680.v1.p1.S0800_BC_Subject.var_report.xml									phs001883.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht006428.v1.p1.CYSC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/14				./data/phs001238.v2.pht006661.v1.p1.GENOA_EuropeanAmerican_Phase2_LabData.var_report.xml									phs001238.v2.p1	Hypertension
			08/20/2013				./data/phs000285.v3.pht001591.v2.p2.A5F06A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht003146.v1.p1.mlf.var_report.xml									phs000343.v3.p1	Stroke
			2020/06/18				./data/phs000280.v7.pht004179.v2.p1.RTASWF33.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2.0			2017/11/09	4.0			./data/phs001400.v1.pht006824.v1.p1.Mega_Haplotypes_CRC_Subject_Phenotypes.var_report.xml	0.0			2.0					phs001400.v1.p1	Cancer, Colorectal
			2020/03/11				./data/phs001919.v1.pht009591.v1.p1.Melanoma_Anti_PD_1_Subject.var_report.xml									phs001919.v1.p1	Melanoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000548.v2.p3.simphen149.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/12/30				./data/phs002290.v1.pht010822.v1.p1.cfDNA_Metastasis_Sample.var_report.xml									phs002290.v1.p1	Cell-Free Nucleic Acids
			2019/03/11				./data/phs000286.v6.pht008746.v1.p2.ecga_adj.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000743.v5.p13.cva_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001920.v5.p2.JHS_Subject.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			12/01/2015				./data/phs000571.v3.pht003175.v3.p2.PCGC_Sample.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2019/08/01				./data/phs001740.v1.pht008622.v1.p1.CCDG_SAGE_Sample.var_report.xml									phs001740.v1.p1	Autism Spectrum Disorder
			2019/12/06				./data/phs001861.v1.pht009323.v1.p1.sc_UM_Subject.var_report.xml									phs001861.v1.p1	Uveal melanoma
			2018/06/14				./data/phs001238.v2.pht006035.v1.p1.GENOA_AfricanAmerican_JacksonCAC_FamilyHistory.var_report.xml									phs001238.v2.p1	Hypertension
317.0	317.0		2021/03/23	599.0		282.0	./data/phs001122.v1.pht008637.v1.p1.Neonatal_Brain_Subject.var_report.xml	0.0	299.5	24.75	282.0			299.5		phs001122.v1.p1	Brain
			2019/03/11				./data/phs000286.v6.pht001947.v2.p2.csia.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
936.0	123.0		2019/04/25	2096.0		936.0	./data/phs001673.v1.pht008510.v1.p1.ADAGESIII_Pedigree.var_report.xml	0.0	940.0	48.08	123.0			940.0		phs001673.v1.p1	Glaucoma
			08/20/2013				./data/phs000285.v3.pht001600.v2.p2.B2F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002145.v6.p13.l_psel_2005_m_0463s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001009.v4.p3.f41_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/06/30				./data/phs001646.v1.pht008197.v1.p1.GBM_Sample_Attributes.var_report.xml									phs001646.v1.p1	Glioblastoma
2.0			02/02/2016	3.0			./data/phs001067.v1.pht005286.v1.p1.Meningitis_Encephalitis_Subject_Phenotypes.var_report.xml	0.0			1.0					phs001067.v1.p1	Encephalitis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000462.v2.p3.simphen063.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
7015.0	7015.0		2018/08/19	2251.0		90.0	./data/phs000101.v5.pht008311.v1.p1.ALS_Diagnosis.var_report.xml	0.0	750.3	590.7	5214.0			5214.0		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			04/11/2014				./data/phs000735.v1.pht003795.v1.p1.Placental_Microbiome_Subject.var_report.xml									phs000735.v1.p1	Bacterial Infections
1.0	24.0		2021/08/30	25.0		1.0	./data/phs002457.v1.pht011515.v1.p1.TNBC_BrM_Subject.var_report.xml	0.0	12.5	16.26	24.0			12.5		phs002457.v1.p1	Triple Negative Breast Neoplasms
			2019/07/01				./data/phs001810.v1.pht009066.v1.p1.COCCaINE_Sample.var_report.xml									phs001810.v1.p1	Cocaine
3747.0	3747.0		2021/03/17	3747.0		3747.0	./data/phs002226.v1.pht011065.v1.p1.MACS_Subject_Phenotypes.var_report.xml	0.0	3747.0					3747.0		phs002226.v1.p1	HIV
			2017/10/11				./data/phs000578.v1.pht007006.v1.p1.baseline_interimmedicalhistory.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			2018/05/01				./data/phs001568.v1.pht007871.v1.p1.CLL_Subject.var_report.xml									phs001568.v1.p1	Leukemia, Lymphoid
			2021/06/09				./data/phs002448.v1.pht011299.v1.p1.BC_CDK4_6_Sample.var_report.xml									phs002448.v1.p1	Immunologic Memory
			2021/02/03				./data/phs001018.v1.pht010912.v1.p1.Clinical_Renal_Tumors_Sample.var_report.xml									phs001018.v1.p1	
			2019/08/18				./data/phs001201.v2.pht007554.v2.p1.AsPIRES_HINT_Subject.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2021/06/25				./data/phs001466.v2.pht009580.v1.p1.TOPMed_WGS_PharmHU_Sample_Attributes.var_report.xml									phs001466.v2.p1	Sickle Cell Anemia
			2018/04/05				./data/phs001522.v1.pht007730.v1.p1.cDNMs_Sample.var_report.xml									phs001522.v1.p1	
653.0	653.0		2019/05/30	980.0		327.0	./data/phs000424.v8.pht002742.v8.p2.GTEx_Subject_Phenotypes.var_report.xml	0.0	490.0	230.5	327.0			490.0		phs000424.v8.p2	Reference Values
			04/15/2014				./data/phs000719.v1.pht003734.v1.p1.PNTM_Subject.var_report.xml									phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
			2021/08/20				./data/phs002508.v1.pht011501.v1.p1.HVP_scRNA_HepB_Sample.var_report.xml									phs002508.v1.p1	Vaccines
			12/27/2012				./data/phs000522.v1.pht002878.v1.p1.Hyperdiploid_Pediatric_ALL_Subject.var_report.xml									phs000522.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			08/12/2016				./data/phs000888.v1.pht005567.v1.p1.16aGERD_hx_visits_B.var_report.xml									phs000888.v1.p1	
			2017/09/06				./data/phs001261.v1.pht006113.v1.p1.Palindromic_Gene_Amplification_Sample.var_report.xml									phs001261.v1.p1	Breast Neoplasms
			02/08/2017				./data/phs001187.v1.pht005678.v1.p1.CD8_T_Cell_Differentiation_Aging_Sample_Attributes.var_report.xml									phs001187.v1.p1	Aging
			2018/04/16				./data/phs001289.v1.pht007789.v1.p1.cardiacarrhythmia.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			2021/07/07				./data/phs001472.v2.pht007118.v1.p1.TOPMed_WGS_ECLIPSE_Sample_Attributes.var_report.xml									phs001472.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/09/18				./data/phs002015.v1.pht010364.v1.p1.AREDS2_ANM.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2021/07/29				./data/phs001599.v1.pht011436.v1.p1.TOPMed_WGS_Boston_Brazil_SCD_Sample_Attributes.var_report.xml									phs001599.v1.p1	Anemia, Sickle Cell
631.0	631.0		04/10/2014	631.0		631.0	./data/phs000306.v4.pht002082.v1.p1.Non_MEC_Prostate_Cancer_AA_Subject_Phenotypes.var_report.xml	0.0	631.0					631.0		phs000306.v4.p1	Prostatic Neoplasms
			2018/10/29				./data/phs001678.v1.pht008474.v1.p1.scTCR_Sample_Attributes.var_report.xml									phs001678.v1.p1	Humans
10.0	10.0		08/26/2013	12.0		2.0	./data/phs000362.v1.pht003230.v1.p1.ESP_FamilialAtrialFibrillation_Subject_Phenotypes.var_report.xml	0.0	6.0	5.657	2.0			6.0		phs000362.v1.p1	Atrial Fibrillation
			08/29/2016				./data/phs000882.v1.pht005713.v1.p1.PEGASUS_EA_Sample.var_report.xml									phs000882.v1.p1	Prostatic Neoplasms
			02/08/2017				./data/phs001276.v1.pht006121.v1.p1.Interneuron_Development_Sample.var_report.xml									phs001276.v1.p1	Growth and Development
376.0	959.0		2021/07/09	969.0		376.0	./data/phs001207.v3.pht005793.v3.p1.TOPMed_WGS_AA_Sarcoidosis_Subject_Phenotypes.var_report.xml	0.0	667.5	78.49	959.0			667.5		phs001207.v3.p1	Sarcoidosis
8.0	9.0		08/24/2009	45.0		8.0	./data/phs000091.v2.pht000799.v2.p1.Type2Diabetes_NHS_HPFS_Pedigree.var_report_2009_08_24.xml	0.0	8.0	8.485	9.0			8.0		phs000091.v2.p1	Diabetes Mellitus, Type 2
			2020/06/18				./data/phs000280.v7.pht004117.v2.p1.ICTA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/11/2015				./data/phs001034.v1.pht005188.v1.p1.NECC_Ovarian_Cancer_Subject_Phenotypes.var_report.xml									phs001034.v1.p1	Ovarian Neoplasms
			2020/06/30				./data/phs001972.v1.pht009844.v1.p1.REDS_BSCDC_Sample_Attributes.var_report.xml									phs001972.v1.p1	Anemia, Sickle Cell
4344.0	4344.0		2019/08/10	8502.0		705.0	./data/phs001208.v2.pht008655.v1.p1.COGA_SmokeScreen_Pedigree.var_report.xml	0.0	917.5	654.1	705.0			917.5		phs001208.v2.p1	Alcoholism
			2020/03/09				./data/phs001299.v2.pht007619.v1.p1.Nicotine_Addiction_Subject.var_report.xml									phs001299.v2.p1	Behavior, Addictive
			03/28/2016				./data/phs001009.v1.pht005353.v1.p1.RBEL_Asthma_Determinants_Sample_Attributes.var_report.xml									phs001009.v1.p1	Asthma
			2017/11/14				./data/phs001241.v1.pht005923.v1.p1.Metastatic_Melanomas_Subject_Phenotypes.var_report.xml									phs001241.v1.p1	Melanoma
			11/08/2013				./data/phs000200.v9.pht000982.v6.p3.WHI_Subject.var_report.xml									phs000200.v9.p3	Women&#39;s Health
745.0			2018/03/09	1021.0			./data/phs000606.v1.pht007571.v1.p1.crf_initialvisit.var_report.xml	0.0			276.0					phs000606.v1.p1	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009191.v1.p1.lab_results_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			09/14/2015				./data/phs000828.v1.pht004328.v1.p1.Fibrolamellar_HCC_Genomic_Analysis_Sample.var_report.xml									phs000828.v1.p1	Fibrolamellar hepatocellular carcinoma
			04/11/2011				./data/phs000100.v3.pht001126.v1.p1.FUSION_Sample.var_report.xml									phs000100.v3.p1	Diabetes Mellitus, Type 2
			04/22/2009				./data/phs000167.v1.pht000716.v1.p1.nonGAIN_Schizophrenia_controls_questionnaire.var_report_2009_04_22.xml									phs000167.v1.p1	Schizophrenia
			11/16/2016				./data/phs000973.v1.pht004990.v1.p1.JMML_Sample_Attributes.var_report.xml									phs000973.v1.p1	Leukemia, Myelomonocytic, Juvenile
			11/08/2013				./data/phs000200.v9.pht002122.v1.p3.outc_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/06/18				./data/phs000280.v7.pht004147.v2.p1.PULM.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			07/27/2017	135.0			./data/phs000596.v1.pht006706.v1.p1.cfq_adolescents_adults_ages_14.var_report.xml	0.0								phs000596.v1.p1	Primary ciliary dyskinesia
			01/11/2017				./data/phs001242.v1.pht006071.v1.p1.Enhancers_Misregulate_Oncogenes_Subject.var_report.xml									phs001242.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			2019/08/01				./data/phs001839.v1.pht009356.v1.p1.Deep_Seq_Cancers_Sample.var_report.xml									phs001839.v1.p1	Neoplasms
			2020/02/19				./data/phs001221.v1.pht007157.v1.p1.Prostate_Cancer_GWAS_Subject.var_report.xml									phs001221.v1.p1	Prostatic Neoplasms
56.0			08/20/2013	334.0			./data/phs000285.v3.pht001706.v2.p2.D1DEXA.var_report.xml	0.0			92.0					phs000285.v3.p2	Cardiovascular Diseases
			2019/08/01				./data/phs001786.v1.pht008837.v1.p1.SU2C_GEMM_Sample.var_report.xml									phs001786.v1.p1	Melanoma
1420.0	2323.0		03/14/2012	3743.0		1420.0	./data/phs000223.v1.pht002621.v1.p1.ARIC_PAGE_pilot_SubjectGenders.var_report.xml	0.0	1872.0	638.5	2323.0			1872.0		phs000223.v1.p1	Cardiovascular Diseases
			2021/05/07				./data/phs000946.v5.pht004974.v2.p1.TOPMed_WGS_Boston_EO_COPD_Sample_Attributes.var_report.xml									phs000946.v5.p1	Chronic Obstructive Pulmonary Disease
			2020/12/21				./data/phs000007.v32.pht000905.v4.p13.ctpericard1_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/08				./data/phs001422.v2.pht006758.v2.p1.GETHIN_Subject.var_report.xml									phs001422.v2.p1	Insulinoma
7.0	4.0		2021/02/04	4.0		7.0	./data/phs001748.v1.pht008576.v1.p1.Histiocytic_Sarcomas_Subject_Phenotypes.var_report.xml	0.0	8.333	5.132	14.0			7.0		phs001748.v1.p1	Histiocytic Sarcoma
			2018/03/26				./data/phs000697.v1.pht007702.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2021/05/25				./data/phs001945.v1.pht010487.v1.p1.CIDR_ACCME_Sample.var_report.xml									phs001945.v1.p1	Uterine Cervical Neoplasms
			2018/01/08				./data/phs001291.v1.pht007330.v1.p1.Neoadjuvant_Trastuzumab_BC_Sample_Attributes.var_report.xml									phs001291.v1.p1	Breast Neoplasms
			2021/03/17				./data/phs002364.v1.pht011061.v1.p1.HIV_cART_Subject_Phenotypes.var_report.xml									phs002364.v1.p1	HIV
			2020/12/21				./data/phs000007.v32.pht000026.v3.p13.ex0_24s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004074.v2.p1.ECGMA03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000298.v8.p13.crp3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009202.v1.p1.vdi.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2019/10/07				./data/phs000924.v4.pht006322.v4.p1.iPSCORE_Sample.var_report.xml									phs000924.v4.p1	Heart Diseases
			2020/12/21				./data/phs000007.v32.pht003315.v9.p13.vr_survaf_2018_a_1272s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/11				./data/phs000578.v1.pht007018.v1.p1.results_of_laboratory_testing.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			07/05/2017				./data/phs000595.v1.pht006631.v1.p1.deathrecord.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			05/24/2016				./data/phs001065.v1.pht005396.v1.p1.aes.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/10/11				./data/phs001380.v1.pht009228.v1.p1.TS_Sample.var_report.xml									phs001380.v1.p1	Tourette Syndrome
			2018/03/21				./data/phs001512.v1.pht007665.v1.p1.IR_Signatures_Subject.var_report.xml									phs001512.v1.p1	Immune System Phenomena
			2017/08/25				./data/phs001407.v1.pht006666.v1.p1.HNPCC_Sample.var_report.xml									phs001407.v1.p1	Lynch syndrome I
			08/20/2013				./data/phs000285.v3.pht001749.v2.p2.DFLWUP1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008778.v1.p2.pfhb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			03/27/2012				./data/phs000331.v1.pht002092.v1.p1.PGRN_RIKEN_Subject.var_report.xml									phs000331.v1.p1	Long QT Syndrome
			08/25/2015				./data/phs000978.v1.pht004943.v1.p1.Malignant_GCT_Pazopanib_Sample_Attributes.var_report.xml									phs000978.v1.p1	Granular Cell Tumor
			2018/04/16				./data/phs000862.v1.pht007834.v1.p1.LDN_6719_Subject.var_report.xml									phs000862.v1.p1	Mucopolysaccharidosis I
			2018/06/13				./data/phs001521.v1.pht007736.v1.p1.Microbiota_S_Typhi_SRA.var_report.xml									phs001521.v1.p1	Microbiota
			2021/09/29				./data/phs002506.v1.pht011538.v1.p1.Drug_Outcome_SNVs_Sample.var_report.xml									phs002506.v1.p1	Pharmacology
			01/13/2014				./data/phs000666.v1.pht003573.v1.p1.Elderly_Influenza_Vaccine_Sample.var_report.xml									phs000666.v1.p1	Influenza Vaccines
			2021/05/07				./data/phs000946.v5.pht005719.v2.p1.TOPMed_WGS_Boston_EO_COPD_Subject_Phenotypes.var_report.xml									phs000946.v5.p1	Chronic Obstructive Pulmonary Disease
			2018/07/18				./data/phs001645.v1.pht008209.v1.p1.Cutaneous_DLBCL_Subject.var_report.xml									phs001645.v1.p1	Lymphoma, Large B-Cell, Diffuse
			2017/12/20				./data/phs000577.v1.pht007271.v1.p1.interimeventform.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			11/05/2014				./data/phs000209.v13.pht002104.v2.p3.MESA_AncilMesaNAFLDLiverCT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			03/16/2016				./data/phs001000.v1.pht005028.v1.p1.MIGen_Leicester_Subject.var_report.xml									phs001000.v1.p1	Myocardial Infarction
			2021/08/19				./data/phs001662.v2.pht010072.v1.p1.LTRC_R040_subject_six_min_walk.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2017/12/20				./data/phs000577.v1.pht007263.v1.p1.adverse_event.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			01/23/2017				./data/phs001246.v1.pht006082.v1.p1.Arhinia_Subject.var_report.xml									phs001246.v1.p1	Arhinia, choanal atresia, and microphthalmia
592.0			05/04/2011	756.0			./data/phs000361.v1.pht002223.v1.p1.CGEMS_UpperGastrointestinalCancers_Data.var_report.xml	0.0			750.0					phs000361.v1.p1	Intestinal Neoplasms
			12/17/2015				./data/phs000728.v1.pht003767.v1.p1.Lung_Cancer_Smokers_Sample.var_report.xml									phs000728.v1.p1	Lung Neoplasms
			2017/12/20	1.0			./data/phs000577.v1.pht007269.v1.p1.eligibility.var_report.xml	539.0								phs000577.v1.p1	Urea Cycle Disorders, Inborn
			08/20/2013				./data/phs000285.v3.pht001834.v2.p2.F1F62.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/08/18				./data/phs002315.v1.pht011316.v1.p1.Integrated_Multimodal_Single_Cell_Sample_Attributes.var_report.xml									phs002315.v1.p1	Single-Cell Analysis
			07/25/2014				./data/phs000335.v3.pht002116.v1.p2.LHS_COPD_Pedigree_CrypticHalfSibs.var_report.xml									phs000335.v3.p2	COPD
			2020/12/15				./data/phs001404.v1.pht010789.v1.p1.GBC_Sample_Attributes.var_report.xml									phs001404.v1.p1	Gallbladder Cancer
			11/08/2013				./data/phs000200.v9.pht002758.v1.p3.outc_cad_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
464.0	464.0		11/02/2015	787.0		67.0	./data/phs000639.v1.pht004779.v1.p1.Autism_Spectrum_Disorder_Pedigree.var_report.xml	0.0	393.5	99.7	67.0			393.5		phs000639.v1.p1	Autism Spectrum Disorder
			2019/03/28				./data/phs001346.v1.pht006254.v1.p1.CPS_Immunization_P_Falciparum_Subject.var_report.xml									phs001346.v1.p1	Malaria
			2018/09/26				./data/phs001410.v1.pht008420.v1.p1.GMKF_AIS_Subject.var_report.xml									phs001410.v1.p1	Scoliosis
			07/27/2017				./data/phs000247.v5.pht001285.v5.p3.HMP_Neonatal_Enterocolitis_Sample.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			2021/09/21				./data/phs002330.v1.pht011569.v1.p1.GMKF_INCLUDE_Subject.var_report.xml									phs002330.v1.p1	Down Syndrome
			2019/12/19				./data/phs001713.v1.pht008522.v1.p1.LCCC_1108_Subject.var_report.xml									phs001713.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht000611.v6.p13.wholedxa1_7_0708s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/06/2015				./data/phs000811.v1.pht004401.v1.p1.Targeted_DNA_NGS_Sample_Attributes.var_report.xml									phs000811.v1.p1	Neoplasms
			2019/11/08				./data/phs001330.v2.pht007538.v2.p1.p6707_15482_brainmrin.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			10/14/2015				./data/phs000903.v1.pht004873.v1.p1.OCD_OCGAS_Sample_Attributes.var_report.xml									phs000903.v1.p1	Obsessive-Compulsive Disorder
			2018/08/06				./data/phs001398.v1.pht007140.v1.p1.CCDG_BRAVE_Subject.var_report.xml									phs001398.v1.p1	
			04/04/2014				./data/phs000679.v1.pht003655.v1.p1.Anorexia_Nervosa_Subject.var_report.xml									phs000679.v1.p1	Anorexia Nervosa
			12/01/2015				./data/phs000571.v3.pht003189.v3.p2.OtherGeneticTestResults.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2018/05/03				./data/phs001587.v1.pht007886.v1.p1.Prostate_Cancer_Organoids_Sample_Attributes.var_report.xml									phs001587.v1.p1	Prostatic Neoplasms
			2021/06/23				./data/phs001435.v2.pht009873.v1.p1.TOPMed_WGS_AustralianFamilialAF_Subject.var_report.xml									phs001435.v2.p1	Atrial Fibrillation
			2020/12/21				./data/phs000007.v32.pht000144.v7.p13.ct3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010372.v1.p1.AREDS2_CTI.var_report.xml									phs002015.v1.p1	Macular Degeneration
			12/07/2015				./data/phs000970.v1.pht005017.v1.p1.Fetal_Methylmercury_Exposure_Sample.var_report.xml									phs000970.v1.p1	Methylmercury Compounds
			2018/11/15				./data/phs001418.v1.pht007235.v1.p1.CD_Subject.var_report.xml									phs001418.v1.p1	Crohn Disease
			2020/09/03				./data/phs001903.v1.pht009892.v1.p1.OncoArray_CRC_Subject.var_report.xml									phs001903.v1.p1	Colorectal Neoplasms
801.0	801.0		2021/05/05	395.0		98.0	./data/phs002310.v1.pht011205.v1.p1.InC3_Pedigree.var_report.xml	0.0	960.5	543.8	98.0			960.5		phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			2020/07/10				./data/phs000723.v1.pht005210.v1.p1.Cervical_Adenocarcinoma_Chinese_Subject.var_report.xml									phs000723.v1.p1	Uterine Cervical Neoplasms
	1.0		05/20/2015	1.0		1.0	./data/phs000898.v1.pht004643.v1.p1.Colorectal_Cancer_Mb_Scale_Haplotypes_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs000898.v1.p1	Colorectal Neoplasms
4.0	4.0		2020/06/29	8.0		4.0	./data/phs001180.v2.pht006989.v1.p1.GALAII_Pedigree.var_report.xml	0.0	4.0	0	4.0			4.0		phs001180.v2.p1	Lung Diseases
			2017/12/08				./data/phs001279.v1.pht007204.v1.p1.body_morphometric.var_report.xml									phs001279.v1.p1	Bronchiectasis
			2019/03/11				./data/phs000286.v6.pht008725.v1.p2.afulong.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003089.v1.p3.MESA_AncilMesaMineralMetabolite.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006465.v1.p1.PNE.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008755.v1.p2.incevthfder.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000098.v8.p13.act1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/14/2016				./data/phs001050.v1.pht005233.v1.p1.BEAUTY_Subject_Phenotypes.var_report.xml									phs001050.v1.p1	Breast Neoplasms
			2021/01/15				./data/phs000989.v4.pht005022.v4.p1.Cortical_Neurogenesis_Subject_Phenotypes.var_report.xml									phs000989.v4.p1	Stem cells, neural
			2021/06/09				./data/phs001395.v2.pht006626.v1.p1.TOPMed_WGS_HCHS_SOL_Sample.var_report.xml									phs001395.v2.p1	Cardiovascular Diseases
			2020/02/06				./data/phs001430.v2.pht008069.v2.p1.p7001_16388_behaviore.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2018/05/03				./data/phs001587.v1.pht007882.v1.p1.Prostate_Cancer_Organoids_Subject.var_report.xml									phs001587.v1.p1	Prostatic Neoplasms
			2020/02/14				./data/phs000575.v2.pht005893.v2.p1.educationhistory.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			2019/11/08				./data/phs001330.v2.pht007526.v2.p1.LDN_6707_Subject.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			2020/12/21				./data/phs000007.v32.pht002425.v2.p13.l_emppmp_ex08_1_0489s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004052.v2.p1.CHMB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/09				./data/phs002448.v1.pht011300.v1.p1.BC_CDK4_6_Subject_Phenotypes.var_report.xml									phs002448.v1.p1	Immunologic Memory
			07/25/2014				./data/phs000779.v1.pht003961.v1.p1.OFCCR_SNP_CpG_Subject.var_report.xml									phs000779.v1.p1	Colorectal Neoplasms
			03/19/2015				./data/phs000885.v1.pht004604.v1.p1.HCC_CAGE_Profiling_ncRNAs_Sample.var_report.xml									phs000885.v1.p1	Carcinoma, Hepatocellular
			2017/11/01				./data/phs001305.v1.pht007111.v1.p1.treatmenttable.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			2019/03/11				./data/phs000286.v6.pht008775.v1.p2.pacb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			09/25/2015				./data/phs000712.v1.pht003709.v1.p1.UIC_ACE_Subject.var_report.xml									phs000712.v1.p1	Autistic Disorder
			2018/03/21				./data/phs001529.v1.pht007370.v1.p1.scRNASeq_RA_Microfluidic_Sample_Attributes.var_report.xml									phs001529.v1.p1	Arthritis, Rheumatoid
819.0	819.0		2021/08/23	4814.0		767.0	./data/phs001232.v4.pht006075.v4.p2.UDN_Subject.var_report.xml	0.0	793.0	94.05	767.0			793.0		phs001232.v4.p2	Rare Diseases
			2017/10/04				./data/phs001270.v1.pht006251.v1.p1.SACDS_IGHNSS_Sample.var_report.xml									phs001270.v1.p1	Sleep Wake Disorders
			06/12/2017				./data/phs000594.v1.pht006503.v1.p1.Eligibility.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			11/05/2014				./data/phs000209.v13.pht002192.v1.p3.MESA_AirNRAirExposure.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000108.v3.p13.rhd0_9s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000998.v4.p3.f2_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			02/27/2017				./data/phs001036.v1.pht005268.v1.p1.Acral_Melanoma_Subject.var_report.xml									phs001036.v1.p1	Melanoma
			2019/06/24				./data/phs001795.v1.pht008949.v1.p1.CM1_Subject.var_report.xml									phs001795.v1.p1	Arnold-Chiari Malformation
			02/22/2013				./data/phs000339.v2.pht002486.v1.p1.mitogo_dbGaP_SampleAttributesDS.var_report.xml									phs000339.v2.p1	Mitochondrial Diseases
			2017/10/10				./data/phs001372.v1.pht006533.v1.p1.CLL_Integrated_Single_Cell_Sample.var_report.xml									phs001372.v1.p1	Leukemia, Lymphoid
			2018/05/17				./data/phs001596.v1.pht007967.v1.p1.Acral_Melanoma_Sample_Attributes.var_report.xml									phs001596.v1.p1	Melanoma
4.0	4.0		2021/01/21	5.0		1.0	./data/phs002291.v1.pht010800.v1.p1.HSPCs_Aging_MBM_Subject.var_report.xml	0.0	2.5	2.121	1.0			2.5		phs002291.v1.p1	Multiple Myeloma
			2021/08/18				./data/phs002315.v1.pht011317.v1.p1.Integrated_Multimodal_Single_Cell_GEO.var_report.xml									phs002315.v1.p1	Single-Cell Analysis
			2021/08/30				./data/phs001933.v1.pht011514.v1.p1.TOPMed_CCDG_UCSF_AF_Sample_Attributes.var_report.xml									phs001933.v1.p1	Atrial Fibrillation
			2019/10/18				./data/phs001020.v2.pht005784.v2.p1.GPC_Sample_Attributes.var_report.xml									phs001020.v2.p1	Schizophrenia
6.0	60.0		12/19/2014	69.0		8.0	./data/phs000348.v2.pht002230.v2.p1.Myeloma_Subject_Phenotypes.var_report.xml	0.0	68.0	86.06	9.0			6.0		phs000348.v2.p1	Multiple Myeloma
			2017/12/20				./data/phs000577.v1.pht007275.v1.p1.neuropsychforma.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000439.v2.p3.simphen040.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/07/09				./data/phs001772.v2.pht008634.v2.p1.NETs_Sample.var_report.xml									phs001772.v2.p1	Intestinal Neoplasms
			07/18/2012				./data/phs000513.v1.pht002826.v1.p1.MAST_Kinase_Notch_Gene_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs000513.v1.p1	Breast Neoplasms
			11/25/2013				./data/phs000682.v1.pht003594.v1.p1.Neuropsychiatric_Neurodevelopmental_Disorders_Subject.var_report.xml									phs000682.v1.p1	Psychiatry and Psychology Category
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000570.v2.p3.simphen171.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/03/25				./data/phs001747.v1.pht008644.v1.p1.CAREGIVER_Subject_Phenotypes.var_report.xml									phs001747.v1.p1	Coronary Disease
			2018/04/05				./data/phs001196.v1.pht005698.v1.p1.Schizophrenia_Trios_Taiwanese_Subject.var_report.xml									phs001196.v1.p1	Schizophrenia
5.0	5.0		11/08/2012	8.0		3.0	./data/phs000540.v1.pht003046.v1.p1.Ehlers_Danlos_Syndrome_Type_VIII_Subject_Phenotypes.var_report.xml	0.0	4.0	1.414	3.0			4.0		phs000540.v1.p1	Ehlers-Danlos Syndrome
			10/13/2009				./data/phs000210.v1.pht000899.v1.p1.MA27_Event_Data.var_report_2009_10_13.xml									phs000210.v1.p1	Breast Neoplasms
10.0			2021/07/19	10.0			./data/phs002229.v1.pht010556.v1.p1.GCT_PrimaryMetastasis_Subject_Phenotypes.var_report.xml	0.0								phs002229.v1.p1	Neoplasms, Germ Cell and Embryonal
6.0	7.0		11/15/2012	13.0		6.0	./data/phs000405.v1.pht002610.v1.p1.Mendelian_Malignant_Hyperthermia_Subject_Phenotypes.var_report.xml	0.0	6.5	0.7071	7.0			6.5		phs000405.v1.p1	Malignant Hyperthermia
			2018/04/16				./data/phs001326.v1.pht007819.v1.p1.pidtc_17826_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2017/09/19				./data/phs001426.v1.pht006916.v1.p1.T1DGC_RNASeq_Sample.var_report.xml									phs001426.v1.p1	Diabetes Mellitus, Type 1
			2018/06/30				./data/phs001625.v1.pht008186.v1.p1.Psychotic_Major_Depression_Sample_Attributes.var_report.xml									phs001625.v1.p1	Control Groups
			2020/12/21				./data/phs000007.v32.pht000078.v8.p13.bwgt1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/10				./data/phs001954.v1.pht009796.v1.p1.ICPC_LUAD_Taiwan_Subject.var_report.xml									phs001954.v1.p1	Adenocarcinoma of Lung
			11/22/2013				./data/phs000460.v1.pht002548.v1.p1.Recurrent_Nephrolithiasis_Sample.var_report.xml									phs000460.v1.p1	Nephrolithiasis
75.0			2021/07/15	90.0			./data/phs001547.v2.pht009989.v1.p1.TOPMed_CCDG_GENAF_Subject_Phenotypes.var_report.xml	0.0			15.0					phs001547.v2.p1	Atrial Fibrillation
			05/02/2012				./data/phs000478.v1.pht002658.v1.p1.Strabismus_Sample_Attributes.var_report.xml									phs000478.v1.p1	Strabismus
			11/08/2013				./data/phs000200.v9.pht003407.v1.p3.outc_ct_os_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			05/02/2011				./data/phs000311.v1.pht002128.v1.p1.FusionSeq_Sample.var_report.xml									phs000311.v1.p1	Prostatic Neoplasms
			2018/06/01				./data/phs001538.v1.pht008099.v1.p1.Registry_Exams_2.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			2020/12/21				./data/phs000007.v32.pht006006.v4.p13.e_exam_ex01_72_0652s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
	34.0		2020/10/29	34.0		34.0	./data/phs002270.v1.pht010596.v1.p1.Recurrent_GBM_Subject.var_report.xml	0.0	34.0					34.0		phs002270.v1.p1	Glioblastoma
			2017/12/04				./data/phs001385.v1.pht007164.v1.p1.Gallbladder_Cancer_Chileans_Sample.var_report.xml									phs001385.v1.p1	Gallbladder Neoplasms
			02/13/2014				./data/phs000372.v1.pht002859.v1.p1.ADGC_Sample_Attributes.var_report.xml									phs000372.v1.p1	Alzheimer Disease
			Wed Nov 26 07:50:03 2008				./data/phs000017.v3.pht000384.v1.p1.AA_GAIN_phenotype_controls_questionnaire_subset.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2019/07/25				./data/phs001864.v1.pht009266.v1.p1.MAPK_HCL_SH_Sample_Attributes.var_report.xml									phs001864.v1.p1	histiocytosis
			10/19/2016				./data/phs001039.v1.pht005849.v1.p1.IAMDGC_Exome_Chip_Sample_Attributes.var_report.xml									phs001039.v1.p1	Macular Degeneration
			2020/06/18				./data/phs000280.v7.pht004197.v2.p1.STROKE01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000229.v1.p1.DCCT_cbl1.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/11/05				./data/phs001632.v1.pht008534.v1.p1.Multiple_Myeloma_AA_Sample_Attributes.var_report.xml									phs001632.v1.p1	Multiple Myeloma
			2020/06/18				./data/phs000280.v7.pht006437.v1.p1.ECH.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001748.v1.p2.DEATH06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
126.0	126.0		2020/06/10	238.0		112.0	./data/phs002037.v1.pht010267.v1.p1.Mg_Deficiency_CRC_Subject_Phenotypes.var_report.xml	0.0	119.0	9.899	112.0			119.0		phs002037.v1.p1	Magnesium Deficiency
3.0	3.0		2021/08/20	4.0		2.0	./data/phs002557.v1.pht011479.v1.p1.PID_LRBA_Subject.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs002557.v1.p1	LRBA protein, human
			2018/02/27				./data/phs001447.v1.pht007471.v1.p1.MCRPCS_Sample_Attributes.var_report.xml									phs001447.v1.p1	Prostatic Neoplasms
			2020/09/18				./data/phs002015.v1.pht010394.v1.p1.AREDS2_SAE.var_report.xml									phs002015.v1.p1	Macular Degeneration
			05/24/2016				./data/phs001065.v1.pht005422.v1.p1.modrankn.var_report.xml									phs001065.v1.p1	Huntington Disease
			2017/10/19				./data/phs001448.v1.pht007030.v1.p1.ESCC_Sub_Saharan_Sample.var_report.xml									phs001448.v1.p1	Esophageal Neoplasm
41.0	67.0		2021/03/30	108.0		41.0	./data/phs002311.v1.pht010932.v1.p1.GATA2_Deficiency_Pedigree.var_report.xml	0.0	54.0	18.38	67.0			54.0		phs002311.v1.p1	Neoplasms
			2018/06/01				./data/phs001538.v1.pht008089.v1.p1.Registry_FamHx.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			11/24/2010				./data/phs000140.v1.pht000654.v1.p1.T2D_Subject.var_report_2010_11_24.xml									phs000140.v1.p1	Diabetes Mellitus, Type 2
22.0	22.0		2021/05/27	38.0		16.0	./data/phs002433.v1.pht011257.v1.p1.NP_RNAseq_SARS_CoV2_Subject.var_report.xml	0.0	19.0	4.243	16.0			19.0		phs002433.v1.p1	COVID-19
			2019/11/08				./data/phs001332.v2.pht007453.v2.p1.medical_history.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2020/06/18				./data/phs000280.v7.pht006418.v1.p1.AMY.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/29/2016				./data/phs000990.v1.pht004997.v1.p1.MIGen_Lubeck_Sample.var_report.xml									phs000990.v1.p1	Myocardial Infarction
			12/20/2016				./data/phs000768.v2.pht004477.v2.p1.Pediatric_Ewing_Sarcoma_Subject.var_report.xml									phs000768.v2.p1	Sarcoma, Ewing
			01/30/2017				./data/phs001255.v1.pht005990.v1.p1.Molecular_Evolution_Cancer_Subject.var_report.xml									phs001255.v1.p1	Liposarcoma
			11/04/2014				./data/phs000086.v3.pht000334.v1.p1.EDIC_f0502.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			05/24/2017				./data/phs000576.v1.pht006144.v1.p1.developmentaldatasheet.var_report.xml									phs000576.v1.p1	Angelman Syndrome
9.0	9471.0		2019/09/16	9716.0		9.0	./data/phs001123.v2.pht009042.v1.p1.CAAPA_Pedigree.var_report.xml	187.0	8432.0	9.192	9471.0			8432.0		phs001123.v2.p1	Asthma
			11/04/2015				./data/phs001016.v1.pht005082.v1.p1.Radial_Glial_Diversity_Sample_Attributes.var_report.xml									phs001016.v1.p1	Neuroglia
3.0	3.0		08/11/2011	4.0		2.0	./data/phs000365.v1.pht002265.v1.p1.XMEN_Disease_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs000365.v1.p1	Immune System Diseases
			2020/06/25				./data/phs001779.v1.pht010208.v1.p1.CIDR_NIA_Ehlers_Danlos_Sample_Attributes.var_report.xml									phs001779.v1.p1	Ehlers-Danlos syndrome type 3
690.0	690.0		2020/03/09	986.0		296.0	./data/phs001135.v2.pht005983.v1.p1.START_Pedigree.var_report.xml	0.0	493.0	278.6	296.0			493.0		phs001135.v2.p1	Opioid-Related Disorders
			2020/12/21				./data/phs000007.v32.pht004361.v5.p13.l_bamyl_ex02_3b_0818s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/25				./data/phs001752.v1.pht008873.v1.p1.NEPC_cfDNA_Subject.var_report.xml									phs001752.v1.p1	Adenocarcinoma
			2020/04/27				./data/phs002021.v1.pht010160.v1.p1.SCT_GVHD_Sample_Attributes.var_report.xml									phs002021.v1.p1	Graft vs Host Disease
			2018/04/16				./data/phs001326.v1.pht007824.v1.p1.pidtc_17645_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2019/12/12				./data/phs001866.v1.pht009673.v1.p1.ConvertHER_Sample.var_report.xml									phs001866.v1.p1	Breast Neoplasms
			2021/07/22				./data/phs001605.v2.pht010080.v2.p1.TOPMed_WGS_CHIRAH_Sample.var_report.xml									phs001605.v2.p1	Asthma
7.0	8.0		2018/10/19	76.0		9.0	./data/phs000492.v3.pht002709.v3.p2.Developmental_Brain_Disorders_Subject_Phenotypes.var_report.xml	0.0	9.5	7	9.0			9.5		phs000492.v3.p2	Microcephaly
			2020/03/02				./data/phs001870.v1.pht009919.v1.p1.BC_Chinese_Sample_Attributes.var_report.xml									phs001870.v1.p1	Breast Neoplasms
841.0			2017/09/15	3333.0			./data/phs001173.v1.pht005671.v1.p1.Head_Neck_Cancer_GWAS_Subject_Phenotypes.var_report.xml	0.0			812.0					phs001173.v1.p1	Carcinoma, squamous cell of head and neck
			2018/02/20				./data/phs001528.v1.pht007363.v1.p1.SCCOHT_Sample_Attributes.var_report.xml									phs001528.v1.p1	Ovarian Neoplasms
169.0	169.0		2018/03/09	290.0		121.0	./data/phs000933.v2.pht004776.v2.p1.Melanoma_WES_Subject_Phenotypes.var_report.xml	0.0	145.0	33.94	121.0			145.0		phs000933.v2.p1	Melanoma
			2017/09/12				./data/phs001403.v1.pht006842.v1.p1.NF1_PN_Sample.var_report.xml									phs001403.v1.p1	Neurofibromatosis Type I
			07/31/2012				./data/phs000449.v2.pht002778.v2.p1.Genetic_Adaptation_African_Subject.var_report.xml									phs000449.v2.p1	Population Control
278.0	347.0		2019/04/10	625.0		278.0	./data/phs001653.v1.pht008703.v1.p1.Holoprosencephaly_Pedigree.var_report.xml	0.0	312.5	48.79	347.0			312.5		phs001653.v1.p1	Holoprosencephaly
53.0			09/06/2016	69.0			./data/phs000804.v1.pht005376.v1.p1.Ewing_Sarcoma_Subject_Phenotypes.var_report.xml	0.0			49.0					phs000804.v1.p1	Sarcoma, Ewing
59.0	59.0		2018/05/21	57.0		50.0	./data/phs001198.v1.pht007863.v1.p1.Methamphetamine_Abstinence_Pedigree.var_report.xml	0.0	54.5	6.364	50.0			54.5		phs001198.v1.p1	Substance-Related Disorders
			09/12/2014				./data/phs000793.v1.pht004021.v1.p1.AML_Epigenetics_Sample.var_report.xml									phs000793.v1.p1	Leukemia, Myeloid, Acute
			2020/01/21				./data/phs001282.v2.pht006099.v2.p1.Endemic_Burkitt_Lymphoma_Sample_Attributes.var_report.xml									phs001282.v2.p1	Burkitt Lymphoma
			2018/05/31				./data/phs001318.v1.pht008039.v1.p1.revlimiddosage.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
4.0	8.0		04/09/2014	6.0		4.0	./data/phs000437.v1.pht003688.v1.p1.Auriculocondylar_Syndrome_Pedigree.var_report.xml	0.0	6.0	2.828	8.0			6.0		phs000437.v1.p1	Auriculo-condylar syndrome
			08/08/2011				./data/phs000353.v1.pht002251.v1.p1.Preterm_Birth_AA_Sample_Information.var_report.xml									phs000353.v1.p1	Premature Birth
			05/17/2017				./data/phs001328.v1.pht006318.v1.p1.behavioral_measures.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			05/26/2016				./data/phs001107.v1.pht005491.v1.p1.VHL_Renal_Tumors_Sample_Attributes.var_report.xml									phs001107.v1.p1	von Hippel-Lindau Disease
			07/25/2014				./data/phs000560.v1.pht003942.v1.p1.DNHS_Sample_Attributes.var_report.xml									phs000560.v1.p1	Stress Disorders, Post-Traumatic
			2020/02/06				./data/phs001430.v2.pht008059.v2.p1.p7001_15913_behaviore.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			05/14/2013				./data/phs000422.v1.pht003223.v1.p1.LungGO_SevereAsthma_Subject.var_report.xml									phs000422.v1.p1	Asthma
348.0			06/03/2015	630.0			./data/phs000863.v1.pht004744.v1.p1.RCC_AA_Subject_Phenotypes.var_report.xml	0.0			91.0					phs000863.v1.p1	Carcinoma, Renal Cell
			2018/10/05				./data/phs001660.v1.pht008412.v1.p1.Paclitaxel_Cohort_LUPG_Sample.var_report.xml									phs001660.v1.p1	Paclitaxel
			2018/07/18				./data/phs001651.v1.pht008236.v1.p1.Lung_SQCC_AppKY_Sample_Attributes.var_report.xml									phs001651.v1.p1	Lung Neoplasms
			09/10/2013				./data/phs000601.v1.pht003513.v1.p1.Heritable_Breast_Cancer_Subject.var_report.xml									phs000601.v1.p1	Breast Neoplasms
			2019/10/29				./data/phs001465.v1.pht006957.v1.p1.Localized_Prostate_Cancer_Sample.var_report.xml									phs001465.v1.p1	Prostate Neoplasm
			2017/12/20				./data/phs000577.v1.pht007266.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2021/08/26				./data/phs001727.v2.pht010103.v1.p1.TOPMed_WGS_PIMA_Sample_Attributes.var_report.xml									phs001727.v2.p1	Asthma
514.0	511.0		2020/04/30	1006.0		15.0	./data/phs001517.v2.pht007482.v2.p2.GHIRD_Subject_Phenotypes.var_report.xml	0.0	335.3	277.8	480.0			480.0		phs001517.v2.p2	Retinitis Pigmentosa
			2021/08/06				./data/phs001682.v2.pht009765.v1.p1.TOPMed_WGS_PUSH_SCD_Sample_Attributes.var_report.xml									phs001682.v2.p1	Anemia, Sickle Cell
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000417.v2.p3.simphen018.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/06/13				./data/phs001521.v1.pht007720.v1.p1.Microbiota_S_Typhi_Subject.var_report.xml									phs001521.v1.p1	Microbiota
			2020/12/21				./data/phs000007.v32.pht003094.v7.p13.e_exam_2011_m_0017s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
194.0	335.0		01/22/2014	529.0		194.0	./data/phs000670.v1.pht003556.v1.p1.PGRN_AMPS_Subject_Phenotypes.var_report.xml	0.0	264.5	99.7	335.0			264.5		phs000670.v1.p1	Depressive Disorder, Major
			2019/10/28				./data/phs001880.v1.pht009560.v1.p1.CCDG_Emory_Subject.var_report.xml									phs001880.v1.p1	Cardiovascular Diseases
871.0	871.0		03/16/2016	2322.0		349.0	./data/phs001000.v1.pht005030.v1.p1.MIGen_Leicester_Subject_Phenotypes.var_report.xml	0.0	610.0	369.1	349.0			610.0		phs001000.v1.p1	Myocardial Infarction
			2018/09/21				./data/phs001552.v1.pht008394.v1.p1.T2D_GENES_PROMIS_Sample.var_report.xml									phs001552.v1.p1	Diabetes Mellitus, Type 2
			11/30/2015				./data/phs000975.v1.pht004934.v1.p1.NHS_Mammographic_Density_Sample.var_report.xml									phs000975.v1.p1	Mammographic density
			2020/06/18				./data/phs000280.v7.pht006469.v1.p1.PWV.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/11/19				./data/phs002286.v1.pht010636.v1.p1.HPV16_E7_Sample_Attributes.var_report.xml									phs002286.v1.p1	Neoplasms
46.0	46.0		2020/04/14	61.0		15.0	./data/phs001994.v1.pht010010.v1.p1.Tobacco_HNSCC_Subject_Phenotypes.var_report.xml	0.0	30.5	21.92	15.0			30.5		phs001994.v1.p1	Squamous Cell Carcinoma of Head and Neck
			06/20/2013				./data/phs000430.v1.pht003054.v1.p1.HALT_C_Subject_Phenotypes.var_report.xml									phs000430.v1.p1	Hepatitis C
			2020/11/24				./data/phs001052.v2.pht005466.v2.p1.Pediatric_Solid_Tumors_Subject.var_report.xml									phs001052.v2.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht010750.v1.p13.vr_demsurv_2018_a_1281s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
466.0	480.0		04/29/2014	946.0		466.0	./data/phs000630.v1.pht003383.v1.p1.NIMH_Controls_Subject_Phenotypes.var_report.xml	105.0	473.0	9.899	480.0			473.0		phs000630.v1.p1	Normalcy
			Thu Jan 17 21:45:34 2008				./data/phs000019.v1.pht000063.v1.p1.cases.var_report_2008_08_12.xml									phs000019.v1.p1	Psoriasis
			2019/12/16				./data/phs001932.v1.pht009657.v1.p1.MGS_European_Sample_Attributes.var_report.xml									phs001932.v1.p1	Schizophrenia
			08/20/2013				./data/phs000285.v3.pht001858.v2.p2.F2F65.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000542.v2.p3.simphen143.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			01/05/2016				./data/phs001028.v1.pht005128.v1.p1.Circulating_Tumor_Cells_MBC_Subject.var_report.xml									phs001028.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht001514.v4.p3.f134_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/08/26				./data/phs001831.v1.pht009167.v1.p1.Neuroblastoma_Epigenetics_Subject.var_report.xml									phs001831.v1.p1	Neuroblastoma
			2018/05/07				./data/phs000490.v1.pht002969.v1.p1.Lipid_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
8.0	8.0		02/18/2015	15.0		7.0	./data/phs000760.v1.pht004264.v1.p1.Flu_Vaccine_Subject_Phenotypes.var_report.xml	0.0	7.5	0.7071	7.0			7.5		phs000760.v1.p1	Influenza Vaccines
			2019/05/07				./data/phs001524.v1.pht008556.v1.p1.PC_Rare_Variation_Sample.var_report.xml									phs001524.v1.p1	Prostatic Neoplasms
310.0	454.0		09/03/2009	804.0		350.0	./data/phs000166.v2.pht000704.v2.p1.ACRN_CData.var_report_2009_09_03.xml	0.0	402.0	73.54	411.0			402.0		phs000166.v2.p1	Asthma
			2018/10/24				./data/phs001693.v1.pht008489.v1.p1.Maternal_Fetal_IR_Sample.var_report.xml									phs001693.v1.p1	MicroRNAs
			04/16/2012				./data/phs000475.v1.pht002690.v1.p1.Inherited_Reproductive_Disorders_Sample.var_report.xml									phs000475.v1.p1	Hypogonadism 
			07/18/2016				./data/phs001085.v1.pht005647.v1.p1.Melanesian_Individuals_Sample_Attributes.var_report.xml									phs001085.v1.p1	
			2021/06/23				./data/phs001435.v2.pht009876.v1.p1.TOPMed_WGS_AustralianFamilialAF_Sample_Attributes.var_report.xml									phs001435.v2.p1	Atrial Fibrillation
			2020/10/27				./data/phs001616.v2.pht008545.v2.p2.eMERGEseq_Phecodes.var_report.xml									phs001616.v2.p2	Precision Medicine
7232.0	7232.0		2017/12/29	13914.0		6682.0	./data/phs000774.v2.pht004700.v1.p1.CCDG_OFCs_Pedigree.var_report.xml	0.0	6957.0	408.7	6682.0			6957.0		phs000774.v2.p1	Cleft Lip
			06/05/2014				./data/phs000753.v1.pht003874.v1.p1.Lung_Cancer_High_Density_SNP_Subject.var_report.xml									phs000753.v1.p1	Lung Neoplasms
	16.0		2021/05/21	16.0		16.0	./data/phs002411.v1.pht011241.v1.p1.BRCA1_BRCA2_Subject_Phenotypes.var_report.xml	0.0	16.0		16.0			16.0		phs002411.v1.p1	Breast
75.0	48.0		Wed Nov 19 17:41:30 2008	83.0		75.0	./data/phs000092.v1.pht000637.v1.p1.AlcoholDepAdd_Pedigree.var_report_2008_11_26.xml	0.0	41.5	undef	48.0			41.5		phs000092.v1.p1	Alcoholism
			10/19/2016				./data/phs001039.v1.pht005847.v1.p1.IAMDGC_Exome_Chip_Sample.var_report.xml									phs001039.v1.p1	Macular Degeneration
			2020/12/21				./data/phs000007.v32.pht000022.v4.p13.ex0_20s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000397.v3.p13.sleep1_2003s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			Fri Feb 20 11:36:11 2009				./data/phs000160.v1.pht000734.v1.p1.LOAD6k_Pedigree.var_report_2009_02_20.xml									phs000160.v1.p1	Alzheimer Disease
			2018/02/08				./data/phs001531.v1.pht007440.v1.p1.Turner_Syndrome_BAV_Sample.var_report.xml									phs001531.v1.p1	Turner Syndrome
			2020/06/15				./data/phs002008.v1.pht010202.v1.p1.Orofacial_Enhancers_GEO.var_report.xml									phs002008.v1.p1	Embryonic and Fetal Development
			12/03/2009				./data/phs000169.v1.pht000730.v1.p1.HABC_Subject.var_report.xml									phs000169.v1.p1	Obesity
1.0			04/29/2015	3.0			./data/phs000710.v1.pht003986.v1.p1.Cloud_Testing_Pedigree.var_report.xml	0.0			2.0					phs000710.v1.p1	Test study for cloud access
709.0	3890.0		2018/04/04	5795.0		709.0	./data/phs001455.v1.pht007759.v1.p1.Dystonia_CIZ1_Subject_Phenotypes.var_report.xml	0.0	909.5	283.5	3890.0			909.5		phs001455.v1.p1	Dystonia
4.0	6.0		08/20/2014	10.0		4.0	./data/phs000777.v1.pht003972.v1.p1.FSGS_CKD_Pedigree.var_report.xml	0.0	5.0	1.414	6.0			5.0		phs000777.v1.p1	Glomerulosclerosis, Focal Segmental
			2018/06/13				./data/phs001521.v1.pht007721.v1.p1.Microbiota_S_Typhi_Sample.var_report.xml									phs001521.v1.p1	Microbiota
			2020/02/13				./data/phs001975.v1.pht009883.v1.p1.SDV_iPSCs_Sample_Attributes.var_report.xml									phs001975.v1.p1	
919.0	919.0		2021/03/30	919.0		919.0	./data/phs001307.v1.pht011046.v1.p1.TGCT_UPenn_Subject.var_report.xml	0.0	919.0					919.0		phs001307.v1.p1	Testicular Germ Cell Tumor
			07/15/2013				./data/phs000608.v1.pht003344.v1.p1.Schizophrenia_Methylation_Subject_Phenotypes.var_report.xml									phs000608.v1.p1	Schizophrenia
			2021/06/16				./data/phs001402.v3.pht008238.v2.p1.TOPMed_WGS_Mayo_VTE_Sample.var_report.xml									phs001402.v3.p1	Venous Thromboembolism
			2020/09/18				./data/phs002015.v1.pht010368.v1.p1.AREDS2_CDC.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/05/15				./data/phs001311.v1.pht007934.v1.p1.inqol.var_report.xml									phs001311.v1.p1	Myotonia
			08/13/2015				./data/phs000831.v1.pht004904.v1.p1.Sporadic_ALS_Subject.var_report.xml									phs000831.v1.p1	Amyotrophic Lateral Sclerosis
59.0	59.0		2018/10/05	73.0		44.0	./data/phs001660.v1.pht008413.v1.p1.Paclitaxel_Cohort_LUPG_Subject_Phenotypes.var_report.xml	0.0	8.0	9.899	44.0			8.0		phs001660.v1.p1	Paclitaxel
452.0			2018/05/22	900.0			./data/phs001165.v1.pht007987.v1.p1.eMERGE_GCPD_CAG_CHOP_Subject_Phenotypes.var_report.xml	0.0			440.0					phs001165.v1.p1	Pediatrics
			2017/12/08				./data/phs001279.v1.pht007212.v1.p1.lab_results_form.var_report.xml									phs001279.v1.p1	Bronchiectasis
			2021/04/06				./data/phs002389.v1.pht011092.v1.p1.HTN_microRNAs_Sample.var_report.xml									phs002389.v1.p1	Hypertension
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000448.v2.p3.simphen049.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/12/21				./data/phs000007.v32.pht000162.v8.p13.isocreat1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/01/2016				./data/phs000332.v3.pht002337.v3.p2.CIDR_Preterm_Birth_Boston_Sample.var_report.xml									phs000332.v3.p2	Infant, Premature
			11/05/2014				./data/phs000209.v13.pht002101.v1.p3.MESA_AncilMesaLungExam2CT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			09/23/2014				./data/phs000787.v1.pht004260.v1.p1.Immunosenescence_Sample_Attributes.var_report.xml									phs000787.v1.p1	Aging
			2020/01/23				./data/phs000287.v7.pht005981.v1.p1.CHS_VTE_data.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007833.v1.p1.registration.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			09/02/2015				./data/phs000799.v1.pht004293.v1.p1.SBCGS_Breast_Cancer_Chinese_Subject.var_report.xml									phs000799.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004139.v2.p1.NUTV3.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010390.v1.p1.AREDS2_RCA.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2021/03/31				./data/phs001561.v1.pht010999.v1.p1.CCGO_Sample_Attributes.var_report.xml									phs001561.v1.p1	Immunologic Deficiency Syndromes
			2019/03/11				./data/phs000286.v6.pht008784.v1.p2.slea.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004234.v2.p1.V4ECG.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/07/29				./data/phs001855.v1.pht009249.v1.p1.STRRIDE_Subject_Phenotypes.var_report.xml									phs001855.v1.p1	Exercise
			02/11/2016				./data/phs000536.v2.pht002947.v2.p1.Retrotransposition_Colorectal_Tumors_Subject.var_report.xml									phs000536.v2.p1	Colonic Neoplasms
			2017/12/20				./data/phs000577.v1.pht007277.v1.p1.neuropsychformc.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2018/08/03				./data/phs000590.v1.pht008276.v1.p1.fu_medical_history_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2018/03/26				./data/phs000697.v1.pht007692.v1.p1.ae_mro_review.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2019/05/07				./data/phs001329.v2.pht007180.v2.p1.concomitant_meds.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			Thu Oct  2 11:13:19 2008				./data/phs000125.v1.pht000620.v1.p1.COGA_Subject.var_report_2008_10_02.xml									phs000125.v1.p1	Alcoholism
			12/11/2009				./data/phs000171.v1.pht000781.v1.p1.MS_DATA_NEURSTAT2.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/02/14				./data/phs000575.v2.pht005892.v2.p1.diethistory.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			03/29/2017				./data/phs001191.v1.pht006224.v1.p1.eMERGE_NUgene_WGS_Subject.var_report.xml									phs001191.v1.p1	Healthy Volunteers
			11/08/2012				./data/phs000540.v1.pht003045.v1.p1.Ehlers_Danlos_Syndrome_Type_VIII_Sample.var_report.xml									phs000540.v1.p1	Ehlers-Danlos Syndrome
			11/29/2012				./data/phs000539.v1.pht003019.v1.p1.Mendelian_Hyperinsulinism_Subject.var_report.xml									phs000539.v1.p1	Hyperinsulinism, Congenital
			2021/06/16				./data/phs002088.v2.pht010652.v1.p1.LINCS_DToxS_Sample_Attributes.var_report.xml									phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			2021/02/22				./data/phs001812.v1.pht009104.v1.p1.Pediatric_Obesity_Asthma_Subject.var_report.xml									phs001812.v1.p1	Asthma
			11/04/2014				./data/phs000086.v3.pht000226.v1.p1.DCCT_f1221.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/08/01				./data/phs001871.v1.pht009359.v1.p1.CCDG_CCC_AA_Subject.var_report.xml									phs001871.v1.p1	Cardiovascular Diseases
			12/17/2014				./data/phs000799.v1.pht004296.v1.p1.SBCGS_Breast_Cancer_Chinese_Sample_Attributes.var_report.xml									phs000799.v1.p1	Breast Neoplasms
			12/11/2009				./data/phs000171.v1.pht000787.v1.p1.MS_Subject.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2019/01/31				./data/phs001712.v1.pht008679.v1.p1.lvvid_form.var_report.xml									phs001712.v1.p1	Vasculitis
			2018/03/20				./data/phs000605.v1.pht007626.v1.p1.ae_mro_review.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2021/03/09				./data/phs002362.v1.pht011017.v1.p1.CSSCD_Subject.var_report.xml									phs002362.v1.p1	Sickle Cell Disease
			2020/04/29				./data/phs000185.v7.pht003274.v5.p1.Hutterites_Subject.var_report.xml									phs000185.v7.p1	Prospective
			2021/07/13				./data/phs002392.v1.pht011254.v1.p1.NPC_Sample.var_report.xml									phs002392.v1.p1	Niemann-Pick Disease, Type C
			2020/09/22				./data/phs002211.v1.pht010523.v1.p1.GALE_Sample.var_report.xml									phs002211.v1.p1	Bacterial Vaginosis
			2020/12/21				./data/phs000007.v32.pht002427.v4.p13.q_mnshist_2001_1_0650s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000090.v2.p13.hearq0_22s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
	1.0		2020/11/27	2.0		1.0	./data/phs002237.v1.pht010691.v1.p1.MMBIR_CGR_Subject.var_report.xml	0.0	1.0	0				1.0		phs002237.v1.p1	Adenocarcinoma of Lung
73.0	105.0		03/28/2016	178.0		73.0	./data/phs001009.v1.pht005352.v1.p1.RBEL_Asthma_Determinants_Subject_Phenotypes.var_report.xml	0.0	89.0	22.63	105.0			89.0		phs001009.v1.p1	Asthma
			2020/03/26				./data/phs001929.v1.pht010016.v1.p1.Neurogenetics_OCD_Sample_Attributes.var_report.xml									phs001929.v1.p1	Obsessive-Compulsive Disorder
			12/17/2014				./data/phs000486.v1.pht002802.v1.p1.GODOT_Subject.var_report.xml									phs000486.v1.p1	Depressive Disorder, Major
			2018/05/15				./data/phs001484.v1.pht007740.v1.p1.ATV_Bilirubin_Sample_Attributes.var_report.xml									phs001484.v1.p1	Drug-Related Side Effects and Adverse Reactions
			2017/10/05				./data/phs001454.v1.pht006981.v1.p1.Cross_BETRNet_Admixture_Sample.var_report.xml									phs001454.v1.p1	Adenocarcinoma Of Esophagus
			2019/04/04				./data/phs001803.v1.pht008939.v1.p1.Dystonias_Subject_Phenotypes.var_report.xml									phs001803.v1.p1	Cervical Dystonia
			2020/06/18				./data/phs000280.v7.pht004198.v2.p1.STROKE2.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/01/2015				./data/phs000571.v3.pht003183.v3.p2.GeneticTesting.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2018/09/06				./data/phs001505.v1.pht007321.v1.p1.SAB_WES_EA_Sample_Attributes.var_report.xml									phs001505.v1.p1	Staphylococcus aureus
			12/11/2009				./data/phs000171.v1.pht000777.v1.p1.MS_DATA_MSFC3.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2021/09/27				./data/phs000951.v5.pht005051.v5.p5.TOPMed_WGS_COPDGene_Sample.var_report.xml									phs000951.v5.p5	Pulmonary Disease, Chronic Obstructive
			2020/06/18				./data/phs000280.v7.pht004209.v2.p1.UBMDBF02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/01/07				./data/phs001741.v1.pht009164.v1.p1.CCDG_TASC_Sample.var_report.xml									phs001741.v1.p1	Autism Spectrum Disorder
			2020/03/24				./data/phs001641.v1.pht010038.v1.p1.Referrals.var_report.xml									phs001641.v1.p1	Progressive Patient Care
880.0		1.0	08/20/2013	478.0	2.403		./data/phs000285.v3.pht001865.v2.p2.F4F44.var_report.xml	4.0		3.37	993.0	0.0			2.571	phs000285.v3.p2	Cardiovascular Diseases
			2019/10/15				./data/phs001910.v1.pht009535.v1.p1.PNETs_Subject.var_report.xml									phs001910.v1.p1	Neuroendocrine Tumors
			08/20/2013				./data/phs000285.v3.pht001780.v2.p2.E1F12.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/09/18				./data/phs001087.v3.pht005761.v3.p1.UC_Sample_Attributes.var_report.xml									phs001087.v3.p1	Carcinoma, Transitional Cell
			10/25/2011				./data/phs000406.v1.pht002406.v1.p1.Spatiotemporal_Transcriptome_Brain_Sample_Attributes.var_report.xml									phs000406.v1.p1	Aging
			2020/12/21				./data/phs000007.v32.pht000158.v2.p13.heard0_22s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/09/17				./data/phs001677.v1.pht008378.v1.p1.AIS_1000_Exomes_Sample.var_report.xml									phs001677.v1.p1	Scoliosis
1.0	4.0		07/28/2014	5.0		1.0	./data/phs000778.v1.pht003967.v1.p1.Vesicoureteral_Reflux_Pedigree.var_report.xml	0.0	2.5	2.121	4.0			2.5		phs000778.v1.p1	Vesico-Ureteral Reflux
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000436.v2.p3.simphen037.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/13/2014				./data/phs000715.v1.pht003743.v1.p1.Multiple_Sclerosis_Brains_Subject.var_report.xml									phs000715.v1.p1	Multiple Sclerosis, Chronic Progressive
			12/11/2009				./data/phs000171.v1.pht000774.v1.p1.MS_DATA_MME.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			11/24/2015				./data/phs000824.v1.pht005137.v1.p1.Colon_Cancer_Predisposing_Mutations_Sample.var_report.xml									phs000824.v1.p1	Colorectal Neoplasms
			2021/01/21				./data/phs002291.v1.pht010801.v1.p1.HSPCs_Aging_MBM_Sample.var_report.xml									phs002291.v1.p1	Multiple Myeloma
			2020/02/28				./data/phs001109.v3.pht005446.v2.p2.Addictive_Diseases_Sample.var_report.xml									phs001109.v3.p2	Substance-Related Disorders
			2020/04/02				./data/phs000277.v2.pht003389.v2.p1.Heroin_Dependence_Sample_Attributes.var_report.xml									phs000277.v2.p1	Heroin Dependence
			2021/05/14				./data/phs001749.v2.pht009320.v2.p1.CAKUT_Sample_Attributes.var_report.xml									phs001749.v2.p1	Congenital Anomalies Of Kidney And Urinary Tract
			08/20/2013				./data/phs000285.v3.pht001602.v2.p2.B2F09BRD.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008761.v1.p2.medcodesV1.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
10.0			2021/07/19	10.0			./data/phs002229.v1.pht010554.v1.p1.GCT_PrimaryMetastasis_Subject.var_report.xml	0.0								phs002229.v1.p1	Neoplasms, Germ Cell and Embryonal
			11/08/2013				./data/phs000200.v9.pht003411.v1.p3.outc_fracture_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
655.0	803.0		02/24/2012	808.0		655.0	./data/phs000001.v3.pht000373.v2.p1.enrollment_randomization.var_report.xml	0.0	85.0	66.47	803.0			85.0		phs000001.v3.p1	Cataract
			2019/05/07				./data/phs001329.v2.pht007176.v2.p1.lab_form.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/12/21				./data/phs000007.v32.pht000745.v3.p13.sleepecg_2003s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/19				./data/phs001426.v1.pht006914.v1.p1.T1DGC_RNASeq_Subject.var_report.xml									phs001426.v1.p1	Diabetes Mellitus, Type 1
			2021/02/08				./data/phs001422.v2.pht006759.v2.p1.GETHIN_Sample.var_report.xml									phs001422.v2.p1	Insulinoma
			2017/11/06				./data/phs001441.v1.pht007112.v1.p1.SAB_AA_Subject.var_report.xml									phs001441.v1.p1	Staphylococcus aureus
1158.0	1195.0		2021/06/10	2353.0		1158.0	./data/phs001387.v3.pht008970.v2.p1.TOPMed_WGS_THRV_Subject_Phenotypes.var_report.xml	0.0	1177.0	26.16	1195.0			1177.0		phs001387.v3.p1	Blood Pressure
			2018/06/01				./data/phs001317.v1.pht008047.v1.p1.registration.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
			11/05/2014				./data/phs000209.v13.pht003479.v1.p3.MESA_AncilMesaGGT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
522.0	3932.0		09/03/2009	6235.0		899.0	./data/phs000166.v2.pht000703.v2.p1.CARE_LData.var_report_2009_09_03.xml	0.0	3118.0	355.7	312.0			3118.0		phs000166.v2.p1	Asthma
			2020/06/30				./data/phs002049.v1.pht010296.v1.p1.Myeloid_Malignancies_Sample.var_report.xml									phs002049.v1.p1	Acute Myeloid Leukemia
			2018/08/03				./data/phs000590.v1.pht008271.v1.p1.change_of_information_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2018/02/08				./data/phs001531.v1.pht007439.v1.p1.Turner_Syndrome_BAV_Subject.var_report.xml									phs001531.v1.p1	Turner Syndrome
			2020/01/30				./data/phs001707.v2.pht008606.v2.p1.CTL019_CLL_Sample.var_report.xml									phs001707.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2018/11/13				./data/phs001523.v1.pht007509.v1.p1.MOMS_PI_Sample.var_report.xml									phs001523.v1.p1	Pregnancy
			04/16/2012				./data/phs000477.v1.pht002685.v1.p1.Familial_Renal_Disorders_Subject.var_report.xml									phs000477.v1.p1	Hypophosphatemia, Familial
			2020/12/21				./data/phs000007.v32.pht005149.v4.p13.t_aabp_2011_m_0714s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/16/2017				./data/phs001278.v1.pht006273.v1.p1.p7201_14424_disorders.var_report.xml									phs001278.v1.p1	Porphyrias
			04/08/2014				./data/phs000729.v1.pht003775.v1.p1.Follicular_Lymphoma_Subject_Phenotypes.var_report.xml									phs000729.v1.p1	Lymphoma, Follicular
			2021/07/14				./data/phs001546.v2.pht009975.v1.p1.TOPMed_WGS_DECAF_Sample_Attributes.var_report.xml									phs001546.v2.p1	Atrial Fibrillation
			2019/04/15				./data/phs001792.v1.pht008929.v1.p1.InterGEN_Subject.var_report.xml									phs001792.v1.p1	Hypertension
			08/20/2013				./data/phs000285.v3.pht001599.v2.p2.B2F05.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
13.0		1.0	2017/12/04	21.0	1.105		./data/phs001419.v1.pht007095.v1.p1.p6601_15170_pcmtqolpa.var_report.xml	0.0		1.197	8.0	0.0			4.0	phs001419.v1.p1	Charcot-Marie-Tooth Disease
			06/12/2017				./data/phs000594.v1.pht006498.v1.p1.DeathRecord.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2021/05/07				./data/phs001327.v2.pht011180.v1.p1.bodyregionxrt.var_report.xml									phs001327.v2.p1	Neoplasm
			2019/07/16				./data/phs001826.v1.pht009138.v1.p1.IHS_Depression_Sample.var_report.xml									phs001826.v1.p1	Depression
			04/17/2017				./data/phs001157.v1.pht005803.v1.p1.WLS_Aging_Subject.var_report.xml									phs001157.v1.p1	
			01/07/2016				./data/phs000459.v1.pht002545.v1.p1.Oral_Clefts_Multiplex_Families_Sample.var_report.xml									phs000459.v1.p1	Cleft Lip
5.0			09/29/2015	14.0			./data/phs000892.v2.pht004631.v2.p2.CPTAC_ColonSubjectClinicalPhenotypes.var_report.xml	14.0			9.0					phs000892.v2.p2	
			08/20/2013				./data/phs000285.v3.pht001717.v2.p2.D1F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000103.v3.p13.pft0_19s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/14/2013				./data/phs000422.v1.pht003226.v1.p1.LungGO_SevereAsthma_Sample_Attributes.var_report.xml									phs000422.v1.p1	Asthma
			2019/08/30				./data/phs001331.v2.pht009414.v1.p1.p6501_17083_acutegvhd.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
	56.0		2020/09/22	56.0		56.0	./data/phs002211.v1.pht010522.v1.p1.GALE_Subject.var_report.xml	0.0	56.0		56.0			56.0		phs002211.v1.p1	Bacterial Vaginosis
			2020/12/21				./data/phs000007.v32.pht005146.v4.p13.l_rbcfa_ex02_3b_0876s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/23/2014				./data/phs000787.v1.pht004258.v1.p1.Immunosenescence_Sample.var_report.xml									phs000787.v1.p1	Aging
1341.0			11/20/2013	2487.0			./data/phs000638.v1.pht003570.v1.p1.ALL_Relapse_Subject_Phenotypes.var_report.xml	0.0			1146.0					phs000638.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
9.0	6.0		04/23/2010	9.0		9.0	./data/phs000187.v1.pht001218.v1.p1.Melanoma_Pedigree.var_report_2010_04_23.xml	0.0	8.5	5.657	6.0			8.5		phs000187.v1.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht007769.v3.p13.t_mrbrnm3_2017_a_1187s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
763.0	763.0		05/23/2011	613.0		620.0	./data/phs000358.v1.pht002241.v1.p1.PUWMa_Pedigree.var_report.xml	0.0	691.5	14.85	620.0			691.5		phs000358.v1.p1	Attention Deficit Hyperactivity Disorder
			2019/07/26				./data/phs000588.v1.pht009301.v1.p1.lab_results_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			09/14/2011				./data/phs000392.v1.pht002373.v1.p1.Exome_arPEO_Sample_Attributes.var_report.xml									phs000392.v1.p1	Ophthalmoplegia, Chronic Progressive External
6.0	6.0		2020/12/18	39.0		6.0	./data/phs001819.v2.pht009448.v1.p1.Familial_MM_Subject_Phenotypes.var_report.xml	0.0	5.667000000000001	12.73	8.0			8.0		phs001819.v2.p1	Multiple Myeloma
			07/09/2015				./data/phs000564.v2.pht003058.v2.p1.WGS_NICU_Sample.var_report.xml									phs000564.v2.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			04/16/2014				./data/phs000249.v2.pht001876.v2.p1.Brain_QTL_Subject.var_report.xml									phs000249.v2.p1	DNA Methylation
			2019/04/15				./data/phs001792.v1.pht008931.v1.p1.InterGEN_Sample.var_report.xml									phs001792.v1.p1	Hypertension
			12/26/2012				./data/phs000562.v1.pht003105.v1.p1.Burkitt_Lymphoma_Sample.var_report.xml									phs000562.v1.p1	Burkitt Lymphoma
			2021/08/20				./data/phs002557.v1.pht011482.v1.p1.PID_LRBA_Subject_Phenotypes.var_report.xml									phs002557.v1.p1	LRBA protein, human
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000558.v2.p3.simphen159.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/09/21				./data/phs002493.v1.pht011462.v1.p1.Neurogenesis_eQTL_sQTL_Sample.var_report.xml									phs002493.v1.p1	RNA-seq
			2020/12/21				./data/phs000007.v32.pht000206.v2.p13.aortic0_23s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
16.0	18.0		2018/09/19	34.0		16.0	./data/phs001684.v1.pht008391.v1.p1.Pulmonary_Fluid_Immunocompromised_Subject_Phenotypes.var_report.xml	0.0	17.0	1.414	18.0			17.0		phs001684.v1.p1	Immunocompromised Host
			Wed Jan 21 13:20:39 2009				./data/phs000144.v1.pht000721.v1.p1.TSP_ClinPathQA_Data_SampleQA.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000452.v2.p3.simphen053.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
1060.0	1060.0		2021/08/11	1882.0		822.0	./data/phs002480.v1.pht011393.v1.p1.Glomerular_Disorders_Subject.var_report.xml	0.0	941.0	168.3	822.0			941.0		phs002480.v1.p1	Glomerulonephritis
			2020/12/22				./data/phs002301.v1.pht010815.v1.p1.Skull_Based_Chordoma_Sample.var_report.xml									phs002301.v1.p1	chordoma
			08/20/2013				./data/phs000285.v3.pht001582.v2.p2.A4F19.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/11/01				./data/phs001005.v2.pht005041.v2.p1.Neoantigens_Stage3_Melanoma_Sample_Attributes.var_report.xml									phs001005.v2.p1	
			2020/01/30				./data/phs001707.v2.pht008607.v2.p1.CTL019_CLL_Sample_Attributes.var_report.xml									phs001707.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2018/03/09				./data/phs000783.v2.pht004279.v2.p1.CDH_Subject.var_report.xml									phs000783.v2.p1	Hernias, Diaphragmatic, Congenital
			2020/10/21				./data/phs002067.v1.pht010408.v1.p1.TLE_Subject.var_report.xml									phs002067.v1.p1	Epilepsy, Temporal Lobe
			2021/01/07				./data/phs002073.v1.pht010827.v1.p1.Infant_Immunity_Sample.var_report.xml									phs002073.v1.p1	Breast Feeding
			2019/08/30				./data/phs001331.v2.pht006921.v2.p1.p6501_13176_physician.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
4525.0	4525.0		06/23/2015	8003.0		3478.0	./data/phs000648.v1.pht004579.v1.p1.Pancreatic_Cancer_Subject_Phenotypes.var_report.xml	0.0	4002.0	740.3	3478.0			4002.0		phs000648.v1.p1	Pancreatic Neoplasms
			2021/02/02				./data/phs002204.v1.pht010910.v1.p1.cCREs_Sample_Attributes.var_report.xml									phs002204.v1.p1	Heart
			2018/01/29				./data/phs001245.v1.pht005931.v1.p1.CD70_Sample.var_report.xml									phs001245.v1.p1	Immunologic Deficiency Syndromes
			2019/11/14				./data/phs001922.v1.pht009616.v1.p1.Chromosome_Errors_Oocytes_Subject.var_report.xml									phs001922.v1.p1	Aneuploidy
29.0			2021/08/26	73.0			./data/phs001727.v2.pht010102.v1.p1.TOPMed_WGS_PIMA_Subject_Phenotypes.var_report.xml	0.0			44.0					phs001727.v2.p1	Asthma
3.0			2020/07/21	9.0			./data/phs002035.v1.pht010414.v1.p1.PCD_Subject_Phenotype.var_report.xml	0.0			6.0					phs002035.v1.p1	Ciliary Motility Disorders
			2019/03/18				./data/phs001585.v1.pht008827.v1.p1.FALS_Subject.var_report.xml									phs001585.v1.p1	Amyotrophic Lateral Sclerosis
			2020/04/30				./data/phs001323.v2.pht010115.v2.p1.MMGS_Sample.var_report.xml									phs001323.v2.p1	Multiple Myeloma
			2020/12/21				./data/phs000007.v32.pht000084.v8.p13.fib1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008722.v1.p2.af2.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/03/20				./data/phs001715.v1.pht008842.v1.p1.death_form.var_report.xml									phs001715.v1.p1	Vasculitis
			08/20/2013				./data/phs000285.v3.pht001719.v2.p2.D1F18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			05/08/2017				./data/phs001343.v1.pht006346.v1.p1.hESCs_Subject.var_report.xml									phs001343.v1.p1	Human Embryonic Stem Cells
			12/17/2014				./data/phs000486.v1.pht002806.v1.p1.GODOT_Sample_Attributes.var_report.xml									phs000486.v1.p1	Depressive Disorder, Major
			2017/09/22				./data/phs001392.v1.pht006900.v1.p1.pidtc_17645_baselinea.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
72.0	628.0		06/22/2016	983.0		72.0	./data/phs001012.v1.pht005548.v1.p1.Diabetes_Heart_Study_EA_Pedigree.var_report.xml	0.0	96.5	55.86	628.0			96.5		phs001012.v1.p1	Cardiovascular Diseases
			07/05/2017				./data/phs000595.v1.pht006639.v1.p1.other_procedures_tests.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			08/20/2013				./data/phs000285.v3.pht001784.v2.p2.E1F18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000994.v4.p3.f147_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
1683.0	5862.0		05/16/2017	9552.0		3690.0	./data/phs001252.v1.pht006373.v1.p1.bodycomp.var_report.xml	0.0	4776.0	1536	1050.0			4776.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			03/12/2013				./data/phs000343.v3.pht003145.v1.p1.mhx.var_report.xml									phs000343.v3.p1	Stroke
680.0	680.0		2018/09/21	929.0		497.0	./data/phs001552.v1.pht008395.v1.p1.T2D_GENES_PROMIS_Subject_Phenotypes.var_report.xml	0.0	913.0	588.3	497.0			913.0		phs001552.v1.p1	Diabetes Mellitus, Type 2
			11/04/2014				./data/phs000086.v3.pht000276.v1.p1.DCCT_cbl10.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/08/18				./data/phs002315.v1.pht011315.v1.p1.Integrated_Multimodal_Single_Cell_Sample.var_report.xml									phs002315.v1.p1	Single-Cell Analysis
			2021/10/19				./data/phs002632.v1.pht011608.v1.p1.AA_KRT82_Sample_Attributes.var_report.xml									phs002632.v1.p1	Alopecia Areata
			12/09/2016				./data/phs000655.v3.pht003489.v3.p1.Inherited_Muscle_Disease_Sample.var_report.xml									phs000655.v3.p1	Muscular Dystrophies
			08/17/2012				./data/phs000359.v1.pht002902.v1.p1.Hereditary_Spastic_Paraparesis_Sample.var_report.xml									phs000359.v1.p1	Hereditary Spastic Paraplegias
			2020/01/23				./data/phs000287.v7.pht003701.v2.p1.CHS_Mineral_Metablism_and_Vit_D.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000313.v8.p13.urine3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000603.v2.p13.knoa0_18s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			Fri Feb 20 11:36:06 2009				./data/phs000160.v1.pht000733.v1.p1.LOAD6k_Subject.var_report_2009_02_20.xml									phs000160.v1.p1	Alzheimer Disease
			07/08/2016				./data/phs001167.v1.pht005637.v1.p1.T2D_Seq_GWAS_AA_Cohort_Sample.var_report.xml									phs001167.v1.p1	Diabetes Mellitus, Type 2
			2018/09/20				./data/phs001428.v1.pht008388.v1.p1.S0221_BRCA_Toxicities_Sample_Attributes.var_report.xml									phs001428.v1.p1	Peripheral Nervous System Diseases
			2021/07/09				./data/phs001207.v3.pht005792.v3.p1.TOPMed_WGS_AA_Sarcoidosis_Sample.var_report.xml									phs001207.v3.p1	Sarcoidosis
			2020/06/18				./data/phs000280.v7.pht004047.v5.p1.CCORPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002075.v4.p13.t_autbr_2011_m_0709s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/10/2015				./data/phs000545.v1.pht003765.v1.p1.Chemotherapy_Induced_Mucositis_Sample_Attributes.var_report.xml									phs000545.v1.p1	Multiple Myeloma
			2021/09/14				./data/phs002187.v1.pht011546.v1.p1.GMKF_Myeloid_Malignancies_Subject.var_report.xml									phs002187.v1.p1	Leukemia, Myeloid, Acute
			07/27/2017				./data/phs000596.v1.pht006714.v1.p1.lab_form.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			2020/12/21				./data/phs000007.v32.pht000692.v2.p13.ex0_28s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
469.0			2021/10/04	674.0			./data/phs001542.v2.pht009642.v2.p1.TOPMed_WGS_GALAI_Subject.var_report.xml	20.0			535.0					phs001542.v2.p1	
37.0	63.0		11/24/2015	100.0		37.0	./data/phs000824.v1.pht005138.v1.p1.Colon_Cancer_Predisposing_Mutations_Subject_Phenotypes.var_report.xml	0.0	50.0	18.38	63.0			50.0		phs000824.v1.p1	Colorectal Neoplasms
646.0	831.0		2021/06/07	1477.0		646.0	./data/phs000971.v3.pht004918.v2.p1.ClinSeq_Subject_Phenotypes.var_report.xml	0.0	738.5	130.8	831.0			738.5		phs000971.v3.p1	Atherosclerosis
			2020/12/21				./data/phs000007.v32.pht002236.v5.p13.vr_foot_2008_m_0611s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001561.v2.p2.A4F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/10/31				./data/phs001654.v1.pht008444.v1.p1.NSAID_BE_Sample_Attributes.var_report.xml									phs001654.v1.p1	Barrett Esophagus
			09/14/2011				./data/phs000392.v1.pht002370.v1.p1.Exome_arPEO_Subject.var_report.xml									phs000392.v1.p1	Ophthalmoplegia, Chronic Progressive External
			05/09/2016				./data/phs001043.v1.pht005314.v1.p1.Adjuvant_Aromatase_Inhibitors_Breast_Cancer_Sample.var_report.xml									phs001043.v1.p1	Neoplasm
			2018/10/30				./data/phs001724.v1.pht008504.v1.p1.Pain_Resilience_Subject.var_report.xml									phs001724.v1.p1	Erythromelalgia
			08/29/2016				./data/phs000770.v1.pht003928.v1.p1.HER2_Breast_Cancer_Sample_Attributes.var_report.xml									phs000770.v1.p1	Breast Neoplasms
			2020/10/27				./data/phs001925.v1.pht010568.v1.p1.MSI_H_Cancers_Subject.var_report.xml									phs001925.v1.p1	Microsatellite Instability
1.0	2.0		12/16/2010	3.0		1.0	./data/phs000308.v1.pht002084.v1.p1.GLAUGEN_Pedigree.var_report_2010_12_16.xml	0.0	1.5	0.7071	2.0			1.5		phs000308.v1.p1	Glaucoma, Open-Angle
			2020/12/21				./data/phs000007.v32.pht000092.v8.p13.homocys1_2s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/26				./data/phs001732.v2.pht010139.v1.p1.TOPMed_WGS_CARE_TREXA_Subject.var_report.xml									phs001732.v2.p1	Asthma
			10/05/2015				./data/phs000969.v1.pht004930.v1.p1.Sensorineural_Hearing_Loss_Sample.var_report.xml									phs000969.v1.p1	Bilateral deafness
			06/16/2017				./data/phs001278.v1.pht006277.v1.p1.p7201_20285_tobaccous.var_report.xml									phs001278.v1.p1	Porphyrias
676.0	677.0		2020/12/09	677.0		677.0	./data/phs001857.v1.pht010764.v1.p1.MD_Ashkenazi_Subject.var_report.xml	0.0	677.0	478	677.0			677.0		phs001857.v1.p1	Mammographic Breast Density
			2019/09/19				./data/phs001879.v1.pht009455.v1.p1.Kidney_Transplant_Recipients_Subject.var_report.xml									phs001879.v1.p1	Urinary Tract Infections
			10/27/2014				./data/phs000726.v1.pht003779.v1.p1.Myasthenia_Gravis_Subject_Phenotypes.var_report.xml									phs000726.v1.p1	Myasthenia gravis
			2019/01/30				./data/phs001495.v2.pht007198.v2.p1.DAXX_ALT_Sample_Attributes.var_report.xml									phs001495.v2.p1	Osteosarcoma
			2020/01/10				./data/phs001493.v2.pht007297.v2.p1.RCC_Immune_Checkpoint_Sample.var_report.xml									phs001493.v2.p1	Carcinoma, Renal Cell
377.0	594.0		11/24/2010	971.0		377.0	./data/phs000140.v1.pht000630.v1.p1.T2D_Case_Data.var_report_2010_11_24.xml	0.0	485.5	153.4	594.0			485.5		phs000140.v1.p1	Diabetes Mellitus, Type 2
96.0	305.0		2018/09/26	595.0		96.0	./data/phs001130.v1.pht008416.v1.p1.NIDDM_Athero_Hispanic_Pedigree.var_report.xml	0.0	297.5	38.89	305.0			297.5		phs001130.v1.p1	Diabetes Mellitus, Type 2
			2019/03/11				./data/phs000286.v6.pht008741.v1.p2.cenb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/03/13				./data/phs000521.v2.pht007037.v2.p1.conclusionofstudyparticipation.var_report.xml									phs000521.v2.p1	Ataxia
			2019/05/07				./data/phs001329.v2.pht007178.v2.p1.p6704_14112_dnasample.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/03/12				./data/phs001722.v1.pht009887.v1.p1.mCRC_Sample_Attributes.var_report.xml									phs001722.v1.p1	Neoplasms
			05/14/2013				./data/phs000609.v1.pht003286.v1.p1.AutismGeneExpression_Sample_Attributes.var_report.xml									phs000609.v1.p1	Autism
			12/17/2014				./data/phs000486.v1.pht002804.v1.p1.GODOT_Sample.var_report.xml									phs000486.v1.p1	Depressive Disorder, Major
731.0	731.0		2020/03/12	1288.0		557.0	./data/phs000673.v4.pht003662.v4.p1.CSER_Subject_Phenotypes.var_report.xml	0.0	644.0	123	557.0			644.0		phs000673.v4.p1	Neoplasms
			07/14/2014				./data/phs000714.v1.pht003751.v1.p1.Spontaneous_Preterm_Birth_Sample.var_report.xml									phs000714.v1.p1	Premature Birth
			2019/10/18				./data/phs001237.v2.pht005988.v2.p1.TOPMed_WGS_WHI_Sample.var_report.xml									phs001237.v2.p1	Stroke
134.0			2021/07/19	324.0			./data/phs001606.v2.pht010090.v1.p1.TOPMed_WGS_EGCUT_Subject_Phenotypes.var_report.xml	0.0			190.0					phs001606.v2.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004103.v2.p1.HHXB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000079.v8.p13.cd40p1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000588.v2.p3.simphen189.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/05/01				./data/phs000607.v3.pht007881.v1.p2.Interview_Dates_Update.var_report.xml									phs000607.v3.p2	Mental Processes
	112.0		12/18/2014	112.0		112.0	./data/phs000841.v1.pht004421.v1.p1.Endometrial_Tumors_Subject_Phenotypes.var_report.xml	0.0	112.0		112.0			112.0		phs000841.v1.p1	Endometrial Carcinomas
			2020/06/18				./data/phs000280.v7.pht006417.v1.p1.ALC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001942.v2.p2.bpaa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
553.0	1129.0		11/22/2013	1682.0		553.0	./data/phs000460.v1.pht002549.v1.p1.Recurrent_Nephrolithiasis_Subject_Phenotypes.var_report.xml	0.0	841.0	407.3	1129.0			841.0		phs000460.v1.p1	Nephrolithiasis
			2020/12/21				./data/phs000007.v32.pht000197.v8.p13.hrv_1987s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000252.v1.p1.DCCT_f114cmb3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
676.0	676.0		12/03/2013	3033.0		849.0	./data/phs000631.v1.pht003601.v1.p1.ARDSNet_iSPAAR_Subject_Phenotypes.var_report.xml	0.0	959.5	904.4	849.0			959.5		phs000631.v1.p1	Respiration Disorders
42.0			2019/07/26	1096.0			./data/phs000588.v1.pht009308.v1.p1.sf_36.var_report.xml	10.0			151.0					phs000588.v1.p1	Giant Cell Arteritis
			07/12/2017				./data/phs000592.v1.pht006582.v1.p1.bmbx_aspirationcytogenetics.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2019/09/26				./data/phs000974.v4.pht004911.v3.p3.TOPMed_WGS_FHS_Sample_Attributes.var_report.xml									phs000974.v4.p3	Cardiovascular Diseases
			2019/01/07				./data/phs001733.v1.pht008618.v1.p1.Early_Onset_PTD_Subject_Phenotypes.var_report.xml									phs001733.v1.p1	Dystonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000569.v2.p3.simphen170.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/12/2017				./data/phs000592.v1.pht006591.v1.p1.generallaboratory.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2020/06/18				./data/phs000280.v7.pht004228.v2.p1.uc6453.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/11/10				./data/phs002162.v1.pht010661.v1.p1.GMKF_Kidney_UT_Malformations_Sample.var_report.xml									phs002162.v1.p1	Renal Adysplasia
			2017/12/29				./data/phs000950.v1.pht005968.v1.p1.SEER_Ovarian_FFPE_Subject.var_report.xml									phs000950.v1.p1	Neoplasms
			2021/07/07				./data/phs001472.v2.pht007117.v1.p1.TOPMed_WGS_ECLIPSE_Sample.var_report.xml									phs001472.v2.p1	Pulmonary Disease, Chronic Obstructive
			2018/06/18				./data/phs001586.v1.pht008151.v1.p1.RICHS_Sample_Attributes.var_report.xml									phs001586.v1.p1	Child Health
			2021/05/28				./data/phs002259.v1.pht011024.v1.p1.CD4T_European_Sample.var_report.xml									phs002259.v1.p1	RNA-Seq
			2018/05/01				./data/phs000607.v3.pht003442.v2.p2.Neurodevelopmental_Genomics_Subject.var_report.xml									phs000607.v3.p2	Mental Processes
74.0	74.0		2021/02/22	61.0		59.0	./data/phs001812.v1.pht009588.v1.p1.Pediatric_Obesity_Asthma_Pedigree.var_report.xml	0.0	66.5	9.192	59.0			66.5		phs001812.v1.p1	Asthma
			10/07/2011				./data/phs000368.v1.pht002295.v1.p1.NU_PCOS_Sample_Attributes.var_report.xml									phs000368.v1.p1	Polycystic Ovary Syndrome
			06/12/2017				./data/phs001275.v1.pht006541.v1.p1.Cryptorchid_Testes_Sample.var_report.xml									phs001275.v1.p1	Cryptorchidism
			04/29/2014				./data/phs000630.v1.pht003381.v1.p1.NIMH_Controls_Subject.var_report.xml									phs000630.v1.p1	Normalcy
			2021/01/06				./data/phs002252.v1.pht010668.v1.p1.RCC_Subject.var_report.xml									phs002252.v1.p1	Carcinoma, Renal Cell
			2020/04/30				./data/phs001323.v2.pht010117.v2.p1.MMGS_Sample_Attributes.var_report.xml									phs001323.v2.p1	Multiple Myeloma
			2020/12/21				./data/phs000007.v32.pht007775.v3.p13.vr_diab_ex02_3b_0388s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1339.0	8084.0		05/16/2017	13250.0		5166.0	./data/phs001252.v1.pht006389.v1.p1.modats.var_report.xml	0.0	6625.0	2063	855.0			6625.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			06/12/2017				./data/phs000594.v1.pht006497.v1.p1.CTEPAdEERsReportingForm.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
54.0			05/17/2017	91.0			./data/phs001328.v1.pht006310.v1.p1.demographics.var_report.xml	0.0			37.0					phs001328.v1.p1	Mucopolysaccharidoses
			09/08/2016				./data/phs000893.v1.pht005501.v1.p1.Endometrial_Cancer_E2C2_Sample.var_report.xml									phs000893.v1.p1	Carcinoma, Endometrioid
1.0			2019/01/30	5.0			./data/phs001495.v2.pht007197.v1.p1.DAXX_ALT_Subject_Phenotypes.var_report.xml	0.0			4.0					phs001495.v2.p1	Osteosarcoma
			2021/05/07				./data/phs001327.v2.pht006558.v2.p1.CCSS_Subject.var_report.xml									phs001327.v2.p1	Neoplasm
			2019/06/14				./data/phs000589.v1.pht009201.v1.p1.vcrc_16393_vcrcpregna.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2021/05/07				./data/phs001327.v2.pht011186.v1.p1.combinedbmt.var_report.xml									phs001327.v2.p1	Neoplasm
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000430.v2.p3.simphen031.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/07/26				./data/phs001852.v1.pht009277.v1.p1.Height_Jewish_Sample.var_report.xml									phs001852.v1.p1	Body Height
52.0	52.0		2021/07/29	97.0		55.0	./data/phs001607.v3.pht010149.v3.p2.TOPMed_WGS_IPF_Subject.var_report.xml	0.0	88.0	93.35	725.0			88.0		phs001607.v3.p2	Idiopathic Pulmonary Fibrosis
			Mon Oct 27 16:32:34 2008				./data/phs000020.v2.pht000668.v1.p1.NESDA_NTR_Subject.var_report_2008_10_27.xml									phs000020.v2.p1	Depressive Disorder, Major
			01/15/2016				./data/phs000909.v1.pht004874.v1.p1.NEPC_Subject.var_report.xml									phs000909.v1.p1	Adenocarcinoma
782.0	804.0		2018/07/25	3142.0		782.0	./data/phs001367.v1.pht008246.v1.p1.Add_Health_Pedigree.var_report.xml	0.0	793.0	15.56	804.0			793.0		phs001367.v1.p1	Adolescent Health
			2020/11/30				./data/phs002283.v1.pht010685.v1.p1.Selenium_Chemoprevention_Sample_Attributes.var_report.xml									phs002283.v1.p1	
			2018/04/16				./data/phs001289.v1.pht007797.v1.p1.registration.var_report.xml									phs001289.v1.p1	Andersen Syndrome
9.0	9.0		2017/09/25	45.0		6.0	./data/phs001348.v2.pht006233.v2.p1.Gene_Discovery_WGMS_Pedigree.var_report.xml	0.0	7.5	2.121	6.0			7.5		phs001348.v2.p1	
			12/17/2012				./data/phs000567.v1.pht003078.v1.p1.Solitary_Fibrous_Tumor_Subject.var_report.xml									phs000567.v1.p1	Solitary Fibrous Tumors
7546.0	7546.0		11/16/2011	9987.0		7514.0	./data/phs000096.v4.pht001423.v4.p1.HAPO_Pedigree.var_report.xml	0.0	7530.0	3497	7514.0			7530.0		phs000096.v4.p1	Pregnancy Complications
234.0	234.0		2018/05/15	321.0		87.0	./data/phs001484.v1.pht007739.v1.p1.ATV_Bilirubin_Subject_Phenotypes.var_report.xml	0.0	7.5	94.75	87.0			7.5		phs001484.v1.p1	Drug-Related Side Effects and Adverse Reactions
			06/10/2015				./data/phs000918.v1.pht004747.v1.p1.IPDGC_NeuroX_Subject.var_report.xml									phs000918.v1.p1	Parkinson Disease
967.0			2019/10/08	2857.0			./data/phs000224.v3.pht002182.v3.p2.VitGene_Vitiligo_Subject_Phenotypes.var_report.xml	0.0			198.0					phs000224.v3.p2	Vitiligo
4.0	6.0		2017/09/27	37.0		8.0	./data/phs001071.v1.pht005347.v1.p1.CIDR_HD_Onset_Age_Subject_Phenotypes.var_report.xml	0.0	9.5	3.536	8.0			9.5		phs001071.v1.p1	Huntington Disease
			2018/11/05				./data/phs000507.v2.pht002926.v2.p2.BEN_Subject.var_report.xml									phs000507.v2.p2	Neutropenia
	35.0		2019/11/14	35.0		35.0	./data/phs001922.v1.pht009618.v1.p1.Chromosome_Errors_Oocytes_Subject_Phenotypes.var_report.xml	0.0	35.0		35.0			35.0		phs001922.v1.p1	Aneuploidy
			2018/02/08				./data/phs001488.v1.pht007383.v1.p1.conmed.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/12/16				./data/phs000959.v1.pht009703.v1.p1.SCZ_Xhosa_Sample_Attributes.var_report.xml									phs000959.v1.p1	Schizophrenia
			2019/06/14				./data/phs000589.v1.pht009177.v1.p1.angiogram_leftupperextremity.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/12/16				./data/phs001800.v2.pht008928.v2.p1.Pediatric_RMC_Sample_Attributes.var_report.xml									phs001800.v2.p1	SMARCB1 Protein
2.0	2.0		10/05/2015	4.0		2.0	./data/phs000969.v1.pht004929.v1.p1.Sensorineural_Hearing_Loss_Pedigree.var_report.xml	0.0	2.0	0	2.0			2.0		phs000969.v1.p1	Bilateral deafness
120.0	246.0		2020/07/17	366.0		136.0	./data/phs000480.v1.pht002905.v1.p1.FBCS_Pedigree.var_report.xml	0.0	183.0	89.1	246.0			183.0		phs000480.v1.p1	Breast Neoplasms
			2019/08/27				./data/phs001845.v1.pht009409.v1.p1.SDS_Sample_Attributes.var_report.xml									phs001845.v1.p1	Shwachman syndrome [Supplementary Concept]
			08/06/2015				./data/phs000934.v1.pht004879.v1.p1.Antibody_Repertoires_CVID_Subject_Phenotypes.var_report.xml									phs000934.v1.p1	Common Variable Immunodeficiency
			2018/04/30				./data/phs001555.v1.pht007878.v1.p1.LDN_6709_Subject.var_report.xml									phs001555.v1.p1	Pompe Disease
			2018/02/27				./data/phs001064.v1.pht006832.v1.p1.PC_SRC_Bladder_Subject.var_report.xml									phs001064.v1.p1	Carcinoma, Signet Ring Cell
545.0	545.0		2021/10/06	1076.0		531.0	./data/phs001486.v3.pht008700.v3.p3.HCMI_Subject.var_report.xml	0.0	538.0	9.899	531.0			538.0		phs001486.v3.p3	Neoplasms
			2019/08/10				./data/phs001876.v1.pht009388.v1.p1.BSRC_ASD_CNV_Sample.var_report.xml									phs001876.v1.p1	Autism Spectrum Disorder
			2019/09/27				./data/phs001709.v1.pht009492.v1.p1.CMI_MBC_Subject.var_report.xml									phs001709.v1.p1	Breast Neoplasms
			2019/08/01				./data/phs001786.v1.pht008839.v1.p1.SU2C_GEMM_Sample_Attributes.var_report.xml									phs001786.v1.p1	Melanoma
			2017/09/25				./data/phs001348.v2.pht006232.v2.p1.Gene_Discovery_WGMS_Subject.var_report.xml									phs001348.v2.p1	
			08/20/2013				./data/phs000285.v3.pht001711.v2.p2.D1F06BH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/12/06				./data/phs000159.v9.pht000818.v9.p5.AML_Subject.var_report.xml									phs000159.v9.p5	Leukemia, Myeloid, Acute
2420.0	2780.0		06/17/2013	3708.0		628.0	./data/phs000454.v1.pht002650.v1.p1.HIV_Susceptibility_Subject_Phenotypes.var_report.xml	0.0	1236.0	931.2	806.0			918.0		phs000454.v1.p1	HIV
			2020/12/21				./data/phs000007.v32.pht006014.v2.p13.t_ctbonert2_2016_m_0875s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000666.v1.p1.DCCT_EDIC_Subject.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
1.0	2.0		2019/06/24	3.0		1.0	./data/phs001848.v1.pht009206.v1.p1.PIK3CG_Subject_Phenotypes.var_report.xml	0.0	1.5	0.7071	2.0			1.5		phs001848.v1.p1	Immune System Diseases
1.0			2017/12/04	3.0			./data/phs001419.v1.pht007089.v1.p1.itqol.var_report.xml	0.0			2.0					phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/07/24				./data/phs001194.v3.pht005816.v2.p2.MicroarrayResults.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2020/01/31				./data/phs001940.v2.pht009697.v2.p1.Immune_Checkpoint_NSCLC_Sample.var_report.xml									phs001940.v2.p1	Carcinoma, Non-Small-Cell Lung
			2020/12/21				./data/phs000007.v32.pht000209.v8.p13.t_tonla_ex07_1b_1231s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/20/2013				./data/phs000638.v1.pht003569.v1.p1.ALL_Relapse_Sample.var_report.xml									phs000638.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2018/06/07				./data/phs001479.v1.pht008102.v1.p1.STAT5B_Sample.var_report.xml									phs001479.v1.p1	Lymphadenopathy
			01/05/2016				./data/phs000917.v1.pht004741.v1.p1.MIGen_Exome_PROMIS_Sample_Attributes.var_report.xml									phs000917.v1.p1	Coronary Artery Disease
			2020/06/30				./data/phs002049.v1.pht010298.v1.p1.Myeloid_Malignancies_Sample_Attributes.var_report.xml									phs002049.v1.p1	Acute Myeloid Leukemia
			08/27/2013				./data/phs000647.v1.pht003470.v1.p1.Hypoxia_Tolerance_Ethiopian_Highlanders_Sample.var_report.xml									phs000647.v1.p1	Cell Hypoxia
			2019/10/11				./data/phs001406.v1.pht007754.v1.p1.DCC_Sample_Attributes.var_report.xml									phs001406.v1.p1	Cognition
			2020/12/21				./data/phs000007.v32.pht002426.v5.p13.l_estr_2005_m_0622s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/26/2015				./data/phs000851.v1.pht004685.v1.p1.Breast_Cancer_AA_Sample_Attributes.var_report.xml									phs000851.v1.p1	Breast Neoplasms
			06/14/2017				./data/phs001365.v1.pht006407.v1.p1.NAC_Bevacizumab_Subject.var_report.xml									phs001365.v1.p1	Breast Neoplasms
			2019/05/31				./data/phs001296.v2.pht006355.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			2019/08/01				./data/phs000222.v6.pht003452.v2.p2.rh_aparc_area.var_report.xml									phs000222.v6.p2	Huntington Disease
			2021/02/26				./data/phs001754.v4.pht009111.v3.p2.Spit4Science_Sample_Attributes.var_report.xml									phs001754.v4.p2	
			2018/03/20				./data/phs000605.v1.pht007637.v1.p1.laboratory_evaluation_form.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/11/27				./data/phs002060.v1.pht010589.v1.p1.CALGB_40502_Subject.var_report.xml									phs002060.v1.p1	Peripheral Nervous System Diseases
			2020/12/21				./data/phs000007.v32.pht002889.v5.p13.l_fhslab_2011_m_0656s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
105.0	335.0		2021/05/17	440.0		105.0	./data/phs001134.v1.pht011224.v1.p1.Chernobyl_PTC_Subject.var_report.xml	2.0	220.0	162.6	335.0			220.0		phs001134.v1.p1	Thyroid Cancer, Papillary
			10/27/2014				./data/phs000812.v1.pht004298.v1.p1.Breast_Prostate_Cancer_Sample.var_report.xml									phs000812.v1.p1	Prostatic Neoplasms
			08/25/2015				./data/phs000978.v1.pht004942.v1.p1.Malignant_GCT_Pazopanib_Sample.var_report.xml									phs000978.v1.p1	Granular Cell Tumor
			2019/11/08				./data/phs001330.v2.pht007527.v2.p1.p6707_15450_diagnosis.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			03/10/2015				./data/phs000855.v1.pht004551.v1.p1.Lung_Cancer_Resistance_Subject.var_report.xml									phs000855.v1.p1	Carcinoma
92.0	372.0		2019/04/15	464.0		92.0	./data/phs001792.v1.pht008932.v1.p1.InterGEN_Subject_Phenotypes.var_report.xml	0.0	232.0	198	372.0			232.0		phs001792.v1.p1	Hypertension
			2021/05/04				./data/phs002387.v1.pht011178.v1.p1.GBHS_Subject_Phenotypes.var_report.xml									phs002387.v1.p1	Breast Neoplasms
			08/23/2011				./data/phs000388.v1.pht002351.v1.p1.IPM_Cardiovascular_T2DM_Subject.var_report.xml									phs000388.v1.p1	Metabolic Syndrome X
658.0			06/05/2014	2290.0			./data/phs000753.v1.pht003876.v1.p1.Lung_Cancer_High_Density_SNP_Subject_Phenotypes.var_report.xml	0.0			988.0					phs000753.v1.p1	Lung Neoplasms
			2018/09/26				./data/phs001130.v1.pht008417.v1.p1.NIDDM_Athero_Hispanic_Sample.var_report.xml									phs001130.v1.p1	Diabetes Mellitus, Type 2
			2019/03/25				./data/phs001628.v1.pht008863.v1.p1.AML_Crenolanib_Subject.var_report.xml									phs001628.v1.p1	Leukemia, Myeloid, Acute
775.0	212.0		2021/06/09	330.0		775.0	./data/phs001293.v3.pht008894.v1.p1.TOPMed_WGS_HyperGEN_Pedigree.var_report.xml	1.0	887.0	66.47	212.0			887.0		phs001293.v3.p1	Hypertrophy, Left Ventricular
			12/11/2009				./data/phs000171.v1.pht000754.v1.p1.MS_DATA_FAMSEMO.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/02/27				./data/phs001774.v1.pht008802.v1.p1.AVSD_Subject.var_report.xml									phs001774.v1.p1	Complete atrioventricular septal defect
			06/14/2017				./data/phs001297.v1.pht006199.v1.p1.PROP_LymphocyticMarkers_Subject.var_report.xml									phs001297.v1.p1	Premature Infant
			12/01/2015				./data/phs000571.v3.pht003178.v3.p2.Catheterization.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			08/20/2013				./data/phs000285.v3.pht001581.v2.p2.A4F18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/05/2012				./data/phs000561.v1.pht003036.v1.p1.Hypobetalipoproteinemia_Sample_Attributes.var_report.xml									phs000561.v1.p1	Hypobetalipoproteinemias
			2018/02/27				./data/phs001206.v1.pht007347.v1.p1.BSP_AA_Sample_Attributes.var_report.xml									phs001206.v1.p1	Blepharospasm
			2021/06/24				./data/phs001446.v2.pht009626.v1.p1.TOPMed_WGS_SARP_Subject.var_report.xml									phs001446.v2.p1	Asthma
			2018/03/30				./data/phs001108.v1.pht007719.v1.p1.laboratorytesting.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000423.v2.p3.simphen024.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			05/05/2015				./data/phs000517.v3.pht003806.v1.p1.Multiethnic_Cohort_Study_Sample_Attributes.var_report.xml									phs000517.v3.p1	Breast Neoplasms
	812.0		2021/07/21	812.0		812.0	./data/phs002366.v1.pht011343.v1.p1.LC_Asian_Subject.var_report.xml	0.0	812.0		812.0			812.0		phs002366.v1.p1	Lung Neoplasms
			10/31/2014				./data/phs000543.v1.pht002939.v1.p1.PPB_Sample_Attributes.var_report.xml									phs000543.v1.p1	Pleuropulmonary blastoma [Supplementary Concept]
			2020/11/10				./data/phs002162.v1.pht010660.v1.p1.GMKF_Kidney_UT_Malformations_Subject.var_report.xml									phs002162.v1.p1	Renal Adysplasia
1.0	1.0		03/17/2017	1.0		1.0	./data/phs001121.v1.pht005710.v1.p1.Rare_Cancers_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs001121.v1.p1	Sarcoma
899.0	525.0		12/16/2014	924.0		899.0	./data/phs000018.v2.pht004355.v1.p1.GoKinD_GAIN_Pedigree.var_report.xml	0.0	986.0	4.243	525.0			986.0		phs000018.v2.p1	Diabetic Nephropathies
			04/04/2012				./data/phs000433.v1.pht002435.v1.p1.SIGNET_Sample.var_report.xml									phs000433.v1.p1	Type 2 Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht004186.v2.p1.RTAWF34.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
112.0	140.0		2018/06/30	252.0		112.0	./data/phs001625.v1.pht008185.v1.p1.Psychotic_Major_Depression_Subject_Phenotypes.var_report.xml	0.0	126.0	19.8	140.0			126.0		phs001625.v1.p1	Control Groups
			11/08/2013				./data/phs000200.v9.pht000989.v4.p3.ecg_mi_nova_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			01/12/2015				./data/phs000853.v1.pht004430.v1.p1.Normative_Aging_Study_Sample_Attributes.var_report.xml									phs000853.v1.p1	Mortality
			2018/02/08				./data/phs001488.v1.pht007410.v1.p1.mhxhd.var_report.xml									phs001488.v1.p1	Huntington Disease
			09/20/2016				./data/phs000801.v2.pht004613.v2.p1.NHL_Sample.var_report.xml									phs000801.v2.p1	Lymphoma, Non-Hodgkin
16.0	16.0		2021/02/22	18.0		2.0	./data/phs002212.v1.pht010983.v1.p1.ZRSR2_MDS_Subject.var_report.xml	0.0	9.0	9.899	2.0			9.0		phs002212.v1.p1	Myelodysplastic Syndromes
9.0	9.0		2017/09/25	45.0		6.0	./data/phs001348.v2.pht006235.v2.p1.Gene_Discovery_WGMS_Subject_Phenotypes.var_report.xml	0.0	7.5	2.121	6.0			7.5		phs001348.v2.p1	
1.0			2020/06/09	1.0			./data/phs002036.v1.pht010276.v1.p1.Chromoanasynthesis_JBS_Subject_Phenotypes.var_report.xml	0.0								phs002036.v1.p1	Jacobsen Distal 11q Deletion Syndrome
			05/31/2017				./data/phs001030.v1.pht005090.v1.p1.Viral_Respiratory_Pathogens_Genetics_Subject.var_report.xml									phs001030.v1.p1	Influenza, Human
			09/10/2013				./data/phs000601.v1.pht003515.v1.p1.Heritable_Breast_Cancer_Sample.var_report.xml									phs000601.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht001507.v2.p3.outc_cardio_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			05/20/2015				./data/phs000180.v3.pht002744.v1.p2.T1DGC_Sample_Attributes.var_report.xml									phs000180.v3.p2	Diabetes Mellitus, Type 1
			2019/09/16				./data/phs001534.v1.pht008520.v1.p1.Pathways_Subject_Phenotypes.var_report.xml									phs001534.v1.p1	Breast Neoplasms
			2017/11/30				./data/phs001474.v1.pht007154.v1.p1.Metastasis_HNSCC_Sample_Attributes.var_report.xml									phs001474.v1.p1	Carcinoma, Squamous Cell
			2020/12/21				./data/phs000007.v32.pht000386.v4.p13.vr_cabg_2007_m_0007s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/07/21				./data/phs002035.v1.pht010413.v1.p1.PCD_Sample.var_report.xml									phs002035.v1.p1	Ciliary Motility Disorders
			2018/06/22				./data/phs000298.v4.pht002584.v3.p3.Autism_Sequencing_Collaboration_Sample_Attributes.var_report.xml									phs000298.v4.p3	Autistic Disorder
			2018/09/19				./data/phs001581.v1.pht008383.v1.p1.HNSCC_Cell_Lines_Subject_Phenotypes.var_report.xml									phs001581.v1.p1	Head and Neck Neoplasms
			2018/06/01				./data/phs001317.v1.pht008042.v1.p1.intakeform.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
2.0	2.0		11/21/2016	4.0		2.0	./data/phs001251.v1.pht005948.v1.p1.UC_WES_Pedigree.var_report.xml	0.0	2.0	0.7071	2.0			2.0		phs001251.v1.p1	Colitis, Ulcerative
			2020/03/11				./data/phs001919.v1.pht009592.v1.p1.Melanoma_Anti_PD_1_Sample.var_report.xml									phs001919.v1.p1	Melanoma
4.0	4.0		2020/12/22	5.0		1.0	./data/phs001980.v1.pht010077.v1.p1.UTPDTC_PDX_Subject_Phenotypes.var_report.xml	0.0	2.5	2.121	1.0			2.5		phs001980.v1.p1	Lung Neoplasms
			12/01/2015				./data/phs000571.v3.pht003181.v3.p2.ExtracardiacFindings.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2021/05/24				./data/phs002323.v1.pht010880.v1.p1.Pediatric_Immunotherapy_Sample.var_report.xml									phs002323.v1.p1	Immunotherapy
			2019/03/11				./data/phs000286.v6.pht008756.v1.p2.incevtstroke.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007832.v1.p1.pidtc_17395_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2021/01/13				./data/phs001480.v1.pht010831.v1.p1.PRO_CIPN_Sample.var_report.xml									phs001480.v1.p1	Peripheral Nervous System Diseases/drug effects
			2019/08/18				./data/phs001869.v1.pht009397.v1.p1.ADHD_Sample_Attributes.var_report.xml									phs001869.v1.p1	Attention Deficit Disorder with Hyperactivity
			2018/09/26				./data/phs000284.v2.pht001899.v2.p1.CFS_CARe_Subject.var_report.xml									phs000284.v2.p1	Sleep Apnea Syndromes
85.0			2018/01/26	85.0			./data/phs001417.v1.pht007366.v1.p1.Metastatic_Tumors_cfDNA_Subject_Phenotypes.var_report.xml	0.0			409.0					phs001417.v1.p1	Neoplasms
			2018/06/26				./data/phs001526.v1.pht007614.v1.p1.DIPG_Sample_Attributes.var_report.xml									phs001526.v1.p1	Glioma
			11/04/2014				./data/phs000086.v3.pht000345.v1.p1.EDIC_f0922.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
	9995.0		11/08/2013	80540.0		9435.0	./data/phs000200.v9.pht001005.v4.p3.f37_rel1.var_report.xml	988.0	6468.0	961.2	56414.0			6468.0		phs000200.v9.p3	Women&#39;s Health
			2018/08/28				./data/phs001563.v1.pht008323.v1.p1.Blood_Handling_Sample.var_report.xml									phs001563.v1.p1	Cerebral Hemorrhage
			2020/09/18				./data/phs002210.v1.pht010521.v1.p1.Structural_Variants_BC_Sample_Attributes.var_report.xml									phs002210.v1.p1	Breast Neoplasms
			2019/07/26				./data/phs000588.v1.pht009284.v1.p1.angiogram_coronary.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			11/30/2015				./data/phs000260.v4.pht001258.v4.p2.HMP_Foregut_Esophageal_Adenocarcinoma_Subject_Phenotypes.var_report.xml									phs000260.v4.p2	Esophageal Adenocarcinoma
			2020/03/11				./data/phs001919.v1.pht009594.v1.p1.Melanoma_Anti_PD_1_GEO.var_report.xml									phs001919.v1.p1	Melanoma
			12/17/2013				./data/phs000662.v1.pht003560.v1.p1.NCS_AIM_Subject_Phenotypes.var_report.xml									phs000662.v1.p1	Population Groups
			2019/11/08				./data/phs001332.v2.pht007447.v2.p1.p7301_12626_eq5d.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			12/11/2009				./data/phs000171.v1.pht000753.v1.p1.MS_DATA_FAMSADD.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000463.v2.p3.simphen064.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/07/29				./data/phs002437.v1.pht011432.v1.p1.M4OC_PREVENT_Sample_Attributes.var_report.xml									phs002437.v1.p1	Leukoplakia, Oral
120.0	120.0		2018/03/20	226.0		106.0	./data/phs001498.v1.pht007325.v1.p1.INSIGHT_Microbiome_Subject_Phenotypes.var_report.xml	0.0	113.0	9.899	106.0			113.0		phs001498.v1.p1	Pediatric Obesity
			08/06/2015				./data/phs000934.v1.pht004877.v1.p1.Antibody_Repertoires_CVID_Subject.var_report.xml									phs000934.v1.p1	Common Variable Immunodeficiency
88.0	88.0		01/03/2017	88.0		88.0	./data/phs001141.v1.pht005601.v1.p1.PROMOTE_Subject_Phenotypes.var_report.xml	0.0	88.0					88.0		phs001141.v1.p1	Prostatic Neoplasms, Castration-Resistant
			2017/08/18				./data/phs001363.v1.pht006519.v1.p1.P100_Sample_Attributes.var_report.xml									phs001363.v1.p1	Health
			2018/06/01				./data/phs001538.v1.pht008088.v1.p1.NAMDC_7401_Subject.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
2.0	2.0		11/21/2016	4.0		2.0	./data/phs001251.v1.pht005950.v1.p1.UC_WES_Subject_Phenotypes.var_report.xml	0.0	2.0	0.7071	2.0			2.0		phs001251.v1.p1	Colitis, Ulcerative
			08/20/2013				./data/phs000285.v3.pht001628.v2.p2.B2F14.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/01/30				./data/phs001698.v1.pht009602.v1.p1.BPH_Sample.var_report.xml									phs001698.v1.p1	Prostatic Hyperplasia
			11/04/2014				./data/phs000086.v3.pht004261.v1.p1.DCCT_EDIC_Sample_Attributes.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
2.0			2018/05/31	6.0			./data/phs001316.v1.pht008014.v1.p1.sf_36.var_report.xml	0.0			1.0					phs001316.v1.p1	Andersen Syndrome
			10/07/2016				./data/phs001223.v1.pht005799.v1.p1.AR_Prostate_Cancer_Subject.var_report.xml									phs001223.v1.p1	Prostatic Neoplasms
123.0	670.0		2020/03/02	1190.0		520.0	./data/phs001900.v1.pht009633.v1.p1.ASD_SCZ_Development_Sample_Attributes.var_report.xml	0.0	595.0	106.1	96.0			595.0		phs001900.v1.p1	Autism Spectrum Disorder
			2021/06/01				./data/phs001189.v4.pht005980.v2.p1.TOPMed_WGS_CCAF_Sample_Attributes.var_report.xml									phs001189.v4.p1	Atrial Fibrillation
			06/16/2017				./data/phs001278.v1.pht006264.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001278.v1.p1	Porphyrias
163.0	280.0		2021/02/12	443.0		163.0	./data/phs001771.v1.pht008717.v1.p1.IGNITE_Subject_Phenotypes.var_report.xml	0.0	221.5	82.73	280.0			221.5		phs001771.v1.p1	Diabetes Mellitus
			11/08/2013				./data/phs000200.v9.pht001500.v2.p3.outc_dvt_pe_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/07/21				./data/phs002366.v1.pht011345.v1.p1.LC_Asian_Subject_Phenotypes.var_report.xml									phs002366.v1.p1	Lung Neoplasms
			2018/03/27				./data/phs001566.v1.pht007710.v1.p1.MBC_NF1_Sample_Attributes.var_report.xml									phs001566.v1.p1	Neurofibromatosis 1
			08/20/2013				./data/phs000285.v3.pht001792.v2.p2.E1F49.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/10/18				./data/phs001020.v2.pht005781.v2.p1.GPC_Subject.var_report.xml									phs001020.v2.p1	Schizophrenia
			11/05/2014				./data/phs000209.v13.pht004319.v1.p3.MESA_AncilMesaEpigenomicCBC.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/08/30				./data/phs001331.v2.pht006933.v2.p1.imd_medications.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			Wed Nov 26 07:49:48 2008				./data/phs000017.v3.pht000368.v1.p1.AA_DiagnosisPage1.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2018/06/22				./data/phs000298.v4.pht002281.v3.p3.Autism_Sequencing_Collaboration_Subject.var_report.xml									phs000298.v4.p3	Autistic Disorder
60.0	60.0		03/04/2011	97.0		69.0	./data/phs000264.v2.pht001420.v2.p1.HMP_Virome_Febrile_Subject_Phenotypes.var_report.xml	0.0	91.5	9.899	69.0			91.5		phs000264.v2.p1	Virus Diseases
			2019/09/16				./data/phs000979.v3.pht005193.v2.p2.HBCC_Postmortem_Psychiatric_Subject.var_report.xml									phs000979.v3.p2	Schizophrenia
			04/14/2014				./data/phs000732.v1.pht003799.v1.p1.L1_Retrotransposon_Asian_Subject.var_report.xml									phs000732.v1.p1	Molecular Structure
5982.0	5903.0		01/05/2016	7298.0		84.0	./data/phs000917.v1.pht004740.v1.p1.MIGen_Exome_PROMIS_Subject_Phenotypes.var_report.xml	0.0	2433.0	3056	841.0			813.0		phs000917.v1.p1	Coronary Artery Disease
89.0	89.0		2021/08/30	113.0		24.0	./data/phs001933.v1.pht011513.v1.p1.TOPMed_CCDG_UCSF_AF_SubjectPhenotypes.var_report.xml	0.0	56.5	45.96	24.0			56.5		phs001933.v1.p1	Atrial Fibrillation
			03/11/2014				./data/phs000410.v1.pht002449.v1.p1.Colorectal_Cancer_Sample.var_report.xml									phs000410.v1.p1	Colorectal Neoplasms
			2021/08/24				./data/phs002185.v1.pht010967.v1.p1.CIDR_GVHD_Sample.var_report.xml									phs002185.v1.p1	Graft vs Host Disease
			2020/01/23				./data/phs000287.v7.pht001451.v1.p1.BASE2.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
784.0	784.0		2019/10/18	746.0		467.0	./data/phs001020.v2.pht005783.v2.p1.GPC_Subject_Phenotypes.var_report.xml	0.0	625.5	84.15	467.0			625.5		phs001020.v2.p1	Schizophrenia
925.0	925.0		2020/12/18	1812.0		887.0	./data/phs002059.v1.pht010425.v1.p1.GenderDS.var_report.xml	0.0	906.0	26.87	887.0			906.0		phs002059.v1.p1	Heart Defects, Congenital
			08/20/2013				./data/phs000285.v3.pht001615.v2.p2.B2F09MOT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
209.0	209.0	50.0	2020/11/20	389.0	52.63	180.0	./data/phs002255.v1.pht010675.v1.p1.Language_Impairment_Subject_Phenotypes.var_report.xml	0.0	194.5	5.928	180.0	50.0		194.5	73.0	phs002255.v1.p1	Language Development
			2018/04/16				./data/phs001326.v1.pht007815.v1.p1.p6902_17920_day0hcttr.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/06/18				./data/phs000280.v7.pht006474.v1.p1.RETP1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/10				./data/phs002037.v1.pht010268.v1.p1.Mg_Deficiency_CRC_Sample_Attributes.var_report.xml									phs002037.v1.p1	Magnesium Deficiency
			2020/07/24				./data/phs002066.v1.pht010418.v1.p1.Genomic_Instability_Sample_Attributes.var_report.xml									phs002066.v1.p1	Chromosome Fragile Sites
			06/29/2015				./data/phs000838.v1.pht004799.v1.p1.Ghana_Prostate_Study_Sample_Attributes.var_report.xml									phs000838.v1.p1	Prostatic Neoplasms
			11/08/2013				./data/phs000200.v9.pht001013.v3.p3.f45_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			03/28/2014				./data/phs000350.v1.pht002201.v1.p1.FHCRC_Prostate_Cancer_Sample.var_report.xml									phs000350.v1.p1	Prostatic Neoplasms
389.0	4157.0		2020/11/02	5585.0		27.0	./data/phs002046.v1.pht010623.v1.p1.GTP_Pedigree.var_report.xml	0.0	542.0	630.6	4157.0			389.0		phs002046.v1.p1	Stress Disorders, Post-Traumatic
			01/07/2016				./data/phs001016.v1.pht005080.v1.p1.Radial_Glial_Diversity_Sample.var_report.xml									phs001016.v1.p1	Neuroglia
			2019/01/29				./data/phs001298.v1.pht008647.v1.p1.Psoriasis_European_Sample.var_report.xml									phs001298.v1.p1	Psoriasis
			01/27/2014				./data/phs000674.v1.pht003639.v1.p1.Conditions.var_report.xml									phs000674.v1.p1	Aging
			09/15/2016				./data/phs001044.v1.pht005275.v1.p1.Breast_Cancer_Risk_Pathways_Sample_Attributes.var_report.xml									phs001044.v1.p1	Breast Neoplasms
			2019/10/25				./data/phs001858.v1.pht009374.v1.p1.Advanced_Cancer_Sample_Attributes.var_report.xml									phs001858.v1.p1	Neoplasms
1.0	1.0		2021/05/20	2.0		1.0	./data/phs001032.v6.pht007135.v1.p2.TOPMed_WGS_VUH_AF_Pedigree.var_report.xml	0.0	1.0	0	1.0			1.0		phs001032.v6.p2	Atrial Fibrillation
			2018/03/26				./data/phs000697.v1.pht007703.v1.p1.adverse_event.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2021/02/02				./data/phs002327.v1.pht010918.v1.p1.ATR_Stress_Tumors_Sample_Attributes.var_report.xml									phs002327.v1.p1	Small Cell Lung Carcinoma
			01/29/2015				./data/phs000737.v1.pht004445.v1.p1.Metabolic_Syndrome_Hvar_Islanders_Sample.var_report.xml									phs000737.v1.p1	Metabolic Syndrome X
587.0	619.0		Tue Nov 18 09:14:37 2008	664.0		587.0	./data/phs000088.v1.pht000712.v1.p1.GOKIND_NIDDK_Pedigree.var_report_2008_11_20.xml	0.0	603.0	22.63	619.0			603.0		phs000088.v1.p1	Diabetic Nephropathies
14.0	20.0		2019/12/17	34.0		14.0	./data/phs001943.v1.pht009713.v1.p1.UM_Pedigree.var_report.xml	0.0	17.0	4.243	20.0			17.0		phs001943.v1.p1	Uveal melanoma
			10/19/2011				./data/phs000309.v2.pht001997.v2.p2.CARDIA_Subject.var_report.xml									phs000309.v2.p2	Cardiovascular Diseases
			2018/06/14				./data/phs001238.v2.pht006658.v1.p1.GENOA_EuropeanAmerican_Phase2_Brain.var_report.xml									phs001238.v2.p1	Hypertension
			2021/07/13				./data/phs001798.v2.pht008946.v2.p2.23andMe_AfAmSeq_Subject.var_report.xml									phs001798.v2.p2	
			05/24/2016				./data/phs001065.v1.pht005410.v1.p1.drugret.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/03/11				./data/phs000286.v6.pht008765.v1.p2.mhxc.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
817.0	594.0		11/24/2010	970.0		817.0	./data/phs000140.v1.pht000911.v1.p1.T2D_Pedigree.var_report_2010_11_24.xml	0.0	516.5	260.9	594.0			516.5		phs000140.v1.p1	Diabetes Mellitus, Type 2
			05/24/2016				./data/phs001065.v1.pht005420.v1.p1.mhxgen.var_report.xml									phs001065.v1.p1	Huntington Disease
497.0	497.0		07/18/2014	859.0		362.0	./data/phs000775.v1.pht003945.v1.p1.Molecular_Genetics_Schizophrenia_Subject_Phenotypes.var_report.xml	0.0	429.5	95.46	362.0			429.5		phs000775.v1.p1	Schizophrenia
			11/16/2015				./data/phs000896.v1.pht005124.v1.p1.LGG_Probiotics_Metagenome_Sample.var_report.xml									phs000896.v1.p1	Human Microbiome
			2021/05/21				./data/phs001040.v5.pht005205.v2.p1.TOPMed_WGS_WGHS_Sample_Attributes.var_report.xml									phs001040.v5.p1	Atrial Fibrillation
			12/06/2012				./data/phs000565.v1.pht003075.v1.p1.RHD_Sample.var_report.xml									phs000565.v1.p1	Congenital Abnormalities
			06/01/2017				./data/phs000701.v1.pht005512.v1.p1.DevelopmentalHistory.var_report.xml									phs000701.v1.p1	Angelman Syndrome
1725.0	1725.0		11/27/2009	2769.0		1044.0	./data/phs000016.v2.pht000055.v2.p2.IMAGE_Pedigree.var_report_2009_11_27.xml	0.0	1385.0	481.5	1044.0			1385.0		phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			11/08/2013				./data/phs000200.v9.pht003408.v1.p3.outc_death_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/06/18				./data/phs000280.v7.pht004115.v2.p1.HPCB04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/10				./data/phs001359.v3.pht008689.v1.p1.TOPMed_WGS_GOLDN_Sample.var_report.xml									phs001359.v3.p1	Lipids
			2017/10/04				./data/phs000782.v1.pht003993.v1.p1.MedImmune_RHCCS_Sample_Attributes.var_report.xml									phs000782.v1.p1	Carcinoma, Hepatocellular
			04/10/2015				./data/phs000900.v1.pht004652.v1.p1.DIPG_Sample.var_report.xml									phs000900.v1.p1	Glioma
			2019/11/08				./data/phs001330.v2.pht007530.v2.p1.vabs.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
14.0	25.0		2020/12/10	41.0		16.0	./data/phs002071.v1.pht010456.v1.p1.PDA_Sample_Attributes.var_report.xml	0.0	20.5	6.364	10.0			20.5		phs002071.v1.p1	Carcinoma, Pancreatic Ductal
			2019/04/04				./data/phs001742.v2.pht008552.v2.p1.Metastasis_TNBC_Subject.var_report.xml									phs001742.v2.p1	Triple Negative Breast Neoplasms
			2019/08/29				./data/phs001333.v2.pht006530.v2.p1.physical_measurements.var_report.xml									phs001333.v2.p1	Fabry Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000594.v2.p3.simphen195.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
9.0			2020/10/29	43.0			./data/phs000450.v4.pht002526.v3.p1.DLBCL_Subject_Phenotypes.var_report.xml	0.0			9.0					phs000450.v4.p1	Hodgkin Disease
			08/25/2016				./data/phs001153.v1.pht005697.v1.p1.Endometrioid_Endometrial_Carcinoma_Sample_Attributes.var_report.xml									phs001153.v1.p1	Endometrial Neoplasms
			11/08/2013				./data/phs000200.v9.pht001505.v2.p3.outc_cancer_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
7.0	7.0		08/21/2015	8.0		2.0	./data/phs000830.v1.pht004922.v1.p1.cSCC_XPC_Mutation_Rates_Subject_Phenotypes.var_report.xml	0.0	6.5	6.364	2.0			6.5		phs000830.v1.p1	Xeroderma Pigmentosum, Complementation Group C
			11/18/2014				./data/phs000825.v1.pht004351.v1.p1.HUES64_HUES63_Sequencing_Sample.var_report.xml									phs000825.v1.p1	Growth and Development
			11/04/2014				./data/phs000086.v3.pht000239.v1.p1.DCCT_cbl7.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/09/30				./data/phs002614.v1.pht011590.v1.p1.BWS_HB_Subject_Phenotypes.var_report.xml									phs002614.v1.p1	Beckwith-Wiedemann Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000449.v2.p3.simphen050.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			06/12/2017				./data/phs000594.v1.pht006508.v1.p1.PhysicalExam.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2018/05/15				./data/phs001311.v1.pht007922.v1.p1.registration.var_report.xml									phs001311.v1.p1	Myotonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000505.v2.p3.simphen106.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001851.v2.p2.F1REF.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			Wed Nov 26 07:50:28 2008				./data/phs000017.v3.pht000641.v1.p1.Bipolar_Subject.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			06/24/2016				./data/phs001159.v1.pht005597.v1.p1.Lung_Adenocarcinoma_Tumor_Heterogeneity_Sample.var_report.xml									phs001159.v1.p1	Adenocarcinoma of lung
			2020/09/28				./data/phs001459.v1.pht007312.v1.p1.AMP_SLE_Sample_Attributes.var_report.xml									phs001459.v1.p1	Lupus Erythematosus, Systemic
			2021/08/26				./data/phs001727.v2.pht010101.v1.p1.TOPMed_WGS_PIMA_Sample.var_report.xml									phs001727.v2.p1	Asthma
			2019/10/23				./data/phs001176.v3.pht005798.v3.p1.GxE_Complex_Traits_Sample_Attributes.var_report.xml									phs001176.v3.p1	Gene-Environment Interaction
			09/30/2016				./data/phs001015.v1.pht005778.v1.p1.Chronic_Fatigue_Syndrome_Sample.var_report.xml									phs001015.v1.p1	Fatigue Syndrome, Chronic
537.0	537.0		09/27/2010	988.0		975.0	./data/phs000103.v1.pht000190.v1.p1.Preterm_Delivery_Subject_Phenotypes.var_report_2010_09_27.xml	0.0	503.5	83.44	975.0			503.5		phs000103.v1.p1	Premature Birth
			04/08/2014				./data/phs000552.v2.pht003027.v1.p1.Meningiomas_Subject.var_report.xml									phs000552.v2.p1	Meningioma
			06/12/2017				./data/phs001275.v1.pht006540.v1.p1.Cryptorchid_Testes_Subject.var_report.xml									phs001275.v1.p1	Cryptorchidism
			09/09/2013				./data/phs000266.v4.pht001264.v4.p1.HMP_Dermatitis_Immunodeficiency_MRSA_Subject.var_report.xml									phs000266.v4.p1	Dermatitis, Atopic
			2019/03/11				./data/phs000286.v6.pht008763.v1.p2.medcodesV3.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			05/07/2013				./data/phs000462.v1.pht002540.v1.p1.T2D_GENES_Subject.var_report.xml									phs000462.v1.p1	Diabetes Mellitus, Type 2
568.0	568.0		2021/05/07	1123.0		555.0	./data/phs000956.v5.pht005002.v1.p1.TOPMed_WGS_Amish_Subject_Phenotypes.var_report.xml	0.0	561.5	9.192	555.0			561.5		phs000956.v5.p1	Cardiovascular Diseases
			10/21/2015				./data/phs000813.v1.pht004302.v1.p1.Nicotine_Dependence_Genomic_Regions_Subject.var_report.xml									phs000813.v1.p1	Tobacco Use Disorder
			10/16/2014				./data/phs000376.v1.pht002308.v1.p1.CIDR_PD_Exome_Sample.var_report.xml									phs000376.v1.p1	Parkinson Disease
			2017/09/18				./data/phs001310.v1.pht006871.v1.p1.physician_examination.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			2020/06/18				./data/phs000280.v7.pht006472.v1.p1.RETF0.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008781.v1.p2.rhxb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/01/26				./data/phs001427.v2.pht007487.v2.p1.Melanoma_CPB_Resistance_Sample_Attributes.var_report.xml									phs001427.v2.p1	Immunotherapy
			08/20/2013				./data/phs000285.v3.pht001684.v2.p2.C1F42.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/19				./data/phs001288.v1.pht006764.v1.p1.audiology.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/03/11				./data/phs000286.v6.pht001975.v2.p2.soca.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000683.v7.p13.ostcal1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000600.v2.p3.triplet_sim.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/04/2014				./data/phs000086.v3.pht000213.v1.p1.DCCT_f0033.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			11/07/2014				./data/phs000821.v1.pht004338.v1.p1.DNA_Methylation_Age_Scottish_Subject.var_report.xml									phs000821.v1.p1	Mortality
			12/03/2013				./data/phs000367.v1.pht003260.v1.p1.IBDGC_Familial_Crohns_Disease_Subject.var_report.xml									phs000367.v1.p1	Crohn Disease
			2019/03/25				./data/phs001752.v1.pht008875.v1.p1.NEPC_cfDNA_Sample_Attributes.var_report.xml									phs001752.v1.p1	Adenocarcinoma
			2021/06/02				./data/phs002419.v1.pht011265.v1.p1.BC_Sample_Attributes.var_report.xml									phs002419.v1.p1	Breast Neoplasms
			2019/11/01				./data/phs001005.v2.pht005040.v2.p1.Neoantigens_Stage3_Melanoma_Subject_Phenotypes.var_report.xml									phs001005.v2.p1	
			2020/09/18				./data/phs002015.v1.pht010376.v1.p1.AREDS2_DEM.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/03/20				./data/phs000605.v1.pht007636.v1.p1.initial_physical_exam_form.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			08/20/2013				./data/phs000285.v3.pht001856.v2.p2.F2F09MAD.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
5.0	69.0		2019/05/13	82.0		5.0	./data/phs001811.v1.pht009062.v1.p1.Early_Lung_ADC_Subject_Phenotypes.var_report.xml	0.0	51.0	7.071	69.0			51.0		phs001811.v1.p1	Adenocarcinoma of Lung
			2017/11/07				./data/phs001461.v1.pht007122.v1.p1.Pediatric_Ependymoma_Sample_Attributes.var_report.xml									phs001461.v1.p1	Ependymoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000509.v2.p3.simphen110.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			04/18/2012	56.0			./data/phs000369.v1.pht002587.v1.p1.Breast_Carcinoma_Subtypes_Subject_Phenotypes.var_report.xml	0.0			56.0					phs000369.v1.p1	Carcinoma, Ductal, Breast
178.0	178.0		2021/03/05	268.0		90.0	./data/phs002328.v1.pht010853.v1.p1.EPIPARK_HBS2_Subject.var_report.xml	0.0	134.0	62.23	90.0			134.0		phs002328.v1.p1	Parkinson Disease
			2020/12/22				./data/phs001980.v1.pht010075.v1.p1.UTPDTC_PDX_Subject.var_report.xml									phs001980.v1.p1	Lung Neoplasms
			12/27/2012				./data/phs000524.v1.pht002916.v1.p1.CRIC_Subject.var_report.xml									phs000524.v1.p1	Chronic Renal Insufficiency
			2020/12/21				./data/phs000007.v32.pht000694.v8.p13.vitd3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/07/2014				./data/phs000738.v1.pht003837.v1.p1.Schizophrenia_Families_Sample_Attributes.var_report.xml									phs000738.v1.p1	Schizophrenia
			08/12/2016				./data/phs000888.v1.pht005586.v1.p1.Diverticulosis_data_all_adult_sites.var_report.xml									phs000888.v1.p1	
			11/27/2009				./data/phs000016.v2.pht001038.v1.p2.IMAGE_Sample.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			05/11/2012				./data/phs000291.v2.pht002270.v2.p1.LHS_COPD_Sample.var_report.xml									phs000291.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/01/23				./data/phs000287.v7.pht003700.v2.p1.SHHS2_PSG.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003121.v3.p3.MESA_AncilMesaNeighborScalesExam3.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/09/28				./data/phs001459.v1.pht007309.v1.p1.AMP_SLE_Subject.var_report.xml									phs001459.v1.p1	Lupus Erythematosus, Systemic
1792.0	2096.0		2020/11/09	3888.0		1792.0	./data/phs000976.v2.pht005686.v1.p1.CIDR_COGA_AA_Family_Subject_Phenotypes.var_report.xml	0.0	1944.0	215	2096.0			1944.0		phs000976.v2.p1	Alcoholism
			02/27/2017				./data/phs001226.v1.pht006170.v1.p1.Embryonic_Development_Sample_Attributes.var_report.xml									phs001226.v1.p1	Embryonic Development
			2018/05/22				./data/phs001165.v1.pht007986.v1.p1.eMERGE_GCPD_CAG_CHOP_Sample.var_report.xml									phs001165.v1.p1	Pediatrics
296.0	313.0		05/24/2016	609.0		296.0	./data/phs001065.v1.pht005427.v1.p1.randomized.var_report.xml	0.0	304.5	12.02	313.0			304.5		phs001065.v1.p1	Huntington Disease
			Wed Nov 19 17:41:20 2008				./data/phs000092.v1.pht000635.v1.p1.AlcoholDepAdd_Sample.var_report_2008_11_26.xml									phs000092.v1.p1	Alcoholism
			2017/12/12				./data/phs000676.v2.pht003587.v2.p2.Breast_Tissues_Sequence_Analysis_Sample.var_report.xml									phs000676.v2.p2	Breast Neoplasms
629.0	649.0		07/21/2016	2348.0		542.0	./data/phs000840.v1.pht005643.v1.p1.GoT2D_Subject_Phenotypes.var_report.xml	0.0	588.5	85.56	649.0			588.5		phs000840.v1.p1	Type 2 Diabetes Mellitus
			2019/10/10				./data/phs001273.v3.pht006171.v2.p2.OncoArray_Lung_Cancer_Subject.var_report.xml									phs001273.v3.p2	Lung Neoplasms
			2020/02/06				./data/phs001935.v1.pht009766.v1.p1.GAPPS_Subject.var_report.xml									phs001935.v1.p1	Stomach Neoplasms
			11/16/2012				./data/phs000413.v2.pht002732.v2.p1.AML_FABM7_Subject.var_report.xml									phs000413.v2.p1	Acute Megakaryoblastic Leukemia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000581.v2.p3.simphen182.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/08/18				./data/phs001549.v1.pht008251.v1.p1.EWS_European_Sample.var_report.xml									phs001549.v1.p1	Sarcoma, Ewing
			2018/03/15				./data/phs001516.v1.pht007492.v1.p1.PheRS_eMERGE_Sample.var_report.xml									phs001516.v1.p1	Genetic Diseases, Inborn
			2021/06/23				./data/phs001435.v2.pht009874.v1.p1.TOPMed_WGS_AustralianFamilialAF_Sample.var_report.xml									phs001435.v2.p1	Atrial Fibrillation
			03/12/2013				./data/phs000343.v3.pht003148.v1.p1.med.var_report.xml									phs000343.v3.p1	Stroke
8.0	8.0		08/21/2014	28.0		7.0	./data/phs000758.v1.pht003999.v1.p1.Congenital_Heart_Defects_Pedigree.var_report.xml	0.0	7.0	1.414	7.0			7.0		phs000758.v1.p1	Heart Septal Defects
826.0			2021/05/20	1134.0			./data/phs001032.v6.pht005675.v3.p2.TOPMed_WGS_VUH_AF_Subject_Phenotypes.var_report.xml	0.0			308.0					phs001032.v6.p2	Atrial Fibrillation
			2020/06/02				./data/phs002040.v1.pht010261.v1.p1.IL37_IBD_Sample_Attributes.var_report.xml									phs002040.v1.p1	Inflammatory Bowel Diseases
			2018/10/11				./data/phs001706.v1.pht008458.v1.p1.MCD_Sample_Attributes.var_report.xml									phs001706.v1.p1	Castleman Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000549.v2.p3.simphen150.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/01/23				./data/phs000287.v7.pht003698.v2.p1.SHHS2_ecg.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
7.0	9.0		2019/12/11	6.0		5.0	./data/phs001906.v1.pht009662.v1.p1.GISTs_Subject_Phenotypes.var_report.xml	0.0	7.0	2	9.0			7.0		phs001906.v1.p1	Gastrointestinal Stromal Tumors
			08/20/2013				./data/phs000285.v3.pht001811.v2.p2.F1F08.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001630.v2.p2.B2F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
4392.0	4943.0		2018/12/27	9335.0		4392.0	./data/phs000756.v1.pht008613.v1.p1.FINRISK_Subject_Phenotypes.var_report.xml	0.0	4668.0	389.6	4943.0			4668.0		phs000756.v1.p1	
			2019/02/11				./data/phs001780.v1.pht008712.v1.p1.African_Demographic_Sample.var_report.xml									phs001780.v1.p1	
40.0	4189.0		10/07/2011	4229.0		40.0	./data/phs000368.v1.pht002292.v1.p1.NU_PCOS_Pedigree.var_report.xml	0.0	3055.0	2934	4189.0			3055.0		phs000368.v1.p1	Polycystic Ovary Syndrome
893.0			2019/03/25	969.0			./data/phs001415.v1.pht006686.v1.p1.CIDR_GECCO_CRC_Subject_Phenotypes.var_report.xml	0.0			993.0					phs001415.v1.p1	
			2018/10/15				./data/phs001106.v1.pht007335.v1.p1.Genomics_HCC_Subject.var_report.xml									phs001106.v1.p1	
392.0	392.0		2021/07/30	720.0		5.0	./data/phs002444.v1.pht011383.v1.p1.Osteosarcoma_Subject.var_report.xml	0.0	240.0	206.4	323.0			323.0		phs002444.v1.p1	Osteosarcoma
			03/27/2013				./data/phs000525.v1.pht002934.v1.p1.Cancer_Pseudogenes_Transcription_Sample.var_report.xml									phs000525.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht010724.v1.p13.e_exam_ex03_3b_1069s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/31				./data/phs001654.v1.pht008441.v1.p1.NSAID_BE_Subject.var_report.xml									phs001654.v1.p1	Barrett Esophagus
			2020/02/04				./data/phs001507.v1.pht008695.v1.p1.ET_Turkish_Subject.var_report.xml									phs001507.v1.p1	Essential Tremor
			2020/06/18				./data/phs000280.v7.pht006455.v1.p1.NCS.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004128.v2.p1.MSCA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000200.v4.p13.igf1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/05/07				./data/phs001409.v1.pht006798.v1.p1.Uterine_Fibroids_AA_EA_Subject.var_report.xml									phs001409.v1.p1	Leiomyoma
			2020/12/21				./data/phs000007.v32.pht002896.v6.p13.l_opg_2008_m_0434s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			04/16/2012				./data/phs000477.v1.pht002688.v1.p1.Familial_Renal_Disorders_Sample_Attributes.var_report.xml									phs000477.v1.p1	Hypophosphatemia, Familial
			2020/02/06				./data/phs001935.v1.pht009770.v1.p1.GAPPS_Sample_Attributes.var_report.xml									phs001935.v1.p1	Stomach Neoplasms
			04/13/2015				./data/phs000874.v1.pht004657.v1.p1.GERFHS_Sample_Attributes.var_report.xml									phs000874.v1.p1	Intracerebral Hemorrhage
			2020/12/21				./data/phs000007.v32.pht000081.v8.p13.crp1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1.0	1.0		04/16/2012	1.0		1.0	./data/phs000475.v1.pht002691.v1.p1.Inherited_Reproductive_Disorders_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs000475.v1.p1	Hypogonadism 
			08/24/2009				./data/phs000091.v2.pht000798.v2.p1.Type2Diabetes_NHS_HPFS_Subject.var_report_2009_08_24.xml									phs000091.v2.p1	Diabetes Mellitus, Type 2
458.0	510.0		11/14/2016	968.0		458.0	./data/phs000741.v2.pht003918.v2.p1.GOLDN_Lipid_Lowering_Subject_Phenotypes.var_report.xml	0.0	484.0	36.77	510.0			484.0		phs000741.v2.p1	Metabolomics
			05/24/2017				./data/phs000576.v1.pht006153.v1.p1.interimmedicalhistory.var_report.xml									phs000576.v1.p1	Angelman Syndrome
63.0	63.0		2021/08/20	63.0		63.0	./data/phs001939.v2.pht009664.v2.p1.CMI_MPCproject_Subject.var_report.xml	0.0	63.0					63.0		phs001939.v2.p1	Prostatic Neoplasms
			08/21/2013				./data/phs000641.v1.pht003477.v1.p1.Combined_Immunodeficiency_Multiple_Intestinal_Atresias_Sample_Attributes.var_report.xml									phs000641.v1.p1	Immunological Deficiency Syndrome
			2021/07/02				./data/phs001017.v1.pht005077.v1.p1.Breast_Cancer_Susceptibility_Sample_Attributes.var_report.xml									phs001017.v1.p1	Breast Neoplasms
			2019/06/14				./data/phs001824.v1.pht009112.v1.p1.pDC_HNSCC_Subject.var_report.xml									phs001824.v1.p1	Dendritic Cells
			2020/07/17				./data/phs000481.v3.pht002660.v3.p2.Cholesterol_and_Pharmacogenetics_Sample.var_report.xml									phs000481.v3.p2	Hypercholesterolemia
			03/01/2016				./data/phs001054.v1.pht005277.v1.p1.Angiocentric_Glioma_Sample.var_report.xml									phs001054.v1.p1	Glioma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000564.v2.p3.simphen165.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000587.v2.p3.simphen188.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
2791.0	2791.0		2021/08/17	5464.0		2673.0	./data/phs001661.v3.pht010560.v1.p1.TOPMed_WGS_GCPD_A_Subject_Phenotypes.var_report.xml	0.0	2732.0	83.44	2673.0			2732.0		phs001661.v3.p1	Asthma
15.0	34.0		2019/11/12	54.0		20.0	./data/phs001575.v2.pht008207.v1.p1.LDN_6716_MRI.var_report.xml	0.0	27.0	9.899	26.0			27.0		phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2021/08/05				./data/phs002499.v1.pht011449.v1.p1.CTCLs_JAK_STAT_Sample_Attributes.var_report.xml									phs002499.v1.p1	Lymphoma, T-Cell, Cutaneous
			2021/08/19				./data/phs001662.v2.pht010068.v1.p1.LTRC_R040_subject_family_hx_quest.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			06/20/2014				./data/phs000439.v1.pht002930.v1.p1.PGRN_RIKEN_Rate_Ctrl_Subject.var_report.xml									phs000439.v1.p1	Atrial Fibrillation
			02/02/2012				./data/phs000417.v2.pht002399.v2.p1.Brain_Cloud_Subject_Phenotypes.var_report.xml									phs000417.v2.p1	Aging
			03/24/2015				./data/phs000872.v1.pht004575.v1.p1.Autism_Postmortem_Brain_GEO.var_report.xml									phs000872.v1.p1	Autistic Disorder
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000443.v2.p3.simphen044.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004221.v2.p1.UBMFWF02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/09/18				./data/phs001310.v1.pht006868.v1.p1.eligibility_form.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			2017/11/30				./data/phs000373.v1.pht007129.v1.p1.MrOS_Subject_Phenotypes.var_report.xml									phs000373.v1.p1	Osteoporosis
			11/05/2014				./data/phs000209.v13.pht004321.v1.p3.MESA_AncilMesaNeighborSESExam1.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2021/03/17				./data/phs002226.v1.pht011064.v1.p1.MACS_Sample.var_report.xml									phs002226.v1.p1	HIV
25.0			2019/11/08	40.0			./data/phs001330.v2.pht007532.v2.p1.demographics.var_report.xml	0.0			15.0					phs001330.v2.p1	Mucopolysaccharidosis III
81.0	97.0		2020/03/09	92.0		75.0	./data/phs001491.v2.pht007254.v2.p1.CIDR_Tooth_Disorders_Subject_Phenotypes.var_report.xml	0.0	88.0	9.192	97.0			88.0		phs001491.v2.p1	Amelogenesis Imperfecta
			2018/12/14				./data/phs001439.v1.pht006814.v1.p1.POP_Subject.var_report.xml									phs001439.v1.p1	Pelvic Organ Prolapse
			2018/02/27				./data/phs001206.v1.pht007342.v1.p1.BSP_AA_Subject.var_report.xml									phs001206.v1.p1	Blepharospasm
			2019/07/29				./data/phs001855.v1.pht009250.v1.p1.STRRIDE_Sample_Attributes.var_report.xml									phs001855.v1.p1	Exercise
72.0	72.0		2018/04/30	144.0		72.0	./data/phs001555.v1.pht007880.v1.p1.LDN6709.var_report.xml	0.0	72.0	0	72.0			72.0		phs001555.v1.p1	Pompe Disease
			2020/12/21				./data/phs000007.v32.pht000165.v7.p13.mcp11_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/05				./data/phs001304.v1.pht008314.v1.p1.BPV_Subject_Phenotypes.var_report.xml									phs001304.v1.p1	Carcinoma, Renal Cell
3910.0	3910.0		2019/03/05	4777.0		867.0	./data/phs001788.v1.pht008815.v1.p1.CNICS_Pedigree.var_report.xml	0.0	2389.0	2153	867.0			2389.0		phs001788.v1.p1	HIV Infections
			2021/01/12				./data/phs001617.v1.pht010621.v1.p1.Growth_Disorders_Sample_Attributes.var_report.xml									phs001617.v1.p1	Growth Disorders
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000444.v2.p3.simphen045.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/02/08				./data/phs002335.v1.pht010941.v1.p1.CLL_Sample.var_report.xml									phs002335.v1.p1	Leukemia
680.0	981.0		2021/06/08	549.0		680.0	./data/phs001215.v4.pht008629.v2.p2.TOPMed_WGS_SAFHS_Pedigree.var_report.xml	0.0	830.5	82.73	981.0			830.5		phs001215.v4.p2	Cardiovascular Diseases
			2020/01/07				./data/phs001953.v1.pht009771.v1.p1.UM_AEB071_Subject.var_report.xml									phs001953.v1.p1	Uveal Neoplasms
			Fri Feb 20 11:36:16 2009				./data/phs000160.v1.pht000735.v1.p1.LOAD6k_Sample.var_report_2009_02_20.xml									phs000160.v1.p1	Alzheimer Disease
			2021/02/24				./data/phs002342.v1.pht011003.v1.p1.Polyepitope_Neoantigen_DNA_Vaccines_Subject_Phenotypes.var_report.xml									phs002342.v1.p1	Carcinoma, Neuroendocrine
			05/24/2017				./data/phs000576.v1.pht006150.v1.p1.familyqolandpsidatasheet.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			02/23/2017				./data/phs001253.v1.pht006163.v1.p1.Efavirenz_CNS_Symptoms_Subject.var_report.xml									phs001253.v1.p1	Central Nervous System Diseases
55.0	146.0		11/04/2014	274.0		128.0	./data/phs000086.v3.pht000257.v1.p1.DCCT_ms5event.var_report.xml	0.0	137.0	12.73	50.0			137.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/10/15				./data/phs000256.v4.pht001237.v4.p3.HMP_Vaginal_Microbiome_Subject.var_report.xml									phs000256.v4.p3	Microbiomes, Human
			10/19/2011				./data/phs000309.v2.pht001998.v2.p2.CARDIA_Sample.var_report.xml									phs000309.v2.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000456.v2.p3.simphen057.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/10/07				./data/phs001351.v1.pht009412.v1.p1.Inherited_Neuropathy_Sample_Attributes.var_report.xml									phs001351.v1.p1	Inherited Peripheral Neuropathy
			2021/07/08				./data/phs001543.v2.pht009911.v1.p1.AFLMU_Subject.var_report.xml									phs001543.v2.p1	Atrial Fibrillation
			2020/12/21				./data/phs000007.v32.pht003905.v6.p13.vr_mrbdates_2019_a_1228s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/10/01				./data/phs001416.v2.pht009013.v1.p1.TOPMed_WGS_MESA_Subject.var_report.xml									phs001416.v2.p1	Cardiovascular Diseases
			2019/03/18				./data/phs001585.v1.pht008831.v1.p1.FALS_Sample_Attributes.var_report.xml									phs001585.v1.p1	Amyotrophic Lateral Sclerosis
			03/29/2017				./data/phs001191.v1.pht006227.v1.p1.eMERGE_NUgene_WGS_Sample_Attributes.var_report.xml									phs001191.v1.p1	Healthy Volunteers
45.0	47.0		2020/11/13	92.0		45.0	./data/phs001584.v2.pht009216.v2.p2.eMERGE_III_HRC_Pedigree.var_report.xml	0.0	46.0	1.414	47.0			46.0		phs001584.v2.p2	
			2017/10/04				./data/phs000782.v1.pht003991.v1.p1.MedImmune_RHCCS_Sample.var_report.xml									phs000782.v1.p1	Carcinoma, Hepatocellular
5431.0			2020/04/24	9201.0			./data/phs001676.v1.pht009436.v1.p1.CCDG_Autism_SSC_Pedigree.var_report.xml	0.0			3770.0					phs001676.v1.p1	Autism Spectrum Disorder
			08/15/2016				./data/phs000473.v2.pht002601.v2.p2.Schizophrenia_Swedish_Sample_Attributes.var_report.xml									phs000473.v2.p2	Schizophrenia
			2019/09/20				./data/phs001436.v1.pht007248.v1.p1.GMKF_NBL_Subject.var_report.xml									phs001436.v1.p1	Neuroblastoma
			2020/06/18				./data/phs000280.v7.pht004137.v2.p1.NUTV2.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006441.v1.p1.HIS.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
718.0	784.0		08/09/2013	704.0		718.0	./data/phs000367.v1.pht003261.v1.p1.IBDGC_Familial_Crohns_Disease_Pedigree.var_report.xml	0.0	751.0	46.67	784.0			751.0		phs000367.v1.p1	Crohn Disease
			11/08/2013				./data/phs000200.v9.pht002770.v2.p3.outc_self_ct_os_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
7.0	9.0		2019/01/07	2.0		7.0	./data/phs001733.v1.pht008616.v1.p1.Early_Onset_PTD_Pedigree.var_report.xml	0.0	8.5	2.121	9.0			8.5		phs001733.v1.p1	Dystonia
			12/16/2013				./data/phs000633.v1.pht003626.v1.p1.Lung_Microbiome_Inflammation_Sample_Attributes.var_report.xml									phs000633.v1.p1	Pneumonia
			2021/01/15				./data/phs002240.v1.pht010864.v1.p1.Sex_Differences_Placentas_Subject_Phenotypes.var_report.xml									phs002240.v1.p1	Birth Weight
7.0	7.0		06/20/2012	6.0		4.0	./data/phs000455.v1.pht002575.v1.p1.Developmental_Brain_Disorders_Pedigree.var_report.xml	0.0	5.0	2.828	3.0			5.0		phs000455.v1.p1	Brain Diseases
			2020/04/24				./data/phs001676.v1.pht009435.v1.p1.CCDG_Autism_SSC_Subject.var_report.xml									phs001676.v1.p1	Autism Spectrum Disorder
			2020/02/27				./data/phs000452.v3.pht002590.v3.p1.MelanomaCIP_Sample.var_report.xml									phs000452.v3.p1	Melanoma
			08/12/2016				./data/phs000888.v1.pht005558.v1.p1.07aAsthma_hx_labs.var_report.xml									phs000888.v1.p1	
			Wed Nov 26 07:45:16 2008				./data/phs000017.v3.pht000292.v1.p1.EA_GAIN_phenotype_controls_questionnaire_subset.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2019/02/21				./data/phs001281.v2.pht006127.v2.p1.eeg.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			04/04/2014				./data/phs000734.v1.pht003772.v1.p1.Osteosarcoma_Risk_Sample_Attributes.var_report.xml									phs000734.v1.p1	Osteosarcoma
			2019/10/07				./data/phs001854.v1.pht009251.v1.p1.BRAF_PA_Subject.var_report.xml									phs001854.v1.p1	Astrocytoma
			2021/07/02				./data/phs001782.v2.pht008799.v2.p1.LOI_Stunting_Malian_Sample.var_report.xml									phs001782.v2.p1	Growth
			2021/05/17				./data/phs002383.v1.pht011233.v1.p1.Walk_PhaSST_Subject.var_report.xml									phs002383.v1.p1	Sickle Cell Anemia
			10/24/2013				./data/phs000618.v1.pht003302.v1.p1.Hypertriglyceridemia_Mexican_Sample.var_report.xml									phs000618.v1.p1	Hypertriglyceridemia
			2020/12/21				./data/phs000007.v32.pht001039.v5.p13.l_cortisol_ex06_1b_0495s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/11/27				./data/phs000510.v1.pht010696.v1.p1.SOF_Sample.var_report.xml									phs000510.v1.p1	Osteoporosis
			2020/12/21				./data/phs000007.v32.pht003310.v5.p13.t_echocs_ex08_1_0705s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/16				./data/phs001800.v2.pht008926.v2.p1.Pediatric_RMC_Sample.var_report.xml									phs001800.v2.p1	SMARCB1 Protein
2.0			2021/02/02	4.0			./data/phs002204.v1.pht010909.v1.p1.cCREs_Subject_Phenotypes.var_report.xml	0.0			2.0					phs002204.v1.p1	Heart
			08/20/2013				./data/phs000285.v3.pht001791.v2.p2.E1F48.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/24/2017				./data/phs001336.v1.pht006204.v1.p1.ECLS_HCT_GVHD_Subject.var_report.xml									phs001336.v1.p1	Bone Marrow Transplantation
			11/04/2014				./data/phs000086.v3.pht000219.v1.p1.DCCT_cbl6.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			08/09/2016				./data/phs001096.v1.pht005607.v1.p1.T2D_GENES_KARE_East_Asian_Sample.var_report.xml									phs001096.v1.p1	Diabetes Mellitus, Type 2
			05/05/2015	2576.0			./data/phs000147.v3.pht000663.v3.p1.CGEMS_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0			2576.0					phs000147.v3.p1	Breast Neoplasms
			2018/02/27				./data/phs001364.v1.pht007465.v1.p1.HCP_Young_Adults_Sample.var_report.xml									phs001364.v1.p1	Connectome
			03/11/2015				./data/phs000691.v2.pht003652.v2.p1.Sickle_Cell_CIP_Sample.var_report.xml									phs000691.v2.p1	Anemia, Sickle Cell
			2020/12/21				./data/phs000007.v32.pht000082.v8.p13.crp1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
7.0	7.0		05/16/2013	12.0		5.0	./data/phs000582.v1.pht003244.v1.p1.ESP_FamilialInterstitialPneumonia_Subject_Phenotypes.var_report.xml	0.0	6.0	1.414	5.0			6.0		phs000582.v1.p1	Idiopathic Pulmonary Fibrosis
			2020/12/21				./data/phs000007.v32.pht005158.v3.p13.t_ctperfat_2011_m_0671s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/21/2015				./data/phs000789.v1.pht004292.v1.p1.CSGNM_Sample_Attributes.var_report.xml									phs000789.v1.p1	
			2020/12/21				./data/phs000007.v32.pht001177.v10.p13.fhorm_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/25				./data/phs000771.v2.pht003981.v2.p1.Bladder_Cancer_Chemotherapy_Response_Subject.var_report.xml									phs000771.v2.p1	Urinary Bladder Neoplasms
			2019/03/25				./data/phs001777.v1.pht008858.v1.p1.SCO_Syndrome_Sample_Attributes.var_report.xml									phs001777.v1.p1	Sertoli Cell-Only Syndrome
			2019/06/14				./data/phs000589.v1.pht009170.v1.p1.VCRC_5503_Subject.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2018/01/04				./data/phs001503.v1.pht007317.v1.p1.WIHS_Sample_Attributes.var_report.xml									phs001503.v1.p1	HIV
			2019/01/30				./data/phs001495.v2.pht007195.v1.p1.DAXX_ALT_Subject.var_report.xml									phs001495.v2.p1	Osteosarcoma
			01/25/2016				./data/phs001058.v1.pht005235.v1.p1.MIGen_BioImage_Subject.var_report.xml									phs001058.v1.p1	Myocardial Infarction
			2017/12/20				./data/phs000577.v1.pht007282.v1.p1.p5101_16897_familyhis.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2020/06/18				./data/phs000280.v7.pht004133.v2.p1.MSRCOD26.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/01/02				./data/phs001895.v2.pht009445.v2.p1.Lung_Cancer_EA_AA_Sample_Attributes.var_report.xml									phs001895.v2.p1	Lung Neoplasms
			2020/06/18				./data/phs000280.v7.pht006459.v1.p1.NSS.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010366.v1.p1.AREDS2_BLD.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2018/03/26				./data/phs000697.v1.pht007698.v1.p1.treatmenttable.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2021/04/16				./data/phs002398.v1.pht011126.v1.p1.PrCa_Sample_Attributes.var_report.xml									phs002398.v1.p1	Prostatic Neoplasms
7.0	7.0		2020/01/07	7.0		7.0	./data/phs001941.v1.pht009744.v1.p1.Otitis_Media_Subject_Phenotypes.var_report.xml	0.0	7.0					7.0		phs001941.v1.p1	Otitis Media
			2019/06/03				./data/phs001292.v2.pht007853.v2.p1.pediatric_daytime_sleepiness.var_report.xml									phs001292.v2.p1	Angelman Syndrome
1.0	1.0		2021/03/18	2.0		1.0	./data/phs002361.v1.pht011069.v1.p1.Pneumococcal_Vaccines_Elderly_Subject_Phenotypes.var_report.xml	0.0	1.0	0	1.0			1.0		phs002361.v1.p1	
			2020/06/18				./data/phs000280.v7.pht006445.v1.p1.MME.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht005163.v3.p13.t_ctthrtac_2011_m_0683s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
5.0	10.0		2019/03/28	15.0		5.0	./data/phs001346.v1.pht006256.v1.p1.CPS_Immunization_P_Falciparum_Subject_Phenotypes.var_report.xml	0.0	7.5	3.536	10.0			7.5		phs001346.v1.p1	Malaria
			2020/11/13				./data/phs001584.v2.pht009070.v2.p2.eMERGE_III_HRC_Sample.var_report.xml									phs001584.v2.p2	
			2019/11/08				./data/phs001332.v2.pht007454.v2.p1.registration.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2019/10/11				./data/phs001406.v1.pht007750.v1.p1.sleep_times_ds.var_report.xml									phs001406.v1.p1	Cognition
			2018/02/27				./data/phs001469.v1.pht007167.v1.p1.DM_Anti_PD1_Subject.var_report.xml									phs001469.v1.p1	Immunotherapy
			2019/06/07				./data/phs001340.v1.pht009154.v1.p1.RA_Subject.var_report.xml									phs001340.v1.p1	Arthritis, Rheumatoid
			2020/07/07				./data/phs002051.v1.pht010313.v1.p1.RMS_PDX_Sample_Attributes.var_report.xml									phs002051.v1.p1	Rhabdomyosarcoma
			2020/02/06				./data/phs001430.v2.pht008087.v2.p1.p7001_18432_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			07/26/2016				./data/phs000916.v1.pht004735.v1.p1.MIGen_Exome_Munich_MI_Sample.var_report.xml									phs000916.v1.p1	Coronary Artery Disease
			2019/03/27				./data/phs001670.v1.pht008882.v1.p1.DeKAF_Tac_AA_EA_SRA.var_report.xml									phs001670.v1.p1	Tacrolimus
			2017/10/19				./data/phs001288.v1.pht006783.v1.p1.registration.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2020/06/26				./data/phs001630.v1.pht008171.v1.p1.Measles_Immunity_Sample.var_report.xml									phs001630.v1.p1	Measles Vaccine
			04/14/2014				./data/phs000370.v2.pht002381.v1.p1.Head_Neck_Squamous_Cell_Carcinoma_Subject.var_report.xml									phs000370.v2.p1	Head and Neck Neoplasms
599.0	599.0		05/09/2016	539.0		482.0	./data/phs001101.v1.pht005367.v1.p1.MIGen_MDC_Subject_Phenotypes.var_report.xml	0.0	540.5	82.73	482.0			540.5		phs001101.v1.p1	Myocardial Infarction
			2017/12/04				./data/phs000906.v1.pht007147.v1.p1.ECG.var_report.xml									phs000906.v1.p1	Pharmacogenetics
			2019/09/16				./data/phs000979.v3.pht005194.v3.p2.HBCC_Postmortem_Psychiatric_Sample.var_report.xml									phs000979.v3.p2	Schizophrenia
1240.0	1240.0		2019/09/16	2095.0		855.0	./data/phs001718.v1.pht009426.v1.p1.C9ORF72_Subject_Phenotypes.var_report.xml	0.0	1048.0	272.2	855.0			1048.0		phs001718.v1.p1	Amyotrophic Lateral Sclerosis
3.0	6.0		01/13/2016	9.0		3.0	./data/phs000928.v1.pht004939.v1.p1.LGG_Probiotics_Transcriptome_Subject_Phenotypes.var_report.xml	2.0	4.5	2.121	6.0			4.5		phs000928.v1.p1	Volunteers, Human
	1.0		2017/11/07	1.0		1.0	./data/phs001461.v1.pht007121.v1.p1.Pediatric_Ependymoma_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs001461.v1.p1	Ependymoma
			02/09/2011				./data/phs000330.v1.pht002126.v1.p1.Prostate_Cancer_Characterization_Sample_Attributes.var_report_2011_02_09.xml									phs000330.v1.p1	Prostatic Neoplasms
			2018/11/05				./data/phs001690.v1.pht008366.v1.p1.EC_SCNA_Sample.var_report.xml									phs001690.v1.p1	Endometrial Neoplasms
28.0	28.0		05/24/2016	44.0		16.0	./data/phs001065.v1.pht005404.v1.p1.deaths.var_report.xml	0.0	22.0	8.485	16.0			22.0		phs001065.v1.p1	Huntington Disease
			2020/03/19				./data/phs001970.v1.pht010022.v1.p1.DNAMethylation_RMS_Sample.var_report.xml									phs001970.v1.p1	Rhabdomyosarcoma
			2017/12/12				./data/phs001405.v1.pht006829.v1.p1.GSK1120212_TNBC_Kinome_Sample_Attributes.var_report.xml									phs001405.v1.p1	Triple Negative Breast Neoplasms
			08/27/2013				./data/phs000647.v1.pht003472.v1.p1.Hypoxia_Tolerance_Ethiopian_Highlanders_Sample_Attributes.var_report.xml									phs000647.v1.p1	Cell Hypoxia
91.0	109.0		07/14/2014	200.0		91.0	./data/phs000708.v1.pht003727.v1.p1.POAT_GEDWR_Subject_Phenotypes.var_report.xml	0.0	100.0	12.73	109.0			100.0		phs000708.v1.p1	Thromboembolism
			08/20/2013				./data/phs000285.v3.pht001760.v2.p2.E1F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/08/27				./data/phs000966.v2.pht005307.v2.p2.Essential_Tremor_FASET_Subject_Phenotypes.var_report.xml									phs000966.v2.p2	Essential Tremor
			02/18/2016				./data/phs001057.v1.pht005303.v1.p1.Smallpox_Vaccine_Immune_Response_Sample_Attributes.var_report.xml									phs001057.v1.p1	Smallpox Vaccine
			2020/10/02				./data/phs002244.v1.pht010553.v1.p1.NSCLC_Pembrolizumab_Sample_Attributes.var_report.xml									phs002244.v1.p1	Carcinoma, Non-Small-Cell Lung
			12/11/2012				./data/phs000383.v1.pht002869.v1.p1.ROOT_Breast_Cancer_Sample.var_report.xml									phs000383.v1.p1	Breast Neoplasms
			05/02/2011				./data/phs000311.v1.pht002130.v1.p1.FusionSeq_Sample_Attributes.var_report.xml									phs000311.v1.p1	Prostatic Neoplasms
			01/26/2015				./data/phs000856.v1.pht004458.v1.p1.Chromothripsis_WHIM_Sample_Attributes.var_report.xml									phs000856.v1.p1	WHIM syndrome
98.0	101.0		2018/06/18	199.0		98.0	./data/phs001586.v1.pht008150.v1.p1.RICHS_Subject_Phenotypes.var_report.xml	0.0	99.5	2.121	101.0			99.5		phs001586.v1.p1	Child Health
13.0			2020/02/06	25.0			./data/phs001430.v2.pht008084.v2.p1.demographics.var_report.xml	0.0			12.0					phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2020/11/24				./data/phs001052.v2.pht005467.v2.p1.Pediatric_Solid_Tumors_Sample.var_report.xml									phs001052.v2.p1	Neoplasms
			09/03/2013				./data/phs000652.v1.pht003455.v1.p1.GliomaScan_Subject.var_report.xml									phs000652.v1.p1	Glioma
3.0	8.0		2020/09/17	6.0		3.0	./data/phs002222.v1.pht010525.v1.p1.Tcells_CNS_Subject.var_report.xml	0.0	5.5	3.536	8.0			5.5		phs002222.v1.p1	Multiple Sclerosis
			2019/12/10				./data/phs001913.v1.pht009515.v1.p1.CCDG_eMERGE_Northwestern_Sample_Attributes.var_report.xml									phs001913.v1.p1	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005429.v1.p1.tobuse.var_report.xml									phs001065.v1.p1	Huntington Disease
			02/27/2017				./data/phs001226.v1.pht006168.v1.p1.Embryonic_Development_Subject.var_report.xml									phs001226.v1.p1	Embryonic Development
			01/26/2015				./data/phs000807.v1.pht004389.v1.p1.CALGB40101_Early_Breast_Cancer_Sample_Attributes.var_report.xml									phs000807.v1.p1	Breast Neoplasms
			2018/06/01				./data/phs001046.v1.pht005293.v1.p1.AMD_Progression_Treatment_Response_Subject.var_report.xml									phs001046.v1.p1	Macular Degeneration
			2020/07/29				./data/phs001290.v1.pht010333.v1.p1.CIDR_CRC_Survival_Sample.var_report.xml									phs001290.v1.p1	Colorectal Neoplasms
			2018/04/09				./data/phs001483.v1.pht007306.v1.p1.DRIVE_BC_WGS_Sample.var_report.xml									phs001483.v1.p1	Breast Neoplasms
			2019/11/08				./data/phs001332.v2.pht007457.v2.p1.p7301_12573_patientgl.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			07/05/2017				./data/phs000595.v1.pht006628.v1.p1.MCC_5902_Subject.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2021/04/06				./data/phs002389.v1.pht011093.v1.p1.HTN_microRNAs_Subject_Phenotypes.var_report.xml									phs002389.v1.p1	Hypertension
			2019/05/07				./data/phs001329.v2.pht007177.v2.p1.eligibility.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/12/21				./data/phs000007.v32.pht000201.v2.p13.knee0_18s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/21				./data/phs001282.v2.pht006097.v2.p1.Endemic_Burkitt_Lymphoma_Sample.var_report.xml									phs001282.v2.p1	Burkitt Lymphoma
			12/11/2012				./data/phs000383.v1.pht002871.v1.p1.ROOT_Breast_Cancer_Sample_Attributes.var_report.xml									phs000383.v1.p1	Breast Neoplasms
			2018/05/22				./data/phs001314.v1.pht007999.v1.p1.eligibilityform.var_report.xml									phs001314.v1.p1	Steroid 21-Hydroxylase
1685.0	5817.0		05/16/2017	9467.0		3650.0	./data/phs001252.v1.pht006388.v1.p1.mmrccd.var_report.xml	0.0	4734.0	1532	1053.0			4734.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			04/25/2016				./data/phs000474.v3.pht002694.v3.p2.Human_Hematopoiesis_Genetics_Sample.var_report.xml									phs000474.v3.p2	Anemia, Dyserythropoietic, Congenital
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000533.v2.p3.simphen134.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/20/2013				./data/phs000285.v3.pht001761.v2.p2.E1F08.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/06/2016				./data/phs001193.v1.pht005974.v1.p1.Colorectal_Cancer_Hispanic_Sample.var_report.xml									phs001193.v1.p1	Colorectal Neoplasms
			04/07/2017				./data/phs001174.v1.pht006243.v1.p1.Primary_Ovarian_Insufficiency_Sample_Attributes.var_report.xml									phs001174.v1.p1	Infertility, Female
			04/07/2017	98.0			./data/phs001174.v1.pht006242.v1.p1.Primary_Ovarian_Insufficiency_Subject_Phenotypes.var_report.xml	0.0			98.0					phs001174.v1.p1	Infertility, Female
			12/06/2016				./data/phs001203.v1.pht005967.v1.p1.STARNET_Sample_Attributes.var_report.xml									phs001203.v1.p1	Coronary Artery Disease
			2019/11/22				./data/phs001325.v3.pht006349.v1.p1.iPSCORE_WGS_Subject.var_report.xml									phs001325.v3.p1	Heart Diseases
			2018/09/07				./data/phs001502.v1.pht007261.v1.p1.CCDG_UPenn_EOCAD_Sample_Attributes.var_report.xml									phs001502.v1.p1	Cardiovascular Diseases
570.0		2.0	05/13/2014	5953.0	2.0		./data/phs000678.v1.pht003563.v1.p1.Young_Onset_Breast_Cancer_Pedigree.var_report.xml	0.0		0.4348	525.0	2.0			2.0	phs000678.v1.p1	Breast Neoplasms
9.0	3.0		01/23/2017	5.0		9.0	./data/phs001246.v1.pht006083.v1.p1.Arhinia_Pedigree.var_report.xml	0.0	9.5	4.95	2.0			9.5		phs001246.v1.p1	Arhinia, choanal atresia, and microphthalmia
			2020/12/21				./data/phs000007.v32.pht000293.v7.p13.hsa1_7_0708s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000342.v1.p1.EDIC_f0903.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht002430.v4.p13.t_quadstr_ex02_3_0643s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/29				./data/phs001608.v2.pht009734.v1.p1.TOPMed_WGS_OMG_SCD_Sample.var_report.xml									phs001608.v2.p1	Anemia, Sickle Cell
			2019/01/07				./data/phs001733.v1.pht008615.v1.p1.Early_Onset_PTD_Subject.var_report.xml									phs001733.v1.p1	Dystonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000571.v2.p3.simphen172.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004131.v2.p1.MSRC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/14				./data/phs001238.v2.pht006649.v1.p1.GENOA_EuropeanAmerican_CKD_Exam.var_report.xml									phs001238.v2.p1	Hypertension
28.0			2018/03/26	34.0			./data/phs000697.v1.pht007695.v1.p1.demographicinformation.var_report.xml	0.0			6.0					phs000697.v1.p1	Myelodysplastic Syndromes
			09/29/2016				./data/phs001216.v1.pht005785.v1.p1.Asthma_Puerto_Rican_Children_Subject.var_report.xml									phs001216.v1.p1	Asthma
			01/07/2014				./data/phs000611.v1.pht003501.v1.p1.Breast_Cancer_Xenotransplants_Sample.var_report.xml									phs000611.v1.p1	Breast Neoplasms
			2018/06/14				./data/phs001238.v2.pht006049.v1.p1.GENOA_AfricanAmerican_Phase2_Medications.var_report.xml									phs001238.v2.p1	Hypertension
331.0	331.0		2018/08/19	514.0		68.0	./data/phs001647.v1.pht008199.v1.p1.Impulsivity_Addiction_Pedigree.var_report.xml	0.0	98.5	77.07	68.0			98.5		phs001647.v1.p1	Impulsive Behavior
			2018/04/20				./data/phs001231.v2.pht006180.v2.p1.NeuroLINCS_ALS_SMA_Sample.var_report.xml									phs001231.v2.p1	Amyotrophic Lateral Sclerosis
			07/01/2016				./data/phs001095.v1.pht005621.v1.p1.T2D_GENES_Ashkenazi_Sample_Attributes.var_report.xml									phs001095.v1.p1	Diabetes Mellitus, Type 2
			06/01/2017				./data/phs001306.v1.pht006189.v1.p1.Psoriasis_Associated_Variants_Subject_Phenotypes.var_report.xml									phs001306.v1.p1	Psoriasis
			08/20/2013				./data/phs000285.v3.pht001814.v2.p2.F1F09MED.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			06/27/2017				./data/phs001389.v1.pht006604.v1.p1.GBM_Tumors_Sample_Attributes.var_report.xml									phs001389.v1.p1	Glioblastoma
			2018/04/09				./data/phs001483.v1.pht007307.v1.p1.DRIVE_BC_WGS_Subject_Phenotypes.var_report.xml									phs001483.v1.p1	Breast Neoplasms
			2019/07/25				./data/phs001864.v1.pht009263.v1.p1.MAPK_HCL_SH_Subject.var_report.xml									phs001864.v1.p1	histiocytosis
			2020/06/10				./data/phs001169.v2.pht006186.v2.p1.EAGLE_Lung_Adenocarcinoma_Sample_Attributes.var_report.xml									phs001169.v2.p1	Adenocarcinoma of lung
			08/20/2013				./data/phs000285.v3.pht001738.v2.p2.D1HCY.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			10/31/2014				./data/phs000543.v1.pht002937.v1.p1.PPB_Sample.var_report.xml									phs000543.v1.p1	Pleuropulmonary blastoma [Supplementary Concept]
			08/11/2015				./data/phs000941.v1.pht004903.v1.p1.Melanoma_Metastasis_Sample_Attributes.var_report.xml									phs000941.v1.p1	Melanoma
			2021/07/15				./data/phs001600.v2.pht011020.v2.p2.TOPMed_CCDG_CATHGEN_Sample.var_report.xml									phs001600.v2.p2	Atrial Fibrillation
8.0	8.0		2020/04/29	16.0		8.0	./data/phs000185.v7.pht003281.v3.p1.Hutterites_16WGS_Subject_Phenotypes.var_report.xml	0.0	8.0	0	8.0			8.0		phs000185.v7.p1	Prospective
			03/07/2016				./data/phs000961.v1.pht005332.v1.p1.eMERGE_III_Columbia_GENIE_Subject_Phenotypes.var_report.xml									phs000961.v1.p1	
			11/06/2015				./data/phs001025.v1.pht005084.v1.p1.SLE_Amerindian_Hispanics_Sample.var_report.xml									phs001025.v1.p1	Lupus Erythematosus, Systemic
			12/11/2009				./data/phs000171.v1.pht000750.v1.p1.MS_DATA_CONSENT.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2019/01/31				./data/phs001712.v1.pht008674.v1.p1.baseline_medical_history.var_report.xml									phs001712.v1.p1	Vasculitis
			2017/11/06				./data/phs001391.v1.pht007079.v1.p1.OncoArray_Prostate_Cancer_Sample.var_report.xml									phs001391.v1.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht001183.v3.p13.vr_fxrev_2012_0_0746s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004040.v3.p1.ATRFIB41.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000824.v7.p13.foapain_2001s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht009757.v2.p13.l_tau_2011_a_1022s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001725.v2.p2.D1F46.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/10/2016				./data/phs000952.v1.pht005317.v1.p1.Substance_Dependence_EA_AA_Subject.var_report.xml									phs000952.v1.p1	Substance-Related Disorders
			11/22/2013				./data/phs000251.v2.pht001260.v2.p2.HMP_Cutaneous_Psoriasis_Subject.var_report.xml									phs000251.v2.p2	Psoriasis
			2019/06/14				./data/phs000589.v1.pht009185.v1.p1.death_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/25/2013				./data/phs000682.v1.pht003596.v1.p1.Neuropsychiatric_Neurodevelopmental_Disorders_Sample.var_report.xml									phs000682.v1.p1	Psychiatry and Psychology Category
			2020/12/21				./data/phs000007.v32.pht000670.v7.p13.l_epc_2007_m_0041s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/03				./data/phs001961.v1.pht011027.v1.p1.LungMAP_Subject.var_report.xml									phs001961.v1.p1	Lung
			2017/09/08				./data/phs001105.v1.pht006839.v1.p1.Aggressive_Prostate_Tumors_Sample_Attributes.var_report.xml									phs001105.v1.p1	Prostatic Neoplasms
			2019/07/26				./data/phs000588.v1.pht009304.v1.p1.lvvid_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
930.0	930.0		2020/02/19	930.0		930.0	./data/phs001221.v1.pht007158.v1.p1.Prostate_Cancer_GWAS_Pedigree.var_report.xml	0.0	930.0	478.7	461.0			930.0		phs001221.v1.p1	Prostatic Neoplasms
			08/23/2011				./data/phs000290.v1.pht002274.v1.p1.PAH_Subject.var_report.xml									phs000290.v1.p1	Hypertension, Pulmonary
			2019/09/06				./data/phs001885.v1.pht009429.v1.p1.ECAC_European_Sample.var_report.xml									phs001885.v1.p1	Endometrial Neoplasms
			10/16/2014				./data/phs000713.v1.pht004272.v1.p1.GDNF_Anxiety_Depression_Sample.var_report.xml									phs000713.v1.p1	Anxiety
			2020/12/21				./data/phs000007.v32.pht001041.v8.p13.l_mhorm_2005_m_0490s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/10/02				./data/phs001696.v1.pht008432.v1.p1.EAC_Chinese_Sample_Attributes.var_report.xml									phs001696.v1.p1	Esophageal Neoplasms
			02/10/2014				./data/phs000689.v1.pht003679.v1.p1.Peripheral_T_Cell_Lymphomas_Subject.var_report.xml									phs000689.v1.p1	Lymphoma, T-Cell, Peripheral
			06/28/2013				./data/phs000563.v1.pht003085.v1.p1.NF1_Pilocytic_Astrocytoma_Sample_Attributes.var_report.xml									phs000563.v1.p1	Pilocytic Astrocytoma
			07/12/2017				./data/phs000592.v1.pht006581.v1.p1.bmaspirationflowcytometry.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			11/21/2016				./data/phs001233.v1.pht005946.v1.p1.Familial_Dysautonomia_Sample_Attributes.var_report.xml									phs001233.v1.p1	Dysautonomia, Familial
			2020/06/10				./data/phs002037.v1.pht010265.v1.p1.Mg_Deficiency_CRC_Subject.var_report.xml									phs002037.v1.p1	Magnesium Deficiency
			2020/08/26				./data/phs000998.v2.pht005055.v2.p1.iPSC_Pulmonary_Hypertension_Sample.var_report.xml									phs000998.v2.p1	Pulmonary Arterial Hypertension
			2021/09/14				./data/phs002410.v1.pht011553.v1.p1.final_CAMP_CData.var_report.xml									phs002410.v1.p1	Heart Failure
			2019/02/05				./data/phs001158.v2.pht005593.v2.p1.Human_Dorsal_Root_Ganglion_Sample.var_report.xml									phs001158.v2.p1	Chronic Pain
			2019/03/11				./data/phs000286.v6.pht008779.v1.p2.rdfa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/08/01				./data/phs000222.v6.pht002873.v3.p2.Demographic_Genetics.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/11/02				./data/phs002130.v1.pht010595.v1.p1.GMKF_CFM_Sample.var_report.xml									phs002130.v1.p1	
			2020/11/27				./data/phs002237.v1.pht010692.v1.p1.MMBIR_CGR_Sample.var_report.xml									phs002237.v1.p1	Adenocarcinoma of Lung
			2018/04/09				./data/phs001483.v1.pht007305.v1.p1.DRIVE_BC_WGS_Subject.var_report.xml									phs001483.v1.p1	Breast Neoplasms
			2018/10/11				./data/phs001234.v1.pht006617.v1.p1.ER_Positive_Breast_Tumors_Tamoxifen_Subject.var_report.xml									phs001234.v1.p1	Breast Neoplasms
			03/26/2015				./data/phs000761.v1.pht004498.v1.p1.OPPERA_Subject_Phenotypes.var_report.xml									phs000761.v1.p1	Temporomandibular Joint Disorders
			08/20/2013				./data/phs000285.v3.pht001614.v2.p2.B2F09MHT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/23/2014				./data/phs000703.v1.pht003668.v1.p1.5a_dbGaP_CATHGEN_Cohort_Subject.var_report.xml									phs000703.v1.p1	Coronary Disease
			2020/03/13				./data/phs000521.v2.pht007042.v2.p1.eligibility.var_report.xml									phs000521.v2.p1	Ataxia
	923.0		07/14/2014	747.0		57.0	./data/phs000714.v1.pht003752.v1.p1.Spontaneous_Preterm_Birth_Subject_Phenotypes.var_report.xml	5.0	369.0	398.9				248.0		phs000714.v1.p1	Premature Birth
			05/02/2017				./data/phs001358.v1.pht006333.v1.p1.RareBliss_Subject.var_report.xml									phs001358.v1.p1	Bipolar Disorder
			2019/03/01				./data/phs001775.v1.pht008810.v1.p1.Multiplex_AD_Families_Sample_Attributes.var_report.xml									phs001775.v1.p1	Alcoholism
21.0			2020/01/10	50.0			./data/phs000791.v2.pht004593.v1.p1.Roadmap_Epigenomics_UCSF_Subject_Phenotypes.var_report.xml	0.0			23.0					phs000791.v2.p1	Neoplasms
			2021/08/19				./data/phs001662.v2.pht010070.v1.p1.LTRC_R040_subject_occu_expo_quest.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			05/26/2016				./data/phs001107.v1.pht005488.v1.p1.VHL_Renal_Tumors_Subject.var_report.xml									phs001107.v1.p1	von Hippel-Lindau Disease
			2019/06/24				./data/phs001784.v1.pht009000.v1.p1.HCC_Imaging_Subject.var_report.xml									phs001784.v1.p1	Carcinoma, Hepatocellular
			2020/07/14				./data/phs001816.v1.pht009124.v1.p1.ASD_CRISPR_Subject.var_report.xml									phs001816.v1.p1	Autism Spectrum Disorder
18.0			06/25/2013	46.0			./data/phs000354.v1.pht003347.v1.p1.ESP_Family_Studies_PAH_Pedigree.var_report.xml	0.0			28.0					phs000354.v1.p1	Hypertension, Pulmonary
			2019/03/11				./data/phs000286.v6.pht008748.v1.p2.fsta.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004083.v2.p1.ESMA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/21/2010				./data/phs000261.v1.pht001229.v1.p1.HMP_Bacterial_Vaginosis_Subject.var_report.xml									phs000261.v1.p1	Vaginosis, Bacterial
			2020/01/10				./data/phs001471.v1.pht009801.v1.p1.HHL_Sample.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
35.0			2018/05/15	61.0			./data/phs001311.v1.pht007935.v1.p1.demographics_form.var_report.xml	0.0			26.0					phs001311.v1.p1	Myotonia
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000412.v2.p3.simphen013.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/12/2016				./data/phs000888.v1.pht005555.v1.p1.04aADHD_hx_visits.var_report.xml									phs000888.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000608.v3.p13.t_mrcdwma_2006_1b_0909s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/08/25				./data/phs001728.v2.pht010123.v1.p1.TOPMed_WGS_CARE_BADGER_Sample.var_report.xml									phs001728.v2.p1	Asthma
			2021/05/21				./data/phs001062.v5.pht005261.v3.p2.TOPMed_WGS_MGH_AF_Subject.var_report.xml									phs001062.v5.p2	Atrial Fibrillation
			2020/04/14				./data/phs001570.v2.pht007867.v1.p1.CALGB_40601_Subject.var_report.xml									phs001570.v2.p1	Neoplasms
			2020/11/04				./data/phs002062.v1.pht010638.v1.p1.BC_TDLUs_Sample.var_report.xml									phs002062.v1.p1	Breast Neoplasms
	59364.0		11/08/2013	91429.0		32065.0	./data/phs000200.v9.pht003397.v1.p3.f33_rel4.var_report.xml	4369.0	45715.0	86464	56334.0			45715.0		phs000200.v9.p3	Women&#39;s Health
			2018/05/22				./data/phs001165.v1.pht007988.v1.p1.eMERGE_GCPD_CAG_CHOP_Sample_Attributes.var_report.xml									phs001165.v1.p1	Pediatrics
			2020/12/21				./data/phs000007.v32.pht002431.v5.p13.vr_foot2_2008_m_0651s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/11				./data/phs002000.v1.pht010282.v1.p1.HC_Mongolian_GEO.var_report.xml									phs002000.v1.p1	Carcinoma, Hepatocellular
			2019/01/31				./data/phs001712.v1.pht008682.v1.p1.vdi.var_report.xml									phs001712.v1.p1	Vasculitis
214.0			05/11/2012	337.0			./data/phs000291.v2.pht002272.v1.p1.LHS_COPD_Subject_Phenotypes_Baseline_Measures.var_report.xml	0.0			67.0					phs000291.v2.p1	Pulmonary Disease, Chronic Obstructive
			2021/05/20				./data/phs001024.v5.pht005117.v2.p1.TOPMed_WGS_Partners_AFGen_Sample.var_report.xml									phs001024.v5.p1	Atrial Fibrillation
			04/16/2012				./data/phs000476.v1.pht002668.v1.p1.Parathyroidism_Subject.var_report.xml									phs000476.v1.p1	Pseudohypoparathyroidism
			2018/06/22				./data/phs000298.v4.pht002282.v3.p3.Autism_Sequencing_Collaboration_Sample.var_report.xml									phs000298.v4.p3	Autistic Disorder
			03/03/2011				./data/phs000259.v2.pht001416.v1.p1.HMP_Urethral_Males_Trace_Trace.var_report.xml									phs000259.v2.p1	Urethritis
			2020/03/04				./data/phs001892.v1.pht009943.v1.p1.miRNA_Profiling_Sample_Attributes.var_report.xml									phs001892.v1.p1	
463.0	600.0		08/03/2011	1063.0		463.0	./data/phs000240.v1.pht002280.v1.p1.CIDR_QT_Glaucoma_Subject_Phenotypes.var_report.xml	0.0	531.5	96.87	600.0			531.5		phs000240.v1.p1	Glaucoma, Open-Angle
			09/18/2014				./data/phs000792.v1.pht004248.v1.p1.MPNST_Subject.var_report.xml									phs000792.v1.p1	Neurilemmoma
			2020/12/21				./data/phs000007.v32.pht004805.v3.p13.l_insulin_ex09_1b_0882s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/04				./data/phs002333.v1.pht010922.v1.p1.Chronic_Rhinosinusitis_Sample_Attributes.var_report.xml									phs002333.v1.p1	Paranasal Sinus Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000593.v2.p3.simphen194.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
757.0	953.0		03/28/2014	888.0		883.0	./data/phs000496.v1.pht003169.v1.p1.Late_Onset_Alzheimers_Subject_Phenotypes.var_report.xml	0.0	972.5	871.9	922.0			972.5		phs000496.v1.p1	Alzheimer Disease
			08/20/2013				./data/phs000285.v3.pht001683.v2.p2.C1F41RS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/07/09				./data/phs001772.v2.pht008636.v2.p1.NETs_Sample_Attributes.var_report.xml									phs001772.v2.p1	Intestinal Neoplasms
			2020/06/18				./data/phs000280.v7.pht004164.v2.p1.RTABF03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/08/22				./data/phs001209.v1.pht006805.v1.p1.MIDCIRS_Sample_Attributes.var_report.xml									phs001209.v1.p1	Malaria
4836.0	9988.0		2018/05/01	9996.0		8.0	./data/phs000607.v3.pht003444.v3.p2.Neurodevelopmental_Genomics_Pedigree.var_report.xml	0.0	4998.0	7057	5159.0			4998.0		phs000607.v3.p2	Mental Processes
			2021/09/21				./data/phs002493.v1.pht011463.v1.p1.Neurogenesis_eQTL_sQTL_Subject_Phenotypes.var_report.xml									phs002493.v1.p1	RNA-seq
7.0	7.0		2019/06/11	79.0		3.0	./data/phs001807.v1.pht008978.v1.p1.InTEAM_RNAseq_Subject_Phenotypes.var_report.xml	0.0	5.0	21.73	30.0			5.0		phs001807.v1.p1	Hepatitis, Alcoholic
			05/24/2017				./data/phs000576.v1.pht006154.v1.p1.neurologicalassessment.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2020/12/21				./data/phs000007.v32.pht000825.v7.p13.vegf3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/10/2012				./data/phs000434.v1.pht002604.v1.p1.Atypical_Werner_Syndrome_Subject.var_report.xml									phs000434.v1.p1	Werner Syndrome
			2020/12/21				./data/phs000007.v32.pht000044.v2.p13.mnp0_14s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/12/04				./data/phs001419.v1.pht007093.v1.p1.p6601_15126_pcmtqolch.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/12/18				./data/phs001073.v2.pht005954.v2.p1.Epigenetics_Malnutrition_Sample.var_report.xml									phs001073.v2.p1	Stunting
			2019/03/11				./data/phs000286.v6.pht008757.v1.p2.jhs_nb_analytic_long.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/09/28				./data/phs002254.v1.pht010540.v1.p1.CF_Nasal_Epithelium_Sample.var_report.xml									phs002254.v1.p1	Cystic Fibrosis
			2018/11/21				./data/phs001746.v1.pht008567.v1.p1.GTEx_WGBS_Subject.var_report.xml									phs001746.v1.p1	Reference Values
			03/07/2016				./data/phs001084.v1.pht005326.v1.p1.Colorectal_Tumors_Primary_Metastatic_Subject.var_report.xml									phs001084.v1.p1	Colorectal Neoplasms
			2019/06/03				./data/phs001292.v2.pht007852.v2.p1.narcolepsy_score.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			12/18/2014				./data/phs000841.v1.pht004420.v1.p1.Endometrial_Tumors_Sample.var_report.xml									phs000841.v1.p1	Endometrial Carcinomas
			2021/01/26				./data/phs001427.v2.pht007484.v1.p1.Melanoma_CPB_Resistance_Subject.var_report.xml									phs001427.v2.p1	Immunotherapy
			08/21/2015				./data/phs000830.v1.pht004921.v1.p1.cSCC_XPC_Mutation_Rates_Sample.var_report.xml									phs000830.v1.p1	Xeroderma Pigmentosum, Complementation Group C
969.0	84.0		2020/08/06	2243.0		969.0	./data/phs001571.v1.pht009504.v1.p1.IBD_AA_Pedigree.var_report.xml	0.0	58.5	36.06	84.0			58.5		phs001571.v1.p1	Crohn Disease
			2020/02/28				./data/phs001109.v3.pht005448.v2.p2.Addictive_Diseases_Sample_Attributes.var_report.xml									phs001109.v3.p2	Substance-Related Disorders
			02/27/2014				./data/phs000716.v1.pht003706.v1.p1.Lung_Cancer_Never_Smoking_Asian_Sample.var_report.xml									phs000716.v1.p1	Lung Neoplasms
			2021/08/06				./data/phs001682.v2.pht009763.v1.p1.TOPMed_WGS_PUSH_SCD_Sample.var_report.xml									phs001682.v2.p1	Anemia, Sickle Cell
			03/12/2013				./data/phs000343.v3.pht002722.v1.p1.frq.var_report.xml									phs000343.v3.p1	Stroke
			2021/09/24				./data/phs002346.v1.pht011574.v1.p1.EAGLE_Immune_Related_Subject.var_report.xml									phs002346.v1.p1	Lung Neoplasms
			2018/01/08				./data/phs001291.v1.pht007327.v1.p1.Neoadjuvant_Trastuzumab_BC_Subject.var_report.xml									phs001291.v1.p1	Breast Neoplasms
			08/12/2016				./data/phs000888.v1.pht005574.v1.p1.caMRSA_data_all_expected_sites.var_report.xml									phs000888.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000170.v8.p13.pai3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1497.0	1789.0		2018/07/23	3286.0		1497.0	./data/phs000742.v1.pht008107.v1.p1.EPGP_Subject_Phenotypes.var_report.xml	0.0	1643.0	206.5	1789.0			1643.0		phs000742.v1.p1	Epilepsy
			10/16/2014				./data/phs000713.v1.pht004271.v1.p1.GDNF_Anxiety_Depression_Subject.var_report.xml									phs000713.v1.p1	Anxiety
			08/12/2016				./data/phs000888.v1.pht005559.v1.p1.08aAsthma_hx_meds.var_report.xml									phs000888.v1.p1	
			2019/08/01				./data/phs000222.v6.pht007351.v1.p2.Comorbid_Conditions.var_report.xml									phs000222.v6.p2	Huntington Disease
			05/23/2011				./data/phs000358.v1.pht002240.v1.p1.PUWMa_Subject.var_report.xml									phs000358.v1.p1	Attention Deficit Hyperactivity Disorder
			2021/08/20				./data/phs001939.v2.pht009665.v2.p1.CMI_MPCproject_Sample.var_report.xml									phs001939.v2.p1	Prostatic Neoplasms
			06/22/2017				./data/phs001250.v1.pht006325.v1.p1.Primary_Breast_Cancers_Subject.var_report.xml									phs001250.v1.p1	Breast Neoplasms
			03/12/2013				./data/phs000343.v3.pht002214.v1.p1.BAR.var_report.xml									phs000343.v3.p1	Stroke
			2019/12/12				./data/phs001866.v1.pht009672.v1.p1.ConvertHER_Subject.var_report.xml									phs001866.v1.p1	Breast Neoplasms
			06/28/2017				./data/phs001338.v1.pht006362.v1.p1.Tibetan_High_Altitude_Adaptation_Subject.var_report.xml									phs001338.v1.p1	
			12/26/2012				./data/phs000562.v1.pht003107.v1.p1.Burkitt_Lymphoma_Sample_Attributes.var_report.xml									phs000562.v1.p1	Burkitt Lymphoma
8.0			08/23/2011	96.0			./data/phs000290.v1.pht002277.v1.p1.PAH_Subject_Phenotypes_Baseline_Measures.var_report.xml	0.0			80.0					phs000290.v1.p1	Hypertension, Pulmonary
			11/08/2013				./data/phs000200.v9.pht003398.v1.p3.f45_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
4.0	17.0		2021/08/10	28.0		4.0	./data/phs001467.v2.pht011387.v1.p2.TOPMed_WGS_SAPPHIRE_Pedigree.var_report.xml	0.0	7.0	4.243	17.0			7.0		phs001467.v2.p2	Asthma
			08/20/2013				./data/phs000285.v3.pht001718.v2.p2.D1F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001455.v1.p1.CARE_ADIPONECTIN.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002080.v2.p13.t_xrbonefxv_1993_0_0554s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
1258.0	1502.0		04/29/2016	2760.0		1258.0	./data/phs000128.v3.pht000363.v1.p3.offspring.var_report.xml	0.0	1380.0	172.5	1502.0			1380.0		phs000128.v3.p3	Coronary Disease
			12/16/2013				./data/phs000633.v1.pht003625.v1.p1.Lung_Microbiome_Inflammation_Subject_Phenotypes.var_report.xml									phs000633.v1.p1	Pneumonia
			03/24/2017				./data/phs001336.v1.pht006207.v1.p1.ECLS_HCT_GVHD_Sample_Attributes.var_report.xml									phs001336.v1.p1	Bone Marrow Transplantation
			01/22/2014				./data/phs000670.v1.pht003557.v1.p1.PGRN_AMPS_Sample_Attributes.var_report.xml									phs000670.v1.p1	Depressive Disorder, Major
			2019/12/12				./data/phs001930.v1.pht009670.v1.p1.Vit_E_NAFLD_Subject_Phenotypes.var_report.xml									phs001930.v1.p1	Non-alcoholic Fatty Liver Disease
42.0			03/19/2015	55.0			./data/phs000885.v1.pht004605.v1.p1.HCC_CAGE_Profiling_ncRNAs_Subject_Phenotypes.var_report.xml	0.0			8.0					phs000885.v1.p1	Carcinoma, Hepatocellular
			2018/01/18				./data/phs000819.v1.pht004381.v1.p1.Normal_Human_Tissue_Sequencing_Sample_Attributes.var_report.xml									phs000819.v1.p1	
			03/12/2013				./data/phs000343.v3.pht002217.v1.p1.OPR.var_report.xml									phs000343.v3.p1	Stroke
			2021/05/20				./data/phs001024.v5.pht005118.v2.p1.TOPMed_WGS_Partners_AFGen_Sample_Attributes.var_report.xml									phs001024.v5.p1	Atrial Fibrillation
	3.0		2017/11/30	4.0		2.0	./data/phs001341.v1.pht007171.v1.p1.PhLiPS_Pedigree.var_report.xml	0.0	2.0	1.414	2.0			2.0		phs001341.v1.p1	Lipids
			05/08/2017				./data/phs001362.v1.pht006342.v1.p1.Gastric_Cancer_Metastases_Subject.var_report.xml									phs001362.v1.p1	Stomach Neoplasms
			2020/06/18				./data/phs000280.v7.pht004224.v2.p1.UBMGBF01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			03/29/2017				./data/phs000707.v2.pht003717.v2.p1.Hereditary_Neurological_Disorders_Sample_Attributes.var_report.xml									phs000707.v2.p1	Nervous System Diseases
			08/29/2016				./data/phs000126.v2.pht000385.v2.p1.CIDR_PD_Subject.var_report.xml									phs000126.v2.p1	Parkinson Disease
			06/16/2017				./data/phs001278.v1.pht006266.v1.p1.deathrecord.var_report.xml									phs001278.v1.p1	Porphyrias
			2018/07/25				./data/phs001367.v1.pht008247.v1.p1.Add_Health_Sample.var_report.xml									phs001367.v1.p1	Adolescent Health
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000467.v2.p3.simphen068.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/12/26				./data/phs001949.v1.pht009707.v1.p1.P3DT_Sample_Attributes.var_report.xml									phs001949.v1.p1	Diabetes Mellitus, Type 1
			12/01/2015				./data/phs000571.v3.pht003186.v3.p2.MaternalDemographics.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			08/23/2011				./data/phs000388.v1.pht002352.v1.p1.IPM_Cardiovascular_T2DM_Sample.var_report.xml									phs000388.v1.p1	Metabolic Syndrome X
			2018/01/18				./data/phs000819.v1.pht004379.v1.p1.Normal_Human_Tissue_Sequencing_Sample.var_report.xml									phs000819.v1.p1	
			2020/10/14				./data/phs001912.v1.pht009623.v1.p1.BE_EA_Sample.var_report.xml									phs001912.v1.p1	Barrett Esophagus
			2017/08/25				./data/phs001321.v1.pht006197.v1.p1.OncoArray_CIMBA_Subject_Phenotypes.var_report.xml									phs001321.v1.p1	Breast Neoplasms
			2018/02/08				./data/phs001488.v1.pht007430.v1.p1.uhdr6.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/11/27				./data/phs001177.v2.pht005667.v2.p1.Familial_Melanoma_Sample_Attributes.var_report.xml									phs001177.v2.p1	Melanoma, Cutaneous Malignant
			2019/09/20				./data/phs001436.v1.pht007250.v1.p1.GMKF_NBL_Sample.var_report.xml									phs001436.v1.p1	Neuroblastoma
34.0	34.0		2017/08/18	62.0		28.0	./data/phs001363.v1.pht006793.v1.p1.P100_Pedigree.var_report.xml	0.0	31.0	4.243	28.0			31.0		phs001363.v1.p1	Health
			2018/04/16				./data/phs001326.v1.pht007805.v1.p1.p6902_18009_12mthdeve.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/03/12				./data/phs001722.v1.pht009886.v1.p1.mCRC_Sample.var_report.xml									phs001722.v1.p1	Neoplasms
			2020/02/06				./data/phs001430.v2.pht008073.v2.p1.stanfordbinetintelligencescale.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2018/04/16				./data/phs001326.v1.pht007810.v1.p1.p6902_17944_day0hcttr.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2018/06/01				./data/phs001317.v1.pht008044.v1.p1.medicalquestionnaire.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
			2018/06/11				./data/phs000220.v2.pht006616.v1.p2.PAGE_MEC_Metabochip_Sample_Attributes.var_report.xml									phs000220.v2.p2	Neoplasms
			2020/06/15				./data/phs002008.v1.pht010199.v1.p1.Orofacial_Enhancers_Subject.var_report.xml									phs002008.v1.p1	Embryonic and Fetal Development
			05/26/2016				./data/phs000886.v1.pht004650.v1.p1.Asthma_MZ_Twins_Sample_Attributes.var_report.xml									phs000886.v1.p1	Asthma
			01/07/2016				./data/phs000814.v1.pht004584.v1.p1.MIGen_Exome_Italian_ATVB_Sample_Attributes.var_report.xml									phs000814.v1.p1	Coronary Artery Disease
			2020/06/18				./data/phs000280.v7.pht004215.v2.p1.UBMEBM4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/27/2017				./data/phs000428.v2.pht005036.v1.p2.Version_Mapping_Phase12_NoHapMap.var_report.xml									phs000428.v2.p2	Aging
			08/16/2013				./data/phs000623.v1.pht003339.v1.p1.Rare_Mendelian_Disease_Plain_Sample_Attributes.var_report.xml									phs000623.v1.p1	Developmental Disabilities
32.0	32.0		12/26/2012	59.0		13.0	./data/phs000562.v1.pht003106.v1.p1.Burkitt_Lymphoma_Subject_Phenotypes.var_report.xml	0.0	19.67	10.69	13.0			14.0		phs000562.v1.p1	Burkitt Lymphoma
			2018/02/08				./data/phs001488.v1.pht007376.v1.p1.aes.var_report.xml									phs001488.v1.p1	Huntington Disease
441.0	592.0		11/24/2010	1033.0		441.0	./data/phs000140.v1.pht000631.v1.p1.T2D_Control_Data.var_report_2010_11_24.xml	0.0	516.5	106.8	592.0			516.5		phs000140.v1.p1	Diabetes Mellitus, Type 2
			2018/12/27				./data/phs000756.v1.pht007371.v1.p1.FINRISK_Subject.var_report.xml									phs000756.v1.p1	
			03/20/2013				./data/phs000573.v1.pht003217.v1.p1.DiffuseLargeBCellLymphoma_Sample_Attributes.var_report.xml									phs000573.v1.p1	Lymphoma, Large B-Cell, Diffuse
12.0	3.0		2018/06/01	3.0		8.0	./data/phs001342.v1.pht008049.v1.p1.Statin_Induced_Myopathy_Pedigree.var_report.xml	0.0	8.5	4.95	8.0			8.5		phs001342.v1.p1	Myopathy
			2020/06/18				./data/phs000280.v7.pht001440.v5.p1.ARIC_Subject.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/18/2015				./data/phs000857.v1.pht004487.v1.p1.ER_Positive_Breast_Cancer_Subject.var_report.xml									phs000857.v1.p1	Breast Neoplasms
			10/18/2012				./data/phs000547.v1.pht003007.v1.p1.GARNET_SUCCESS_Subject_Phenotypes.var_report.xml									phs000547.v1.p1	Breast Neoplasms
			2019/05/31				./data/phs001296.v2.pht006361.v2.p1.registration.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			10/28/2013				./data/phs000598.v2.pht003323.v2.p2.EsophagealAdenocarcinoma_Sample.var_report.xml									phs000598.v2.p2	Esophageal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001864.v2.p2.F3SCORT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht001042.v8.p13.renaldo3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/12/2015				./data/phs000853.v1.pht004428.v1.p1.Normative_Aging_Study_Sample.var_report.xml									phs000853.v1.p1	Mortality
			07/09/2012				./data/phs000511.v1.pht002816.v1.p1.Hypertriglyceridemia_I_III_V_Subject.var_report.xml									phs000511.v1.p1	Hypertriglyceridemia
			2020/03/24				./data/phs001641.v1.pht010033.v1.p1.GeneticTestingCounselingOutcomes.var_report.xml									phs001641.v1.p1	Progressive Patient Care
799.0	799.0		11/04/2014	56.0		717.0	./data/phs000086.v3.pht000669.v2.p1.DCCT_EDIC_Pedigree.var_report.xml	0.0	758.0	57.98	717.0			758.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			07/14/2010				./data/phs000244.v1.pht001519.v1.p1.Miller_Syndrome_Exome_Subject.var_report_2010_07_14.xml									phs000244.v1.p1	Genee-Wiedemann Syndrome
			2020/12/21				./data/phs000007.v32.pht003311.v2.p13.t_eegsigma_1998_m_0767s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/25/2014				./data/phs000335.v3.pht002113.v2.p2.LHS_COPD_Subject.var_report.xml									phs000335.v3.p2	COPD
			01/06/2010				./data/phs000199.v1.pht000893.v1.p1.CHOP_CNV_Sample.var_report_2010_01_06.xml									phs000199.v1.p1	Normalcy
			01/19/2010				./data/phs000219.v1.pht001099.v1.p1.d_prvc.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
600.0	805.0		01/29/2015	1405.0		600.0	./data/phs000737.v1.pht004446.v1.p1.Metabolic_Syndrome_Hvar_Islanders_Subject_Phenotypes.var_report.xml	0.0	702.5	145	805.0			702.5		phs000737.v1.p1	Metabolic Syndrome X
29.0			2018/08/03	413.0			./data/phs000590.v1.pht008284.v1.p1.sf_36.var_report.xml	1.0			36.0					phs000590.v1.p1	Polyarteritis Nodosa
			2020/12/21				./data/phs000007.v32.pht000610.v3.p13.wholedxa0_24_0708s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht004811.v4.p13.t_physactf_ex02_3b_0914s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/24/2011				./data/phs000268.v1.pht002163.v1.p1.CEPH_FamilyPanels_Subject.var_report_2011_02_24.xml									phs000268.v1.p1	Cell Line
			10/06/2011				./data/phs000333.v1.pht002315.v1.p1.FIND_Sample_Attributes.var_report.xml									phs000333.v1.p1	Diabetes Mellitus
			2017/09/08				./data/phs001105.v1.pht006836.v1.p1.Aggressive_Prostate_Tumors_Subject.var_report.xml									phs001105.v1.p1	Prostatic Neoplasms
			2018/08/19				./data/phs001647.v1.pht008202.v1.p1.Impulsivity_Addiction_Sample_Attributes.var_report.xml									phs001647.v1.p1	Impulsive Behavior
			2018/05/24				./data/phs000929.v1.pht007982.v1.p1.High_Risk_Breast_Cancer_Sample.var_report.xml									phs000929.v1.p1	Breast Neoplasms
3344.0	3344.0		12/01/2015	6260.0		2916.0	./data/phs000571.v3.pht003357.v3.p2.Gender.var_report.xml	0.0	3130.0	304.1	2916.0			3130.0		phs000571.v3.p2	Heart Defects, Congenital
			2019/03/11				./data/phs000286.v6.pht008772.v1.p2.nbhdrecreation.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000441.v2.p3.simphen042.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/09/18				./data/phs002217.v1.pht010535.v1.p1.MELAS_Subject_Phenotypes.var_report.xml									phs002217.v1.p1	MELAS Syndrome
			07/26/2017				./data/phs001357.v1.pht006700.v1.p1.TSC_Sample_Attributes.var_report.xml									phs001357.v1.p1	Tuberous Sclerosis
			02/18/2015				./data/phs000509.v1.pht004312.v1.p1.Hepatocellular_Carcinoma_Sequencing_Subject.var_report.xml									phs000509.v1.p1	Carcinoma, Hepatocellular
			11/16/2016				./data/phs000973.v1.pht004988.v1.p1.JMML_Sample.var_report.xml									phs000973.v1.p1	Leukemia, Myelomonocytic, Juvenile
			2020/12/21				./data/phs000007.v32.pht000019.v3.p13.ex0_17s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/11/04				./data/phs001444.v2.pht006961.v1.p1.Genomic_Variation_DLBCL_Sample.var_report.xml									phs001444.v2.p1	Lymphoma, Large B-Cell, Diffuse
			2017/10/05				./data/phs001454.v1.pht006982.v1.p1.Cross_BETRNet_Admixture_Sample_Attributes.var_report.xml									phs001454.v1.p1	Adenocarcinoma Of Esophagus
			2017/10/11				./data/phs000578.v1.pht007019.v1.p1.screening_information.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			2020/10/27				./data/phs001616.v2.pht008542.v2.p2.eMERGEseq_BMI.var_report.xml									phs001616.v2.p2	Precision Medicine
			01/19/2010				./data/phs000219.v1.pht001093.v1.p1.d_mme_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			07/05/2016				./data/phs001097.v1.pht005617.v1.p1.T2D_GENES_Singapore_Asian_Sample_Attributes.var_report.xml									phs001097.v1.p1	Diabetes Mellitus, Type 2
			2020/12/21				./data/phs000007.v32.pht000681.v7.p13.ffreq1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/22				./data/phs001211.v4.pht005757.v3.p3.TOPMed_WGS_ARIC_Sample_Attributes.var_report.xml									phs001211.v4.p3	Cardiovascular Diseases
			06/27/2017				./data/phs001389.v1.pht006601.v1.p1.GBM_Tumors_Subject.var_report.xml									phs001389.v1.p1	Glioblastoma
			11/05/2014				./data/phs000209.v13.pht001122.v2.p3.MESA_FamilySpirometry.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
799.0	799.0		2019/08/01	1392.0		593.0	./data/phs001828.v1.pht009369.v1.p1.CKD_Subject_Phenotypes.var_report.xml	0.0	696.0	145.7	593.0			696.0		phs001828.v1.p1	Renal Insufficiency, Chronic
			08/20/2013				./data/phs000285.v3.pht001769.v1.p2.E1F09MCP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/09/2013				./data/phs000636.v1.pht003427.v1.p1.Familial_Intracranial_Aneurysm_Sequence_Sample.var_report.xml									phs000636.v1.p1	Intracranial Aneurysm
40.0	40.0		08/08/2011	73.0		33.0	./data/phs000353.v1.pht002253.v1.p1.Preterm_Birth_AA_Subject_Phenotypes_112.var_report.xml	0.0	36.5	4.95	33.0			36.5		phs000353.v1.p1	Premature Birth
			08/20/2013				./data/phs000285.v3.pht001691.v2.p2.C1F9PRG3.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/04				./data/phs000782.v1.pht003990.v1.p1.MedImmune_RHCCS_Subject.var_report.xml									phs000782.v1.p1	Carcinoma, Hepatocellular
			12/03/2012				./data/phs000548.v1.pht003071.v1.p1.HV1_Cohort_Subject_Phenotypes.var_report.xml									phs000548.v1.p1	Aspirin
			2020/12/21				./data/phs000007.v32.pht010749.v1.p13.vr_cogtest_ex03_3b_1241s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
19.0	19.0		2021/04/07	36.0		17.0	./data/phs002377.v1.pht011113.v1.p1.Ipilimumab_Nivolumab_HCT_Subject.var_report.xml	0.0	18.0	1.414	17.0			18.0		phs002377.v1.p1	Hematologic Malignancy
			2020/07/17				./data/phs001995.v1.pht009994.v1.p1.Himba_Sample_Attributes.var_report.xml									phs001995.v1.p1	Sex
			2020/12/21				./data/phs000007.v32.pht000202.v8.p13.laba1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/25/2010				./data/phs000021.v3.pht000067.v2.p2.EA_GAIN_phenotype_cases.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
86.0	99.0		2021/03/18	94.0		88.0	./data/phs001489.v2.pht008584.v2.p2.CCDG_Epi25_Subject_Phenotypes.var_report.xml	0.0	923.0	790.9	99.0			84.0		phs001489.v2.p2	Epilepsy
			2017/12/12				./data/phs000295.v2.pht001532.v1.p1.Kabuki_Subject_Phenotypes.var_report.xml									phs000295.v2.p1	Kabuki syndrome
			2018/08/03				./data/phs000590.v1.pht008262.v1.p1.angiogram_celiacmesentericrenal.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			11/05/2014				./data/phs000209.v13.pht003119.v3.p3.MESA_AncilMesaNeighborScalesExam1.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2017/10/19				./data/phs001288.v1.pht006775.v1.p1.maternal_family_hx.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2018/10/29				./data/phs001626.v1.pht008475.v1.p1.IBDMDB_Subject.var_report.xml									phs001626.v1.p1	Inflammatory Bowel Diseases
			2021/09/24				./data/phs002346.v1.pht011575.v1.p1.EAGLE_Immune_Related_Sample.var_report.xml									phs002346.v1.p1	Lung Neoplasms
			2020/12/21				./data/phs000007.v32.pht000088.v7.p13.hear1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/05/28				./data/phs002259.v1.pht011026.v1.p1.CD4T_European_Sample_Attributes.var_report.xml									phs002259.v1.p1	RNA-Seq
			08/21/2013				./data/phs000641.v1.pht003474.v1.p1.Combined_Immunodeficiency_Multiple_Intestinal_Atresias_Subject.var_report.xml									phs000641.v1.p1	Immunological Deficiency Syndrome
			2020/09/17				./data/phs002222.v1.pht010527.v1.p1.Tcells_CNS_Subject_Phenotypes.var_report.xml									phs002222.v1.p1	Multiple Sclerosis
65.0			2020/03/13	253.0			./data/phs000521.v2.pht007046.v2.p1.sf_36.var_report.xml	2.0			53.0					phs000521.v2.p1	Ataxia
			2018/10/02				./data/phs001699.v1.pht008397.v1.p1.BC_Epigenetic_Heritability_Subject.var_report.xml									phs001699.v1.p1	
			2017/11/28				./data/phs001482.v1.pht007124.v1.p1.Carrier_Screening_Sample.var_report.xml									phs001482.v1.p1	Infertility
			2017/12/04				./data/phs000906.v1.pht007148.v1.p1.LABS.var_report.xml									phs000906.v1.p1	Pharmacogenetics
			03/12/2013				./data/phs000343.v3.pht002728.v1.p1.hcg.var_report.xml									phs000343.v3.p1	Stroke
			11/08/2013				./data/phs000200.v9.pht001021.v4.p3.f82_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/06/14				./data/phs001238.v2.pht006648.v2.p1.GENOA_Sample.var_report.xml									phs001238.v2.p1	Hypertension
			2020/01/30				./data/phs001698.v1.pht009604.v1.p1.BPH_Sample_Attributes.var_report.xml									phs001698.v1.p1	Prostatic Hyperplasia
			2018/05/31				./data/phs001318.v1.pht008022.v1.p1.survival_transformationtoaml.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
359.0	359.0		2020/12/09	395.0		36.0	./data/phs002298.v1.pht010758.v1.p1.Skin_Pigmentation_AA_Subject.var_report.xml	0.0	197.5	228.4	36.0			197.5		phs002298.v1.p1	Skin Pigmentation (Melanin Index)
3715.0	3715.0		2021/08/24	5916.0		2201.0	./data/phs002185.v1.pht010966.v1.p1.CIDR_GVHD_Subject.var_report.xml	0.0	2958.0	1071	2201.0			2958.0		phs002185.v1.p1	Graft vs Host Disease
			02/27/2017				./data/phs001226.v1.pht006169.v1.p1.Embryonic_Development_Sample.var_report.xml									phs001226.v1.p1	Embryonic Development
			2017/11/01				./data/phs000833.v7.pht004358.v6.p1.SCAPT_allCenters_Subject.var_report.xml									phs000833.v7.p1	
			2020/06/18				./data/phs000280.v7.pht004039.v3.p1.ATRFIB31.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/06/11				./data/phs001807.v1.pht008980.v1.p1.InTEAM_RNAseq_Sample_Attributes.var_report.xml									phs001807.v1.p1	Hepatitis, Alcoholic
722.0			2019/12/19	2074.0			./data/phs001713.v1.pht008524.v1.p1.LCCC_1108_Subject_Phenotypes.var_report.xml	0.0			1352.0					phs001713.v1.p1	Neoplasms
			2021/05/20				./data/phs001032.v6.pht005098.v2.p2.TOPMed_WGS_VUH_AF_Subject.var_report.xml									phs001032.v6.p2	Atrial Fibrillation
			03/24/2017				./data/phs001257.v2.pht006000.v2.p1.Anti_CTLA_4_Sample_Attributes.var_report.xml									phs001257.v2.p1	Melanoma
			06/20/2012				./data/phs000455.v1.pht002574.v1.p1.Developmental_Brain_Disorders_Subject.var_report.xml									phs000455.v1.p1	Brain Diseases
			11/04/2014				./data/phs000086.v3.pht000337.v1.p1.EDIC_f0612.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/11/08				./data/phs001332.v2.pht007443.v2.p1.CRC_SCA_7301_Subject.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			05/24/2016				./data/phs001065.v1.pht005402.v1.p1.conmed.var_report.xml									phs001065.v1.p1	Huntington Disease
			11/08/2013				./data/phs000200.v9.pht001515.v3.p3.f150_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/05/22	16.0			./data/phs001314.v1.pht007998.v1.p1.demographics.var_report.xml	0.0			15.0					phs001314.v1.p1	Steroid 21-Hydroxylase
			01/19/2010				./data/phs000219.v1.pht001100.v1.p1.d_relation_index.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			08/28/2012				./data/phs000448.v1.pht002508.v1.p1.AJ_SZ_Subject.var_report.xml									phs000448.v1.p1	Schizophrenia
			09/11/2014	1.0			./data/phs000795.v1.pht004015.v1.p1.Gastric_Cancer_Metastasis_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000795.v1.p1	Stomach Neoplasms
			2019/11/08				./data/phs001330.v2.pht007528.v2.p1.sanfilippo_behavior.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			2018/03/20				./data/phs001498.v1.pht007322.v1.p1.INSIGHT_Microbiome_Subject.var_report.xml									phs001498.v1.p1	Pediatric Obesity
			2021/09/08				./data/phs001735.v2.pht009982.v2.p1.TOPMed_WGS_PCGC_Sample_Attributes.var_report.xml									phs001735.v2.p1	Heart Defects, Congenital
			2018/10/02				./data/phs001664.v1.pht008440.v1.p1.PDCGC_Sample_Attributes.var_report.xml									phs001664.v1.p1	Parkinson Disease
			2018/01/18				./data/phs001300.v1.pht006721.v1.p1.NABEC_Sample.var_report.xml									phs001300.v1.p1	Gene Expression Profiling
			2020/12/21				./data/phs000007.v32.pht002897.v6.p13.l_psel_2008_m_0466s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/11/10				./data/phs002172.v1.pht010663.v1.p1.GMKF_Microtia_Hispanic_Sample.var_report.xml									phs002172.v1.p1	Congenital Microtia
			2018/05/03				./data/phs001264.v1.pht007900.v1.p1.CD47_Breast_Cancer_Sample.var_report.xml									phs001264.v1.p1	Breast Neoplasms
			05/08/2017				./data/phs001343.v1.pht006347.v1.p1.hESCs_Sample.var_report.xml									phs001343.v1.p1	Human Embryonic Stem Cells
			2018/12/11				./data/phs001750.v1.pht008589.v1.p1.sc_Pulmonary_Fibrosis_Sample_Attributes.var_report.xml									phs001750.v1.p1	Pulmonary Fibrosis
			2021/05/14				./data/phs001749.v2.pht009319.v2.p1.CAKUT_Subject_Phenotypes.var_report.xml									phs001749.v2.p1	Congenital Anomalies Of Kidney And Urinary Tract
			2019/05/31				./data/phs001296.v2.pht006358.v2.p1.physical_and_neurological_exam.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			02/18/2015				./data/phs000509.v1.pht004314.v1.p1.Hepatocellular_Carcinoma_Sequencing_Subject_Phenotypes.var_report.xml									phs000509.v1.p1	Carcinoma, Hepatocellular
			2018/03/21				./data/phs001529.v1.pht007368.v1.p1.scRNASeq_RA_Microfluidic_Subject.var_report.xml									phs001529.v1.p1	Arthritis, Rheumatoid
1.0			2017/10/03	9.0			./data/phs001382.v1.pht006975.v1.p1.reproductivehealthsurve.var_report.xml	467.0			9.0					phs001382.v1.p1	Vasculitis
99.0	99.0		2019/10/11	893.0		94.0	./data/phs001380.v1.pht009229.v1.p1.TS_GWAS1_Subject_Phenotypes.var_report.xml	0.0	99.0	96.87	56.0			99.0		phs001380.v1.p1	Tourette Syndrome
			05/02/2014				./data/phs000739.v1.pht003828.v1.p1.Ameloblastoma_Mutations_Sample_Attributes.var_report.xml									phs000739.v1.p1	Ameloblastoma
			2021/04/23				./data/phs002228.v1.pht010857.v1.p1.Deamination_Leukemia_Subject.var_report.xml									phs002228.v1.p1	Myeloproliferative Disorders
			2019/12/19				./data/phs001713.v1.pht008523.v1.p1.LCCC_1108_Sample.var_report.xml									phs001713.v1.p1	Neoplasms
			11/08/2013				./data/phs000200.v9.pht000988.v3.p3.ecg_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/01/10				./data/phs001609.v1.pht008139.v1.p1.Lupus_Nephritis_Subject.var_report.xml									phs001609.v1.p1	Lupus Erythematosus, Systemic
			2019/11/08				./data/phs001330.v2.pht007536.v2.p1.sleep_questionnaire.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			2017/10/11				./data/phs000578.v1.pht007013.v1.p1.nerve_conduction_emg.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			2017/10/05				./data/phs001432.v1.pht006977.v1.p1.Tumor_Heterogeneity_Thoracic_Sample.var_report.xml									phs001432.v1.p1	Adenocarcinoma of lung
			2021/06/28				./data/phs001598.v2.pht009995.v1.p1.TOPMed_CCDG_JHU_AF_Subject.var_report.xml									phs001598.v2.p1	Atrial Fibrillation
			2020/12/21				./data/phs000007.v32.pht000146.v8.p13.creacys1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/08/01				./data/phs000222.v6.pht009349.v1.p2.sMR_BRAINS_volumes.var_report.xml									phs000222.v6.p2	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001774.v2.p2.E1F09MRI.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
20.0			2017/09/22	30.0			./data/phs001392.v1.pht006885.v1.p1.demographics.var_report.xml	0.0			10.0					phs001392.v1.p1	Severe Combined Immunodeficiency
			2020/11/09				./data/phs000976.v2.pht005687.v1.p1.CIDR_COGA_AA_Family_Sample_Attributes.var_report.xml									phs000976.v2.p1	Alcoholism
			11/04/2014				./data/phs000086.v3.pht000260.v1.p1.DCCT_cbl9.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/12/09				./data/phs001842.v1.pht009244.v1.p1.Sjogrens_Syndrome_Sample.var_report.xml									phs001842.v1.p1	Sjogren&#39;s Syndrome
6.0	6.0		2018/02/27	7.0		6.0	./data/phs001206.v1.pht007345.v1.p1.BSP_AA_Subject_Phenotypes.var_report.xml	0.0	6.0	0.7071	6.0			6.0		phs001206.v1.p1	Blepharospasm
			12/01/2015				./data/phs000571.v3.pht003190.v3.p2.PaternalDemographics.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2020/12/21				./data/phs000007.v32.pht001045.v2.p13.laba0_20s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002571.v2.p13.t_ctsps_2005_m_0664s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/24/2016				./data/phs001214.v1.pht005878.v1.p1.Simul_seq_Sample_Attributes.var_report.xml									phs001214.v1.p1	Esophageal Neoplasms
			08/06/2010				./data/phs000182.v2.pht000795.v1.p1.AMD_MMAP_Phenotype.var_report_2010_08_06.xml									phs000182.v2.p1	Macular Degeneration
			2019/10/01				./data/phs001416.v2.pht009015.v1.p1.TOPMed_WGS_MESA_Sample_Attributes.var_report.xml									phs001416.v2.p1	Cardiovascular Diseases
			2021/06/02				./data/phs002421.v1.pht011272.v1.p1.ALT_nonMYCN_NBL_Sample_Attributes.var_report.xml									phs002421.v1.p1	Neuroblastoma
			2018/09/17				./data/phs001154.v1.pht008375.v1.p1.CNV_Developmental_Disorders_Subject_Phenotypes.var_report.xml									phs001154.v1.p1	Developmental Disabilities
			2020/06/18				./data/phs000280.v7.pht004060.v5.p1.csdxps16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/11/2009				./data/phs000181.v1.pht000793.v1.p1.OZALC_Phenotype.var_report_2009_12_11.xml									phs000181.v1.p1	Alcohol-Related Disorders
			2020/06/18				./data/phs000280.v7.pht006470.v1.p1.RETC0.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004033.v2.p1.ANTB.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			07/05/2017				./data/phs000595.v1.pht006641.v1.p1.registration.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2018/10/22				./data/phs001550.v2.pht007504.v1.p1.Melanocytic_Neoplasms_Subject.var_report.xml									phs001550.v2.p1	Melanoma
			2020/06/18				./data/phs000280.v7.pht006468.v1.p1.PULP.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
935.0	941.0		2020/07/21	1578.0		637.0	./data/phs001011.v2.pht005532.v1.p1.eMERGE_CCHMC_IIIA_Subject_Phenotypes.var_report.xml	0.0	789.0	215	633.0			789.0		phs001011.v2.p1	
			08/20/2013				./data/phs000285.v3.pht001733.v2.p2.D1F9PRG2.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002565.v5.p13.l_mtblcmhi1_ex05_1_0662s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
623.0	623.0		2020/02/28	925.0		704.0	./data/phs001109.v3.pht009221.v1.p2.Addictive_Diseases_Pedigree.var_report.xml	0.0	934.5	89.1	704.0			934.5		phs001109.v3.p2	Substance-Related Disorders
			10/27/2014				./data/phs000812.v1.pht004299.v1.p1.Breast_Subject_Phenotypes.var_report.xml									phs000812.v1.p1	Prostatic Neoplasms
			2018/02/08				./data/phs001488.v1.pht007432.v1.p1.uhdr8.var_report.xml									phs001488.v1.p1	Huntington Disease
			11/08/2013				./data/phs000200.v9.pht001513.v2.p3.outc_strk_carotid_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/20/2013				./data/phs000285.v3.pht001779.v2.p2.E1F11.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/11/08				./data/phs001332.v2.pht007460.v2.p1.concomitant_meds.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
61.0			2019/01/31	152.0			./data/phs001712.v1.pht008676.v1.p1.demographic_form.var_report.xml	0.0			91.0					phs001712.v1.p1	Vasculitis
			2020/02/06				./data/phs001430.v2.pht008072.v2.p1.p7001_19747_developme.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000489.v2.p3.simphen090.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/10/07				./data/phs001918.v2.pht010050.v2.p1.STAMPEED_HCT_Sample_Attributes.var_report.xml									phs001918.v2.p1	Graft vs Host Disease
			2018/02/08				./data/phs001488.v1.pht007386.v1.p1.ctcc_ertekg.var_report.xml									phs001488.v1.p1	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001793.v2.p2.E1F50.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001051.v1.p1.d_ascertainment.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/06/09				./data/phs001395.v2.pht006627.v1.p1.TOPMed_WGS_HCHS_SOL_Sample_Attributes.var_report.xml									phs001395.v2.p1	Cardiovascular Diseases
210.0	210.0		2020/11/20	391.0		181.0	./data/phs002255.v1.pht010672.v1.p1.Language_Impairment_Subject.var_report.xml	0.0	195.5	20.51	181.0			195.5		phs002255.v1.p1	Language Development
4.0	6.0		08/20/2014	10.0		4.0	./data/phs000777.v1.pht003974.v1.p1.FSGS_CKD_Subject_Phenotypes.var_report.xml	0.0	5.0	1.414	6.0			5.0		phs000777.v1.p1	Glomerulosclerosis, Focal Segmental
1.0	1.0		2021/03/18	2.0		1.0	./data/phs002361.v1.pht011067.v1.p1.Pneumococcal_Vaccines_Elderly_Subject.var_report.xml	0.0	1.0	0	1.0			1.0		phs002361.v1.p1	
811.0			2018/02/28	933.0			./data/phs001001.v1.pht005655.v1.p1.MGH_AF_Subject_Phenotypes.var_report.xml	0.0			214.0					phs001001.v1.p1	Atrial Fibrillation
			08/16/2013				./data/phs000623.v1.pht003337.v1.p1.Rare_Mendelian_Disease_Plain_Sample.var_report.xml									phs000623.v1.p1	Developmental Disabilities
			2021/01/15				./data/phs000989.v4.pht005020.v4.p1.Cortical_Neurogenesis_Subject.var_report.xml									phs000989.v4.p1	Stem cells, neural
			2021/08/19				./data/phs001662.v2.pht010063.v1.p1.LTRC_R040_subject_smoking_history.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/07/24				./data/phs001194.v3.pht005821.v2.p2.CopynumberResults.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2018/02/27				./data/phs001364.v1.pht007466.v1.p1.HCP_Young_Adults_Subject_Phenotypes.var_report.xml									phs001364.v1.p1	Connectome
			2021/02/03				./data/phs001018.v1.pht010913.v1.p1.Clinical_Renal_Tumors_Subject_Phenotypes.var_report.xml									phs001018.v1.p1	
			2019/09/27				./data/phs001576.v2.pht008216.v2.p2.P6705_PHYSICIAN_FLOW_SHEET_FOLL.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			09/27/2010				./data/phs000245.v1.pht001914.v1.p1.Triple_Negative_Breast_Cancer_Sample.var_report_2010_09_27.xml									phs000245.v1.p1	Breast Neoplasms
			2019/12/12				./data/phs000785.v1.pht004010.v1.p1.SCC_Sample_Attributes.var_report.xml									phs000785.v1.p1	Carcinoma, Squamous Cell
99.0			2018/09/17	668.0			./data/phs001677.v1.pht008379.v1.p1.AIS_1000_Exomes_Subject_Phenotypes.var_report.xml	0.0			911.0					phs001677.v1.p1	Scoliosis
			2020/10/29				./data/phs002270.v1.pht010598.v1.p1.Recurrent_GBM_Subject_Phenotypes.var_report.xml									phs002270.v1.p1	Glioblastoma
			2020/03/31				./data/phs001976.v2.pht009901.v2.p1.Melorheostosis_Sample.var_report.xml									phs001976.v2.p1	Melorheostosis
			05/13/2014				./data/phs000678.v1.pht003565.v1.p1.Young_Onset_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs000678.v1.p1	Breast Neoplasms
			2019/05/03				./data/phs000681.v2.pht003873.v1.p1.Diabetes_Prevention_Program_Sample_Attributes.var_report.xml									phs000681.v2.p1	Diabetes Mellitus, Type 2
			2018/05/16				./data/phs001592.v1.pht007977.v1.p1.CCDG_ATVB_Sample.var_report.xml									phs001592.v1.p1	Atherosclerosis
			2020/06/18				./data/phs000280.v7.pht004187.v2.p1.RTAWF42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht009760.v2.p13.vr_raceall_2008_a_0712s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/27				./data/phs001566.v1.pht007708.v1.p1.MBC_NF1_Sample.var_report.xml									phs001566.v1.p1	Neurofibromatosis 1
			06/14/2017				./data/phs001297.v1.pht006202.v1.p1.PROP_LymphocyticMarkers_Sample_Attributes.var_report.xml									phs001297.v1.p1	Premature Infant
			04/18/2014				./data/phs000438.v1.pht003318.v1.p1.ACE_Inhibitor_Angioedema_Subject.var_report.xml									phs000438.v1.p1	Angioedema
			08/12/2016				./data/phs000888.v1.pht005591.v1.p1.Geisinger_exObesity.var_report.xml									phs000888.v1.p1	
			2021/02/26				./data/phs001120.v2.pht005808.v2.p2.ELLIPSE_Sample.var_report.xml									phs001120.v2.p2	Prostatic Neoplasms
			01/09/2017				./data/phs001244.v1.pht006058.v1.p1.NPC_WES_Sample_Attributes.var_report.xml									phs001244.v1.p1	Nasopharyngeal Neoplasms
			2021/03/17				./data/phs002048.v2.pht010314.v1.p1.SLE_Subject.var_report.xml									phs002048.v2.p1	Lupus Erythematosus, Systemic
			2017/12/04				./data/phs001419.v1.pht007091.v1.p1.p6601_12800_neurology.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/07/06				./data/phs001955.v1.pht009795.v1.p1.REDS_III_RBCOmics_Sample_Attributes.var_report.xml									phs001955.v1.p1	
			2018/10/02				./data/phs001702.v1.pht008427.v1.p1.Lupus_eQTL_Subject_Phenotypes.var_report.xml									phs001702.v1.p1	Lupus Erythematosus, Systemic
			2017/11/30				./data/phs001474.v1.pht007152.v1.p1.Metastasis_HNSCC_Sample.var_report.xml									phs001474.v1.p1	Carcinoma, Squamous Cell
			2020/12/21				./data/phs000007.v32.pht000396.v4.p13.sleep1_1999s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht003404.v1.p3.outc_cancer_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
3.0	3.0		2020/09/15	4.0		1.0	./data/phs002234.v1.pht010514.v1.p1.Xq28_Deletion_HH_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs002234.v1.p1	Hypogonadism
			08/08/2011				./data/phs000353.v1.pht002250.v1.p1.Preterm_Birth_AA_Sample.var_report.xml									phs000353.v1.p1	Premature Birth
			09/25/2015				./data/phs000712.v1.pht003711.v1.p1.UIC_CIDR_Sample.var_report.xml									phs000712.v1.p1	Autistic Disorder
			2020/07/16				./data/phs001778.v1.pht009830.v1.p1.MDS_huM_Subject.var_report.xml									phs001778.v1.p1	Myelodysplastic Syndromes
			12/02/2015				./data/phs000810.v1.pht004713.v1.p1.HCHS_SOL_Cohort_Subject.var_report.xml									phs000810.v1.p1	Cardiovascular Diseases
			05/16/2013				./data/phs000582.v1.pht003241.v1.p1.ESP_FamilialInterstitialPneumonia_Subject.var_report.xml									phs000582.v1.p1	Idiopathic Pulmonary Fibrosis
			2021/01/27				./data/phs002313.v1.pht010825.v1.p1.AAOV_Sample_Attributes.var_report.xml									phs002313.v1.p1	Cancer
			2020/06/18				./data/phs000280.v7.pht004071.v2.p1.ECGC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000500.v2.p3.simphen101.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/09/2016				./data/phs001037.v1.pht005920.v1.p1.TEDDY_Sample_Attributes.var_report.xml									phs001037.v1.p1	Diabetes Mellitus, Type 1
			08/20/2013				./data/phs000285.v3.pht001777.v2.p2.E1F09TOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			01/15/2016				./data/phs000883.v1.pht004596.v1.p1.MIGen_PROCARDIS_Sample.var_report.xml									phs000883.v1.p1	Coronary Artery Disease
7.0	7.0		12/18/2014	12.0		5.0	./data/phs000794.v1.pht004310.v1.p1.Longitudinal_CLL_Subject_Phenotypes.var_report.xml	0.0	6.0	1.414	5.0			6.0		phs000794.v1.p1	Chronic Lymphocytic Leukemia
822.0	1150.0		12/13/2011	1972.0		822.0	./data/phs000404.v1.pht002369.v1.p1.GENEVA_Smoking_Cessation_Subject_Phenotypes_UW_TTURC.var_report.xml	0.0	986.0	231.9	1150.0			986.0		phs000404.v1.p1	Smoking Cessation
			2020/12/21				./data/phs000007.v32.pht000102.v9.p13.pft3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht001984.v1.p3.MESA_AncilMesaInflammation.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/03/11				./data/phs001757.v1.pht008670.v1.p1.Odorant_Receptors_Sample_Attributes.var_report.xml									phs001757.v1.p1	Smell
			2020/06/18				./data/phs000280.v7.pht004232.v2.p1.V2ECG.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/27/2014				./data/phs000674.v1.pht003642.v1.p1.GERA_Sample_Attributes.var_report.xml									phs000674.v1.p1	Aging
26.0	85.0		04/18/2011	8.0		26.0	./data/phs000237.v1.pht002160.v1.p1.NU_VU_T2D_Pedigree.var_report.xml	0.0	55.5	9.899	85.0			55.5		phs000237.v1.p1	Diabetes Mellitus, Type 2
			08/20/2013				./data/phs000285.v3.pht001569.v2.p2.A4F08.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/10/2010				./data/phs000305.v1.pht001917.v1.p1.NSABP_Sample.var_report_2010_11_10.xml									phs000305.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht001023.v4.p3.f84_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			05/17/2016				./data/phs000796.v1.pht005387.v1.p1.OPPERA_Chronic_TMJD_Sample_Attributes.var_report.xml									phs000796.v1.p1	Temporomandibular Joint Disorders
			2017/09/06				./data/phs000554.v1.pht003197.v1.p1.CRPC_GEO.var_report.xml									phs000554.v1.p1	Prostatic Neoplasms
632.0	989.0		01/19/2010	825.0		632.0	./data/phs000219.v1.pht001048.v1.p1.phenotype.var_report_2010_01_19.xml	0.0	810.5	94.05	989.0			810.5		phs000219.v1.p1	Alzheimer Disease
			2021/01/08				./data/phs002309.v1.pht010841.v1.p1.Melanoma_Associated_Vitiligo_Sample_Attributes.var_report.xml									phs002309.v1.p1	Melanoma
			2017/09/22				./data/phs001392.v1.pht006893.v1.p1.pidtc_15611_ndbayleys.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			06/16/2017				./data/phs001278.v1.pht006278.v1.p1.physical_exam.var_report.xml									phs001278.v1.p1	Porphyrias
			10/13/2012				./data/phs000518.v1.pht002848.v1.p1.ESP_Family_Studies_IB_Sample.var_report.xml									phs000518.v1.p1	Bronchiectasis
			08/20/2013				./data/phs000285.v3.pht001639.v2.p2.B2F9PRG1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
3.0	3.0		2018/02/27	6.0		3.0	./data/phs001064.v1.pht006834.v1.p1.PC_SRC_Bladder_Subject_Phenotypes.var_report.xml	0.0	3.0	0	3.0			3.0		phs001064.v1.p1	Carcinoma, Signet Ring Cell
5.0	7.0		03/13/2015	8.0		5.0	./data/phs000873.v1.pht004556.v1.p1.Bleeding_Disorders_Pedigree.var_report.xml	0.0	6.0	2.828	7.0			6.0		phs000873.v1.p1	Thrombocytopenia
			2018/08/03				./data/phs000590.v1.pht008260.v1.p1.VCRC_5504_Subject.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			07/31/2015				./data/phs000957.v1.pht004853.v1.p1.eMERGE_III_MyCode_Sample.var_report.xml									phs000957.v1.p1	Aortic Aneurysm, Abdominal
			03/08/2011				./data/phs000124.v2.pht002173.v1.p1.COG_Neuroblastoma_Subject_Phenotypes.var_report_2011_03_08.xml									phs000124.v2.p1	Neuroblastoma
			2018/11/19				./data/phs000915.v2.pht004945.v2.p2.mCRPC_SU2C_Sample.var_report.xml									phs000915.v2.p2	Prostatic Neoplasms
			2019/08/01				./data/phs000222.v6.pht002874.v3.p2.Functional_P.var_report.xml									phs000222.v6.p2	Huntington Disease
9833.0	1853.0		2018/06/11	3028.0		9833.0	./data/phs000220.v2.pht002387.v2.p2.PAGE_MEC_Metabochip_Subject_Phenotypes.var_report.xml	0.0	1514.0	479.4	13606.0			1514.0		phs000220.v2.p2	Neoplasms
			2021/07/19				./data/phs001601.v2.pht010667.v1.p2.PMBB_AF_Sample_Attributes.var_report.xml									phs001601.v2.p2	Atrial Fibrillation
			2021/09/24				./data/phs001927.v1.pht011579.v1.p1.TOPMed_WGS_SPIROMICS_Sample.var_report.xml									phs001927.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/12/21				./data/phs000007.v32.pht000024.v5.p13.ex0_22s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/20				./data/phs000605.v1.pht007628.v1.p1.concurrent_medications_log.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			06/25/2013				./data/phs000354.v1.pht003349.v1.p1.ESP_Family_Studies_PAH_Subject_Phenotypes.var_report.xml									phs000354.v1.p1	Hypertension, Pulmonary
			06/27/2011				./data/phs000344.v1.pht002169.v1.p1.Finnish_ALS_Sample.var_report.xml									phs000344.v1.p1	Amyotrophic Lateral Sclerosis
			2020/06/18				./data/phs000280.v7.pht006452.v1.p1.MRW.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/12/20				./data/phs000577.v1.pht007264.v1.p1.ae_mro_review.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2019/02/05				./data/phs001158.v2.pht005595.v2.p1.Human_Dorsal_Root_Ganglion_Sample_Attributes.var_report.xml									phs001158.v2.p1	Chronic Pain
			2018/10/23				./data/phs001692.v1.pht008487.v1.p1.LIFE_Sample_Attributes.var_report.xml									phs001692.v1.p1	MicroRNAs
			2017/10/19				./data/phs001288.v1.pht006772.v1.p1.initial_hx.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/11/08				./data/phs001332.v2.pht007451.v2.p1.physical_exam.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2021/08/26				./data/phs001729.v2.pht010129.v1.p1.TOPMed_WGS_CARE_CLIC_Sample_Attributes.var_report.xml									phs001729.v2.p1	Asthma
			2020/08/04				./data/phs001793.v1.pht008900.v1.p1.PDGCL_Sample.var_report.xml									phs001793.v1.p1	Glioma
			2018/05/31				./data/phs001318.v1.pht008033.v1.p1.urinalysis.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			08/06/2010				./data/phs000182.v2.pht000797.v1.p1.AMD_MMAP_Sample.var_report.xml									phs000182.v2.p1	Macular Degeneration
			11/05/2014				./data/phs000209.v13.pht003090.v1.p3.MESA_AncilMesaVitaminK.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
95.0	97.0		Thu Oct  2 11:09:51 2008	99.0		98.0	./data/phs000125.v1.pht000320.v1.p1.COGA_SSAGA.var_report_2008_10_02.xml	994.0	99.5	9.899	96.0			99.5		phs000125.v1.p1	Alcoholism
			2020/06/18				./data/phs000280.v7.pht004027.v2.p1.ABI04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/10/19				./data/phs001288.v1.pht006774.v1.p1.labs_form.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2020/11/19				./data/phs002286.v1.pht010634.v1.p1.HPV16_E7_Sample.var_report.xml									phs002286.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht003317.v9.p13.vr_survdth_2018_a_1268s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/24				./data/phs001352.v1.pht007065.v1.p1.Travelers_Diarrhea_Sample.var_report.xml									phs001352.v1.p1	Diarrhea
			08/20/2013				./data/phs000285.v3.pht001558.v2.p2.A4COT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/04/24				./data/phs001829.v1.pht010168.v1.p1.Rectal_Chemoradiation_Sample_Attributes.var_report.xml									phs001829.v1.p1	Rectal Neoplasms
732.0	732.0		2018/03/08	69.0		413.0	./data/phs001494.v1.pht007192.v1.p1.ALIVE_Smokescreen_Subject_Phenotypes.var_report.xml	0.0	572.5	24.75	413.0			572.5		phs001494.v1.p1	Substance-Related Disorders
			02/29/2012				./data/phs000402.v1.pht002538.v1.p1.ESP_HeartGO_JHS_Sample.var_report_2012_02_29.xml									phs000402.v1.p1	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001054.v1.p1.d_bcu_exm.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			06/04/2013				./data/phs000581.v1.pht003207.v1.p1.ESP_Dilated_Cardiomyopathy_Sample_Attributes.var_report.xml									phs000581.v1.p1	Cardiomyopathy, Dilated
			2021/09/22				./data/phs001211.v4.pht005754.v4.p3.TOPMed_WGS_ARIC_Subject.var_report.xml									phs001211.v4.p3	Cardiovascular Diseases
			2019/12/26				./data/phs001889.v1.pht009738.v1.p1.ALS_TDP_Sample.var_report.xml									phs001889.v1.p1	Amyotrophic Lateral Sclerosis
			Wed Nov 19 17:41:25 2008				./data/phs000092.v1.pht000636.v1.p1.AlcoholDepAdd_Subject.var_report_2008_11_26.xml									phs000092.v1.p1	Alcoholism
695.0	2449.0		Mon Oct 27 16:30:03 2008	3741.0		552.0	./data/phs000020.v2.pht000070.v1.p1.NESDA_NTR_MDD_GAIN_data.var_report_2008_10_27.xml	0.0	910.5	567.6	2449.0		1.0	910.5		phs000020.v2.p1	Depressive Disorder, Major
			08/20/2013				./data/phs000285.v3.pht001807.v2.p2.F1CHEM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/16/2014				./data/phs000018.v2.pht004357.v1.p1.GoKinD_GAIN_Sample_Attributes.var_report.xml									phs000018.v2.p1	Diabetic Nephropathies
			11/18/2016				./data/phs001243.v1.pht005934.v1.p1.BRCA1_Carrier_Subject.var_report.xml									phs001243.v1.p1	Breast Neoplasms
			04/24/2015				./data/phs000629.v1.pht003388.v1.p1.Familial_Lung_Cancer_Sample_Attributes.var_report.xml									phs000629.v1.p1	Lung Neoplasms
			2020/06/18				./data/phs000280.v7.pht004124.v2.p1.LIPD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000232.v1.p1.DCCT_f0241.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
158.0			2019/11/08	346.0			./data/phs001332.v2.pht007445.v2.p1.demographics.var_report.xml	1.0			188.0					phs001332.v2.p1	Spinocerebellar Ataxias
			2021/05/24				./data/phs000922.v2.pht004927.v2.p1.CLL8_Cohort_Sample_Attributes.var_report.xml									phs000922.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			06/07/2016				./data/phs001111.v1.pht005496.v1.p1.CRC_Mutation_Classification_Subject.var_report.xml									phs001111.v1.p1	Colorectal Neoplasms
			2020/06/18				./data/phs000280.v7.pht004149.v2.p1.REXA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			03/24/2015				./data/phs000872.v1.pht004576.v1.p1.Autism_Postmortem_Brain_Sample_Attributes.var_report.xml									phs000872.v1.p1	Autistic Disorder
			2020/07/24				./data/phs002066.v1.pht010417.v1.p1.Genomic_Instability_Sample.var_report.xml									phs002066.v1.p1	Chromosome Fragile Sites
			2021/06/16				./data/phs001412.v3.pht006743.v2.p1.TOPMed_WGS_DHS_Subject.var_report.xml									phs001412.v3.p1	Cardiovascular Disease
			2021/06/03				./data/phs002417.v1.pht011273.v1.p1.FFCWS_Subject.var_report.xml									phs002417.v1.p1	Population Groups
564.0	564.0		02/29/2016	896.0		72.0	./data/phs000990.v1.pht004998.v1.p1.MIGen_Lubeck_Subject_Phenotypes.var_report.xml	0.0	588.7	503.6	616.0			616.0		phs000990.v1.p1	Myocardial Infarction
			01/18/2013				./data/phs000550.v1.pht003130.v1.p1.Pancreatic_Adenocarcinoma_Sample_Attributes.var_report.xml									phs000550.v1.p1	Pancreatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001659.v1.p2.C1F09MCH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
628.0	628.0		04/23/2010	3115.0		871.0	./data/phs000187.v1.pht000814.v1.p1.Melanoma_Data.var_report_2010_04_23.xml	0.0	530.0	362.7	871.0			530.0		phs000187.v1.p1	Melanoma
862.0	99.0		Thu Oct  2 11:09:39 2008	711.0		904.0	./data/phs000125.v1.pht000319.v1.p1.COGA_all_subjects.var_report_2008_10_02.xml	0.0	972.5	96.87	99.0			972.5		phs000125.v1.p1	Alcoholism
			05/11/2016				./data/phs000823.v1.pht005049.v1.p1.Melanoma_Predisposing_Mutations_Sample_Attributes.var_report.xml									phs000823.v1.p1	Melanoma
			09/08/2016				./data/phs000893.v1.pht005503.v1.p1.Endometrial_Cancer_E2C2_EXOME_Subject_Phenotypes.var_report.xml									phs000893.v1.p1	Carcinoma, Endometrioid
			2019/03/11				./data/phs000286.v6.pht008777.v1.p2.pericardialfat.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			12/18/2013				./data/phs000677.v1.pht003582.v1.p1.APOBEC_Cytidine_Deaminase_Sample.var_report.xml									phs000677.v1.p1	Neoplasms
			2021/09/24				./data/phs001726.v2.pht009837.v1.p1.TOPMed_WGS_CAMP_Sample_Attributes.var_report.xml									phs001726.v2.p1	Asthma
			05/02/2014				./data/phs000739.v1.pht003825.v1.p1.Ameloblastoma_Mutations_Subject.var_report.xml									phs000739.v1.p1	Ameloblastoma
			2019/12/11				./data/phs001906.v1.pht009659.v1.p1.GISTs_Subject.var_report.xml									phs001906.v1.p1	Gastrointestinal Stromal Tumors
			11/08/2013				./data/phs000200.v9.pht002755.v1.p3.fust_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/08/30				./data/phs001331.v2.pht006932.v2.p1.imd_onset_form.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
1.0	3.0		02/05/2016	4.0		2.0	./data/phs000944.v1.pht005288.v1.p1.eMERGE_PhaseIII_Partners_Biobank_Pedigree.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs000944.v1.p1	Hypercholesterolemia
			2020/01/23				./data/phs000287.v7.pht001459.v1.p1.CHS_CAC.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2019/10/02				./data/phs001901.v1.pht009500.v1.p1.CCDG_Coronary_Sample.var_report.xml									phs001901.v1.p1	Myocardial Infarction
			2018/06/14				./data/phs001238.v2.pht006050.v1.p1.GENOA_AfricanAmerican_Phase2_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2017/11/30				./data/phs000373.v1.pht007127.v1.p1.MrOS_Subject.var_report.xml									phs000373.v1.p1	Osteoporosis
			03/16/2015				./data/phs000868.v1.pht004587.v1.p1.Pediatric_Neuroblastoma_Subject.var_report.xml									phs000868.v1.p1	Neuroblastoma
292.0	735.0		11/06/2015	886.0		292.0	./data/phs001025.v1.pht005085.v1.p1.SLE_Amerindian_Hispanics_Subject_Phenotypes.var_report.xml	0.0	696.5	785.6	735.0			696.5		phs001025.v1.p1	Lupus Erythematosus, Systemic
			2020/09/04				./data/phs001993.v1.pht010087.v1.p1.NF1_AtypicalNeurofibromas_Sample_Attributes.var_report.xml									phs001993.v1.p1	Neurofibromatosis 1
			2020/06/18				./data/phs000280.v7.pht004126.v2.p1.MHXA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005566.v1.p1.15aGERD_hx_visits_A.var_report.xml									phs000888.v1.p1	
			2017/09/15				./data/phs001173.v1.pht005669.v1.p1.Head_Neck_Cancer_GWAS_Subject.var_report.xml									phs001173.v1.p1	Carcinoma, squamous cell of head and neck
			03/07/2016				./data/phs001084.v1.pht005329.v1.p1.Colorectal_Tumors_Primary_Metastatic_Sample_Attributes.var_report.xml									phs001084.v1.p1	Colorectal Neoplasms
8.0	8.0		03/10/2015	15.0		7.0	./data/phs000855.v1.pht004553.v1.p1.Lung_Cancer_Resistance_Subject_Phenotypes.var_report.xml	0.0	7.5	0.7071	7.0			7.5		phs000855.v1.p1	Carcinoma
			2018/06/01				./data/phs001538.v1.pht008096.v1.p1.Registry_Death.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			2021/04/16				./data/phs002398.v1.pht011125.v1.p1.PrCa_Subject_Phenotypes.var_report.xml									phs002398.v1.p1	Prostatic Neoplasms
			2019/07/26				./data/phs000588.v1.pht009288.v1.p1.angiogram_rightlowerextremity.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
	1001.0		04/04/2014	1001.0		1001.0	./data/phs000679.v1.pht003657.v1.p1.Anorexia_Nervosa_Subject_Phenotypes.var_report.xml	0.0	1001.0		1001.0			1001.0		phs000679.v1.p1	Anorexia Nervosa
			02/01/2016				./data/phs000332.v3.pht002336.v2.p2.CIDR_Preterm_Birth_Boston_Subject.var_report.xml									phs000332.v3.p2	Infant, Premature
			2020/12/21				./data/phs000007.v32.pht001178.v10.p13.ige_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000492.v2.p3.simphen093.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/04/2014				./data/phs000086.v3.pht000355.v1.p1.EDIC_f1402.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/03/04				./data/phs001969.v1.pht009935.v1.p1.CGD_TCL_Sample.var_report.xml									phs001969.v1.p1	Lymphoma, T-Cell, Cutaneous
1685.0	60412.0		05/16/2017	94432.0		34020.0	./data/phs001252.v1.pht006370.v1.p1.biomarka.var_report.xml	0.0	47216.0	18662	1053.0			47216.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			06/16/2017				./data/phs001278.v1.pht006282.v1.p1.registration.var_report.xml									phs001278.v1.p1	Porphyrias
			2021/01/26				./data/phs001451.v3.pht007132.v3.p1.Melanoma_Neoantigen_Vaccine_Sample.var_report.xml									phs001451.v3.p1	Melanoma
			2018/08/03				./data/phs000590.v1.pht008268.v1.p1.baseline_comordity_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			11/02/2015				./data/phs000639.v1.pht004778.v1.p1.Autism_Spectrum_Disorder_Subject.var_report.xml									phs000639.v1.p1	Autism Spectrum Disorder
			03/12/2013				./data/phs000343.v3.pht002724.v1.p1.enddth.var_report.xml									phs000343.v3.p1	Stroke
693.0	693.0		03/15/2012	1353.0		660.0	./data/phs000440.v1.pht002492.v1.p1.Marazita_Guatemala_PedigreeDS_Pedigree.var_report.xml	0.0	676.5	23.33	660.0			676.5		phs000440.v1.p1	Dental Caries
			2019/12/17				./data/phs001943.v1.pht009712.v1.p1.UM_Subject.var_report.xml									phs001943.v1.p1	Uveal melanoma
			2019/07/26				./data/phs000588.v1.pht009300.v1.p1.hospitalization_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/12/21				./data/phs000007.v32.pht002235.v6.p13.l_sst2_ex06_1_0532s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000607.v5.p13.cmrplaq1_2006s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/04/29				./data/phs000185.v7.pht008407.v1.p1.Hutterites_Nasal_Microbiome_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			2019/02/21	0.0			./data/phs001281.v2.pht006136.v2.p1.second_test_screening_form.var_report.xml	40.0								phs001281.v2.p1	Sturge-Weber Syndrome
			07/18/2014				./data/phs000733.v1.pht003820.v1.p1.Familial_Prostate_Cancer_Sample.var_report.xml									phs000733.v1.p1	Prostate cancer, familial
	9.0		2021/01/06	94.0		9.0	./data/phs001383.v1.pht010790.v1.p1.Moebius_Syndrome_Subject.var_report.xml	0.0	92.0	7.778				92.0		phs001383.v1.p1	Mobius Syndrome
			2018/05/22				./data/phs001314.v1.pht008000.v1.p1.intakeform.var_report.xml									phs001314.v1.p1	Steroid 21-Hydroxylase
			01/13/2012				./data/phs000380.v1.pht002457.v1.p1.METABOCHIP_Sample.var_report.xml									phs000380.v1.p1	Obesity
6.0	6.0		2021/08/05	9.0		3.0	./data/phs002499.v1.pht011446.v1.p1.CTCLs_JAK_STAT_Subject.var_report.xml	0.0	4.5	2.121	3.0			4.5		phs002499.v1.p1	Lymphoma, T-Cell, Cutaneous
			05/11/2016				./data/phs000823.v1.pht005046.v1.p1.Melanoma_Predisposing_Mutations_Subject.var_report.xml									phs000823.v1.p1	Melanoma
			2021/09/23				./data/phs001089.v4.pht005485.v4.p1.CSER_DD_ID_Children_Sample.var_report.xml									phs001089.v4.p1	Intellectual Disability
4.0	4.0		09/29/2014	5.0		1.0	./data/phs000797.v1.pht004269.v1.p1.CTLA4_Haploinsufficiency_Subject_Phenotypes.var_report.xml	0.0	2.5	2.121	1.0			2.5		phs000797.v1.p1	Autoimmune enteropathy
81.0	97.0		2020/03/09	92.0		75.0	./data/phs001491.v2.pht007252.v2.p1.CIDR_Tooth_Disorders_Pedigree.var_report.xml	0.0	88.0	9.192	97.0			88.0		phs001491.v2.p1	Amelogenesis Imperfecta
			11/16/2015				./data/phs000980.v1.pht004963.v1.p1.NSCLC_Pembrolizumab_Sample_Attributes.var_report.xml									phs000980.v1.p1	Carcinoma, Non-Small-Cell Lung
			2018/03/09				./data/phs001554.v1.pht007607.v1.p1.GECCO_CRC_Susceptibility_Subject.var_report.xml									phs001554.v1.p1	Colorectal Neoplasms
17.0			2018/08/18	30.0			./data/phs001049.v1.pht005229.v1.p1.Relapsed_SCLC_Subject_Phenotypes.var_report.xml	0.0			13.0					phs001049.v1.p1	Small Cell Lung Carcinoma
			02/18/2016				./data/phs001057.v1.pht005302.v1.p1.immport_linkage.var_report.xml									phs001057.v1.p1	Smallpox Vaccine
			2021/07/29				./data/phs001607.v3.pht010152.v3.p2.TOPMed_WGS_IPF_Sample_Attributes.var_report.xml									phs001607.v3.p2	Idiopathic Pulmonary Fibrosis
			11/14/2016				./data/phs000827.v3.pht004472.v3.p1.CSER_NCGENES_Sample_Attributes.var_report.xml									phs000827.v3.p1	Genetic Diseases, Inborn
			2018/06/01				./data/phs001317.v1.pht008046.v1.p1.psychologicalquestionsummary.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
			05/23/2012				./data/phs000409.v1.pht002738.v1.p1.WGS_Medulloblastoma_Sample_Attributes.var_report.xml									phs000409.v1.p1	Medulloblastoma
			2019/04/10				./data/phs001653.v1.pht008704.v1.p1.Holoprosencephaly_Sample.var_report.xml									phs001653.v1.p1	Holoprosencephaly
			2018/12/14				./data/phs001439.v1.pht006815.v1.p1.POP_Sample.var_report.xml									phs001439.v1.p1	Pelvic Organ Prolapse
104.0			2020/06/10	132.0			./data/phs001169.v2.pht006185.v2.p1.EAGLE_Lung_Adenocarcinoma_Subject_Phenotypes.var_report.xml	0.0			28.0					phs001169.v2.p1	Adenocarcinoma of lung
			2021/08/19				./data/phs001662.v2.pht010058.v1.p1.LTRC_R040_subject_diagnoses.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/08/24				./data/phs001501.v1.pht007225.v1.p1.Race_Genetics_BetaBlocker_Subject.var_report.xml									phs001501.v1.p1	Heart Failure
			2020/07/14				./data/phs001816.v1.pht009126.v1.p1.ASD_CRISPR_Sample_Attributes.var_report.xml									phs001816.v1.p1	Autism Spectrum Disorder
			2020/06/18				./data/phs000280.v7.pht004070.v2.p1.DTIC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010388.v1.p1.AREDS2_OPR_LE.var_report.xml									phs002015.v1.p1	Macular Degeneration
			08/20/2013				./data/phs000285.v3.pht001840.v2.p2.F1F68.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			02/05/2015				./data/phs000808.v1.pht004464.v1.p1.diLQTS_Susceptibility_Subject.var_report.xml									phs000808.v1.p1	Long QT Syndrome
			08/20/2013				./data/phs000285.v3.pht001726.v2.p2.D1F9MASA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/24				./data/phs001641.v1.pht010034.v1.p1.GeneticTestingResults.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2018/10/02				./data/phs001696.v1.pht008431.v1.p1.EAC_Chinese_Subject_Phenotypes.var_report.xml									phs001696.v1.p1	Esophageal Neoplasms
			03/28/2017				./data/phs001249.v1.pht006176.v1.p1.SCLC_Chemoresistance_Sample.var_report.xml									phs001249.v1.p1	Lung Neoplasms
			08/12/2016				./data/phs000888.v1.pht005576.v1.p1.emerge2_appendicitis_featuresdisease.var_report.xml									phs000888.v1.p1	
30.0			2017/09/18	55.0			./data/phs001310.v1.pht006867.v1.p1.demographic_form.var_report.xml	74.0			25.0					phs001310.v1.p1	Kartagener Syndrome
			2019/12/06				./data/phs001861.v1.pht009324.v1.p1.sc_UM_Sample.var_report.xml									phs001861.v1.p1	Uveal melanoma
645.0	645.0		2019/04/23	3147.0		790.0	./data/phs001804.v1.pht008963.v1.p1.GEODB_Pedigree.var_report.xml	0.0	982.5	922.8	790.0			982.5		phs001804.v1.p1	Opioid-Related Disorders
			2020/02/25				./data/phs001914.v1.pht009888.v1.p1.MSI_CRC_Subject.var_report.xml									phs001914.v1.p1	Colorectal Neoplasms
2.0	2.0		2021/03/30	3.0		1.0	./data/phs002146.v1.pht011084.v1.p1.Chromatin_Transcriptional_Regulation_Subject.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs002146.v1.p1	
438.0	813.0		04/23/2014	1251.0		438.0	./data/phs000378.v1.pht002318.v1.p1.CIDR_Dementia_Baseline_Data.var_report.xml	0.0	625.5	265.2	813.0			625.5		phs000378.v1.p1	Alzheimer Disease
9.0			2019/06/14	640.0			./data/phs000589.v1.pht009198.v1.p1.sf_36.var_report.xml	4.0			127.0					phs000589.v1.p1	Takayasu Arteritis
			2018/02/08				./data/phs001488.v1.pht007414.v1.p1.pecn.var_report.xml									phs001488.v1.p1	Huntington Disease
			2018/09/19				./data/phs000257.v3.pht003092.v1.p1.HMP_Gut_Crohns_Function_Subject_Phenotypes_16SrRNA.var_report.xml									phs000257.v3.p1	Crohn Disease
			2019/06/24				./data/phs001784.v1.pht009001.v1.p1.HCC_Imaging_Sample.var_report.xml									phs001784.v1.p1	Carcinoma, Hepatocellular
			2017/09/27				./data/phs000747.v2.pht003843.v2.p1.IBBE_Sporadic_ALS_Subject.var_report.xml									phs000747.v2.p1	Amyotrophic Lateral Sclerosis
			03/19/2015				./data/phs000885.v1.pht004606.v1.p1.HCC_CAGE_Profiling_ncRNAs_Sample_Attributes.var_report.xml									phs000885.v1.p1	Carcinoma, Hepatocellular
91.0	91.0		03/31/2017	175.0		84.0	./data/phs000558.v1.pht006230.v1.p1.NEIGHBOR_POAG_Subject_Phenotypes.var_report.xml	0.0	87.5	4.95	84.0			87.5		phs000558.v1.p1	Glaucoma
			05/23/2014				./data/phs000612.v1.pht003529.v1.p1.Adenoid_Cystic_Carcinoma_Sample_Attributes.var_report.xml									phs000612.v1.p1	Cancer
1.0	1.0		2020/07/24	2.0		1.0	./data/phs002066.v1.pht010416.v1.p1.Genomic_Instability_Subject.var_report.xml	0.0	1.0	0				1.0		phs002066.v1.p1	Chromosome Fragile Sites
			07/17/2012				./data/phs000314.v1.pht002070.v1.p1.CIDR_Clubfoot_Sample.var_report.xml									phs000314.v1.p1	Clubfoot
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000590.v2.p3.simphen191.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2017/09/22				./data/phs001460.v1.pht006911.v1.p1.Recurrent_Glioblastoma_Sample.var_report.xml									phs001460.v1.p1	Glioblastoma
			04/19/2012				./data/phs000444.v1.pht002701.v1.p1.Italian_Primary_Biliary_Cirrhosis_Subject.var_report.xml									phs000444.v1.p1	Liver Cirrhosis, Biliary
			01/26/2015				./data/phs000807.v1.pht004386.v1.p1.CALGB40101_Early_Breast_Cancer_Subject.var_report.xml									phs000807.v1.p1	Breast Neoplasms
			2019/10/02				./data/phs001901.v1.pht009501.v1.p1.CCDG_Coronary_Subject_Phenotypes.var_report.xml									phs001901.v1.p1	Myocardial Infarction
			11/04/2014				./data/phs000086.v3.pht000247.v1.p1.DCCT_f0481.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/03/11				./data/phs000286.v6.pht008727.v1.p2.allevthf.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht002705.v1.p3.MESA_AncilMesaBMD.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007395.v1.p1.genphyex.var_report.xml									phs001488.v1.p1	Huntington Disease
13495.0	15325.0		2019/12/26	28820.0		13495.0	./data/phs001949.v1.pht009706.v1.p1.P3DT_Subject_Phenotypes.var_report.xml	0.0	14410.0	1294	15325.0			14410.0		phs001949.v1.p1	Diabetes Mellitus, Type 1
			2018/11/16				./data/phs001272.v1.pht007304.v1.p1.Broad_CMG_Sample_Attributes.var_report.xml									phs001272.v1.p1	Genetic Diseases, Inborn
			06/01/2012				./data/phs000484.v1.pht002681.v1.p1.Inherited_Kidney_Dysfunction_Subject.var_report.xml									phs000484.v1.p1	Glomerulosclerosis, Focal Segmental 
			08/20/2013				./data/phs000285.v3.pht001675.v2.p2.C1F35.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/08/18				./data/phs001475.v1.pht007583.v1.p1.Infection_Malnutrition_Bangladesh_Sample.var_report.xml									phs001475.v1.p1	Sprue, Tropical
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000496.v2.p3.simphen097.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000484.v2.p3.simphen085.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/06/30				./data/phs001625.v1.pht008184.v1.p1.Psychotic_Major_Depression_Sample.var_report.xml									phs001625.v1.p1	Control Groups
			2018/10/24				./data/phs001693.v1.pht008491.v1.p1.Maternal_Fetal_IR_Sample_Attributes.var_report.xml									phs001693.v1.p1	MicroRNAs
			2020/12/21				./data/phs000007.v32.pht006020.v1.p13.vr_meno_ex02_2_0719s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/10				./data/phs001493.v2.pht007296.v1.p1.RCC_Immune_Checkpoint_Subject.var_report.xml									phs001493.v2.p1	Carcinoma, Renal Cell
			2017/10/11				./data/phs000578.v1.pht007005.v1.p1.aprtrs_episode_report.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			06/15/2017				./data/phs001229.v1.pht006550.v1.p1.Follicular_Lymphoma_Seq_Sample_Attributes.var_report.xml									phs001229.v1.p1	Lymphoma, Follicular
			2021/04/09				./data/phs002316.v1.pht011112.v1.p1.TEA_seq_Sample_Attributes.var_report.xml									phs002316.v1.p1	
			02/09/2017				./data/phs001082.v1.pht005378.v1.p1.VZV_TCell_Subject.var_report.xml									phs001082.v1.p1	Herpes Zoster
			2019/03/28				./data/phs001794.v1.pht008903.v1.p1.BWS_miRNA_Subject.var_report.xml									phs001794.v1.p1	Beckwith-Wiedemann Syndrome
			11/04/2014				./data/phs000086.v3.pht000263.v1.p1.DCCT_f0217.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
685.0	685.0		2020/03/09	979.0		294.0	./data/phs001135.v2.pht005985.v1.p1.START_Subject_Phenotypes.var_report.xml	0.0	489.5	276.5	294.0			489.5		phs001135.v2.p1	Opioid-Related Disorders
			2019/09/27				./data/phs001709.v1.pht009495.v1.p1.CMI_MBC_Sample_Attributes.var_report.xml									phs001709.v1.p1	Breast Neoplasms
			2017/12/20	24.0			./data/phs000577.v1.pht007274.v1.p1.medicalrecordreviewform.var_report.xml	0.0								phs000577.v1.p1	Urea Cycle Disorders, Inborn
			11/14/2016				./data/phs000827.v3.pht004469.v3.p1.CSER_NCGENES_Subject.var_report.xml									phs000827.v3.p1	Genetic Diseases, Inborn
298.0	380.0		2020/07/17	678.0		298.0	./data/phs001995.v1.pht009993.v1.p1.Himba_Subject_Phenotypes.var_report.xml	0.0	339.0	57.98	380.0			339.0		phs001995.v1.p1	Sex
			08/20/2013				./data/phs000285.v3.pht001612.v2.p2.B2F09MHB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/15				./data/phs001473.v1.pht009689.v1.p1.Ibrutinib_CLL_Subject_Phenotypes.var_report.xml									phs001473.v1.p1	Leukemia, Lymphoid
			2019/09/16				./data/phs001718.v1.pht009424.v1.p1.C9ORF72_Subject.var_report.xml									phs001718.v1.p1	Amyotrophic Lateral Sclerosis
			2021/05/13				./data/phs001423.v3.pht006987.v3.p2.TIC_Genetics_WES_Sample_Attributes.var_report.xml									phs001423.v3.p2	Tourette Disorder
90.0	90.0		2020/08/05	9924.0		81.0	./data/phs001856.v1.pht009599.v1.p1.CORECT_Axiom_Subject_Phenotypes.var_report.xml	0.0	93.0	91.22	822.0			93.0		phs001856.v1.p1	Colorectal Neoplasms
1691.0	11883.0		05/16/2017	19315.0		7432.0	./data/phs001252.v1.pht006393.v1.p1.pft.var_report.xml	0.0	9658.0	3147	1055.0			9658.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2020/03/19				./data/phs001990.v1.pht010020.v1.p1.Aneurysmal_SAH_Sample_Attributes.var_report.xml									phs001990.v1.p1	Subarachnoid Hemorrhage
271.0	271.0		2020/05/13	499.0		228.0	./data/phs002024.v1.pht010233.v1.p1.DCCT_EDIC_DNAme_Subject_Phenotypes.var_report.xml	0.0	249.5	30.41	228.0			249.5		phs002024.v1.p1	Diabetes Mellitus, Type 1
			2017/08/14				./data/phs000803.v2.pht004565.v2.p1.Colon_Cancer_Sample.var_report.xml									phs000803.v2.p1	Colonic Neoplasms
			2020/03/13				./data/phs000521.v2.pht007047.v2.p1.sf10_for_age5_13.var_report.xml									phs000521.v2.p1	Ataxia
			2019/06/07				./data/phs001340.v1.pht009155.v1.p1.RA_Sample.var_report.xml									phs001340.v1.p1	Arthritis, Rheumatoid
			2018/04/04				./data/phs001527.v1.pht007518.v1.p1.Oral_Microbiome_EAC_Sample.var_report.xml									phs001527.v1.p1	Esophageal Neoplasms
			2020/02/14				./data/phs000575.v2.pht005885.v2.p1.behaviorhistory.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			2020/12/21				./data/phs000007.v32.pht000211.v5.p13.t_tonla_ex26_0_1229s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/03/01				./data/phs002294.v1.pht010812.v1.p1.HGSOC_Sample_Attributes.var_report.xml									phs002294.v1.p1	Ovarian Neoplasms
			11/04/2014				./data/phs000086.v3.pht000227.v1.p1.DCCT_m9exdka.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			12/11/2009				./data/phs000181.v1.pht000894.v1.p1.OZALC_Sample.var_report_2009_12_11.xml									phs000181.v1.p1	Alcohol-Related Disorders
			11/13/2015				./data/phs000820.v1.pht004331.v1.p1.Lone_Atrial_Fibrillation_Sample.var_report.xml									phs000820.v1.p1	Atrial Fibrillation
			2018/05/17				./data/phs001313.v1.pht007974.v1.p1.registration.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			08/20/2013				./data/phs000285.v3.pht001731.v2.p2.D1F9MOTA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000764.v1.p1.MS_DATA_MHQCOUNTRY.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2019/08/01				./data/phs001740.v1.pht008624.v1.p1.CCDG_SAGE_Sample_Attributes.var_report.xml									phs001740.v1.p1	Autism Spectrum Disorder
			2021/03/10				./data/phs001619.v3.pht008178.v3.p1.IRD_Sample_Attributes.var_report.xml									phs001619.v3.p1	Retinal Degeneration
			02/23/2016				./data/phs001038.v1.pht005206.v1.p1.Melanoma_DNMTi_Immunotherapy_Subject.var_report.xml									phs001038.v1.p1	Melanoma
			10/16/2014				./data/phs000376.v1.pht002310.v1.p1.CIDR_PD_Exome_Sample_Attributes.var_report.xml									phs000376.v1.p1	Parkinson Disease
			2021/05/20				./data/phs001032.v6.pht005099.v3.p2.TOPMed_WGS_VUH_AF_Sample.var_report.xml									phs001032.v6.p2	Atrial Fibrillation
			2018/02/08				./data/phs001531.v1.pht007442.v1.p1.Turner_Syndrome_BAV_Sample_Attributes.var_report.xml									phs001531.v1.p1	Turner Syndrome
			2019/11/27				./data/phs001177.v2.pht005664.v2.p1.Familial_Melanoma_Subject.var_report.xml									phs001177.v2.p1	Melanoma, Cutaneous Malignant
			2020/12/21				./data/phs000007.v32.pht000822.v7.p13.hgf3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003604.v2.p3.MESA_AncilMesaNeighborScalesExam5.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			07/31/2012				./data/phs000449.v2.pht002779.v2.p1.Genetic_Adaptation_African_Sample.var_report.xml									phs000449.v2.p1	Population Control
			11/08/2013				./data/phs000200.v9.pht001026.v4.p3.f92_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/12/21				./data/phs000007.v32.pht000093.v8.p13.icam1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002076.v7.p13.l_neurofact_2001_m_0546s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/01/29				./data/phs001767.v1.pht008660.v1.p1.GC_miRNA_Korean_Sample.var_report.xml									phs001767.v1.p1	Circulating MicroRNA
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000561.v2.p3.simphen162.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/05/15				./data/phs001311.v1.pht007925.v1.p1.prolonged_excercise_test.var_report.xml									phs001311.v1.p1	Myotonia
			2018/01/30				./data/phs000912.v1.pht004730.v1.p1.Breast_Cancer_Latina_Subject.var_report.xml									phs000912.v1.p1	Breast Neoplasms
			2017/10/19				./data/phs001448.v1.pht007029.v1.p1.ESCC_Sub_Saharan_Subject.var_report.xml									phs001448.v1.p1	Esophageal Neoplasm
			2018/08/03				./data/phs000590.v1.pht008285.v1.p1.tobacco_alcohol_drug_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
1323.0	7510.0		05/16/2017	11562.0		4052.0	./data/phs001252.v1.pht006375.v1.p1.borg6mwt.var_report.xml	0.0	5781.0	2445	709.0			5781.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
23.0			2018/12/06	35.0			./data/phs001688.v1.pht008592.v1.p1.Psoriasis_Secukinumab_Subject_Phenotypes.var_report.xml	0.0			12.0					phs001688.v1.p1	Psoriasis
84.0			2021/05/20	128.0			./data/phs001024.v5.pht005693.v1.p1.TOPMed_WGS_Partners_AFGen_Subject_Phenotypes.var_report.xml	0.0			44.0					phs001024.v5.p1	Atrial Fibrillation
			2019/03/11				./data/phs000286.v6.pht001957.v2.p2.hcaa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
69.0			2020/12/01	219.0			./data/phs002105.v1.pht010707.v1.p1.Opioid_Pharmacogenomics_Children_Subject_Phenotypes.var_report.xml	0.0			150.0					phs002105.v1.p1	Opioid-Related Disorders
2.0	207.0		2019/11/22	385.0		2.0	./data/phs001325.v3.pht006350.v1.p1.iPSCORE_WGS_Pedigree.var_report.xml	0.0	2.0	24.04	207.0			2.0		phs001325.v3.p1	Heart Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000499.v2.p3.simphen100.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/25/2014				./data/phs000335.v3.pht002115.v2.p2.LHS_COPD_Sample.var_report.xml									phs000335.v3.p2	COPD
			2018/03/09				./data/phs000606.v1.pht007566.v1.p1.RTD_5801_Subject.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007807.v1.p1.p6902_17146_treatment.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/06/18				./data/phs000280.v7.pht004093.v2.p1.FTRC04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001019.v4.p3.f80_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			08/06/2015				./data/phs000934.v1.pht004878.v1.p1.Antibody_Repertoires_CVID_Sample.var_report.xml									phs000934.v1.p1	Common Variable Immunodeficiency
94.0	55.0		2018/11/19	300.0		94.0	./data/phs001178.v1.pht008548.v1.p1.GMKF_DSD_Pedigree.var_report.xml	0.0	98.5	85.74	47.0			98.5		phs001178.v1.p1	Disorders of Sex Development
	9.0		2018/08/13	34.0		8.0	./data/phs001535.v1.pht008294.v1.p1.DDP_Subject_Phenotypes.var_report.xml	0.0	8.5	1.414	34.0			8.5		phs001535.v1.p1	Diabetes, Gestational
			2018/05/03				./data/phs000304.v3.pht001906.v2.p1.GABC_Sample.var_report.xml									phs000304.v3.p1	von Willebrand Disease
			2020/06/18				./data/phs000280.v7.pht006461.v1.p1.PAC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/06/14				./data/phs001833.v1.pht009151.v1.p1.MS_Severity_Sample.var_report.xml									phs001833.v1.p1	Multiple Sclerosis
			2019/09/27				./data/phs001576.v2.pht008224.v2.p2.P6705_CONCLUSION_OF_STUDY_PARTI.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			06/07/2016				./data/phs001111.v1.pht005497.v1.p1.CRC_Mutation_Classification_Sample.var_report.xml									phs001111.v1.p1	Colorectal Neoplasms
82.0	95.0		08/18/2011	350.0		82.0	./data/phs000302.v1.pht002178.v1.p1.T2D_Proteinuria_Subject_Phenotypes.var_report.xml	0.0	88.5	9.192	95.0			88.5		phs000302.v1.p1	Diabetic Nephropathies
			2018/10/24				./data/phs001694.v1.pht008492.v1.p1.HIV_CSF_Subject.var_report.xml									phs001694.v1.p1	MicroRNAs
			2020/12/21				./data/phs000007.v32.pht000908.v10.p13.vr_afcum_2019_a_1186s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/19				./data/phs001168.v2.pht007581.v2.p2.GMKF_OFC_Sample_Attributes.var_report.xml									phs001168.v2.p2	Cleft Lip
			2020/02/27				./data/phs001774.v1.pht008804.v1.p1.AVSD_Sample.var_report.xml									phs001774.v1.p1	Complete atrioventricular septal defect
			2021/01/21				./data/phs002291.v1.pht010803.v1.p1.HSPCs_Aging_MBM_Sample_Attributes.var_report.xml									phs002291.v1.p1	Multiple Myeloma
			11/05/2014				./data/phs000209.v13.pht002102.v2.p3.MESA_AncilMesaLungExam3CT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
242.0	607.0		2021/10/19	849.0		242.0	./data/phs002632.v1.pht011605.v1.p1.AA_KRT82_Subject.var_report.xml	0.0	424.5	258.1	607.0			424.5		phs002632.v1.p1	Alopecia Areata
			2018/11/13				./data/phs001523.v1.pht007510.v1.p1.phenotype_clinical.var_report.xml									phs001523.v1.p1	Pregnancy
			11/25/2016				./data/phs000907.v1.pht004697.v1.p1.Lung_Cancer_Brain_Metastasis_Subject_Phenotypes.var_report.xml									phs000907.v1.p1	Squamous Cell Carcinoma
48.0	52.0		08/31/2015	100.0		48.0	./data/phs000958.v1.pht004959.v1.p1.CSER_MedSeq_MedSeq_Subject_Phenotypes.var_report.xml	0.0	50.0	2.828	52.0			50.0		phs000958.v1.p1	Cardiomyopathies
			2021/05/21				./data/phs002331.v1.pht011102.v1.p1.DASH_Sample.var_report.xml									phs002331.v1.p1	Drug Users
			2019/10/11				./data/phs001406.v1.pht007743.v1.p1.acute_topiramate_surveyds.var_report.xml									phs001406.v1.p1	Cognition
			2018/09/19				./data/phs001581.v1.pht008384.v1.p1.HNSCC_Cell_Lines_Sample_Attributes.var_report.xml									phs001581.v1.p1	Head and Neck Neoplasms
38.0	38.0		2019/03/22	62.0		9.0	./data/phs001597.v1.pht008126.v1.p1.Bevacizumab_Hypertension_Subject_Phenotypes.var_report.xml	0.0	9.5	9.899	9.0			9.5		phs001597.v1.p1	Hypertension
			2021/06/24				./data/phs001446.v2.pht009629.v1.p1.TOPMed_WGS_SARP_Sample_Attributes.var_report.xml									phs001446.v2.p1	Asthma
			2019/12/17				./data/phs001943.v1.pht009714.v1.p1.UM_Sample.var_report.xml									phs001943.v1.p1	Uveal melanoma
			2020/06/18				./data/phs000280.v7.pht009475.v1.p1.GNDps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000097.v3.p13.dis0_18s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/10/05				./data/phs001432.v1.pht006976.v1.p1.Tumor_Heterogeneity_Thoracic_Subject.var_report.xml									phs001432.v1.p1	Adenocarcinoma of lung
			2020/12/21				./data/phs000007.v32.pht002073.v4.p13.t_ecgcc_1998_m_0551s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001568.v2.p2.A4F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/11/2015				./data/phs000941.v1.pht004902.v1.p1.Melanoma_Metastasis_Sample.var_report.xml									phs000941.v1.p1	Melanoma
36.0	36.0		2020/06/11	71.0		1.0	./data/phs002000.v1.pht010120.v1.p1.HC_Mongolian_Subject_Phenotypes.var_report.xml	0.0	23.67	19.66	34.0			34.0		phs002000.v1.p1	Carcinoma, Hepatocellular
801.0	801.0		2021/05/05	395.0		98.0	./data/phs002310.v1.pht011204.v1.p1.InC3_Subject.var_report.xml	0.0	960.5	543.8	98.0			960.5		phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			09/16/2013				./data/phs000328.v2.pht002134.v2.p1.DLBCL_Sample_Attributes.var_report.xml									phs000328.v2.p1	Lymphoma, Large B-Cell, Diffuse
			2018/05/31				./data/phs001318.v1.pht008037.v1.p1.deathrecord.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2020/09/18				./data/phs002015.v1.pht010381.v1.p1.AREDS2_FAM.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2021/05/11				./data/phs002340.v1.pht010938.v1.p1.scAtlas_Gynecological_Malignancies_Subject_Phenotypes.var_report.xml									phs002340.v1.p1	Carcinoma, Ovarian Epithelial
13.0	13.0		08/27/2013	13.0		13.0	./data/phs000647.v1.pht003471.v1.p1.Hypoxia_Tolerance_Ethiopian_Highlanders_Subject_Phenotypes.var_report.xml	0.0	13.0					13.0		phs000647.v1.p1	Cell Hypoxia
			01/23/2017				./data/phs001246.v1.pht006084.v1.p1.Arhinia_Sample.var_report.xml									phs001246.v1.p1	Arhinia, choanal atresia, and microphthalmia
			01/19/2010				./data/phs000219.v1.pht001078.v1.p1.d_destruct.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			04/09/2014				./data/phs000437.v1.pht003691.v1.p1.Auriculocondylar_Syndrome_Sample_Attributes.var_report.xml									phs000437.v1.p1	Auriculo-condylar syndrome
55.0			11/27/2013	92.0			./data/phs000504.v2.pht002822.v2.p2.Medulloblastoma_Subject_Phenotypes.var_report.xml	0.0			37.0					phs000504.v2.p2	Medulloblastoma
			06/16/2017				./data/phs001278.v1.pht006265.v1.p1.concomitant_meds.var_report.xml									phs001278.v1.p1	Porphyrias
			2018/01/29				./data/phs001245.v1.pht005929.v1.p1.CD70_Subject.var_report.xml									phs001245.v1.p1	Immunologic Deficiency Syndromes
			2018/02/08				./data/phs001488.v1.pht007423.v1.p1.tel.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/03/24				./data/phs001641.v1.pht010026.v1.p1.PersonalHistory.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2019/09/27				./data/phs001648.v2.pht008907.v1.p1.mCRPC_Subject.var_report.xml									phs001648.v2.p1	Prostatic Neoplasms, Castration-Resistant
			05/04/2011				./data/phs000361.v1.pht002221.v1.p1.CGEMS_UpperGastrointestinalCancers_Subject.var_report.xml									phs000361.v1.p1	Intestinal Neoplasms
			2019/10/07				./data/phs000924.v4.pht006324.v4.p1.iPSCORE_Sample_Attributes.var_report.xml									phs000924.v4.p1	Heart Diseases
5275.0	5386.0		12/11/2009	6775.0		675.0	./data/phs000181.v1.pht000794.v1.p1.OZALC_Pedigree.var_report_2009_12_11.xml	0.0	885.0	78.49	675.0			885.0		phs000181.v1.p1	Alcohol-Related Disorders
			2021/08/11				./data/phs002056.v1.pht010450.v1.p1.CIDR_PC_AS_Subject.var_report.xml									phs002056.v1.p1	Prostatic Neoplasms
489.0			2017/12/04	990.0			./data/phs001419.v1.pht007087.v1.p1.demographics.var_report.xml	1.0			501.0					phs001419.v1.p1	Charcot-Marie-Tooth Disease
573.0	545.0		2020/08/05	887.0		573.0	./data/phs001815.v1.pht009011.v1.p1.MHGRID_Subject_Phenotypes.var_report.xml	0.0	818.5	347.2	545.0			818.5		phs001815.v1.p1	Hypertension
			2020/10/27				./data/phs001616.v2.pht008539.v2.p2.eMERGEseq_Subject.var_report.xml									phs001616.v2.p2	Precision Medicine
607.0	607.0		01/20/2016	784.0		91.0	./data/phs000902.v1.pht004670.v1.p1.MIGen_Regicor_Subject_Phenotypes.var_report.xml	0.0	392.0	304.1	91.0			392.0		phs000902.v1.p1	Coronary Artery Disease
			08/20/2013				./data/phs000285.v3.pht001848.v2.p2.F1LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/07/25				./data/phs001045.v1.pht009262.v1.p1.MECC_Ashkenazi_Sample_Attributes.var_report.xml									phs001045.v1.p1	Colorectal Neoplasms
33200.0	47621.0		2018/02/01	80834.0		47.0	./data/phs000788.v2.pht004626.v2.p3.RPGEH_Pedigree.var_report.xml	0.0	26945.0	24390	47634.0			33166.0		phs000788.v2.p3	Aging
			2020/06/18				./data/phs000280.v7.pht006462.v1.p1.PEX.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/09/06				./data/phs000554.v1.pht003196.v1.p1.CRPC_Subject_Phenotypes.var_report.xml									phs000554.v1.p1	Prostatic Neoplasms
			07/21/2010				./data/phs000239.v2.pht001221.v2.p1.MS_MZTwins_Sample.var_report_2010_07_21.xml									phs000239.v2.p1	Multiple Sclerosis
928.0	928.0		2020/07/20	3999.0		896.0	./data/phs002025.v1.pht010237.v1.p1.TB_3q23_Peruvians_Subject_Phenotypes.var_report.xml	0.0	912.0	398.1	896.0			912.0		phs002025.v1.p1	Tuberculosis, Pulmonary
			2021/02/23				./data/phs002230.v1.pht010963.v1.p1.TSP_Hypertension_Sample.var_report.xml									phs002230.v1.p1	Hypertension
			2018/08/03				./data/phs000590.v1.pht008269.v1.p1.baseline_vasculitis_med_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			05/13/2011				./data/phs000351.v1.pht002204.v1.p1.CGEMS_RenalCellCarcinoma_Subject.var_report.xml									phs000351.v1.p1	Carcinoma, Renal Cell
5.0			2017/12/08	11.0			./data/phs001279.v1.pht007213.v1.p1.medical_history.var_report.xml	27.0			6.0					phs001279.v1.p1	Bronchiectasis
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000460.v2.p3.simphen061.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/11/12				./data/phs001575.v2.pht008206.v1.p1.LDN_6716_Subject.var_report.xml									phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2020/02/06				./data/phs001430.v2.pht008057.v2.p1.p7001_16086_developme.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2018/03/20	285.0			./data/phs000605.v1.pht007640.v1.p1.sf_36.var_report.xml	1.0			89.0					phs000605.v1.p1	Lymphangioleiomyomatosis
32.0	32.0		2021/01/07	32.0		32.0	./data/phs002083.v1.pht010654.v1.p1.TS_ccRCC_Subject.var_report.xml	0.0	32.0					32.0		phs002083.v1.p1	Carcinoma, Renal Cell
			2018/09/07				./data/phs001577.v1.pht008351.v1.p1.mCRPC_Sample.var_report.xml									phs001577.v1.p1	Prostatic Neoplasms, Castration-Resistant
			2020/03/19				./data/phs001982.v1.pht010007.v1.p1.MFS_UPS_Sample_Attributes.var_report.xml									phs001982.v1.p1	Sarcoma, Soft Tissue
			2021/08/19				./data/phs001662.v2.pht010071.v1.p1.LTRC_R040_subject_sf12_surv.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
12.0			2017/09/22	16.0			./data/phs001460.v1.pht006912.v1.p1.Recurrent_Glioblastoma_Subject_Phenotypes.var_report.xml	0.0			4.0					phs001460.v1.p1	Glioblastoma
			2019/05/30				./data/phs000424.v8.pht002743.v8.p2.GTEx_Sample_Attributes.var_report.xml									phs000424.v8.p2	Reference Values
			2018/04/16				./data/phs001326.v1.pht007804.v1.p1.pidtc_17607_baselinea.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2019/11/15				./data/phs000700.v2.pht003648.v2.p1.Roadmap_Epigenomics_Broad_Subject.var_report.xml									phs000700.v2.p1	Nervous System Diseases
			11/06/2015				./data/phs001025.v1.pht005086.v1.p1.SLE_Amerindian_Hispanics_Sample_Attributes.var_report.xml									phs001025.v1.p1	Lupus Erythematosus, Systemic
			2020/06/18				./data/phs000280.v7.pht004065.v2.p1.DERIVE47.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004121.v2.p1.LIPA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/05/21				./data/phs002411.v1.pht011242.v1.p1.BRCA1_BRCA2_Sample_Attributes.var_report.xml									phs002411.v1.p1	Breast
			2021/04/07				./data/phs002304.v1.pht010852.v1.p1.GEARS_Sample_Attributes.var_report.xml									phs002304.v1.p1	Rhabdomyosarcoma
			2018/02/27				./data/phs001364.v1.pht007467.v1.p1.HCP_Young_Adults_Sample_Attributes.var_report.xml									phs001364.v1.p1	Connectome
			06/10/2015				./data/phs000918.v1.pht004749.v1.p1.IPDGC_NeuroX_Subject_Phenotypes.var_report.xml									phs000918.v1.p1	Parkinson Disease
			2020/04/15				./data/phs001894.v1.pht009525.v1.p1.CCDG_HMCA_Sample_Attributes.var_report.xml									phs001894.v1.p1	Autism Spectrum Disorder
61.0	61.0		06/04/2013	51.0		59.0	./data/phs000581.v1.pht003204.v1.p1.ESP_Dilated_Cardiomyopathy_Pedigree.var_report.xml	0.0	60.0	4.95	59.0			60.0		phs000581.v1.p1	Cardiomyopathy, Dilated
			2019/03/11				./data/phs000286.v6.pht008745.v1.p2.disb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2017/09/18				./data/phs001310.v1.pht006874.v1.p1.volumetric_chest_ct.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			11/04/2014				./data/phs000086.v3.pht000333.v1.p1.EDIC_f0423.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/05/24				./data/phs000929.v1.pht007983.v1.p1.High_Risk_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs000929.v1.p1	Breast Neoplasms
			2017/12/04				./data/phs001419.v1.pht007097.v1.p1.rd_20806_minimaldatas.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2021/06/07				./data/phs002440.v1.pht011284.v1.p1.ALS_NMJ_Subject_Phenotypes.var_report.xml									phs002440.v1.p1	Amyotrophic Lateral Sclerosis
			11/08/2013				./data/phs000200.v9.pht001022.v4.p3.f83_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/07/24				./data/phs001194.v3.pht005829.v2.p2.PatientDiagnosis.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			06/01/2010				./data/phs000138.v2.pht000619.v2.p1.Bone_Fragility_Subject.var_report_2010_06_01.xml									phs000138.v2.p1	Osteoporosis
			2019/05/01				./data/phs001753.v1.pht009019.v1.p1.Nama_Pigmentation_Sample_Attributes.var_report.xml									phs001753.v1.p1	Skin Pigmentation
175.0	175.0		2018/08/19	276.0		101.0	./data/phs000101.v5.pht000186.v1.p1.ALS_First_Stage_Cases.var_report.xml	0.0	138.0	52.33	101.0			138.0		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			09/09/2013				./data/phs000266.v4.pht001446.v4.p1.HMP_Dermatitis_Immunodeficiency_MRSA_GenBank.var_report.xml									phs000266.v4.p1	Dermatitis, Atopic
			2019/06/14				./data/phs000589.v1.pht009179.v1.p1.angiogram_rightlowerextremity.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/13/2015				./data/phs000730.v1.pht005058.v1.p1.Brain_Metastasis_Subject.var_report.xml									phs000730.v1.p1	Neoplasms
			2021/02/02				./data/phs002327.v1.pht010916.v1.p1.ATR_Stress_Tumors_Sample.var_report.xml									phs002327.v1.p1	Small Cell Lung Carcinoma
			2017/11/01				./data/phs001305.v1.pht007109.v1.p1.physicalexam.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			2019/06/11				./data/phs001807.v1.pht008976.v1.p1.InTEAM_Subject.var_report.xml									phs001807.v1.p1	Hepatitis, Alcoholic
			2017/08/24				./data/phs001433.v1.pht006810.v1.p1.HB_Wnt_Bcatenin_Subject.var_report.xml									phs001433.v1.p1	Hepatoblastoma
			11/08/2013				./data/phs000200.v9.pht001516.v3.p3.f151_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			Wed Nov 26 07:33:36 2008				./data/phs000017.v3.pht000056.v1.p1.EA_DIGS2_Data.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			08/20/2013				./data/phs000285.v3.pht001770.v2.p2.E1F09MHB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/19				./data/phs001448.v1.pht007031.v1.p1.ESCC_Sub_Saharan_Subject_Phenotypes.var_report.xml									phs001448.v1.p1	Esophageal Neoplasm
24.0	24.0		04/22/2014	30.0		6.0	./data/phs000740.v1.pht003817.v1.p1.Waldenstroms_Macroglobulinemia_Subject_Phenotypes.var_report.xml	0.0	15.0	12.73	6.0			15.0		phs000740.v1.p1	Waldenstrom Macroglobulinemia
			11/26/2013				./data/phs000597.v1.pht003202.v1.p1.DNA_Methylation_Prostate_Cancer_Sample_Attributes.var_report.xml									phs000597.v1.p1	Prostatic Neoplasms
			2021/04/28				./data/phs002393.v1.pht011139.v1.p1.ABCA4_Sample_Attributes.var_report.xml									phs002393.v1.p1	Retina
			2020/11/10				./data/phs002161.v1.pht010658.v1.p1.GMKF_EA_TEF_Subject.var_report.xml									phs002161.v1.p1	Tracheoesophageal Fistula
			11/05/2014				./data/phs000209.v13.pht004323.v1.p3.MESA_AncilMesaNeighborSESExam3.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			08/29/2016				./data/phs000126.v2.pht005717.v1.p1.CIDR_PD_Sample_Attributes.var_report.xml									phs000126.v2.p1	Parkinson Disease
			2018/01/18				./data/phs001513.v1.pht007359.v1.p1.Chemo_Resistance_T_ALL_Sample_Attributes.var_report.xml									phs001513.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			2021/08/19				./data/phs001662.v2.pht010064.v1.p1.LTRC_R040_subject_spirometry.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
718.0	959.0		2021/07/09	969.0		718.0	./data/phs001207.v3.pht005790.v3.p1.TOPMed_WGS_AA_Sarcoidosis_Subject.var_report.xml	0.0	959.5	78.49	959.0			959.5		phs001207.v3.p1	Sarcoidosis
			06/01/2012				./data/phs000384.v1.pht002462.v1.p1.Genentech_Hepatocellular_Carcinoma_Sample.var_report.xml									phs000384.v1.p1	Hepatocellular Carcinomas
174.0	788.0		11/15/2011	962.0		174.0	./data/phs000408.v1.pht002440.v1.p1.eMERGE_Obesity_Subject_Phenotypes.var_report.xml	0.0	481.0	434.2	788.0			481.0		phs000408.v1.p1	Obesity
			12/10/2014				./data/phs000848.v1.pht004410.v1.p1.Autosomal_Recessive_TPP2_Mutations_Sample.var_report.xml									phs000848.v1.p1	Immunologic Deficiency Syndromes
			2020/12/16				./data/phs001800.v2.pht008925.v2.p1.Pediatric_RMC_Subject.var_report.xml									phs001800.v2.p1	SMARCB1 Protein
			2020/12/21				./data/phs000007.v32.pht000393.v8.p13.natpep1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/02				./data/phs002421.v1.pht011271.v1.p1.ALT_nonMYCN_NBL_Sample.var_report.xml									phs002421.v1.p1	Neuroblastoma
			08/02/2013				./data/phs000644.v1.pht003422.v1.p1.Menstrual_Cycle_Effect_Breast_Sample.var_report.xml									phs000644.v1.p1	Menstrual Cycle
			2020/06/30				./data/phs002045.v1.pht010307.v1.p1.PDAC_Subject.var_report.xml									phs002045.v1.p1	Carcinoma, Pancreatic Ductal
			07/25/2013				./data/phs000293.v1.pht003366.v1.p1.Familial_Intracranial_Aneurysm_Subject_Phenotypes.var_report.xml									phs000293.v1.p1	Intracranial Aneurysm
	9.0		2019/12/09	9.0		9.0	./data/phs001842.v1.pht009245.v1.p1.Sjogrens_Syndrome_Subject_Phenotypes.var_report.xml	0.0	9.0		9.0			9.0		phs001842.v1.p1	Sjogren&#39;s Syndrome
2986.0	3192.0		2021/05/07	6178.0		2986.0	./data/phs001327.v2.pht011189.v1.p1.particip.var_report.xml	0.0	3089.0	145.7	3192.0			3089.0		phs001327.v2.p1	Neoplasm
			03/12/2013				./data/phs000343.v3.pht002213.v2.p1.GARNET_VISP_Sample.var_report.xml									phs000343.v3.p1	Stroke
			2018/03/27				./data/phs001195.v1.pht006860.v1.p1.Atomoxetine_Methamphetamine_Sample.var_report.xml									phs001195.v1.p1	Sex/Gender Identity
			2021/07/30				./data/phs002444.v1.pht011386.v1.p1.Osteosarcoma_Sample_Attributes.var_report.xml									phs002444.v1.p1	Osteosarcoma
			2021/05/20				./data/phs000997.v5.pht005087.v3.p2.TOPMed_WGS_VAFAR_Subject.var_report.xml									phs000997.v5.p2	Atrial Fibrillation
2592.0	2810.0		01/22/2014	5402.0		2592.0	./data/phs000276.v2.pht002005.v1.p1.NFBC66_Subject_Phenotypes.var_report.xml	0.0	2701.0	154.1	2810.0			2701.0		phs000276.v2.p1	Metabolic Syndrome X
			2020/01/16				./data/phs001386.v2.pht006610.v1.p1.Smoking_Vaginal_Microbiome_Sample_Attributes.var_report.xml									phs001386.v2.p1	Smoking
			11/04/2014				./data/phs000086.v3.pht000245.v1.p1.DCCT_f021cmb6.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
1691.0	1691.0		05/16/2017	2746.0		1055.0	./data/phs001252.v1.pht006379.v1.p1.covars.var_report.xml	0.0	1373.0	449.7	1055.0			1373.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2018/06/07				./data/phs001228.v1.pht008133.v1.p1.GMKF_EWS_Subject.var_report.xml									phs001228.v1.p1	Sarcoma, Ewing
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000501.v2.p3.simphen102.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
3.0	3.0		2019/12/06	6.0		3.0	./data/phs001875.v1.pht009652.v1.p1.Venetoclax_Resistance_Subject_Phenotypes.var_report.xml	0.0	3.0	0	3.0			3.0		phs001875.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2021/08/18				./data/phs001725.v2.pht010092.v1.p1.TOPMed_CCDG_GGAF_Subject.var_report.xml									phs001725.v2.p1	Atrial Fibrillation
			2019/05/31				./data/phs001296.v2.pht008999.v1.p1.ucdc_13423_laboratory.var_report.xml									phs001296.v2.p1	Urea Cycle Disorders, Inborn
			05/24/2016				./data/phs001065.v1.pht005437.v1.p1.uhdr8.var_report.xml									phs001065.v1.p1	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht000605.v5.p13.t_mrcdafat_2005_1b_0905s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/01				./data/phs001189.v4.pht005977.v3.p1.TOPMed_WGS_CCAF_Subject.var_report.xml									phs001189.v4.p1	Atrial Fibrillation
2.0	3.0		06/21/2016	5.0		2.0	./data/phs001151.v1.pht005540.v1.p1.Retina_RPE_Choroid_Subject_Phenotypes.var_report.xml	0.0	2.5	0.7071	3.0			2.5		phs001151.v1.p1	
			04/18/2011				./data/phs000237.v1.pht002159.v1.p1.NU_VU_T2D_Subject.var_report.xml									phs000237.v1.p1	Diabetes Mellitus, Type 2
			2019/11/25				./data/phs001541.v1.pht008306.v1.p1.ANGI_Sample.var_report.xml									phs001541.v1.p1	Anorexia Nervosa
			2021/03/24				./data/phs002386.v1.pht011082.v1.p1.STOPII_Subject.var_report.xml									phs002386.v1.p1	
			06/13/2014				./data/phs000687.v1.pht003694.v1.p1.Schizophrenia_De_Novo_Mutations_Sample.var_report.xml									phs000687.v1.p1	Schizophrenia
			2019/12/06				./data/phs000159.v9.pht000819.v9.p5.AML_Sample.var_report.xml									phs000159.v9.p5	Leukemia, Myeloid, Acute
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000518.v2.p3.simphen119.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
1789.0	367.0		2021/08/03	542.0		1789.0	./data/phs001591.v1.pht009691.v1.p1.CIDR_COHRA_Subject.var_report.xml	1924.0	271.0	962.4	367.0			271.0		phs001591.v1.p1	Dental Caries
			2021/08/13				./data/phs001442.v3.pht010304.v2.p2.TEDDY_Cohort_Sample_Attributes.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			2020/12/21				./data/phs000007.v32.pht000741.v3.p13.vr_fxrev_2011_0_0613s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/28/2012				./data/phs000448.v1.pht002511.v1.p1.AJ_SZ_Sample_Attributes.var_report.xml									phs000448.v1.p1	Schizophrenia
			2020/12/21				./data/phs000007.v32.pht005173.v1.p13.vr_meds_ex31_0_0763s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/29/2016				./data/phs001199.v1.pht005704.v1.p1.TIGER_LC_OncoVar_Subject.var_report.xml									phs001199.v1.p1	Carcinoma, Hepatocellular
			03/12/2013				./data/phs000343.v3.pht003150.v1.p1.HOS.var_report.xml									phs000343.v3.p1	Stroke
			02/08/2017				./data/phs001271.v1.pht006117.v1.p1.KIDRISK_Sample.var_report.xml									phs001271.v1.p1	Carcinoma, Renal Cell
91.0	97.0		11/05/2014	20.0		91.0	./data/phs000209.v13.pht003086.v3.p3.MESA_AirNRExam5Main.var_report.xml	0.0	99.0	11.31	97.0			99.0		phs000209.v13.p3	Cardiovascular Diseases
905.0	921.0		06/13/2014	621.0		905.0	./data/phs000687.v1.pht003695.v1.p1.Schizophrenia_De_Novo_Mutations_Subject_Phenotypes.var_report.xml	0.0	913.0	3.536	921.0			913.0		phs000687.v1.p1	Schizophrenia
			2020/12/21				./data/phs000007.v32.pht000107.v8.p13.resp1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/10/2015				./data/phs000855.v1.pht004552.v1.p1.Lung_Cancer_Resistance_Sample.var_report.xml									phs000855.v1.p1	Carcinoma
			2018/08/13				./data/phs001535.v1.pht008292.v1.p1.DDP_Subject.var_report.xml									phs001535.v1.p1	Diabetes, Gestational
			2017/10/05				./data/phs001432.v1.pht006979.v1.p1.Tumor_Heterogeneity_Thoracic_Sample_Attributes.var_report.xml									phs001432.v1.p1	Adenocarcinoma of lung
31.0	31.0		2020/02/25	48.0		1.0	./data/phs001914.v1.pht009890.v1.p1.MSI_CRC_Subject_Phenotypes.var_report.xml	0.0	16.0	15	16.0			16.0		phs001914.v1.p1	Colorectal Neoplasms
651.0	651.0		2020/02/27	778.0		590.0	./data/phs001213.v2.pht005839.v1.p1.Heroin_Dependence_China_Subject_Phenotypes.var_report.xml	0.0	855.5	375.5	590.0			855.5		phs001213.v2.p1	Drug Dependence
			2019/11/19				./data/phs000572.v8.pht004306.v5.p4.CaseControlEnrichedPhenotypesWES_y0.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			04/11/2017				./data/phs000897.v1.pht004638.v1.p1.Early_Stage_Ovarian_Cancer_Sample.var_report.xml									phs000897.v1.p1	Cystadenocarcinoma, Serous
			2020/12/21				./data/phs000007.v32.pht005169.v2.p13.t_pftpreal_ex09_1b_0867s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/03/05				./data/phs001388.v2.pht006876.v1.p1.SIGMA_DMS_Subject.var_report.xml									phs001388.v2.p1	Diabetes Mellitus, Type 2
27.0	27.0		2019/10/11	44.0		26.0	./data/phs001380.v1.pht009227.v1.p1.TS_Pedigree.var_report.xml	0.0	73.0	7.071	26.0			73.0		phs001380.v1.p1	Tourette Syndrome
			11/04/2014				./data/phs000086.v3.pht000264.v1.p1.DCCT_f0372.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			06/12/2017				./data/phs000594.v1.pht006496.v1.p1.ConcomitantMedications.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			08/20/2013				./data/phs000285.v3.pht001754.v2.p2.E1EBCT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001578.v2.p2.A4F15.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/07/18				./data/phs001618.v1.pht008228.v1.p1.TIL_NSCLC_Sample_Attributes.var_report.xml									phs001618.v1.p1	Neoplasms
			07/01/2016				./data/phs001095.v1.pht005618.v1.p1.T2D_GENES_Ashkenazi_Subject.var_report.xml									phs001095.v1.p1	Diabetes Mellitus, Type 2
			10/21/2015				./data/phs000789.v1.pht004289.v1.p1.CSGNM_Pedigree.var_report.xml									phs000789.v1.p1	
			2017/12/04				./data/phs001366.v1.pht006578.v1.p1.SCLC_CTCA_Sample_Attributes.var_report.xml									phs001366.v1.p1	Small Cell Lung Carcinoma
			06/05/2014				./data/phs000753.v1.pht003875.v1.p1.Lung_Cancer_High_Density_SNP_Sample.var_report.xml									phs000753.v1.p1	Lung Neoplasms
			2021/06/03				./data/phs002417.v1.pht011276.v1.p1.FFCWS_Sample_Attributes.var_report.xml									phs002417.v1.p1	Population Groups
			01/12/2015				./data/phs000853.v1.pht004429.v1.p1.Normative_Aging_Study_Subject_Phenotypes.var_report.xml									phs000853.v1.p1	Mortality
			2019/03/27				./data/phs001670.v1.pht008883.v1.p1.DeKAF_Tac_AA_EA_Sample_Attributes.var_report.xml									phs001670.v1.p1	Tacrolimus
			08/18/2015				./data/phs000206.v5.pht003729.v2.p3.CGEMS_PANSCAN_Sample_Attributes.var_report.xml									phs000206.v5.p3	Pancreatic Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000471.v2.p3.simphen072.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			12/13/2011				./data/phs000426.v1.pht002454.v1.p1.3a_dbGaP_SubjectPhenotypesDS.var_report.xml									phs000426.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000502.v2.p3.simphen103.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/25/2014				./data/phs000560.v1.pht003067.v1.p1.DNHS_Sample.var_report.xml									phs000560.v1.p1	Stress Disorders, Post-Traumatic
			2020/12/21				./data/phs000007.v32.pht002149.v6.p13.t_wbdxa_2010_3_0585s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/05/07				./data/phs001719.v1.pht008920.v1.p1.Prediabetes_Sample_Attributes.var_report.xml									phs001719.v1.p1	Prediabetic State
75.0	75.0		2020/09/03	75.0		75.0	./data/phs000968.v2.pht004914.v1.p1.Cardiopulmonary_Particulate_Exposure_Subject_Phenotypes.var_report.xml	0.0	75.0					75.0		phs000968.v2.p1	Cardiovascular Disease
			2019/10/07				./data/phs001854.v1.pht009252.v1.p1.BRAF_PA_Sample.var_report.xml									phs001854.v1.p1	Astrocytoma
			11/10/2010				./data/phs000305.v1.pht001918.v1.p1.NSABP_Clinical_Data.var_report_2010_11_10.xml									phs000305.v1.p1	Breast Neoplasms
			11/08/2013				./data/phs000200.v9.pht003415.v1.p3.outc_strk_carotid_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			01/19/2010				./data/phs000219.v1.pht001075.v1.p1.d_csa09.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/12/21				./data/phs000007.v32.pht009756.v2.p13.l_rbcfae_ex08_1b_1072s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/04/16				./data/phs001289.v1.pht007787.v1.p1.baseline_interimmedicalhistory.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			09/23/2014				./data/phs000787.v1.pht004257.v1.p1.Immunosenescence_Subject.var_report.xml									phs000787.v1.p1	Aging
252.0	252.0		2021/05/24	337.0		2.0	./data/phs000922.v2.pht004924.v2.p1.CLL8_Cohort_Subject.var_report.xml	0.0	112.3	127.6	83.0			83.0		phs000922.v2.p1	Leukemia, Lymphocytic, Chronic, B-Cell
72.0	72.0		2020/10/14	80.0		8.0	./data/phs001912.v1.pht009624.v1.p1.BE_EA_Subject_Phenotypes.var_report.xml	0.0	40.0	45.25	8.0			40.0		phs001912.v1.p1	Barrett Esophagus
			01/09/2017				./data/phs001244.v1.pht006055.v1.p1.NPC_WES_Subject.var_report.xml									phs001244.v1.p1	Nasopharyngeal Neoplasms
			2020/12/21				./data/phs000007.v32.pht002234.v6.p13.l_mtbli1_ex05_1_0610s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
3.0			10/15/2015	3.0			./data/phs000870.v1.pht004549.v1.p1.Alternative_Splicing_Subject_Phenotypes.var_report.xml	0.0								phs000870.v1.p1	
			2019/07/22				./data/phs001124.v1.pht009255.v1.p1.Sulfonamide_HS_Subject.var_report.xml									phs001124.v1.p1	Drug Hypersensitivity Syndrome
			2018/02/27				./data/phs001539.v1.pht007521.v1.p1.MAGNet_Subject.var_report.xml									phs001539.v1.p1	Atrial Fibrillation
			2018/06/14				./data/phs001238.v2.pht006047.v1.p1.GENOA_AfricanAmerican_Phase2_FamilyHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2018/05/22				./data/phs001314.v1.pht007997.v1.p1.registration.var_report.xml									phs001314.v1.p1	Steroid 21-Hydroxylase
			08/06/2015				./data/phs000934.v1.pht004880.v1.p1.Antibody_Repertoires_CVID_Sample_Attributes.var_report.xml									phs000934.v1.p1	Common Variable Immunodeficiency
			02/24/2012				./data/phs000001.v3.pht000372.v2.p1.dietary.var_report.xml									phs000001.v3.p1	Cataract
			2020/09/18				./data/phs002015.v1.pht010380.v1.p1.AREDS2_ENROLL.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2021/08/13				./data/phs002486.v1.pht011472.v1.p1.Nivolumab_TIL_NSCLC_Sample_Attributes.var_report.xml									phs002486.v1.p1	Carcinoma, Non-Small-Cell Lung
			2021/05/20				./data/phs001024.v5.pht005116.v2.p1.TOPMed_WGS_Partners_AFGen_Subject.var_report.xml									phs001024.v5.p1	Atrial Fibrillation
			2017/10/11				./data/phs000578.v1.pht007009.v1.p1.eligibility.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			11/30/2016				./data/phs001210.v1.pht005961.v1.p1.Lung_Cancer_Smoking_AA_Subject.var_report.xml									phs001210.v1.p1	Lung Neoplasms
			2021/01/06				./data/phs001383.v1.pht010793.v1.p1.Moebius_Syndrome_Subject_Phenotypes.var_report.xml									phs001383.v1.p1	Mobius Syndrome
517.0	523.0		2021/01/08	1040.0		517.0	./data/phs000649.v2.pht003758.v2.p2.PEAR_Subject.var_report.xml	0.0	520.0	4.243	523.0			520.0		phs000649.v2.p2	Hypertension
			01/07/2016				./data/phs000459.v1.pht004746.v1.p1.Oral_Clefts_Multiplex_Families_Sample_Attributes.var_report.xml									phs000459.v1.p1	Cleft Lip
			2019/06/13				./data/phs001611.v1.pht009161.v1.p1.Organoid_Profiling_PC_Sample_Attributes.var_report.xml									phs001611.v1.p1	Neoplasms
			2019/03/11				./data/phs000286.v6.pht001921.v2.p2.abba.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht010725.v1.p13.l_dbtlab_ex07_1b_1237s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/09/2013				./data/phs000636.v1.pht003428.v1.p1.Familial_Intracranial_Aneurysm_Sequence_Subject_Phenotypes.var_report.xml									phs000636.v1.p1	Intracranial Aneurysm
			11/05/2014				./data/phs000209.v13.pht002198.v2.p3.MESA_AncilMesaAbdBodyComposition.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007800.v1.p1.pidtc_17968_commentfo.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
18.0			2018/03/23	148.0			./data/phs000698.v1.pht007682.v1.p1.sf_36.var_report.xml	1.0			32.0					phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000457.v2.p3.simphen058.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
332.0	334.0		11/16/2012	666.0		332.0	./data/phs000391.v1.pht002996.v1.p1.PAPI_Subject_Phenotypes.var_report.xml	0.0	333.0	1.414	334.0			333.0		phs000391.v1.p1	Platelets
			2021/01/06				./data/phs002252.v1.pht010669.v1.p1.RCC_Sample.var_report.xml									phs002252.v1.p1	Carcinoma, Renal Cell
			Wed Nov 26 07:46:08 2008				./data/phs000017.v3.pht000323.v1.p1.DIGS2and3_Ped_Data.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2019/09/11				./data/phs001887.v1.pht009432.v1.p1.Sperm_Donors_Subject.var_report.xml									phs001887.v1.p1	Spermatozoa
530.0	651.0		2020/12/21	5002.0		530.0	./data/phs000007.v32.pht006027.v3.p13.vr_wkthru_ex09_1_1001s.var_report.xml	0.0	590.5	85.56	651.0			590.5		phs000007.v32.p13	Cardiovascular Diseases
			2019/03/25				./data/phs001415.v1.pht006684.v1.p1.CIDR_GECCO_CRC_Subject.var_report.xml									phs001415.v1.p1	
			11/16/2016				./data/phs001200.v1.pht005925.v1.p1.West_Nile_Virus_NAb_Subject.var_report.xml									phs001200.v1.p1	West Nile Fever
			2021/07/13				./data/phs001545.v2.pht009965.v1.p1.TOPMed_CCDG_INSPIRE_AF_Sample.var_report.xml									phs001545.v2.p1	Atrial Fibrillation
			07/05/2017				./data/phs000595.v1.pht006636.v1.p1.lab_form.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2017/10/11				./data/phs000578.v1.pht007012.v1.p1.investigators_clinical_diagnosi.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			11/08/2013				./data/phs000200.v9.pht000990.v4.p3.f143_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/12/21				./data/phs000007.v32.pht001226.v4.p13.ctkidney1_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/25/2016				./data/phs001058.v1.pht005236.v1.p1.MIGen_BioImage_Sample.var_report.xml									phs001058.v1.p1	Myocardial Infarction
			2020/10/09				./data/phs002262.v1.pht010573.v1.p1.HGSOC_Sample.var_report.xml									phs002262.v1.p1	
			2019/03/28				./data/phs001743.v1.pht008923.v1.p1.Urothelial_Cancer_Subject_Phenotypes.var_report.xml									phs001743.v1.p1	Urologic Neoplasms
325.0	325.0		2020/03/26	600.0		75.0	./data/phs001929.v1.pht010013.v1.p1.Neurogenetics_OCD_Pedigree.var_report.xml	0.0	300.0	35.36	75.0			300.0		phs001929.v1.p1	Obsessive-Compulsive Disorder
29.0	49.0		2019/03/18	78.0		29.0	./data/phs001796.v1.pht008834.v1.p1.CTS_Nerve_Repair_Subject_Phenotypes.var_report.xml	0.0	39.0	14.14	49.0			39.0		phs001796.v1.p1	Carpal Tunnel Syndrome
			2020/04/15				./data/phs001894.v1.pht009523.v1.p1.CCDG_HMCA_Sample.var_report.xml									phs001894.v1.p1	Autism Spectrum Disorder
			2020/06/18				./data/phs000280.v7.pht006478.v1.p1.RPN.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005588.v1.p1.Geisinger_AAA_BP.var_report.xml									phs000888.v1.p1	
			2019/12/06				./data/phs000159.v9.pht002460.v7.p5.AML_Sample_Attributes.var_report.xml									phs000159.v9.p5	Leukemia, Myeloid, Acute
			11/18/2014				./data/phs000825.v1.pht004352.v1.p1.HUES64_HUES63_Sequencing_Sample_Attributes.var_report.xml									phs000825.v1.p1	Growth and Development
			2020/12/21				./data/phs000007.v32.pht002154.v6.p13.l_fabp_2005_m_0511s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/07/29				./data/phs001599.v1.pht011434.v1.p1.TOPMed_WGS_Boston_Brazil_SCD_Sample.var_report.xml									phs001599.v1.p1	Anemia, Sickle Cell
			2018/10/24				./data/phs001695.v1.pht008499.v1.p1.UCSF_CRH_Sample_Attributes.var_report.xml									phs001695.v1.p1	MicroRNAs
			02/03/2014	1.0			./data/phs000706.v1.pht003666.v1.p1.RAD50_Hypomorphism_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000706.v1.p1	Ureteral Neoplasms
			2020/06/18				./data/phs000280.v7.pht004104.v2.p1.HHXC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/21/2016				./data/phs000984.v1.pht005703.v1.p1.T2DM_Metformin_Weight.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
			2019/02/06				./data/phs001745.v1.pht008598.v1.p1.Lung_eQTL_Subject.var_report.xml									phs001745.v1.p1	Smoking
			2020/12/21				./data/phs000007.v32.pht005160.v3.p13.t_ctthravc_2011_m_0685s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/08				./data/phs001217.v3.pht007763.v1.p1.TOPMed_WGS_GenSalt_Sample.var_report.xml									phs001217.v3.p1	Arterial Pressure, Mean
			05/02/2012				./data/phs000456.v1.pht002640.v1.p1.RACE_Subject.var_report.xml									phs000456.v1.p1	Stroke
			2017/12/13				./data/phs001053.v1.pht007229.v1.p1.XFS_Glaucoma_Subject.var_report.xml									phs001053.v1.p1	Glaucoma
			2018/06/13				./data/phs001490.v1.pht008135.v1.p1.T2D_GENES_BioMe_Subject.var_report.xml									phs001490.v1.p1	Diabetes Mellitus, Type 2
			2018/06/14				./data/phs001238.v2.pht006042.v1.p1.GENOA_AfricanAmerican_Phase1_Medications.var_report.xml									phs001238.v2.p1	Hypertension
	115.0		11/12/2013	115.0		115.0	./data/phs000600.v1.pht003239.v1.p1.Cervical_Cancer_Subject_Phenotypes.var_report.xml	0.0	115.0		115.0			115.0		phs000600.v1.p1	Uterine Cervical Neoplasms
			08/20/2013				./data/phs000285.v3.pht001873.v1.p2.Z33B06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/07/10				./data/phs002022.v1.pht010180.v1.p1.pPCL_Subject.var_report.xml									phs002022.v1.p1	Leukemia, Plasma Cell
			03/12/2013				./data/phs000343.v3.pht002720.v1.p1.ecg.var_report.xml									phs000343.v3.p1	Stroke
			03/24/2015				./data/phs000196.v3.pht000876.v1.p1.NGRC_Subject.var_report.xml									phs000196.v3.p1	Parkinson Disease
			11/16/2015				./data/phs000896.v1.pht005127.v1.p1.LGG_Probiotics_Metagenome_SRA.var_report.xml									phs000896.v1.p1	Human Microbiome
			2019/03/11				./data/phs000286.v6.pht008759.v1.p2.locau24h.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008751.v1.p2.ftrv.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/01/08				./data/phs002308.v1.pht010844.v1.p1.BM_MPN_Sample_Attributes.var_report.xml									phs002308.v1.p1	Myeloproliferative Disorders
			11/13/2015				./data/phs000985.v1.pht005101.v1.p1.PrCa_Risk_SNPs_Subject.var_report.xml									phs000985.v1.p1	
			2020/04/30				./data/phs001517.v2.pht007483.v2.p2.GHIRD_Sample_Attributes.var_report.xml									phs001517.v2.p2	Retinitis Pigmentosa
			2021/03/22				./data/phs002188.v1.pht011032.v1.p1.Lymphoma_Sample.var_report.xml									phs002188.v1.p1	Lymphoma
			07/03/2014				./data/phs000767.v1.pht003929.v1.p1.UCSD_CLL_Subject.var_report.xml									phs000767.v1.p1	Chronic Lymphocytic Leukemia
			2018/02/08				./data/phs001488.v1.pht007413.v1.p1.optcnsnt.var_report.xml									phs001488.v1.p1	Huntington Disease
4.0	4.0		2019/06/13	6.0		2.0	./data/phs001840.v1.pht009148.v1.p1.PDAC_CAFs_Subject_Phenotypes.var_report.xml	0.0	3.0	1.414	2.0			3.0		phs001840.v1.p1	Carcinoma, Pancreatic Ductal
			2019/11/12				./data/phs001575.v2.pht009607.v1.p1.general_eligibility_form.var_report.xml									phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2020/12/21				./data/phs000007.v32.pht000820.v7.p13.adma1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/12/04				./data/phs001385.v1.pht007166.v1.p1.Gallbladder_Cancer_Chileans_Sample_Attributes.var_report.xml									phs001385.v1.p1	Gallbladder Neoplasms
			2019/04/25				./data/phs001673.v1.pht008513.v1.p1.ADAGESIII_Sample_Attributes.var_report.xml									phs001673.v1.p1	Glaucoma
			2020/10/29				./data/phs002258.v1.pht010606.v1.p1.SARS_CoV2_LAMP_RNASeq_Sample.var_report.xml									phs002258.v1.p1	COVID-19
			11/04/2014				./data/phs000086.v3.pht000325.v1.p1.EDIC_f0023.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
	939.0		2019/09/06	939.0		939.0	./data/phs001885.v1.pht009430.v1.p1.ECAC_European_Subject_Phenotypes.var_report.xml	0.0	939.0		939.0			939.0		phs001885.v1.p1	Endometrial Neoplasms
596.0	767.0		08/14/2014	9721.0		596.0	./data/phs000615.v1.pht003307.v1.p1.IschemicStroke_Subject_Phenotypes.var_report.xml	0.0	681.5	83.44	767.0			681.5		phs000615.v1.p1	Cerebral infarction
			05/26/2016				./data/phs000886.v1.pht004648.v1.p1.Asthma_MZ_Twins_Sample.var_report.xml									phs000886.v1.p1	Asthma
			07/19/2012				./data/phs000494.v1.pht002801.v1.p1.eMERGE_Pediatric_CCHMC_Subject_Phenotypes.var_report.xml									phs000494.v1.p1	Child Health
			2021/04/07				./data/phs001349.v2.pht010327.v1.p1.TGCT_Subject.var_report.xml									phs001349.v2.p1	Testicular Germ Cell Tumor
			2017/12/07				./data/phs001312.v1.pht007200.v1.p1.POAAGG_Sample.var_report.xml									phs001312.v1.p1	Glaucoma, Open-Angle
			06/14/2017				./data/phs001365.v1.pht006409.v1.p1.NAC_Bevacizumab_Subject_Phenotypes.var_report.xml									phs001365.v1.p1	Breast Neoplasms
			11/10/2015				./data/phs000936.v1.pht004892.v1.p1.GOESP_Broad_EOMI_ExomeChip_Sample_Attributes.var_report.xml									phs000936.v1.p1	
51.0	51.0		2019/07/26	88.0		37.0	./data/phs001852.v1.pht009276.v1.p1.Height_Jewish_Pedigree.var_report.xml	0.0	44.0	9.899	37.0			44.0		phs001852.v1.p1	Body Height
			08/20/2013				./data/phs000285.v3.pht001562.v2.p2.A4F04.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/22				./data/phs001597.v1.pht008127.v1.p1.Bevacizumab_Hypertension_Sample_Attributes.var_report.xml									phs001597.v1.p1	Hypertension
			2020/01/07				./data/phs001953.v1.pht009773.v1.p1.UM_AEB071_Sample_Attributes.var_report.xml									phs001953.v1.p1	Uveal Neoplasms
			2020/08/05				./data/phs002053.v1.pht010449.v1.p1.Pazopanib_RCC_Sample_Attributes.var_report.xml									phs002053.v1.p1	Carcinoma, Renal Cell
			2019/09/27				./data/phs001576.v2.pht008223.v2.p2.P6705_MEDICAL_HISTORY.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			2020/09/18				./data/phs002015.v1.pht010382.v1.p1.AREDS2_GIC.var_report.xml									phs002015.v1.p1	Macular Degeneration
			06/22/2016				./data/phs001012.v1.pht005549.v1.p1.Diabetes_Heart_Study_EA_Sample.var_report.xml									phs001012.v1.p1	Cardiovascular Diseases
			12/03/2013				./data/phs000551.v1.pht003064.v1.p1.CATHGEN_Sample_Attributes.var_report.xml									phs000551.v1.p1	Cardiovascular Diseases
25.0			2018/04/16	53.0			./data/phs001326.v1.pht007806.v1.p1.p6902_17410_day0hcttr.var_report.xml	5.0			6.0					phs001326.v1.p1	Severe Combined Immunodeficiency
943.0	965.0		03/26/2015	4844.0		90.0	./data/phs000766.v1.pht003940.v1.p1.GEI_Psoriasis_Subject_Phenotypes.var_report.xml	0.0	971.0	782.2	965.0			943.0		phs000766.v1.p1	Psoriasis
			06/01/2012				./data/phs000384.v1.pht002464.v1.p1.Genentech_Hepatocellular_Carcinoma_Sample_Attributes.var_report.xml									phs000384.v1.p1	Hepatocellular Carcinomas
			2019/02/21				./data/phs001281.v2.pht006135.v2.p1.registration.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
74.0	74.0		2021/09/13	127.0		53.0	./data/phs000095.v4.pht002546.v2.p2.MARAZITA_USCohort_DentalCariesPhenotypeDS.var_report.xml	0.0	63.5	14.85	53.0			63.5		phs000095.v4.p2	Dental Caries
			2020/07/29				./data/phs002007.v1.pht010169.v1.p1.Innate_Tcells_Subject.var_report.xml									phs002007.v1.p1	Lymphocyte Subsets
94.0	94.0		2021/06/23	16.0		8.0	./data/phs001027.v4.pht005214.v3.p1.Epigenetics_AML_Subject.var_report.xml	0.0	8.0	23.33	8.0			8.0		phs001027.v4.p1	Acute Myeloid Leukemia
			05/16/2017				./data/phs001252.v1.pht006367.v1.p1.ECLIPSE_Sample.var_report.xml									phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			Thu Oct  2 11:13:21 2008				./data/phs000125.v1.pht000634.v1.p1.COGA_Sample.var_report_2008_10_02.xml									phs000125.v1.p1	Alcoholism
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000428.v2.p3.simphen029.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			09/08/2016				./data/phs000893.v1.pht005504.v1.p1.Endometrial_Cancer_E2C2_Sample_Attributes.var_report.xml									phs000893.v1.p1	Carcinoma, Endometrioid
			2020/05/26				./data/phs002020.v1.pht010226.v1.p1.ROP_Subject.var_report.xml									phs002020.v1.p1	Retinopathy of Prematurity
			2020/04/27				./data/phs002021.v1.pht010157.v1.p1.SCT_GVHD_Subject.var_report.xml									phs002021.v1.p1	Graft vs Host Disease
			2018/02/08				./data/phs001488.v1.pht007388.v1.p1.dnablood.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/11				./data/phs002000.v1.pht010119.v1.p1.HC_Mongolian_Sample.var_report.xml									phs002000.v1.p1	Carcinoma, Hepatocellular
			2018/03/15				./data/phs001516.v1.pht007494.v1.p1.PheRS_eMERGE_Sample_Attributes.var_report.xml									phs001516.v1.p1	Genetic Diseases, Inborn
			2020/12/21				./data/phs000007.v32.pht000076.v8.p13.ankle1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/22				./data/phs001460.v1.pht006913.v1.p1.Recurrent_Glioblastoma_Sample_Attributes.var_report.xml									phs001460.v1.p1	Glioblastoma
903.0	863.0		10/19/2011	276.0		903.0	./data/phs000309.v2.pht001999.v2.p2.CARDIA_Subject_Phenotypes.var_report.xml	0.0	963.0	84.85	863.0			963.0		phs000309.v2.p2	Cardiovascular Diseases
			01/27/2017				./data/phs000428.v2.pht005037.v1.p2.HRS_Sample_Attributes.var_report.xml									phs000428.v2.p2	Aging
			11/16/2012				./data/phs000413.v2.pht003038.v1.p1.AML_FABM7_GEO.var_report.xml									phs000413.v2.p1	Acute Megakaryoblastic Leukemia
70.0	70.0		2021/03/31	75.0		65.0	./data/phs001561.v1.pht010995.v1.p1.CCGO_Subject.var_report.xml	0.0	67.5	4.95	65.0			67.5		phs001561.v1.p1	Immunologic Deficiency Syndromes
			08/12/2016				./data/phs000888.v1.pht005589.v1.p1.Geisinger_AAA_Labs.var_report.xml									phs000888.v1.p1	
			2021/05/18				./data/phs002224.v1.pht010848.v1.p1.Crosstalk_Asthma_Sample_Attributes.var_report.xml									phs002224.v1.p1	Asthma
			2019/11/20				./data/phs000921.v4.pht004881.v4.p1.TOPMed_WGS_SAGE_Subject.var_report.xml									phs000921.v4.p1	Lung Diseases
			2020/06/18				./data/phs000280.v7.pht006473.v1.p1.RETF1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/01/26				./data/phs001451.v3.pht007131.v2.p1.Melanoma_Neoantigen_Vaccine_Subject.var_report.xml									phs001451.v3.p1	Melanoma
			2020/06/18				./data/phs000280.v7.pht006483.v1.p1.THYR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/07/13				./data/phs002392.v1.pht011256.v1.p1.NPC_Sample_Attributes.var_report.xml									phs002392.v1.p1	Niemann-Pick Disease, Type C
34.0	119.0		2020/06/25	153.0		34.0	./data/phs001779.v1.pht010207.v1.p1.CIDR_NIA_Ehlers_Danlos_Subject_Phenotypes.var_report.xml	0.0	76.5	60.1	119.0			76.5		phs001779.v1.p1	Ehlers-Danlos syndrome type 3
			07/06/2016				./data/phs001093.v1.pht005613.v1.p1.T2D_GENES_UK_South_Asian_Sample_Attributes.var_report.xml									phs001093.v1.p1	Diabetes Mellitus, Type 2
			12/01/2015				./data/phs000571.v3.pht003191.v3.p2.PatientDiagnosis.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000421.v2.p3.simphen022.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/18/2012				./data/phs000395.v1.pht002363.v1.p1.CIDR_Mammographic_Density_Subject_Phenotypes.var_report.xml									phs000395.v1.p1	Breast Neoplasms
80.0	87.0		2021/01/13	80.0		80.0	./data/phs001480.v1.pht010830.v1.p1.PRO_CIPN_Subject.var_report.xml	0.0	78.5	80.61	87.0			78.5		phs001480.v1.p1	Peripheral Nervous System Diseases/drug effects
7982.0	944.0		2020/12/21	1625.0		7900.0	./data/phs000007.v32.pht000183.v13.p13.Framingham_Pedigree.var_report.xml	0.0	812.5	57.98	944.0			812.5		phs000007.v32.p13	Cardiovascular Diseases
500.0	7872.0		09/03/2009	12785.0		4913.0	./data/phs000166.v2.pht000701.v1.p1.CAMP_LData.var_report_2009_09_03.xml	0.0	6393.0	2092	313.0			6393.0		phs000166.v2.p1	Asthma
			2017/10/25				./data/phs000771.v2.pht003984.v2.p1.Bladder_Cancer_Chemotherapy_Response_Sample_Attributes.var_report.xml									phs000771.v2.p1	Urinary Bladder Neoplasms
1685.0	61040.0		05/16/2017	95416.0		34376.0	./data/phs001252.v1.pht006371.v1.p1.biomarkf.var_report.xml	0.0	47708.0	18854	1053.0			47708.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
33.0	33.0		2018/02/12	62.0		29.0	./data/phs001525.v1.pht007475.v1.p1.XDP_Pedigree.var_report.xml	0.0	31.0	2.828	29.0			31.0		phs001525.v1.p1	X-Linked Dystonia Parkinsonism
			11/12/2013				./data/phs000600.v1.pht003237.v1.p1.Cervical_Cancer_Subject.var_report.xml									phs000600.v1.p1	Uterine Cervical Neoplasms
1080.0	1150.0		06/09/2015	2230.0		1080.0	./data/phs000718.v1.pht003841.v1.p1.T21NDJ_Subject_Phenotypes.var_report.xml	0.0	1115.0	49.5	1150.0			1115.0		phs000718.v1.p1	Nondisjunction, Genetic
			01/26/2015				./data/phs000846.v1.pht004451.v1.p1.Bisulfite_Sequencing_ccf_DNA_Sample_Attributes.var_report.xml									phs000846.v1.p1	DNA Methylation
			2018/06/01				./data/phs001342.v1.pht008050.v1.p1.Statin_Induced_Myopathy_Sample.var_report.xml									phs001342.v1.p1	Myopathy
			2017/11/30				./data/phs001341.v1.pht006244.v1.p1.PhLiPS_Subject.var_report.xml									phs001341.v1.p1	Lipids
			2021/08/03				./data/phs001591.v1.pht009693.v1.p1.CIDR_COHRA_Sample.var_report.xml									phs001591.v1.p1	Dental Caries
4901.0	4901.0		03/02/2016	7880.0		2979.0	./data/phs000267.v5.pht002305.v3.p2.Autism_Genome_Project_Subject_Phenotypes.var_report.xml	0.0	3940.0	1359	2979.0			3940.0		phs000267.v5.p2	Autistic Disorder
			12/01/2014				./data/phs000839.v1.pht004391.v1.p1.Bitter_Taste_Blockers_Sample.var_report.xml									phs000839.v1.p1	Taste Perception
			2018/09/26				./data/phs000284.v2.pht001901.v1.p1.CFS_CARe_Sample.var_report.xml									phs000284.v2.p1	Sleep Apnea Syndromes
			2021/09/08				./data/phs001497.v2.pht007242.v2.p1.Adult_Glioma_Sample_Attributes.var_report.xml									phs001497.v2.p1	
			06/16/2017				./data/phs001278.v1.pht006263.v1.p1.PC_7201_Subject.var_report.xml									phs001278.v1.p1	Porphyrias
			2017/11/30				./data/phs001474.v1.pht007151.v1.p1.Metastasis_HNSCC_Subject.var_report.xml									phs001474.v1.p1	Carcinoma, Squamous Cell
			2019/06/03				./data/phs001292.v2.pht009128.v1.p1.deathrecord.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			07/15/2010				./data/phs000292.v1.pht001526.v1.p1.GEOS_Sample.var_report_2010_07_15.xml									phs000292.v1.p1	Stroke
			2021/06/16				./data/phs002088.v2.pht010715.v1.p1.LINCS_DToxS_Clinical_Data.var_report.xml									phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			2020/12/21				./data/phs000007.v32.pht000087.v8.p13.fibrin1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/06/03				./data/phs001292.v2.pht007847.v2.p1.ARP_5207_Subject.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			2021/03/30				./data/phs002311.v1.pht010933.v1.p1.GATA2_Deficiency_Sample.var_report.xml									phs002311.v1.p1	Neoplasms
			2018/10/02				./data/phs001699.v1.pht008399.v1.p1.BC_Epigenetic_Heritability_Subject_Phenotypes.var_report.xml									phs001699.v1.p1	
			2019/03/25				./data/phs001781.v1.pht008859.v1.p1.SCC_Subject.var_report.xml									phs001781.v1.p1	Carcinoma, Non-Small-Cell Lung
92.0	372.0		2019/04/15	464.0		92.0	./data/phs001792.v1.pht008930.v1.p1.InterGEN_Pedigree.var_report.xml	0.0	232.0	198	372.0			232.0		phs001792.v1.p1	Hypertension
			01/19/2016				./data/phs000908.v1.pht004707.v1.p1.PD_Rare_Variants_Sample.var_report.xml									phs000908.v1.p1	
7858.0	7858.0		12/16/2013	15256.0		840.0	./data/phs000559.v1.pht003616.v1.p1.PAGE_EAGLE_BioVU_Cancer_Subject_Phenotypes.var_report.xml	0.0	5085.0	3734	6558.0			6558.0		phs000559.v1.p1	Neoplasms
			2021/09/29				./data/phs002506.v1.pht011539.v1.p1.Drug_Outcome_SNVs_Subject_Phenotypes.var_report.xml									phs002506.v1.p1	Pharmacology
			2021/02/22				./data/phs002212.v1.pht010986.v1.p1.ZRSR2_MDS_Sample_Attributes.var_report.xml									phs002212.v1.p1	Myelodysplastic Syndromes
			2020/12/18				./data/phs001819.v2.pht009446.v1.p1.Familial_MM_Subject.var_report.xml									phs001819.v2.p1	Multiple Myeloma
			2021/07/19				./data/phs001606.v2.pht010091.v1.p1.TOPMed_WGS_EGCUT_Sample_Attributes.var_report.xml									phs001606.v2.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004160.v2.p1.RLBA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/05/21				./data/phs001040.v5.pht005203.v2.p1.TOPMed_WGS_WGHS_Subject.var_report.xml									phs001040.v5.p1	Atrial Fibrillation
			11/08/2013				./data/phs000200.v9.pht002760.v1.p3.outc_cancer_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
127.0	144.0		09/03/2014	271.0		127.0	./data/phs000750.v1.pht003934.v1.p1.GOAL_Pedigree.var_report.xml	0.0	135.5	12.02	144.0			135.5		phs000750.v1.p1	Population Groups
1.0	1.0		2018/11/07	2.0		1.0	./data/phs001691.v1.pht008537.v1.p1.HTX_Subject_Phenotypes.var_report.xml	0.0	1.0	0	1.0			1.0		phs001691.v1.p1	Heterotaxy Syndrome
			11/05/2014				./data/phs000209.v13.pht004325.v1.p3.MESA_AncilMesaNeighborSESExam5.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2018/12/31				./data/phs001758.v1.pht008610.v1.p1.FNMTC_Sample.var_report.xml									phs001758.v1.p1	Thyroid Cancer, Papillary
			08/20/2013				./data/phs000285.v3.pht001757.v2.p2.E1F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/04/23				./data/phs001219.v1.pht007861.v1.p1.LPD_Sample_Attributes.var_report.xml									phs001219.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2020/12/21				./data/phs000007.v32.pht006016.v4.p13.t_mrbrcomm_2015_a_0994s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/10/29				./data/phs000450.v4.pht002525.v3.p1.DLBCL_Sample.var_report.xml									phs000450.v4.p1	Hodgkin Disease
			2020/01/23				./data/phs000287.v7.pht001458.v1.p1.CARE_DOB_CAT.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			03/29/2017				./data/phs001319.v1.pht006210.v1.p1.GICC_Subject_Phenotypes.var_report.xml									phs001319.v1.p1	Glioma
			2018/10/23				./data/phs001692.v1.pht008485.v1.p1.LIFE_Sample.var_report.xml									phs001692.v1.p1	MicroRNAs
			2017/10/19	1.0			./data/phs001288.v1.pht006784.v1.p1.sf_36.var_report.xml	0.0			1.0					phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2020/12/21				./data/phs000007.v32.pht000746.v7.p13.ankle1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006439.v4.p1.HFCCFDPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/03				./data/phs000304.v3.pht001907.v2.p1.GABC_Subject_Phenotypes.var_report.xml									phs000304.v3.p1	von Willebrand Disease
			2020/12/21				./data/phs000007.v32.pht004362.v1.p13.l_umtbl_ex06_1_0742s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/04/19				./data/phs001295.v2.pht006237.v2.p1.INC_6604_Subject.var_report.xml									phs001295.v2.p1	Charcot-Marie-Tooth Disease
			2020/09/03				./data/phs000968.v2.pht004913.v2.p1.Cardiopulmonary_Particulate_Exposure_Sample.var_report.xml									phs000968.v2.p1	Cardiovascular Disease
			2018/03/23				./data/phs000698.v1.pht007675.v1.p1.inspiratory_ctscan_80mas.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			11/08/2013				./data/phs000200.v9.pht001501.v2.p3.outc_dvt_pe_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
45.0	45.0		03/23/2015	87.0		42.0	./data/phs000866.v1.pht004619.v1.p1.Bipolar_Disorder_Family_Genomics_Pedigree.var_report.xml	0.0	43.5	4.243	42.0			43.5		phs000866.v1.p1	Bipolar Disorder
			04/18/2011				./data/phs000237.v1.pht002161.v1.p1.NU_VU_T2D_Sample.var_report.xml									phs000237.v1.p1	Diabetes Mellitus, Type 2
61.0	61.0		2019/02/19	78.0		170.0	./data/phs001649.v1.pht008516.v1.p1.CEDAR_Subject_Phenotypes.var_report.xml	0.0	39.0	91.22	170.0			39.0		phs001649.v1.p1	Substance-Related Disorders
			01/19/2010				./data/phs000219.v1.pht001101.v1.p1.d_sib_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2018/11/16				./data/phs001272.v1.pht007300.v1.p1.Broad_CMG_Subject.var_report.xml									phs001272.v1.p1	Genetic Diseases, Inborn
			2019/09/11				./data/phs001887.v1.pht009434.v1.p1.Sperm_Donors_Sample_Attributes.var_report.xml									phs001887.v1.p1	Spermatozoa
			2021/08/25				./data/phs001728.v2.pht010125.v1.p1.TOPMed_WGS_CARE_BADGER_Sample_Attributes.var_report.xml									phs001728.v2.p1	Asthma
			2020/12/21				./data/phs000007.v32.pht000034.v9.p13.ex1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			06/01/2017				./data/phs000701.v1.pht005510.v1.p1.ConclusionofStudyParticipation.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			07/27/2017				./data/phs000596.v1.pht006713.v1.p1.eligibility.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			2020/02/14				./data/phs000575.v2.pht005887.v2.p1.conclusionofstudyparticipation.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			07/22/2013				./data/phs000614.v1.pht003288.v1.p1.PLGGs_Sample.var_report.xml									phs000614.v1.p1	Astrocytoma
			09/01/2015				./data/phs000858.v1.pht004460.v1.p1.IVF_Blastocyst_Biopsies_Subject.var_report.xml									phs000858.v1.p1	Fertilization in Vitro
			09/28/2012				./data/phs000549.v1.pht002990.v1.p1.AML_Clonal_Evolution_Subject.var_report.xml									phs000549.v1.p1	Leukemia, Myeloid, Acute
			07/27/2017				./data/phs000247.v5.pht001287.v4.p3.HMP_Neonatal_Enterocolitis_Subject_Maternal_Baseline_Phenotypes.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
964.0	84.0		2020/08/06	2234.0		964.0	./data/phs001571.v1.pht009506.v1.p1.IBD_AA_Subject_Phenotypes.var_report.xml	0.0	58.5	36.06	84.0			58.5		phs001571.v1.p1	Crohn Disease
			05/17/2017				./data/phs001328.v1.pht006304.v1.p1.cognitive_gt8.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
7.0			10/31/2014	15.0			./data/phs000543.v1.pht002938.v1.p1.PPB_Subject_Phenotypes.var_report.xml	0.0			8.0					phs000543.v1.p1	Pleuropulmonary blastoma [Supplementary Concept]
			2017/12/20				./data/phs000577.v1.pht007285.v1.p1.pedsql4_core_child_5_7.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000466.v2.p3.simphen067.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
2.0	5.0		11/29/2012	7.0		2.0	./data/phs000541.v1.pht003050.v1.p1.Mendelian_Muscle_Hypertrophy_Subject_Phenotypes.var_report.xml	0.0	3.5	2.121	5.0			3.5		phs000541.v1.p1	Hypertrophy
			2020/12/02				./data/phs002287.v1.pht010712.v1.p1.ER_Positive_BC_Subject_Phenotypes.var_report.xml									phs002287.v1.p1	Breast Neoplasms
			06/04/2014				./data/phs000660.v1.pht003510.v1.p1.Chinese_AHC_Sample.var_report.xml									phs000660.v1.p1	Alternating hemiplegia of childhood
			02/18/2016				./data/phs001057.v1.pht005299.v1.p1.Smallpox_Vaccine_Immune_Response_Subject.var_report.xml									phs001057.v1.p1	Smallpox Vaccine
			2021/02/11				./data/phs001711.v1.pht008530.v1.p1.GI_Carcinomas_Sample_Attributes.var_report.xml									phs001711.v1.p1	Gastrointestinal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001818.v2.p2.F1F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/25				./data/phs002061.v1.pht010837.v1.p1.Zidovudine_Children_Sample_Attributes.var_report.xml									phs002061.v1.p1	HIV
4331.0	4696.0		04/17/2017	9027.0		4331.0	./data/phs001157.v1.pht005805.v1.p1.WLS_Aging_Subject_Phenotypes.var_report.xml	0.0	4514.0	258.1	4696.0			4514.0		phs001157.v1.p1	
			08/26/2013				./data/phs000619.v1.pht003352.v1.p1.Autism_Epigenetics_Sample.var_report.xml									phs000619.v1.p1	Autistic Disorder
650.0	650.0		02/20/2015	902.0		838.0	./data/phs000431.v2.pht002484.v1.p1.IGAN_Subject_Phenotypes.var_report.xml	0.0	597.0	74.95	838.0			597.0		phs000431.v2.p1	Glomerulonephritis, IGA
			2020/08/05				./data/phs001856.v1.pht009596.v1.p1.CORECT_Axiom_Subject.var_report.xml									phs001856.v1.p1	Colorectal Neoplasms
			05/19/2014				./data/phs000745.v1.pht003849.v1.p1.Alzheimers_Posterior_Cingulate_Astrocytes_Subject_Phenotypes.var_report.xml									phs000745.v1.p1	Alzheimer Disease
			2019/05/02				./data/phs001378.v1.pht006692.v1.p1.FL_Tumors_Sample_Attributes.var_report.xml									phs001378.v1.p1	Lymphoma, Follicular
			01/05/2017				./data/phs001260.v1.pht006054.v1.p1.Antibiotic_Resistance_Sample_Attributes.var_report.xml									phs001260.v1.p1	Diarrhea
			2018/04/27				./data/phs001197.v1.pht007565.v1.p1.Methamphetamine_Dependence_Sample_Attributes.var_report.xml									phs001197.v1.p1	Substance-Related Disorders
			2020/10/21				./data/phs002067.v1.pht010411.v1.p1.TLE_Sample_Attributes.var_report.xml									phs002067.v1.p1	Epilepsy, Temporal Lobe
			2019/05/07				./data/phs001329.v2.pht007172.v2.p1.LDN_6704_Subject.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/06/18				./data/phs000280.v7.pht006450.v1.p1.MRR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/05/2015				./data/phs000808.v1.pht004467.v1.p1.diLQTS_Susceptibility_Sample_Attributes.var_report.xml									phs000808.v1.p1	Long QT Syndrome
			2019/06/04				./data/phs001817.v1.pht009134.v1.p1.GeneScreen_Sample.var_report.xml									phs001817.v1.p1	Genetics, Population
			2018/07/18				./data/phs001618.v1.pht008226.v1.p1.TIL_NSCLC_Sample.var_report.xml									phs001618.v1.p1	Neoplasms
			2017/08/14				./data/phs000803.v2.pht004564.v2.p1.Colon_Cancer_Subject.var_report.xml									phs000803.v2.p1	Colonic Neoplasms
644.0	644.0		2020/02/27	766.0		611.0	./data/phs001213.v2.pht005837.v1.p1.Heroin_Dependence_China_Pedigree.var_report.xml	0.0	885.5	388.2	611.0			885.5		phs001213.v2.p1	Drug Dependence
1.0	1.0		2021/02/24	1.0		1.0	./data/phs002342.v1.pht011001.v1.p1.Polyepitope_Neoantigen_DNA_Vaccines_Subject.var_report.xml	0.0	1.0					1.0		phs002342.v1.p1	Carcinoma, Neuroendocrine
			09/11/2014				./data/phs000790.v1.pht004019.v1.p1.Colorectal_Cancer_Lesions_Sample_Attributes.var_report.xml									phs000790.v1.p1	Colorectal Neoplasms
			2021/03/31				./data/phs002365.v1.pht011088.v1.p1.BWS_Sample.var_report.xml									phs002365.v1.p1	Beckwith-Wiedemann Syndrome
377.0			2021/04/07	621.0			./data/phs002304.v1.pht010849.v1.p1.GEARS_Subject.var_report.xml	0.0			244.0					phs002304.v1.p1	Rhabdomyosarcoma
3375.0	3375.0		05/06/2016	6669.0		3294.0	./data/phs000911.v1.pht004979.v1.p1.T1DGC_ImmunoChip_Subject_Phenotypes_UKGRID.var_report.xml	0.0	3335.0	57.28	3294.0			3335.0		phs000911.v1.p1	Diabetes Mellitus, Type 1
			2020/12/21				./data/phs000007.v32.pht000672.v7.p13.menarche1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/14/2015				./data/phs000903.v1.pht004872.v1.p1.OCD_OCGAS_Subject_Phenotypes.var_report.xml									phs000903.v1.p1	Obsessive-Compulsive Disorder
			2020/07/07				./data/phs002051.v1.pht010311.v1.p1.RMS_PDX_Subject.var_report.xml									phs002051.v1.p1	Rhabdomyosarcoma
			11/04/2014				./data/phs000086.v3.pht000217.v1.p1.DCCT_f057cmb3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			05/17/2017				./data/phs001328.v1.pht006312.v1.p1.adaptive_qol.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			2018/06/14				./data/phs001238.v2.pht006650.v1.p1.GENOA_EuropeanAmerican_CKD_Labs.var_report.xml									phs001238.v2.p1	Hypertension
241.0	241.0		09/29/2016	447.0		206.0	./data/phs001216.v1.pht005787.v1.p1.Asthma_Puerto_Rican_Children_Subject_Phenotypes.var_report.xml	0.0	223.5	24.75	206.0			223.5		phs001216.v1.p1	Asthma
			2020/06/18				./data/phs000280.v7.pht004098.v2.p1.HEMA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/09/18				./data/phs001310.v1.pht006870.v1.p1.nasal_nitric_oxide.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
			06/07/2016				./data/phs001111.v1.pht005499.v1.p1.CRC_Mutation_Classification_Sample_Attributes.var_report.xml									phs001111.v1.p1	Colorectal Neoplasms
			2020/09/18				./data/phs002015.v1.pht010377.v1.p1.AREDS2_DTH.var_report.xml									phs002015.v1.p1	Macular Degeneration
			08/05/2016				./data/phs000360.v3.pht003253.v2.p1.MergedSet_BMI.var_report.xml									phs000360.v3.p1	Electronic Health Records
			2019/11/14				./data/phs001337.v1.pht009620.v1.p1.AACR_GENIE_Subject.var_report.xml									phs001337.v1.p1	Neoplasms
			Tue Nov 18 09:14:35 2008				./data/phs000088.v1.pht000711.v1.p1.GOKIND_NIDDK_Subject.var_report_2008_11_20.xml									phs000088.v1.p1	Diabetic Nephropathies
			03/21/2017				./data/phs000228.v4.pht002157.v1.p1.EMMES_HMP_DTP_DHX_DVD.var_report.xml									phs000228.v4.p1	Metagenomics
			2017/12/07				./data/phs001312.v1.pht007202.v1.p1.POAAGG_Sample_Attributes.var_report.xml									phs001312.v1.p1	Glaucoma, Open-Angle
			2019/11/12				./data/phs001575.v2.pht009605.v1.p1.LDN_6716_MRI_DS2.var_report.xml									phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2020/12/21				./data/phs000007.v32.pht000035.v10.p13.ex1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006480.v1.p1.SBP.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001085.v1.p1.d_img_assessment_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			11/04/2014				./data/phs000086.v3.pht000215.v1.p1.DCCT_cbl00.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			01/06/2010				./data/phs000202.v1.pht000880.v1.p1.OMRF_SLEGEN_Sample.var_report_2010_01_06.xml									phs000202.v1.p1	Lupus Erythematosus, Systemic
			2020/12/21				./data/phs000007.v32.pht000309.v15.p13.vr_soe_2019_a_1217s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
9507.0	9507.0		05/06/2016	5220.0		9339.0	./data/phs000911.v1.pht004976.v1.p1.T1DGC_ImmunoChip_Pedigree.var_report.xml	0.0	9423.0	345.1	9339.0			9423.0		phs000911.v1.p1	Diabetes Mellitus, Type 1
			2020/01/16				./data/phs001960.v1.pht009824.v1.p1.Osteoporosis_Risk_Subject_Phenotypes.var_report.xml									phs001960.v1.p1	Osteoporosis
			2019/04/23				./data/phs001259.v1.pht006090.v1.p1.VIRGO_AMI_Sample_Attributes.var_report.xml									phs001259.v1.p1	Myocardial Infarction
			05/02/2011				./data/phs000310.v1.pht002096.v1.p1.NonETS_Fusions_Sample.var_report.xml									phs000310.v1.p1	Prostatic Neoplasms
			06/24/2010				./data/phs000282.v1.pht001443.v1.p1.Framingham_CARe_Sample.var_report_2010_06_24.xml									phs000282.v1.p1	Cardiovascular Diseases
1.0			12/10/2014	3.0			./data/phs000848.v1.pht004411.v1.p1.Autosomal_Recessive_TPP2_Mutations_Subject_Phenotypes.var_report.xml	0.0			2.0					phs000848.v1.p1	Immunologic Deficiency Syndromes
			02/08/2017				./data/phs001276.v1.pht006120.v1.p1.Interneuron_Development_Subject.var_report.xml									phs001276.v1.p1	Growth and Development
			03/15/2016				./data/phs000337.v1.pht005336.v1.p1.Developmental_Disabilities_Sample.var_report.xml									phs000337.v1.p1	Intellectual Disability
			2017/10/19				./data/phs001288.v1.pht006768.v1.p1.eligibility.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000578.v2.p3.simphen179.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/04/30				./data/phs001323.v2.pht010114.v2.p1.MMGS_Subject.var_report.xml									phs001323.v2.p1	Multiple Myeloma
932.0	892.0		11/15/2013	5053.0		932.0	./data/phs000238.v1.pht002008.v1.p1.NEIGHBOR_Glaucoma_Subject_Phenotypes.var_report.xml	0.0	987.5	89.8	892.0			987.5		phs000238.v1.p1	Glaucoma
			06/12/2017				./data/phs000594.v1.pht006500.v1.p1.DosageAdjustment.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
745.0			06/28/2017	745.0			./data/phs001303.v1.pht006613.v1.p1.TGCT_Subject_Phenotypes.var_report.xml	0.0			72.0					phs001303.v1.p1	Germinoma
			2020/12/21				./data/phs000007.v32.pht010736.v1.p13.t_petamy_2020_3_1284s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
171.0	171.0		2019/04/10	307.0		136.0	./data/phs001048.v2.pht005660.v2.p1.FUSION_Tissue_Biopsy_Subject_Phenotypes.var_report.xml	0.0	153.5	24.75	136.0			153.5		phs001048.v2.p1	Diabetes Mellitus, Type 2
			2021/03/10				./data/phs001485.v2.pht007186.v2.p1.Cell_ID_Sample.var_report.xml									phs001485.v2.p1	Cockayne Syndrome
95.0			05/24/2017	92.0			./data/phs000576.v1.pht006149.v1.p1.familydata.var_report.xml	80.0			82.0					phs000576.v1.p1	Angelman Syndrome
			09/19/2016				./data/phs001185.v1.pht005762.v1.p1.Early_Onset_Prostate_Cancer_Subject.var_report.xml									phs001185.v1.p1	Prostatic Neoplasms
			08/18/2015				./data/phs000206.v5.pht000897.v4.p3.CGEMS_PANSCAN_Sample.var_report.xml									phs000206.v5.p3	Pancreatic Neoplasms
			2018/09/17				./data/phs001687.v1.pht008357.v1.p1.WABCS_Subject.var_report.xml									phs001687.v1.p1	Breast Neoplasms
			2019/06/14				./data/phs000589.v1.pht009192.v1.p1.lvv_baseline_med_hx_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/04/2014				./data/phs000086.v3.pht000357.v1.p1.EDIC_f1413.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/12/21				./data/phs000007.v32.pht000823.v7.p13.bnp3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/01/04				./data/phs000755.v2.pht004991.v1.p1.BrainSpan_Atlas_Project_Subject.var_report.xml									phs000755.v2.p1	Brain Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000446.v2.p3.simphen047.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/15/2016				./data/phs000337.v1.pht005338.v1.p1.Developmental_Disabilities_Sample_Attributes.var_report.xml									phs000337.v1.p1	Intellectual Disability
			2017/10/19				./data/phs001288.v1.pht006765.v1.p1.current_meds.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2018/11/26				./data/phs001686.v1.pht008563.v1.p1.IL17_PD_Subject.var_report.xml									phs001686.v1.p1	Parkinson Disease
			08/20/2013				./data/phs000285.v3.pht001607.v2.p2.B2F09HRT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007408.v1.p1.mhxdxhd3.var_report.xml									phs001488.v1.p1	Huntington Disease
4.0	8.0		2021/03/17	8.0		8.0	./data/phs002048.v2.pht010316.v1.p1.SLE_Subject_Phenotypes.var_report.xml	0.0	8.5	8.485	8.0			8.5		phs002048.v2.p1	Lupus Erythematosus, Systemic
			2020/01/07				./data/phs001741.v1.pht009166.v1.p1.CCDG_TASC_Sample_Attributes.var_report.xml									phs001741.v1.p1	Autism Spectrum Disorder
			2020/06/18				./data/phs000280.v7.pht004068.v2.p1.dtia.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/28				./data/phs001598.v2.pht009998.v1.p1.TOPMed_CCDG_JHU_AF_Sample_Attributes.var_report.xml									phs001598.v2.p1	Atrial Fibrillation
			2019/03/25				./data/phs001752.v1.pht008874.v1.p1.NEPC_cfDNA_Sample.var_report.xml									phs001752.v1.p1	Adenocarcinoma
			2018/09/17				./data/phs001677.v1.pht008380.v1.p1.AIS_1000_Exomes_Sample_Attributes.var_report.xml									phs001677.v1.p1	Scoliosis
			06/24/2016				./data/phs001159.v1.pht005598.v1.p1.Lung_Adenocarcinoma_Tumor_Heterogeneity_Sample_Attributes.var_report.xml									phs001159.v1.p1	Adenocarcinoma of lung
			2020/12/21				./data/phs000007.v32.pht000388.v7.p13.liverct3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/26/2013				./data/phs000362.v1.pht003229.v1.p1.ESP_FamilialAtrialFibrillation_Sample.var_report.xml									phs000362.v1.p1	Atrial Fibrillation
			08/27/2012				./data/phs000523.v1.pht002921.v1.p1.CLHNS_Sample.var_report.xml									phs000523.v1.p1	Maternal Nutritional Physiological Phenomena
			2020/12/21				./data/phs000007.v32.pht004368.v5.p13.vr_demrev_2018_a_1254s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/27/2017				./data/phs000247.v5.pht001283.v4.p3.HMP_Neonatal_Enterocolitis_Subject.var_report.xml									phs000247.v5.p3	Enterocolitis, Necrotizing
			07/09/2013				./data/phs000546.v1.pht003142.v1.p1.ESP_ISGS_Sample.var_report.xml									phs000546.v1.p1	Stroke
			07/14/2014				./data/phs000708.v1.pht003726.v1.p1.POAT_GEDWR_Sample.var_report.xml									phs000708.v1.p1	Thromboembolism
			03/13/2014				./data/phs000715.v1.pht003745.v1.p1.Multiple_Sclerosis_Brains_Subject_Phenotypes.var_report.xml									phs000715.v1.p1	Multiple Sclerosis, Chronic Progressive
6.0	6.0		2020/02/06	6.0		6.0	./data/phs001935.v1.pht009767.v1.p1.GAPPS_Pedigree.var_report.xml	0.0	6.0	0.7071	6.0			6.0		phs001935.v1.p1	Stomach Neoplasms
			2018/07/25				./data/phs001367.v1.pht008249.v1.p1.Add_Health_Sample_Attributes.var_report.xml									phs001367.v1.p1	Adolescent Health
			08/20/2013				./data/phs000285.v3.pht001610.v2.p2.B2F09LIV.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/07/24				./data/phs001194.v3.pht005814.v3.p2.PCGC_Cohort_Sample.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2017/12/19				./data/phs001438.v1.pht006818.v1.p1.Cortical_Neurogenesis_Open_Chromatin_Subject.var_report.xml									phs001438.v1.p1	Chromatin
			2018/05/17				./data/phs001313.v1.pht007972.v1.p1.p5607_10726_day1labte.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2020/10/16				./data/phs002245.v1.pht010529.v1.p1.COVID19_Subject.var_report.xml									phs002245.v1.p1	COVID-19
67.0	67.0		09/15/2011	902.0		59.0	./data/phs000345.v1.pht002376.v1.p1.IBD_UC_Subject_Phenotypes.var_report.xml	0.0	63.0	5.657	59.0			63.0		phs000345.v1.p1	Colitis, Ulcerative
			2021/06/11				./data/phs002208.v1.pht010500.v1.p1.BAL_HCT_Subject_Phenotypes.var_report.xml									phs002208.v1.p1	Hematopoietic Stem Cell Transplantation
			12/17/2015				./data/phs000728.v1.pht003768.v1.p1.Lung_Cancer_Smokers_Sample_Attributes.var_report.xml									phs000728.v1.p1	Lung Neoplasms
			2018/10/29				./data/phs001678.v1.pht008472.v1.p1.scTCR_Sample.var_report.xml									phs001678.v1.p1	Humans
165.0	216.0		Wed Jan 21 13:20:37 2009	381.0		165.0	./data/phs000144.v1.pht000720.v1.p1.TSP_ClinPath_Phenotypes.var_report_2009_01_22.xml	3.0	190.5	36.06	216.0			190.5		phs000144.v1.p1	Neoplasms
			2021/08/19				./data/phs001662.v2.pht010054.v2.p1.LTRC_Sample_Attributes.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			08/27/2012				./data/phs000523.v1.pht002920.v1.p1.CLHNS_Subject.var_report.xml									phs000523.v1.p1	Maternal Nutritional Physiological Phenomena
8.0	8.0		2019/08/05	17.0		2.0	./data/phs001867.v1.pht009351.v1.p1.Aging_Cells_Pedigree.var_report.xml	0.0	5.667000000000001	3.215	9.0			7.0		phs001867.v1.p1	Hutchinson-Gilford Progeria Syndrome
			08/20/2013				./data/phs000285.v3.pht001658.v2.p2.C1F09MBC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/06/2013				./data/phs000646.v1.pht003434.v1.p1.Breakpoint_Detection_LI_WGS_Subject.var_report.xml									phs000646.v1.p1	Chromosome Breakpoints
6.0			11/05/2012	11.0			./data/phs000561.v1.pht003035.v1.p1.Hypobetalipoproteinemia_Subject_Phenotypes.var_report.xml	0.0			5.0					phs000561.v1.p1	Hypobetalipoproteinemias
			2019/03/28				./data/phs001743.v1.pht008922.v1.p1.Urothelial_Cancer_Sample.var_report.xml									phs001743.v1.p1	Urologic Neoplasms
			2021/05/07				./data/phs001327.v2.pht011181.v1.p1.chemodose.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/06/18				./data/phs000280.v7.pht004135.v2.p1.MSRCOD43.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000474.v2.p3.simphen075.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
314.0			2019/07/26	568.0			./data/phs001705.v1.pht009273.v1.p1.EMBLEM_Subject_Phenotypes.var_report.xml	0.0			67.0					phs001705.v1.p1	Burkitt Lymphoma
7.0	7.0		05/16/2013	30.0		5.0	./data/phs000582.v1.pht003242.v1.p1.ESP_FamilialInterstitialPneumonia_Pedigree.var_report.xml	0.0	6.0	1.414	5.0			6.0		phs000582.v1.p1	Idiopathic Pulmonary Fibrosis
			2018/03/23				./data/phs000698.v1.pht007683.v1.p1.registration.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/08/29				./data/phs001333.v2.pht006527.v2.p1.registration.var_report.xml									phs001333.v2.p1	Fabry Disease
			2020/12/21				./data/phs000007.v32.pht000014.v3.p13.ex0_12s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000550.v2.p3.simphen151.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			05/19/2016				./data/phs001115.v1.pht005479.v1.p1.Melanoma_Genetic_Analysis_Subject.var_report.xml									phs001115.v1.p1	Melanoma, Cutaneous Malignant
121.0	121.0		12/06/2012	192.0		71.0	./data/phs000565.v1.pht003076.v1.p1.RHD_Subject_Phenotypes.var_report.xml	0.0	96.0	35.36	71.0			96.0		phs000565.v1.p1	Congenital Abnormalities
			05/24/2017				./data/phs000576.v1.pht006142.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000576.v1.p1	Angelman Syndrome
70.0	657.0		2021/05/12	88.0		70.0	./data/phs000964.v5.pht005766.v2.p1.TOPMed_WGS_JHS_Pedigree.var_report.xml	0.0	510.5	82.02	657.0			510.5		phs000964.v5.p1	Cardiovascular Diseases
			2019/04/15				./data/phs001792.v1.pht008933.v1.p1.InterGEN_Sample_Attributes.var_report.xml									phs001792.v1.p1	Hypertension
			04/04/2014				./data/phs000679.v1.pht003658.v1.p1.Anorexia_Nervosa_Sample_Attributes.var_report.xml									phs000679.v1.p1	Anorexia Nervosa
181.0	181.0		2021/04/06	348.0		167.0	./data/phs001163.v1.pht011096.v1.p1.Chernobyl_Radiation_Pedigree.var_report.xml	0.0	174.0	9.899	167.0			174.0		phs001163.v1.p1	
			02/23/2016				./data/phs001038.v1.pht005207.v1.p1.Melanoma_DNMTi_Immunotherapy_Sample.var_report.xml									phs001038.v1.p1	Melanoma
			2019/11/27				./data/phs001884.v1.pht009641.v1.p1.Giftedness_Saudi_Arabia_Sample_Attributes.var_report.xml									phs001884.v1.p1	Intelligence
817.0	588.0		08/08/2011	564.0		6.0	./data/phs000353.v1.pht002249.v1.p1.Preterm_Birth_AA_Pedigree.var_report.xml	0.0	377.0	325.6	588.0			817.0		phs000353.v1.p1	Premature Birth
500.0	500.0		2021/09/14	813.0		84.0	./data/phs002410.v1.pht011552.v1.p1.FHIR_Test_BETA_Subject.var_report.xml	0.0	406.5	50.91	84.0			406.5		phs002410.v1.p1	Heart Failure
			2018/05/31				./data/phs001318.v1.pht008038.v1.p1.ae_mro_review.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
317.0	317.0		2021/03/23	599.0		282.0	./data/phs001122.v1.pht008638.v1.p1.Neonatal_Brain_Pedigree.var_report.xml	0.0	299.5	24.75	282.0			299.5		phs001122.v1.p1	Brain
36.0	54.0		2017/11/30	90.0		36.0	./data/phs001341.v1.pht006246.v1.p1.PhLiPS_Subject_Phenotypes.var_report.xml	0.0	45.0	12.73	54.0			45.0		phs001341.v1.p1	Lipids
			09/20/2010				./data/phs000272.v1.pht001445.v1.p1.Behcets_Disease_Turk_Sample.var_report_2010_09_20.xml									phs000272.v1.p1	Behcet Syndrome
			2021/04/28				./data/phs001500.v2.pht007247.v2.p1.Melanocyte_QTL_Sample_Attributes.var_report.xml									phs001500.v2.p1	Melanocytes
			2020/07/29				./data/phs001290.v1.pht010332.v1.p1.CIDR_CRC_Survival_Subject.var_report.xml									phs001290.v1.p1	Colorectal Neoplasms
	45374.0		11/08/2013	70981.0		25607.0	./data/phs000200.v9.pht001002.v3.p3.f33_rel1.var_report.xml	2522.0	35491.0	92615	9250.0			35491.0		phs000200.v9.p3	Women&#39;s Health
			11/05/2014				./data/phs000209.v13.pht003610.v1.p3.MESA_AncilMesaNeighborScalesSodiumExam1.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
	12.0		2017/12/12	12.0		12.0	./data/phs001405.v1.pht006828.v1.p1.GSK1120212_TNBC_Kinome_Subject_Phenotypes.var_report.xml	0.0	12.0		12.0			12.0		phs001405.v1.p1	Triple Negative Breast Neoplasms
606.0	606.0		2019/02/05	1014.0		8.0	./data/phs000748.v7.pht003888.v7.p4.MMRF_Pedigree.var_report.xml	0.0	338.0	303.8	400.0			400.0		phs000748.v7.p4	Multiple Myeloma
			2021/07/15				./data/phs001600.v2.pht011021.v2.p2.TOPMed_CCDG_CATHGEN_Subject_Phenotypes.var_report.xml									phs001600.v2.p2	Atrial Fibrillation
			2018/05/31				./data/phs001316.v1.pht008009.v1.p1.p5305_12509_baselinem.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			04/10/2014				./data/phs000602.v2.pht003222.v1.p1.DiverseCancers_Sample_Attributes.var_report.xml									phs000602.v2.p1	Neoplasms
			07/26/2017				./data/phs000852.v1.pht006696.v1.p1.GEDI_SUDs_Sample_Attributes.var_report.xml									phs000852.v1.p1	Substance-Related Disorders
			08/20/2013				./data/phs000285.v3.pht001853.v2.p2.F2CRP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/25				./data/phs001779.v1.pht010206.v1.p1.CIDR_NIA_Ehlers_Danlos_Sample.var_report.xml									phs001779.v1.p1	Ehlers-Danlos syndrome type 3
			2020/06/18				./data/phs000280.v7.pht004178.v2.p1.RTASWF24.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/26/2015				./data/phs000846.v1.pht004450.v1.p1.Bisulfite_Sequencing_ccf_DNA_Subject_Phenotypes.var_report.xml									phs000846.v1.p1	DNA Methylation
410.0	410.0		11/13/2015	543.0		133.0	./data/phs000820.v1.pht004332.v1.p1.Lone_Atrial_Fibrillation_Subject_Phenotypes.var_report.xml	0.0	271.5	195.9	133.0			271.5		phs000820.v1.p1	Atrial Fibrillation
			09/15/2016				./data/phs001044.v1.pht005274.v1.p1.Breast_Cancer_Risk_Pathways_Subject_Phenotypes.var_report.xml									phs001044.v1.p1	Breast Neoplasms
			11/10/2015				./data/phs000936.v1.pht004890.v1.p1.GOESP_Broad_EOMI_ExomeChip_Sample.var_report.xml									phs000936.v1.p1	
			2020/02/06				./data/phs001430.v2.pht008079.v2.p1.p7001_18441_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			11/05/2014				./data/phs000209.v13.pht003376.v1.p3.MESA_AncilMesaEyeRetinalPhotoE2.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005579.v1.p1.emerge2_autism_featuresdisease.var_report.xml									phs000888.v1.p1	
			07/09/2015				./data/phs000564.v2.pht003060.v2.p1.WGS_NICU_Sample_Attributes.var_report.xml									phs000564.v2.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2018/05/07				./data/phs000490.v1.pht002968.v1.p1.ADHD_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			05/11/2012				./data/phs000414.v1.pht002730.v1.p1.Core_Binding_Factor_AML_Sample.var_report.xml									phs000414.v1.p1	Leukemia, Myeloid, Acute
			2020/01/10				./data/phs001834.v1.pht009420.v1.p1.Fuchs_Corneal_Dystrophy_Subject.var_report.xml									phs001834.v1.p1	Fuchs&#39; Endothelial Dystrophy
			2021/06/10				./data/phs001359.v3.pht008688.v1.p1.TOPMed_WGS_GOLDN_Subject.var_report.xml									phs001359.v3.p1	Lipids
527.0	527.0		05/08/2015	537.0		6.0	./data/phs000864.v1.pht004494.v1.p1.Combat_Stress_Predictors_Subject_Phenotypes.var_report.xml	0.0	268.5	365.6	6.0			268.5		phs000864.v1.p1	Stress Disorders, Post-Traumatic
			2017/12/20				./data/phs000577.v1.pht007272.v1.p1.laboratoryform.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2019/03/11				./data/phs000286.v6.pht008752.v1.p2.hcta.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006420.v1.p1.AQC.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/04/16				./data/phs000862.v1.pht007838.v1.p1.registration.var_report.xml									phs000862.v1.p1	Mucopolysaccharidosis I
			12/11/2015				./data/phs001034.v1.pht005187.v1.p1.NECC_Ovarian_Cancer_Subject.var_report.xml									phs001034.v1.p1	Ovarian Neoplasms
			09/27/2010				./data/phs000103.v1.pht001889.v1.p1.Preterm_Delivery_Sample.var_report_2010_09_27.xml									phs000103.v1.p1	Premature Birth
			2018/03/09				./data/phs000933.v2.pht004775.v2.p1.Melanoma_WES_Sample.var_report.xml									phs000933.v2.p1	Melanoma
			2020/12/21				./data/phs000007.v32.pht009753.v2.p13.l_glial1_ex09_1b_1074s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/28				./data/phs001680.v1.pht008912.v1.p1.T_Cell_States_Melanoma_Subject.var_report.xml									phs001680.v1.p1	Immunotherapy
			2020/12/21				./data/phs000007.v32.pht000675.v4.p13.avmv1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/11/13				./data/phs001523.v1.pht007511.v1.p1.phenotype_reviewOfSystemsSurvey.var_report.xml									phs001523.v1.p1	Pregnancy
121.0	121.0		2021/10/04	202.0		81.0	./data/phs002238.v1.pht011519.v1.p1.Beat_Childhood_Cancer_Subject.var_report.xml	0.0	101.0	28.28	81.0			101.0		phs002238.v1.p1	Neoplasms
			06/10/2015				./data/phs000545.v1.pht003762.v1.p1.Chemotherapy_Induced_Mucositis_Subject.var_report.xml									phs000545.v1.p1	Multiple Myeloma
			08/29/2016	14.0			./data/phs000770.v1.pht003927.v1.p1.HER2_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0			14.0					phs000770.v1.p1	Breast Neoplasms
			2019/03/18				./data/phs001585.v1.pht008830.v1.p1.FALS_Subject_Phenotypes.var_report.xml									phs001585.v1.p1	Amyotrophic Lateral Sclerosis
			08/12/2016				./data/phs000888.v1.pht005570.v1.p1.19aGERD_procedures_surgeries.var_report.xml									phs000888.v1.p1	
5.0	20.0		2021/05/28	25.0		5.0	./data/phs002259.v1.pht011023.v1.p1.CD4T_European_Subject.var_report.xml	0.0	12.5	10.61	20.0			12.5		phs002259.v1.p1	RNA-Seq
			2019/03/18				./data/phs001796.v1.pht008832.v1.p1.CTS_Nerve_Repair_Subject.var_report.xml									phs001796.v1.p1	Carpal Tunnel Syndrome
			07/12/2017				./data/phs000592.v1.pht006597.v1.p1.physicalexam.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2021/02/12				./data/phs002334.v1.pht010958.v1.p1.EGFR_Driven_LUAD_Sample.var_report.xml									phs002334.v1.p1	Adenocarcinoma, Lung
3064.0	3064.0		10/09/2009	3937.0		873.0	./data/phs000093.v2.pht000119.v1.p2.Eagle_Cases_Ctls_Data.var_report_2009_10_09.xml	0.0	996.0	802.6	873.0			996.0		phs000093.v2.p2	Lung Neoplasms
			11/08/2013				./data/phs000200.v9.pht001032.v6.p3.WHI_Sample.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			04/10/2014				./data/phs000418.v2.pht002615.v1.p1.Temporal_Dissection_Tumorigenesis_Subject.var_report.xml									phs000418.v2.p1	Carcinoma, Squamous Cell
			07/18/2012				./data/phs000395.v1.pht002361.v1.p1.CIDR_Mammographic_Density_Subject.var_report.xml									phs000395.v1.p1	Breast Neoplasms
			04/08/2014				./data/phs000487.v2.pht003118.v1.p1.Prostate_Cancer_Risk_Sample_Attributes.var_report.xml									phs000487.v2.p1	Prostatic Neoplasms
			2018/03/09				./data/phs000606.v1.pht007567.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2017/09/22				./data/phs001392.v1.pht006905.v1.p1.rd_8403_qualityoflife.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2020/01/16				./data/phs001386.v2.pht006609.v1.p1.Brotman_long.var_report.xml									phs001386.v2.p1	Smoking
			03/18/2010				./data/phs000093.v2.pht000120.v2.p2.PLCO_Eagle_Subject.var_report_2010_03_18.xml									phs000093.v2.p2	Lung Neoplasms
			11/15/2011				./data/phs000408.v1.pht002438.v1.p1.eMERGE_Obesity_Subject.var_report.xml									phs000408.v1.p1	Obesity
9.0	11.0		2017/08/22	22.0		2.0	./data/phs001209.v1.pht006804.v1.p1.MIDCIRS_Subject_Phenotypes.var_report.xml	0.0	7.332999999999999	4.726	11.0			9.0		phs001209.v1.p1	Malaria
			2020/06/18				./data/phs000280.v7.pht006438.v1.p1.ECO.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/03				./data/phs002417.v1.pht011274.v1.p1.FFCWS_Sample.var_report.xml									phs002417.v1.p1	Population Groups
			2018/02/12				./data/phs001525.v1.pht007478.v1.p1.XDP_DNA_Sample_Attributes.var_report.xml									phs001525.v1.p1	X-Linked Dystonia Parkinsonism
6.0	6.0		2019/03/28	12.0		6.0	./data/phs001794.v1.pht008905.v1.p1.BWS_miRNA_Subject_Phenotypes.var_report.xml	0.0	6.0	0	6.0			6.0		phs001794.v1.p1	Beckwith-Wiedemann Syndrome
807.0	928.0		2020/10/01	4384.0		807.0	./data/phs001881.v1.pht010564.v1.p1.CNV_NDD_Subject_Phenotypes.var_report.xml	0.0	867.5	915	928.0			867.5		phs001881.v1.p1	Autism Spectrum Disorder
			11/08/2013				./data/phs000200.v9.pht001031.v4.p3.rand_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/01/30				./data/phs001495.v2.pht007196.v2.p1.DAXX_ALT_Sample.var_report.xml									phs001495.v2.p1	Osteosarcoma
944.0			2020/06/29	4458.0			./data/phs001180.v2.pht006991.v1.p1.GALAII_Subject_Phenotypes.var_report.xml	0.0			2264.0					phs001180.v2.p1	Lung Diseases
			2019/08/30				./data/phs001331.v2.pht006920.v2.p1.lab_results.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			11/09/2016				./data/phs001037.v1.pht005916.v1.p1.TEDDY_Subject.var_report.xml									phs001037.v1.p1	Diabetes Mellitus, Type 1
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000521.v2.p3.simphen122.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/01/07				./data/phs001518.v1.pht007332.v1.p1.TRIUMPH_Sample.var_report.xml									phs001518.v1.p1	Myocardial Infarction
			2021/06/09				./data/phs001345.v3.pht008604.v1.p1.TOPMed_WGS_GENOA_Sample_Attributes.var_report.xml									phs001345.v3.p1	Hypertension
92.0	92.0		01/25/2016	503.0		60.0	./data/phs001058.v1.pht005237.v1.p1.MIGen_BioImage_Subject_Phenotypes.var_report.xml	0.0	76.0	77.07	60.0			76.0		phs001058.v1.p1	Myocardial Infarction
			2020/12/21				./data/phs000007.v32.pht002072.v7.p13.l_hstn_ex06_1_0534s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/01/31				./data/phs001712.v1.pht008671.v1.p1.VCRC_5510_Subject.var_report.xml									phs001712.v1.p1	Vasculitis
			01/14/2016				./data/phs001050.v1.pht005232.v1.p1.BEAUTY_Sample.var_report.xml									phs001050.v1.p1	Breast Neoplasms
			2021/02/19				./data/phs002273.v1.pht010906.v1.p1.Urine_cfDNA_Sample_Attributes.var_report.xml									phs002273.v1.p1	Cell-Free Nucleic Acids
			05/24/2016				./data/phs001065.v1.pht005413.v1.p1.inex.var_report.xml									phs001065.v1.p1	Huntington Disease
6778.0	7753.0		04/29/2016	7232.0		6778.0	./data/phs000128.v3.pht000833.v2.p3.shareid_consent_Subject.var_report.xml	2865.0	7266.0	689.4	7753.0			7266.0		phs000128.v3.p3	Coronary Disease
			03/12/2013				./data/phs000343.v3.pht002716.v1.p1.bss.var_report.xml									phs000343.v3.p1	Stroke
86.0	970.0		11/05/2014	230.0		86.0	./data/phs000209.v13.pht001121.v3.p3.MESA_FamilyExamMain.var_report.xml	0.0	808.0	41.01	970.0			808.0		phs000209.v13.p3	Cardiovascular Diseases
1.0	2.0		2019/06/24	3.0		1.0	./data/phs001848.v1.pht009204.v1.p1.PIK3CG_Pedigree.var_report.xml	0.0	1.5	0.7071	2.0			1.5		phs001848.v1.p1	Immune System Diseases
	15.0		2020/07/10	15.0		15.0	./data/phs000723.v1.pht005212.v1.p1.Cervical_Adenocarcinoma_Chinese_Subject_Phenotypes.var_report.xml	0.0	15.0		15.0			15.0		phs000723.v1.p1	Uterine Cervical Neoplasms
8474.0	894.0		08/05/2016	7190.0		8474.0	./data/phs000360.v3.pht003255.v2.p1.MergedSet_Subject_Phenotypes.var_report.xml	0.0	9332.0	922.1	894.0			9332.0		phs000360.v3.p1	Electronic Health Records
			08/20/2013				./data/phs000285.v3.pht001651.v2.p2.C1ECHO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/06/14				./data/phs000589.v1.pht009189.v1.p1.fu_medical_history_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			04/25/2016				./data/phs000474.v3.pht002696.v3.p2.Human_Hematopoiesis_Genetics_Sample_Attributes.var_report.xml									phs000474.v3.p2	Anemia, Dyserythropoietic, Congenital
			05/21/2010				./data/phs000261.v1.pht001231.v1.p1.HMP_Bacterial_Vaginosis_Subject_Time_Independent_Phenotype.var_report.xml									phs000261.v1.p1	Vaginosis, Bacterial
			2020/03/11				./data/phs001919.v1.pht009595.v1.p1.Melanoma_Anti_PD_1_Sample_Attributes.var_report.xml									phs001919.v1.p1	Melanoma
			2019/07/29				./data/phs001736.v1.pht009328.v1.p1.RCC_European_Sample.var_report.xml									phs001736.v1.p1	Carcinoma, Renal Cell
			2021/05/21				./data/phs001062.v5.pht005262.v4.p2.TOPMed_WGS_MGH_AF_Sample.var_report.xml									phs001062.v5.p2	Atrial Fibrillation
8.0	9.0		2021/07/29	17.0		8.0	./data/phs002437.v1.pht011429.v1.p1.M4OC_PREVENT_Subject.var_report.xml	0.0	8.5	0.7071	9.0			8.5		phs002437.v1.p1	Leukoplakia, Oral
			11/04/2014				./data/phs000086.v3.pht000241.v1.p1.DCCT_f0271.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			03/15/2012				./data/phs000440.v1.pht002491.v1.p1.Marazita_Guatemala_SubjectDS_Subject.var_report.xml									phs000440.v1.p1	Dental Caries
			08/22/2012				./data/phs000495.v1.pht002866.v1.p1.TGP_Subject_Phenotypes.var_report.xml									phs000495.v1.p1	Non-Neoplastic Pediatric Disorder
			2020/12/21				./data/phs000007.v32.pht000299.v12.p13.ecg_alls.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006453.v1.p1.MSR.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/04/04				./data/phs001803.v1.pht008940.v1.p1.Dystonias_Sample_Attributes.var_report.xml									phs001803.v1.p1	Cervical Dystonia
1001.0	1001.0		2021/06/08	1893.0		892.0	./data/phs001217.v3.pht007764.v1.p1.TOPMed_WGS_GenSalt_Subject_Phenotypes.var_report.xml	0.0	946.5	77.07	892.0			946.5		phs001217.v3.p1	Arterial Pressure, Mean
			2018/01/26				./data/phs001417.v1.pht007364.v1.p1.Metastatic_Tumors_cfDNA_Subject.var_report.xml									phs001417.v1.p1	Neoplasms
			02/05/2013				./data/phs000339.v2.pht002138.v2.p1.Mitochondrial_OXPHOS_Diseases_Subject_Phenotypes.var_report.xml									phs000339.v2.p1	Mitochondrial Diseases
			03/31/2016				./data/phs001072.v1.pht005355.v1.p1.Relapsed_Pediatric_ALL_Sample.var_report.xml									phs001072.v1.p1	Leukemia, Lymphoid
			2020/07/29				./data/phs001290.v1.pht010335.v1.p1.CIDR_CRC_Survival_Sample_Attributes.var_report.xml									phs001290.v1.p1	Colorectal Neoplasms
			2020/03/24				./data/phs001641.v1.pht010029.v1.p1.Baseline.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			01/20/2016				./data/phs000902.v1.pht004669.v1.p1.MIGen_Regicor_Sample.var_report.xml									phs000902.v1.p1	Coronary Artery Disease
			2019/11/08				./data/phs001330.v2.pht007534.v2.p1.ados.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			11/07/2012				./data/phs000538.v1.pht003042.v1.p1.Mendelian_Familial_Hyperlipidemia_Sample_Attributes.var_report.xml									phs000538.v1.p1	Hyperlipidemia, Familial Combined
			01/15/2016				./data/phs000806.v1.pht004771.v1.p1.MIGen_Ottawa_Heart_Sample.var_report.xml									phs000806.v1.p1	
			Thu Jan 17 21:45:41 2008				./data/phs000019.v1.pht000180.v1.p1.trio_information.var_report_2008_08_12.xml									phs000019.v1.p1	Psoriasis
			2020/12/21				./data/phs000007.v32.pht000096.v8.p13.opg1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/08/03				./data/phs000590.v1.pht008275.v1.p1.followup_comorbidity_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
5.0	5.0		05/14/2013	8.0		9.0	./data/phs000609.v1.pht003285.v1.p1.AutismGeneExpression_Subject_Phenotypes.var_report.xml	0.0	9.5	6.364	9.0			9.5		phs000609.v1.p1	Autism
			2020/02/14				./data/phs000575.v2.pht005886.v2.p1.childhoodweighthx.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
5.0	516.0		2021/06/16	981.0		5.0	./data/phs001412.v3.pht006744.v2.p1.TOPMed_WGS_DHS_Pedigree.var_report.xml	0.0	490.5	9.899	516.0			490.5		phs001412.v3.p1	Cardiovascular Disease
156.0	156.0		2018/08/19	292.0		136.0	./data/phs000101.v5.pht003747.v1.p1.ALS_Pedigree.var_report.xml	0.0	146.0	14.14	136.0			146.0		phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2019/06/14				./data/phs000589.v1.pht009200.v1.p1.unscheduled_visit_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
775.0	212.0		2021/06/09	330.0		775.0	./data/phs001293.v3.pht008896.v1.p1.TOPMed_WGS_HyperGEN_Subject_Phenotypes.var_report.xml	0.0	887.0	66.47	212.0			887.0		phs001293.v3.p1	Hypertrophy, Left Ventricular
7.0	7.0		2018/02/27	7.0		7.0	./data/phs001447.v1.pht007470.v1.p1.MCRPCS_Subject_Phenotypes.var_report.xml	0.0	7.0					7.0		phs001447.v1.p1	Prostatic Neoplasms
2.0	4.0		07/21/2010	6.0		2.0	./data/phs000239.v2.pht001222.v1.p1.MS_MZTwins_Subject_Phenotypes.var_report_2010_07_21.xml	0.0	3.0	1.414	4.0			3.0		phs000239.v2.p1	Multiple Sclerosis
			2017/08/24				./data/phs001433.v1.pht006811.v1.p1.HB_Wnt_Bcatenin_Sample.var_report.xml									phs001433.v1.p1	Hepatoblastoma
			03/12/2013				./data/phs000343.v3.pht003152.v1.p1.phq.var_report.xml									phs000343.v3.p1	Stroke
			2019/06/13				./data/phs001840.v1.pht009149.v1.p1.PDAC_CAFs_Sample_Attributes.var_report.xml									phs001840.v1.p1	Carcinoma, Pancreatic Ductal
			04/14/2014				./data/phs000732.v1.pht003800.v1.p1.L1_Retrotransposon_Asian_Sample.var_report.xml									phs000732.v1.p1	Molecular Structure
			2021/08/19				./data/phs001662.v2.pht010056.v1.p1.LTRC_R040_subject_ctscanreport.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2020/08/06				./data/phs001571.v1.pht009507.v1.p1.IBD_AA_Sample_Attributes.var_report.xml									phs001571.v1.p1	Crohn Disease
			08/20/2013				./data/phs000285.v3.pht001716.v2.p2.D1F09PER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
7.0	7.0		05/02/2012	13.0		6.0	./data/phs000478.v1.pht002657.v1.p1.Strabismus_Subject_Phenotypes.var_report.xml	0.0	6.5	0.7071	6.0			6.5		phs000478.v1.p1	Strabismus
			06/30/2016				./data/phs001096.v1.pht005606.v1.p1.T2D_GENES_KARE_East_Asian_Subject.var_report.xml									phs001096.v1.p1	Diabetes Mellitus, Type 2
			2021/01/06				./data/phs001383.v1.pht010794.v1.p1.Moebius_Syndrome_Sample_Attributes.var_report.xml									phs001383.v1.p1	Mobius Syndrome
			2018/09/20				./data/phs001428.v1.pht008387.v1.p1.S0221_BRCA_Toxicities_Subject_Phenotypes.var_report.xml									phs001428.v1.p1	Peripheral Nervous System Diseases
			2021/10/19				./data/phs002632.v1.pht011606.v1.p1.AA_KRT82_Sample.var_report.xml									phs002632.v1.p1	Alopecia Areata
			08/20/2013				./data/phs000285.v3.pht001736.v2.p2.D1FIBR.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
377.0	5.0		2020/04/30	9.0		279.0	./data/phs001323.v2.pht010116.v2.p1.MMGS_Subject_Phenotypes.var_report.xml	0.0	326.5	67.18	5.0			326.5		phs001323.v2.p1	Multiple Myeloma
5.0	7.0		11/16/2015	12.0		5.0	./data/phs000896.v1.pht005125.v1.p1.LGG_Probiotics_Metagenome_Subject_Phenotypes.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs000896.v1.p1	Human Microbiome
			09/21/2016				./data/phs000984.v1.pht005011.v1.p1.T2DM_Metformin_Sample_Attributes.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
			11/04/2014				./data/phs000086.v3.pht000348.v1.p1.EDIC_f0932.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
91.0	108.0		2021/08/27	199.0		91.0	./data/phs000966.v2.pht011076.v1.p2.Essential_Tremor_Duke_Subject_Phenotypes.var_report.xml	0.0	99.5	12.02	108.0			99.5		phs000966.v2.p2	Essential Tremor
624.0	510.0		2019/05/21	4825.0		624.0	./data/phs001090.v1.pht009052.v1.p1.CIDR_OFC_African_Pedigree.var_report.xml	0.0	510.0	644.2	510.0			510.0		phs001090.v1.p1	Cleft Lip
			2018/07/25				./data/phs001367.v1.pht008248.v1.p1.Add_Health_Subject_Phenotypes.var_report.xml									phs001367.v1.p1	Adolescent Health
			2020/01/10				./data/phs001834.v1.pht009421.v1.p1.Fuchs_Corneal_Dystrophy_Sample.var_report.xml									phs001834.v1.p1	Fuchs&#39; Endothelial Dystrophy
	5367.0		05/26/2015	5367.0		5367.0	./data/phs000851.v1.pht004684.v1.p1.Breast_Cancer_AA_Subject_Phenotypes.var_report.xml	0.0	5367.0		5367.0			5367.0		phs000851.v1.p1	Breast Neoplasms
			2021/08/26				./data/phs001727.v2.pht010100.v1.p1.TOPMed_WGS_PIMA_Subject.var_report.xml									phs001727.v2.p1	Asthma
8.0	8.0		04/06/2016	88.0		7.0	./data/phs001080.v1.pht005370.v1.p1.Hereditary_Spastic_Paraplegia_Pedigree.var_report.xml	0.0	7.5	14.85	7.0			7.5		phs001080.v1.p1	Spastic Paraplegia, Hereditary
			2020/12/22				./data/phs002301.v1.pht010814.v1.p1.Skull_Based_Chordoma_Subject.var_report.xml									phs002301.v1.p1	chordoma
			2018/02/08				./data/phs001488.v1.pht007398.v1.p1.hvlt.var_report.xml									phs001488.v1.p1	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001870.v2.p2.YM006.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002900.v4.p13.vr_ffreq_ex02_3_0713s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/05/2010				./data/phs000188.v1.pht001895.v1.p1.QRS_Sample.var_report_2010_10_05.xml									phs000188.v1.p1	Heart Conduction System
			01/19/2010				./data/phs000219.v1.pht001062.v1.p1.d_consent_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/12/21				./data/phs000007.v32.pht003632.v5.p13.t_pftprealb_2011_m_0646s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/12/12				./data/phs000785.v1.pht004008.v1.p1.SCC_Subject.var_report.xml									phs000785.v1.p1	Carcinoma, Squamous Cell
3.0	3.0		2019/04/09	5.0		2.0	./data/phs001802.v1.pht008960.v1.p1.Lymphatic_Anomalies_CAG_Subject_Phenotypes.var_report.xml	0.0	2.5	0.7071	2.0			2.5		phs001802.v1.p1	Lymphatic Diseases
			2019/11/08				./data/phs001332.v2.pht007452.v2.p1.conclusionofstudyparticipation.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2021/02/10				./data/phs001675.v1.pht010218.v1.p1.OFC_Subject.var_report.xml									phs001675.v1.p1	Cleft Lip
			2018/11/19				./data/phs000915.v2.pht004946.v2.p2.mCRPC_SU2C_Subject_Phenotypes.var_report.xml									phs000915.v2.p2	Prostatic Neoplasms
			07/12/2017				./data/phs000592.v1.pht006590.v1.p1.enrollmentmedicalillness.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			11/26/2013				./data/phs000597.v1.pht003200.v1.p1.DNA_Methylation_Prostate_Cancer_Sample.var_report.xml									phs000597.v1.p1	Prostatic Neoplasms
			2021/03/25				./data/phs002061.v1.pht010835.v1.p1.Zidovudine_Children_Sample.var_report.xml									phs002061.v1.p1	HIV
			02/18/2015				./data/phs000760.v1.pht004262.v1.p1.Flu_Vaccine_Subject.var_report.xml									phs000760.v1.p1	Influenza Vaccines
			2020/06/18				./data/phs000280.v7.pht004138.v2.p1.NUTV2X.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000585.v2.p3.simphen186.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
71.0	71.0		2018/04/04	73.0		6.0	./data/phs001527.v1.pht007519.v1.p1.Oral_Microbiome_EAC_Subject_Phenotypes.var_report.xml	0.0	73.0	97.58	6.0			73.0		phs001527.v1.p1	Esophageal Neoplasms
			2018/01/18				./data/phs001300.v1.pht006720.v1.p1.NABEC_Subject.var_report.xml									phs001300.v1.p1	Gene Expression Profiling
49.0	49.0		2018/10/22	49.0		49.0	./data/phs001666.v1.pht008466.v1.p1.Alisertib_PC_Subject_Phenotypes.var_report.xml	0.0	49.0					49.0		phs001666.v1.p1	Adenocarcinoma
			2020/12/21				./data/phs000007.v32.pht001415.v20.p13.Framingham_Sample.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/09/2011				./data/phs000330.v1.pht002111.v1.p1.Prostate_Cancer_Characterization_Sample.var_report_2011_02_09.xml									phs000330.v1.p1	Prostatic Neoplasms
			2018/10/22				./data/phs001550.v2.pht007505.v2.p1.Melanocytic_Neoplasms_Sample.var_report.xml									phs001550.v2.p1	Melanoma
			2018/10/15				./data/phs001106.v1.pht007337.v1.p1.Genomics_HCC_Sample_Attributes.var_report.xml									phs001106.v1.p1	
			2019/04/04				./data/phs001768.v1.pht008694.v1.p1.Methylmercury_Pregnancy_Sample_Attributes.var_report.xml									phs001768.v1.p1	
684.0	1284.0		08/26/2015	1968.0		684.0	./data/phs000948.v1.pht004850.v1.p1.eMERGE_PhaseII_Subject_Phenotypes.var_report.xml	0.0	984.0	424.3	1284.0			984.0		phs000948.v1.p1	
			2019/12/19				./data/phs001937.v1.pht009708.v1.p1.PEPP3_Subject.var_report.xml									phs001937.v1.p1	Pre-Eclampsia
			06/17/2013				./data/phs000454.v1.pht002648.v1.p1.HIV_Susceptibility_Subject.var_report.xml									phs000454.v1.p1	HIV
			11/05/2014				./data/phs000209.v13.pht001205.v1.p3.MESA_AncilMesaExam4AbdominalAorticCT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			12/03/2012				./data/phs000548.v1.pht003073.v1.p1.asa2_Sample_Attributes.var_report.xml									phs000548.v1.p1	Aspirin
			2019/03/11				./data/phs000286.v6.pht008724.v1.p2.afea.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			04/04/2014				./data/phs000734.v1.pht003769.v1.p1.Osteosarcoma_Risk_Subject.var_report.xml									phs000734.v1.p1	Osteosarcoma
			2021/07/29				./data/phs001624.v2.pht008230.v2.p2.TOPMed_CCDG_BioVU_Sample.var_report.xml									phs001624.v2.p2	Atrial Fibrillation
			2018/10/02				./data/phs001702.v1.pht008426.v1.p1.Lupus_eQTL_Sample.var_report.xml									phs001702.v1.p1	Lupus Erythematosus, Systemic
			2019/07/31				./data/phs001872.v1.pht009366.v1.p1.CEPH_Utah_Sample_Attributes.var_report.xml									phs001872.v1.p1	Population Groups
			03/06/2017				./data/phs000574.v1.pht005857.v1.p1.chq.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2020/08/26				./data/phs001958.v1.pht009930.v1.p1.caQTL_Subject.var_report.xml									phs001958.v1.p1	Mental Disorders
			2021/06/28				./data/phs001598.v2.pht009996.v1.p1.TOPMed_CCDG_JHU_AF_Sample.var_report.xml									phs001598.v2.p1	Atrial Fibrillation
235.0	235.0		2021/06/07	416.0		181.0	./data/phs001710.v1.pht011292.v1.p1.TOAA_Subject_Phenotypes.var_report.xml	0.0	208.0	38.18	181.0			208.0		phs001710.v1.p1	
56.0	89.0		2020/01/23	5.0		56.0	./data/phs000287.v7.pht003699.v2.p1.SHHS1_PSG.var_report.xml	26.0	72.5	399.5	89.0			72.5		phs000287.v7.p1	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007428.v1.p1.uhdr4.var_report.xml									phs001488.v1.p1	Huntington Disease
11.0			2019/05/31	41.0			./data/phs001296.v2.pht006359.v2.p1.medical_records_form.var_report.xml	0.0			30.0					phs001296.v2.p1	Urea Cycle Disorders, Inborn
			2021/04/08				./data/phs001590.v2.pht007892.v2.p1.NESARCIII_Sample.var_report.xml									phs001590.v2.p1	Alcoholism
			08/20/2013				./data/phs000285.v3.pht001695.v2.p2.C1LIP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
134.0	134.0		2021/09/24	160.0		26.0	./data/phs002346.v1.pht011576.v1.p1.EAGLE_Immune_Related_Subject_Phenotypes.var_report.xml	0.0	80.0	76.37	26.0			80.0		phs002346.v1.p1	Lung Neoplasms
			08/20/2013				./data/phs000285.v3.pht001844.v2.p2.F1F9PRG3.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/10				./data/phs001485.v2.pht007184.v1.p1.Cell_ID_Subject.var_report.xml									phs001485.v2.p1	Cockayne Syndrome
			2018/05/01				./data/phs001568.v1.pht007873.v1.p1.CLL_Sample_Attributes.var_report.xml									phs001568.v1.p1	Leukemia, Lymphoid
			08/20/2013				./data/phs000285.v3.pht001677.v2.p2.C1F37.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/07/03				./data/phs001850.v1.pht009238.v1.p1.Subtype_SLE_Sample_Attributes.var_report.xml									phs001850.v1.p1	Lupus Erythematosus, Systemic
			07/21/2015				./data/phs000938.v1.pht004785.v1.p1.WES_HybCapture_vs_Amplicon_Subject_Phenotypes.var_report.xml									phs000938.v1.p1	
			09/28/2012				./data/phs000275.v1.pht002972.v1.p1.BWH_MS_Sample.var_report.xml									phs000275.v1.p1	Multiple Sclerosis
			08/12/2016				./data/phs000888.v1.pht004676.v1.p1.eMERGE_Imputed_Subject.var_report.xml									phs000888.v1.p1	
			2020/08/20				./data/phs002069.v1.pht010471.v1.p1.BAVM_Hemorrhage_Subject_Phenotypes.var_report.xml									phs002069.v1.p1	Intracranial Arteriovenous Malformations
			2018/06/01				./data/phs001046.v1.pht005294.v1.p1.AMD_Progression_Treatment_Response_Sample.var_report.xml									phs001046.v1.p1	Macular Degeneration
			2020/12/21				./data/phs000007.v32.pht010756.v1.p13.vr_meds_ex32_0_0880s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/13/2015				./data/phs001008.v1.pht005109.v1.p1.IRAS_Family_Study_Sample.var_report.xml									phs001008.v1.p1	Insulin Resistance
			03/14/2012				./data/phs000223.v1.pht002619.v1.p1.ARIC_PAGE_pilot_Subject.var_report.xml									phs000223.v1.p1	Cardiovascular Diseases
43.0	43.0		2017/09/19	82.0		39.0	./data/phs001426.v1.pht006917.v1.p1.T1DGC_RNASeq_Subject_Phenotypes.var_report.xml	0.0	41.0	2.828	39.0			41.0		phs001426.v1.p1	Diabetes Mellitus, Type 1
			2021/08/30				./data/phs000235.v17.pht001132.v16.p4.CGCI_Subject.var_report.xml									phs000235.v17.p4	Neoplasms
			04/16/2013				./data/phs000145.v4.pht000661.v3.p2.POPRES_Subject.var_report.xml									phs000145.v4.p2	Normalcy
			2017/12/12				./data/phs000676.v2.pht003589.v1.p2.Breast_Tissues_Sequence_Analysis_GEO.var_report.xml									phs000676.v2.p2	Breast Neoplasms
213.0			07/05/2017	1465.0			./data/phs000595.v1.pht006642.v1.p1.relative_questionnaire.var_report.xml	7.0			262.0					phs000595.v1.p1	Primary ciliary dyskinesia
			12/07/2015				./data/phs000970.v1.pht005019.v1.p1.Fetal_Methylmercury_Exposure_Sample_Attributes.var_report.xml									phs000970.v1.p1	Methylmercury Compounds
260.0	387.0		2017/09/22	647.0		260.0	./data/phs001394.v1.pht006949.v1.p1.GUARDIAN_HTN_IR_Subject_Phenotypes.var_report.xml	0.0	323.5	89.8	387.0			323.5		phs001394.v1.p1	Hypertension
			11/21/2016				./data/phs000341.v2.pht002675.v2.p1.Hypodiploid_ALL_Sample_Attributes.var_report.xml									phs000341.v2.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2021/03/24				./data/phs002341.v1.pht011060.v1.p1.Dermal_Fibroblasts_Pluripotency_Sample_Attributes.var_report.xml									phs002341.v1.p1	Fibroblast-Derived Induced Pluripotent Stem Cells
			2020/07/15				./data/phs002054.v1.pht010347.v1.p1.9p_Deletion_Subject.var_report.xml									phs002054.v1.p1	Chromosome 9p Deletion Syndrome
			2020/07/24				./data/phs001194.v3.pht005824.v2.p2.CardiacAbnormalities.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			2019/11/19				./data/phs000572.v8.pht003390.v5.p4.ADSP_Subject.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			2021/04/27				./data/phs001908.v2.pht009534.v2.p1.Spatiotemporal_Cerebellum_Sample_Attributes.var_report.xml									phs001908.v2.p1	Neural Stem Cells
			2018/03/30				./data/phs001108.v1.pht007716.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
			01/30/2017				./data/phs001255.v1.pht005991.v1.p1.Molecular_Evolution_Cancer_Sample.var_report.xml									phs001255.v1.p1	Liposarcoma
			11/16/2016				./data/phs000935.v1.pht004819.v1.p1.CSER_PediSeq_Sample_Attributes.var_report.xml									phs000935.v1.p1	Genetic Testing
			2019/03/11				./data/phs001717.v1.pht008579.v1.p1.Placental_Regulation_Sample.var_report.xml									phs001717.v1.p1	Control Groups
			2020/03/09				./data/phs001299.v2.pht007621.v2.p1.Nicotine_Addiction_Sample.var_report.xml									phs001299.v2.p1	Behavior, Addictive
			11/30/2015				./data/phs001007.v1.pht005069.v1.p1.HNSCC_Metastasis_Recurrence_Sample_Attributes.var_report.xml									phs001007.v1.p1	Carcinoma, squamous cell of head and neck
			2018/07/09				./data/phs001650.v1.pht008205.v1.p1.LCL_Expansions_Sample_Attributes.var_report.xml									phs001650.v1.p1	Control Groups
			2017/10/19				./data/phs001288.v1.pht006771.v1.p1.imagingform.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			03/13/2014				./data/phs000715.v1.pht003746.v1.p1.Multiple_Sclerosis_Brains_Sample_Attributes.var_report.xml									phs000715.v1.p1	Multiple Sclerosis, Chronic Progressive
			08/12/2016				./data/phs000888.v1.pht004681.v1.p1.eMERGE_Imputed_Sample_Attributes.var_report.xml									phs000888.v1.p1	
			2020/01/23				./data/phs000287.v7.pht001469.v1.p1.MRI1RECS.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/02/04				./data/phs002333.v1.pht010921.v1.p1.Chronic_Rhinosinusitis_Subject_Phenotypes.var_report.xml									phs002333.v1.p1	Paranasal Sinus Diseases
			2020/04/06				./data/phs002003.v1.pht010109.v1.p1.Single_Cell_Atlas_Sample_Attributes.var_report.xml									phs002003.v1.p1	Human Development
			2020/06/18				./data/phs000280.v7.pht004075.v2.p1.ECGMB22.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/03/22				./data/phs001375.v2.pht006521.v2.p1.SIGMA_MCDS_Sample.var_report.xml									phs001375.v2.p1	Diabetes Mellitus, Type 2
30.0	689.0		09/28/2012	924.0		30.0	./data/phs000275.v1.pht002971.v1.p1.BWH_MS_Pedigree.var_report.xml	0.0	462.0	321	689.0			462.0		phs000275.v1.p1	Multiple Sclerosis
1691.0	23734.0		05/16/2017	38584.0		14850.0	./data/phs001252.v1.pht006391.v1.p1.ns_ios.var_report.xml	0.0	19292.0	6282	1055.0			19292.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
2.0	2.0		06/01/2012	4.0		2.0	./data/phs000384.v1.pht002463.v1.p1.Genentech_Hepatocellular_Carcinoma_Subject_Phenotypes.var_report.xml	0.0	2.0	0	2.0			2.0		phs000384.v1.p1	Hepatocellular Carcinomas
			2019/07/26				./data/phs000588.v1.pht009287.v1.p1.angiogram_pulmonary.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			03/22/2017				./data/phs000925.v1.pht005177.v1.p1.PAGE_IPM_BioMe_Biobank_Sample.var_report.xml									phs000925.v1.p1	Cardiovascular Diseases
44.0	57.0		2018/02/27	101.0		44.0	./data/phs001539.v1.pht007523.v1.p1.MAGNet_Subject_Phenotypes.var_report.xml	0.0	50.5	9.192	57.0			50.5		phs001539.v1.p1	Atrial Fibrillation
			11/08/2013				./data/phs000200.v9.pht001030.v3.p3.outc_self_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
5164.0	5164.0		2021/10/07	9088.0		3924.0	./data/phs001918.v2.pht010049.v1.p1.STAMPEED_HCT_Subject_Phenotypes.var_report.xml	0.0	4544.0	876.8	3924.0			4544.0		phs001918.v2.p1	Graft vs Host Disease
			2017/11/06				./data/phs000288.v2.pht002520.v2.p2.Ciliopathies_Exome_Sample_Attributes.var_report.xml									phs000288.v2.p2	Congenital Abnormalities
			2018/02/27				./data/phs001364.v1.pht007464.v1.p1.HCP_Young_Adults_Pedigree.var_report.xml									phs001364.v1.p1	Connectome
			2019/03/08				./data/phs001759.v1.pht008708.v1.p1.SAH_Sample.var_report.xml									phs001759.v1.p1	Circulating MicroRNA
			2018/01/11				./data/phs001421.v1.pht007026.v1.p1.Uveal_Melanoma_Pathogenesis_Sample.var_report.xml									phs001421.v1.p1	Uveal melanoma
			2020/07/24				./data/phs001194.v3.pht005826.v2.p2.MaternalDemographics.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			08/20/2013				./data/phs000285.v3.pht001575.v2.p2.A4F12.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
	59.0		2017/12/29	59.0		59.0	./data/phs000950.v1.pht005970.v1.p1.SEER_Ovarian_FFPE_Subject_Phenotypes.var_report.xml	0.0	59.0		59.0			59.0		phs000950.v1.p1	Neoplasms
			2019/03/11				./data/phs000286.v6.pht008721.v1.p2.af1.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/06/07				./data/phs001998.v1.pht010505.v1.p1.CLL_allo_HSCT_Sample_Attributes.var_report.xml									phs001998.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2018/06/01				./data/phs001538.v1.pht008093.v1.p1.Registry_Manifest_2.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			11/08/2013				./data/phs000200.v9.pht002757.v1.p3.outc_bc_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/11/08				./data/phs001330.v2.pht007529.v2.p1.eligibility.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			10/19/2016				./data/phs001039.v1.pht005846.v1.p1.IAMDGC_Exome_Chip_Subject.var_report.xml									phs001039.v1.p1	Macular Degeneration
			2020/05/06				./data/phs002023.v1.pht010195.v1.p1.CRPM_Sample.var_report.xml									phs002023.v1.p1	Peritoneal Neoplasms
353.0	353.0		2019/08/01	580.0		40.0	./data/phs001740.v1.pht008621.v1.p1.CCDG_SAGE_Pedigree.var_report.xml	0.0	193.3	84.85	40.0			226.0		phs001740.v1.p1	Autism Spectrum Disorder
			2020/07/24				./data/phs001194.v3.pht005828.v2.p2.ExtracardiacFindings.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
			06/28/2017				./data/phs001303.v1.pht006612.v1.p1.TGCT_Sample.var_report.xml									phs001303.v1.p1	Germinoma
			2019/06/03				./data/phs001814.v1.pht009007.v1.p1.Heterotaxy_Subject_Phenotypes.var_report.xml									phs001814.v1.p1	Heterotaxy Syndrome
			2021/03/22				./data/phs002188.v1.pht011033.v1.p1.Lymphoma_Subject_Phenotypes.var_report.xml									phs002188.v1.p1	Lymphoma
			2017/10/11				./data/phs000578.v1.pht007017.v1.p1.registration.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			05/09/2016				./data/phs001101.v1.pht005366.v1.p1.MIGen_MDC_Sample.var_report.xml									phs001101.v1.p1	Myocardial Infarction
			12/12/2014				./data/phs000699.v1.pht004383.v1.p1.Osteosarcoma_Genomics_Sample.var_report.xml									phs000699.v1.p1	Osteosarcoma
			05/09/2016				./data/phs001112.v1.pht005473.v1.p1.ChrX_Mosaicism_Methylation_Sample_Attributes.var_report.xml									phs001112.v1.p1	Neoplasm
			08/20/2013				./data/phs000285.v3.pht001698.v2.p2.CARE_BIRTHYR.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht006471.v1.p1.RETC1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001646.v2.p2.BFLWUP1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			10/25/2016				./data/phs000488.v2.pht002912.v2.p1.LUAD_CIP_Sample_Attributes.var_report.xml									phs000488.v2.p1	Carcinoma, Non-Small-Cell Lung
			2020/01/06				./data/phs001188.v2.pht006302.v2.p1.FUSION_Islet_Sample_Attributes.var_report.xml									phs001188.v2.p1	Diabetes Mellitus, Type 2
36.0	36.0		2021/03/24	72.0		36.0	./data/phs002341.v1.pht011059.v1.p1.Dermal_Fibroblasts_Pluripotency_Subject_Phenotypes.var_report.xml	0.0	36.0	0	36.0			36.0		phs002341.v1.p1	Fibroblast-Derived Induced Pluripotent Stem Cells
			2019/08/10				./data/phs001657.v1.pht009392.v1.p1.AML_Sample.var_report.xml									phs001657.v1.p1	Leukemia, Myeloid, Acute
			04/09/2014				./data/phs000437.v1.pht003689.v1.p1.Auriculocondylar_Syndrome_Sample.var_report.xml									phs000437.v1.p1	Auriculo-condylar syndrome
			06/28/2017				./data/phs001338.v1.pht006365.v1.p1.Tibetan_High_Altitude_Adaptation_Sample_Attributes.var_report.xml									phs001338.v1.p1	
			2021/05/07				./data/phs001327.v2.pht011190.v1.p1.schroniccondition.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/12/21				./data/phs000007.v32.pht002074.v6.p13.t_ecger_ex01_3_0556s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht003403.v1.p3.outc_cancer_cad_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
409.0			01/11/2016	736.0			./data/phs000279.v2.pht001437.v2.p1.ESP_Broad_EOMI_Subject_Phenotypes.var_report.xml	0.0			327.0					phs000279.v2.p1	Myocardial Infarction
			07/08/2016				./data/phs001167.v1.pht005636.v1.p1.T2D_Seq_GWAS_AA_Cohort_Subject.var_report.xml									phs001167.v1.p1	Diabetes Mellitus, Type 2
			2020/01/23				./data/phs000287.v7.pht001473.v1.p1.ULTRAYR5.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/12/10				./data/phs002299.v1.pht010773.v1.p1.PETAL_ORCHID_Subject.var_report.xml									phs002299.v1.p1	COVID-19
			01/30/2017				./data/phs000725.v2.pht003883.v2.p1.Rare_Cancer_Tumors_Project_Sample.var_report.xml									phs000725.v2.p1	Neoplasms
			05/05/2015				./data/phs000517.v3.pht002914.v1.p1.Multiethnic_Cohort_Study_Sample.var_report.xml									phs000517.v3.p1	Breast Neoplasms
			2017/09/22				./data/phs001392.v1.pht006906.v1.p1.rd_8444_1qualityoflif.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2019/05/07				./data/phs001329.v2.pht007182.v2.p1.medical_history.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			03/16/2015				./data/phs000868.v1.pht004590.v1.p1.Pediatric_Neuroblastoma_Sample_Attributes.var_report.xml									phs000868.v1.p1	Neuroblastoma
526.0	526.0		2019/08/18	745.0		475.0	./data/phs001869.v1.pht009396.v1.p1.ADHD_Subject_Phenotypes.var_report.xml	0.0	500.5	7.071	475.0			500.5		phs001869.v1.p1	Attention Deficit Disorder with Hyperactivity
			2021/01/22				./data/phs001962.v1.pht009818.v1.p1.PTCL_Subject.var_report.xml									phs001962.v1.p1	Lymphoma, T-Cell, Peripheral
			02/08/2017				./data/phs001271.v1.pht006116.v1.p1.KIDRISK_Subject.var_report.xml									phs001271.v1.p1	Carcinoma, Renal Cell
			Wed Nov 26 07:50:33 2008				./data/phs000017.v3.pht000696.v1.p1.DIGS2and3_PedData_Diagnosis.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2020/04/29				./data/phs001573.v1.pht010177.v1.p1.pRCC_Sample.var_report.xml									phs001573.v1.p1	Carcinoma, Renal Cell
			2020/12/21				./data/phs000007.v32.pht004806.v1.p13.l_platagg_ex01_7_0236s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000495.v2.p3.simphen096.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/03/25				./data/phs001781.v1.pht008862.v1.p1.SCC_Sample_Attributes.var_report.xml									phs001781.v1.p1	Carcinoma, Non-Small-Cell Lung
			01/19/2010				./data/phs000219.v1.pht001056.v1.p1.d_bne2_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2019/03/25				./data/phs001747.v1.pht008645.v1.p1.CAREGIVER_Sample_Attributes.var_report.xml									phs001747.v1.p1	Coronary Disease
			2020/09/04				./data/phs001993.v1.pht010085.v1.p1.NF1_AtypicalNeurofibromas_Sample.var_report.xml									phs001993.v1.p1	Neurofibromatosis 1
			2017/10/10				./data/phs001424.v1.pht007001.v1.p1.Glioblastoma_Phylogeny_Sample_Attributes.var_report.xml									phs001424.v1.p1	Glioblastoma
			2018/08/13				./data/phs001247.v1.pht008298.v1.p1.GMKF_CCDD_Sample.var_report.xml									phs001247.v1.p1	Cranial Nerve Diseases
438.0	437.0		2020/05/26	1064.0		276.0	./data/phs002020.v1.pht010229.v1.p1.ROP_Subject_Phenotypes.var_report.xml	0.0	354.7	80.56	352.0			351.0		phs002020.v1.p1	Retinopathy of Prematurity
			2017/12/20				./data/phs000577.v1.pht007289.v1.p1.rd_8444_1qualityoflif.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2020/12/21				./data/phs000007.v32.pht009752.v1.p13.l_crp_2005_m_0695s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/18/2012				./data/phs000513.v1.pht002825.v1.p1.MAST_Kinase_Notch_Gene_Breast_Cancer_Sample.var_report.xml									phs000513.v1.p1	Breast Neoplasms
			09/10/2015				./data/phs000967.v1.pht004863.v1.p1.Clear_Cell_Endometrial_Cancer_WES_Sample_Attributes.var_report.xml									phs000967.v1.p1	Endometrial Neoplasms
			05/06/2016				./data/phs000911.v1.pht004977.v1.p1.T1DGC_ImmunoChip_Sample.var_report.xml									phs000911.v1.p1	Diabetes Mellitus, Type 1
			08/02/2013				./data/phs000644.v1.pht003424.v1.p1.Menstrual_Cycle_Effect_Breast_Sample_Attributes.var_report.xml									phs000644.v1.p1	Menstrual Cycle
			02/02/2016				./data/phs001067.v1.pht005287.v1.p1.Meningitis_Encephalitis_Sample_Attributes.var_report.xml									phs001067.v1.p1	Encephalitis
			2020/06/30				./data/phs001972.v1.pht009841.v1.p1.REDS_BSCDC_Subject.var_report.xml									phs001972.v1.p1	Anemia, Sickle Cell
			05/17/2017				./data/phs001328.v1.pht006317.v1.p1.cognitive_6to8.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			11/08/2013				./data/phs000200.v9.pht001499.v3.p3.ext_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/11/13				./data/phs001584.v2.pht009069.v2.p2.eMERGE_III_HRC_Subject.var_report.xml									phs001584.v2.p2	
			2020/01/23				./data/phs000287.v7.pht001460.v1.p1.CHS_SHHS1_15K.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/03/10				./data/phs001619.v3.pht008177.v3.p1.IRD_Subject_Phenotypes.var_report.xml									phs001619.v3.p1	Retinal Degeneration
			2019/06/24				./data/phs001848.v1.pht009203.v1.p1.PIK3CG_Subject.var_report.xml									phs001848.v1.p1	Immune System Diseases
19.0	19.0		07/09/2013	29.0		10.0	./data/phs000347.v1.pht003125.v1.p1.ESP_Family_Studies_Aortic_Disease_Subject_Phenotypes.var_report.xml	0.0	14.5	6.364	10.0			14.5		phs000347.v1.p1	Aortic Diseases
			2019/06/14				./data/phs001824.v1.pht009113.v1.p1.pDC_HNSCC_Sample.var_report.xml									phs001824.v1.p1	Dendritic Cells
			2020/05/06				./data/phs002023.v1.pht010196.v1.p1.CRPM_GEO.var_report.xml									phs002023.v1.p1	Peritoneal Neoplasms
105.0			2021/05/17	440.0			./data/phs001134.v1.pht011227.v1.p1.Chernobyl_PTC_Subject_Phenotypes.var_report.xml	0.0			335.0					phs001134.v1.p1	Thyroid Cancer, Papillary
			11/08/2012				./data/phs000540.v1.pht003043.v1.p1.Ehlers_Danlos_Syndrome_Type_VIII_Subject.var_report.xml									phs000540.v1.p1	Ehlers-Danlos Syndrome
			04/05/2017				./data/phs000987.v1.pht004971.v1.p1.WES_P1_22q11_Sample_Attributes.var_report.xml									phs000987.v1.p1	DiGeorge Syndrome
			06/13/2014				./data/phs000687.v1.pht003692.v1.p1.Schizophrenia_De_Novo_Mutations_Subject.var_report.xml									phs000687.v1.p1	Schizophrenia
			08/20/2013				./data/phs000285.v3.pht001604.v2.p2.B2F09DIB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/21/2014				./data/phs000758.v1.pht003998.v1.p1.Congenital_Heart_Defects_Subject.var_report.xml									phs000758.v1.p1	Heart Septal Defects
911.0	1204.0		2021/05/14	2115.0		911.0	./data/phs001749.v2.pht009317.v2.p1.CAKUT_Subject.var_report.xml	0.0	1058.0	207.2	1204.0			1058.0		phs001749.v2.p1	Congenital Anomalies Of Kidney And Urinary Tract
	7116.0		11/08/2013	9511.0		992.0	./data/phs000200.v9.pht001006.v4.p3.f38_rel1.var_report.xml	87.0	9318.0	812.2	9020.0			9363.0		phs000200.v9.p3	Women&#39;s Health
			2020/06/18				./data/phs000280.v7.pht006443.v4.p1.INCps16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/12/26				./data/phs001862.v1.pht009746.v1.p1.PBB_Subject.var_report.xml									phs001862.v1.p1	Endocrine Disruptors
278.0	380.0		2019/12/26	658.0		278.0	./data/phs001862.v1.pht009748.v1.p1.PBB_Subject_Phenotypes.var_report.xml	0.0	329.0	72.12	380.0			329.0		phs001862.v1.p1	Endocrine Disruptors
			2018/09/07				./data/phs001551.v1.pht008349.v1.p1.CURE_EGI_Sample_Attributes.var_report.xml									phs001551.v1.p1	Epilepsy
13.0			2020/09/02	27.0			./data/phs002006.v2.pht010161.v2.p1.Segmental_Overgrowth_Subject.var_report.xml	0.0			13.0					phs002006.v2.p1	Proteus Syndrome
766.0	882.0		2021/08/27	1654.0		6.0	./data/phs000966.v2.pht005305.v2.p2.Essential_Tremor_Pedigree.var_report.xml	0.0	551.3	475.8	883.0			766.0		phs000966.v2.p2	Essential Tremor
16.0	17.0		05/08/2017	33.0		16.0	./data/phs000871.v1.pht004570.v1.p1.Pancreatic_Neuroendocrine_Tumors_Subject_Phenotypes.var_report.xml	0.0	16.5	0.7071	17.0			16.5		phs000871.v1.p1	Carcinoma, Neuroendocrine
			2017/10/26				./data/phs001277.v1.pht006854.v1.p1.iPSCs_Sample.var_report.xml									phs001277.v1.p1	Platelet Disorder, Familial, with Associated Myeloid Malignancy
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000243.v1.p1.DCCT_ms4exprt.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
115.0	258.0		04/29/2016	373.0		115.0	./data/phs000128.v3.pht000362.v1.p3.cohort.var_report.xml	0.0	186.5	101.1	258.0			186.5		phs000128.v3.p3	Coronary Disease
761.0	761.0		11/04/2014	1439.0		678.0	./data/phs000086.v3.pht000249.v1.p1.DCCT_f001cmb6.var_report.xml	0.0	719.5	58.69	678.0			719.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			02/18/2016				./data/phs001057.v1.pht005300.v1.p1.Smallpox_Vaccine_Immune_Response_Sample.var_report.xml									phs001057.v1.p1	Smallpox Vaccine
			2020/03/19				./data/phs001982.v1.pht010003.v1.p1.MFS_UPS_Subject.var_report.xml									phs001982.v1.p1	Sarcoma, Soft Tissue
			2019/03/28				./data/phs001797.v1.pht008890.v1.p1.mUC_Sample.var_report.xml									phs001797.v1.p1	Urogenital Neoplasms
			2018/06/14				./data/phs001238.v2.pht006652.v1.p1.GENOA_EuropeanAmerican_CKD_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
1849.0	2114.0		04/29/2016	3963.0		1849.0	./data/phs000128.v3.pht000364.v2.p3.gen3.var_report.xml	0.0	1982.0	187.4	2114.0			1982.0		phs000128.v3.p3	Coronary Disease
			2017/09/22				./data/phs001392.v1.pht006897.v1.p1.pidtc_17395_baselinea.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			02/05/2015				./data/phs000808.v1.pht004466.v1.p1.diLQTS_Susceptibility_Subject_Phenotypes.var_report.xml									phs000808.v1.p1	Long QT Syndrome
			2021/04/09				./data/phs002292.v1.pht011108.v1.p1.Neocortical_Neurons_Sample_Attributes.var_report.xml									phs002292.v1.p1	Neocortex
			2020/12/21				./data/phs000007.v32.pht000680.v7.p13.ffreq1_5s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2.0			08/15/2012	3.0			./data/phs000514.v1.pht002839.v1.p1.Familial_Coronary_Artery_Disease_Subject_Phenotypes.var_report.xml	0.0			4.0					phs000514.v1.p1	Coronary Artery Disease
			03/11/2015				./data/phs000691.v2.pht003651.v2.p1.Sickle_Cell_CIP_Subject.var_report.xml									phs000691.v2.p1	Anemia, Sickle Cell
			2020/12/10				./data/phs002071.v1.pht010455.v1.p1.PDA_Sample.var_report.xml									phs002071.v1.p1	Carcinoma, Pancreatic Ductal
			06/09/2010				./data/phs000255.v1.pht001251.v1.p1.HMP_Crohns_Risk_Subject.var_report.xml									phs000255.v1.p1	Crohn Disease
			11/05/2014				./data/phs000209.v13.pht003609.v1.p3.MESA_AncilMesaNeighborFoodExam5.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004185.v2.p1.RTAWF25.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/07/19				./data/phs002229.v1.pht010555.v1.p1.GCT_PrimaryMetastasis_Sample.var_report.xml									phs002229.v1.p1	Neoplasms, Germ Cell and Embryonal
			04/08/2014				./data/phs000729.v1.pht003774.v1.p1.Follicular_Lymphoma_Sample.var_report.xml									phs000729.v1.p1	Lymphoma, Follicular
			2018/04/16				./data/phs001326.v1.pht007830.v1.p1.pidtc_17390_day0datet.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/06/18				./data/phs000280.v7.pht004212.v2.p1.UBMDWM02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/11/27				./data/phs002060.v1.pht010592.v1.p1.CALGB_40502_Sample_Attributes.var_report.xml									phs002060.v1.p1	Peripheral Nervous System Diseases
			01/27/2014				./data/phs000674.v1.pht003641.v1.p1.Survey.var_report.xml									phs000674.v1.p1	Aging
			06/27/2016				./data/phs000888.v1.pht004680.v1.p1.EMERGEII_BMI_merged.var_report.xml									phs000888.v1.p1	
			2018/10/30				./data/phs001724.v1.pht008508.v1.p1.Pain_Resilience_Sample_Attributes.var_report.xml									phs001724.v1.p1	Erythromelalgia
7.0	7.0		04/10/2014	8.0		1.0	./data/phs000418.v2.pht002617.v1.p1.Temporal_Dissection_Tumorigenesis_Subject_Phenotypes.var_report.xml	0.0	4.0	4.243	1.0			4.0		phs000418.v2.p1	Carcinoma, Squamous Cell
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000508.v2.p3.simphen109.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/11/30				./data/phs001578.v1.pht007877.v1.p1.Preterm_Infant_Microbiome_Sample_Attributes.var_report.xml									phs001578.v1.p1	Microbiota
			2020/12/18				./data/phs001819.v2.pht009447.v1.p1.Familial_MM_Sample.var_report.xml									phs001819.v2.p1	Multiple Myeloma
132.0	132.0		2021/09/16	132.0		132.0	./data/phs001813.v2.pht009035.v2.p1.PC_Integrative_Tissue_Analysis_Subject.var_report.xml	0.0	132.0					132.0		phs001813.v2.p1	Prostatic Neoplasms
			11/18/2016				./data/phs001243.v1.pht005936.v1.p1.BRCA1_Carrier_Subject_Phenotypes.var_report.xml									phs001243.v1.p1	Breast Neoplasms
9.0	9.0		2021/01/28	13.0		4.0	./data/phs002289.v1.pht010891.v1.p1.YSPORE_SC2_Subject.var_report.xml	0.0	6.5	3.536	4.0			6.5		phs002289.v1.p1	single-cell analysis
			2019/10/31				./data/phs001623.v2.pht008364.v2.p1.HNSCC_Sample_Attributes.var_report.xml									phs001623.v2.p1	Carcinoma, squamous cell of head and neck
	90.0		2020/04/27	73.0		88.0	./data/phs002017.v1.pht010155.v1.p1.C_RNA_Preeclampsia_Subject_Phenotypes.var_report.xml	0.0	89.0	7.778	73.0			89.0		phs002017.v1.p1	Pre-Eclampsia
			2019/03/11				./data/phs000286.v6.pht008776.v1.p2.pdsb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000503.v2.p3.simphen104.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/12/2013				./data/phs000343.v3.pht002727.v1.p1.fss.var_report.xml									phs000343.v3.p1	Stroke
			11/27/2013				./data/phs000504.v2.pht002820.v2.p2.Medulloblastoma_Subject.var_report.xml									phs000504.v2.p2	Medulloblastoma
			2020/12/21				./data/phs000007.v32.pht000821.v7.p13.l_angtie_ex01_3b_0269s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000591.v2.p3.simphen192.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/02				./data/phs002030.v1.pht010263.v1.p1.MEIs_Transcriptome_Sample.var_report.xml									phs002030.v1.p1	Reference Values
			08/20/2013				./data/phs000285.v3.pht001693.v2.p2.C1GMP.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
22.0	22.0		2019/03/25	41.0		8.0	./data/phs001164.v1.pht008869.v1.p1.ASD_ROHs_DNMs_Pedigree.var_report.xml	0.0	20.5	2.828	8.0			20.5		phs001164.v1.p1	Autism Spectrum Disorder
			2020/07/21				./data/phs002035.v1.pht010412.v1.p1.PCD_Subject.var_report.xml									phs002035.v1.p1	Ciliary Motility Disorders
			05/26/2011				./data/phs000289.v2.pht001885.v1.p1.Venous_Thrombosis_Sample.var_report.xml									phs000289.v2.p1	Venous Thrombosis
			2020/12/21				./data/phs000007.v32.pht010732.v1.p13.t_echocs_ex03_7_0901s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/26/2015				./data/phs000846.v1.pht004449.v1.p1.Bisulfite_Sequencing_ccf_DNA_Sample.var_report.xml									phs000846.v1.p1	DNA Methylation
729.0	729.0		2021/09/23	855.0		674.0	./data/phs001089.v4.pht005484.v4.p1.CSER_DD_ID_Children_Pedigree.var_report.xml	0.0	701.5	81.32	674.0			701.5		phs001089.v4.p1	Intellectual Disability
			2019/08/26				./data/phs001837.v1.pht009312.v1.p1.NAFLD_Microbiome_Subject.var_report.xml									phs001837.v1.p1	Non-alcoholic Fatty Liver Disease
4.0	4.0		2018/01/29	7.0		3.0	./data/phs001245.v1.pht005930.v1.p1.CD70_Pedigree.var_report.xml	0.0	3.5	0.7071	3.0			3.5		phs001245.v1.p1	Immunologic Deficiency Syndromes
			2020/12/21				./data/phs000007.v32.pht007771.v3.p13.vr_dgai2010_ex02_3_0996s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/08/13				./data/phs001659.v1.pht008302.v1.p1.SGDs_NIPD_Subject.var_report.xml									phs001659.v1.p1	
			08/06/2010				./data/phs000182.v2.pht000796.v1.p1.AMD_MMAP_Subject.var_report.xml									phs000182.v2.p1	Macular Degeneration
			2019/08/01				./data/phs000222.v6.pht007353.v1.p2.Imaging.var_report.xml									phs000222.v6.p2	Huntington Disease
752.0	752.0		06/13/2014	894.0		728.0	./data/phs000625.v1.pht003852.v1.p1.Cleft_Lip_Palate_Pedigree.var_report.xml	0.0	683.5	88.39	728.0			683.5		phs000625.v1.p1	Orofacial Cleft, Nonsyndromic
			2019/08/29				./data/phs001333.v2.pht006525.v2.p1.lab_results.var_report.xml									phs001333.v2.p1	Fabry Disease
			2020/07/29				./data/phs002007.v1.pht010434.v1.p1.Innate_Tcells_GEO.var_report.xml									phs002007.v1.p1	Lymphocyte Subsets
			2019/10/23				./data/phs001176.v3.pht005796.v3.p1.GxE_Complex_Traits_Sample.var_report.xml									phs001176.v3.p1	Gene-Environment Interaction
			2021/03/24				./data/phs000711.v7.pht003724.v6.p2.BH_CMG_Sample_Attributes.var_report.xml									phs000711.v7.p2	Mendelian Conditions
			04/10/2014				./data/phs000418.v2.pht002618.v1.p1.Temporal_Dissection_Tumorigenesis_Sample_Attributes.var_report.xml									phs000418.v2.p1	Carcinoma, Squamous Cell
			2018/10/16				./data/phs001704.v1.pht008461.v1.p1.CLL_Enhancer_Mapping_Sample.var_report.xml									phs001704.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2021/08/20				./data/phs001939.v2.pht009666.v2.p1.CMI_MPCproject_Subject_Phenotypes.var_report.xml									phs001939.v2.p1	Prostatic Neoplasms
			09/03/2013				./data/phs000652.v1.pht003458.v1.p1.GliomaScan_Sample_Attributes.var_report.xml									phs000652.v1.p1	Glioma
			2018/03/23				./data/phs000698.v1.pht007673.v1.p1.medical_history.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			03/28/2014				./data/phs000496.v1.pht003170.v1.p1.Late_Onset_Alzheimers_Sample_Attributes.var_report.xml									phs000496.v1.p1	Alzheimer Disease
			2020/07/07				./data/phs001938.v2.pht009635.v2.p1.ADT_PC_Sample.var_report.xml									phs001938.v2.p1	Prostatic Neoplasms
489.0	489.0		2021/03/05	976.0		487.0	./data/phs001504.v2.pht007910.v2.p1.T2D_GENES_Hong_Kong_Subject_Phenotypes.var_report.xml	0.0	488.0	4.243	487.0			488.0		phs001504.v2.p1	Diabetes Mellitus, Type 2
			04/21/2011				./data/phs000336.v1.pht002219.v1.p1.CGEMS_Lung_Cancer_Sample.var_report.xml									phs000336.v1.p1	Lung Neoplasms
			09/03/2010				./data/phs000127.v2.pht000650.v1.p1.IrishALS_Subject.var_report_2010_09_03.xml									phs000127.v2.p1	Amyotrophic Lateral Sclerosis
4.0	8.0		04/09/2014	6.0		4.0	./data/phs000437.v1.pht003690.v1.p1.Auriculocondylar_Syndrome_Subject_Phenotypes.var_report.xml	0.0	6.0	2.828	8.0			6.0		phs000437.v1.p1	Auriculo-condylar syndrome
93.0	93.0		2021/03/10	550.0		92.0	./data/phs001619.v3.pht008174.v3.p1.IRD_Subject.var_report.xml	0.0	89.0	9.899	85.0			89.0		phs001619.v3.p1	Retinal Degeneration
			01/22/2014				./data/phs000276.v2.pht002003.v2.p1.NFBC66_Subject.var_report.xml									phs000276.v2.p1	Metabolic Syndrome X
			2018/05/17				./data/phs001313.v1.pht007969.v1.p1.xenobioticexposuredata.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2020/06/18				./data/phs000280.v7.pht004089.v2.p1.ETLD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
84.0	84.0		08/13/2015	54.0		73.0	./data/phs000831.v1.pht004905.v1.p1.Sporadic_ALS_Pedigree.var_report.xml	0.0	78.5	7.778	73.0			78.5		phs000831.v1.p1	Amyotrophic Lateral Sclerosis
			12/11/2009				./data/phs000171.v1.pht000762.v1.p1.MS_DATA_MHQALCSMK.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			05/14/2013				./data/phs000609.v1.pht003284.v1.p1.AutismGeneExpression_Sample.var_report.xml									phs000609.v1.p1	Autism
			12/19/2014				./data/phs000348.v2.pht002231.v2.p1.Myeloma_Sample_Attributes.var_report.xml									phs000348.v2.p1	Multiple Myeloma
			11/19/2013				./data/phs000436.v1.pht002834.v1.p1.Autism_Disorders_Sample.var_report.xml									phs000436.v1.p1	Autistic Disorder
			05/23/2014				./data/phs000612.v1.pht003527.v1.p1.Adenoid_Cystic_Carcinoma_Sample.var_report.xml									phs000612.v1.p1	Cancer
			02/04/2016				./data/phs001066.v1.pht005280.v1.p1.ALL_Subject.var_report.xml									phs001066.v1.p1	Neoplasms
			2019/07/31				./data/phs001872.v1.pht009365.v1.p1.CEPH_Utah_Sample.var_report.xml									phs001872.v1.p1	Population Groups
			08/05/2010				./data/phs000269.v1.pht001497.v1.p1.Chromosomal_Aberration_Sample.var_report_2010_08_05.xml									phs000269.v1.p1	Chromosome Disorders
	58253.0		11/08/2013	89881.0		31628.0	./data/phs000200.v9.pht002119.v2.p3.f33_rel2.var_report.xml	3713.0	44941.0	82647	54678.0			44941.0		phs000200.v9.p3	Women&#39;s Health
			2020/11/02				./data/phs002130.v1.pht010594.v1.p1.GMKF_CFM_Subject.var_report.xml									phs002130.v1.p1	
			10/05/2010				./data/phs000188.v1.pht000980.v1.p1.QRS_Subject.var_report_2010_10_05.xml									phs000188.v1.p1	Heart Conduction System
			12/03/2013				./data/phs000551.v1.pht003062.v1.p1.CATHGEN_Sample.var_report.xml									phs000551.v1.p1	Cardiovascular Diseases
			2021/03/30				./data/phs002146.v1.pht011086.v1.p1.Chromatin_Transcriptional_Regulation_Sample_Attributes.var_report.xml									phs002146.v1.p1	
982.0	982.0		07/06/2016	982.0		982.0	./data/phs000743.v1.pht005603.v1.p1.METSIM_Subject_Phenotypes.var_report.xml	0.0	982.0					982.0		phs000743.v1.p1	Metabolic Syndrome X
			05/05/2015				./data/phs000147.v3.pht000664.v2.p1.CGEMS_Breast_Cancer_Subject.var_report.xml									phs000147.v3.p1	Breast Neoplasms
			2021/09/23				./data/phs001089.v4.pht005487.v4.p1.CSER_DD_ID_Children_Sample_Attributes.var_report.xml									phs001089.v4.p1	Intellectual Disability
			2018/03/20				./data/phs000605.v1.pht007634.v1.p1.functional_performance_inventory.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			01/07/2014				./data/phs000611.v1.pht003500.v1.p1.Breast_Cancer_Xenotransplants_Subject.var_report.xml									phs000611.v1.p1	Breast Neoplasms
			2018/02/08				./data/phs001488.v1.pht007389.v1.p1.dose.var_report.xml									phs001488.v1.p1	Huntington Disease
			2018/08/06				./data/phs001655.v1.pht008257.v1.p1.Acne_Skin_Metagenome_Sample.var_report.xml									phs001655.v1.p1	Acne Vulgaris
			08/12/2016				./data/phs000888.v1.pht005575.v1.p1.colonPolyp_colonoscopy_data_all_expected_sites.var_report.xml									phs000888.v1.p1	
			2020/02/14				./data/phs000575.v2.pht005900.v2.p1.pwsimpressions.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			07/31/2015				./data/phs000957.v1.pht004855.v1.p1.eMERGE_III_MyCode_Sample_Attributes.var_report.xml									phs000957.v1.p1	Aortic Aneurysm, Abdominal
			2019/08/30				./data/phs001331.v2.pht006927.v2.p1.patient_sociodemographics.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			2018/01/30				./data/phs000904.v1.pht004686.v1.p1.Familial_Adenomatous_Polyposis_Subject.var_report.xml									phs000904.v1.p1	Familial Adenomatous Polyposis
			2021/07/16				./data/phs001603.v2.pht009968.v1.p1.TOPMed_WGS_ChildrensHS_IGERA_Subject.var_report.xml									phs001603.v2.p1	Asthma
			2018/09/17				./data/phs001685.v1.pht008369.v1.p1.OVCA_Organoids_Subject.var_report.xml									phs001685.v1.p1	Ovarian Neoplasms
			2019/05/30				./data/phs000424.v8.pht002740.v8.p2.GTEx_Subject.var_report.xml									phs000424.v8.p2	Reference Values
			2018/02/08				./data/phs001488.v1.pht007411.v1.p1.mntcnsnt.var_report.xml									phs001488.v1.p1	Huntington Disease
			2017/09/22				./data/phs001392.v1.pht006889.v1.p1.p6901_15907_scidearly.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2021/07/20				./data/phs001882.v1.pht010493.v1.p1.OncoArray_FOCI_Sample_Attributes.var_report.xml									phs001882.v1.p1	Carcinoma, Ovarian Epithelial
			2021/07/06				./data/phs002462.v1.pht011370.v1.p1.NEPC_Sample_Attributes.var_report.xml									phs002462.v1.p1	Prostatic Neoplasms
			2020/06/09				./data/phs002036.v1.pht010275.v1.p1.Chromoanasynthesis_JBS_Sample.var_report.xml									phs002036.v1.p1	Jacobsen Distal 11q Deletion Syndrome
			2018/05/31				./data/phs001318.v1.pht008031.v1.p1.concomitantmedications.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			06/10/2015				./data/phs000918.v1.pht004750.v1.p1.IPDGC_NeuroX_Sample_Attributes.var_report.xml									phs000918.v1.p1	Parkinson Disease
			10/07/2011				./data/phs000368.v1.pht002293.v1.p1.NU_PCOS_Sample.var_report.xml									phs000368.v1.p1	Polycystic Ovary Syndrome
			2020/06/18				./data/phs000280.v7.pht004078.v2.p1.ECGX02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
43.0	43.0		2021/04/16	43.0		43.0	./data/phs002398.v1.pht011123.v1.p1.PrCa_Subject.var_report.xml	0.0	43.0					43.0		phs002398.v1.p1	Prostatic Neoplasms
			07/09/2013				./data/phs000556.v1.pht003140.v1.p1.ESP_AtypicalCysticFibrosis_Sample_Attributes.var_report.xml									phs000556.v1.p1	Cystic Fibrosis
			2020/01/16				./data/phs001386.v2.pht006607.v1.p1.Smoking_Vaginal_Microbiome_Sample.var_report.xml									phs001386.v2.p1	Smoking
			2021/07/16				./data/phs001604.v2.pht009984.v1.p1.TOPMed_WGS_ChildrensHS_MetaAir_Sample.var_report.xml									phs001604.v2.p1	Asthma
			2018/09/07				./data/phs001577.v1.pht008350.v1.p1.mCRPC_Subject.var_report.xml									phs001577.v1.p1	Prostatic Neoplasms, Castration-Resistant
			2019/01/29				./data/phs001767.v1.pht008662.v1.p1.GC_miRNA_Korean_Sample_Attributes.var_report.xml									phs001767.v1.p1	Circulating MicroRNA
			2020/02/06				./data/phs001430.v2.pht008086.v2.p1.mutation_report.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			11/08/2013				./data/phs000200.v9.pht001517.v4.p3.f60_item_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000410.v2.p3.simphen011.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht006425.v1.p1.CDS.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/19				./data/phs000257.v3.pht001248.v3.p1.HMP_Gut_Crohns_Function_Subject.var_report.xml									phs000257.v3.p1	Crohn Disease
			2021/01/26				./data/phs002068.v1.pht010874.v1.p1.SALSA_SGC_Sample_Attributes.var_report.xml									phs002068.v1.p1	Amyotrophic Lateral Sclerosis
			10/17/2011				./data/phs000265.v3.pht001274.v3.p1.HMP_Pediatric_Abdominal_Pain_IBD_Subject_Phenotypes.var_report.xml									phs000265.v3.p1	Irritable Bowel Syndrome
			08/14/2014				./data/phs000615.v1.pht003308.v1.p1.IschemicStroke_Sample_Attributes.var_report.xml									phs000615.v1.p1	Cerebral infarction
			2020/03/05				./data/phs001959.v1.pht009952.v1.p1.CLL_SF3B1_Subject_Phenotypes.var_report.xml									phs001959.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2020/04/27				./data/phs002017.v1.pht010156.v1.p1.C_RNA_Preeclampsia_Sample_Attributes.var_report.xml									phs002017.v1.p1	Pre-Eclampsia
			2020/07/15				./data/phs002054.v1.pht010349.v1.p1.9p_Deletion_Subject_Phenotypes.var_report.xml									phs002054.v1.p1	Chromosome 9p Deletion Syndrome
			2019/03/11				./data/phs000286.v6.pht008774.v1.p2.occode_dv.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			06/16/2017				./data/phs001278.v1.pht006272.v1.p1.p7201_14218_eligibili.var_report.xml									phs001278.v1.p1	Porphyrias
			10/14/2015				./data/phs000903.v1.pht004869.v1.p1.OCD_OCGAS_Subject.var_report.xml									phs000903.v1.p1	Obsessive-Compulsive Disorder
			2018/07/06				./data/phs000416.v2.pht002746.v2.p1.GOCHA_Sample.var_report.xml									phs000416.v2.p1	Intracranial Hemorrhage
			08/20/2013				./data/phs000285.v3.pht001775.v2.p2.E1F09PER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000268.v1.p1.DCCT_f0561.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000568.v2.p3.simphen169.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			04/17/2017				./data/phs000816.v2.pht004342.v2.p1.X_Chromosome_Inactivation_Sample.var_report.xml									phs000816.v2.p1	X Chromosome Inactivation
			2019/01/10				./data/phs001609.v1.pht008140.v1.p1.Lupus_Nephritis_Sample.var_report.xml									phs001609.v1.p1	Lupus Erythematosus, Systemic
			2020/03/03				./data/phs001987.v1.pht009929.v1.p1.GMKF_Enchondromatoses_Sample.var_report.xml									phs001987.v1.p1	Enchondromatosis
			2020/03/13				./data/phs000521.v2.pht007045.v1.p1.registration.var_report.xml									phs000521.v2.p1	Ataxia
			12/01/2015				./data/phs000571.v3.pht003180.v3.p2.Demographics.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2018/06/07				./data/phs001228.v1.pht008134.v1.p1.GMKF_EWS_Sample.var_report.xml									phs001228.v1.p1	Sarcoma, Ewing
			09/30/2016				./data/phs001015.v1.pht005780.v1.p1.Chronic_Fatigue_Syndrome_Sample_Attributes.var_report.xml									phs001015.v1.p1	Fatigue Syndrome, Chronic
			2020/06/18				./data/phs000280.v7.pht004192.v2.p1.SBPA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			07/18/2014				./data/phs000733.v1.pht003822.v1.p1.Familial_Prostate_Cancer_Sample_Attributes.var_report.xml									phs000733.v1.p1	Prostate cancer, familial
			2017/11/09				./data/phs001400.v1.pht006822.v1.p1.Mega_Haplotypes_CRC_Subject.var_report.xml									phs001400.v1.p1	Cancer, Colorectal
			01/19/2010				./data/phs000219.v1.pht001104.v1.p1.d_vitl.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			03/26/2015				./data/phs000766.v1.pht003941.v1.p1.GEI_Psoriasis_Sample_Attributes.var_report.xml									phs000766.v1.p1	Psoriasis
650.0			10/21/2013	1267.0			./data/phs000637.v1.pht003536.v1.p1.ALL_Methotrexate_Clearance_Subject_Phenotypes.var_report.xml	0.0			617.0					phs000637.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
43.0	43.0	2.0	2021/05/21	57.0	4.658	588.0	./data/phs002331.v1.pht011103.v1.p1.DASH_Subject_Phenotypes.var_report.xml	7.0	28.5	893.1	599.0	0.0		28.5	700.0	phs002331.v1.p1	Drug Users
			05/06/2016				./data/phs000911.v1.pht004980.v1.p1.T1DGC_ImmunoChip_Sample_Attributes.var_report.xml									phs000911.v1.p1	Diabetes Mellitus, Type 1
			11/05/2014				./data/phs000209.v13.pht003374.v1.p3.MESA_AncilMesaApoE.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/03/18				./data/phs001585.v1.pht008829.v1.p1.FALS_Sample.var_report.xml									phs001585.v1.p1	Amyotrophic Lateral Sclerosis
			05/24/2016				./data/phs001065.v1.pht005426.v1.p1.pregnanc.var_report.xml									phs001065.v1.p1	Huntington Disease
			01/07/2016				./data/phs000459.v1.pht002543.v1.p1.Oral_Clefts_Multiplex_Families_Subject.var_report.xml									phs000459.v1.p1	Cleft Lip
			11/21/2016				./data/phs001233.v1.pht005944.v1.p1.Familial_Dysautonomia_Sample.var_report.xml									phs001233.v1.p1	Dysautonomia, Familial
			2018/07/18				./data/phs001651.v1.pht008233.v1.p1.Lung_SQCC_AppKY_Subject.var_report.xml									phs001651.v1.p1	Lung Neoplasms
			01/19/2016				./data/phs000908.v1.pht004705.v1.p1.PD_Rare_Variants_Subject.var_report.xml									phs000908.v1.p1	
			06/01/2012				./data/phs000384.v1.pht002461.v1.p1.Genentech_Hepatocellular_Carcinoma_Subject.var_report.xml									phs000384.v1.p1	Hepatocellular Carcinomas
			2020/12/18				./data/phs001819.v2.pht009449.v1.p1.Familial_MM_Sample_Attributes.var_report.xml									phs001819.v2.p1	Multiple Myeloma
1578.0	1578.0		2021/06/03	3085.0		1507.0	./data/phs002417.v1.pht011275.v1.p1.FFCWS_Subject_Phenotypes.var_report.xml	0.0	1543.0	50.2	1507.0			1543.0		phs002417.v1.p1	Population Groups
			04/11/2014				./data/phs000735.v1.pht003797.v1.p1.Placental_Microbiome_Subject_Phenotypes.var_report.xml									phs000735.v1.p1	Bacterial Infections
			2018/02/08				./data/phs001488.v1.pht007402.v1.p1.lab.var_report.xml									phs001488.v1.p1	Huntington Disease
			09/01/2015				./data/phs000858.v1.pht004462.v1.p1.IVF_Blastocyst_Biopsies_Sample.var_report.xml									phs000858.v1.p1	Fertilization in Vitro
58.0	58.0		03/22/2013	94.0		36.0	./data/phs000327.v1.pht003012.v1.p1.ESP_HeartGO_SWISS_Subject_Phenotypes.var_report.xml	0.0	47.0	15.56	36.0			47.0		phs000327.v1.p1	Stroke
			2020/12/21				./data/phs000007.v32.pht002572.v8.p13.t_echo_2008_m_0549s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/01/2014				./data/phs000839.v1.pht004393.v1.p1.Bitter_Taste_Blockers_Sample_Attributes.var_report.xml									phs000839.v1.p1	Taste Perception
			2020/09/18				./data/phs001087.v3.pht005760.v3.p1.UC_Subject_Phenotypes.var_report.xml									phs001087.v3.p1	Carcinoma, Transitional Cell
1684.0	2995.0		05/16/2017	4897.0		1902.0	./data/phs001252.v1.pht006378.v1.p1.cesd.var_report.xml	0.0	2449.0	772.9	1054.0			2449.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			04/08/2014				./data/phs000552.v2.pht003028.v1.p1.Meningiomas_Sample.var_report.xml									phs000552.v2.p1	Meningioma
			2018/03/20				./data/phs000605.v1.pht007624.v1.p1.RLD_5702_Subject.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2020/04/14				./data/phs001570.v2.pht007868.v1.p1.CALGB_40601_Sample.var_report.xml									phs001570.v2.p1	Neoplasms
37.0			07/09/2012	48.0			./data/phs000511.v1.pht002818.v1.p1.Hypertriglyceridemia_I_III_V_Subject_Phenotypes.var_report.xml	0.0			11.0					phs000511.v1.p1	Hypertriglyceridemia
			01/07/2016				./data/phs000814.v1.pht004581.v1.p1.MIGen_Exome_Italian_ATVB_Subject.var_report.xml									phs000814.v1.p1	Coronary Artery Disease
			2021/05/07				./data/phs000956.v5.pht005003.v2.p1.TOPMed_WGS_Amish_Sample_Attributes.var_report.xml									phs000956.v5.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000021.v3.p13.ex0_19s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/19				./data/phs001426.v1.pht006918.v1.p1.T1DGC_RNASeq_SampleAttributesDS.var_report.xml									phs001426.v1.p1	Diabetes Mellitus, Type 1
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000407.v2.p3.simphen008.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/11/05				./data/phs001632.v1.pht008531.v1.p1.Multiple_Myeloma_AA_Subject.var_report.xml									phs001632.v1.p1	Multiple Myeloma
			2020/09/22				./data/phs002211.v1.pht010538.v1.p1.Time_Varying_Subject_Phenotypes.var_report.xml									phs002211.v1.p1	Bacterial Vaginosis
			2020/12/09				./data/phs001857.v1.pht010766.v1.p1.MD_Ashkenazi_Sample.var_report.xml									phs001857.v1.p1	Mammographic Breast Density
			03/20/2013				./data/phs000573.v1.pht003214.v1.p1.DiffuseLargeBCellLymphoma_Sample.var_report.xml									phs000573.v1.p1	Lymphoma, Large B-Cell, Diffuse
			11/08/2013				./data/phs000200.v9.pht001029.v3.p3.outc_self_ct_os_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
6.0	6.0		02/07/2014	23.0		4.0	./data/phs000632.v1.pht003577.v1.p1.ESP_Hematological_Cancers_Pedigree.var_report.xml	0.0	5.0	2.121	4.0			5.0		phs000632.v1.p1	Hemic and Lymphatic Diseases
5.0	5.0		06/01/2012	7.0		2.0	./data/phs000484.v1.pht002683.v1.p1.Inherited_Kidney_Dysfunction_Subject_Phenotypes.var_report.xml	0.0	3.5	2.121	2.0			3.5		phs000484.v1.p1	Glomerulosclerosis, Focal Segmental 
			2020/09/15				./data/phs002234.v1.pht010516.v1.p1.Xq28_Deletion_HH_Subject_Phenotypes.var_report.xml									phs002234.v1.p1	Hypogonadism
			01/13/2014				./data/phs000666.v1.pht003572.v1.p1.Elderly_Influenza_Vaccine_Subject.var_report.xml									phs000666.v1.p1	Influenza Vaccines
85.0	96.0		02/24/2011	181.0		85.0	./data/phs000268.v1.pht002164.v1.p1.CEPH_FamilyPanels_Pedigree.var_report_2011_02_24.xml	0.0	90.5	7.778	96.0			90.5		phs000268.v1.p1	Cell Line
			05/13/2011				./data/phs000351.v1.pht002205.v1.p1.CGEMS_RenalCellCarcinoma_Sample.var_report.xml									phs000351.v1.p1	Carcinoma, Renal Cell
676.0	677.0		2020/12/09	677.0		677.0	./data/phs001857.v1.pht010765.v1.p1.MD_Ashkenazi_Pedigree.var_report.xml	0.0	677.0	478	677.0			677.0		phs001857.v1.p1	Mammographic Breast Density
			05/09/2016				./data/phs001043.v1.pht005313.v1.p1.Adjuvant_Aromatase_Inhibitors_Breast_Cancer_Subject.var_report.xml									phs001043.v1.p1	Neoplasm
4.0	5.0		06/15/2017	9.0		4.0	./data/phs001376.v1.pht006552.v1.p1.CD55_Deficiency_Pedigree.var_report.xml	0.0	4.5	0.7071	5.0			4.5		phs001376.v1.p1	Protein-Losing Enteropathies
	466.0		03/23/2016	466.0		466.0	./data/phs000822.v1.pht005134.v1.p1.Breast_Cancer_Predisposing_Mutations_Subject_Phenotypes.var_report.xml	0.0	466.0		466.0			466.0		phs000822.v1.p1	Breast Neoplasms
			11/04/2014				./data/phs000086.v3.pht000340.v1.p1.EDIC_f0704.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			12/11/2009				./data/phs000171.v1.pht000771.v1.p1.MS_DATA_MHQPARDEM.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2019/08/01				./data/phs000222.v6.pht001154.v4.p2.Predict_HD_Subject.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004223.v2.p1.UBMG42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/09/22				./data/phs001460.v1.pht006910.v1.p1.Recurrent_Glioblastoma_Subject.var_report.xml									phs001460.v1.p1	Glioblastoma
			11/08/2013				./data/phs000200.v9.pht001007.v4.p3.f39_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/08/29				./data/phs001333.v2.pht006531.v2.p1.concomitant_medications_form.var_report.xml									phs001333.v2.p1	Fabry Disease
			2019/08/18				./data/phs001201.v2.pht007560.v2.p1.AsPIRES_HINT_Sample_Attributes.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2020/02/14				./data/phs000575.v2.pht005898.v2.p1.medicationhistory.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000527.v2.p3.simphen128.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/06/14				./data/phs001833.v1.pht009150.v1.p1.MS_Severity_Subject.var_report.xml									phs001833.v1.p1	Multiple Sclerosis
			2020/12/21				./data/phs000007.v32.pht006005.v1.p13.e_exam_ex01_2_0813s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001502.v2.p3.outc_bc_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/03/18				./data/phs001489.v2.pht008582.v2.p2.CCDG_Epi25_Subject.var_report.xml									phs001489.v2.p2	Epilepsy
			07/21/2009				./data/phs000142.v1.pht000889.v1.p1.MyopiaGlaucoma_Sample.var_report_2009_07_21.xml									phs000142.v1.p1	Eye Diseases
			2018/08/03				./data/phs000590.v1.pht008261.v1.p1.angiogram_aortaandbranches.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2019/03/28				./data/phs001794.v1.pht008906.v1.p1.BWS_miRNA_Sample_Attributes.var_report.xml									phs001794.v1.p1	Beckwith-Wiedemann Syndrome
			2020/06/18				./data/phs000280.v7.pht004238.v2.p1.VITA03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
716.0	813.0		2021/02/05	1529.0		716.0	./data/phs002319.v1.pht010923.v1.p1.INVEST_Subject.var_report.xml	0.0	764.5	68.59	813.0			764.5		phs002319.v1.p1	Heart Disease
1.0	2.0		2019/08/01	3.0		1.0	./data/phs001839.v1.pht009357.v1.p1.Deep_Seq_Cancers_Subject_Phenotypes.var_report.xml	0.0	1.5	0.7071	2.0			1.5		phs001839.v1.p1	Neoplasms
			2021/05/21				./data/phs002331.v1.pht011104.v1.p1.DASH_Sample_Attributes.var_report.xml									phs002331.v1.p1	Drug Users
			11/08/2013				./data/phs000200.v9.pht002751.v2.p3.f153_medications_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			02/11/2016				./data/phs000536.v2.pht002950.v2.p1.Retrotransposition_Colorectal_Tumors_Subject_Pool_Mapping.var_report.xml									phs000536.v2.p1	Colonic Neoplasms
327.0	377.0		08/09/2013	704.0		327.0	./data/phs000367.v1.pht003263.v1.p1.IBDGC_Familial_Crohns_Disease_Subject_Phenotypes.var_report.xml	0.0	352.0	4.243	377.0			352.0		phs000367.v1.p1	Crohn Disease
3.0	3.0		2020/09/18	3.0		3.0	./data/phs002217.v1.pht010533.v1.p1.MELAS_Subject.var_report.xml	0.0	3.0					3.0		phs002217.v1.p1	MELAS Syndrome
			2019/09/06				./data/phs001885.v1.pht009431.v1.p1.ECAC_European_Sample_Attributes.var_report.xml									phs001885.v1.p1	Endometrial Neoplasms
			2021/02/08				./data/phs002335.v1.pht010942.v1.p1.CLL_Subject_Phenotypes.var_report.xml									phs002335.v1.p1	Leukemia
325.0	325.0		2020/03/26	600.0		75.0	./data/phs001929.v1.pht010015.v1.p1.Neurogenetics_OCD_Subject_Phenotypes.var_report.xml	0.0	300.0	35.36	75.0			300.0		phs001929.v1.p1	Obsessive-Compulsive Disorder
			2018/02/08				./data/phs001488.v1.pht007417.v1.p1.psq.var_report.xml									phs001488.v1.p1	Huntington Disease
			2021/08/08				./data/phs001644.v2.pht009947.v2.p2.TOPMed_CCDG_BioME_Sample_Attributes.var_report.xml									phs001644.v2.p2	Coronary Artery Disease
			2021/03/10				./data/phs001485.v2.pht007188.v2.p1.Cell_ID_Sample_Attributes.var_report.xml									phs001485.v2.p1	Cockayne Syndrome
			2020/12/21				./data/phs000007.v32.pht000390.v2.p13.eye0_1975s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/15/2012				./data/phs000479.v1.pht002663.v1.p1.SCID_Exome_Subject.var_report.xml									phs000479.v1.p1	Severe Combined Immunodeficiency
			2017/09/15				./data/phs001173.v1.pht005672.v1.p1.Head_Neck_Cancer_GWAS_Sample_Attributes.var_report.xml									phs001173.v1.p1	Carcinoma, squamous cell of head and neck
			2019/05/07				./data/phs001719.v1.pht008917.v1.p1.Prediabetes_Subject.var_report.xml									phs001719.v1.p1	Prediabetic State
			11/27/2009				./data/phs000016.v2.pht000054.v2.p2.SDQTeacher.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
28.0			2018/05/31	41.0			./data/phs001318.v1.pht008026.v1.p1.demographicinformation.var_report.xml	0.0			13.0					phs001318.v1.p1	Myelodysplastic Syndromes
			03/15/2012				./data/phs000440.v1.pht002495.v1.p1.MARAZITA_Guatemala_Cleft_PhenotypeDS.var_report.xml									phs000440.v1.p1	Dental Caries
			2021/09/14				./data/phs002545.v1.pht011487.v1.p1.MSS_CRC_PDAC_Sample_Attributes.var_report.xml									phs002545.v1.p1	Immunotherapy
			2019/04/04				./data/phs001768.v1.pht008692.v1.p1.Methylmercury_Pregnancy_Sample.var_report.xml									phs001768.v1.p1	
			05/30/2014				./data/phs000751.v1.pht003869.v1.p1.Fibrosing_Interstitial_Lung_Disease_Sample_Attributes.var_report.xml									phs000751.v1.p1	Lung Diseases, Interstitial
			01/19/2010				./data/phs000219.v1.pht001072.v1.p1.d_csa06_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/07/16				./data/phs001602.v2.pht009977.v1.p1.TOPMed_WGS_ChildrensHS_GAP_Sample.var_report.xml									phs001602.v2.p1	Asthma
			2019/02/11				./data/phs001780.v1.pht008711.v1.p1.African_Demographic_Subject.var_report.xml									phs001780.v1.p1	
			06/15/2017				./data/phs001376.v1.pht006555.v1.p1.CD55_Deficiency_Sample_Attributes.var_report.xml									phs001376.v1.p1	Protein-Losing Enteropathies
			08/15/2012				./data/phs000479.v1.pht002665.v1.p1.SCID_Exome_Sample.var_report.xml									phs000479.v1.p1	Severe Combined Immunodeficiency
			2021/06/01				./data/phs001143.v4.pht005902.v1.p1.TOPMed_WGS_BAGS_Subject.var_report.xml									phs001143.v4.p1	Asthma
			11/10/2015				./data/phs000936.v1.pht004889.v1.p1.GOESP_Broad_EOMI_ExomeChip_Subject.var_report.xml									phs000936.v1.p1	
			2020/06/18				./data/phs000280.v7.pht004141.v2.p1.PAQA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/09/2015				./data/phs000937.v1.pht005191.v1.p1.Antisense_Expression_Cancers_Subject_Phenotypes.var_report.xml									phs000937.v1.p1	Neoplasms
8.0	8.0		02/22/2013	27.0		8.0	./data/phs000339.v2.pht002136.v1.p1.Mitochondrial_OXPHOS_Diseases_Pedigree.var_report.xml	0.0	5.5	3.536	8.0			5.5		phs000339.v2.p1	Mitochondrial Diseases
			2020/06/10				./data/phs002039.v1.pht010269.v1.p1.IAV_IBV_Subject.var_report.xml									phs002039.v1.p1	Influenza, Human
			2019/07/25				./data/phs001864.v1.pht009264.v1.p1.MAPK_HCL_SH_Sample.var_report.xml									phs001864.v1.p1	histiocytosis
			2020/09/18				./data/phs002015.v1.pht010393.v1.p1.AREDS2_SAD.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2020/12/21				./data/phs000007.v32.pht005154.v3.p13.t_ctabrac_2011_m_0670s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/05/20				./data/phs000993.v5.pht005015.v2.p2.TOPMed_WGS_HVH_Sample_Attributes.var_report.xml									phs000993.v5.p2	Cardiovascular Disease
			04/05/2017				./data/phs000987.v1.pht004967.v1.p1.WES_P1_22q11_Subject.var_report.xml									phs000987.v1.p1	DiGeorge Syndrome
			06/12/2017				./data/phs000594.v1.pht006509.v1.p1.Registration.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			2019/08/05				./data/phs001867.v1.pht009350.v1.p1.Aging_Cells_Subject.var_report.xml									phs001867.v1.p1	Hutchinson-Gilford Progeria Syndrome
			2020/01/23				./data/phs000287.v7.pht001461.v1.p1.CHS_YR9_BIRTHYEAR.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
30.0			09/10/2013	80.0			./data/phs000601.v1.pht003514.v1.p1.Heritable_Breast_Cancer_Pedigree.var_report.xml	0.0			50.0					phs000601.v1.p1	Breast Neoplasms
			2019/03/11				./data/phs000286.v6.pht008788.v1.p2.stxa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			12/01/2015				./data/phs000571.v3.pht003187.v3.p2.MicroarrayResults.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
902.0		2.0	08/20/2013	492.0	1.61		./data/phs000285.v3.pht001667.v2.p2.C1F12PF.var_report.xml	0.0		0.4977	836.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			2018/04/04				./data/phs001455.v1.pht007760.v1.p1.Dystonia_CIZ1_Sample_Attributes.var_report.xml									phs001455.v1.p1	Dystonia
			04/08/2014				./data/phs000552.v2.pht003030.v1.p1.Meningiomas_Sample_Attributes.var_report.xml									phs000552.v2.p1	Meningioma
			04/01/2016				./data/phs000895.v1.pht005071.v1.p1.Periampullary_Tumors_Sample.var_report.xml									phs000895.v1.p1	
			03/03/2015				./data/phs000620.v1.pht003896.v1.p1.MCTFR_Substance_Abuse_Sample_Attributes.var_report.xml									phs000620.v1.p1	Substance-Related Disorders
			04/25/2016				./data/phs000474.v3.pht002693.v3.p2.Human_Hematopoiesis_Genetics_Subject.var_report.xml									phs000474.v3.p2	Anemia, Dyserythropoietic, Congenital
27.0			04/24/2012	27.0			./data/phs000447.v1.pht002581.v1.p1.Prostate_CIP_Subject_Phenotypes.var_report.xml	0.0								phs000447.v1.p1	Prostatic Neoplasms
			08/22/2012				./data/phs000495.v1.pht002867.v1.p1.TGP_Sample_Attributes.var_report.xml									phs000495.v1.p1	Non-Neoplastic Pediatric Disorder
751.0	4246.0		11/04/2014	8274.0		1.0	./data/phs000086.v3.pht000246.v1.p1.DCCT_f1081.var_report.xml	47.0	2069.0	2389	670.0			2014.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			11/08/2013				./data/phs000200.v9.pht002121.v1.p3.outc_ct_os_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			04/10/2014				./data/phs000418.v2.pht002616.v1.p1.Temporal_Dissection_Tumorigenesis_Sample.var_report.xml									phs000418.v2.p1	Carcinoma, Squamous Cell
			12/16/2014				./data/phs000018.v2.pht004354.v1.p1.GoKinD_GAIN_Subject.var_report.xml									phs000018.v2.p1	Diabetic Nephropathies
			2017/10/05				./data/phs001397.v1.pht006953.v1.p1.GUARDIAN_MACAD_Sample.var_report.xml									phs001397.v1.p1	Coronary Artery Disease
			2017/12/12				./data/phs000676.v2.pht003588.v2.p2.Breast_Tissues_Sequence_Analysis_Subject_Phenotypes.var_report.xml									phs000676.v2.p2	Breast Neoplasms
			2020/03/09				./data/phs001135.v2.pht005982.v1.p1.START_Subject.var_report.xml									phs001135.v2.p1	Opioid-Related Disorders
			2019/08/07				./data/phs001823.v1.pht009057.v1.p1.Lung_Cancer_Cell_Lines_Sample.var_report.xml									phs001823.v1.p1	Carcinoma, Non-Small-Cell Lung
			2017/08/17				./data/phs001399.v1.pht006683.v1.p1.Neoadjuvant_Adjuvant_Therapies_Sample_Attributes.var_report.xml									phs001399.v1.p1	Prostatic Neoplasms
748.0			09/03/2013	6811.0			./data/phs000652.v1.pht003457.v1.p1.GliomaScan_Subject_Phenotypes.var_report.xml	0.0			792.0					phs000652.v1.p1	Glioma
45.0	45.0		2019/03/25	65.0		244.0	./data/phs001734.v1.pht008825.v1.p1.Drug_Abuse_ADHD_Subject_Phenotypes.var_report.xml	0.0	32.5	84.15	244.0			32.5		phs001734.v1.p1	Attention Deficit Disorder with Hyperactivity
7.0	10.0		09/11/2014	17.0		7.0	./data/phs000795.v1.pht004013.v1.p1.Gastric_Cancer_Metastasis_Pedigree.var_report.xml	0.0	8.5	2.121	10.0			8.5		phs000795.v1.p1	Stomach Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000552.v2.p3.simphen153.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/31/2011				./data/phs000374.v1.pht002356.v1.p1.Colorectal_Adenocarcinomas_Subject.var_report.xml									phs000374.v1.p1	Colonic Neoplasms
			11/08/2013				./data/phs000200.v9.pht002762.v1.p3.outc_cardio_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
3135.0	3649.0		03/03/2015	6784.0		3135.0	./data/phs000620.v1.pht003894.v1.p1.MCTFR_Substance_Abuse_Subject_Phenotypes.var_report.xml	0.0	3392.0	363.5	3649.0			3392.0		phs000620.v1.p1	Substance-Related Disorders
			2020/02/14				./data/phs000575.v2.pht005897.v2.p1.medicalhistory.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
			11/16/2012				./data/phs000413.v2.pht002734.v2.p1.AML_FABM7_Sample_Attributes.var_report.xml									phs000413.v2.p1	Acute Megakaryoblastic Leukemia
9.0	9.0		11/18/2016	17.0		8.0	./data/phs001224.v1.pht005939.v1.p1.Platinum_Genomes_Pedigree.var_report.xml	0.0	8.5	0.7071	8.0			8.5		phs001224.v1.p1	Computational Biology
			2020/06/18				./data/phs000280.v7.pht004106.v2.p1.HHXD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			04/24/2012				./data/phs000491.v1.pht002699.v1.p1.Renal_Cell_Carcinoma_Subject_Phenotypes.var_report.xml									phs000491.v1.p1	Carcinoma, Renal Cell
			2020/12/21				./data/phs000007.v32.pht000204.v8.p13.laba1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht010737.v1.p13.t_petamyc_2020_3_1283s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/08				./data/phs001217.v3.pht007765.v1.p1.TOPMed_WGS_GenSalt_Sample_Attributes.var_report.xml									phs001217.v3.p1	Arterial Pressure, Mean
			08/20/2013				./data/phs000285.v3.pht001720.v2.p2.D1F20A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000770.v1.p1.MS_DATA_MHQMEDHIS3.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/04/27				./data/phs002017.v1.pht010154.v1.p1.C_RNA_Preeclampsia_Sample.var_report.xml									phs002017.v1.p1	Pre-Eclampsia
			2019/09/11				./data/phs001437.v1.pht006807.v1.p1.PPTC_Sample.var_report.xml									phs001437.v1.p1	Leukemia, Lymphoid
			2019/03/28				./data/phs000645.v5.pht003741.v5.p1.Intellectual_Disabilities_Sample.var_report.xml									phs000645.v5.p1	Dubowitz Syndrome
			2020/12/21				./data/phs000007.v32.pht000147.v5.p13.ebct1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/05/15				./data/phs001825.v1.pht009048.v1.p1.5UTR_Mutations_PC_Sample.var_report.xml									phs001825.v1.p1	Prostatic Neoplasms
			08/19/2016				./data/phs001192.v1.pht005690.v1.p1.Thoracic_PDX_Subject.var_report.xml									phs001192.v1.p1	Lung Neoplasms
			08/20/2013				./data/phs000285.v3.pht001797.v2.p2.E1F9PRG2.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000434.v2.p3.simphen035.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004113.v2.p1.HPBA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007384.v1.p1.creatlab.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/04/23				./data/phs001259.v1.pht006087.v1.p1.VIRGO_AMI_Subject.var_report.xml									phs001259.v1.p1	Myocardial Infarction
			05/23/2012				./data/phs000409.v1.pht002739.v1.p1.WGS_Medulloblastoma_GEO.var_report.xml									phs000409.v1.p1	Medulloblastoma
			01/20/2016				./data/phs000902.v1.pht004668.v1.p1.MIGen_Regicor_Subject.var_report.xml									phs000902.v1.p1	Coronary Artery Disease
			2020/09/18				./data/phs002015.v1.pht010387.v1.p1.AREDS2_OPP.var_report.xml									phs002015.v1.p1	Macular Degeneration
20.0	20.0		11/16/2016	29.0		9.0	./data/phs000973.v1.pht004989.v1.p1.JMML_Subject_Phenotypes.var_report.xml	0.0	14.5	7.778	9.0			14.5		phs000973.v1.p1	Leukemia, Myelomonocytic, Juvenile
			2021/09/09				./data/phs001515.v2.pht009567.v2.p2.TOPMed_WGS_MLOF_Sample_Attributes.var_report.xml									phs001515.v2.p2	Hemophilia
			10/05/2015				./data/phs000983.v1.pht005005.v1.p1.Rheumatoid_Arthritis_Therapy_Sample.var_report.xml									phs000983.v1.p1	Arthritis, Rheumatoid
			2020/12/21				./data/phs000007.v32.pht007776.v1.p13.vr_soechf_2016_a_1070s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/09/18				./data/phs001310.v1.pht006865.v1.p1.complete_med_hx.var_report.xml									phs001310.v1.p1	Kartagener Syndrome
56.0	56.0		03/15/2016	94.0		8.0	./data/phs000337.v1.pht005337.v1.p1.Developmental_Disabilities_Subject_Phenotypes.var_report.xml	0.0	8.0	9.192	8.0			8.0		phs000337.v1.p1	Intellectual Disability
			03/21/2014				./data/phs000583.v1.pht003296.v1.p1.Type2Diabetes_AsianIndians_Sample_Attributes.var_report.xml									phs000583.v1.p1	Metabolic Syndrome X
			2018/10/22				./data/phs001674.v1.pht008469.v1.p1.BC_Paired_Tumor_Sample.var_report.xml									phs001674.v1.p1	Breast Neoplasms
			2019/08/29				./data/phs001333.v2.pht006524.v2.p1.LDN_6702_Subject.var_report.xml									phs001333.v2.p1	Fabry Disease
67.0			05/14/2013	191.0			./data/phs000422.v1.pht003225.v1.p1.LungGO_SevereAsthma_Subject_Phenotypes.var_report.xml	0.0			124.0					phs000422.v1.p1	Asthma
			2019/06/14				./data/phs000589.v1.pht009172.v1.p1.angiogram_aortaandbranches.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			10/18/2012				./data/phs000547.v1.pht003006.v1.p1.GARNET_SUCCESS_Sample.var_report.xml									phs000547.v1.p1	Breast Neoplasms
89.0	89.0		2021/09/08	870.0		816.0	./data/phs001497.v2.pht007239.v2.p1.Adult_Glioma_Subject.var_report.xml	0.0	929.0	7.778	816.0			929.0		phs001497.v2.p1	
2164.0	2493.0		2021/09/13	4657.0		2164.0	./data/phs000095.v4.pht001211.v4.p2.GENEVA_DentalCaries_Subject.var_report.xml	901.0	2329.0	232.6	2493.0			2329.0		phs000095.v4.p2	Dental Caries
			2020/12/21				./data/phs000007.v32.pht010726.v1.p13.l_fhslab_ex03_3b_1170s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/10/14				./data/phs001912.v1.pht009625.v1.p1.BE_EA_Sample_Attributes.var_report.xml									phs001912.v1.p1	Barrett Esophagus
			04/16/2013				./data/phs000145.v4.pht000662.v3.p2.POPRES_Sample.var_report.xml									phs000145.v4.p2	Normalcy
			11/08/2013				./data/phs000200.v9.pht002773.v1.p3.spec_draws_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			05/08/2017				./data/phs001320.v1.pht006289.v1.p1.Placentation_Pregnancy_CVS_Sample.var_report.xml									phs001320.v1.p1	Pre-eclampsia
			12/20/2016				./data/phs000768.v2.pht004478.v2.p1.Pediatric_Ewing_Sarcoma_Sample.var_report.xml									phs000768.v2.p1	Sarcoma, Ewing
			2020/05/26				./data/phs001820.v1.pht010241.v1.p1.Oncologic_Hematologic_Sample.var_report.xml									phs001820.v1.p1	Neoplasms
			2021/06/16				./data/phs001402.v3.pht008240.v1.p1.TOPMed_WGS_Mayo_VTE_Sample_Attributes.var_report.xml									phs001402.v3.p1	Venous Thromboembolism
103.0	103.0		2020/07/21	201.0		98.0	./data/phs001011.v2.pht005530.v1.p1.eMERGE_CCHMC_IIIA_Pedigree.var_report.xml	0.0	100.5	3.536	98.0			100.5		phs001011.v2.p1	
			2020/12/21				./data/phs000007.v32.pht000302.v2.p13.homocys0_16s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/14/2011				./data/phs000392.v1.pht002372.v1.p1.Exome_arPEO_Subject_Phenotypes.var_report.xml									phs000392.v1.p1	Ophthalmoplegia, Chronic Progressive External
			02/29/2016				./data/phs000990.v1.pht004999.v1.p1.MIGen_Lubeck_Sample_Attributes.var_report.xml									phs000990.v1.p1	Myocardial Infarction
7956.0	9127.0		2019/10/25	17152.0		69.0	./data/phs001858.v1.pht009373.v1.p1.Advanced_Cancer_Subject_Phenotypes.var_report.xml	0.0	5717.0	4927	9127.0			7956.0		phs001858.v1.p1	Neoplasms
			2018/02/27				./data/phs001364.v1.pht007463.v1.p1.HCP_Young_Adults_Subject.var_report.xml									phs001364.v1.p1	Connectome
			08/20/2013				./data/phs000285.v3.pht001634.v2.p2.B2F29.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/29/2017				./data/phs001191.v1.pht006225.v1.p1.eMERGE_NUgene_WGS_Sample.var_report.xml									phs001191.v1.p1	Healthy Volunteers
			09/18/2014				./data/phs000792.v1.pht004251.v1.p1.MPNST_Sample_Attributes.var_report.xml									phs000792.v1.p1	Neurilemmoma
			03/29/2017				./data/phs001319.v1.pht006209.v1.p1.GICC_Sample.var_report.xml									phs001319.v1.p1	Glioma
			09/03/2010				./data/phs000127.v2.pht000651.v1.p1.IrishALS_Sample.var_report_2010_09_03.xml									phs000127.v2.p1	Amyotrophic Lateral Sclerosis
			11/04/2014				./data/phs000086.v3.pht000356.v1.p1.EDIC_f1412.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/09/18				./data/phs002210.v1.pht010519.v1.p1.Structural_Variants_BC_Sample.var_report.xml									phs002210.v1.p1	Breast Neoplasms
			2020/04/03				./data/phs001916.v2.pht009724.v2.p1.PBMCs_Aging_Sample_Attributes.var_report.xml									phs001916.v2.p1	Healthy Aging
			03/07/2016				./data/phs001083.v1.pht005324.v1.p1.SCLC_Chinese_Sample.var_report.xml									phs001083.v1.p1	Small Cell Lung Carcinoma
			2019/11/14				./data/phs001865.v1.pht009612.v1.p1.AAMP_Sample_Attributes.var_report.xml									phs001865.v1.p1	
			11/05/2014				./data/phs000209.v13.pht004320.v1.p3.MESA_AncilMesaGlycA.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2017/12/12				./data/phs000295.v2.pht001531.v2.p1.Kabuki_Sample.var_report.xml									phs000295.v2.p1	Kabuki syndrome
			08/22/2012				./data/phs000495.v1.pht002865.v1.p1.TGP_Sample.var_report.xml									phs000495.v1.p1	Non-Neoplastic Pediatric Disorder
			2018/06/14				./data/phs001238.v2.pht006041.v1.p1.GENOA_AfricanAmerican_Phase1_LabData.var_report.xml									phs001238.v2.p1	Hypertension
			11/07/2014				./data/phs000826.v1.pht004335.v1.p1.Adjuvant_Trastuzumab_Breast_Cancer_Sample.var_report.xml									phs000826.v1.p1	Breast Neoplasms
			05/17/2017				./data/phs001328.v1.pht006308.v1.p1.p6703_14071_labs.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
81.0	81.0		2018/08/18	29.0		57.0	./data/phs001549.v1.pht008252.v1.p1.EWS_European_Subject_Phenotypes.var_report.xml	0.0	61.0	5.657	70.0			70.0		phs001549.v1.p1	Sarcoma, Ewing
			05/08/2015				./data/phs000864.v1.pht004491.v1.p1.Combat_Stress_Predictors_Subject.var_report.xml									phs000864.v1.p1	Stress Disorders, Post-Traumatic
			11/04/2014				./data/phs000086.v3.pht000248.v1.p1.DCCT_ms3exprt.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
1313.0	1480.0		2020/06/30	2793.0		1313.0	./data/phs001972.v1.pht009843.v1.p1.REDS_BSCDC_Subject_Phenotypes.var_report.xml	0.0	1397.0	118.1	1480.0			1397.0		phs001972.v1.p1	Anemia, Sickle Cell
3.0	3.0		2021/06/01	4.0		2.0	./data/phs001189.v4.pht006138.v2.p1.TOPMed_WGS_CCAF_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs001189.v4.p1	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht004129.v2.p1.MSRA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/05/20				./data/phs000972.v5.pht005680.v2.p1.TOPMed_WGS_Samoans_Adiposity_Sample.var_report.xml									phs000972.v5.p1	Obesity
			2020/06/18				./data/phs000280.v7.pht004034.v2.p1.ANTC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/09/03				./data/phs000968.v2.pht004912.v1.p1.Cardiopulmonary_Particulate_Exposure_Subject.var_report.xml									phs000968.v2.p1	Cardiovascular Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000404.v2.p3.simphen005.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/09/16				./data/phs001534.v1.pht008521.v1.p1.Pathways_Sample_Attributes.var_report.xml									phs001534.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004222.v2.p1.UBMFWM02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
828.0	865.0		2018/07/23	5538.0		828.0	./data/phs000742.v1.pht008108.v1.p1.7_1_Participants.var_report.xml	0.0	846.5	297	865.0			846.5		phs000742.v1.p1	Epilepsy
			02/13/2014				./data/phs000372.v1.pht002857.v1.p1.ADGC_Sample.var_report.xml									phs000372.v1.p1	Alzheimer Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000482.v2.p3.simphen083.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/03/31				./data/phs001976.v2.pht009900.v1.p1.Melorheostosis_Subject.var_report.xml									phs001976.v2.p1	Melorheostosis
			03/10/2015				./data/phs000516.v2.pht002831.v2.p1.Pancreatic_Ductal_Adenocarcinoma_Sample_Attributes.var_report.xml									phs000516.v2.p1	Carcinoma, Pancreatic Ductal
			2020/11/13				./data/phs001584.v2.pht009071.v2.p2.eMERGE_III_HRC_BMI.var_report.xml									phs001584.v2.p2	
			2021/05/07				./data/phs001327.v2.pht011195.v1.p1.surgerydetails.var_report.xml									phs001327.v2.p1	Neoplasm
			2021/10/04				./data/phs002238.v1.pht011521.v1.p1.Beat_Childhood_Cancer_Subject_Phenotypes.var_report.xml									phs002238.v1.p1	Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000560.v2.p3.simphen161.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/07/29				./data/phs001599.v1.pht011435.v1.p1.TOPMed_WGS_Boston_Brazil_SCD_Subject_Phenotypes.var_report.xml									phs001599.v1.p1	Anemia, Sickle Cell
			2020/07/07				./data/phs002051.v1.pht010312.v1.p1.RMS_PDX_Sample.var_report.xml									phs002051.v1.p1	Rhabdomyosarcoma
			11/05/2014				./data/phs000209.v13.pht002099.v2.p3.MESA_AncilMesaIL10.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
6.0			2019/10/11	13.0			./data/phs001406.v1.pht007753.v1.p1.sleep_survey_ds.var_report.xml	0.0			7.0					phs001406.v1.p1	Cognition
			2020/12/21				./data/phs000007.v32.pht000140.v7.p13.abdomct3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001024.v3.p3.f85_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/02/10				./data/phs001675.v1.pht010221.v1.p1.OFC_Subject_Phenotypes.var_report.xml									phs001675.v1.p1	Cleft Lip
276.0			2018/01/18	432.0			./data/phs001300.v1.pht006722.v1.p1.NABEC_Subject_Phenotypes.var_report.xml	0.0			156.0					phs001300.v1.p1	Gene Expression Profiling
			2018/09/07				./data/phs001551.v1.pht008345.v1.p1.CURE_EGI_Subject.var_report.xml									phs001551.v1.p1	Epilepsy
			2020/12/21				./data/phs000007.v32.pht005156.v2.p13.t_ctiliac_2005_1_0614s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/04/09				./data/phs001805.v1.pht008954.v1.p1.Neoantigens_NSCLC_Subject.var_report.xml									phs001805.v1.p1	Adenocarcinoma of Lung
238.0	238.0		2018/06/07	456.0		83.0	./data/phs001481.v1.pht008129.v1.p1.IBMFS_Pedigree.var_report.xml	0.0	97.0	5.657	83.0			97.0		phs001481.v1.p1	Bone Marrow Failure Syndromes
6.0	6.0		09/23/2014	9.0		3.0	./data/phs000787.v1.pht004259.v1.p1.Immunosenescence_Subject_Phenotypes.var_report.xml	0.0	4.5	2.121	3.0			4.5		phs000787.v1.p1	Aging
			12/11/2009				./data/phs000171.v1.pht000755.v1.p1.MS_DATA_FAMSFAM.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2018/01/18				./data/phs000382.v3.pht002321.v3.p1.CIDR_Joubert_Syndrome_Subject.var_report.xml									phs000382.v3.p1	Joubert syndrome 1
	2.0		2020/04/27	2.0		2.0	./data/phs002021.v1.pht010159.v1.p1.SCT_GVHD_Subject_Phenotypes.var_report.xml	0.0	2.0		2.0			2.0		phs002021.v1.p1	Graft vs Host Disease
			06/01/2017				./data/phs001306.v1.pht006187.v1.p1.Psoriasis_Associated_Variants_Subject.var_report.xml									phs001306.v1.p1	Psoriasis
			2018/05/15				./data/phs001311.v1.pht007933.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001311.v1.p1	Myotonia
			2020/03/13				./data/phs000521.v2.pht007034.v2.p1.adverse_event.var_report.xml									phs000521.v2.p1	Ataxia
			2020/12/21				./data/phs000007.v32.pht000109.v8.p13.sf36_1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/09/28				./data/phs000988.v5.pht005249.v5.p1.TOPMed_WGS_Asthma_Costa_Rica_Sample_Attributes.var_report.xml									phs000988.v5.p1	Asthma
18.0	20.0		2021/05/10	38.0		18.0	./data/phs002176.v2.pht010946.v1.p1.PD1_PDL1_SCLC_Subject.var_report.xml	0.0	19.0	1.414	20.0			19.0		phs002176.v2.p1	Small Cell Lung Carcinoma
			2017/12/19				./data/phs001438.v1.pht006821.v1.p1.Cortical_Neurogenesis_Open_Chromatin_Sample_Attributes.var_report.xml									phs001438.v1.p1	Chromatin
			2020/04/27				./data/phs002002.v1.pht010192.v1.p1.ILCs_HNSCC_Sample_Attributes.var_report.xml									phs002002.v1.p1	Squamous Cell Carcinoma of the Head and Neck
			2019/01/15				./data/phs001175.v2.pht007756.v2.p2.CTSP_Sample.var_report.xml									phs001175.v2.p2	Breast
			2019/11/19				./data/phs000572.v8.pht003393.v5.p4.FamilySubjectPhenotypesWGS_y1.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			2020/06/18				./data/phs000280.v7.pht004177.v2.p1.RTASBM42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/07/19				./data/phs001601.v2.pht010666.v2.p2.PMBB_AF_Subject_Phenotypes.var_report.xml									phs001601.v2.p2	Atrial Fibrillation
			2021/05/05				./data/phs002310.v1.pht011207.v1.p1.InC3_Subject_Phenotypes.var_report.xml									phs002310.v1.p1	Hepatitis C, Followup studies, Drug dependence
			2019/10/02				./data/phs001901.v1.pht009502.v1.p1.CCDG_Coronary_Sample_Attributes.var_report.xml									phs001901.v1.p1	Myocardial Infarction
			2020/02/03				./data/phs000815.v2.pht008405.v1.p1.Human_Leukocytes_Splice_QTL_Sample_Attributes.var_report.xml									phs000815.v2.p1	
			2020/06/18				./data/phs000280.v7.pht004053.v5.p1.CHRMPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/09/26				./data/phs000284.v2.pht001903.v1.p1.CFS_CARe_ECG.var_report.xml									phs000284.v2.p1	Sleep Apnea Syndromes
			04/24/2015				./data/phs000629.v1.pht003386.v1.p1.Familial_Lung_Cancer_Sample.var_report.xml									phs000629.v1.p1	Lung Neoplasms
			2018/04/16				./data/phs001289.v1.pht007795.v1.p1.periodicparalysishistory.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			10/25/2011				./data/phs000303.v1.pht001897.v1.p1.KORA_Sample.var_report.xml									phs000303.v1.p1	Population Control
			2019/10/23				./data/phs001176.v3.pht005795.v2.p1.GxE_Complex_Traits_Subject.var_report.xml									phs001176.v3.p1	Gene-Environment Interaction
			2018/07/23				./data/phs000742.v1.pht008114.v1.p1.7_7_Elig_Controls.var_report.xml									phs000742.v1.p1	Epilepsy
			2019/03/11				./data/phs000286.v6.pht008726.v1.p2.allevtchd.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/11/27				./data/phs001703.v3.pht008453.v2.p1.DICE_Sample_Attributes.var_report.xml									phs001703.v3.p1	
			2020/09/18				./data/phs001133.v1.pht007495.v1.p1.FOCI_Subject.var_report.xml									phs001133.v1.p1	Ovarian Neoplasms
2731.0	3446.0		2018/06/14	6177.0		2731.0	./data/phs001238.v2.pht006029.v2.p1.GENOA_Pedigree.var_report.xml	0.0	3089.0	630.7	3446.0			3089.0		phs001238.v2.p1	Hypertension
			2020/06/18				./data/phs000280.v7.pht004125.v2.p1.MHQA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
22.0	22.0		2019/03/25	41.0		8.0	./data/phs001164.v1.pht008871.v1.p1.ASD_ROHs_DNMs_Subject_Phenotypes.var_report.xml	0.0	20.5	2.828	8.0			20.5		phs001164.v1.p1	Autism Spectrum Disorder
			2017/11/09				./data/phs001400.v1.pht006823.v1.p1.Mega_Haplotypes_CRC_Sample.var_report.xml									phs001400.v1.p1	Cancer, Colorectal
			2020/06/18				./data/phs000280.v7.pht004205.v2.p1.TIBE04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
53.0	53.0		11/28/2011	100.0		47.0	./data/phs000385.v1.pht002341.v1.p1.Epigenetic_Colorectal_Cancer_Subject_Phenotypes.var_report.xml	0.0	50.0	4.243	47.0			50.0		phs000385.v1.p1	Colorectal Neoplasms
			2021/09/13				./data/phs000095.v4.pht001213.v4.p2.GENEVA_DentalCaries_Sample.var_report.xml									phs000095.v4.p2	Dental Caries
			2019/10/29				./data/phs001924.v1.pht009576.v1.p1.Cholangiocarcinoma_Sample_Attributes.var_report.xml									phs001924.v1.p1	Cholangiocarcinoma
			2020/06/18				./data/phs000280.v7.pht004062.v2.p1.DERIVE2_10.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
4.0	4.0		2020/08/26	8.0		4.0	./data/phs000998.v2.pht005474.v1.p1.iPSC_Pulmonary_Hypertension_Pedigree.var_report.xml	0.0	4.0	0.7071	4.0			4.0		phs000998.v2.p1	Pulmonary Arterial Hypertension
			2020/12/21				./data/phs000007.v32.pht002141.v7.p13.l_adi_2005_m_0558s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/04/15				./data/phs001894.v1.pht009524.v1.p1.CCDG_HMCA_Subject_Phenotypes.var_report.xml									phs001894.v1.p1	Autism Spectrum Disorder
			2018/08/19				./data/phs001647.v1.pht008198.v1.p1.Impulsivity_Addiction_Subject.var_report.xml									phs001647.v1.p1	Impulsive Behavior
			2018/08/18				./data/phs001549.v1.pht008250.v1.p1.EWS_European_Subject.var_report.xml									phs001549.v1.p1	Sarcoma, Ewing
31.0	55.0		11/13/2015	86.0		31.0	./data/phs000730.v1.pht005060.v1.p1.Brain_Metastasis_Subject_Phenotypes.var_report.xml	0.0	43.0	16.97	55.0			43.0		phs000730.v1.p1	Neoplasms
			2018/06/14				./data/phs001238.v2.pht006657.v1.p1.GENOA_EuropeanAmerican_Phase1_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			2019/04/04				./data/phs001742.v2.pht008936.v1.p1.Metastasis_TNBC_GEO.var_report.xml									phs001742.v2.p1	Triple Negative Breast Neoplasms
			2018/02/27				./data/phs001469.v1.pht007170.v1.p1.DM_Anti_PD1_Sample_Attributes.var_report.xml									phs001469.v1.p1	Immunotherapy
			2017/10/11				./data/phs000578.v1.pht007007.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			07/18/2011				./data/phs000226.v2.pht002288.v1.p1.STAMPEED_CHS_Subject.var_report.xml									phs000226.v2.p1	Cardiovascular Diseases
			06/01/2017				./data/phs000701.v1.pht005506.v1.p1.Adverse_Event.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2019/05/16				./data/phs001761.v1.pht009030.v1.p1.MPNs_Chernobyl_Sample_Attributes.var_report.xml									phs001761.v1.p1	Primary Myelofibrosis
			2019/10/08				./data/phs000224.v3.pht002181.v3.p2.VitGene_Vitiligo_Sample.var_report.xml									phs000224.v3.p2	Vitiligo
			2020/12/21				./data/phs000007.v32.pht000040.v5.p13.vr_diab_ex28_0_0601s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000485.v2.p3.simphen086.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/04/2014				./data/phs000086.v3.pht000269.v1.p1.DCCT_cbl5.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2019/07/26				./data/phs000588.v1.pht009292.v1.p1.bvas.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2021/08/16				./data/phs001806.v1.pht011474.v1.p1.GMKF_Nonsyndromic_Craniosynostosis_Sample.var_report.xml									phs001806.v1.p1	Craniosynostoses
			2017/11/07				./data/phs001461.v1.pht007120.v1.p1.Pediatric_Ependymoma_Sample.var_report.xml									phs001461.v1.p1	Ependymoma
			2019/09/11				./data/phs001437.v1.pht006809.v1.p1.PPTC_Sample_Attributes.var_report.xml									phs001437.v1.p1	Leukemia, Lymphoid
97.0	577.0		10/11/2012	7309.0		990.0	./data/phs000254.v2.pht002227.v2.p1.ESP_LungGO_CF_PA_Culture_Data.var_report.xml	0.0	979.0	55.15	92.0			979.0		phs000254.v2.p1	Cystic Fibrosis
95.0	62.0		2018/09/26	98.0		95.0	./data/phs001410.v1.pht008421.v1.p1.GMKF_AIS_Pedigree.var_report.xml	0.0	93.5	77.07	36.0			93.5		phs001410.v1.p1	Scoliosis
			2018/02/01				./data/phs000788.v2.pht004627.v2.p3.RPGEH_Sample.var_report.xml									phs000788.v2.p3	Aging
			2020/03/13				./data/phs000521.v2.pht007038.v2.p1.deathrecord.var_report.xml									phs000521.v2.p1	Ataxia
			08/21/2014				./data/phs000772.v1.pht003995.v1.p1.GenePARE_Sample.var_report.xml									phs000772.v1.p1	Prostatic Neoplasms
			2021/05/10				./data/phs002176.v2.pht010948.v1.p1.PD1_PDL1_SCLC_Subject_Phenotypes.var_report.xml									phs002176.v2.p1	Small Cell Lung Carcinoma
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001589.v2.p2.A4REF.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			2020/02/19				./data/phs001853.v1.pht009810.v1.p1.GI_Malignancies_Subject.var_report.xml									phs001853.v1.p1	Colorectal Neoplasms
			2020/04/27				./data/phs002021.v1.pht010158.v1.p1.SCT_GVHD_Sample.var_report.xml									phs002021.v1.p1	Graft vs Host Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000431.v2.p3.simphen032.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
8887.0	9734.0		08/12/2016	6868.0		8887.0	./data/phs000888.v1.pht004678.v1.p1.eMERGE_Imputed_Subject_Phenotypes.var_report.xml	0.0	9311.0	95.46	9734.0			9311.0		phs000888.v1.p1	
			2017/10/03				./data/phs001382.v1.pht006974.v1.p1.registration.var_report.xml									phs001382.v1.p1	Vasculitis
			2020/11/02				./data/phs001899.v2.pht009570.v2.p1.CSI_Sample.var_report.xml									phs001899.v2.p1	Immunologic Deficiency Syndromes
			01/19/2010				./data/phs000219.v1.pht001061.v1.p1.d_condhist_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/09/02				./data/phs002006.v2.pht010164.v2.p1.Segmental_Overgrowth_Sample_Attributes.var_report.xml									phs002006.v2.p1	Proteus Syndrome
9.0	20.0		2020/08/05	40.0		9.0	./data/phs002052.v1.pht010320.v1.p1.mtDNA_Deletion_POLG_Subject_Phenotypes.var_report.xml	0.0	9.5	0.7071	20.0			9.5		phs002052.v1.p1	Mitochondrial Diseases
			12/16/2010				./data/phs000308.v1.pht002083.v1.p1.GLAUGEN_Subject.var_report_2010_12_16.xml									phs000308.v1.p1	Glaucoma, Open-Angle
			2020/06/18				./data/phs000280.v7.pht006427.v1.p1.CHM.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
716.0	716.0		12/19/2011	910.0		194.0	./data/phs000387.v1.pht002444.v1.p1.eMERGE_GeM_AAA_Subject_Phenotypes.var_report.xml	0.0	455.0	369.1	194.0			455.0		phs000387.v1.p1	Abdominal Aortic Aneurysms
			11/04/2014				./data/phs000086.v3.pht000360.v1.p1.EDIC_f1443.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			10/14/2015				./data/phs000879.v1.pht005035.v1.p1.Relapsed_CLL_Sample_Attributes.var_report.xml									phs000879.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
321.0	321.0		2017/09/22	365.0		44.0	./data/phs001377.v1.pht006942.v1.p1.Cocaine_Nicotine_Addiction_Pedigree.var_report.xml	0.0	78.0	82.02	44.0			78.0		phs001377.v1.p1	Cocaine-Related Disorders
			2018/05/17				./data/phs001313.v1.pht007968.v1.p1.GSD_5607_Subject.var_report.xml									phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2019/07/26				./data/phs000588.v1.pht009280.v1.p1.VCRC_5502_Subject.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/06/18				./data/phs000280.v7.pht004225.v2.p1.UBMGBM01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/07/29				./data/phs002437.v1.pht011431.v1.p1.M4OC_PREVENT_Subject_Phenotypes.var_report.xml									phs002437.v1.p1	Leukoplakia, Oral
7.0	7.0		2019/06/14	7.0		7.0	./data/phs001824.v1.pht009114.v1.p1.pDC_HNSCC_Subject_Phenotypes.var_report.xml	0.0	7.0					7.0		phs001824.v1.p1	Dendritic Cells
77.0	104.0		2018/09/26	181.0		77.0	./data/phs001130.v1.pht008418.v1.p1.NIDDM_Athero_Hispanic_Subject_Phenotypes.var_report.xml	0.0	90.5	19.09	104.0			90.5		phs001130.v1.p1	Diabetes Mellitus, Type 2
			2021/02/12				./data/phs001771.v1.pht008716.v1.p1.IGNITE_Sample.var_report.xml									phs001771.v1.p1	Diabetes Mellitus
			2020/03/19				./data/phs001990.v1.pht010018.v1.p1.Aneurysmal_SAH_Sample.var_report.xml									phs001990.v1.p1	Subarachnoid Hemorrhage
			2019/03/11				./data/phs001757.v1.pht008668.v1.p1.Odorant_Receptors_Sample.var_report.xml									phs001757.v1.p1	Smell
			04/29/2016				./data/phs000128.v3.pht000884.v2.p3.share_samp_Sample.var_report.xml									phs000128.v3.p3	Coronary Disease
			2017/10/13				./data/phs001212.v1.pht006563.v1.p1.Globin_Sickle_Cell_iPSC_Sample.var_report.xml									phs001212.v1.p1	Anemia, Sickle Cell
			2020/01/23				./data/phs000287.v7.pht001468.v1.p1.IMT_POLACK.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			03/24/2015				./data/phs000872.v1.pht004573.v1.p1.Autism_Postmortem_Brain_Sample.var_report.xml									phs000872.v1.p1	Autistic Disorder
			2020/06/18				./data/phs000280.v7.pht006429.v1.p1.DCF.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
8.0	88.0		04/15/2014	78.0		8.0	./data/phs000719.v1.pht003737.v1.p1.PNTM_Subject_Phenotypes.var_report.xml	0.0	51.0	52.33	88.0			51.0		phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
			03/20/2013				./data/phs000573.v1.pht003215.v1.p1.DiffuseLargeBCellLymphoma_SampleGEOMapping.var_report.xml									phs000573.v1.p1	Lymphoma, Large B-Cell, Diffuse
			06/09/2015				./data/phs000718.v1.pht003840.v1.p1.T21NDJ_Sample.var_report.xml									phs000718.v1.p1	Nondisjunction, Genetic
8.0	8.0		05/02/2011	8.0		8.0	./data/phs000311.v1.pht002129.v1.p1.FusionSeq_Subject_Phenotypes.var_report.xml	0.0	8.0					8.0		phs000311.v1.p1	Prostatic Neoplasms
			2019/11/27				./data/phs001703.v3.pht008451.v2.p1.DICE_Sample.var_report.xml									phs001703.v3.p1	
			08/12/2016				./data/phs000888.v1.pht005554.v1.p1.03aADHD_hx_other_conditions.var_report.xml									phs000888.v1.p1	
			2017/10/05				./data/phs001397.v1.pht006951.v1.p1.GUARDIAN_MACAD_Subject.var_report.xml									phs001397.v1.p1	Coronary Artery Disease
			06/12/2017				./data/phs000594.v1.pht006502.v1.p1.EfficacyForm.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
45.0	45.0		03/17/2015	72.0		94.0	./data/phs000884.v1.pht004601.v1.p1.Gut_Microbiome_Controls_Subject_Phenotypes.var_report.xml	0.0	84.0	36.77	94.0			84.0		phs000884.v1.p1	Human Microbiome
			2020/12/09				./data/phs001857.v1.pht010768.v1.p1.MD_Ashkenazi_Sample_Attributes.var_report.xml									phs001857.v1.p1	Mammographic Breast Density
8.0	3.0		2021/04/09	3.0		8.0	./data/phs002292.v1.pht011105.v1.p1.Neocortical_Neurons_Subject.var_report.xml	0.0	3.0	2.828	12.0			3.0		phs002292.v1.p1	Neocortex
			2020/06/18				./data/phs000280.v7.pht006436.v1.p1.ECG.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000281.v1.p1.DCCT_f0922.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/06/07				./data/phs000971.v3.pht004919.v3.p1.ClinSeq_Sample_Attributes.var_report.xml									phs000971.v3.p1	Atherosclerosis
			10/28/2011				./data/phs000352.v1.pht002284.v1.p1.Retinoblastoma_Subject.var_report.xml									phs000352.v1.p1	Retinoblastoma
			2020/07/21				./data/phs001011.v2.pht005533.v1.p1.eMERGE_CCHMC_IIIA_Sample_Attributes.var_report.xml									phs001011.v2.p1	
			12/11/2009				./data/phs000171.v1.pht000782.v1.p1.MS_DATA_PAIN.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/06/02				./data/phs001339.v1.pht006789.v1.p1.22q11_2_Deletion_Syndrome_Sample_Attributes.var_report.xml									phs001339.v1.p1	DiGeorge Syndrome
			05/11/2016				./data/phs000823.v1.pht005047.v1.p1.Melanoma_Predisposing_Mutations_Sample.var_report.xml									phs000823.v1.p1	Melanoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000479.v2.p3.simphen080.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			09/15/2016				./data/phs001044.v1.pht005273.v1.p1.Breast_Cancer_Risk_Pathways_Sample.var_report.xml									phs001044.v1.p1	Breast Neoplasms
			2021/03/24				./data/phs000720.v4.pht003879.v4.p1.Pediatric_Rhabdomyosarcoma_Sample.var_report.xml									phs000720.v4.p1	Rhabdomyosarcoma
			06/25/2013				./data/phs000354.v1.pht003346.v1.p1.ESP_Family_Studies_PAH_Subject.var_report.xml									phs000354.v1.p1	Hypertension, Pulmonary
			2019/11/22				./data/phs001325.v3.pht006353.v2.p1.iPSCORE_WGS_Sample_Attributes.var_report.xml									phs001325.v3.p1	Heart Diseases
			2020/12/21				./data/phs000007.v32.pht000012.v3.p13.ex0_10s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			02/02/2012				./data/phs000417.v2.pht002396.v2.p1.Brain_Cloud_Subject.var_report.xml									phs000417.v2.p1	Aging
99.0	99.0		2019/05/09	35.0		92.0	./data/phs001284.v1.pht009033.v1.p1.WM_LPL_Subject_Phenotypes.var_report.xml	0.0	91.0	23.33	92.0			91.0		phs001284.v1.p1	Waldenstrom Macroglobulinemia
			2019/02/01				./data/phs001770.v1.pht008686.v1.p1.general_eligibility_form.var_report.xml									phs001770.v1.p1	Dent Disease
			2021/05/18				./data/phs002416.v1.pht011232.v1.p1.LMD_Sample_Attributes.var_report.xml									phs002416.v1.p1	Leptomeningeal Carcinomatosis
			2019/11/12				./data/phs001575.v2.pht009608.v1.p1.registration.var_report.xml									phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			12/17/2012				./data/phs000567.v1.pht003081.v1.p1.Solitary_Fibrous_Tumor_Sample_Attributes.var_report.xml									phs000567.v1.p1	Solitary Fibrous Tumors
4.0	4.0		09/29/2014	5.0		1.0	./data/phs000797.v1.pht004267.v1.p1.CTLA4_Haploinsufficiency_Pedigree.var_report.xml	0.0	2.5	2.121	1.0			2.5		phs000797.v1.p1	Autoimmune enteropathy
			04/17/2017				./data/phs000816.v2.pht004340.v2.p1.X_Chromosome_Inactivation_Subject.var_report.xml									phs000816.v2.p1	X Chromosome Inactivation
			2019/10/25				./data/phs001858.v1.pht009372.v1.p1.Advanced_Cancer_Sample.var_report.xml									phs001858.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht002350.v6.p13.vr_ffreq_ex08_1_0615s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000464.v2.p3.simphen065.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004057.v2.p1.CNFC04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht002196.v1.p3.MESA_FamilyAirExposure.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			11/20/2013				./data/phs000638.v1.pht003568.v1.p1.ALL_Relapse_Subject.var_report.xml									phs000638.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000432.v2.p3.simphen033.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/04/09				./data/phs001483.v1.pht007308.v1.p1.DRIVE_BC_WGS_Sample_Attributes.var_report.xml									phs001483.v1.p1	Breast Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000506.v2.p3.simphen107.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/20/2013				./data/phs000285.v3.pht001657.v2.p2.C1F09MAS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht008766.v1.p2.mribV2.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			03/06/2017				./data/phs000574.v1.pht005862.v1.p1.concomitant_meds.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2018/08/13				./data/phs001247.v1.pht008296.v1.p1.GMKF_CCDD_Subject.var_report.xml									phs001247.v1.p1	Cranial Nerve Diseases
			06/26/2013				./data/phs000553.v1.pht003135.v1.p1.Rare_Pediatric_Phenotypes_Sample_Attributes.var_report.xml									phs000553.v1.p1	Mendelian
			2017/12/29				./data/phs000774.v2.pht004701.v1.p1.CCDG_OFCs_Sample.var_report.xml									phs000774.v2.p1	Cleft Lip
			2019/06/03				./data/phs001292.v2.pht007856.v2.p1.unique_questionnaire.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			2018/03/09				./data/phs000606.v1.pht007569.v1.p1.crf_followupvisitpart1.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2021/02/22				./data/phs001812.v1.pht009107.v1.p1.Pediatric_Obesity_Asthma_Sample_Attributes.var_report.xml									phs001812.v1.p1	Asthma
			2019/08/01				./data/phs001839.v1.pht009358.v1.p1.Deep_Seq_Cancers_Sample_Attributes.var_report.xml									phs001839.v1.p1	Neoplasms
			03/27/2013				./data/phs000525.v1.pht002935.v1.p1.Cancer_Pseudogenes_Transcription_Sample_Attributes.var_report.xml									phs000525.v1.p1	Neoplasms
			2018/05/17	3.0			./data/phs001313.v1.pht007970.v1.p1.urinecollection.var_report.xml	1.0			3.0					phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2019/08/01				./data/phs001828.v1.pht009368.v1.p1.CKD_Sample.var_report.xml									phs001828.v1.p1	Renal Insufficiency, Chronic
			2020/12/21				./data/phs000007.v32.pht000155.v2.p13.hba0_23s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000830.v2.p13.dopecho0_20s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			Wed Nov 26 07:37:03 2008				./data/phs000017.v3.pht000057.v1.p1.EA_DIGS3_Data.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
57.0			2020/11/24	83.0			./data/phs001052.v2.pht005468.v2.p1.Pediatric_Solid_Tumors_Subject_Phenotypes.var_report.xml	0.0			26.0					phs001052.v2.p1	Neoplasms
			2021/08/13				./data/phs001442.v3.pht010302.v1.p2.TEDDY_Cohort_casecntrl_t1dlist3.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			2019/03/11				./data/phs000286.v6.pht001977.v2.p2.toba.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/04/09				./data/phs001802.v1.pht008961.v1.p1.Lymphatic_Anomalies_CAG_Sample_Attributes.var_report.xml									phs001802.v1.p1	Lymphatic Diseases
			2019/04/10				./data/phs001653.v1.pht008702.v1.p1.Holoprosencephaly_Subject.var_report.xml									phs001653.v1.p1	Holoprosencephaly
			2019/03/11				./data/phs000286.v6.pht008792.v1.p2.vap.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001491.v2.p1.YR5OLD.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/09/08				./data/phs001735.v2.pht009981.v2.p1.TOPMed_WGS_PCGC_Sample.var_report.xml									phs001735.v2.p1	Heart Defects, Congenital
			10/21/2015				./data/phs001002.v1.pht005042.v1.p1.CALGB90401_Prostate_Cancer_Subject.var_report.xml									phs001002.v1.p1	Prostatic Neoplasms
736.0	736.0		01/07/2016	38.0		8.0	./data/phs000459.v1.pht002544.v1.p1.Oral_Clefts_Multiplex_Families_Pedigree.var_report.xml	0.0	709.5	9.192	8.0			709.5		phs000459.v1.p1	Cleft Lip
			11/07/2014				./data/phs000826.v1.pht004336.v1.p1.Adjuvant_Trastuzumab_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs000826.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs001787.v1.pht009043.v1.p1.CRC_High_Risk_Families_Subject.var_report.xml									phs001787.v1.p1	Colorectal Neoplasms, Hereditary Nonpolyposis
			10/25/2016				./data/phs000371.v2.pht002985.v1.p1.Huntingtons_Disease_Subject.var_report.xml									phs000371.v2.p1	Huntington Disease
			2020/01/16				./data/phs001386.v2.pht006606.v1.p1.Smoking_Vaginal_Microbiome_Subject.var_report.xml									phs001386.v2.p1	Smoking
			2021/07/13				./data/phs002481.v1.pht011374.v1.p1.SCA_Sample_Attributes.var_report.xml									phs002481.v1.p1	Aneuploidy
			2021/07/16				./data/phs001604.v2.pht009983.v1.p1.TOPMed_WGS_ChildrensHS_MetaAir_Subject.var_report.xml									phs001604.v2.p1	Asthma
			2019/03/22				./data/phs001597.v1.pht008125.v1.p1.Bevacizumab_Hypertension_Sample.var_report.xml									phs001597.v1.p1	Hypertension
5.0	5.0		2020/05/26	6.0		4.0	./data/phs001820.v1.pht010240.v1.p1.Oncologic_Hematologic_Pedigree.var_report.xml	0.0	4.0	2.828	1.0			4.0		phs001820.v1.p1	Neoplasms
			06/14/2016				./data/phs001127.v1.pht005527.v1.p1.Endometrial_Cancer_Primaries_Metastases_Subject_Phenotypes.var_report.xml									phs001127.v1.p1	Endometrial Neoplasms
			05/12/2015				./data/phs000894.v1.pht004658.v1.p1.Acute_Kidney_Injury_Vancomycin_Subject.var_report.xml									phs000894.v1.p1	Acute Kidney Injury
			2018/06/30				./data/phs001643.v1.pht008191.v1.p1.Chordoma_Subject.var_report.xml									phs001643.v1.p1	Chordoma
			2018/09/20				./data/phs001428.v1.pht008385.v1.p1.S0221_BRCA_Toxicities_Subject.var_report.xml									phs001428.v1.p1	Peripheral Nervous System Diseases
			05/24/2017				./data/phs000574.v1.pht005856.v1.p1.ae_mro_review.var_report.xml									phs000574.v1.p1	Rett Syndrome
16.0			2019/11/12	42.0			./data/phs001575.v2.pht009606.v1.p1.demographics.var_report.xml	0.0			26.0					phs001575.v2.p1	Late Infantile Neuronal Ceroid Lipofuscinosis
			2018/02/08				./data/phs001488.v1.pht007385.v1.p1.ctcc_covance.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/06/18				./data/phs000280.v7.pht004217.v2.p1.UBMEWM4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/08/2016				./data/phs000949.v1.pht005222.v1.p1.CIDR_Facial_Variation_Subject.var_report.xml									phs000949.v1.p1	Anthropometry
			03/31/2016				./data/phs001072.v1.pht005354.v1.p1.Relapsed_Pediatric_ALL_Subject.var_report.xml									phs001072.v1.p1	Leukemia, Lymphoid
			2021/05/07				./data/phs001327.v2.pht011188.v1.p1.mrafsumm.var_report.xml									phs001327.v2.p1	Neoplasm
974.0	974.0		10/09/2009	834.0		655.0	./data/phs000093.v2.pht000118.v2.p2.PLCO_Cases_Ctls_Data.var_report_2009_10_09.xml	0.0	814.5	89.1	655.0			814.5		phs000093.v2.p2	Lung Neoplasms
			2018/05/31				./data/phs001316.v1.pht008010.v1.p1.p5305_12515_followupe.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			2019/11/08				./data/phs001332.v2.pht007450.v2.p1.p7301_12576_uhdrsiv.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2020/12/01				./data/phs002105.v1.pht010705.v1.p1.Opioid_Pharmacogenomics_Children_Subject.var_report.xml									phs002105.v1.p1	Opioid-Related Disorders
			2019/07/26				./data/phs000588.v1.pht009294.v1.p1.death_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
67.0	67.0		2018/04/20	100.0		33.0	./data/phs001556.v1.pht007845.v1.p1.BRAINcode_Subject_Phenotypes.var_report.xml	0.0	50.0	24.04	33.0			50.0		phs001556.v1.p1	Parkinson Disease
			2018/03/26				./data/phs000697.v1.pht007691.v1.p1.BMF_5406_Subject.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2020/12/21				./data/phs000007.v32.pht002349.v2.p13.t_wbdxa_2011_3_0624s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/30/2013				./data/phs000659.v1.pht003524.v1.p1.Ileal_Pouch_Microbiome_Sample_Attributes.var_report.xml									phs000659.v1.p1	Inflammatory Bowel Diseases
			2021/08/27				./data/phs000966.v2.pht005306.v2.p2.Essential_Tremor_Sample.var_report.xml									phs000966.v2.p2	Essential Tremor
14.0			2020/03/04	20.0			./data/phs001969.v1.pht009936.v1.p1.CGD_TCL_Subject_Phenotypes.var_report.xml	0.0			6.0					phs001969.v1.p1	Lymphoma, T-Cell, Cutaneous
			2020/12/21				./data/phs000007.v32.pht002428.v1.p13.q_psysocalp_ex10_0_0657s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001955.v2.p2.echa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			04/14/2011				./data/phs000258.v2.pht001240.v2.p1.HMP_Gut_Obesity_Subject.var_report.xml									phs000258.v2.p1	Obesity
238.0			2019/06/03	776.0			./data/phs001292.v2.pht007850.v2.p1.demographics.var_report.xml	2.0			538.0					phs001292.v2.p1	Angelman Syndrome
			2018/05/14				./data/phs001396.v1.pht006738.v1.p1.Pigmentation_Eastern_Southern_African_Sample_Attributes.var_report.xml									phs001396.v1.p1	Skin Pigmentation
			05/24/2016				./data/phs001065.v1.pht005432.v1.p1.uhdr3.var_report.xml									phs001065.v1.p1	Huntington Disease
			07/28/2014				./data/phs000778.v1.pht003968.v1.p1.Vesicoureteral_Reflux_Sample.var_report.xml									phs000778.v1.p1	Vesico-Ureteral Reflux
			11/08/2013				./data/phs000200.v9.pht001509.v2.p3.outc_death_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/10/21				./data/phs001138.v4.pht007939.v3.p2.GMKF_CHD_PCGC_Sample.var_report.xml									phs001138.v4.p2	Heart Defects, Congenital
			2020/06/18				./data/phs000280.v7.pht006447.v1.p1.MRF_FINAL.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/05/2014				./data/phs000209.v13.pht003120.v3.p3.MESA_AncilMesaNeighborScalesExam2.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht000395.v9.p13.sleep1_1998s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
	12.0		2020/08/19	12.0		12.0	./data/phs002075.v1.pht010457.v1.p1.Chorioamniotic_Membranes_Subject.var_report.xml	0.0	12.0		12.0			12.0		phs002075.v1.p1	Placenta Previa
			02/24/2012				./data/phs000001.v3.pht000379.v2.p1.lens.var_report.xml									phs000001.v3.p1	Cataract
			01/16/2015				./data/phs000763.v1.pht004252.v1.p1.COGA_Family_GWAS_Subject.var_report.xml									phs000763.v1.p1	Alcoholism
			08/29/2016				./data/phs000770.v1.pht003926.v1.p1.HER2_Breast_Cancer_Sample.var_report.xml									phs000770.v1.p1	Breast Neoplasms
2.0	4.0		2020/10/27	6.0		2.0	./data/phs001925.v1.pht010570.v1.p1.MSI_H_Cancers_Subject_Phenotypes.var_report.xml	0.0	3.0	1.414	4.0			3.0		phs001925.v1.p1	Microsatellite Instability
			12/07/2015				./data/phs000970.v1.pht005018.v1.p1.Fetal_Methylmercury_Exposure_Subject_Phenotypes.var_report.xml									phs000970.v1.p1	Methylmercury Compounds
			2020/11/30				./data/phs002283.v1.pht010683.v1.p1.Selenium_Chemoprevention_Sample.var_report.xml									phs002283.v1.p1	
556.0	3094.0		07/21/2009	4373.0		556.0	./data/phs000142.v1.pht000888.v1.p1.MyopiaGlaucoma_Pedigree.var_report_2009_07_21.xml	0.0	2187.0	1284	3094.0			2187.0		phs000142.v1.p1	Eye Diseases
			07/08/2016				./data/phs001166.v1.pht005632.v1.p1.T2D_Seq_GWAS_Starr_County_Cohort_Sample.var_report.xml									phs001166.v1.p1	Diabetes Mellitus, Type 2
			2021/08/19				./data/phs001662.v2.pht010069.v1.p1.LTRC_R040_subject_local_pathology.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			11/18/2016				./data/phs001224.v1.pht005940.v1.p1.Platinum_Genomes_Sample.var_report.xml									phs001224.v1.p1	Computational Biology
			2021/06/02				./data/phs002419.v1.pht011263.v1.p1.BC_Sample.var_report.xml									phs002419.v1.p1	Breast Neoplasms
			2020/04/30				./data/phs001517.v2.pht007480.v2.p2.GHIRD_Subject.var_report.xml									phs001517.v2.p2	Retinitis Pigmentosa
			08/20/2013				./data/phs000285.v3.pht001640.v2.p2.B2F9PRG2.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005552.v1.p1.01aADHD_hx.var_report.xml									phs000888.v1.p1	
8.0	8.0		2019/10/31	9.0		11.0	./data/phs001623.v2.pht008363.v2.p1.HNSCC_Subject_Phenotypes.var_report.xml	0.0	4.5	8.485	11.0			4.5		phs001623.v2.p1	Carcinoma, squamous cell of head and neck
			01/19/2010				./data/phs000219.v1.pht001097.v1.p1.d_oars_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
680.0			2018/12/10	680.0			./data/phs001621.v1.pht008154.v1.p1.Platinum_Study_Subject_Phenotypes.var_report.xml	0.0								phs001621.v1.p1	
			2021/02/10				./data/phs001675.v1.pht010219.v1.p1.OFC_Pedigree.var_report.xml									phs001675.v1.p1	Cleft Lip
285.0			04/25/2016	556.0			./data/phs000474.v3.pht002695.v3.p2.Human_Hematopoiesis_Genetics_Subject_Phenotypes.var_report.xml	0.0			261.0					phs000474.v3.p2	Anemia, Dyserythropoietic, Congenital
676.0	718.0		05/07/2013	727.0		676.0	./data/phs000462.v1.pht002541.v1.p1.T2D_GENES_Pedigree.var_report.xml	0.0	697.0	94.05	718.0			697.0		phs000462.v1.p1	Diabetes Mellitus, Type 2
			2021/04/23				./data/phs002228.v1.pht010860.v1.p1.Deamination_Leukemia_Sample_Attributes.var_report.xml									phs002228.v1.p1	Myeloproliferative Disorders
			2020/04/03				./data/phs001916.v2.pht009721.v1.p1.PBMCs_Aging_Subject.var_report.xml									phs001916.v2.p1	Healthy Aging
			Wed Jan 21 13:20:49 2009				./data/phs000144.v1.pht000725.v1.p1.TSP_ClinPathQA_Data_NormalSamplePheno.var_report_2009_01_22.xml									phs000144.v1.p1	Neoplasms
			08/31/2011				./data/phs000374.v1.pht002357.v1.p1.Colorectal_Adenocarcinomas_Sample.var_report.xml									phs000374.v1.p1	Colonic Neoplasms
3.0	3.0		2021/08/11	4.0		2.0	./data/phs002480.v1.pht011458.v1.p1.Glomerular_Disorders_Pedigree.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs002480.v1.p1	Glomerulonephritis
			2019/07/26				./data/phs000588.v1.pht009310.v1.p1.unscheduled_visit_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2020/11/27				./data/phs002237.v1.pht010693.v1.p1.MMBIR_CGR_Subject_Phenotypes.var_report.xml									phs002237.v1.p1	Adenocarcinoma of Lung
1394.0	1394.0		05/16/2017	2138.0		744.0	./data/phs001252.v1.pht006377.v1.p1.ca_diam.var_report.xml	0.0	1069.0	459.6	744.0			1069.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			2018/08/02				./data/phs001487.v1.pht007136.v1.p1.CCDG_TAICHI_Subject.var_report.xml									phs001487.v1.p1	
			2019/03/11				./data/phs000286.v6.pht008760.v1.p2.mdea.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht007772.v2.p13.vr_dgai2010_ex05_1_1013s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004193.v2.p1.SBPB02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
45.0	45.0		03/23/2015	87.0		42.0	./data/phs000866.v1.pht004621.v1.p1.Bipolar_Disorder_Family_Genomics_Subject_Phenotypes.var_report.xml	0.0	43.5	4.243	42.0			43.5		phs000866.v1.p1	Bipolar Disorder
			2020/12/21				./data/phs000007.v32.pht002148.v5.p13.t_hsa_ex01_3_0588s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001055.v1.p1.d_bne1_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
	6.0		2020/12/10	8.0		2.0	./data/phs002065.v1.pht010769.v1.p1.Genitourinary_Cancers_Subject.var_report.xml	0.0	4.0	2.828				4.0		phs002065.v1.p1	Bladder Neoplasms
			01/26/2015				./data/phs000837.v1.pht004438.v1.p1.22q11DS_Subject.var_report.xml									phs000837.v1.p1	Tetralogy of Fallot
			05/21/2013				./data/phs000421.v1.pht003234.v1.p1.FuchsEndothelialCornealDystrophy_Sample.var_report.xml									phs000421.v1.p1	Fuchs&#39; Endothelial Dystrophy
			07/18/2016				./data/phs001085.v1.pht005646.v1.p1.Melanesian_Individuals_Sample.var_report.xml									phs001085.v1.p1	
			2021/05/21				./data/phs001062.v5.pht005263.v3.p2.TOPMed_WGS_MGH_AF_Sample_Attributes.var_report.xml									phs001062.v5.p2	Atrial Fibrillation
			2020/06/18				./data/phs000280.v7.pht006423.v1.p1.CDI.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/18				./data/phs001315.v1.pht006194.v1.p1.CIDR_GECCO_Colorectal_Cancer_GxE_Sample_Attributes.var_report.xml									phs001315.v1.p1	Colorectal Neoplasms
			2018/02/08				./data/phs001488.v1.pht007421.v1.p1.sitexfer.var_report.xml									phs001488.v1.p1	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001808.v2.p2.F1F02.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/02				./data/phs001900.v1.pht009631.v1.p1.ASD_SCZ_Development_Sample.var_report.xml									phs001900.v1.p1	Autism Spectrum Disorder
11.0	11.0		11/04/2014	11.0		11.0	./data/phs000086.v3.pht000254.v1.p1.DCCT_m9exdeth.var_report.xml	0.0	11.0					11.0		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht004172.v2.p1.RTASBF24.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000993.v4.p3.f146_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			09/29/2015	13.0			./data/phs000892.v2.pht004630.v2.p2.CPTAC_OvarianSubjectClinicalPhenotypes.var_report.xml	13.0			13.0					phs000892.v2.p2	
			2021/07/19				./data/phs002229.v1.pht010557.v1.p1.GCT_PrimaryMetastasis_Sample_Attributes.var_report.xml									phs002229.v1.p1	Neoplasms, Germ Cell and Embryonal
	7067.0		12/17/2009	12771.0		5704.0	./data/phs000090.v1.pht000114.v1.p1.ARIC_CARE_Data.var_report_2009_12_17.xml	0.0	6386.0	963.8				6386.0		phs000090.v1.p1	Cardiovascular Diseases
1.0	1.0		2021/01/28	1.0		1.0	./data/phs002089.v1.pht010494.v1.p1.dMMR_Tumors_Subject.var_report.xml	0.0	1.0					1.0		phs002089.v1.p1	Small Cell Lung Carcinoma
			2020/06/10				./data/phs002039.v1.pht010272.v1.p1.IAV_IBV_Sample_Attributes_SC.var_report.xml									phs002039.v1.p1	Influenza, Human
			2021/09/23				./data/phs001468.v3.pht009552.v1.p1.TOPMed_WGS_REDSIII_Brazil_SCD_Subject.var_report.xml									phs001468.v3.p1	Sickle Cell Anemia
			08/20/2013				./data/phs000285.v3.pht001861.v2.p2.F2IGE.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/03/26				./data/phs000697.v1.pht007693.v1.p1.physicalexam.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
46.0	125.0		2020/06/25	171.0		46.0	./data/phs001779.v1.pht010205.v1.p1.CIDR_NIA_Ehlers_Danlos_Pedigree.var_report.xml	0.0	85.5	60.1	125.0			85.5		phs001779.v1.p1	Ehlers-Danlos syndrome type 3
			2018/03/23				./data/phs000698.v1.pht007671.v1.p1.baseline_physical_exam.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			03/07/2011				./data/phs000252.v2.pht001271.v1.p1.HMP_Gut_Crohns_Diet_COMBO_Subject_Phenotypes.var_report.xml									phs000252.v2.p1	Crohn Disease
980.0	1000.0		10/25/2011	1980.0		980.0	./data/phs000303.v1.pht001898.v1.p1.KORA_Phenotype_Data.var_report.xml	0.0	990.0	14.14	1000.0			990.0		phs000303.v1.p1	Population Control
			2020/12/21				./data/phs000007.v32.pht000676.v9.p13.meds3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/30/2017				./data/phs001255.v1.pht005992.v1.p1.Molecular_Evolution_Cancer_Sample_Attributes.var_report.xml									phs001255.v1.p1	Liposarcoma
			2018/04/05				./data/phs001553.v1.pht007733.v1.p1.INC_6603_Subject.var_report.xml									phs001553.v1.p1	Charcot-Marie-Tooth Disease
			07/12/2017				./data/phs000592.v1.pht006585.v1.p1.conclusionofstudyparticipation.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
			2019/12/03				./data/phs001897.v1.pht009543.v1.p1.Peanut_OIT_Sample_Attributes.var_report.xml									phs001897.v1.p1	Peanut Hypersensitivity
			01/22/2014				./data/phs000670.v1.pht003555.v1.p1.PGRN_AMPS_Sample.var_report.xml									phs000670.v1.p1	Depressive Disorder, Major
			06/23/2015				./data/phs000648.v1.pht004577.v1.p1.Pancreatic_Cancer_Subject.var_report.xml									phs000648.v1.p1	Pancreatic Neoplasms
408.0			04/20/2012	1617.0			./data/phs000390.v1.pht002327.v1.p1.Female_Osteoporosis_Risk_Genes_Subject_Phenotypes.var_report.xml	0.0			1209.0					phs000390.v1.p1	Osteoporosis
			08/20/2013				./data/phs000285.v3.pht001620.v2.p2.B2F09THY.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001000.v5.p3.f31_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/12/22				./data/phs001980.v1.pht010078.v1.p1.UTPDTC_PDX_Sample_Attributes.var_report.xml									phs001980.v1.p1	Lung Neoplasms
			2021/06/08				./data/phs001218.v3.pht005957.v1.p1.TOPMed_WGS_GeneSTAR_Subject.var_report.xml									phs001218.v3.p1	Platelet Aggregation
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000481.v2.p3.simphen082.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/08/01				./data/phs000222.v6.pht005789.v2.p2.HDPET_FDG.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht000033.v10.p13.ex1_4s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/23				./data/phs001434.v2.pht009859.v1.p1.TOPMed_WGS_miRhythm_Sample_Attributes.var_report.xml									phs001434.v2.p1	Atrial Fibrillation
725.0	1155.0		2021/06/24	1880.0		725.0	./data/phs001446.v2.pht009628.v1.p1.TOPMed_WGS_SARP_Subject_Phenotypes.var_report.xml	2.0	940.0	304.1	1155.0			940.0		phs001446.v2.p1	Asthma
			2021/01/08				./data/phs000649.v2.pht003761.v2.p2.PEAR_Sample_Attributes.var_report.xml									phs000649.v2.p2	Hypertension
761.0	761.0		11/04/2014	1441.0		680.0	./data/phs000086.v3.pht000212.v1.p1.DCCT_ms7exf10.var_report.xml	0.0	720.5	57.28	680.0			720.5		phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			09/11/2012				./data/phs000535.v1.pht002958.v1.p1.Bladder_Cancer_Sample.var_report.xml									phs000535.v1.p1	Urinary Bladder Neoplasms
			2020/06/18				./data/phs000280.v7.pht004227.v2.p1.UBMGWM01.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/02/08				./data/phs001488.v1.pht007422.v1.p1.socioeco.var_report.xml									phs001488.v1.p1	Huntington Disease
2474.0	2474.0		09/03/2009	4650.0		882.0	./data/phs000166.v2.pht000728.v1.p1.CAMP_CARE_ACRN_Pedigree.var_report_2009_09_03.xml	0.0	968.0	210.7	882.0			968.0		phs000166.v2.p1	Asthma
3.0	16.0		2021/05/18	19.0		3.0	./data/phs002416.v1.pht011231.v1.p1.LMD_Subject_Phenotypes.var_report.xml	0.0	9.5	9.192	16.0			9.5		phs002416.v1.p1	Leptomeningeal Carcinomatosis
			10/25/2016				./data/phs000371.v2.pht002988.v1.p1.Huntingtons_Disease_Subject_Phenotypes.var_report.xml									phs000371.v2.p1	Huntington Disease
33.0	33.0		10/25/2016	60.0		27.0	./data/phs000371.v2.pht002986.v1.p1.Huntingtons_Disease_Pedigree.var_report.xml	0.0	30.0	4.243	27.0			30.0		phs000371.v2.p1	Huntington Disease
			2020/08/24				./data/phs001501.v1.pht007226.v1.p1.Race_Genetics_BetaBlocker_Sample.var_report.xml									phs001501.v1.p1	Heart Failure
			2019/03/15				./data/phs001791.v1.pht008852.v1.p1.Brain_Cell_Types_Subject.var_report.xml									phs001791.v1.p1	Cerebral Cortex
			2020/12/21				./data/phs000007.v32.pht004809.v1.p13.l_urine24_ex09_1b_0857s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			03/27/2013				./data/phs000525.v1.pht002933.v1.p1.Cancer_Pseudogenes_Transcription_Subject.var_report.xml									phs000525.v1.p1	Neoplasms
			2021/06/28				./data/phs001514.v2.pht009814.v1.p1.Walk_PHaSST_Subject.var_report.xml									phs001514.v2.p1	Anemia, Sickle Cell
			2018/02/15				./data/phs001496.v1.pht007338.v1.p1.Warfarin_Caribbean_Hispanics_Subject.var_report.xml									phs001496.v1.p1	Warfarin Sensitivity
			2020/08/26				./data/phs001958.v1.pht009938.v1.p1.caQTL_Subject_Phenotypes.var_report.xml									phs001958.v1.p1	Mental Disorders
			2019/10/07				./data/phs000924.v4.pht006320.v3.p1.iPSCORE_Subject.var_report.xml									phs000924.v4.p1	Heart Diseases
114.0			2021/07/09	121.0			./data/phs001544.v2.pht009898.v1.p1.TOPMed_CCDG_MPP_Subject_Phenotypes.var_report.xml	0.0			7.0					phs001544.v2.p1	Atrial Fibrillation
			05/24/2016				./data/phs001065.v1.pht005411.v1.p1.genphyex.var_report.xml									phs001065.v1.p1	Huntington Disease
			2018/05/31				./data/phs001318.v1.pht008032.v1.p1.physicalexam.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			02/23/2017				./data/phs001139.v1.pht006160.v1.p1.GENESiPS_Insulin_Resistance_Sample.var_report.xml									phs001139.v1.p1	Insulin Resistance
9.0	89.0		2020/08/17	4824.0		9.0	./data/phs000397.v3.pht002408.v3.p3.LLFS_Pedigree.var_report.xml	0.0	68.0	319.6	89.0			68.0		phs000397.v3.p3	Longevity
			03/01/2016				./data/phs000942.v1.pht004837.v1.p1.Cancer_Genetics_Clinic_Sample_Attributes.var_report.xml									phs000942.v1.p1	Neoplasms
	6.0		2021/04/09	6.0		6.0	./data/phs002316.v1.pht011109.v1.p1.TEA_seq_Subject.var_report.xml	0.0	6.0					6.0		phs002316.v1.p1	
			04/03/2012				./data/phs000407.v1.pht002646.v1.p1.dbGaP_Subject.var_report.xml									phs000407.v1.p1	Attention Deficit Disorder with Hyperactivity
			2020/04/27				./data/phs002017.v1.pht010153.v1.p1.C_RNA_Preeclampsia_Subject.var_report.xml									phs002017.v1.p1	Pre-Eclampsia
167.0	233.0		09/16/2009	400.0		167.0	./data/phs000211.v1.pht000912.v1.p1.NIGMS_Variation_Panels_Data.var_report_2009_09_16.xml	0.0	200.0	46.67	233.0			200.0		phs000211.v1.p1	Normalcy
			03/07/2016				./data/phs001083.v1.pht005323.v1.p1.SCLC_Chinese_Subject.var_report.xml									phs001083.v1.p1	Small Cell Lung Carcinoma
			06/12/2014				./data/phs000602.v2.pht003220.v1.p1.DiverseCancers_Subject.var_report.xml									phs000602.v2.p1	Neoplasms
			2018/03/09				./data/phs000606.v1.pht007576.v1.p1.registration.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2018/05/31				./data/phs001318.v1.pht008036.v1.p1.bmdifferential.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2019/05/02				./data/phs001378.v1.pht006689.v1.p1.FL_Tumors_Subject.var_report.xml									phs001378.v1.p1	Lymphoma, Follicular
			07/16/2015				./data/phs000153.v9.pht000837.v6.p8.vr_lapse_2008_m_0649sn.var_report.xml									phs000153.v9.p8	Social Behavior
			2017/09/08				./data/phs001105.v1.pht006838.v1.p1.Aggressive_Prostate_Tumors_Subject_Phenotypes.var_report.xml									phs001105.v1.p1	Prostatic Neoplasms
			2020/06/18				./data/phs000280.v7.pht004072.v2.p1.ECGD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/07/19				./data/phs001230.v1.pht009242.v1.p1.Estonian_Biobank_Sample_Attributes.var_report.xml									phs001230.v1.p1	Population Groups
			2018/06/01				./data/phs001538.v1.pht008098.v1.p1.Registry_Exams_1.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			2018/06/14				./data/phs001238.v2.pht006048.v1.p1.GENOA_AfricanAmerican_Phase2_LabData.var_report.xml									phs001238.v2.p1	Hypertension
			08/13/2015				./data/phs000831.v1.pht004908.v1.p1.Sporadic_ALS_Sample_Attributes.var_report.xml									phs000831.v1.p1	Amyotrophic Lateral Sclerosis
			2018/05/22				./data/phs001165.v1.pht007985.v1.p1.eMERGE_GCPD_CAG_CHOP_Subject.var_report.xml									phs001165.v1.p1	Pediatrics
			2019/07/26				./data/phs000588.v1.pht009281.v1.p1.angiogram_aortaandbranches.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			08/20/2013				./data/phs000285.v3.pht001593.v2.p2.A7F22.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002347.v2.p13.t_ctfacet_2005_m_0618s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			04/08/2014				./data/phs000487.v2.pht002924.v1.p1.Prostate_Cancer_Risk_Sample.var_report.xml									phs000487.v2.p1	Prostatic Neoplasms
			03/28/2014				./data/phs000496.v1.pht003168.v1.p1.Late_Onset_Alzheimers_Sample.var_report.xml									phs000496.v1.p1	Alzheimer Disease
			2018/02/27				./data/phs001539.v1.pht007522.v1.p1.MAGNet_Sample.var_report.xml									phs001539.v1.p1	Atrial Fibrillation
			08/22/2016				./data/phs001152.v1.pht005534.v1.p1.Endometrial_Carcinosarcomas_Subject.var_report.xml									phs001152.v1.p1	Endometrial Neoplasms
			2019/03/11				./data/phs000286.v6.pht008723.v1.p2.af3.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/09/16				./data/phs001123.v2.pht006060.v2.p1.CAAPA_Sample.var_report.xml									phs001123.v2.p1	Asthma
			2021/05/11				./data/phs000954.v4.pht006297.v2.p2.TOPMed_WGS_CFS_Subject.var_report.xml									phs000954.v4.p2	Sleep Apnea Syndromes
			2019/12/12				./data/phs001930.v1.pht009668.v1.p1.Vit_E_NAFLD_Subject.var_report.xml									phs001930.v1.p1	Non-alcoholic Fatty Liver Disease
			2020/02/06				./data/phs001430.v2.pht008063.v2.p1.p7001_15485_eligibili.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2020/07/10				./data/phs002055.v1.pht010344.v1.p1.GTAC_ALS_FTD_Sample.var_report.xml									phs002055.v1.p1	Amyotrophic Lateral Sclerosis
			2019/06/14				./data/phs000589.v1.pht009197.v1.p1.registration.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			11/16/2015				./data/phs000980.v1.pht004962.v1.p1.NSCLC_Pembrolizumab_Sample.var_report.xml									phs000980.v1.p1	Carcinoma, Non-Small-Cell Lung
3570.0	3570.0		11/09/2016	7012.0		3442.0	./data/phs001037.v1.pht005919.v1.p1.TEDDY_Subject_Phenotypes.var_report.xml	0.0	3506.0	90.51	3442.0			3506.0		phs001037.v1.p1	Diabetes Mellitus, Type 1
			05/17/2017				./data/phs001328.v1.pht006313.v1.p1.eligibility.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			2020/12/21				./data/phs000007.v32.pht001225.v6.p13.ctpaof3_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000487.v2.p3.simphen088.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004079.v2.p1.ECHA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/08/10				./data/phs001467.v2.pht009732.v2.p2.TOPMed_WGS_SAPPHIRE_Sample_Attributes.var_report.xml									phs001467.v2.p2	Asthma
			02/10/2014				./data/phs000248.v1.pht001201.v1.p1.HCV_Sample.var_report.xml									phs000248.v1.p1	Hepatitis C
			09/08/2016				./data/phs000893.v1.pht005502.v1.p1.Endometrial_Cancer_E2C2_GWAS_Subject_Phenotypes.var_report.xml									phs000893.v1.p1	Carcinoma, Endometrioid
			2020/12/21				./data/phs000007.v32.pht005143.v3.p13.l_fhslab_ex01_3b_0800s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/11/2016				./data/phs000963.v1.pht004857.v1.p1.Statins_CV_Sample.var_report.xml									phs000963.v1.p1	Myocardial Revascularization
			03/07/2016				./data/phs001084.v1.pht005327.v1.p1.Colorectal_Tumors_Primary_Metastatic_Sample.var_report.xml									phs001084.v1.p1	Colorectal Neoplasms
			08/30/2013				./data/phs000657.v1.pht003492.v1.p1.Advanced_Cancers_Subject.var_report.xml									phs000657.v1.p1	Carcinoma
			11/16/2015				./data/phs001026.v1.pht005122.v1.p1.CSER_BASIC3_Sample_Attributes.var_report.xml									phs001026.v1.p1	Genes, Neoplasm
			2021/05/20				./data/phs000993.v5.pht005013.v2.p2.TOPMed_WGS_HVH_Subject.var_report.xml									phs000993.v5.p2	Cardiovascular Disease
			2020/07/15				./data/phs002054.v1.pht010348.v1.p1.9p_Deletion_Sample.var_report.xml									phs002054.v1.p1	Chromosome 9p Deletion Syndrome
282.0			07/05/2017	607.0			./data/phs000595.v1.pht006634.v1.p1.family_history_form.var_report.xml	7.0			325.0					phs000595.v1.p1	Primary ciliary dyskinesia
			2018/06/30				./data/phs001625.v1.pht008183.v1.p1.Psychotic_Major_Depression_Subject.var_report.xml									phs001625.v1.p1	Control Groups
			2020/12/21				./data/phs000007.v32.pht000308.v9.p13.sawin1_4s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/07/18				./data/phs001615.v1.pht008242.v1.p1.RA_FLS_Sample.var_report.xml									phs001615.v1.p1	Arthritis, Rheumatoid
			11/05/2014				./data/phs000209.v13.pht002296.v2.p3.MESA_AirNRAorticCalciumCT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2019/02/21				./data/phs001281.v2.pht006137.v2.p1.transcranial_doppler.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2018/03/30				./data/phs001108.v1.pht007714.v1.p1.eligibility.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
			2020/06/02				./data/phs001339.v1.pht006787.v1.p1.22q11_2_Deletion_Syndrome_Sample.var_report.xml									phs001339.v1.p1	DiGeorge Syndrome
			2018/04/16				./data/phs001326.v1.pht007831.v1.p1.p6902_18054_1120yrlif.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
44.0			2020/01/10	70.0			./data/phs001493.v2.pht007298.v1.p1.RCC_Immune_Checkpoint_Subject_Phenotypes.var_report.xml	0.0			24.0					phs001493.v2.p1	Carcinoma, Renal Cell
			08/23/2011				./data/phs000388.v1.pht002353.v1.p1.IPM_Cardiovascular_T2DM_All_Race_Subject_Phenotypes.var_report.xml									phs000388.v1.p1	Metabolic Syndrome X
			2021/06/10				./data/phs001359.v3.pht008690.v1.p1.TOPMed_WGS_GOLDN_Sample_Attributes.var_report.xml									phs001359.v3.p1	Lipids
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000520.v2.p3.simphen121.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
51.0			2018/05/15	106.0			./data/phs001309.v1.pht007915.v1.p1.demographics_form.var_report.xml	0.0			54.0					phs001309.v1.p1	Pulmonary Alveolar Proteinosis
			2019/07/26				./data/phs000588.v1.pht009309.v1.p1.tobacco_alcohol_drug_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2018/06/01				./data/phs001342.v1.pht008048.v1.p1.Statin_Induced_Myopathy_Subject.var_report.xml									phs001342.v1.p1	Myopathy
			2019/08/30				./data/phs001331.v2.pht006934.v2.p1.comorbidities.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			05/02/2011				./data/phs000311.v1.pht002127.v1.p1.FusionSeq_Subject.var_report.xml									phs000311.v1.p1	Prostatic Neoplasms
9.0			2017/10/11	5.0			./data/phs000578.v1.pht007010.v1.p1.family_history.var_report.xml	91.0			7.0					phs000578.v1.p1	Nondystrophic myotonia
			11/05/2014				./data/phs000209.v13.pht004324.v1.p3.MESA_AncilMesaNeighborSESExam4.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/11/20				./data/phs002255.v1.pht010676.v1.p1.Language_Impairment_Sample_Attributes.var_report.xml									phs002255.v1.p1	Language Development
			02/02/2016				./data/phs001067.v1.pht005284.v1.p1.Meningitis_Encephalitis_Subject.var_report.xml									phs001067.v1.p1	Encephalitis
12.0	16.0		04/16/2012	31.0		15.0	./data/phs000477.v1.pht002687.v1.p1.Familial_Renal_Disorders_Subject_Phenotypes.var_report.xml	0.0	15.5	0.7071	9.0			15.5		phs000477.v1.p1	Hypophosphatemia, Familial
1.0	1.0		2021/07/21	1.0		1.0	./data/phs002471.v1.pht011410.v1.p1.AATD_iPSCs_Subject.var_report.xml	0.0	1.0					1.0		phs002471.v1.p1	alpha 1-Antitrypsin Deficiency
			2017/09/22				./data/phs001377.v1.pht006941.v1.p1.Cocaine_Nicotine_Addiction_Subject.var_report.xml									phs001377.v1.p1	Cocaine-Related Disorders
			2019/08/18				./data/phs001869.v1.pht009394.v1.p1.ADHD_Subject.var_report.xml									phs001869.v1.p1	Attention Deficit Disorder with Hyperactivity
			2020/04/29				./data/phs000185.v7.pht008410.v1.p1.Hutterites_Response_eQTLs_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
266.0	410.0		05/01/2017	676.0		410.0	./data/phs000722.v2.pht003899.v2.p2.Colon_CIP_Subject_Phenotypes.var_report.xml	0.0	410.0	101.8	410.0			410.0		phs000722.v2.p2	Colorectal Neoplasms
			2020/08/19				./data/phs002075.v1.pht010460.v1.p1.Chorioamniotic_Membranes_Sample_Attributes.var_report.xml									phs002075.v1.p1	Placenta Previa
159.0	15790.0		05/24/2016	31020.0		15230.0	./data/phs001065.v1.pht005415.v1.p1.mayolab.var_report.xml	0.0	15510.0	396	164.0			15510.0		phs001065.v1.p1	Huntington Disease
			2021/03/10				./data/phs001619.v3.pht008176.v3.p1.IRD_Sample.var_report.xml									phs001619.v3.p1	Retinal Degeneration
			2018/02/08				./data/phs001488.v1.pht007433.v1.p1.vital.var_report.xml									phs001488.v1.p1	Huntington Disease
			2017/11/14				./data/phs001241.v1.pht005924.v1.p1.Metastatic_Melanomas_Sample_Attributes.var_report.xml									phs001241.v1.p1	Melanoma
			2020/01/16				./data/phs001386.v2.pht006608.v2.p1.Brotman_cross.var_report.xml									phs001386.v2.p1	Smoking
15.0	23.0		2018/06/18	38.0		15.0	./data/phs001594.v1.pht008146.v1.p1.Mucosal_Melanomas_Subject_Phenotypes.var_report.xml	0.0	19.0	5.657	23.0			19.0		phs001594.v1.p1	Melanoma
31.0	5.0		2017/09/05	50.0		8.0	./data/phs000262.v3.pht006261.v1.p2.HMP_Gut_Ulcerative_Colitis_Subject_Phenotypes.var_report.xml	0.0	5.0	13.87	11.0			5.0		phs000262.v3.p2	Pouchitis
			2020/09/17				./data/phs002222.v1.pht010528.v1.p1.Tcells_CNS_Sample_Attributes.var_report.xml									phs002222.v1.p1	Multiple Sclerosis
			08/05/2016				./data/phs000360.v3.pht003256.v2.p1.MergedSet_Sample_Attributes.var_report.xml									phs000360.v3.p1	Electronic Health Records
			2018/10/19				./data/phs000492.v3.pht002707.v3.p2.Developmental_Brain_Disorders_Subject.var_report.xml									phs000492.v3.p2	Microcephaly
			02/27/2015				./data/phs000170.v2.pht000807.v1.p1.Marshfield_Data_BMI.var_report.xml									phs000170.v2.p1	Cataract
17.0	17.0		2018/10/11	32.0		15.0	./data/phs001706.v1.pht008456.v1.p1.MCD_Pedigree.var_report.xml	0.0	16.0	1.414	15.0			16.0		phs001706.v1.p1	Castleman Disease
			11/04/2014				./data/phs000086.v3.pht000361.v1.p1.EDIC_f1452.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/01/30				./data/phs000904.v1.pht004690.v1.p1.Familial_Adenomatous_Polyposis_Sample_Attributes.var_report.xml									phs000904.v1.p1	Familial Adenomatous Polyposis
			04/19/2012				./data/phs000444.v1.pht002702.v1.p1.Italian_Primary_Biliary_Cirrhosis_Sample.var_report.xml									phs000444.v1.p1	Liver Cirrhosis, Biliary
			2020/10/29				./data/phs002258.v1.pht010607.v1.p1.SARS_CoV2_LAMP_RNASeq_Sample_Attributes.var_report.xml									phs002258.v1.p1	COVID-19
32.0	32.0		2020/12/16	48.0		8.0	./data/phs001981.v1.pht010701.v1.p1.Brain_AUD_Subject_Phenotypes.var_report.xml	0.0	24.0	5.657	8.0			24.0		phs001981.v1.p1	Alcoholism
			2019/02/22				./data/phs001739.v1.pht008793.v1.p1.sPTB_Subject.var_report.xml									phs001739.v1.p1	Premature Birth
			07/26/2017				./data/phs001357.v1.pht006698.v1.p1.TSC_Sample.var_report.xml									phs001357.v1.p1	Tuberous Sclerosis
			2021/03/17				./data/phs002048.v2.pht010317.v2.p1.SLE_Sample_Attributes.var_report.xml									phs002048.v2.p1	Lupus Erythematosus, Systemic
			2021/07/21				./data/phs002464.v1.pht011335.v1.p1.Familial_AF_Subject_Phenotypes.var_report.xml									phs002464.v1.p1	Atrial Fibrillation
			08/15/2012				./data/phs000514.v1.pht002840.v1.p1.Familial_Coronary_Artery_Disease_Sample_Attributes.var_report.xml									phs000514.v1.p1	Coronary Artery Disease
28.0			2020/02/27	50.0			./data/phs000452.v3.pht002591.v3.p1.MelanomaCIP_Subject_Phenotypes.var_report.xml	198.0			86.0					phs000452.v3.p1	Melanoma
			2021/05/14				./data/phs001749.v2.pht009318.v2.p1.CAKUT_Sample.var_report.xml									phs001749.v2.p1	Congenital Anomalies Of Kidney And Urinary Tract
			2020/12/21				./data/phs000007.v32.pht006018.v2.p13.vr_chfinit_2013_a_0828s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/07/09				./data/phs001544.v2.pht009899.v1.p1.TOPMed_CCDG_MPP_Sample_Attributes.var_report.xml									phs001544.v2.p1	Atrial Fibrillation
306.0	306.0		2020/09/08	594.0		90.0	./data/phs001110.v3.pht006512.v2.p1.GMKF_CDH_Pedigree.var_report.xml	0.0	99.0	12.73	90.0			99.0		phs001110.v3.p1	Hernias, Diaphragmatic, Congenital
			2020/12/21				./data/phs000007.v32.pht003313.v3.p13.t_mrimcbl_2009_m_0971s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			04/09/2014				./data/phs000201.v2.pht000887.v1.p1.AML_Sample.var_report.xml									phs000201.v2.p1	Leukemia, Myeloid, Acute
			2018/11/19				./data/phs000915.v2.pht004944.v2.p2.mCRPC_SU2C_Subject.var_report.xml									phs000915.v2.p2	Prostatic Neoplasms
4.0	4.0		2017/10/05	6.0		2.0	./data/phs001432.v1.pht006978.v1.p1.Tumor_Heterogeneity_Thoracic_Subject_Phenotypes.var_report.xml	0.0	3.0	1.414	2.0			3.0		phs001432.v1.p1	Adenocarcinoma of lung
			02/23/2017				./data/phs001139.v1.pht006161.v1.p1.GENESiPS_Insulin_Resistance_GEO.var_report.xml									phs001139.v1.p1	Insulin Resistance
			2020/06/18				./data/phs000280.v7.pht004090.v2.p1.FHXA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/04/2014				./data/phs000086.v3.pht000335.v1.p1.EDIC_f0503.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/06/26				./data/phs001526.v1.pht007611.v1.p1.DIPG_Subject.var_report.xml									phs001526.v1.p1	Glioma
			2021/02/22				./data/phs001812.v1.pht009105.v1.p1.Pediatric_Obesity_Asthma_Sample.var_report.xml									phs001812.v1.p1	Asthma
			2020/02/06				./data/phs001430.v2.pht008080.v2.p1.p7001_16189_visioneva.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
7.0	14.0		2017/09/12	21.0		7.0	./data/phs001403.v1.pht006841.v1.p1.NF1_PN_Pedigree.var_report.xml	0.0	10.5	4.95	14.0			10.5		phs001403.v1.p1	Neurofibromatosis Type I
41.0	41.0		05/07/2014	54.0		99.0	./data/phs000738.v1.pht003834.v1.p1.Schizophrenia_Families_Pedigree.var_report.xml	0.0	27.0	7.071	99.0			27.0		phs000738.v1.p1	Schizophrenia
3.0	3.0		2020/09/15	4.0		1.0	./data/phs002234.v1.pht010513.v1.p1.Xq28_Deletion_HH_Subject.var_report.xml	0.0	2.0	1.414	1.0			2.0		phs002234.v1.p1	Hypogonadism
			2018/06/01				./data/phs001317.v1.pht008045.v1.p1.neuropsychologicaltestingtools.var_report.xml									phs001317.v1.p1	Adrenal Hyperplasia, Congenital
1848.0	1848.0		01/16/2015	3557.0		1709.0	./data/phs000763.v1.pht004253.v1.p1.COGA_Family_GWAS_Pedigree.var_report.xml	0.0	1779.0	98.29	1709.0			1779.0		phs000763.v1.p1	Alcoholism
			2019/07/26				./data/phs001705.v1.pht009272.v1.p1.EMBLEM_Sample.var_report.xml									phs001705.v1.p1	Burkitt Lymphoma
			2020/01/10				./data/phs000791.v2.pht004594.v2.p1.Roadmap_Epigenomics_UCSF_Sample_Attributes.var_report.xml									phs000791.v2.p1	Neoplasms
			01/27/2014				./data/phs000674.v1.pht003640.v1.p1.PrincipalComponentsScores.var_report.xml									phs000674.v1.p1	Aging
			2020/12/21				./data/phs000007.v32.pht010731.v1.p13.t_bmdhs_ex02_72_1243s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/12/03				./data/phs001897.v1.pht009541.v1.p1.Peanut_OIT_Sample.var_report.xml									phs001897.v1.p1	Peanut Hypersensitivity
7.0	7.0		2021/07/13	5.0		5.0	./data/phs002481.v1.pht011397.v1.p1.SCA_Pedigree.var_report.xml	0.0	5.0	2.828	3.0			5.0		phs002481.v1.p1	Aneuploidy
			2019/01/04				./data/phs000755.v2.pht004992.v2.p1.BrainSpan_Atlas_Project_Sample.var_report.xml									phs000755.v2.p1	Brain Diseases
			2018/01/29				./data/phs001245.v1.pht005933.v1.p1.CD70_Sample_Attributes.var_report.xml									phs001245.v1.p1	Immunologic Deficiency Syndromes
			10/18/2016				./data/phs000669.v1.pht003733.v1.p1.AMBER_Sample_Attributes.var_report.xml									phs000669.v1.p1	Breast Neoplasms
			2018/02/20				./data/phs001528.v1.pht007503.v1.p1.SCCOHT_GEO.var_report.xml									phs001528.v1.p1	Ovarian Neoplasms
36.0			2018/07/18	51.0			./data/phs001651.v1.pht008235.v1.p1.Lung_SQCC_AppKY_Subject_Phenotypes.var_report.xml	0.0			15.0					phs001651.v1.p1	Lung Neoplasms
			2019/09/27				./data/phs001576.v2.pht008214.v2.p2.P6705_DXA_DATA.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			2017/10/24				./data/phs001352.v1.pht007064.v1.p1.Travelers_Diarrhea_Subject.var_report.xml									phs001352.v1.p1	Diarrhea
			04/12/2010				./data/phs000094.v1.pht001134.v1.p1.Oral_Clefts_Subject_Phenotype.var_report_2010_04_12.xml									phs000094.v1.p1	Cleft Palate
			2020/08/20				./data/phs002069.v1.pht010470.v1.p1.BAVM_Hemorrhage_Sample.var_report.xml									phs002069.v1.p1	Intracranial Arteriovenous Malformations
			2020/12/21				./data/phs000007.v32.pht010734.v1.p13.t_echodop_ex08_1b_0988s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			10/25/2010				./data/phs000021.v3.pht000289.v1.p2.AA_GAIN_phenotype_cases.var_report_2010_10_25.xml									phs000021.v3.p2	Schizophrenia
			01/11/2016				./data/phs000279.v2.pht003003.v1.p1.ESP_Broad_EOMI_Sample_Attributes.var_report.xml									phs000279.v2.p1	Myocardial Infarction
			06/09/2015				./data/phs000718.v1.pht003838.v1.p1.T21NDJ_Subject.var_report.xml									phs000718.v1.p1	Nondisjunction, Genetic
			2018/08/13				./data/phs001535.v1.pht008295.v1.p1.DDP_Sample_Attributes.var_report.xml									phs001535.v1.p1	Diabetes, Gestational
			2017/10/19				./data/phs001448.v1.pht007032.v1.p1.ESCC_Sub_Saharan_Sample_Attributes.var_report.xml									phs001448.v1.p1	Esophageal Neoplasm
			08/20/2013				./data/phs000285.v3.pht001655.v2.p2.C1F07.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/02/25				./data/phs001914.v1.pht009891.v1.p1.MSI_CRC_Sample_Attributes.var_report.xml									phs001914.v1.p1	Colorectal Neoplasms
			2019/09/19				./data/phs001877.v1.pht009481.v1.p1.Mycosis_Fungoides_Subject.var_report.xml									phs001877.v1.p1	Mycosis Fungoides
			08/20/2013				./data/phs000285.v3.pht001768.v1.p2.E1F09MCH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/31/2015				./data/phs000958.v1.pht004957.v1.p1.CSER_MedSeq_Subject.var_report.xml									phs000958.v1.p1	Cardiomyopathies
			06/25/2015				./data/phs000634.v1.pht003832.v1.p1.Lung_Cancer_Never_Smokers_Sample_Attributes.var_report.xml									phs000634.v1.p1	Lung Neoplasms
			11/09/2016				./data/phs001037.v1.pht005918.v1.p1.TEDDY_Sample.var_report.xml									phs001037.v1.p1	Diabetes Mellitus, Type 1
			2019/05/21				./data/phs001090.v1.pht009055.v1.p1.CIDR_OFC_African_Sample_Attributes.var_report.xml									phs001090.v1.p1	Cleft Lip
			05/24/2016				./data/phs001065.v1.pht005401.v1.p1.concl.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/06/07				./data/phs001340.v1.pht009156.v1.p1.RA_Subject_Phenotypes.var_report.xml									phs001340.v1.p1	Arthritis, Rheumatoid
			11/04/2014				./data/phs000086.v3.pht000285.v1.p1.EDIC_neuro_8yr.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			10/06/2011				./data/phs000333.v1.pht002313.v1.p1.FIND_Sample.var_report.xml									phs000333.v1.p1	Diabetes Mellitus
			2020/06/18				./data/phs000280.v7.pht006481.v1.p1.SFE.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/07/26				./data/phs000588.v1.pht009283.v1.p1.angiogram_cerebral.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			04/20/2016				./data/phs000914.v1.pht005254.v1.p1.Samoans_Adiposity_Sample_Attributes.var_report.xml									phs000914.v1.p1	Obesity
			08/20/2015				./data/phs000910.v1.pht004727.v1.p1.T1DGC_CNV_Sample.var_report.xml									phs000910.v1.p1	Diabetes Mellitus, Type 1
			2020/11/24				./data/phs001846.v1.pht010680.v1.p1.GMKF_Cancer_Birth_Defects_Sample.var_report.xml									phs001846.v1.p1	Neoplasms
			2021/02/23				./data/phs002230.v1.pht010965.v1.p1.TSP_Hypertension_Sample_Attributes.var_report.xml									phs002230.v1.p1	Hypertension
			2018/10/15				./data/phs001106.v1.pht007336.v1.p1.Genomics_HCC_Sample.var_report.xml									phs001106.v1.p1	
			01/06/2010				./data/phs000199.v1.pht000891.v1.p1.CHOP_CNV_Subject.var_report_2010_01_06.xml									phs000199.v1.p1	Normalcy
			2021/07/29				./data/phs002437.v1.pht011430.v1.p1.M4OC_PREVENT_Sample.var_report.xml									phs002437.v1.p1	Leukoplakia, Oral
			05/14/2014				./data/phs000684.v1.pht003643.v1.p1.AMD_MMAP_Cohort_Subject.var_report.xml									phs000684.v1.p1	Macular Degeneration
1.0			2018/04/16	5.0			./data/phs000862.v1.pht007836.v1.p1.demographics.var_report.xml	0.0			4.0					phs000862.v1.p1	Mucopolysaccharidosis I
			2019/03/11				./data/phs001717.v1.pht008578.v1.p1.Placental_Regulation_Subject.var_report.xml									phs001717.v1.p1	Control Groups
360.0	360.0		2020/11/19	715.0		355.0	./data/phs002050.v1.pht010357.v1.p1.OICR_CRC_Subject.var_report.xml	0.0	357.5	6.364	355.0			357.5		phs002050.v1.p1	Colorectal Neoplasms
			2020/12/21				./data/phs000007.v32.pht005174.v3.p13.vr_mmse_ex09_1b_0943s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
5.0	7.0		06/04/2014	6.0		5.0	./data/phs000660.v1.pht003509.v1.p1.Chinese_AHC_Pedigree.var_report.xml	0.0	6.0	1.414	7.0			6.0		phs000660.v1.p1	Alternating hemiplegia of childhood
			2019/05/09				./data/phs001284.v1.pht009031.v1.p1.WM_LPL_Subject.var_report.xml									phs001284.v1.p1	Waldenstrom Macroglobulinemia
			2018/07/18				./data/phs001588.v1.pht007960.v1.p1.Low_LDL_EHRs_Subject.var_report.xml									phs001588.v1.p1	Diabetes Mellitus, Type 2
781.0	941.0		2019/11/27	3357.0		781.0	./data/phs001177.v2.pht005666.v2.p1.Familial_Melanoma_Subject_Phenotypes.var_report.xml	0.0	861.0	287.8	941.0			861.0		phs001177.v2.p1	Melanoma, Cutaneous Malignant
			08/26/2013				./data/phs000656.v1.pht003481.v1.p1.Influenza_Vaccination_B_cell_Recall_Sample.var_report.xml									phs000656.v1.p1	Influenza Vaccines
			2020/05/26				./data/phs002020.v1.pht010230.v1.p1.ROP_Sample_Attributes.var_report.xml									phs002020.v1.p1	Retinopathy of Prematurity
			10/24/2012				./data/phs000537.v1.pht003026.v1.p1.Mendelian_fHLH_Sample_Attributes.var_report.xml									phs000537.v1.p1	Lymphohistiocytosis, Hemophagocytic
			10/06/2011				./data/phs000333.v1.pht002312.v1.p1.FIND_Pedigree.var_report.xml									phs000333.v1.p1	Diabetes Mellitus
2.0	2.0		2019/04/09	4.0		2.0	./data/phs001805.v1.pht008956.v1.p1.Neoantigens_NSCLC_Subject_Phenotypes.var_report.xml	0.0	2.0	0	2.0			2.0		phs001805.v1.p1	Adenocarcinoma of Lung
			2017/09/22				./data/phs001392.v1.pht006886.v1.p1.eligibility_screening_form.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			04/22/2014				./data/phs000740.v1.pht003815.v1.p1.Waldenstroms_Macroglobulinemia_Subject.var_report.xml									phs000740.v1.p1	Waldenstrom Macroglobulinemia
			2019/07/29				./data/phs001799.v1.pht008878.v1.p1.Neutrophilic_Leukemias_Sample_Attributes.var_report.xml									phs001799.v1.p1	Leukemia
			2020/06/18				./data/phs000280.v7.pht004055.v2.p1.CNFA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht002749.v1.p3.f151_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/11/14				./data/phs001865.v1.pht009609.v1.p1.AAMP_Subject.var_report.xml									phs001865.v1.p1	
			01/11/2017				./data/phs001242.v1.pht006072.v1.p1.Enhancers_Misregulate_Oncogenes_Sample.var_report.xml									phs001242.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			04/10/2014				./data/phs000306.v4.pht001908.v2.p1.MEC_Prostate_Cancer_Subject.var_report.xml									phs000306.v4.p1	Prostatic Neoplasms
592.0	6525.0		2020/11/13	6489.0		4826.0	./data/phs001584.v2.pht010215.v1.p2.eMERGE_III_HRC_Demographics.var_report.xml	0.0	5452.0	990.7	6525.0			5452.0		phs001584.v2.p2	
			2020/06/18				./data/phs000280.v7.pht006424.v1.p1.CDP.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/05/21				./data/phs002411.v1.pht011240.v1.p1.BRCA1_BRCA2_Sample.var_report.xml									phs002411.v1.p1	Breast
			10/27/2014				./data/phs000727.v1.pht003862.v1.p1.Alzheimers_Parkinsons_Extracellular_miRNA_Subject.var_report.xml									phs000727.v1.p1	Alzheimer Disease
			2020/11/04				./data/phs002062.v1.pht010637.v1.p1.BC_TDLUs_Subject.var_report.xml									phs002062.v1.p1	Breast Neoplasms
			2018/05/07				./data/phs000490.v1.pht002966.v1.p1.Controls_Phenotype.var_report.xml									phs000490.v1.p1	Non-Neoplastic Pediatric Disorder
			2018/05/15				./data/phs001311.v1.pht007918.v1.p1.medical_history_form.var_report.xml									phs001311.v1.p1	Myotonia
			2020/09/18				./data/phs002015.v1.pht010367.v1.p1.AREDS2_CAD.var_report.xml									phs002015.v1.p1	Macular Degeneration
2791.0	2791.0		2021/08/17	5464.0		2673.0	./data/phs001661.v3.pht010558.v2.p1.TOPMed_WGS_GCPD_A_Subject.var_report.xml	0.0	2732.0	83.44	2673.0			2732.0		phs001661.v3.p1	Asthma
			2021/03/24				./data/phs000711.v7.pht003722.v6.p2.BH_CMG_Sample.var_report.xml									phs000711.v7.p2	Mendelian Conditions
			2018/02/08				./data/phs001488.v1.pht007400.v1.p1.inex.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/12/21				./data/phs000007.v32.pht000164.v8.p13.lppla2a1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/21/2016				./data/phs001233.v1.pht005943.v1.p1.Familial_Dysautonomia_Subject.var_report.xml									phs001233.v1.p1	Dysautonomia, Familial
			03/28/2017				./data/phs001249.v1.pht006175.v1.p1.SCLC_Chemoresistance_Subject.var_report.xml									phs001249.v1.p1	Lung Neoplasms
			07/31/2015				./data/phs000957.v1.pht004854.v1.p1.eMERGE_III_MyCode_Subject_Phenotypes.var_report.xml									phs000957.v1.p1	Aortic Aneurysm, Abdominal
			11/13/2015				./data/phs000730.v1.pht005059.v1.p1.Brain_Metastasis_Sample.var_report.xml									phs000730.v1.p1	Neoplasms
			2018/05/01				./data/phs000607.v3.pht003445.v3.p2.Neurodevelopmental_Genomics_Subject_Phenotypes.var_report.xml									phs000607.v3.p2	Mental Processes
			2020/10/27				./data/phs001925.v1.pht010571.v1.p1.MSI_H_Cancers_Sample_Attributes.var_report.xml									phs001925.v1.p1	Microsatellite Instability
1.0	5.0		2020/11/19	6.0		1.0	./data/phs002286.v1.pht010635.v1.p1.HPV16_E7_Subject_Phenotypes.var_report.xml	0.0	3.0	2.828	5.0			3.0		phs002286.v1.p1	Neoplasms
			11/04/2014				./data/phs000086.v3.pht000280.v1.p1.DCCT_hbam.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/06/14				./data/phs001238.v2.pht006651.v1.p1.GENOA_EuropeanAmerican_CKD_Medications.var_report.xml									phs001238.v2.p1	Hypertension
			2020/07/24				./data/phs002063.v1.pht010404.v1.p1.PD_Immunity_Subject.var_report.xml									phs002063.v1.p1	Parkinson Disease
			03/11/2015				./data/phs000691.v2.pht003654.v2.p1.Sickle_Cell_CIP_Sample_Attributes.var_report.xml									phs000691.v2.p1	Anemia, Sickle Cell
	9.0		2021/01/06	94.0		9.0	./data/phs001383.v1.pht010791.v1.p1.Moebius_Syndrome_Pedigree.var_report.xml	0.0	92.0	7.778				92.0		phs001383.v1.p1	Mobius Syndrome
			08/18/2011				./data/phs000302.v1.pht002176.v1.p1.T2D_Proteinuria_Subject.var_report.xml									phs000302.v1.p1	Diabetic Nephropathies
			2017/09/22				./data/phs001392.v1.pht006899.v1.p1.pidtc_17607_baselinea.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2021/02/23				./data/phs002230.v1.pht010961.v1.p1.TSP_Hypertension_Subject.var_report.xml									phs002230.v1.p1	Hypertension
			2020/04/06				./data/phs002003.v1.pht010106.v1.p1.Single_Cell_Atlas_Subject.var_report.xml									phs002003.v1.p1	Human Development
1853.0	2146.0		2020/11/09	3999.0		9210.0	./data/phs000976.v2.pht005684.v2.p1.CIDR_COGA_AA_Family_Pedigree.var_report.xml	0.0	9952.0	207.2	9210.0			9952.0		phs000976.v2.p1	Alcoholism
			2019/03/28				./data/phs001794.v1.pht008904.v1.p1.BWS_miRNA_Sample.var_report.xml									phs001794.v1.p1	Beckwith-Wiedemann Syndrome
			2018/04/16				./data/phs001326.v1.pht007814.v1.p1.p6902_17529_day0hcttr.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2020/06/18				./data/phs000280.v7.pht004031.v2.p1.AMHA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			02/29/2016				./data/phs000990.v1.pht004996.v1.p1.MIGen_Lubeck_Subject.var_report.xml									phs000990.v1.p1	Myocardial Infarction
			2018/09/19				./data/phs001684.v1.pht008390.v1.p1.Pulmonary_Fluid_Immunocompromised_Sample.var_report.xml									phs001684.v1.p1	Immunocompromised Host
			2021/08/26				./data/phs001732.v2.pht010140.v1.p1.TOPMed_WGS_CARE_TREXA_Sample.var_report.xml									phs001732.v2.p1	Asthma
			06/22/2017				./data/phs001250.v1.pht006326.v1.p1.Primary_Breast_Cancers_Sample.var_report.xml									phs001250.v1.p1	Breast Neoplasms
			11/16/2012				./data/phs000413.v2.pht002733.v2.p1.AML_FABM7_Sample.var_report.xml									phs000413.v2.p1	Acute Megakaryoblastic Leukemia
			2019/11/08				./data/phs001332.v2.pht007458.v2.p1.p7301_12625_neurologi.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			2017/10/11				./data/phs000578.v1.pht007011.v1.p1.inqol.var_report.xml									phs000578.v1.p1	Nondystrophic myotonia
			2017/11/06				./data/phs001391.v1.pht007080.v1.p1.OncoArray_Prostate_Cancer_Subject_Phenotypes.var_report.xml									phs001391.v1.p1	Prostatic Neoplasms
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001804.v2.p2.E1REF.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
4.0	2597.0		05/24/2016	3388.0		791.0	./data/phs001065.v1.pht005397.v1.p1.auslab.var_report.xml	173.0	1694.0	1277	12.0			1694.0		phs001065.v1.p1	Huntington Disease
			2019/08/01				./data/phs000222.v6.pht002876.v3.p2.Psychiatric_C.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/02/06				./data/phs001430.v2.pht008076.v2.p1.p7001_16339_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
469.0	583.0		2020/02/04	4793.0		469.0	./data/phs001723.v1.pht009727.v1.p1.IBDGC_Repo_EC_Subject_Phenotypes.var_report.xml	0.0	526.0	80.61	583.0			526.0		phs001723.v1.p1	Inflammatory Bowel Disease
232.0			2021/05/04	415.0			./data/phs002317.v1.pht011165.v1.p1.ALL_Bone_Toxicities_Subject_Phenotypes.var_report.xml	0.0			183.0					phs002317.v1.p1	Fractures, Bone
500.0	500.0		09/03/2009	813.0		313.0	./data/phs000166.v2.pht000700.v1.p1.CAMP_CData.var_report_2009_09_03.xml	0.0	406.5	132.2	313.0			406.5		phs000166.v2.p1	Asthma
4063.0	4063.0		08/20/2015	8005.0		3942.0	./data/phs000910.v1.pht004728.v1.p1.T1DGC_CNV_Subject_Phenotypes.var_report.xml	0.0	4003.0	85.56	3942.0			4003.0		phs000910.v1.p1	Diabetes Mellitus, Type 1
			08/31/2012				./data/phs000451.v1.pht002940.v1.p1.NECS_Sample_Attributes.var_report.xml									phs000451.v1.p1	Centenarian
9564.0	12137.0		2018/03/15	21701.0		9564.0	./data/phs001516.v1.pht007493.v1.p1.PheRS_eMERGE_Subject_Phenotypes.var_report.xml	0.0	10851.0	1819	12137.0			10851.0		phs001516.v1.p1	Genetic Diseases, Inborn
			2018/11/26				./data/phs001686.v1.pht008564.v1.p1.IL17_PD_Sample.var_report.xml									phs001686.v1.p1	Parkinson Disease
			Thu Jan 17 21:45:39 2008				./data/phs000019.v1.pht000064.v1.p1.controls.var_report_2008_08_12.xml									phs000019.v1.p1	Psoriasis
			04/05/2017				./data/phs000927.v1.pht004752.v1.p1.CSER_Carrier_Testing_Sample.var_report.xml									phs000927.v1.p1	
			08/17/2012				./data/phs000359.v1.pht002903.v1.p1.Hereditary_Spastic_Paraparesis_Sample_Attributes.var_report.xml									phs000359.v1.p1	Hereditary Spastic Paraplegias
			2021/08/13				./data/phs002486.v1.pht011471.v1.p1.Nivolumab_TIL_NSCLC_Subject_Phenotypes.var_report.xml									phs002486.v1.p1	Carcinoma, Non-Small-Cell Lung
			08/20/2013				./data/phs000285.v3.pht001661.v1.p2.C1F09MHM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/23/2011				./data/phs000290.v1.pht002275.v1.p1.PAH_Sample.var_report.xml									phs000290.v1.p1	Hypertension, Pulmonary
			04/24/2012				./data/phs000447.v1.pht002579.v1.p1.Prostate_CIP_Subject.var_report.xml									phs000447.v1.p1	Prostatic Neoplasms
			2020/08/05				./data/phs001815.v1.pht009010.v1.p1.MHGRID_Sample.var_report.xml									phs001815.v1.p1	Hypertension
			2019/12/06				./data/phs001861.v1.pht009325.v1.p1.sc_UM_Sample_Attributes.var_report.xml									phs001861.v1.p1	Uveal melanoma
			2020/09/29				./data/phs002225.v1.pht010484.v1.p1.HTAN_MCL_PCAPP_Breast_CA_Subject_Phenotypes.var_report.xml									phs002225.v1.p1	Carcinoma, Intraductal, Noninfiltrating
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000597.v2.p3.simphen198.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2019/08/18				./data/phs001201.v2.pht007556.v1.p1.QPCR.var_report.xml									phs001201.v2.p1	Respiratory Syncytial Virus Infections
			2020/12/22				./data/phs001980.v1.pht010076.v1.p1.UTPDTC_PDX_Sample.var_report.xml									phs001980.v1.p1	Lung Neoplasms
			2020/02/05				./data/phs001957.v1.pht009838.v1.p1.DNA_Replication_Timing_Subject.var_report.xml									phs001957.v1.p1	
2.0	2.0		01/18/2013	4.0		1.0	./data/phs000550.v1.pht003129.v1.p1.Pancreatic_Adenocarcinoma_Subject_Phenotypes.var_report.xml	0.0	1.3330000000000002	0.5774	1.0			1.0		phs000550.v1.p1	Pancreatic Neoplasms
			2020/08/24				./data/phs001501.v1.pht007228.v1.p1.Race_Genetics_BetaBlocker_Sample_Attributes.var_report.xml									phs001501.v1.p1	Heart Failure
			08/20/2013				./data/phs000285.v3.pht001841.v2.p2.F1F69.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/12/26				./data/phs001889.v1.pht009739.v1.p1.ALS_TDP_GEO.var_report.xml									phs001889.v1.p1	Amyotrophic Lateral Sclerosis
			04/16/2012				./data/phs000475.v1.pht002692.v1.p1.Inherited_Reproductive_Disorders_Sample_Attributes.var_report.xml									phs000475.v1.p1	Hypogonadism 
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000534.v2.p3.simphen135.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/03/26				./data/phs000697.v1.pht007701.v1.p1.deathrecord.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
			2020/01/21				./data/phs001936.v1.pht009646.v1.p1.Gastric_Cancer_BDI_Subject.var_report.xml									phs001936.v1.p1	Gastrointestinal Neoplasms
31.0	31.0		12/20/2016	93.0		3.0	./data/phs000768.v2.pht004479.v2.p1.Pediatric_Ewing_Sarcoma_Subject_Phenotypes.var_report.xml	0.0	18.6	13.43	22.0			22.0		phs000768.v2.p1	Sarcoma, Ewing
			2017/09/12				./data/phs001403.v1.pht006840.v1.p1.NF1_PN_Subject.var_report.xml									phs001403.v1.p1	Neurofibromatosis Type I
			2020/06/09				./data/phs002036.v1.pht010277.v1.p1.Chromoanasynthesis_JBS_Sample_Attributes.var_report.xml									phs002036.v1.p1	Jacobsen Distal 11q Deletion Syndrome
			08/13/2015				./data/phs000415.v1.pht002411.v1.p1.CIDR_Tourette_Syndrome_Subject.var_report.xml									phs000415.v1.p1	Tourette Syndrome
5.0			05/02/2014	7.0			./data/phs000739.v1.pht003827.v1.p1.Ameloblastoma_Mutations_Subject_Phenotypes.var_report.xml	0.0			2.0					phs000739.v1.p1	Ameloblastoma
			2020/03/09				./data/phs001266.v2.pht007220.v1.p1.Addiction_Susceptibility_Genes_Subject.var_report.xml									phs001266.v2.p1	Opioid-Related Disorders
			2019/04/04				./data/phs001803.v1.pht008938.v1.p1.Dystonias_Sample.var_report.xml									phs001803.v1.p1	Cervical Dystonia
3.0	3.0		2020/02/06	6.0		3.0	./data/phs001935.v1.pht009769.v1.p1.GAPPS_Subject_Phenotypes.var_report.xml	0.0	3.0	0.7071	3.0			3.0		phs001935.v1.p1	Stomach Neoplasms
			04/10/2015				./data/phs000900.v1.pht004651.v1.p1.DIPG_Subject.var_report.xml									phs000900.v1.p1	Glioma
			2019/08/01				./data/phs000222.v6.pht003449.v2.p2.lh_aparc_a2009s_area.var_report.xml									phs000222.v6.p2	Huntington Disease
			2019/07/03				./data/phs001850.v1.pht009237.v1.p1.Subtype_SLE_Subject_Phenotypes.var_report.xml									phs001850.v1.p1	Lupus Erythematosus, Systemic
			11/08/2013				./data/phs000200.v9.pht002756.v1.p3.outc_bc_cad_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			04/22/2014				./data/phs000740.v1.pht003816.v1.p1.Waldenstroms_Macroglobulinemia_Sample.var_report.xml									phs000740.v1.p1	Waldenstrom Macroglobulinemia
			09/21/2016				./data/phs000984.v1.pht005702.v1.p1.T2DM_Metformin_HbA1c.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
			2019/06/28				./data/phs001851.v1.pht009223.v1.p1.LEAP_Sample.var_report.xml									phs001851.v1.p1	Peanut Hypersensitivity
			2021/10/06				./data/phs002276.v1.pht011554.v1.p1.GMKF_T_ALL_Subject.var_report.xml									phs002276.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			05/24/2016				./data/phs001065.v1.pht005408.v1.p1.dosebyday.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/10/11				./data/phs001380.v1.pht009230.v1.p1.TS_GWAS1_Sample_Attributes.var_report.xml									phs001380.v1.p1	Tourette Syndrome
			06/16/2017				./data/phs001278.v1.pht006270.v1.p1.lab_results.var_report.xml									phs001278.v1.p1	Porphyrias
5.0	8.0		2020/06/10	6.0		5.0	./data/phs002039.v1.pht010271.v1.p1.IAV_IBV_Subject_Phenotypes.var_report.xml	0.0	9.0	5.657	8.0			9.0		phs002039.v1.p1	Influenza, Human
260.0	293.0		2018/02/08	553.0		260.0	./data/phs001488.v1.pht007418.v1.p1.randomized.var_report.xml	0.0	276.5	23.33	293.0			276.5		phs001488.v1.p1	Huntington Disease
			03/23/2016				./data/phs000822.v1.pht005135.v1.p1.Breast_Cancer_Predisposing_Mutations_Sample_Attributes.var_report.xml									phs000822.v1.p1	Breast Neoplasms
			2021/08/19				./data/phs001662.v2.pht010067.v1.p1.LTRC_R040_subject_environ_quest.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2021/07/14				./data/phs002484.v1.pht011401.v1.p1.Aging_Lungs_GEO.var_report.xml									phs002484.v1.p1	Lung
			05/24/2016				./data/phs001065.v1.pht005430.v1.p1.uhdr1.var_report.xml									phs001065.v1.p1	Huntington Disease
			08/12/2016				./data/phs000888.v1.pht004679.v1.p1.EMERGEII_LABS_MERGED.var_report.xml									phs000888.v1.p1	
			2018/05/22				./data/phs001595.v1.pht007993.v1.p1.ARD_6103_Subject.var_report.xml									phs001595.v1.p1	Hypotension, Orthostatic
			2020/12/21				./data/phs000007.v32.pht001182.v8.p13.t_bmdhs_2009_3_0627s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/07				./data/phs001710.v1.pht011293.v1.p1.TOAA_Sample_Attributes.var_report.xml									phs001710.v1.p1	
			01/13/2017				./data/phs000743.v1.pht004822.v1.p1.METSIM_Sample.var_report.xml									phs000743.v1.p1	Metabolic Syndrome X
947.0	356.0		08/20/2013	511.0		3.0	./data/phs000285.v3.pht001576.v2.p2.A4F13.var_report.xml	0.0	170.3	177.2	896.0			152.0		phs000285.v3.p2	Cardiovascular Diseases
290.0	352.0		2021/09/29	642.0		290.0	./data/phs001608.v2.pht009735.v1.p1.TOPMed_WGS_OMG_SCD_Subject_Phenotypes.var_report.xml	0.0	321.0	43.84	352.0			321.0		phs001608.v2.p1	Anemia, Sickle Cell
			2018/07/18				./data/phs001645.v1.pht008210.v1.p1.Cutaneous_DLBCL_Sample.var_report.xml									phs001645.v1.p1	Lymphoma, Large B-Cell, Diffuse
6076.0	6076.0		2020/02/19	6076.0		6076.0	./data/phs001221.v1.pht007161.v1.p1.Prostate_Cancer_GWAS_Subject_Phenotypes.var_report.xml	0.0	6076.0					6076.0		phs001221.v1.p1	Prostatic Neoplasms
			2017/08/16				./data/phs001055.v1.pht005911.v1.p1.DeNovo_Mutation_Rates_Subject.var_report.xml									phs001055.v1.p1	Preterm Birth
291.0	291.0		03/11/2015	651.0		163.0	./data/phs000691.v2.pht003653.v2.p1.Sickle_Cell_CIP_Subject_Phenotypes.var_report.xml	0.0	217.0	66.3	197.0			197.0		phs000691.v2.p1	Anemia, Sickle Cell
			2019/08/30				./data/phs001331.v2.pht009415.v1.p1.p6501_20282_sclerosis.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			06/13/2014				./data/phs000687.v1.pht003696.v1.p1.Schizophrenia_De_Novo_Mutations_Sample_Attributes.var_report.xml									phs000687.v1.p1	Schizophrenia
			07/18/2014				./data/phs000775.v1.pht003944.v1.p1.Molecular_Genetics_Schizophrenia_Sample.var_report.xml									phs000775.v1.p1	Schizophrenia
			06/14/2016				./data/phs001127.v1.pht005525.v1.p1.Endometrial_Cancer_Primaries_Metastases_Subject.var_report.xml									phs001127.v1.p1	Endometrial Neoplasms
			2020/02/05				./data/phs001957.v1.pht009839.v1.p1.DNA_Replication_Timing_Sample.var_report.xml									phs001957.v1.p1	
			2018/04/16				./data/phs001289.v1.pht007785.v1.p1.aprtrs_episodereport.var_report.xml									phs001289.v1.p1	Andersen Syndrome
			2020/11/13				./data/phs002019.v1.pht010172.v1.p1.SCCIS_Subject.var_report.xml									phs002019.v1.p1	Carcinoma in Situ
199.0	224.0		04/17/2017	423.0		199.0	./data/phs000816.v2.pht004341.v2.p1.X_Chromosome_Inactivation_Pedigree.var_report.xml	0.0	211.5	17.68	224.0			211.5		phs000816.v2.p1	X Chromosome Inactivation
			2020/12/16				./data/phs001981.v1.pht010700.v1.p1.Brain_AUD_Sample.var_report.xml									phs001981.v1.p1	Alcoholism
			2017/10/10				./data/phs001372.v1.pht006532.v1.p1.CLL_Integrated_Single_Cell_Subject.var_report.xml									phs001372.v1.p1	Leukemia, Lymphoid
			2020/06/18				./data/phs000280.v7.pht004213.v2.p1.UBME4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/06/30				./data/phs002045.v1.pht010310.v1.p1.PDAC_Sample_Attributes.var_report.xml									phs002045.v1.p1	Carcinoma, Pancreatic Ductal
			01/29/2015				./data/phs000737.v1.pht004443.v1.p1.Metabolic_Syndrome_Hvar_Islanders_Subject.var_report.xml									phs000737.v1.p1	Metabolic Syndrome X
			06/12/2017				./data/phs000594.v1.pht006491.v1.p1._12_Lead_EKG.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
			08/04/2015				./data/phs000926.v1.pht004866.v1.p1.Crohn_Disease_Childhood_Onset_Sample.var_report.xml									phs000926.v1.p1	Crohn Disease
			2021/07/06				./data/phs002462.v1.pht011369.v1.p1.NEPC_Subject_Phenotypes.var_report.xml									phs002462.v1.p1	Prostatic Neoplasms
			2018/03/09				./data/phs000783.v2.pht004280.v2.p1.CDH_Sample.var_report.xml									phs000783.v2.p1	Hernias, Diaphragmatic, Congenital
			08/31/2015				./data/phs000958.v1.pht004960.v1.p1.CSER_MedSeq_Sample_Attributes.var_report.xml									phs000958.v1.p1	Cardiomyopathies
			2018/04/20				./data/phs001572.v1.pht007840.v1.p1.PD_1_Immunotherapy_Sample.var_report.xml									phs001572.v1.p1	Neoplasms
			12/18/2014				./data/phs000794.v1.pht004308.v1.p1.Longitudinal_CLL_Subject.var_report.xml									phs000794.v1.p1	Chronic Lymphocytic Leukemia
			12/11/2009				./data/phs000171.v1.pht000779.v1.p1.MS_DATA_MSHIST2.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2017/09/22				./data/phs001394.v1.pht006950.v1.p1.GUARDIAN_HTN_IR_Sample_Attributes.var_report.xml									phs001394.v1.p1	Hypertension
			06/04/2014				./data/phs000660.v1.pht003512.v1.p1.Chinese_AHC_Sample_Attributes.var_report.xml									phs000660.v1.p1	Alternating hemiplegia of childhood
			2021/07/14				./data/phs001546.v2.pht009972.v1.p1.TOPMed_WGS_DECAF_Subject.var_report.xml									phs001546.v2.p1	Atrial Fibrillation
			2021/03/23				./data/phs001122.v1.pht008639.v1.p1.Neonatal_Brain_Sample.var_report.xml									phs001122.v1.p1	Brain
			10/25/2013				./data/phs000671.v1.pht003547.v1.p1.Hairy_Cell_Leukemia_Sample.var_report.xml									phs000671.v1.p1	Leukemia, Hairy Cell
			2019/10/11				./data/phs001406.v1.pht007752.v1.p1.sleep_pvt_ds.var_report.xml									phs001406.v1.p1	Cognition
			03/06/2017				./data/phs000574.v1.pht005859.v1.p1.clinicalcriteria.var_report.xml									phs000574.v1.p1	Rett Syndrome
			2019/06/13				./data/phs001840.v1.pht009146.v1.p1.PDAC_CAFs_Subject.var_report.xml									phs001840.v1.p1	Carcinoma, Pancreatic Ductal
			2020/11/19				./data/phs002202.v1.pht010548.v1.p1.Heterochromatin_Structure_Sample.var_report.xml									phs002202.v1.p1	Healthy Volunteers
			2019/05/30				./data/phs001222.v1.pht005908.v1.p1.CCDG_T1DGC_Sample.var_report.xml									phs001222.v1.p1	Diabetes Mellitus, Type 1
			09/27/2010	1.0			./data/phs000245.v1.pht001915.v1.p1.Triple_Negative_Breast_Cancer_Subject_Phenotypes.var_report_2010_09_27.xml	0.0			1.0					phs000245.v1.p1	Breast Neoplasms
3.0	5.0		2021/09/08	8.0		3.0	./data/phs001735.v2.pht009980.v2.p1.TOPMed_WGS_PCGC_Subject.var_report.xml	0.0	4.0	1322	5.0			4.0		phs001735.v2.p1	Heart Defects, Congenital
106.0			2021/04/28	106.0			./data/phs001500.v2.pht007246.v2.p1.Melanocyte_QTL_Subject_Phenotypes.var_report.xml	0.0								phs001500.v2.p1	Melanocytes
			2020/05/01				./data/phs001890.v1.pht009547.v1.p1.CIViC_smMIPs_Sample_Attributes.var_report.xml									phs001890.v1.p1	
			2020/08/05				./data/phs002053.v1.pht010447.v1.p1.Pazopanib_RCC_Sample.var_report.xml									phs002053.v1.p1	Carcinoma, Renal Cell
			2021/02/12				./data/phs002334.v1.pht010960.v1.p1.EGFR_Driven_LUAD_Sample_Attributes.var_report.xml									phs002334.v1.p1	Adenocarcinoma, Lung
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000529.v2.p3.simphen130.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004134.v2.p1.MSRCOD36.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/11/13				./data/phs001013.v3.pht005312.v2.p2.HVH_Sample_Attributes.var_report.xml									phs001013.v3.p2	Cardiovascular Disease
			11/25/2013				./data/phs000661.v1.pht003540.v1.p1.Aggressive_Prostate_Carcinoma_Subject_Phenotypes.var_report.xml									phs000661.v1.p1	Neoplasms
4.0	4.0		2018/02/28	8.0		4.0	./data/phs001001.v1.pht007525.v1.p1.MGH_AF_Pedigree.var_report.xml	0.0	4.0	0	4.0			4.0		phs001001.v1.p1	Atrial Fibrillation
			2020/12/21				./data/phs000007.v32.pht000295.v5.p13.mcarpel_98s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/06/18				./data/phs001594.v1.pht008144.v1.p1.Mucosal_Melanomas_Subject.var_report.xml									phs001594.v1.p1	Melanoma
12.0			2018/04/16	45.0			./data/phs001289.v1.pht007798.v1.p1.sf_36.var_report.xml	1.0			11.0					phs001289.v1.p1	Andersen Syndrome
			2017/09/05				./data/phs000262.v3.pht006262.v1.p2.HMP_Gut_Ulcerative_Colitis_Sample_Attributes.var_report.xml									phs000262.v3.p2	Pouchitis
			2020/01/23				./data/phs000287.v7.pht001481.v1.p1.YR14PH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
10.0			2018/03/30	46.0			./data/phs001108.v1.pht007715.v1.p1.medical_records_form.var_report.xml	0.0			36.0					phs001108.v1.p1	Urea Cycle Disorders, Inborn
11.0	11.0		2020/02/19	15.0		4.0	./data/phs001853.v1.pht009812.v1.p1.GI_Malignancies_Subject_Phenotypes.var_report.xml	0.0	7.5	4.95	4.0			7.5		phs001853.v1.p1	Colorectal Neoplasms
			2018/06/01				./data/phs001538.v1.pht008095.v1.p1.Registry_PtsItems.var_report.xml									phs001538.v1.p1	Mitochondrial Diseases
			2018/08/03				./data/phs000590.v1.pht008280.v1.p1.pan_baseline_med_hx_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2017/11/14				./data/phs001241.v1.pht005921.v1.p1.Metastatic_Melanomas_Subject.var_report.xml									phs001241.v1.p1	Melanoma
			2018/05/31				./data/phs001316.v1.pht008011.v1.p1.p5305_12534_trial2sta.var_report.xml									phs001316.v1.p1	Andersen Syndrome
177.0			2020/02/14	390.0			./data/phs000575.v2.pht005890.v2.p1.demogrphicanddx.var_report.xml	0.0			213.0					phs000575.v2.p1	Prader-Willi Syndrome
			2018/01/11				./data/phs001421.v1.pht007027.v1.p1.Uveal_Melanoma_Pathogenesis_Subject_Phenotypes.var_report.xml									phs001421.v1.p1	Uveal melanoma
			2020/06/18				./data/phs000280.v7.pht004180.v2.p1.RTASWF42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000575.v2.p3.simphen176.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/03/2011				./data/phs000259.v2.pht001246.v2.p1.HMP_Urethral_Males_STI_Data.var_report.xml									phs000259.v2.p1	Urethritis
			04/25/2014				./data/phs000587.v1.pht003520.v1.p1.ESP_Family_Studies_MLD_Sample_Attributes.var_report.xml									phs000587.v1.p1	Hyperlipoproteinemia Type II
			2021/10/07				./data/phs001918.v2.pht010047.v1.p1.STAMPEED_HCT_Subject.var_report.xml									phs001918.v2.p1	Graft vs Host Disease
			09/24/2013				./data/phs000364.v2.pht002260.v2.p1.ChronicLymphocyticLeukemia_Subject.var_report.xml									phs000364.v2.p1	Chronic Lymphocytic Leukemia
			2019/05/09				./data/phs001284.v1.pht009032.v1.p1.WM_LPL_Sample.var_report.xml									phs001284.v1.p1	Waldenstrom Macroglobulinemia
9.0	84.0		2019/09/16	9172.0		9.0	./data/phs001123.v2.pht006061.v2.p1.CAAPA_Subject_Phenotypes.var_report.xml	0.0	79.5	9.192	84.0			79.5		phs001123.v2.p1	Asthma
			2020/06/18				./data/phs000280.v7.pht004157.v2.p1.RIAA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/10/04				./data/phs001270.v1.pht006253.v1.p1.SACDS_IGHNSS_Sample_Attributes.var_report.xml									phs001270.v1.p1	Sleep Wake Disorders
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000468.v2.p3.simphen069.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/12/2013				./data/phs000600.v1.pht003240.v1.p1.Cervical_Cancer_Sample_Attributes.var_report.xml									phs000600.v1.p1	Uterine Cervical Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000563.v2.p3.simphen164.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2017/12/19				./data/phs001438.v1.pht006820.v1.p1.Cortical_Neurogenesis_Open_Chromatin_Subject_Phenotypes.var_report.xml									phs001438.v1.p1	Chromatin
			2020/03/26				./data/phs001929.v1.pht010014.v1.p1.Neurogenetics_OCD_Sample.var_report.xml									phs001929.v1.p1	Obsessive-Compulsive Disorder
			2020/08/17				./data/phs000397.v3.pht002407.v3.p3.LLFS_Subject.var_report.xml									phs000397.v3.p3	Longevity
			11/08/2013				./data/phs000200.v9.pht002752.v2.p3.f154_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			07/27/2017	123.0			./data/phs000596.v1.pht006712.v1.p1.demographic_form.var_report.xml	340.0								phs000596.v1.p1	Primary ciliary dyskinesia
327.0	465.0		2021/07/02	792.0		327.0	./data/phs001782.v2.pht008798.v2.p1.LOI_Stunting_Malian_Pedigree.var_report.xml	0.0	396.0	97.58	465.0			396.0		phs001782.v2.p1	Growth
			03/06/2017				./data/phs000574.v1.pht005863.v1.p1.currenthistory.var_report.xml									phs000574.v1.p1	Rett Syndrome
			10/28/2011				./data/phs000352.v1.pht002287.v1.p1.Retinoblastoma_Sample_Attributes.var_report.xml									phs000352.v1.p1	Retinoblastoma
5.0	5.0		2018/11/05	9.0		4.0	./data/phs000507.v2.pht002927.v2.p2.BEN_Pedigree.var_report.xml	0.0	4.5	0.7071	4.0			4.5		phs000507.v2.p2	Neutropenia
			2017/11/01				./data/phs001305.v1.pht007103.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			2021/08/13				./data/phs001442.v3.pht010299.v1.p2.TEDDY_Cohort_casecntrl_ialist1.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			2020/06/18				./data/phs000280.v7.pht004216.v2.p1.UBMEWF4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/03/27				./data/phs001195.v1.pht006862.v1.p1.Atomoxetine_Methamphetamine_Sample_Attributes.var_report.xml									phs001195.v1.p1	Sex/Gender Identity
			2020/12/21				./data/phs000007.v32.pht000207.v7.p13.t_obsper_2005_m_0162s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/13/2014				./data/phs000658.v1.pht003498.v1.p1.MDD2000AFFY_Subject_Phenotypes.var_report.xml									phs000658.v1.p1	Depressive Disorder, Major
			08/20/2013				./data/phs000285.v3.pht001778.v2.p2.E1F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
6.0	6.0		2020/04/27	8.0		2.0	./data/phs002002.v1.pht010191.v1.p1.ILCs_HNSCC_Subject_Phenotypes.var_report.xml	0.0	4.0	2.828	2.0			4.0		phs002002.v1.p1	Squamous Cell Carcinoma of the Head and Neck
			08/26/2015				./data/phs000948.v1.pht004849.v1.p1.eMERGE_PhaseII_Sample.var_report.xml									phs000948.v1.p1	
			2019/03/25				./data/phs001628.v1.pht008864.v1.p1.AML_Crenolanib_Sample.var_report.xml									phs001628.v1.p1	Leukemia, Myeloid, Acute
			08/20/2013				./data/phs000285.v3.pht001663.v2.p2.C1F09PER.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/11/06				./data/phs001391.v1.pht007081.v1.p1.OncoArray_Prostate_Cancer_Sample_Attributes.var_report.xml									phs001391.v1.p1	Prostatic Neoplasms
13.0	13.0		2020/10/21	16.0		3.0	./data/phs001942.v1.pht010587.v1.p1.Histiocytic_Dendritic_Sarcoma_Subject_Phenotypes.var_report.xml	0.0	8.0	7.071	3.0			8.0		phs001942.v1.p1	Histiocytic Sarcoma
			01/29/2015				./data/phs000737.v1.pht004447.v1.p1.Metabolic_Syndrome_Hvar_Islanders_Sample_Attributes.var_report.xml									phs000737.v1.p1	Metabolic Syndrome X
			2020/12/21				./data/phs000007.v32.pht010746.v1.p13.t_tonla_ex09_1b_1233s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004169.v2.p1.RTABM25.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/05/13				./data/phs001811.v1.pht009061.v1.p1.Early_Lung_ADC_Sample.var_report.xml									phs001811.v1.p1	Adenocarcinoma of Lung
			2017/08/02				./data/phs001384.v1.pht006739.v1.p1.Polyp_To_Cancer_Subject.var_report.xml									phs001384.v1.p1	Colorectal Neoplasms
			08/20/2013				./data/phs000285.v3.pht001842.v2.p2.F1F9PRG1.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001587.v2.p2.A4INS.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
5.0	5.0		05/02/2012	9.0		4.0	./data/phs000456.v1.pht002641.v1.p1.RACE_Pedigree.var_report.xml	0.0	4.5	0.7071	4.0			4.5		phs000456.v1.p1	Stroke
			12/11/2009				./data/phs000171.v1.pht000760.v1.p1.MS_DATA_LAB.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			08/20/2013				./data/phs000285.v3.pht001687.v2.p2.C1F42C.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/05/03				./data/phs001587.v1.pht007885.v1.p1.Prostate_Cancer_Organoids_GEO.var_report.xml									phs001587.v1.p1	Prostatic Neoplasms
1.0	10.0		2017/08/25	11.0		1.0	./data/phs001407.v1.pht006831.v1.p1.HNPCC_Subject_Phenotypes.var_report.xml	0.0	5.5	6.364	10.0			5.5		phs001407.v1.p1	Lynch syndrome I
			2020/03/19				./data/phs001979.v1.pht009999.v1.p1.Skin_SingleCell_Subject.var_report.xml									phs001979.v1.p1	Melanoma
			2020/10/21				./data/phs001942.v1.pht010585.v1.p1.Histiocytic_Dendritic_Sarcoma_Subject.var_report.xml									phs001942.v1.p1	Histiocytic Sarcoma
			2020/05/05				./data/phs001360.v1.pht006294.v1.p1.CLEAR_Sample.var_report.xml									phs001360.v1.p1	Arthritis, Rheumatoid
			2021/09/14				./data/phs002545.v1.pht011486.v1.p1.MSS_CRC_PDAC_Subject_Phenotypes.var_report.xml									phs002545.v1.p1	Immunotherapy
			2020/12/21				./data/phs000007.v32.pht000086.v3.p13.fib0_21s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			07/05/2016				./data/phs001097.v1.pht005614.v1.p1.T2D_GENES_Singapore_Asian_Subject.var_report.xml									phs001097.v1.p1	Diabetes Mellitus, Type 2
			04/16/2012				./data/phs000485.v1.pht002680.v1.p1.Congenital_Diaphragmatic_Hernia_Sample_Attributes.var_report.xml									phs000485.v1.p1	Congenital diaphragmatic hernia
			09/11/2014				./data/phs000795.v1.pht004012.v1.p1.Gastric_Cancer_Metastasis_Subject.var_report.xml									phs000795.v1.p1	Stomach Neoplasms
			2021/04/09				./data/phs002316.v1.pht011111.v1.p1.TEA_seq_GEO.var_report.xml									phs002316.v1.p1	
			2020/12/16				./data/phs001981.v1.pht010702.v1.p1.Brain_AUD_Sample_Attributes.var_report.xml									phs001981.v1.p1	Alcoholism
			2018/03/23				./data/phs000698.v1.pht007684.v1.p1.eligibility_checklist.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
1.0			2018/05/17	5.0			./data/phs001313.v1.pht007973.v1.p1.demographics.var_report.xml	0.0			4.0					phs001313.v1.p1	Adrenal Hyperplasia, Congenital
			2020/06/18				./data/phs000280.v7.pht004235.v2.p1.VENA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005561.v1.p1.10aAtopic_dermatitis_hx_visits.var_report.xml									phs000888.v1.p1	
			2019/03/27				./data/phs001670.v1.pht008879.v1.p1.DeKAF_Tac_AA_EA_Subject.var_report.xml									phs001670.v1.p1	Tacrolimus
209.0	209.0		2021/01/08	401.0		192.0	./data/phs000649.v2.pht008341.v1.p2.PEAR2.var_report.xml	0.0	200.5	12.02	192.0			200.5		phs000649.v2.p2	Hypertension
			11/04/2013				./data/phs000579.v1.pht003277.v1.p1.SmallBowelNeuroendocrineTumors_Subject.var_report.xml									phs000579.v1.p1	Intestinal Neoplasms
			2020/07/24				./data/phs002063.v1.pht010407.v1.p1.PD_Immunity_Sample_Attributes.var_report.xml									phs002063.v1.p1	Parkinson Disease
			06/19/2017				./data/phs001381.v1.pht006569.v1.p1.Gut_Microbiome_Colorectal_Polyps_Sample_Attributes.var_report.xml									phs001381.v1.p1	Colonic Polyps
2986.0	3192.0		2021/05/07	6178.0		2986.0	./data/phs001327.v2.pht006560.v2.p1.CCSS_Subject_Phenotypes.var_report.xml	0.0	3089.0	145.7	3192.0			3089.0		phs001327.v2.p1	Neoplasm
			11/05/2014				./data/phs000209.v13.pht001208.v2.p3.MESA_AncilMesaSexHormone.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2017/10/19				./data/phs001288.v1.pht006767.v1.p1.diagnosis.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2020/01/21				./data/phs001936.v1.pht009647.v1.p1.Gastric_Cancer_BDI_Sample.var_report.xml									phs001936.v1.p1	Gastrointestinal Neoplasms
			12/01/2015				./data/phs000571.v3.pht003177.v3.p2.CardiacSurgeriesProcedures.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			2017/12/07				./data/phs001312.v1.pht007201.v1.p1.POAAGG_Subject_Phenotypes.var_report.xml									phs001312.v1.p1	Glaucoma, Open-Angle
74.0	74.0		2020/05/26	118.0		44.0	./data/phs001820.v1.pht010242.v1.p1.Oncologic_Hematologic_Subject_Phenotypes.var_report.xml	0.0	59.0	21.21	44.0			59.0		phs001820.v1.p1	Neoplasms
			2021/03/05				./data/phs001504.v2.pht007911.v1.p1.T2D_GENES_Hong_Kong_Sample_Attributes.var_report.xml									phs001504.v2.p1	Diabetes Mellitus, Type 2
2.0	2.0		2020/11/03	2.0		2.0	./data/phs002279.v1.pht010629.v1.p1.GIMs_Spermatids_Subject.var_report.xml	0.0	2.0					2.0		phs002279.v1.p1	Germ Cells
			2020/06/18				./data/phs000280.v7.pht004182.v2.p1.RTASWM33.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht001504.v2.p3.outc_cancer_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/02/08				./data/phs001488.v1.pht007375.v1.p1.aefu.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/03/11				./data/phs000286.v6.pht008785.v1.p2.ssfb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/11/08				./data/phs001330.v2.pht007531.v2.p1.p6707_15460_chq.var_report.xml									phs001330.v2.p1	Mucopolysaccharidosis III
			2017/09/22				./data/phs001392.v1.pht006883.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			08/20/2013				./data/phs000285.v3.pht001664.v2.p2.C1F09TOB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht003149.v1.p1.ifi.var_report.xml									phs000343.v3.p1	Stroke
			2021/06/23				./data/phs001434.v2.pht009857.v1.p1.TOPMed_WGS_miRhythm_Sample.var_report.xml									phs001434.v2.p1	Atrial Fibrillation
			05/21/2013				./data/phs000421.v1.pht003236.v1.p1.FuchsEndothelialCornealDystrophy_Sample_Attributes.var_report.xml									phs000421.v1.p1	Fuchs&#39; Endothelial Dystrophy
			01/30/2017				./data/phs000725.v2.pht003882.v2.p1.Rare_Cancer_Tumors_Project_Subject.var_report.xml									phs000725.v2.p1	Neoplasms
			10/05/2015				./data/phs000983.v1.pht005006.v1.p1.Rheumatoid_Arthritis_Therapy_Subject_Phenotypes.var_report.xml									phs000983.v1.p1	Arthritis, Rheumatoid
			2021/05/17				./data/phs001134.v1.pht011228.v1.p1.Chernobyl_PTC_Sample_Attributes.var_report.xml									phs001134.v1.p1	Thyroid Cancer, Papillary
			08/25/2016				./data/phs001153.v1.pht005695.v1.p1.Endometrioid_Endometrial_Carcinoma_Sample.var_report.xml									phs001153.v1.p1	Endometrial Neoplasms
			2021/01/08				./data/phs002309.v1.pht010840.v1.p1.Melanoma_Associated_Vitiligo_Subject_Phenotypes.var_report.xml									phs002309.v1.p1	Melanoma
			2020/06/18				./data/phs000280.v7.pht004061.v5.p1.cstrps16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/10/22				./data/phs001550.v2.pht007507.v2.p1.Melanocytic_Neoplasms_Sample_Attributes.var_report.xml									phs001550.v2.p1	Melanoma
			01/19/2010				./data/phs000219.v1.pht001084.v1.p1.d_img.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2018/04/20				./data/phs001231.v2.pht006179.v1.p1.NeuroLINCS_ALS_SMA_Subject.var_report.xml									phs001231.v2.p1	Amyotrophic Lateral Sclerosis
			01/19/2010				./data/phs000219.v1.pht001098.v1.p1.d_prevtest_other_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2020/12/21				./data/phs000007.v32.pht010735.v1.p13.t_livrvcte_ex03_3b_1253s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/01/27				./data/phs000584.v1.pht010797.v1.p1.CIDR_Longevity_Sample.var_report.xml									phs000584.v1.p1	Longevity
			2018/02/08				./data/phs001488.v1.pht007380.v1.p1.cgburden.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/12/12				./data/phs001883.v1.pht009683.v1.p1.S0800_BC_GEO.var_report.xml									phs001883.v1.p1	Breast Neoplasms
			2019/04/09				./data/phs001802.v1.pht008958.v1.p1.Lymphatic_Anomalies_CAG_Subject.var_report.xml									phs001802.v1.p1	Lymphatic Diseases
			2021/01/27				./data/phs002313.v1.pht010820.v1.p1.AAOV_Subject_Phenotypes.var_report.xml									phs002313.v1.p1	Cancer
			2018/09/20				./data/phs001428.v1.pht008386.v1.p1.S0221_BRCA_Toxicities_Sample.var_report.xml									phs001428.v1.p1	Peripheral Nervous System Diseases
2.0	2.0		2018/04/20	4.0		8.0	./data/phs001231.v2.pht006181.v2.p1.NeuroLINCS_ALS_SMA_Subject_Phenotypes.var_report.xml	0.0	8.0	2.828	8.0			8.0		phs001231.v2.p1	Amyotrophic Lateral Sclerosis
			2021/09/14				./data/phs002121.v1.pht011551.v1.p1.Hematological_Transcriptomic_Sample_Attributes.var_report.xml									phs002121.v1.p1	Myeloproliferative Neoplasms
4864.0	7881.0		03/22/2017	12754.0		9.0	./data/phs000925.v1.pht006203.v1.p1.PAGE_IPM_BioMe_Biobank_Subject_Phenotypes.var_report.xml	0.0	4251.0	3972	7881.0			4864.0		phs000925.v1.p1	Cardiovascular Diseases
			06/13/2014				./data/phs000625.v1.pht003855.v1.p1.Cleft_Lip_Palate_Sample_Attributes.var_report.xml									phs000625.v1.p1	Orofacial Cleft, Nonsyndromic
			06/21/2016				./data/phs001151.v1.pht005539.v1.p1.Retina_RPE_Choroid_Sample.var_report.xml									phs001151.v1.p1	
			2020/06/18				./data/phs000280.v7.pht009472.v1.p1.GENps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/06/24				./data/phs001848.v1.pht009205.v1.p1.PIK3CG_Sample.var_report.xml									phs001848.v1.p1	Immune System Diseases
			2020/01/23				./data/phs000287.v7.pht001465.v1.p1.EVENT_TIME_TO_CENSUS.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001601.v2.p2.B2F08.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/05/14				./data/phs001396.v1.pht006736.v1.p1.Pigmentation_Eastern_Southern_African_Sample.var_report.xml									phs001396.v1.p1	Skin Pigmentation
			2018/09/14				./data/phs001658.v1.pht008344.v1.p1.Adrenocortical_Carcinoma_Sample_Attributes.var_report.xml									phs001658.v1.p1	Adrenocortical Carcinoma
156.0	156.0		2018/03/20	186.0		30.0	./data/phs001559.v1.pht007661.v1.p1.Oxycodone_Abuse_Pedigree.var_report.xml	0.0	93.0	89.8	30.0			93.0		phs001559.v1.p1	Heroin Dependence
			2020/02/13				./data/phs000960.v2.pht004843.v1.p1.Biliary_Atresia_Sample_Attributes.var_report.xml									phs000960.v2.p1	Biliary Atresia
			2020/12/21				./data/phs000007.v32.pht010752.v1.p13.vr_ffreq_ex01_72_0975s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001671.v2.p2.C1F20.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/03/30				./data/phs001988.v1.pht010930.v1.p1.mCRPC_Sample_Attributes.var_report.xml									phs001988.v1.p1	Prostatic Neoplasms
			2021/08/08				./data/phs001644.v2.pht009945.v2.p2.TOPMed_CCDG_BioME_Sample.var_report.xml									phs001644.v2.p2	Coronary Artery Disease
	800.0		06/01/2015	800.0		800.0	./data/phs000912.v1.pht004732.v1.p1.Breast_Cancer_Latina_Subject_Phenotypes.var_report.xml	0.0	800.0		800.0			800.0		phs000912.v1.p1	Breast Neoplasms
			05/02/2011				./data/phs000310.v1.pht002131.v1.p1.NonETS_Fusions_Sample_Attributes.var_report.xml									phs000310.v1.p1	Prostatic Neoplasms
			02/03/2014				./data/phs000706.v1.pht003667.v1.p1.RAD50_Hypomorphism_Sample_Attributes.var_report.xml									phs000706.v1.p1	Ureteral Neoplasms
			05/17/2016				./data/phs000796.v1.pht005384.v1.p1.OPPERA_Chronic_TMJD_Sample.var_report.xml									phs000796.v1.p1	Temporomandibular Joint Disorders
57.0	57.0		2017/10/02	83.0		26.0	./data/phs000962.v1.pht006967.v1.p1.CIDR_Brain_Growth_Children_Subject_Phenotypes.var_report.xml	0.0	41.5	45.96	26.0			41.5		phs000962.v1.p1	Cerebral Cortex
			2020/09/08				./data/phs001110.v3.pht006513.v3.p1.GMKF_CDH_Sample.var_report.xml									phs001110.v3.p1	Hernias, Diaphragmatic, Congenital
			11/29/2012				./data/phs000539.v1.pht003022.v1.p1.Mendelian_Hyperinsulinism_Sample_Attributes.var_report.xml									phs000539.v1.p1	Hyperinsulinism, Congenital
			2019/04/10				./data/phs001653.v1.pht008705.v1.p1.Holoprosencephaly_Subject_Phenotypes.var_report.xml									phs001653.v1.p1	Holoprosencephaly
			08/20/2013				./data/phs000285.v3.pht001737.v2.p2.D1GLU.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/28				./data/phs000645.v5.pht003742.v5.p1.Intellectual_Disabilities_Sample_Attributes.var_report.xml									phs000645.v5.p1	Dubowitz Syndrome
			2020/11/17				./data/phs002197.v1.pht010611.v1.p1.Taupathy_Sample_Attributes.var_report.xml									phs002197.v1.p1	Pick Disease of the Brain
			2020/12/21				./data/phs000007.v32.pht005172.v3.p13.vr_meds_ex01_3b_0825s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/01/29				./data/phs001765.v1.pht008664.v1.p1.Parathyroid_Cancer_Sample.var_report.xml									phs001765.v1.p1	Parathyroid Neoplasms
			2020/02/04				./data/phs001507.v1.pht008699.v1.p1.ET_Turkish_Sample_Attributes.var_report.xml									phs001507.v1.p1	Essential Tremor
			02/24/2012				./data/phs000001.v3.pht002477.v1.p1.AREDS_Subject.var_report.xml									phs000001.v3.p1	Cataract
			2020/12/21				./data/phs000007.v32.pht002898.v5.p13.l_tnfr_2005_m_0465s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
801.0	82.0		06/25/2015	946.0		89.0	./data/phs000634.v1.pht003831.v1.p1.Lung_Cancer_Never_Smokers_Subject_Phenotypes.var_report.xml	0.0	999.0	507.7	89.0			999.0		phs000634.v1.p1	Lung Neoplasms
			10/27/2014				./data/phs000812.v1.pht004297.v1.p1.Breast_Prostate_Cancer_Subject.var_report.xml									phs000812.v1.p1	Prostatic Neoplasms
			05/13/2014				./data/phs000678.v1.pht003562.v1.p1.Young_Onset_Breast_Cancer_Subject.var_report.xml									phs000678.v1.p1	Breast Neoplasms
			2021/07/20				./data/phs001882.v1.pht010492.v1.p1.OncoArray_FOCI_Subject_Phenotypes.var_report.xml									phs001882.v1.p1	Carcinoma, Ovarian Epithelial
			2017/09/22				./data/phs001392.v1.pht006896.v1.p1.pidtc_17390_day0datet.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2018/03/23				./data/phs000698.v1.pht007690.v1.p1.lab_testing.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
947.0		2.0	08/20/2013	511.0	1.607		./data/phs000285.v3.pht001744.v2.p2.D1REFA.var_report.xml	0.0		0.4976	896.0	1.0			2.0	phs000285.v3.p2	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000761.v1.p1.MS_DATA_LASTMEAL.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2017/11/07				./data/phs001461.v1.pht007119.v1.p1.Pediatric_Ependymoma_Subject.var_report.xml									phs001461.v1.p1	Ependymoma
			2020/11/24				./data/phs001846.v1.pht010679.v1.p1.GMKF_Cancer_Birth_Defects_Subject.var_report.xml									phs001846.v1.p1	Neoplasms
			04/16/2012				./data/phs000485.v1.pht002678.v1.p1.Congenital_Diaphragmatic_Hernia_Sample.var_report.xml									phs000485.v1.p1	Congenital diaphragmatic hernia
			2020/12/21				./data/phs000007.v32.pht000909.v5.p13.quad1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001823.v2.p2.F1F31.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
9.0	9.0		2021/07/21	6.0		4.0	./data/phs002464.v1.pht011332.v1.p1.Familial_AF_Subject.var_report.xml	0.0	8.0	5.657	4.0			8.0		phs002464.v1.p1	Atrial Fibrillation
			05/02/2011				./data/phs000349.v1.pht002190.v1.p1.SEA_Phase2_Sample.var_report.xml									phs000349.v1.p1	Atherosclerosis
			2018/09/19				./data/phs000357.v2.pht002332.v1.p1.Systemic_Sclerosis_Clinical_Attributes.var_report.xml									phs000357.v2.p1	Systemic Sclerosis
			2021/08/31				./data/phs000663.v3.pht003552.v3.p3.DILIN_Subject_Phenotypes.var_report.xml									phs000663.v3.p3	Drug-Induced Liver Injury
28.0	40.0		07/06/2017	89.0		9.0	./data/phs001370.v1.pht006646.v1.p1.Uveal_Melanoma_Subject_Phenotypes.var_report.xml	0.0	29.67	9.609	9.0			28.0		phs001370.v1.p1	Melanoma, Uveal
			2019/02/01				./data/phs001770.v1.pht008683.v1.p1.RKSC_6408_Subject.var_report.xml									phs001770.v1.p1	Dent Disease
8.0	40.0		2020/01/23	7.0		2.0	./data/phs000287.v7.pht001488.v1.p1.YR3.var_report.xml	5524.0	21.0	26.87	4.0			21.0		phs000287.v7.p1	Cardiovascular Diseases
177.0	177.0		2020/07/10	279.0		3.0	./data/phs002055.v1.pht010345.v1.p1.GTAC_ALS_FTD_Subject_Phenotypes.var_report.xml	0.0	93.0	87.16	99.0			99.0		phs002055.v1.p1	Amyotrophic Lateral Sclerosis
			2019/10/18				./data/phs001020.v2.pht005782.v2.p1.GPC_Sample.var_report.xml									phs001020.v2.p1	Schizophrenia
9.0	9.0		2018/02/27	3.0		5.0	./data/phs001469.v1.pht007169.v1.p1.DM_Anti_PD1_Subject_Phenotypes.var_report.xml	0.0	8.5	4.95	5.0			8.5		phs001469.v1.p1	Immunotherapy
			11/08/2013				./data/phs000200.v9.pht001025.v4.p3.f90_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000416.v2.p3.simphen017.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			08/20/2013				./data/phs000285.v3.pht001764.v2.p2.E1F09CT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000999.v4.p3.f30_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			12/31/2012				./data/phs000500.v1.pht003117.v1.p1.Fetal_Genome_Sample_Attributes.var_report.xml									phs000500.v1.p1	Prenatal Care
			2018/05/31				./data/phs001316.v1.pht008012.v1.p1.physicalexamination.var_report.xml									phs001316.v1.p1	Andersen Syndrome
			2018/05/22				./data/phs001595.v1.pht007994.v1.p1.adverse_event.var_report.xml									phs001595.v1.p1	Hypotension, Orthostatic
6.0	8.0		07/09/2013	6.0		6.0	./data/phs000556.v1.pht003137.v1.p1.ESP_AtypicalCysticFibrosis_Pedigree.var_report.xml	0.0	7.0	2.828	8.0			7.0		phs000556.v1.p1	Cystic Fibrosis
			2018/10/02				./data/phs001699.v1.pht008398.v1.p1.BC_Epigenetic_Heritability_Sample.var_report.xml									phs001699.v1.p1	
1.0	1.0		2018/07/23	1.0		1.0	./data/phs001627.v1.pht008189.v1.p1.AML_scDNA_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs001627.v1.p1	Leukemia, Myeloid, Acute
			2021/03/09				./data/phs002362.v1.pht011018.v1.p1.CSSCD_Sample.var_report.xml									phs002362.v1.p1	Sickle Cell Disease
			2018/07/23				./data/phs001627.v1.pht008187.v1.p1.AML_scDNA_Subject.var_report.xml									phs001627.v1.p1	Leukemia, Myeloid, Acute
			2020/02/06				./data/phs001430.v2.pht008064.v2.p1.p7001_18440_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			11/08/2013				./data/phs000200.v9.pht003396.v1.p3.f151_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
716.0	813.0		2021/02/05	1529.0		716.0	./data/phs002319.v1.pht010925.v1.p1.INVEST_Subject_Phenotypes.var_report.xml	0.0	764.5	68.59	813.0			764.5		phs002319.v1.p1	Heart Disease
			2021/06/16				./data/phs002088.v2.pht010716.v1.p1.LINCS_DToxS_Image_Mapping.var_report.xml									phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
			08/12/2016				./data/phs000888.v1.pht005582.v1.p1.emerge2_obesity_historydisease.var_report.xml									phs000888.v1.p1	
79.0			2019/08/01	348.0			./data/phs001871.v1.pht009361.v1.p1.CCDG_CCC_AA_Subject_Phenotypes.var_report.xml	0.0			211.0					phs001871.v1.p1	Cardiovascular Diseases
			2021/08/06				./data/phs001682.v2.pht009764.v1.p1.TOPMed_WGS_PUSH_SCD_Subject_Phenotypes.var_report.xml									phs001682.v2.p1	Anemia, Sickle Cell
			2020/06/18				./data/phs000280.v7.pht004207.v2.p1.UBMD4.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005395.v1.p1.aefu.var_report.xml									phs001065.v1.p1	Huntington Disease
			04/04/2012				./data/phs000433.v1.pht002436.v1.p1.SIGNET_Subject_Phenotypes.var_report.xml									phs000433.v1.p1	Type 2 Diabetes Mellitus
			04/20/2012				./data/phs000390.v1.pht002325.v1.p1.Female_Osteoporosis_Risk_Genes_Subject.var_report.xml									phs000390.v1.p1	Osteoporosis
			2021/02/11				./data/phs001140.v1.pht010945.v1.p1.ALCHEMIST_Sample.var_report.xml									phs001140.v1.p1	
			2020/12/21				./data/phs000007.v32.pht005145.v4.p13.l_mtbtarg1_ex01_3_0955s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2017/12/29				./data/phs001347.v2.pht006797.v2.p1.PRISM_Sample_Attributes.var_report.xml									phs001347.v2.p1	Infant, Premature
			2019/06/14				./data/phs000589.v1.pht009187.v1.p1.eligibility_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/01/06				./data/phs001188.v2.pht006300.v2.p1.FUSION_Islet_Sample.var_report.xml									phs001188.v2.p1	Diabetes Mellitus, Type 2
8.0	8.0		2021/07/21	6.0		4.0	./data/phs002464.v1.pht011333.v1.p1.Familial_AF_Pedigree.var_report.xml	0.0	6.0	2.828	4.0			6.0		phs002464.v1.p1	Atrial Fibrillation
			11/22/2013				./data/phs000251.v2.pht001261.v2.p2.HMP_Cutaneous_Psoriasis_Sample.var_report.xml									phs000251.v2.p2	Psoriasis
3990.0	3990.0		07/18/2014	3990.0		3990.0	./data/phs000733.v1.pht003821.v1.p1.Familial_Prostate_Cancer_Subject_Phenotypes.var_report.xml	0.0	3990.0					3990.0		phs000733.v1.p1	Prostate cancer, familial
			08/21/2015				./data/phs000626.v1.pht003430.v1.p1.CD4_Tcells_Healthy_Humans_Subject.var_report.xml									phs000626.v1.p1	Immune System Processes
			11/08/2013				./data/phs000200.v9.pht001010.v4.p3.f42_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/02/06				./data/phs001430.v2.pht008058.v2.p1.p7001_16326_feedingev.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2019/03/08				./data/phs001759.v1.pht008707.v1.p1.SAH_Subject.var_report.xml									phs001759.v1.p1	Circulating MicroRNA
			2021/06/07				./data/phs002440.v1.pht011283.v1.p1.ALS_NMJ_Sample.var_report.xml									phs002440.v1.p1	Amyotrophic Lateral Sclerosis
			2021/06/10				./data/phs001387.v3.pht008967.v2.p1.TOPMed_WGS_THRV_Subject.var_report.xml									phs001387.v3.p1	Blood Pressure
			12/11/2009				./data/phs000171.v1.pht000763.v1.p1.MS_DATA_MHQCAFOWT.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/10/16				./data/phs002269.v1.pht010582.v1.p1.Tumor_Neoantigens_Sample_Attributes.var_report.xml									phs002269.v1.p1	Antigens, Neoplasm
			11/05/2014				./data/phs000209.v13.pht001204.v2.p3.MESA_AncilMesaExam3AbdominalAorticCT.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/02/18				./data/phs001227.v1.pht005833.v1.p1.WUCADS_Sample.var_report.xml									phs001227.v1.p1	Coronary Artery Disease
			08/20/2013				./data/phs000285.v3.pht001636.v2.p2.B2F31.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/06/20				./data/phs001629.v1.pht008161.v1.p1.BRAF_V600E_Sample.var_report.xml									phs001629.v1.p1	Ganglioglioma
			2019/04/10				./data/phs001048.v2.pht008898.v1.p1.FUSION_Tissue_Biopsy_Sample_Attributes.var_report.xml									phs001048.v2.p1	Diabetes Mellitus, Type 2
			06/01/2017				./data/phs000701.v1.pht005508.v1.p1.BSIQuestionnaire.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2019/04/09				./data/phs001805.v1.pht008957.v1.p1.Neoantigens_NSCLC_Sample_Attributes.var_report.xml									phs001805.v1.p1	Adenocarcinoma of Lung
			2019/03/11				./data/phs000286.v6.pht001941.v2.p2.bapa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2021/03/09				./data/phs001374.v2.pht008334.v2.p1.APOLLO_RePOP_Subject.var_report.xml									phs001374.v2.p1	Neoplasms
			07/27/2017	74.0			./data/phs000596.v1.pht006708.v1.p1.cfq_children_ages_12n13.var_report.xml	0.0								phs000596.v1.p1	Primary ciliary dyskinesia
			2020/07/20				./data/phs002025.v1.pht010238.v1.p1.TB_3q23_Peruvians_Sample_Attributes.var_report.xml									phs002025.v1.p1	Tuberculosis, Pulmonary
			2021/05/24				./data/phs002323.v1.pht010883.v1.p1.BulkRNA_Sample_Attributes.var_report.xml									phs002323.v1.p1	Immunotherapy
292.0	311.0		2019/07/31	603.0		292.0	./data/phs001872.v1.pht009364.v1.p1.CEPH_Utah_Pedigree.var_report.xml	0.0	301.5	13.44	311.0			301.5		phs001872.v1.p1	Population Groups
			04/29/2015				./data/phs000710.v1.pht003989.v1.p1.Cloud_Testing_Sample_Attributes.var_report.xml									phs000710.v1.p1	Test study for cloud access
			2021/05/10				./data/phs002176.v2.pht010947.v2.p1.PD1_PDL1_SCLC_Sample.var_report.xml									phs002176.v2.p1	Small Cell Lung Carcinoma
			03/12/2013				./data/phs000343.v3.pht002216.v1.p1.INCCOM.var_report.xml									phs000343.v3.p1	Stroke
			05/17/2017				./data/phs001328.v1.pht006306.v1.p1.cognitive_lt4.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			08/11/2011				./data/phs000365.v1.pht002266.v1.p1.XMEN_Disease_Sample.var_report.xml									phs000365.v1.p1	Immune System Diseases
			2021/06/16				./data/phs002088.v2.pht010653.v1.p1.LINCS_DToxS_GEO.var_report.xml									phs002088.v2.p1	Drug-Related Side Effects and Adverse Reactions
973.0	973.0		2021/05/13	1651.0		678.0	./data/phs001423.v3.pht006984.v3.p2.TIC_Genetics_Pedigree.var_report.xml	0.0	825.5	208.6	678.0			825.5		phs001423.v3.p2	Tourette Disorder
			07/09/2015				./data/phs000564.v2.pht003056.v2.p1.WGS_NICU_Subject.var_report.xml									phs000564.v2.p1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities
			2021/06/02				./data/phs002428.v1.pht011269.v1.p1.hTERT_Tandem_Repeats_Sample_Attributes.var_report.xml									phs002428.v1.p1	Centenarian
			06/09/2015				./data/phs000718.v1.pht003842.v1.p1.T21NDJ_Sample_Attributes.var_report.xml									phs000718.v1.p1	Nondisjunction, Genetic
			2020/07/10				./data/phs000723.v1.pht005211.v1.p1.Cervical_Adenocarcinoma_Chinese_Sample.var_report.xml									phs000723.v1.p1	Uterine Cervical Neoplasms
			2017/09/15				./data/phs001173.v1.pht005670.v1.p1.Head_Neck_Cancer_GWAS_Sample.var_report.xml									phs001173.v1.p1	Carcinoma, squamous cell of head and neck
			2020/03/13				./data/phs000521.v2.pht007043.v2.p1.medical_history.var_report.xml									phs000521.v2.p1	Ataxia
			2021/10/19				./data/phs002632.v1.pht011607.v1.p1.AA_KRT82_Subject_Phenotypes.var_report.xml									phs002632.v1.p1	Alopecia Areata
			02/24/2012				./data/phs000001.v3.pht000380.v2.p1.mortality.var_report.xml									phs000001.v3.p1	Cataract
			11/21/2016				./data/phs001251.v1.pht005947.v1.p1.UC_WES_Subject.var_report.xml									phs001251.v1.p1	Colitis, Ulcerative
104.0	104.0		02/27/2017	186.0		17.0	./data/phs000435.v3.pht002523.v3.p1.CLL_Subject_Phenotypes.var_report.xml	0.0	62.0	43.58	65.0			65.0		phs000435.v3.p1	Chronic Lymphocytic Leukemia
			2018/04/16				./data/phs001289.v1.pht007796.v1.p1.physicalexamination.var_report.xml									phs001289.v1.p1	Andersen Syndrome
14.0	20.0		2019/12/17	34.0		14.0	./data/phs001943.v1.pht009715.v1.p1.UM_Subject_Phenotypes.var_report.xml	0.0	17.0	4.243	20.0			17.0		phs001943.v1.p1	Uveal melanoma
728.0	63.0		05/21/2013	809.0		728.0	./data/phs000421.v1.pht003233.v1.p1.FuchsEndothelialCornealDystrophy_Pedigree.var_report.xml	0.0	886.5	253.9	63.0			886.5		phs000421.v1.p1	Fuchs&#39; Endothelial Dystrophy
			2020/01/23				./data/phs000287.v7.pht001471.v1.p1.ULTRABL.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
64.0	64.0		2017/08/18	108.0		44.0	./data/phs001363.v1.pht006518.v1.p1.P100_Subject_Phenotypes.var_report.xml	0.0	54.0	14.14	44.0			54.0		phs001363.v1.p1	Health
			2018/06/14				./data/phs001238.v2.pht006032.v1.p1.GENOA_AfricanAmerican_CKD_Medications.var_report.xml									phs001238.v2.p1	Hypertension
			02/27/2017				./data/phs001036.v1.pht005271.v1.p1.Acral_Melanoma_Sample_Attributes.var_report.xml									phs001036.v1.p1	Melanoma
			2019/05/16				./data/phs001761.v1.pht009028.v1.p1.MPNs_Chernobyl_Sample.var_report.xml									phs001761.v1.p1	Primary Myelofibrosis
			2017/11/06				./data/phs000288.v2.pht002519.v2.p2.Ciliopathies_Exome_Subject_Phenotypes.var_report.xml									phs000288.v2.p2	Congenital Abnormalities
			2020/06/18				./data/phs000280.v7.pht004194.v2.p1.SBPC04_02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/04/05				./data/phs001522.v1.pht007732.v1.p1.cDNMs_Sample_Attributes.var_report.xml									phs001522.v1.p1	
			01/26/2015				./data/phs000856.v1.pht004456.v1.p1.Chromothripsis_WHIM_Sample.var_report.xml									phs000856.v1.p1	WHIM syndrome
			11/30/2015				./data/phs000975.v1.pht004936.v1.p1.NHS_Mammographic_Density_Sample_Attributes.var_report.xml									phs000975.v1.p1	Mammographic density
			08/20/2013				./data/phs000285.v3.pht001854.v2.p2.F2EBCT.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			04/11/2017				./data/phs000897.v1.pht004639.v1.p1.Early_Stage_Ovarian_Cancer_Subject_Phenotypes.var_report.xml									phs000897.v1.p1	Cystadenocarcinoma, Serous
			11/14/2016				./data/phs000741.v2.pht003915.v2.p1.GOLDN_Lipid_Lowering_Subject.var_report.xml									phs000741.v2.p1	Metabolomics
			04/16/2014				./data/phs000249.v2.pht001877.v2.p1.Brain_QTL_Sample.var_report.xml									phs000249.v2.p1	DNA Methylation
			2020/06/18				./data/phs000280.v7.pht004167.v2.p1.RTABF42.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/08/25				./data/phs001321.v1.pht006195.v1.p1.OncoArray_CIMBA_Subject.var_report.xml									phs001321.v1.p1	Breast Neoplasms
			2018/08/19				./data/phs000101.v5.pht001149.v4.p1.ALS_Sample.var_report.xml									phs000101.v5.p1	Amyotrophic Lateral Sclerosis
			2019/03/11				./data/phs000286.v6.pht008789.v1.p2.stxb.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/11/04				./data/phs001444.v2.pht006960.v1.p1.Genomic_Variation_DLBCL_Subject.var_report.xml									phs001444.v2.p1	Lymphoma, Large B-Cell, Diffuse
5.0	9.0		2017/10/04	14.0		5.0	./data/phs001270.v1.pht006250.v1.p1.SACDS_IGHNSS_Pedigree.var_report.xml	0.0	7.0	2.828	9.0			7.0		phs001270.v1.p1	Sleep Wake Disorders
990.0	5910.0		2018/04/12	2573.0		1.0	./data/phs001458.v1.pht007779.v1.p1.Cannabis_Stimulant_Dependence_Pedigree.var_report.xml	0.0	857.7	798.8	5910.0			990.0		phs001458.v1.p1	Marijuana Abuse
556.0	2372.0		07/21/2009	2928.0		556.0	./data/phs000142.v1.pht000638.v1.p1.MyopiaGlaucoma_Data.var_report_2009_07_21.xml	0.0	1464.0	1284	2372.0			1464.0		phs000142.v1.p1	Eye Diseases
			2020/06/18				./data/phs000280.v7.pht004029.v2.p1.ABI44.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht010754.v1.p13.vr_ffreq_ex09_1_1158s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000758.v1.p1.MS_DATA_FAMSSYM.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2020/12/21				./data/phs000007.v32.pht000210.v8.p13.t_tonla_ex01_3b_1234s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/05/21				./data/phs001198.v1.pht007864.v1.p1.Methamphetamine_Abstinence_Sample.var_report.xml									phs001198.v1.p1	Substance-Related Disorders
4.0	6.0		2021/06/07	9.0		4.0	./data/phs001998.v1.pht010504.v1.p1.CLL_allo_HSCT_Subject_Phenotypes.var_report.xml	0.0	5.0	1.414	6.0			5.0		phs001998.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			2019/06/14				./data/phs000589.v1.pht009193.v1.p1.lvv_physical_exam.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2018/11/13				./data/phs001523.v1.pht007514.v1.p1.phenotype_deliveryAndDischargeSurvey.var_report.xml									phs001523.v1.p1	Pregnancy
			2021/09/14				./data/phs002121.v1.pht011549.v1.p1.Hematological_Transcriptomic_Sample.var_report.xml									phs002121.v1.p1	Myeloproliferative Neoplasms
42.0	42.0		07/31/2012	42.0		42.0	./data/phs000449.v2.pht002780.v1.p1.Genetic_Adaptation_High_Altitude_Ethiopian_Subject_Phenotypes.var_report.xml	0.0	42.0					42.0		phs000449.v2.p1	Population Control
			2017/12/29				./data/phs001347.v2.pht006794.v2.p1.PRISM_Subject.var_report.xml									phs001347.v2.p1	Infant, Premature
			09/18/2014				./data/phs000792.v1.pht004249.v1.p1.MPNST_Sample.var_report.xml									phs000792.v1.p1	Neurilemmoma
95.0			07/12/2017	72.0			./data/phs000592.v1.pht006580.v1.p1.affectedfamilymembers.var_report.xml	33.0			82.0					phs000592.v1.p1	Anemia, Aplastic
			06/22/2016				./data/phs001146.v1.pht005545.v1.p1.Endometrial_Cells_eQTL_Subject_Phenotypes.var_report.xml									phs001146.v1.p1	Fertility
			2018/10/05				./data/phs001304.v1.pht008312.v1.p1.BPV_Subject.var_report.xml									phs001304.v1.p1	Carcinoma, Renal Cell
			07/12/2017				./data/phs000592.v1.pht006583.v1.p1.bmdifferential.var_report.xml									phs000592.v1.p1	Anemia, Aplastic
39.0	39.0		2020/07/07	39.0		39.0	./data/phs001938.v2.pht009636.v2.p1.ADT_PC_Subject_Phenotypes.var_report.xml	0.0	39.0					39.0		phs001938.v2.p1	Prostatic Neoplasms
			08/20/2013				./data/phs000285.v3.pht001637.v2.p2.B2F32.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/12/08				./data/phs001279.v1.pht007206.v1.p1.ct_scoring_form.var_report.xml									phs001279.v1.p1	Bronchiectasis
56.0	60.0		06/09/2010	80.0		56.0	./data/phs000255.v1.pht001253.v1.p1.HMP_Crohns_Risk_Subject_Phenotypes.var_report.xml	0.0	58.0	8.485	60.0			58.0		phs000255.v1.p1	Crohn Disease
			2019/03/11				./data/phs000286.v6.pht008734.v1.p2.asn0035_retinopathy.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			03/16/2015				./data/phs000868.v1.pht004589.v1.p1.Pediatric_Neuroblastoma_Subject_Phenotypes.var_report.xml									phs000868.v1.p1	Neuroblastoma
			2020/09/03				./data/phs000968.v2.pht004915.v1.p1.Cardiopulmonary_Particulate_Exposure_Sample_Attributes.var_report.xml									phs000968.v2.p1	Cardiovascular Disease
			2020/09/30				./data/phs001951.v1.pht009782.v1.p1.Relapsed_ALL_Subject.var_report.xml									phs001951.v1.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			2020/11/09				./data/phs000976.v2.pht005683.v1.p1.CIDR_COGA_AA_Family_Subject.var_report.xml									phs000976.v2.p1	Alcoholism
			06/09/2016				./data/phs000955.v1.pht005449.v1.p1.GeCKO_OAI_Subject.var_report.xml									phs000955.v1.p1	Osteoarthritis
			2021/08/06				./data/phs001783.v2.pht008821.v2.p1.Clinical_Specimens_Subject_Phenotypes.var_report.xml									phs001783.v2.p1	Neoplasms
			2018/01/18				./data/phs001513.v1.pht007356.v1.p1.Chemo_Resistance_T_ALL_Subject.var_report.xml									phs001513.v1.p1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
			11/04/2014				./data/phs000086.v3.pht000326.v1.p1.EDIC_f0024.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
2.0	2.0		08/15/2012	3.0		1.0	./data/phs000479.v1.pht002664.v1.p1.SCID_Exome_Pedigree.var_report.xml	0.0	1.5	0.7071	1.0			1.5		phs000479.v1.p1	Severe Combined Immunodeficiency
			11/22/2013				./data/phs000460.v1.pht003585.v1.p1.Recurrent_Nephrolithiasis_Sample_Attributes.var_report.xml									phs000460.v1.p1	Nephrolithiasis
			2018/02/08				./data/phs001488.v1.pht007399.v1.p1.imgcnsnt.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/05/07				./data/phs001997.v1.pht010217.v1.p1.GMKF_OFC_Sample.var_report.xml									phs001997.v1.p1	Cleft Lip
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000419.v2.p3.simphen020.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/11/27				./data/phs000510.v1.pht010698.v1.p1.SOF_Sample_Attributes.var_report.xml									phs000510.v1.p1	Osteoporosis
			01/19/2010				./data/phs000219.v1.pht001071.v1.p1.d_csa05L2_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/02/24				./data/phs002342.v1.pht011004.v1.p1.Polyepitope_Neoantigen_DNA_Vaccines_Sample_Attributes.var_report.xml									phs002342.v1.p1	Carcinoma, Neuroendocrine
			2020/08/05				./data/phs002052.v1.pht010321.v1.p1.mtDNA_Deletion_POLG_Sample_Attributes.var_report.xml									phs002052.v1.p1	Mitochondrial Diseases
			01/05/2017				./data/phs001260.v1.pht006052.v1.p1.Antibiotic_Resistance_Sample.var_report.xml									phs001260.v1.p1	Diarrhea
9.0	9.0		2020/11/17	16.0		7.0	./data/phs002197.v1.pht010608.v1.p1.Taupathy_Subject.var_report.xml	0.0	8.0	1.414	7.0			8.0		phs002197.v1.p1	Pick Disease of the Brain
			2020/12/21				./data/phs000007.v32.pht003901.v4.p13.l_insulin_2008_m_0704s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			11/08/2013				./data/phs000200.v9.pht000992.v4.p3.f145_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
30.0	39.0		2020/09/04	69.0		30.0	./data/phs001993.v1.pht010084.v1.p1.NF1_AtypicalNeurofibromas_Pedigree.var_report.xml	0.0	34.5	6.364	39.0			34.5		phs001993.v1.p1	Neurofibromatosis 1
			02/23/2016				./data/phs001038.v1.pht005209.v1.p1.Melanoma_DNMTi_Immunotherapy_Sample_Attributes.var_report.xml									phs001038.v1.p1	Melanoma
			2020/04/17				./data/phs001868.v1.pht009781.v1.p1.CM_Risk_Sample_Attributes.var_report.xml									phs001868.v1.p1	Melanoma
			08/20/2013				./data/phs000285.v3.pht001850.v2.p2.F1MOOD.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
1224.0	4075.0		2020/06/18	7567.0		3492.0	./data/phs000280.v7.pht009477.v2.p1.HFCOCCPS16.var_report.xml	1.0	3784.0	412.2	2.0			3784.0		phs000280.v7.p1	Cardiovascular Diseases
			03/24/2017				./data/phs001336.v1.pht006206.v1.p1.ECLS_HCT_GVHD_Subject_Phenotypes.var_report.xml									phs001336.v1.p1	Bone Marrow Transplantation
6.0	6.0		11/07/2014	8.0		2.0	./data/phs000809.v1.pht004348.v1.p1.Glycosylation_Congenital_Disorder_Subject_Phenotypes.var_report.xml	0.0	4.0	2.828	2.0			4.0		phs000809.v1.p1	Congenital Disorders of Glycosylation
			2020/12/01				./data/phs002105.v1.pht010709.v1.p1.Opioid_Pharmacogenomics_Children_Sample_Attributes.var_report.xml									phs002105.v1.p1	Opioid-Related Disorders
			2018/02/28				./data/phs001001.v1.pht005653.v1.p1.MGH_AF_Subject.var_report.xml									phs001001.v1.p1	Atrial Fibrillation
71.0	71.0		2018/04/27	76.0		83.0	./data/phs001197.v1.pht007564.v1.p1.Methamphetamine_Dependence_Subject_Phenotypes.var_report.xml	0.0	96.5	19.09	83.0			96.5		phs001197.v1.p1	Substance-Related Disorders
			2018/06/14				./data/phs001238.v2.pht006043.v1.p1.GENOA_AfricanAmerican_Phase1_SubjectHistory.var_report.xml									phs001238.v2.p1	Hypertension
			08/22/2016				./data/phs001152.v1.pht005537.v1.p1.Endometrial_Carcinosarcomas_Sample_Attributes.var_report.xml									phs001152.v1.p1	Endometrial Neoplasms
			2018/06/30				./data/phs001646.v1.pht008195.v1.p1.GBM_Subject.var_report.xml									phs001646.v1.p1	Glioblastoma
			2020/12/21				./data/phs000007.v32.pht001893.v8.p13.t_ctbonevbd_2005_m_0544s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/03/20				./data/phs001715.v1.pht008845.v1.p1.protocol_termination.var_report.xml									phs001715.v1.p1	Vasculitis
			07/25/2014				./data/phs000560.v1.pht003066.v1.p1.DNHS_Subject.var_report.xml									phs000560.v1.p1	Stress Disorders, Post-Traumatic
11.0	4.0		2019/02/05	4.0		6.0	./data/phs001158.v2.pht005594.v2.p1.Human_Dorsal_Root_Ganglion_Subject_Phenotypes.var_report.xml	0.0	8.5	3.536	6.0			8.5		phs001158.v2.p1	Chronic Pain
			09/03/2014				./data/phs000750.v1.pht003933.v1.p1.GOAL_Subject.var_report.xml									phs000750.v1.p1	Population Groups
			2019/02/21				./data/phs001281.v2.pht006130.v2.p1.house_classification.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2018/10/24				./data/phs001695.v1.pht008498.v1.p1.UCSF_CRH_Subject_Phenotypes.var_report.xml									phs001695.v1.p1	MicroRNAs
			08/26/2015				./data/phs000948.v1.pht004848.v1.p1.eMERGE_PhaseII_Subject.var_report.xml									phs000948.v1.p1	
			2018/04/20				./data/phs001556.v1.pht007844.v1.p1.BRAINcode_Sample.var_report.xml									phs001556.v1.p1	Parkinson Disease
222.0	317.0		2018/06/01	539.0		222.0	./data/phs001538.v1.pht008094.v1.p1.Registry_Pts.var_report.xml	0.0	269.5	67.18	317.0			269.5		phs001538.v1.p1	Mitochondrial Diseases
			04/08/2014				./data/phs000729.v1.pht003776.v1.p1.Follicular_Lymphoma_Sample_Attributes.var_report.xml									phs000729.v1.p1	Lymphoma, Follicular
			07/09/2013				./data/phs000621.v1.pht003328.v1.p1.Chronic_Lymphocytic_Leukemia_Trial_Subject.var_report.xml									phs000621.v1.p1	Leukemia, Lymphoid
			2020/06/18				./data/phs000280.v7.pht004076.v2.p1.ECGMC35.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
7.0	56.0		09/30/2016	80.0		7.0	./data/phs001015.v1.pht005779.v1.p1.Chronic_Fatigue_Syndrome_Subject_Phenotypes.var_report.xml	0.0	40.0	5.657	56.0			40.0		phs001015.v1.p1	Fatigue Syndrome, Chronic
			04/14/2014				./data/phs000732.v1.pht003802.v1.p1.L1_Retrotransposon_Asian_Sample_Attributes.var_report.xml									phs000732.v1.p1	Molecular Structure
			05/05/2015				./data/phs000147.v3.pht000665.v2.p1.CGEMS_Breast_Cancer_Sample.var_report.xml									phs000147.v3.p1	Breast Neoplasms
			08/27/2013				./data/phs000647.v1.pht003469.v1.p1.Hypoxia_Tolerance_Ethiopian_Highlanders_Subject.var_report.xml									phs000647.v1.p1	Cell Hypoxia
			2019/09/27				./data/phs001576.v2.pht008221.v2.p2.P6705_ELIGIBILITY.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			08/20/2013				./data/phs000285.v3.pht001694.v2.p2.C1HEMO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/16				./data/phs001981.v1.pht010699.v1.p1.Brain_AUD_Subject.var_report.xml									phs001981.v1.p1	Alcoholism
			07/25/2014				./data/phs000779.v1.pht003962.v1.p1.OFCCR_SNP_CpG_Sample.var_report.xml									phs000779.v1.p1	Colorectal Neoplasms
			2020/06/18				./data/phs000280.v7.pht004173.v2.p1.RTASBF33.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/11/2009				./data/phs000171.v1.pht000778.v1.p1.MS_DATA_MSHIST1.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			01/03/2017				./data/phs001141.v1.pht005599.v1.p1.PROMOTE_Subject.var_report.xml									phs001141.v1.p1	Prostatic Neoplasms, Castration-Resistant
			2021/03/25				./data/phs002061.v1.pht010834.v1.p1.Zidovudine_Children_Subject.var_report.xml									phs002061.v1.p1	HIV
			08/20/2013				./data/phs000285.v3.pht001789.v2.p2.E1F40.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/03/13				./data/phs000521.v2.pht007044.v2.p1.physical_exam.var_report.xml									phs000521.v2.p1	Ataxia
			2017/09/27				./data/phs000747.v2.pht003846.v2.p1.IBBE_Sporadic_ALS_Sample_Attributes.var_report.xml									phs000747.v2.p1	Amyotrophic Lateral Sclerosis
			2021/07/19				./data/phs001601.v2.pht010665.v2.p2.PMBB_AF_Sample.var_report.xml									phs001601.v2.p2	Atrial Fibrillation
			2021/08/24				./data/phs002185.v1.pht010970.v1.p1.CIDR_GVHD_Sample_Attributes.var_report.xml									phs002185.v1.p1	Graft vs Host Disease
12.0	12.0		11/02/2015	19.0		7.0	./data/phs000994.v1.pht005064.v1.p1.CTCL_Sezary_Syndrome_Subject_Phenotypes.var_report.xml	23.0	9.5	3.536	7.0			9.5		phs000994.v1.p1	Sezary Syndrome
7.0	6.0		2018/11/15	33.0		7.0	./data/phs001418.v1.pht007237.v1.p1.CD_Subject_Phenotypes.var_report.xml	0.0	5.5	5.657	5.0			5.5		phs001418.v1.p1	Crohn Disease
			2020/01/31				./data/phs001934.v1.pht009777.v1.p1.Immune_Aging_Sample_Attributes.var_report.xml									phs001934.v1.p1	
			08/20/2013				./data/phs000285.v3.pht001753.v2.p2.E1CHEM.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/27/2017				./data/phs000596.v1.pht006705.v1.p1.MCC_5901_Subject.var_report.xml									phs000596.v1.p1	Primary ciliary dyskinesia
			03/22/2017				./data/phs000925.v1.pht005178.v1.p1.PAGE_IPM_BioMe_Biobank_Sample_Attributes.var_report.xml									phs000925.v1.p1	Cardiovascular Diseases
			12/02/2016				./data/phs000847.v2.pht004635.v2.p1.T2D_GENES_SAMAFS_Sample.var_report.xml									phs000847.v2.p1	Diabetes Mellitus, Type 2
			11/04/2014				./data/phs000086.v3.pht000352.v1.p1.EDIC_f0943.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2020/06/10				./data/phs002039.v1.pht010270.v1.p1.IAV_IBV_Sample.var_report.xml									phs002039.v1.p1	Influenza, Human
			2017/08/02				./data/phs001384.v1.pht006742.v1.p1.Polyp_To_Cancer_Sample_Attributes.var_report.xml									phs001384.v1.p1	Colorectal Neoplasms
			2021/05/20				./data/phs000972.v5.pht005679.v1.p1.TOPMed_WGS_Samoans_Adiposity_Subject.var_report.xml									phs000972.v5.p1	Obesity
			2018/10/19				./data/phs000492.v3.pht006688.v1.p2.Developmental_Brain_Disorders_Trace.var_report.xml									phs000492.v3.p2	Microcephaly
6.0	6.0		08/30/2013	15.0		3.0	./data/phs000657.v1.pht003494.v1.p1.Advanced_Cancers_Subject_Phenotypes.var_report.xml	0.0	5.0	1.732	3.0			6.0		phs000657.v1.p1	Carcinoma
752.0	752.0		2020/03/09	616.0		579.0	./data/phs001266.v2.pht007223.v1.p1.Addiction_Susceptibility_Genes_Subject_Phenotypes.var_report.xml	0.0	665.5	84.85	579.0			665.5		phs001266.v2.p1	Opioid-Related Disorders
8.0	10.0		03/12/2013	18.0		8.0	./data/phs000343.v3.pht002212.v1.p1.GARNET_VISP_Pedigree.var_report.xml	0.0	9.0	1.414	10.0			9.0		phs000343.v3.p1	Stroke
	1799.0		08/27/2012	1799.0		1799.0	./data/phs000523.v1.pht002922.v1.p1.CLHNS_Subject_Phenotypes.var_report.xml	0.0	1799.0		1799.0			1799.0		phs000523.v1.p1	Maternal Nutritional Physiological Phenomena
91.0	132.0		2019/05/01	225.0		2.0	./data/phs001753.v1.pht009018.v1.p1.Nama_Pigmentation_Subject_Phenotypes.var_report.xml	0.0	75.0	66.46	132.0			91.0		phs001753.v1.p1	Skin Pigmentation
			2020/07/17				./data/phs000481.v3.pht002659.v3.p2.Cholesterol_and_Pharmacogenetics_Subject.var_report.xml									phs000481.v3.p2	Hypercholesterolemia
			05/24/2016				./data/phs001065.v1.pht005407.v1.p1.dose.var_report.xml									phs001065.v1.p1	Huntington Disease
179.0			07/12/2017	324.0			./data/phs000592.v1.pht006587.v1.p1.demographicinformation.var_report.xml	2.0			145.0					phs000592.v1.p1	Anemia, Aplastic
			2018/04/30				./data/phs001322.v2.pht006329.v2.p1.ALS4_Subject.var_report.xml									phs001322.v2.p1	Amyotrophic Lateral Sclerosis 4, Juvenile
			11/08/2013				./data/phs000200.v9.pht002769.v2.p3.outc_self_cad_rel3.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/10/16				./data/phs001373.v2.pht006704.v2.p2.Human_Microglia_Sample_Attributes.var_report.xml									phs001373.v2.p2	Epilepsy
613.0			2019/03/11	770.0			./data/phs000286.v6.pht008730.v1.p2.analysis2.var_report.xml	0.0			84.0					phs000286.v6.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001857.v2.p2.F2F20.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			06/16/2017				./data/phs001278.v1.pht006276.v1.p1.p7201_20283_alcoholco.var_report.xml									phs001278.v1.p1	Porphyrias
			2021/05/04				./data/phs002317.v1.pht011166.v1.p1.ALL_Bone_Toxicities_Sample_Attributes.var_report.xml									phs002317.v1.p1	Fractures, Bone
			02/05/2016				./data/phs000944.v1.pht004844.v1.p1.eMERGE_PhaseIII_Partners_Biobank_Subject.var_report.xml									phs000944.v1.p1	Hypercholesterolemia
			08/20/2013				./data/phs000285.v3.pht001728.v1.p2.D1F9MCHA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			03/12/2013				./data/phs000343.v3.pht003153.v1.p1.mms.var_report.xml									phs000343.v3.p1	Stroke
15.0	15.0		09/18/2014	18.0		3.0	./data/phs000792.v1.pht004250.v1.p1.MPNST_Subject_Phenotypes.var_report.xml	0.0	9.0	8.485	3.0			9.0		phs000792.v1.p1	Neurilemmoma
8.0			2017/10/04	7.0			./data/phs000782.v1.pht003992.v1.p1.MedImmune_RHCCS_Subject_Phenotypes.var_report.xml	0.0			1.0					phs000782.v1.p1	Carcinoma, Hepatocellular
			2017/09/11				./data/phs000472.v2.pht002594.v2.p1.BRC77_Sample.var_report.xml									phs000472.v2.p1	Breast Neoplasms
			2018/02/15				./data/phs001496.v1.pht007340.v1.p1.Warfarin_Caribbean_Hispanics_Subject_Phenotypes.var_report.xml									phs001496.v1.p1	Warfarin Sensitivity
			2021/10/04				./data/phs002238.v1.pht011522.v1.p1.Beat_Childhood_Cancer_Sample_Attributes.var_report.xml									phs002238.v1.p1	Neoplasms
			2019/07/26				./data/phs001852.v1.pht009275.v1.p1.Height_Jewish_Subject.var_report.xml									phs001852.v1.p1	Body Height
			10/07/2016				./data/phs001223.v1.pht005800.v1.p1.AR_Prostate_Cancer_Sample.var_report.xml									phs001223.v1.p1	Prostatic Neoplasms
			2018/04/27				./data/phs001197.v1.pht007563.v1.p1.Methamphetamine_Dependence_Sample.var_report.xml									phs001197.v1.p1	Substance-Related Disorders
			2021/05/11				./data/phs002340.v1.pht011218.v1.p1.scAtlas_Gynecological_Malignancies_GEO.var_report.xml									phs002340.v1.p1	Carcinoma, Ovarian Epithelial
			05/23/2012				./data/phs000409.v1.pht002736.v1.p1.WGS_Medulloblastoma_Sample.var_report.xml									phs000409.v1.p1	Medulloblastoma
			2020/12/21				./data/phs000007.v32.pht000612.v8.p13.diff3_1s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/06/18				./data/phs000280.v7.pht004028.v2.p1.ABI34.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/08/06				./data/phs001398.v1.pht007143.v1.p1.CCDG_BRAVE_Sample_Attributes.var_report.xml									phs001398.v1.p1	
			08/17/2010				./data/phs000294.v1.pht001535.v1.p1.MIGen_Sample.var_report_2010_08_17.xml									phs000294.v1.p1	Myocardial Infarction
			2019/11/01				./data/phs001005.v2.pht005038.v2.p1.Neoantigens_Stage3_Melanoma_Subject.var_report.xml									phs001005.v2.p1	
			2019/12/11				./data/phs001906.v1.pht009661.v1.p1.GISTs_GEO.var_report.xml									phs001906.v1.p1	Gastrointestinal Stromal Tumors
			2021/03/11				./data/phs002368.v1.pht011044.v1.p1.CaBagE_Sample.var_report.xml									phs002368.v1.p1	Amyotrophic Lateral Sclerosis
			2018/10/24				./data/phs001694.v1.pht008494.v1.p1.HIV_CSF_Subject_Phenotypes.var_report.xml									phs001694.v1.p1	MicroRNAs
			2020/12/21				./data/phs000007.v32.pht000039.v13.p13.vr_cancer_2019_a_1162s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/02/19				./data/phs002273.v1.pht010905.v1.p1.Urine_cfDNA_Sample.var_report.xml									phs002273.v1.p1	Cell-Free Nucleic Acids
			2020/12/21				./data/phs000007.v32.pht010729.v1.p13.l_scler_ex03_3b_1190s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			08/26/2013				./data/phs000362.v1.pht003231.v1.p1.ESP_FamilialAtrialFibrillation_Sample_Attributes.var_report.xml									phs000362.v1.p1	Atrial Fibrillation
			11/08/2013				./data/phs000200.v9.pht003409.v1.p3.outc_death_rel4.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2018/04/16				./data/phs000862.v1.pht007837.v1.p1.general_eligibility_form.var_report.xml									phs000862.v1.p1	Mucopolysaccharidosis I
			04/24/2015				./data/phs000629.v1.pht003385.v1.p1.Familial_Lung_Cancer_Subject.var_report.xml									phs000629.v1.p1	Lung Neoplasms
			2020/03/04				./data/phs000876.v2.pht005185.v2.p1.TRICL_Sample.var_report.xml									phs000876.v2.p1	Lung Neoplasms
			01/19/2010				./data/phs000219.v1.pht001057.v1.p1.d_bnediag_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2018/06/14				./data/phs001238.v2.pht006030.v1.p1.GENOA_AfricanAmerican_CKD_Exam.var_report.xml									phs001238.v2.p1	Hypertension
			06/03/2015				./data/phs000863.v1.pht004742.v1.p1.RCC_AA_Subject.var_report.xml									phs000863.v1.p1	Carcinoma, Renal Cell
			2019/06/24				./data/phs001836.v1.pht009217.v1.p1.Neocortical_Development_Subject.var_report.xml									phs001836.v1.p1	Autism Spectrum Disorder
			11/13/2015				./data/phs000820.v1.pht004330.v1.p1.Lone_Atrial_Fibrillation_Subject.var_report.xml									phs000820.v1.p1	Atrial Fibrillation
			2019/07/16				./data/phs001826.v1.pht009139.v1.p1.IHS_Depression_Subject_Phenotypes.var_report.xml									phs001826.v1.p1	Depression
4.0	5.0		08/09/2013	9.0		4.0	./data/phs000636.v1.pht003426.v1.p1.Familial_Intracranial_Aneurysm_Sequence_Pedigree.var_report.xml	0.0	4.5	8.485	5.0			4.5		phs000636.v1.p1	Intracranial Aneurysm
26.0	232.0		03/01/2016	258.0		26.0	./data/phs000942.v1.pht004836.v1.p1.Cancer_Genetics_Clinic_Subject_Phenotypes.var_report.xml	0.0	129.0	145.7	232.0			129.0		phs000942.v1.p1	Neoplasms
			08/20/2013				./data/phs000285.v3.pht001685.v2.p2.C1F42A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/04/07				./data/phs002304.v1.pht010850.v1.p1.GEARS_Sample.var_report.xml									phs002304.v1.p1	Rhabdomyosarcoma
			2019/09/27				./data/phs001648.v2.pht008910.v2.p1.mCRPC_Sample_Attributes.var_report.xml									phs001648.v2.p1	Prostatic Neoplasms, Castration-Resistant
			2019/06/03				./data/phs001292.v2.pht007851.v2.p1.eligibility.var_report.xml									phs001292.v2.p1	Angelman Syndrome
			2018/11/21				./data/phs001746.v1.pht008568.v1.p1.GTEx_WGBS_Sample.var_report.xml									phs001746.v1.p1	Reference Values
			2019/02/21				./data/phs001281.v2.pht006131.v2.p1.limited_data_set.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2017/10/03				./data/phs001464.v1.pht006969.v1.p1.HLA_Class_I_Antigen_Lung_Cancer_Subject.var_report.xml									phs001464.v1.p1	Carcinoma, Non-Small-Cell Lung
			2020/04/29				./data/phs000185.v7.pht005972.v2.p1.Hutterites_98WGS_Sample_Attributes.var_report.xml									phs000185.v7.p1	Prospective
			2018/09/26				./data/phs001410.v1.pht008422.v1.p1.GMKF_AIS_Sample.var_report.xml									phs001410.v1.p1	Scoliosis
			01/19/2010				./data/phs000219.v1.pht001068.v1.p1.d_csa04_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000418.v2.p3.simphen019.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/27/2009				./data/phs000016.v2.pht000050.v2.p2.ConnersParent.var_report_2009_11_27.xml									phs000016.v2.p2	Attention Deficit Disorder with Hyperactivity
			2017/09/22				./data/phs001392.v1.pht006898.v1.p1.pidtc_17560_baselinea.var_report.xml									phs001392.v1.p1	Severe Combined Immunodeficiency
			2019/03/11				./data/phs000286.v6.pht008787.v1.p2.stsa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
1.0	3.0		2021/05/17	4.0		2.0	./data/phs001134.v1.pht011225.v1.p1.Chernobyl_PTC_Pedigree.var_report.xml	0.0	2.0	1.414	3.0			2.0		phs001134.v1.p1	Thyroid Cancer, Papillary
			2020/01/23				./data/phs000287.v7.pht001464.v1.p1.EVENT_SUMMARY.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/07/15				./data/phs001600.v2.pht011022.v2.p2.TOPMed_CCDG_CATHGEN_Sample_Attributes.var_report.xml									phs001600.v2.p2	Atrial Fibrillation
			02/27/2015				./data/phs000170.v2.pht003533.v1.p1.Marshfield_Sample_Attributes.var_report.xml									phs000170.v2.p1	Cataract
3187.0	3187.0		01/07/2016	3592.0		405.0	./data/phs000814.v1.pht004583.v1.p1.MIGen_Exome_Italian_ATVB_Subject_Phenotypes.var_report.xml	0.0	911.5	963.8	405.0			911.5		phs000814.v1.p1	Coronary Artery Disease
			2020/01/07				./data/phs001518.v1.pht007333.v1.p1.TRIUMPH_Subject_Phenotypes.var_report.xml									phs001518.v1.p1	Myocardial Infarction
			2020/11/19				./data/phs002050.v1.pht010358.v1.p1.OICR_CRC_Sample.var_report.xml									phs002050.v1.p1	Colorectal Neoplasms
336.0	466.0		04/01/2010	802.0		336.0	./data/phs000089.v3.pht000177.v3.p2.cde_ctl.var_report_2010_04_01.xml	0.0	401.0	91.92	466.0			401.0		phs000089.v3.p2	Parkinson Disease
			2021/05/07				./data/phs001327.v2.pht011193.v1.p1.sibneoplasm.var_report.xml									phs001327.v2.p1	Neoplasm
			2020/01/10				./data/phs001956.v1.pht009786.v1.p1.sc_Liver_Sample.var_report.xml									phs001956.v1.p1	
			2020/12/21				./data/phs000007.v32.pht007774.v2.p13.vr_dgai2010_ex08_1_1009s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/04/12				./data/phs001411.v1.pht007726.v1.p1.ACCORD_Sample_Attributes.var_report.xml									phs001411.v1.p1	Diabetes Mellitus, Type 2
			05/20/2015				./data/phs000180.v3.pht000792.v2.p2.T1DGC_Sample.var_report.xml									phs000180.v3.p2	Diabetes Mellitus, Type 1
			03/13/2015				./data/phs000873.v1.pht004555.v1.p1.Bleeding_Disorders_Subject.var_report.xml									phs000873.v1.p1	Thrombocytopenia
			2017/12/04				./data/phs001419.v1.pht007082.v1.p1.INC_6601_Subject.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
			2020/01/10				./data/phs001956.v1.pht009785.v1.p1.sc_Liver_Subject.var_report.xml									phs001956.v1.p1	
			2018/06/01				./data/phs001046.v1.pht005298.v1.p1.AMD_Progression_Treatment_Response_Sample_Attributes.var_report.xml									phs001046.v1.p1	Macular Degeneration
			2021/05/25				./data/phs001945.v1.pht010489.v1.p1.CIDR_ACCME_Sample_Attributes.var_report.xml									phs001945.v1.p1	Uterine Cervical Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000403.v2.p3.simphen004.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			10/30/2013				./data/phs000659.v1.pht003521.v1.p1.Ileal_Pouch_Microbiome_Subject.var_report.xml									phs000659.v1.p1	Inflammatory Bowel Diseases
			01/07/2014				./data/phs000611.v1.pht003503.v1.p1.Breast_Cancer_Xenotransplants_Sample_Attributes.var_report.xml									phs000611.v1.p1	Breast Neoplasms
			2017/09/06				./data/phs001261.v1.pht006115.v1.p1.Palindromic_Gene_Amplification_Sample_Attributes.var_report.xml									phs001261.v1.p1	Breast Neoplasms
			2020/12/30				./data/phs002290.v1.pht010824.v1.p1.cfDNA_Metastasis_Sample_Attributes.var_report.xml									phs002290.v1.p1	Cell-Free Nucleic Acids
	1.0		2019/10/29	1.0		1.0	./data/phs001924.v1.pht009575.v1.p1.Cholangiocarcinoma_Subject_Phenotypes.var_report.xml	0.0	1.0		1.0			1.0		phs001924.v1.p1	Cholangiocarcinoma
			2018/12/28				./data/phs001663.v1.pht008401.v1.p1.GBM_POLE_Deficiency_Subject.var_report.xml									phs001663.v1.p1	Glioblastoma
			12/03/2009				./data/phs000169.v1.pht000731.v1.p1.HABC_Sample.var_report.xml									phs000169.v1.p1	Obesity
			11/05/2014				./data/phs000209.v13.pht001529.v2.p3.MESA_FamilyEyeRetinalPhoto.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2017/12/20				./data/phs000577.v1.pht007267.v1.p1.deathrecord.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2019/06/14				./data/phs000589.v1.pht009181.v1.p1.baseline_comordity_form.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/06/18				./data/phs000280.v7.pht004155.v2.p1.RHXCOD32.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			12/11/2012				./data/phs000383.v1.pht002868.v1.p1.ROOT_Breast_Cancer_Subject.var_report.xml									phs000383.v1.p1	Breast Neoplasms
			07/05/2017	0.0			./data/phs000595.v1.pht006637.v1.p1.medical_history.var_report.xml	615.0								phs000595.v1.p1	Primary ciliary dyskinesia
			08/20/2013				./data/phs000285.v3.pht001734.v2.p2.D1F9PRG3.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/03/25				./data/phs001415.v1.pht006685.v1.p1.CIDR_GECCO_CRC_Sample.var_report.xml									phs001415.v1.p1	
			2021/06/25				./data/phs001466.v2.pht009578.v1.p1.TOPMed_WGS_PharmHU_Sample.var_report.xml									phs001466.v2.p1	Sickle Cell Anemia
			03/22/2013				./data/phs000327.v1.pht003011.v1.p1.ESP_HeartGO_SWISS_Sample.var_report.xml									phs000327.v1.p1	Stroke
			2018/02/08				./data/phs001488.v1.pht007406.v1.p1.mhxdxhd1.var_report.xml									phs001488.v1.p1	Huntington Disease
			2020/02/06				./data/phs001430.v2.pht008070.v2.p1.p7001_15785_bionutrit.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			2021/08/20				./data/phs002557.v1.pht011483.v1.p1.PID_LRBA_Sample_Attributes.var_report.xml									phs002557.v1.p1	LRBA protein, human
			2020/06/30				./data/phs001972.v1.pht009842.v1.p1.REDS_BSCDC_Sample.var_report.xml									phs001972.v1.p1	Anemia, Sickle Cell
			11/08/2013				./data/phs000200.v9.pht001512.v2.p3.outc_strk_carotid_cad_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/06/18				./data/phs000280.v7.pht004204.v2.p1.TIAE04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			11/07/2014				./data/phs000826.v1.pht004334.v1.p1.Adjuvant_Trastuzumab_Breast_Cancer_Subject.var_report.xml									phs000826.v1.p1	Breast Neoplasms
6.0	6.0		03/19/2015	2.0		4.0	./data/phs000869.v1.pht004608.v1.p1.BEAGESS_Pedigree.var_report.xml	0.0	5.0	1.414	4.0			5.0		phs000869.v1.p1	Esophageal Neoplasms
56.0	56.0		06/20/2014	95.0		626.0	./data/phs000439.v1.pht002932.v1.p1.PGRN_RIKEN_Rate_Ctrl_Subject_Phenotypes.var_report.xml	0.0	96.0	76.37	626.0			96.0		phs000439.v1.p1	Atrial Fibrillation
			03/03/2011				./data/phs000259.v2.pht001247.v2.p1.HMP_Urethral_Males_Symptoms_Data.var_report.xml									phs000259.v2.p1	Urethritis
			2020/11/27				./data/phs002060.v1.pht010590.v1.p1.CALGB_40502_Sample.var_report.xml									phs002060.v1.p1	Peripheral Nervous System Diseases
			04/20/2012				./data/phs000390.v1.pht002326.v1.p1.Female_Osteoporosis_Risk_Genes_Sample.var_report.xml									phs000390.v1.p1	Osteoporosis
			2021/09/28				./data/phs002001.v1.pht010097.v1.p1.Osimertinib_EGFR_LC_Sample.var_report.xml									phs002001.v1.p1	Lung Neoplasms
			01/06/2015				./data/phs000811.v1.pht004398.v1.p1.Targeted_DNA_NGS_Subject.var_report.xml									phs000811.v1.p1	Neoplasms
			2019/03/20				./data/phs001715.v1.pht008843.v1.p1.eligibility_checklist.var_report.xml									phs001715.v1.p1	Vasculitis
676.0			07/25/2014	2402.0			./data/phs000779.v1.pht003963.v1.p1.OFCCR_SNP_CpG_Subject_Phenotypes.var_report.xml	0.0			682.0					phs000779.v1.p1	Colorectal Neoplasms
			2020/11/13				./data/phs001584.v2.pht009073.v2.p2.eMERGE_III_HRC_Sample_Attributes.var_report.xml									phs001584.v2.p2	
			11/05/2014				./data/phs000209.v13.pht004316.v1.p3.MESA_ancilmesalungvariant.var_report.xml									phs000209.v13.p3	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht002566.v4.p13.l_mtbli2_ex05_1_0660s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/02/22				./data/phs001739.v1.pht008796.v1.p1.sPTB_Sample_Attributes.var_report.xml									phs001739.v1.p1	Premature Birth
			04/18/2012				./data/phs000369.v1.pht002585.v1.p1.Breast_Carcinoma_Subtypes_Subject.var_report.xml									phs000369.v1.p1	Carcinoma, Ductal, Breast
			2021/02/24				./data/phs002342.v1.pht011002.v1.p1.Polyepitope_Neoantigen_DNA_Vaccines_Sample.var_report.xml									phs002342.v1.p1	Carcinoma, Neuroendocrine
			08/20/2013				./data/phs000285.v3.pht001860.v2.p2.F2HRV.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
124.0	455.0		01/19/2010	680.0		3.0	./data/phs000219.v1.pht001059.v1.p1.d_care_info.var_report_2010_01_19.xml	0.0	340.0	162.6	2.0			340.0		phs000219.v1.p1	Alzheimer Disease
			2017/12/04				./data/phs001385.v1.pht007163.v1.p1.Gallbladder_Cancer_Chileans_Subject.var_report.xml									phs001385.v1.p1	Gallbladder Neoplasms
			2021/09/30				./data/phs002614.v1.pht011591.v1.p1.BWS_HB_Sample_Attributes.var_report.xml									phs002614.v1.p1	Beckwith-Wiedemann Syndrome
			2021/05/11				./data/phs000954.v4.pht006298.v2.p2.TOPMed_WGS_CFS_Sample.var_report.xml									phs000954.v4.p2	Sleep Apnea Syndromes
			02/13/2014				./data/phs000372.v1.pht002856.v1.p1.ADGC_Subject.var_report.xml									phs000372.v1.p1	Alzheimer Disease
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000532.v2.p3.simphen133.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			02/27/2017				./data/phs001036.v1.pht005269.v1.p1.Acral_Melanoma_Sample.var_report.xml									phs001036.v1.p1	Melanoma
592.0	6525.0		2020/11/13	6489.0		7.0	./data/phs001584.v2.pht009072.v2.p2.eMERGE_III_HRC_CaseControl.var_report.xml	0.0	8881.0	990.7	6525.0			5452.0		phs001584.v2.p2	
922.0	50.0		01/06/2010	78.0		922.0	./data/phs000199.v1.pht000890.v1.p1.CHOP_CNV_Data.var_report_2010_01_06.xml	0.0	39.0	15.56	50.0			39.0		phs000199.v1.p1	Normalcy
			11/04/2014				./data/phs000086.v3.pht000270.v1.p1.DCCT_ms7exgee.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
60.0	60.0		2019/11/27	9.0		56.0	./data/phs001177.v2.pht006091.v1.p1.Familial_Melanoma_Pedigree.var_report.xml	0.0	58.0	2.828	56.0			58.0		phs001177.v2.p1	Melanoma, Cutaneous Malignant
			08/26/2013				./data/phs000619.v1.pht003355.v1.p1.Autism_Epigenetics_Sample_Attributes.var_report.xml									phs000619.v1.p1	Autistic Disorder
			07/05/2017				./data/phs000595.v1.pht006643.v1.p1.spirometry.var_report.xml									phs000595.v1.p1	Primary ciliary dyskinesia
			2019/10/07				./data/phs001351.v1.pht009411.v1.p1.Inherited_Neuropathy_Sample.var_report.xml									phs001351.v1.p1	Inherited Peripheral Neuropathy
			04/29/2015				./data/phs000710.v1.pht003987.v1.p1.Cloud_Testing_Sample.var_report.xml									phs000710.v1.p1	Test study for cloud access
			2020/08/05				./data/phs001815.v1.pht009012.v1.p1.MHGRID_Sample_Attributes.var_report.xml									phs001815.v1.p1	Hypertension
			11/30/2016				./data/phs001210.v1.pht005962.v1.p1.Lung_Cancer_Smoking_AA_Sample.var_report.xml									phs001210.v1.p1	Lung Neoplasms
			2020/02/19				./data/phs001221.v1.pht007162.v1.p1.Prostate_Cancer_GWAS_Sample_Attributes.var_report.xml									phs001221.v1.p1	Prostatic Neoplasms
8.0	8.0		2020/02/04	3.0		8.0	./data/phs001507.v1.pht008696.v1.p1.ET_Turkish_Pedigree.var_report.xml	0.0	8.0	2.121	8.0			8.0		phs001507.v1.p1	Essential Tremor
			2021/04/27				./data/phs001908.v2.pht009532.v2.p1.Spatiotemporal_Cerebellum_Sample.var_report.xml									phs001908.v2.p1	Neural Stem Cells
363.0	532.0		08/29/2016	895.0		363.0	./data/phs000126.v2.pht000322.v2.p1.CIDR_PD_Control.var_report.xml	0.0	447.5	119.5	532.0			447.5		phs000126.v2.p1	Parkinson Disease
			2020/11/02				./data/phs001899.v2.pht009568.v2.p1.CSI_Subject.var_report.xml									phs001899.v2.p1	Immunologic Deficiency Syndromes
	897.0		02/01/2016	722.0		882.0	./data/phs000332.v3.pht002338.v2.p2.CIDR_Preterm_Birth_Boston_Subject_Phenotypes.var_report.xml	0.0	889.5	12.02	722.0			889.5		phs000332.v3.p2	Infant, Premature
			08/20/2013				./data/phs000285.v3.pht001554.v3.p2.CARDIA_Cohort_Subject.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			Thu Nov 20 13:22:56 2008				./data/phs000139.v1.pht000621.v1.p1.TRIOS_IMSGC_Data.var_report_2008_11_26.xml									phs000139.v1.p1	Multiple Sclerosis
5031.0	7019.0		2021/08/08	12050.0		5031.0	./data/phs001644.v2.pht009946.v2.p2.TOPMed_CCDG_BioME_Subject_Phenotypes.var_report.xml	0.0	6025.0	1406	7019.0			6025.0		phs001644.v2.p2	Coronary Artery Disease
3.0			05/26/2016	6.0			./data/phs001107.v1.pht005490.v1.p1.VHL_Renal_Tumors_Subject_Phenotypes.var_report.xml	0.0			3.0					phs001107.v1.p1	von Hippel-Lindau Disease
			2018/05/31				./data/phs001318.v1.pht008025.v1.p1.registration.var_report.xml									phs001318.v1.p1	Myelodysplastic Syndromes
			2019/02/19				./data/phs001649.v1.pht008517.v1.p1.CEDAR_Sample_Attributes.var_report.xml									phs001649.v1.p1	Substance-Related Disorders
			07/18/2012				./data/phs000395.v1.pht002364.v1.p1.CIDR_Mammographic_Density_Sample_Attributes.var_report.xml									phs000395.v1.p1	Breast Neoplasms
			08/06/2010				./data/phs000182.v2.pht000797.v1.p1.AMD_MMAP_Sample.var_report_2010_08_06.xml									phs000182.v2.p1	Macular Degeneration
			07/21/2015				./data/phs000938.v1.pht004784.v1.p1.WES_HybCapture_vs_Amplicon_Sample.var_report.xml									phs000938.v1.p1	
			2020/12/21				./data/phs000007.v32.pht000104.v8.p13.pft1_6s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001073.v1.p1.d_csa07_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/06/02				./data/phs002419.v1.pht011264.v1.p1.BC_Subject_Phenotypes.var_report.xml									phs002419.v1.p1	Breast Neoplasms
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000490.v2.p3.simphen091.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/07/18				./data/phs001615.v1.pht008243.v1.p1.RA_FLS_GEO.var_report.xml									phs001615.v1.p1	Arthritis, Rheumatoid
			10/05/2010				./data/phs000188.v1.pht000979.v1.p1.QRS_ICD.var_report_2010_10_05.xml									phs000188.v1.p1	Heart Conduction System
			04/13/2015				./data/phs000874.v1.pht004654.v1.p1.GERFHS_Subject.var_report.xml									phs000874.v1.p1	Intracerebral Hemorrhage
9.0	9.0		09/12/2014	5.0		5.0	./data/phs000793.v1.pht004022.v1.p1.AML_Epigenetics_Subject_Phenotypes.var_report.xml	0.0	9.0	5.657	5.0			9.0		phs000793.v1.p1	Leukemia, Myeloid, Acute
			2018/07/23				./data/phs000742.v1.pht008120.v1.p1.7_13_AED_Header.var_report.xml									phs000742.v1.p1	Epilepsy
			2020/06/18				./data/phs000280.v7.pht004042.v2.p1.BPUA03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001660.v2.p2.C1F09MHB.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
1789.0	367.0		2021/08/03	542.0		1789.0	./data/phs001591.v1.pht009694.v1.p1.CIDR_COHRA_Subject_Phenotypes.var_report.xml	0.0	271.0	962.4	367.0			271.0		phs001591.v1.p1	Dental Caries
			2020/12/02				./data/phs002287.v1.pht010713.v1.p1.ER_Positive_BC_GEO.var_report.xml									phs002287.v1.p1	Breast Neoplasms
			2018/11/30				./data/phs001578.v1.pht007876.v1.p1.Preterm_Infant_Microbiome_Subject_Phenotypes.var_report.xml									phs001578.v1.p1	Microbiota
			2019/05/07				./data/phs001329.v2.pht009040.v1.p1.adverse_event.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/08/26				./data/phs001831.v1.pht009169.v1.p1.Neuroblastoma_Epigenetics_Sample_Attributes.var_report.xml									phs001831.v1.p1	Neuroblastoma
85.0			02/29/2012	32.0			./data/phs000402.v1.pht002539.v1.p1.ESP_HeartGO_JHS_LDLandEOMI_Subject_Phenotypes.var_report_2012_02_29.xml	0.0			78.0					phs000402.v1.p1	Cardiovascular Diseases
			2020/01/23				./data/phs000287.v7.pht001493.v1.p1.YR7.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2021/06/11				./data/phs002208.v1.pht010501.v1.p1.BAL_HCT_Sample_Attributes.var_report.xml									phs002208.v1.p1	Hematopoietic Stem Cell Transplantation
1271.0			2021/07/19	2210.0			./data/phs001601.v2.pht010664.v2.p2.PMBB_AF_Subject.var_report.xml	0.0			939.0					phs001601.v2.p2	Atrial Fibrillation
			2021/05/07				./data/phs001327.v2.pht011192.v1.p1.secondneoplasm.var_report.xml									phs001327.v2.p1	Neoplasm
387.0	387.0		Tue Mar  4 09:22:57 2008	664.0		277.0	./data/phs000048.v1.pht000184.v1.p1.uploaddemot2.var_report_2008_08_12.xml	0.0	332.0	77.78	277.0			332.0		phs000048.v1.p1	Parkinson Disease
			2019/12/19				./data/phs001713.v1.pht008525.v1.p1.LCCC_1108_Sample_Attributes.var_report.xml									phs001713.v1.p1	Neoplasms
328.0	380.0		10/16/2014	708.0		328.0	./data/phs000713.v1.pht004273.v1.p1.GDNF_Anxiety_Depression_Subject_Phenotypes.var_report.xml	0.0	354.0	36.77	380.0			354.0		phs000713.v1.p1	Anxiety
			2021/01/27				./data/phs000584.v1.pht010799.v1.p1.CIDR_Longevity_Sample_Attributes.var_report.xml									phs000584.v1.p1	Longevity
			02/23/2017				./data/phs001253.v1.pht006164.v1.p1.Efavirenz_CNS_Symptoms_Sample.var_report.xml									phs001253.v1.p1	Central Nervous System Diseases
			2020/10/29				./data/phs002258.v1.pht010605.v1.p1.SARS_CoV2_LAMP_RNASeq_Subject.var_report.xml									phs002258.v1.p1	COVID-19
			2017/08/25				./data/phs001321.v1.pht006196.v1.p1.OncoArray_CIMBA_Sample.var_report.xml									phs001321.v1.p1	Breast Neoplasms
			11/04/2014				./data/phs000086.v3.pht000273.v1.p1.DCCT_f106cmb3.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			11/04/2014				./data/phs000086.v3.pht000262.v1.p1.DCCT_f028one.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			06/27/2011				./data/phs000344.v1.pht002168.v1.p1.Finnish_ALS_Subject.var_report.xml									phs000344.v1.p1	Amyotrophic Lateral Sclerosis
			01/13/2012				./data/phs000380.v1.pht002456.v1.p1.METABOCHIP_Subject.var_report.xml									phs000380.v1.p1	Obesity
			2021/06/25				./data/phs001466.v2.pht009577.v1.p1.TOPMed_WGS_PharmHU_Subject.var_report.xml									phs001466.v2.p1	Sickle Cell Anemia
			10/13/2009				./data/phs000210.v1.pht000900.v1.p1.MA27_Subject.var_report_2009_10_13.xml									phs000210.v1.p1	Breast Neoplasms
			04/05/2017				./data/phs000927.v1.pht004754.v1.p1.CSER_Carrier_Testing_Sample_Attributes.var_report.xml									phs000927.v1.p1	
26.0	36.0		2020/03/19	62.0		26.0	./data/phs001982.v1.pht010006.v1.p1.MFS_UPS_Subject_Phenotypes.var_report.xml	0.0	31.0	7.071	36.0			31.0		phs001982.v1.p1	Sarcoma, Soft Tissue
			10/21/2015				./data/phs000789.v1.pht004291.v1.p1.CSGNM_Subject_Phenotypes.var_report.xml									phs000789.v1.p1	
	889.0		06/05/2017	889.0		889.0	./data/phs001265.v1.pht006340.v1.p1.OncoArray_DRIVE_Subject_Phenotypes.var_report.xml	0.0	920.5	492.9	889.0			920.5		phs001265.v1.p1	Breast Neoplasms
			11/30/2016				./data/phs001210.v1.pht005964.v1.p1.Lung_Cancer_Smoking_AA_Sample_Attributes.var_report.xml									phs001210.v1.p1	Lung Neoplasms
			2020/06/29				./data/phs001180.v2.pht006990.v2.p1.GALAII_Sample.var_report.xml									phs001180.v2.p1	Lung Diseases
			2020/06/18				./data/phs000280.v7.pht004231.v2.p1.V1ECG.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/07/26				./data/phs001705.v1.pht009274.v1.p1.EMBLEM_Sample_Attributes.var_report.xml									phs001705.v1.p1	Burkitt Lymphoma
			2019/08/07				./data/phs001823.v1.pht009059.v1.p1.Lung_Cancer_Cell_Lines_Sample_Attributes.var_report.xml									phs001823.v1.p1	Carcinoma, Non-Small-Cell Lung
			2020/08/20				./data/phs002069.v1.pht010472.v1.p1.BAVM_Hemorrhage_Sample_Attributes.var_report.xml									phs002069.v1.p1	Intracranial Arteriovenous Malformations
			2018/09/17				./data/phs001154.v1.pht008373.v1.p1.CNV_Developmental_Disorders_Subject.var_report.xml									phs001154.v1.p1	Developmental Disabilities
			2019/04/10				./data/phs001048.v2.pht005659.v2.p1.FUSION_Tissue_Biopsy_Sample.var_report.xml									phs001048.v2.p1	Diabetes Mellitus, Type 2
			2018/06/30				./data/phs001646.v1.pht008196.v1.p1.GBM_Sample.var_report.xml									phs001646.v1.p1	Glioblastoma
137.0	137.0		2021/03/23	239.0		102.0	./data/phs001122.v1.pht008640.v1.p1.Neonatal_Brain_Subject_Phenotypes.var_report.xml	0.0	119.5	24.75	102.0			119.5		phs001122.v1.p1	Brain
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000511.v2.p3.simphen112.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2018/07/18				./data/phs001618.v1.pht008225.v1.p1.TIL_NSCLC_Subject.var_report.xml									phs001618.v1.p1	Neoplasms
			2020/06/18				./data/phs000280.v7.pht004190.v2.p1.RTAWM34.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/14/2017				./data/phs001365.v1.pht006410.v1.p1.NAC_Bevacizumab_Sample_Attributes.var_report.xml									phs001365.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004105.v2.p1.HHXCOD22.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/08/17				./data/phs001022.v1.pht005440.v1.p1.PsychENCODE_ASD_Subject.var_report.xml									phs001022.v1.p1	Autistic Disorder
			2020/06/02				./data/phs002030.v1.pht010264.v1.p1.MEIs_Transcriptom_Sample_Attributes.var_report.xml									phs002030.v1.p1	Reference Values
			2020/04/24				./data/phs001676.v1.pht009437.v1.p1.CCDG_Autism_SSC_Sample.var_report.xml									phs001676.v1.p1	Autism Spectrum Disorder
			2017/10/03				./data/phs001464.v1.pht006972.v1.p1.HLA_Class_I_Antigen_Lung_Cancer_Sample_Attributes.var_report.xml									phs001464.v1.p1	Carcinoma, Non-Small-Cell Lung
			2018/07/25				./data/phs001367.v1.pht008245.v1.p1.Add_Health_Subject.var_report.xml									phs001367.v1.p1	Adolescent Health
			11/21/2016				./data/phs000341.v2.pht002672.v2.p1.Hypodiploid_ALL_Subject.var_report.xml									phs000341.v2.p1	Precursor Cell Lymphoblastic Leukemia-Lymphoma
			12/19/2011				./data/phs000387.v1.pht002442.v1.p1.eMERGE_GeM_AAA_Subject.var_report.xml									phs000387.v1.p1	Abdominal Aortic Aneurysms
			2019/07/25				./data/phs001045.v1.pht009259.v1.p1.MECC_Ashkenazi_Subject.var_report.xml									phs001045.v1.p1	Colorectal Neoplasms
			2021/03/24				./data/phs000711.v7.pht003723.v6.p2.BH_CMG_Subject_Phenotypes.var_report.xml									phs000711.v7.p2	Mendelian Conditions
			2019/03/25				./data/phs001777.v1.pht008856.v1.p1.SCO_Syndrome_Subject.var_report.xml									phs001777.v1.p1	Sertoli Cell-Only Syndrome
			2020/07/23				./data/phs001992.v1.pht010284.v1.p1.C4_Imputation_Sample.var_report.xml									phs001992.v1.p1	
			2019/08/27				./data/phs001845.v1.pht009407.v1.p1.SDS_Sample.var_report.xml									phs001845.v1.p1	Shwachman syndrome [Supplementary Concept]
			2020/04/29				./data/phs000185.v7.pht008406.v1.p1.Hutterites_Nasal_Microbiome_Subject_Phenotypes.var_report.xml									phs000185.v7.p1	Prospective
			2021/03/05				./data/phs001388.v2.pht006877.v2.p1.SIGMA_DMS_Sample.var_report.xml									phs001388.v2.p1	Diabetes Mellitus, Type 2
			2019/02/22				./data/phs001739.v1.pht008794.v1.p1.sPTB_Sample.var_report.xml									phs001739.v1.p1	Premature Birth
			2019/10/07				./data/phs001854.v1.pht009254.v1.p1.BRAF_PA_Sample_Attributes.var_report.xml									phs001854.v1.p1	Astrocytoma
			2019/12/26				./data/phs001949.v1.pht009705.v1.p1.P3DT_Sample.var_report.xml									phs001949.v1.p1	Diabetes Mellitus, Type 1
			08/12/2016				./data/phs000888.v1.pht005573.v1.p1.BPH_submission.var_report.xml									phs000888.v1.p1	
688.0	943.0		2017/12/04	989.0		688.0	./data/phs000906.v1.pht007149.v1.p1.eMERGE_PGx_Subject_Phenotypes.var_report.xml	0.0	815.5	547.3	943.0			815.5		phs000906.v1.p1	Pharmacogenetics
			2017/12/12				./data/phs001405.v1.pht006827.v1.p1.GSK1120212_TNBC_Kinome_Sample.var_report.xml									phs001405.v1.p1	Triple Negative Breast Neoplasms
			05/02/2017				./data/phs001358.v1.pht006335.v1.p1.RareBliss_Sample.var_report.xml									phs001358.v1.p1	Bipolar Disorder
			11/08/2013				./data/phs000200.v9.pht002774.v1.p3.spec_results_rel2.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2021/08/05				./data/phs002499.v1.pht011447.v1.p1.CTCLs_JAK_STAT_Sample.var_report.xml									phs002499.v1.p1	Lymphoma, T-Cell, Cutaneous
			2020/01/23				./data/phs000287.v7.pht001463.v1.p1.DNA_DRAW_YEAR.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht003630.v5.p13.t_echorv_ex08_1b_0830s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/12/14				./data/phs001984.v1.pht010783.v1.p1.MN_Sample.var_report.xml									phs001984.v1.p1	Glomerulonephritis, Membranous
	2.0		2018/02/20	2.0		2.0	./data/phs001528.v1.pht007362.v1.p1.SCCOHT_Subject_Phenotypes.var_report.xml	0.0	2.0		2.0			2.0		phs001528.v1.p1	Ovarian Neoplasms
			11/04/2015				./data/phs001016.v1.pht005079.v1.p1.Radial_Glial_Diversity_Subject.var_report.xml									phs001016.v1.p1	Neuroglia
			2021/06/09				./data/phs001293.v3.pht008897.v1.p1.TOPMed_WGS_HyperGEN_Sample_Attributes.var_report.xml									phs001293.v3.p1	Hypertrophy, Left Ventricular
			05/24/2017				./data/phs000576.v1.pht006141.v1.p1.clinicalseverityscale.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2018/02/08				./data/phs001488.v1.pht007434.v1.p1.vitdose.var_report.xml									phs001488.v1.p1	Huntington Disease
			2019/05/24				./data/phs001830.v1.pht009119.v1.p1.FGFR2_CCA_Sample_Attributes.var_report.xml									phs001830.v1.p1	Cholangiocarcinoma
			2017/11/01				./data/phs001305.v1.pht007106.v1.p1.missedivinfusionlog.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
1624.0	354.0		03/06/2012	500.0		931.0	./data/phs000425.v1.pht002503.v1.p1.dbGAP_phenotype.var_report.xml	0.0	250.0	386.8	931.0			250.0		phs000425.v1.p1	Alcoholism
			2020/04/27				./data/phs002002.v1.pht010189.v1.p1.ILCs_HNSCC_Subject.var_report.xml									phs002002.v1.p1	Squamous Cell Carcinoma of the Head and Neck
661.0			05/02/2012	1222.0			./data/phs000456.v1.pht002644.v1.p1.RACE_Controls_1_Subject_Phenotypes.var_report.xml	0.0			561.0					phs000456.v1.p1	Stroke
			11/04/2014				./data/phs000086.v3.pht000328.v1.p1.EDIC_f0043.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
1678.0	240000.0		05/16/2017	387030.0		150000.0	./data/phs001252.v1.pht006395.v1.p1.sgrqc.var_report.xml	0.0	190000.0	62201	1052.0			190000.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			09/29/2015	19.0			./data/phs000892.v2.pht005012.v1.p2.CPTAC_BreastSubjectClinicalPhenotypes.var_report.xml	19.0			19.0					phs000892.v2.p2	
			09/21/2016				./data/phs000984.v1.pht005010.v1.p1.T2DM_Metformin_Basic_Data.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
2814.0	2814.0		2021/09/13	5419.0		2605.0	./data/phs000095.v4.pht001212.v4.p2.GENEVA_DentalCaries_Pedigree.var_report.xml	0.0	2710.0	247.5	2605.0			2710.0		phs000095.v4.p2	Dental Caries
			2021/06/23				./data/phs001027.v4.pht005215.v3.p1.Epigenetics_AML_Sample.var_report.xml									phs001027.v4.p1	Acute Myeloid Leukemia
			06/22/2016				./data/phs001012.v1.pht005547.v1.p1.Diabetes_Heart_Study_EA_Subject.var_report.xml									phs001012.v1.p1	Cardiovascular Diseases
			2020/02/14				./data/phs000575.v2.pht005888.v2.p1.concomitant_meds.var_report.xml									phs000575.v2.p1	Prader-Willi Syndrome
5.0			02/21/2012	25.0			./data/phs000400.v1.pht002536.v1.p1.HeartGO_CHS_LDL_PhenotypeDataFile.var_report.xml	0.0			20.0					phs000400.v1.p1	Cardiovascular Diseases
			08/18/2011				./data/phs000302.v1.pht002177.v1.p1.T2D_Proteinuria_Sample.var_report.xml									phs000302.v1.p1	Diabetic Nephropathies
			2018/09/26				./data/phs001130.v1.pht008419.v1.p1.NIDDM_Athero_Hispanic_Sample_Attributes.var_report.xml									phs001130.v1.p1	Diabetes Mellitus, Type 2
			2021/01/08				./data/phs002308.v1.pht010843.v1.p1.BM_MPN_Sample.var_report.xml									phs002308.v1.p1	Myeloproliferative Disorders
			2020/12/21				./data/phs000007.v32.pht001228.v3.p13.mest1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/07/13				./data/phs001798.v2.pht008948.v2.p2.23andMe_AfAmSeq_Sample_Attributes.var_report.xml									phs001798.v2.p2	
1686.0	2989.0		05/16/2017	4876.0		1887.0	./data/phs001252.v1.pht006383.v1.p1.factf.var_report.xml	0.0	2438.0	779.2	1054.0			2438.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
			09/29/2015				./data/phs000892.v2.pht004632.v2.p2.CPTAC_Sample_Attributes.var_report.xml									phs000892.v2.p2	
			2021/02/17				./data/phs001287.v9.pht006105.v9.p5.CPTAC_3_Sample.var_report.xml									phs001287.v9.p5	Neoplasms
			2020/09/18				./data/phs002015.v1.pht010361.v1.p1.AREDS2_Subject.var_report.xml									phs002015.v1.p1	Macular Degeneration
			03/31/2017				./data/phs000558.v1.pht006228.v1.p1.NEIGHBOR_POAG_Subject.var_report.xml									phs000558.v1.p1	Glaucoma
			05/19/2014				./data/phs000745.v1.pht003847.v1.p1.Alzheimers_Posterior_Cingulate_Astrocytes_Subject.var_report.xml									phs000745.v1.p1	Alzheimer Disease
			11/16/2015				./data/phs000896.v1.pht005123.v1.p1.LGG_Probiotics_Metagenome_Subject.var_report.xml									phs000896.v1.p1	Human Microbiome
			2018/12/10				./data/phs001720.v1.pht008594.v1.p1.Kidney_On_A_Chip_Subject.var_report.xml									phs001720.v1.p1	Podocytes
			2018/07/23				./data/phs000742.v1.pht008112.v1.p1.7_5_Demographics_New.var_report.xml									phs000742.v1.p1	Epilepsy
			2021/03/11				./data/phs001818.v3.pht009022.v3.p1.sc_GI_Cancer_Sample_Attributes.var_report.xml									phs001818.v3.p1	Stomach Neoplasms
			08/31/2015				./data/phs000958.v1.pht004958.v1.p1.CSER_MedSeq_Sample.var_report.xml									phs000958.v1.p1	Cardiomyopathies
1200.0			2017/08/16	2397.0			./data/phs001055.v1.pht005912.v1.p1.DeNovo_Mutation_Rates_Pedigree.var_report.xml	0.0			1197.0					phs001055.v1.p1	Preterm Birth
49.0	49.0		03/20/2013	94.0		11.0	./data/phs000573.v1.pht003216.v1.p1.DiffuseLargeBCellLymphoma_Subject_Phenotypes.var_report.xml	0.0	31.33	19.14	34.0			34.0		phs000573.v1.p1	Lymphoma, Large B-Cell, Diffuse
			02/27/2014				./data/phs000299.v2.pht001553.v2.p1.Genentech_NSCLC_Subject_Phenotypes.var_report.xml									phs000299.v2.p1	Lung Neoplasms
			08/05/2016				./data/phs000923.v1.pht005492.v1.p1.Germ_Cell_Tumors_Subject.var_report.xml									phs000923.v1.p1	Male Germ Cell Tumor
6.0	9.0		2021/09/28	15.0		6.0	./data/phs002001.v1.pht010098.v1.p1.Osimertinib_EGFR_LC_Subject_Phenotypes.var_report.xml	0.0	7.5	2.121	9.0			7.5		phs002001.v1.p1	Lung Neoplasms
			2021/07/30				./data/phs002444.v1.pht011384.v1.p1.Osteosarcoma_Sample.var_report.xml									phs002444.v1.p1	Osteosarcoma
			2020/12/21				./data/phs000007.v32.pht000828.v7.p13.meds1_8s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/11/19				./data/phs000572.v8.pht003391.v5.p4.ADSP_Pedigree.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			07/18/2011				./data/phs000226.v2.pht002289.v1.p1.STAMPEED_CHS_Sample.var_report.xml									phs000226.v2.p1	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005425.v1.p1.peneuro.var_report.xml									phs001065.v1.p1	Huntington Disease
2.0	2.0		2019/08/09	2.0		2.0	./data/phs001847.v1.pht009381.v1.p1.AML_Subject_Phenotypes.var_report.xml	0.0	2.0					2.0		phs001847.v1.p1	Leukemia, Myeloid, Acute
8.0	28.0		2020/02/27	50.0		8.0	./data/phs001774.v1.pht008803.v1.p1.AVSD_Pedigree.var_report.xml	0.0	25.0	4.95	28.0			25.0		phs001774.v1.p1	Complete atrioventricular septal defect
19.0	19.0		2021/03/25	37.0		18.0	./data/phs002235.v1.pht010954.v1.p1.GMbC_Microbiome_Subject.var_report.xml	0.0	18.5	0.7071	18.0			18.5		phs002235.v1.p1	Gastrointestinal Microbiome
			11/16/2016				./data/phs000935.v1.pht004816.v1.p1.CSER_PediSeq_Subject.var_report.xml									phs000935.v1.p1	Genetic Testing
			2020/09/03				./data/phs001903.v1.pht009893.v1.p1.OncoArray_CRC_Sample.var_report.xml									phs001903.v1.p1	Colorectal Neoplasms
			2020/06/18				./data/phs000280.v7.pht004096.v2.p1.GTSA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/06/2016				./data/phs000804.v1.pht005377.v1.p1.Ewing_Sarcoma_Sample_Attributes.var_report.xml									phs000804.v1.p1	Sarcoma, Ewing
18.0	23.0		2021/07/13	41.0		18.0	./data/phs002392.v1.pht011253.v1.p1.NPC_Subject.var_report.xml	0.0	20.5	3.536	23.0			20.5		phs002392.v1.p1	Niemann-Pick Disease, Type C
241.0	351.0		11/14/2016	592.0		241.0	./data/phs000827.v3.pht004471.v3.p1.CSER_NCGENES_Subject_Phenotypes.var_report.xml	0.0	296.0	77.78	351.0			296.0		phs000827.v3.p1	Genetic Diseases, Inborn
62.0			2018/06/13	99.0			./data/phs001521.v1.pht007722.v1.p1.Microbiota_S_Typhi_Subject_Phenotypes.var_report.xml	0.0			31.0					phs001521.v1.p1	Microbiota
			01/23/2017				./data/phs001246.v1.pht006086.v1.p1.Arhinia_Sample_Attributes.var_report.xml									phs001246.v1.p1	Arhinia, choanal atresia, and microphthalmia
			2019/06/03				./data/phs000624.v1.pht009129.v1.p1.LGRC_Subject.var_report.xml									phs000624.v1.p1	Pulmonary Disease, Chronic Obstructive
			Thu Nov 20 13:23:10 2008				./data/phs000139.v1.pht000623.v1.p1.TRIOS_IMSGC_Subject.var_report_2008_11_26.xml									phs000139.v1.p1	Multiple Sclerosis
			08/26/2013				./data/phs000619.v1.pht003351.v1.p1.Autism_Epigenetics_Subject.var_report.xml									phs000619.v1.p1	Autistic Disorder
			2018/07/09				./data/phs001650.v1.pht008203.v1.p1.LCL_Expansions_Subject.var_report.xml									phs001650.v1.p1	Control Groups
			12/11/2009				./data/phs000171.v1.pht000757.v1.p1.MS_DATA_FAMSMOB.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2019/05/16				./data/phs001761.v1.pht009027.v1.p1.MPNs_Chernobyl_Subject.var_report.xml									phs001761.v1.p1	Primary Myelofibrosis
			2020/01/02				./data/phs001895.v2.pht009442.v2.p1.Lung_Cancer_EA_AA_Subject.var_report.xml									phs001895.v2.p1	Lung Neoplasms
			2020/07/24				./data/phs001194.v3.pht005827.v2.p2.Demographics.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
6.0	7.0		11/15/2012	13.0		6.0	./data/phs000405.v1.pht002611.v1.p1.Mendelian_Malignant_Hyperthermia_Family.var_report.xml	0.0	6.5	0.7071	7.0			6.5		phs000405.v1.p1	Malignant Hyperthermia
			2018/07/23				./data/phs000742.v1.pht008105.v1.p1.EPGP_Subject.var_report.xml									phs000742.v1.p1	Epilepsy
			04/07/2017				./data/phs001174.v1.pht006241.v1.p1.Primary_Ovarian_Insufficiency_Sample.var_report.xml									phs001174.v1.p1	Infertility, Female
			08/20/2013				./data/phs000285.v3.pht001704.v2.p2.D1CATECH.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			07/06/2017				./data/phs001370.v1.pht006644.v1.p1.Uveal_Melanoma_Subject.var_report.xml									phs001370.v1.p1	Melanoma, Uveal
			2019/12/16				./data/phs001188.v2.pht006615.v2.p1.FUSION_Islet_Subject.var_report.xml									phs001188.v2.p1	Diabetes Mellitus, Type 2
			2020/12/21				./data/phs000007.v32.pht002570.v4.p13.l_vitb612f_ex01_3_0488s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/09				./data/phs000606.v1.pht007570.v1.p1.crf_followupvisitpart2.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			07/19/2012				./data/phs000494.v1.pht002798.v1.p1.eMERGE_Pediatric_CCHMC_Subject.var_report.xml									phs000494.v1.p1	Child Health
			2018/02/12				./data/phs001525.v1.pht007474.v1.p1.XDP_Subject.var_report.xml									phs001525.v1.p1	X-Linked Dystonia Parkinsonism
1243.0	1369.0		01/16/2015	2612.0		1243.0	./data/phs000763.v1.pht004255.v1.p1.COGA_Family_GWAS_Subject_Phenotypes.var_report.xml	0.0	1306.0	89.1	1369.0			1306.0		phs000763.v1.p1	Alcoholism
			2021/06/02				./data/phs002428.v1.pht011267.v1.p1.hTERT_Tandem_Repeats_Sample.var_report.xml									phs002428.v1.p1	Centenarian
			2021/08/13				./data/phs002405.v1.pht011238.v1.p1.PPGL_Sample_Attributes.var_report.xml									phs002405.v1.p1	Paraganglioma
			05/24/2016				./data/phs001065.v1.pht005431.v1.p1.uhdr2.var_report.xml									phs001065.v1.p1	Huntington Disease
			12/11/2009				./data/phs000171.v1.pht000768.v1.p1.MS_DATA_MHQMEDHIS1.var_report_2009_12_11.xml									phs000171.v1.p1	Multiple Sclerosis
			2018/04/16				./data/phs001326.v1.pht007817.v1.p1.p6902_18574_crf01pati.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2021/08/11				./data/phs002480.v1.pht011395.v1.p1.Glomerular_Disorders_Subject_Phenotypes.var_report.xml									phs002480.v1.p1	Glomerulonephritis
			01/19/2016				./data/phs000908.v1.pht004709.v1.p1.PD_Rare_Variants_Sample_Attributes.var_report.xml									phs000908.v1.p1	
			2021/07/14				./data/phs002484.v1.pht011399.v1.p1.Aging_Lungs_Sample.var_report.xml									phs002484.v1.p1	Lung
			2021/03/18				./data/phs002361.v1.pht011068.v1.p1.Pneumococcal_Vaccines_Elderly_Sample.var_report.xml									phs002361.v1.p1	
			2020/11/27				./data/phs002237.v1.pht010694.v1.p1.MMBIR_CGR_Sample_Attributes.var_report.xml									phs002237.v1.p1	Adenocarcinoma of Lung
			2018/06/14				./data/phs001238.v2.pht006660.v1.p1.GENOA_EuropeanAmerican_Phase2_FamilyHistory.var_report.xml									phs001238.v2.p1	Hypertension
			11/25/2013				./data/phs000661.v1.pht003541.v1.p1.Aggressive_Prostate_Carcinoma_Sample_Attributes.var_report.xml									phs000661.v1.p1	Neoplasms
			2018/07/18				./data/phs001615.v1.pht008241.v1.p1.RA_FLS_Subject.var_report.xml									phs001615.v1.p1	Arthritis, Rheumatoid
			02/25/2016				./data/phs001014.v1.pht005113.v1.p1.IRAS_Classic_Sample.var_report.xml									phs001014.v1.p1	Insulin Resistance
			2021/08/19				./data/phs001662.v2.pht010059.v1.p1.LTRC_R040_subject_labs.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2021/08/13				./data/phs001442.v3.pht010301.v1.p2.TEDDY_Cohort_casecntrl_t1dlist1.var_report.xml									phs001442.v3.p2	Diabetes Mellitus, Type 1
			01/19/2010				./data/phs000219.v1.pht001060.v1.p1.d_clockscale_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			12/01/2015				./data/phs000571.v3.pht003179.v3.p2.CopynumberResults.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
			07/21/2016				./data/phs000840.v1.pht005642.v1.p1.GoT2D_Sample.var_report.xml									phs000840.v1.p1	Type 2 Diabetes Mellitus
	5.0		2021/01/08	9.0		4.0	./data/phs002308.v1.pht010842.v1.p1.BM_MPN_Subject.var_report.xml	0.0	4.5	0.7071				4.5		phs002308.v1.p1	Myeloproliferative Disorders
			11/07/2012				./data/phs000538.v1.pht003040.v1.p1.Mendelian_Familial_Hyperlipidemia_Sample.var_report.xml									phs000538.v1.p1	Hyperlipidemia, Familial Combined
11.0	18.0		2021/02/12	29.0		11.0	./data/phs002334.v1.pht010957.v1.p1.EGFR_Driven_LUAD_Subject.var_report.xml	0.0	14.5	4.95	18.0			14.5		phs002334.v1.p1	Adenocarcinoma, Lung
			04/16/2012				./data/phs000476.v1.pht002671.v1.p1.Parathyroidism_Sample_Attributes.var_report.xml									phs000476.v1.p1	Pseudohypoparathyroidism
			2020/02/27				./data/phs000452.v3.pht002592.v3.p1.MelanomaCIP_Sample_Attributes.var_report.xml									phs000452.v3.p1	Melanoma
			2019/11/22				./data/phs000999.v3.pht005181.v3.p1.CSER_ClinSeq_Cancer_Sample.var_report.xml									phs000999.v3.p1	Colorectal Neoplasms
73.0	73.0		04/10/2014	106.0		33.0	./data/phs000340.v3.pht002209.v2.p1.ETP_T_ALL_Subject_Phenotypes.var_report.xml	0.0	53.0	28.28	33.0			53.0		phs000340.v3.p1	Leukemia, T-cell
			2019/03/01				./data/phs001775.v1.pht008808.v1.p1.Multiplex_AD_Families_Sample.var_report.xml									phs001775.v1.p1	Alcoholism
77.0	77.0		10/09/2009	9.0		7.0	./data/phs000093.v2.pht000698.v2.p2.PLCO_Eagle_Pedigree.var_report_2009_10_09.xml	0.0	9.5	8.485	7.0			9.5		phs000093.v2.p2	Lung Neoplasms
			2020/12/21				./data/phs000007.v32.pht010757.v1.p13.vr_npqerror_2018_a_1278s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/03/09				./data/phs000933.v2.pht004777.v2.p1.Melanoma_WES_Sample_Attributes.var_report.xml									phs000933.v2.p1	Melanoma
			2017/10/19				./data/phs001288.v1.pht006780.v1.p1.pregnancy_hx.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2019/10/25				./data/phs001858.v1.pht009371.v1.p1.Advanced_Cancer_Subject.var_report.xml									phs001858.v1.p1	Neoplasms
			2020/12/21				./data/phs000007.v32.pht005140.v3.p13.e_exam_ex09_1b_0844s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/07				./data/phs001741.v1.pht009162.v1.p1.CCDG_TASC_Subject.var_report.xml									phs001741.v1.p1	Autism Spectrum Disorder
			12/17/2013				./data/phs000662.v1.pht003561.v1.p1.NCS_AIM_Sample_Attributes.var_report.xml									phs000662.v1.p1	Population Groups
			04/06/2016				./data/phs001080.v1.pht005371.v1.p1.Hereditary_Spastic_Paraplegia_Sample.var_report.xml									phs001080.v1.p1	Spastic Paraplegia, Hereditary
			05/13/2015				./data/phs000769.v1.pht004718.v1.p1.LHMP_MIMARKS.var_report.xml									phs000769.v1.p1	HIV
9.0			2019/08/29	20.0			./data/phs001333.v2.pht006528.v2.p1.demographics.var_report.xml	0.0			11.0					phs001333.v2.p1	Fabry Disease
			2020/06/18				./data/phs000280.v7.pht009464.v2.p1.CCHIPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
91.0	91.0		2018/08/13	899.0		90.0	./data/phs001247.v1.pht008297.v1.p1.GMKF_CCDD_Pedigree.var_report.xml	0.0	90.5	3.536	90.0			90.5		phs001247.v1.p1	Cranial Nerve Diseases
991.0	991.0		2021/09/28	4048.0		910.0	./data/phs000988.v5.pht005248.v5.p1.TOPMed_WGS_Asthma_Costa_Rica_Subject_Phenotypes.var_report.xml	0.0	950.5	90.51	910.0			950.5		phs000988.v5.p1	Asthma
			08/20/2013				./data/phs000285.v3.pht001798.v2.p2.E1F9PRG3.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001765.v2.p2.E1F09MAD.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/12/2016				./data/phs000888.v1.pht005560.v1.p1.09aAtopic_dermatitis_hx.var_report.xml									phs000888.v1.p1	
			2018/06/14				./data/phs001238.v2.pht006653.v1.p1.GENOA_EuropeanAmerican_Phase1_Exam.var_report.xml									phs001238.v2.p1	Hypertension
			2020/08/04				./data/phs001793.v1.pht008902.v1.p1.PDGCL_Sample_Attributes.var_report.xml									phs001793.v1.p1	Glioma
352.0	352.0		06/19/2017	667.0		315.0	./data/phs001381.v1.pht006568.v1.p1.Gut_Microbiome_Colorectal_Polyps_Subject_Phenotypes.var_report.xml	0.0	333.5	26.16	315.0			333.5		phs001381.v1.p1	Colonic Polyps
			2019/03/05				./data/phs001788.v1.pht008818.v1.p1.CNICS_Sample_Attributes.var_report.xml									phs001788.v1.p1	HIV Infections
			08/20/2013				./data/phs000285.v3.pht001580.v2.p2.A4F17.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/10/24				./data/phs001352.v1.pht007067.v1.p1.Travelers_Diarrhea_Sample_Attributes.var_report.xml									phs001352.v1.p1	Diarrhea
			2018/02/08				./data/phs001488.v1.pht007381.v1.p1.cgi.var_report.xml									phs001488.v1.p1	Huntington Disease
			03/02/2016				./data/phs000267.v5.pht002304.v4.p2.Autism_Genome_Project_Sample.var_report.xml									phs000267.v5.p2	Autistic Disorder
			2020/03/19				./data/phs001970.v1.pht010023.v1.p1.DNAMethylation_RMS_Sample_Attributes.var_report.xml									phs001970.v1.p1	Rhabdomyosarcoma
1442.0	2059.0		04/20/2016	3501.0		1442.0	./data/phs000914.v1.pht005253.v1.p1.Samoans_Adiposity_Subject_Phenotypes.var_report.xml	0.0	1751.0	436.3	2059.0			1751.0		phs000914.v1.p1	Obesity
			10/27/2014				./data/phs000727.v1.pht003863.v1.p1.Alzheimers_Parkinsons_Extracellular_miRNA_Sample.var_report.xml									phs000727.v1.p1	Alzheimer Disease
			11/19/2013				./data/phs000436.v1.pht002832.v1.p1.Autism_Disorders_Subject.var_report.xml									phs000436.v1.p1	Autistic Disorder
			2020/01/16				./data/phs001960.v1.pht009823.v1.p1.Osteoporosis_Risk_Sample.var_report.xml									phs001960.v1.p1	Osteoporosis
			2020/06/18				./data/phs000280.v7.pht004184.v2.p1.RTAWF03.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
6472.0	9148.0		01/27/2017	15620.0		6472.0	./data/phs000428.v2.pht002614.v2.p2.HRS_Subject_Phenotypes.var_report.xml	0.0	7810.0	1892	9148.0			7810.0		phs000428.v2.p2	Aging
			2019/03/11				./data/phs000286.v6.pht008749.v1.p2.ftra.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/02/03				./data/phs000815.v2.pht006790.v2.p1.Human_Leukocytes_Subject.var_report.xml									phs000815.v2.p1	
1.0	1.0		2018/12/28	1.0		1.0	./data/phs001663.v1.pht008614.v1.p1.GBM_POLE_Deficiency_Subject_Phenotypes.var_report.xml	0.0	1.0					1.0		phs001663.v1.p1	Glioblastoma
			2019/04/25				./data/phs001673.v1.pht008509.v1.p1.ADAGESIII_Subject.var_report.xml									phs001673.v1.p1	Glaucoma
			12/27/2012				./data/phs000522.v1.pht002880.v1.p1.Hyperdiploid_Pediatric_ALL_Sample_Attributes.var_report.xml									phs000522.v1.p1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
			10/25/2011				./data/phs000303.v1.pht001896.v1.p1.KORA_Subject.var_report.xml									phs000303.v1.p1	Population Control
			2020/01/23				./data/phs000287.v7.pht001457.v1.p1.CARE_DDDIMER_WEIGHTS_1_10.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
4.0	8.0		2020/03/31	12.0		4.0	./data/phs001976.v2.pht009902.v1.p1.Melorheostosis_Subject_Phenotypes.var_report.xml	0.0	6.0	2.828	8.0			6.0		phs001976.v2.p1	Melorheostosis
			2020/05/07				./data/phs001997.v1.pht010216.v1.p1.GMKF_OFC_Subject.var_report.xml									phs001997.v1.p1	Cleft Lip
	864.0		2018/01/04	864.0		864.0	./data/phs001503.v1.pht007316.v1.p1.WIHS_Subject_Phenotypes.var_report.xml	0.0	864.0		864.0			864.0		phs001503.v1.p1	HIV
51.0	51.0		04/05/2017	95.0		83.0	./data/phs000987.v1.pht004968.v1.p1.WES_P1_22q11_Pedigree.var_report.xml	0.0	92.0	7.778	83.0			92.0		phs000987.v1.p1	DiGeorge Syndrome
			2018/04/12				./data/phs001457.v1.pht007052.v1.p1.AMP_RA_Subject.var_report.xml									phs001457.v1.p1	Arthritis, Rheumatoid
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000551.v2.p3.simphen152.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2021/05/04				./data/phs002387.v1.pht011179.v1.p1.GBHS_Sample_Attributes.var_report.xml									phs002387.v1.p1	Breast Neoplasms
			08/16/2013				./data/phs000623.v1.pht003336.v1.p1.Rare_Mendelian_Disease_Plain_Subject.var_report.xml									phs000623.v1.p1	Developmental Disabilities
			02/02/2012				./data/phs000417.v2.pht002400.v2.p1.Brain_Cloud_Sample_Attributes.var_report.xml									phs000417.v2.p1	Aging
			06/14/2010				./data/phs000263.v1.pht001428.v1.p1.HMP_Skin_Acne_TraceID.var_report.xml									phs000263.v1.p1	Acne Vulgaris
			2017/07/28				./data/phs001179.v1.pht005673.v1.p1.FM_AD_Sample.var_report.xml									phs001179.v1.p1	Neoplasms
			2019/03/11				./data/phs000286.v6.pht008739.v1.p2.built_environment.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
	3766.0		12/11/2012	3766.0		3766.0	./data/phs000383.v1.pht002870.v1.p1.ROOT_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0	3766.0		3766.0			3766.0		phs000383.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004099.v2.p1.HEMC31.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			01/15/2016				./data/phs000806.v1.pht004770.v1.p1.MIGen_Ottawa_Heart_Subject.var_report.xml									phs000806.v1.p1	
34.0			2021/08/25	50.0			./data/phs001728.v2.pht010124.v1.p1.TOPMed_WGS_CARE_BADGER_Subject_Phenotypes.var_report.xml	0.0			16.0					phs001728.v2.p1	Asthma
			2019/12/19				./data/phs001937.v1.pht009709.v1.p1.PEPP3_Sample.var_report.xml									phs001937.v1.p1	Pre-Eclampsia
			11/04/2014				./data/phs000086.v3.pht000331.v1.p1.EDIC_f0303.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2018/03/20				./data/phs000605.v1.pht007625.v1.p1.adverse_event.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			2019/06/14				./data/phs001824.v1.pht009115.v1.p1.pDC_HNSCC_Sample_Attributes.var_report.xml									phs001824.v1.p1	Dendritic Cells
			07/24/2017				./data/phs001088.v1.pht006669.v1.p1.DRIVE_SBCGS_Sample.var_report.xml									phs001088.v1.p1	Breast Neoplasms
			Wed Nov 26 07:50:31 2008				./data/phs000017.v3.pht000695.v1.p1.AA_GAIN4_Diagnosis.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2020/03/11				./data/phs001964.v1.pht009960.v1.p1.WHS_Accelerometer_d20180514_Pub.var_report.xml									phs001964.v1.p1	Physical Activity
			08/20/2013				./data/phs000285.v3.pht001555.v3.p2.CARDIA_Cohort_Sample.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
41.0	41.0		2021/07/09	82.0		41.0	./data/phs001772.v2.pht008635.v2.p1.NETs_Subject_Phenotypes.var_report.xml	0.0	41.0	0	41.0			41.0		phs001772.v2.p1	Intestinal Neoplasms
			05/17/2017				./data/phs001328.v1.pht006314.v1.p1.registration.var_report.xml									phs001328.v1.p1	Mucopolysaccharidoses
			03/28/2014				./data/phs000350.v1.pht002203.v1.p1.FHCRC_Prostate_Cancer_Sample_Attributes.var_report.xml									phs000350.v1.p1	Prostatic Neoplasms
			2021/03/31				./data/phs001561.v1.pht010998.v1.p1.CCGO_Subject_Phenotypes.var_report.xml									phs001561.v1.p1	Immunologic Deficiency Syndromes
			07/26/2017				./data/phs001357.v1.pht006697.v1.p1.TSC_Subject.var_report.xml									phs001357.v1.p1	Tuberous Sclerosis
			2018/11/07				./data/phs001691.v1.pht008538.v1.p1.HTX_Sample_Attributes.var_report.xml									phs001691.v1.p1	Heterotaxy Syndrome
1.0			04/29/2015	59.0			./data/phs000710.v1.pht003988.v1.p1.Cloud_Testing_Subject_Phenotypes.var_report.xml	0.0			2.0					phs000710.v1.p1	Test study for cloud access
			08/20/2013				./data/phs000285.v3.pht001819.v2.p2.F1F12.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			11/29/2012				./data/phs000541.v1.pht003051.v1.p1.Mendelian_Muscle_Hypertrophy_Sample_Attributes.var_report.xml									phs000541.v1.p1	Hypertrophy
58.0	58.0		03/22/2013	94.0		85.0	./data/phs000327.v1.pht003010.v1.p1.ESP_HeartGO_SWISS_Pedigree.var_report.xml	0.0	96.0	15.56	85.0			96.0		phs000327.v1.p1	Stroke
2.0	2.0		2019/10/07	3.0		2.0	./data/phs000924.v4.pht006323.v2.p1.iPSCORE_Subject_Phenotypes.var_report.xml	0.0	2.0	24.04	152.0			2.0		phs000924.v4.p1	Heart Diseases
			09/06/2016				./data/phs000804.v1.pht005375.v1.p1.Ewing_Sarcoma_Sample.var_report.xml									phs000804.v1.p1	Sarcoma, Ewing
			2021/02/08				./data/phs002335.v1.pht010943.v1.p1.CLL_Sample_Attributes.var_report.xml									phs002335.v1.p1	Leukemia
			05/08/2017	59.0			./data/phs001320.v1.pht006291.v1.p1.Placentation_Pregnancy_CVS_Sample_Attributes.var_report.xml	0.0								phs001320.v1.p1	Pre-eclampsia
			2020/11/30				./data/phs002295.v1.pht010688.v1.p1.CIMAC_CIDC_NSCLC_Sample_Attributes.var_report.xml									phs002295.v1.p1	Carcinoma, Non-Small-Cell Lung
			11/24/2015				./data/phs000824.v1.pht005136.v1.p1.Colon_Cancer_Predisposing_Mutations_Subject.var_report.xml									phs000824.v1.p1	Colorectal Neoplasms
			2019/09/27				./data/phs001576.v2.pht008219.v2.p2.P6705_PHYSICIAN_FLOW_SHEET_BASE.var_report.xml									phs001576.v2.p2	Mucopolysaccharidoses
			2017/12/08				./data/phs001279.v1.pht007211.v1.p1.lab_form.var_report.xml									phs001279.v1.p1	Bronchiectasis
			12/27/2012				./data/phs000524.v1.pht002919.v1.p1.CRIC_Sample_Attributes.var_report.xml									phs000524.v1.p1	Chronic Renal Insufficiency
			2021/07/20				./data/phs001882.v1.pht010491.v1.p1.OncoArray_FOCI_Sample.var_report.xml									phs001882.v1.p1	Carcinoma, Ovarian Epithelial
			2020/12/09				./data/phs002298.v1.pht010759.v1.p1.Skin_Pigmentation_AA_Sample.var_report.xml									phs002298.v1.p1	Skin Pigmentation (Melanin Index)
			2019/06/14				./data/phs000589.v1.pht009176.v1.p1.angiogram_leftlowerextremity.var_report.xml									phs000589.v1.p1	Takayasu Arteritis
			2020/10/16				./data/phs002245.v1.pht010532.v1.p1.COVID19_Sample_Attributes.var_report.xml									phs002245.v1.p1	COVID-19
			2020/06/18				./data/phs000280.v7.pht006421.v1.p1.ARIC_70AAs_4032.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/07				./data/phs001710.v1.pht011291.v1.p1.TOAA_Sample.var_report.xml									phs001710.v1.p1	
			2020/03/24				./data/phs001641.v1.pht010032.v1.p1.EMRlength.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2018/06/14				./data/phs001238.v2.pht006046.v1.p1.GENOA_AfricanAmerican_Phase2_Exam.var_report.xml									phs001238.v2.p1	Hypertension
			2020/01/10				./data/phs001471.v1.pht009800.v1.p1.HHL_Subject.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			2018/04/16				./data/phs001326.v1.pht007828.v1.p1.pidtc_18008_subsequen.var_report.xml									phs001326.v1.p1	Severe Combined Immunodeficiency
			2019/10/30				./data/phs001907.v1.pht009583.v1.p1.CPTAC_MiProt_Sample_Attributes.var_report.xml									phs001907.v1.p1	
			2018/09/17				./data/phs001687.v1.pht008360.v1.p1.WABCS_Sample_Attributes.var_report.xml									phs001687.v1.p1	Breast Neoplasms
			2019/10/29				./data/phs001465.v1.pht006956.v1.p1.Localized_Prostate_Cancer_Subject.var_report.xml									phs001465.v1.p1	Prostate Neoplasm
			08/18/2015				./data/phs000206.v5.pht000896.v4.p3.CGEMS_PANSCAN_Subject.var_report.xml									phs000206.v5.p3	Pancreatic Neoplasms
			2019/05/07				./data/phs001329.v2.pht007181.v2.p1.registration.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2020/02/05				./data/phs001957.v1.pht009840.v1.p1.DNA_Replication_Timing_Sample_Attributes.var_report.xml									phs001957.v1.p1	
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000512.v2.p3.simphen113.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004051.v2.p1.CHMA.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			09/21/2016				./data/phs000984.v1.pht005008.v1.p1.T2DM_Metformin_Subject.var_report.xml									phs000984.v1.p1	Diabetes Mellitus, Type 2
			2019/12/17				./data/phs001258.v2.pht006676.v2.p1.College_Athletes_Subject.var_report.xml									phs001258.v2.p1	MicroRNAs
102.0	12571.0		05/16/2017	18539.0		5968.0	./data/phs001252.v1.pht006398.v1.p1.smth.var_report.xml	0.0	9270.0	4669	47.0			9270.0		phs001252.v1.p1	Pulmonary Disease, Chronic Obstructive
57.0	57.0		2021/09/21	89.0		32.0	./data/phs002493.v1.pht011461.v1.p1.Neurogenesis_eQTL_sQTL_Subject.var_report.xml	0.0	44.5	17.68	32.0			44.5		phs002493.v1.p1	RNA-seq
38.0	38.0		2021/04/23	70.0		32.0	./data/phs002228.v1.pht010859.v1.p1.Deamination_Leukemia_Subject_Phenotypes.var_report.xml	0.0	35.0	4.243	32.0			35.0		phs002228.v1.p1	Myeloproliferative Disorders
			2019/10/11				./data/phs001406.v1.pht007751.v1.p1.metabolomics_ds.var_report.xml									phs001406.v1.p1	Cognition
			2018/05/03				./data/phs000304.v3.pht004468.v1.p1.GABC_Sample_Attributes.var_report.xml									phs000304.v3.p1	von Willebrand Disease
			04/24/2012				./data/phs000491.v1.pht002697.v1.p1.Renal_Cell_Carcinoma_Subject.var_report.xml									phs000491.v1.p1	Carcinoma, Renal Cell
			08/20/2013				./data/phs000285.v3.pht001590.v2.p2.A5F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/12/04				./data/phs001419.v1.pht007090.v1.p1.minimal_dataset.var_report.xml									phs001419.v1.p1	Charcot-Marie-Tooth Disease
15.0	15.0		10/14/2015	30.0		15.0	./data/phs000879.v1.pht005034.v1.p1.Relapsed_CLL_Subject_Phenotypes.var_report.xml	0.0	15.0	0	15.0			15.0		phs000879.v1.p1	Leukemia, Lymphocytic, Chronic, B-Cell
			04/23/2010				./data/phs000187.v1.pht000816.v1.p1.Melanoma_Sample.var_report_2010_04_23.xml									phs000187.v1.p1	Melanoma
			05/24/2016				./data/phs001065.v1.pht005436.v1.p1.uhdr7.var_report.xml									phs001065.v1.p1	Huntington Disease
			08/20/2013				./data/phs000285.v3.pht001567.v2.p2.A4F06Q18.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			05/02/2012				./data/phs000478.v1.pht002656.v1.p1.Strabismus_Sample.var_report.xml									phs000478.v1.p1	Strabismus
			2019/08/30				./data/phs001331.v2.pht006931.v2.p1.imd_14013_protocoldev.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			06/30/2016				./data/phs001096.v1.pht005609.v1.p1.T2D_GENES_KARE_East_Asian_Sample_Attributes.var_report.xml									phs001096.v1.p1	Diabetes Mellitus, Type 2
905.0	921.0		06/13/2014	621.0		905.0	./data/phs000687.v1.pht003693.v1.p1.Schizophrenia_De_Novo_Mutations_Pedigree.var_report.xml	0.0	913.0	3.536	921.0			913.0		phs000687.v1.p1	Schizophrenia
			01/06/2010				./data/phs000202.v1.pht000879.v1.p1.OMRF_SLEGEN_Subject.var_report_2010_01_06.xml									phs000202.v1.p1	Lupus Erythematosus, Systemic
			05/08/2015				./data/phs000864.v1.pht004495.v1.p1.Combat_Stress_Predictors_Sample_Attributes.var_report.xml									phs000864.v1.p1	Stress Disorders, Post-Traumatic
			2019/06/03				./data/phs001814.v1.pht009004.v1.p1.Heterotaxy_Subject.var_report.xml									phs001814.v1.p1	Heterotaxy Syndrome
			2020/06/18				./data/phs000280.v7.pht009480.v2.p1.SISps1.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
72.0	72.0		2021/04/06	130.0		58.0	./data/phs001163.v1.pht011098.v1.p1.Chernobyl_Radiation_Subject_Phenotypes.var_report.xml	0.0	65.0	9.899	58.0			65.0		phs001163.v1.p1	
			2020/12/21				./data/phs000007.v32.pht005141.v1.p13.e_exam_ex29_0_0210s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
15.0			2017/12/08	38.0			./data/phs001279.v1.pht007207.v1.p1.demographics_and_referral.var_report.xml	0.0			23.0					phs001279.v1.p1	Bronchiectasis
			2018/08/03				./data/phs000590.v1.pht008279.v1.p1.lab_results_form.var_report.xml									phs000590.v1.p1	Polyarteritis Nodosa
			2018/04/23				./data/phs000179.v6.pht002237.v3.p2.COPDGene_Subject.var_report.xml									phs000179.v6.p2	Pulmonary Disease, Chronic Obstructive
			2020/12/21				./data/phs000007.v32.pht002232.v7.p13.l_estr_2005_m_0604s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
72.0			2019/03/25	108.0			./data/phs001781.v1.pht008861.v1.p1.SCC_Subject_Phenotypes.var_report.xml	0.0			36.0					phs001781.v1.p1	Carcinoma, Non-Small-Cell Lung
			12/07/2015				./data/phs000482.v1.pht002883.v1.p1.Sporadic_Autism_Sample.var_report.xml									phs000482.v1.p1	Autistic Disorder
			07/21/2016				./data/phs000840.v1.pht005641.v1.p1.GoT2D_Subject.var_report.xml									phs000840.v1.p1	Type 2 Diabetes Mellitus
			11/15/2012				./data/phs000405.v1.pht002608.v1.p1.Mendelian_Malignant_Hyperthermia_Subject.var_report.xml									phs000405.v1.p1	Malignant Hyperthermia
			01/05/2016	1.0			./data/phs001028.v1.pht005130.v1.p1.Circulating_Tumor_Cells_MBC_Subject_Phenotypes.var_report.xml	0.0			1.0					phs001028.v1.p1	Breast Neoplasms
			2020/06/18				./data/phs000280.v7.pht004091.v2.p1.FTRA02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2021/06/03				./data/phs001961.v1.pht011028.v1.p1.LungMAP_Sample.var_report.xml									phs001961.v1.p1	Lung
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000517.v2.p3.simphen118.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			10/18/2016				./data/phs001205.v1.pht005850.v1.p1.Neural_Stem_Cell_Lineages_Subject.var_report.xml									phs001205.v1.p1	Neural Stem Cells
			2019/07/26				./data/phs000588.v1.pht009289.v1.p1.angiogram_rightupperextremity.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			2019/06/11				./data/phs001807.v1.pht008981.v1.p1.InTEAM_Meth_Sample_Attributes.var_report.xml									phs001807.v1.p1	Hepatitis, Alcoholic
			2018/07/23				./data/phs000742.v1.pht008115.v1.p1.7_8_Diagnostic_Interview_Header.var_report.xml									phs000742.v1.p1	Epilepsy
			07/18/2012				./data/phs000513.v1.pht002827.v1.p1.MAST_Kinase_Notch_Gene_Breast_Cancer_Sample_Attributes.var_report.xml									phs000513.v1.p1	Breast Neoplasms
			2020/10/29				./data/phs000450.v4.pht002527.v3.p1.DLBCL_Sample_Attributes.var_report.xml									phs000450.v4.p1	Hodgkin Disease
			09/20/2010				./data/phs000272.v1.pht001444.v1.p1.Behcets_Disease_Turk_Subject.var_report_2010_09_20.xml									phs000272.v1.p1	Behcet Syndrome
			04/12/2010				./data/phs000094.v1.pht001136.v1.p1.Oral_Clefts_Subject.var_report_2010_04_12.xml									phs000094.v1.p1	Cleft Palate
			2021/05/24				./data/phs002323.v1.pht010884.v1.p1.CITESeq_Sample_Attributes.var_report.xml									phs002323.v1.p1	Immunotherapy
			2020/12/21				./data/phs000007.v32.pht000827.v2.p13.meds0_28s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
96.0	96.0		2017/08/17	62.0		24.0	./data/phs001022.v1.pht005442.v1.p1.PsychENCODE_ASD_Subject_Phenotypes.var_report.xml	0.0	60.0	50.91	24.0			60.0		phs001022.v1.p1	Autistic Disorder
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000573.v2.p3.simphen174.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/26/2015				./data/phs000766.v1.pht003939.v1.p1.GEI_Psoriasis_Sample.var_report.xml									phs000766.v1.p1	Psoriasis
			06/25/2013				./data/phs000354.v1.pht003348.v1.p1.ESP_Family_Studies_PAH_Sample.var_report.xml									phs000354.v1.p1	Hypertension, Pulmonary
			2021/04/23				./data/phs002228.v1.pht010858.v1.p1.Deamination_Leukemia_Sample.var_report.xml									phs002228.v1.p1	Myeloproliferative Disorders
797.0	797.0		07/15/2015	935.0		765.0	./data/phs000616.v2.pht003369.v2.p2.VIVA_LA_FAMILIA_Pedigree.var_report.xml	0.0	781.0	25.46	765.0			781.0		phs000616.v2.p2	Obesity
			01/14/2016				./data/phs001050.v1.pht005234.v1.p1.BEAUTY_Sample_Attributes.var_report.xml									phs001050.v1.p1	Breast Neoplasms
			2018/05/03				./data/phs001587.v1.pht007883.v1.p1.Prostate_Cancer_Organoids_Sample.var_report.xml									phs001587.v1.p1	Prostatic Neoplasms
			2021/03/11				./data/phs002368.v1.pht011045.v1.p1.CaBagE_Sample_Attributes.var_report.xml									phs002368.v1.p1	Amyotrophic Lateral Sclerosis
			01/19/2010				./data/phs000219.v1.pht001047.v1.p1.GenADA_Sample.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/08/11				./data/phs002056.v1.pht010453.v1.p1.CIDR_PC_AS_Sample_Attributes.var_report.xml									phs002056.v1.p1	Prostatic Neoplasms
7.0	7.0		02/09/2011	7.0		7.0	./data/phs000330.v1.pht002112.v1.p1.Prostate_Cancer_Characterization_Subject_Phenotypes.var_report_2011_02_09.xml	0.0	7.0					7.0		phs000330.v1.p1	Prostatic Neoplasms
			2018/07/06				./data/phs000416.v2.pht008143.v1.p1.GOCHA_Sample_Attributes.var_report.xml									phs000416.v2.p1	Intracranial Hemorrhage
			04/24/2017				./data/phs001076.v1.pht005364.v1.p1.IBD_Exome_Sample_Attributes.var_report.xml									phs001076.v1.p1	Inflammatory Bowel Diseases
			2019/07/19				./data/phs001230.v1.pht009239.v1.p1.Estonian_Biobank_Subject.var_report.xml									phs001230.v1.p1	Population Groups
			2020/12/21				./data/phs000007.v32.pht000172.v2.p13.psipr_2003s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/12/10				./data/phs001720.v1.pht008597.v1.p1.Kidney_On_A_Chip_Sample_Attributes.var_report.xml									phs001720.v1.p1	Podocytes
			2021/08/11				./data/phs001785.v1.pht011459.v1.p1.GMKF_Hemangiomas_Subject.var_report.xml									phs001785.v1.p1	Hemangioma
			08/20/2013				./data/phs000285.v3.pht001571.v2.p2.A4F09MED.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/01/31				./data/phs001712.v1.pht008681.v1.p1.registration.var_report.xml									phs001712.v1.p1	Vasculitis
			2021/04/06				./data/phs002389.v1.pht011094.v1.p1.HTN_microRNAs_Sample_Attributes.var_report.xml									phs002389.v1.p1	Hypertension
			10/30/2013				./data/phs000659.v1.pht003523.v1.p1.Ileal_Pouch_Microbiome_Subject_Phenotypes.var_report.xml									phs000659.v1.p1	Inflammatory Bowel Diseases
12.0	12.0		2021/07/06	12.0		12.0	./data/phs002462.v1.pht011367.v1.p1.NEPC_Subject.var_report.xml	0.0	12.0					12.0		phs002462.v1.p1	Prostatic Neoplasms
			2019/03/25				./data/phs001164.v1.pht008868.v1.p1.ASD_ROHs_DNMs_Subject.var_report.xml									phs001164.v1.p1	Autism Spectrum Disorder
			2020/06/18				./data/phs000280.v7.pht006414.v1.p1.ABI.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2019/03/11				./data/phs000286.v6.pht001950.v2.p2.disa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
69.0	68.0		2020/11/02	80.0		69.0	./data/phs002046.v1.pht010626.v1.p1.GTP_eur_Subject_Phenotypes.var_report.xml	0.0	99.0	42.43	68.0			99.0		phs002046.v1.p1	Stress Disorders, Post-Traumatic
			2020/06/18				./data/phs000280.v7.pht004219.v2.p1.UBMFBF02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			06/13/2016				./data/phs000205.v6.pht001431.v6.p2.ISCA_Subject_Phenotypes.var_report.xml									phs000205.v6.p2	Developmental Disabilities
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000554.v2.p3.simphen155.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/12/18				./data/phs002059.v1.pht010423.v1.p1.CIDR_CHD_Sample.var_report.xml									phs002059.v1.p1	Heart Defects, Congenital
			2018/03/23				./data/phs000698.v1.pht007679.v1.p1.fu_questionnaire.var_report.xml									phs000698.v1.p1	alpha 1-Antitrypsin Deficiency
			11/04/2014				./data/phs000086.v3.pht000338.v1.p1.EDIC_f0702.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
			2021/05/18				./data/phs002416.v1.pht011230.v1.p1.LMD_Sample.var_report.xml									phs002416.v1.p1	Leptomeningeal Carcinomatosis
			2019/03/11				./data/phs000286.v6.pht008786.v1.p2.ssfc.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2020/02/25				./data/phs001914.v1.pht009889.v1.p1.MSI_CRC_Sample.var_report.xml									phs001914.v1.p1	Colorectal Neoplasms
			2017/10/19				./data/phs001463.v1.pht007058.v1.p1.Differential_Transcription_Brain_Sample_Attributes.var_report.xml									phs001463.v1.p1	Brain
			08/20/2013				./data/phs000285.v3.pht001787.v2.p2.E1F31.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/06/10				./data/phs001387.v3.pht008969.v2.p1.TOPMed_WGS_THRV_Sample.var_report.xml									phs001387.v3.p1	Blood Pressure
			2018/01/08				./data/phs001291.v1.pht007329.v1.p1.Neoadjuvant_Trastuzumab_BC_Subject_Phenotypes.var_report.xml									phs001291.v1.p1	Breast Neoplasms
			02/27/2014	8881.0			./data/phs000716.v1.pht003707.v1.p1.Lung_Cancer_Never_Smoking_Asian_Subject_Phenotypes.var_report.xml	0.0			8881.0					phs000716.v1.p1	Lung Neoplasms
			2020/12/21				./data/phs000007.v32.pht000167.v8.p13.mpo1_7s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/06/08				./data/phs001215.v4.pht008630.v2.p2.TOPMed_WGS_SAFHS_Sample.var_report.xml									phs001215.v4.p2	Cardiovascular Diseases
			2020/08/05				./data/phs001856.v1.pht009600.v1.p1.CORECT_Axiom_Sample_Attributes.var_report.xml									phs001856.v1.p1	Colorectal Neoplasms
34.0		1.0	2017/12/04	80.0	1.3119999999999998		./data/phs001419.v1.pht007094.v1.p1.p6601_15167_pcmtqolpa.var_report.xml	0.0		1.217	45.0	1.0			4.0	phs001419.v1.p1	Charcot-Marie-Tooth Disease
2.0			2017/10/26	75.0			./data/phs001277.v1.pht006855.v1.p1.iPSCs_Sample_Attributes.var_report.xml	0.0								phs001277.v1.p1	Platelet Disorder, Familial, with Associated Myeloid Malignancy
7.0	8.0		07/15/2010	4.0		7.0	./data/phs000292.v1.pht001525.v1.p1.GEOS_Pedigree.var_report_2010_07_15.xml	0.0	7.5	1.414	8.0			7.5		phs000292.v1.p1	Stroke
			2019/12/11				./data/phs001906.v1.pht009663.v1.p1.GISTs_Sample_Attributes.var_report.xml									phs001906.v1.p1	Gastrointestinal Stromal Tumors
			2020/12/18				./data/phs002059.v1.pht010426.v1.p1.SubjectDiagnosisDS.var_report.xml									phs002059.v1.p1	Heart Defects, Congenital
			2021/09/20				./data/phs002407.v1.pht011356.v1.p1.MMRd_MMRp_CRC_Sample.var_report.xml									phs002407.v1.p1	Colorectal Neoplasms
			2018/06/18				./data/phs001586.v1.pht008148.v1.p1.RICHS_Subject.var_report.xml									phs001586.v1.p1	Child Health
	58253.0		11/08/2013	89881.0		31628.0	./data/phs000200.v9.pht002753.v1.p3.f33_rel3.var_report.xml	3998.0	44941.0	82647	54678.0			44941.0		phs000200.v9.p3	Women&#39;s Health
			06/01/2017				./data/phs000701.v1.pht005515.v1.p1.EEGCharacteristics.var_report.xml									phs000701.v1.p1	Angelman Syndrome
			2021/02/12				./data/phs001771.v1.pht008715.v1.p1.IGNITE_Subject.var_report.xml									phs001771.v1.p1	Diabetes Mellitus
			2019/10/11				./data/phs001406.v1.pht007749.v1.p1.novelphe_test_retestds.var_report.xml									phs001406.v1.p1	Cognition
			2020/02/13				./data/phs001564.v3.pht007992.v3.p1.Urinary_cfDNA_Sample_Attributes.var_report.xml									phs001564.v3.p1	Bacteriuria
			08/20/2013				./data/phs000285.v3.pht001874.v1.p2.Z33E06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			12/03/2012				./data/phs000548.v1.pht003069.v1.p1.AsaPgx2_Subject.var_report.xml									phs000548.v1.p1	Aspirin
			2020/12/16				./data/phs001981.v1.pht010804.v1.p1.Brain_AUD_GEO.var_report.xml									phs001981.v1.p1	Alcoholism
			2021/01/07				./data/phs002083.v1.pht010657.v1.p1.TS_ccRCC_Sample_Attributes.var_report.xml									phs002083.v1.p1	Carcinoma, Renal Cell
			2018/06/30				./data/phs001620.v1.pht008182.v1.p1.GUARDD_AA_Sample_Attributes.var_report.xml									phs001620.v1.p1	Apolipoprotein L1
			2018/08/06				./data/phs001398.v1.pht007142.v1.p1.CCDG_BRAVE_Subject_Phenotypes.var_report.xml									phs001398.v1.p1	
			2019/03/11				./data/phs000286.v6.pht008736.v1.p2.asn0095.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/03/20				./data/phs001715.v1.pht008844.v1.p1.pet_ct_imaging_form.var_report.xml									phs001715.v1.p1	Vasculitis
			2020/06/18				./data/phs000280.v7.pht004175.v2.p1.RTASBM24.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/06/07				./data/phs001479.v1.pht008100.v1.p1.STAT5B_Subject.var_report.xml									phs001479.v1.p1	Lymphadenopathy
			2018/02/01				./data/phs000788.v2.pht004625.v2.p3.RPGEH_Subject.var_report.xml									phs000788.v2.p3	Aging
			2020/02/06				./data/phs001430.v2.pht008082.v2.p1.p7001_16082_developme.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			12/18/2014				./data/phs000794.v1.pht004309.v1.p1.Longitudinal_CLL_Sample.var_report.xml									phs000794.v1.p1	Chronic Lymphocytic Leukemia
			08/20/2013				./data/phs000285.v3.pht001745.v2.p2.D2F06.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/02/21				./data/phs001281.v2.pht006132.v2.p1.optical_coherence_tomography.var_report.xml									phs001281.v2.p1	Sturge-Weber Syndrome
			2021/08/25				./data/phs001728.v2.pht010122.v1.p1.TOPMed_WGS_CARE_BADGER_Subject.var_report.xml									phs001728.v2.p1	Asthma
			2020/10/14				./data/phs001912.v1.pht009622.v1.p1.BE_EA_Subject.var_report.xml									phs001912.v1.p1	Barrett Esophagus
			2020/06/18				./data/phs000280.v7.pht004220.v2.p1.UBMFBM02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000425.v2.p3.simphen026.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004132.v2.p1.MSRCOD07.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
12.0			2017/08/24	21.0			./data/phs001433.v1.pht006812.v1.p1.HB_Wnt_Bcatenin_Subject_Phenotypes.var_report.xml	0.0			9.0					phs001433.v1.p1	Hepatoblastoma
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000459.v2.p3.simphen060.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			07/23/2014				./data/phs000703.v1.pht003669.v1.p1.6a_dbGaP_CATHGEN_Cohort_Sample.var_report.xml									phs000703.v1.p1	Coronary Disease
			2019/12/26				./data/phs001889.v1.pht009737.v1.p1.ALS_TDP_Subject.var_report.xml									phs001889.v1.p1	Amyotrophic Lateral Sclerosis
46.0			08/20/2013	3.0			./data/phs000285.v3.pht001795.v2.p2.E1F53.var_report.xml	0.0			63.0					phs000285.v3.p2	Cardiovascular Diseases
			10/25/2016				./data/phs000488.v2.pht002909.v2.p1.LUAD_CIP_Subject.var_report.xml									phs000488.v2.p1	Carcinoma, Non-Small-Cell Lung
2.0	6.0		01/05/2015	8.0		2.0	./data/phs000817.v1.pht004416.v1.p1.Varicella_Zoster_Vaccine_Subject_Phenotypes.var_report.xml	0.0	4.0	2.828	6.0			4.0		phs000817.v1.p1	Varicella Vaccine
			2020/10/09				./data/phs002262.v1.pht010574.v1.p1.HGSOC_GEO.var_report.xml									phs002262.v1.p1	
			01/15/2016				./data/phs000883.v1.pht004598.v1.p1.MIGen_PROCARDIS_Sample_Attributes.var_report.xml									phs000883.v1.p1	Coronary Artery Disease
			2020/03/24				./data/phs001641.v1.pht010040.v1.p1.Vitals.var_report.xml									phs001641.v1.p1	Progressive Patient Care
			2020/02/06				./data/phs001430.v2.pht008055.v2.p1.stair_16205_stableiso.var_report.xml									phs001430.v2.p1	Smith-Lemli-Opitz Syndrome
			06/01/2015				./data/phs000901.v1.pht004675.v1.p1.Parkinson_CSF_Biomarker_Sample_Attributes.var_report.xml									phs000901.v1.p1	Parkinson Disease
			2020/06/18				./data/phs000280.v7.pht004203.v2.p1.TIAD04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
	20.0		2021/01/22	20.0		20.0	./data/phs001962.v1.pht009820.v1.p1.PTCL_Subject_Phenotypes.var_report.xml	0.0	20.0					20.0		phs001962.v1.p1	Lymphoma, T-Cell, Peripheral
			2019/09/16				./data/phs001534.v1.pht008519.v1.p1.Pathways_Sample.var_report.xml									phs001534.v1.p1	Breast Neoplasms
843.0	843.0		2021/08/19	1602.0		1.0	./data/phs001662.v2.pht010052.v2.p1.LTRC_Subject.var_report.xml	0.0	534.0	463.5	758.0			758.0		phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			2018/05/31				./data/phs001316.v1.pht008001.v1.p1.CINCH_5305_Subject.var_report.xml									phs001316.v1.p1	Andersen Syndrome
	3.0		2020/09/29	3.0		3.0	./data/phs002225.v1.pht010482.v1.p1.HTAN_MCL_PCAPP_Breast_CA_Subject.var_report.xml	0.0	3.0		3.0			3.0		phs002225.v1.p1	Carcinoma, Intraductal, Noninfiltrating
			2021/07/06				./data/phs002462.v1.pht011368.v1.p1.NEPC_Sample.var_report.xml									phs002462.v1.p1	Prostatic Neoplasms
			2017/11/01				./data/phs001305.v1.pht007102.v1.p1.baselinelabdataform.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			08/20/2013				./data/phs000285.v3.pht001772.v2.p2.E1F09MOC.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			08/20/2013				./data/phs000285.v3.pht001722.v2.p2.D1F31A.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/11/06				./data/phs000288.v2.pht002518.v2.p2.Ciliopathies_Exome_Sample.var_report.xml									phs000288.v2.p2	Congenital Abnormalities
			02/12/2014				./data/phs000461.v1.pht003684.v1.p1.GLAUGEN_POAG_Methylation_Subject.var_report.xml									phs000461.v1.p1	Glaucoma, Open-Angle
			11/04/2014				./data/phs000086.v3.pht000256.v1.p1.DCCT_f0082.var_report.xml									phs000086.v3.p1	Insulin-Dependent Diabetes Mellitus
6.0			2018/01/18	8.0			./data/phs000819.v1.pht004380.v1.p1.Normal_Human_Tissue_Sequencing_Subject_Phenotypes.var_report.xml	0.0			8.0					phs000819.v1.p1	
			2021/01/12				./data/phs001617.v1.pht010619.v1.p1.Growth_Disorders_Sample.var_report.xml									phs001617.v1.p1	Growth Disorders
			2019/08/06				./data/phs001701.v1.pht009376.v1.p1.INGENIOUS_Sample.var_report.xml									phs001701.v1.p1	Metabolism
			06/12/2017				./data/phs001371.v1.pht006544.v1.p1.TNF_RA_FLS_Subject.var_report.xml									phs001371.v1.p1	Arthritis, Rheumatoid
			2019/08/01				./data/phs001828.v1.pht009367.v1.p1.CKD_Subject.var_report.xml									phs001828.v1.p1	Renal Insufficiency, Chronic
			11/08/2013				./data/phs000200.v9.pht000986.v4.p3.cbc_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/10/11				./data/phs001406.v1.pht007741.v1.p1.DCC_Subject.var_report.xml									phs001406.v1.p1	Cognition
			10/25/2016				./data/phs000488.v2.pht002910.v2.p1.LUAD_CIP_Sample.var_report.xml									phs000488.v2.p1	Carcinoma, Non-Small-Cell Lung
			2020/11/24				./data/phs001052.v2.pht005469.v2.p1.Pediatric_Solid_Tumors_Sample_Attributes.var_report.xml									phs001052.v2.p1	Neoplasms
			08/12/2016				./data/phs000888.v1.pht005568.v1.p1.17aGERD_meds.var_report.xml									phs000888.v1.p1	
			2018/03/20				./data/phs000605.v1.pht007639.v1.p1.registration.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
82.0	82.0		2020/12/30	118.0		36.0	./data/phs002290.v1.pht010823.v1.p1.cfDNA_Metastasis_Subject_Phenotypes.var_report.xml	0.0	59.0	32.53	36.0			59.0		phs002290.v1.p1	Cell-Free Nucleic Acids
			2021/03/22				./data/phs001375.v2.pht006523.v1.p1.SIGMA_MCDS_Sample_Attributes.var_report.xml									phs001375.v2.p1	Diabetes Mellitus, Type 2
			2021/07/13				./data/phs002392.v1.pht011255.v1.p1.NPC_Subject_Phenotypes.var_report.xml									phs002392.v1.p1	Niemann-Pick Disease, Type C
			2019/10/30				./data/phs001921.v1.pht009586.v1.p1.DNA_Methylation_PC_Subject_Phenotypes.var_report.xml									phs001921.v1.p1	Prostatic Neoplasms
			2021/08/20				./data/phs002508.v1.pht011502.v1.p1.HVP_scRNA_HepB_Sample_Attributes.var_report.xml									phs002508.v1.p1	Vaccines
			2020/06/10				./data/phs001169.v2.pht006183.v2.p1.EAGLE_Lung_Adenocarcinoma_Subject.var_report.xml									phs001169.v2.p1	Adenocarcinoma of lung
			2018/04/05				./data/phs001522.v1.pht007728.v1.p1.cDNMs_Subject.var_report.xml									phs001522.v1.p1	
			2020/09/18				./data/phs002015.v1.pht010378.v1.p1.AREDS2_ECAR2A.var_report.xml									phs002015.v1.p1	Macular Degeneration
			07/06/2017				./data/phs001370.v1.pht006645.v1.p1.Uveal_Melanoma_Sample.var_report.xml									phs001370.v1.p1	Melanoma, Uveal
			2020/12/21				./data/phs000007.v32.pht001179.v2.p13.shorm0_21s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2021/07/02				./data/phs001782.v2.pht008801.v2.p1.LOI_Stunting_Malian_Sample_Attributes.var_report.xml									phs001782.v2.p1	Growth
			2021/04/19				./data/phs002394.v1.pht011132.v1.p1.PDAC_Sample.var_report.xml									phs002394.v1.p1	pancreatic cancer
73.0	73.0		07/31/2012	125.0		52.0	./data/phs000449.v2.pht002855.v1.p1.Western_African_Pygmies_Subject_Phenotypes.var_report.xml	0.0	62.5	14.85	52.0			62.5		phs000449.v2.p1	Population Control
560.0	560.0		04/01/2010	937.0		377.0	./data/phs000089.v3.pht000178.v3.p2.cde_pd.var_report_2010_04_01.xml	0.0	468.5	129.4	377.0			468.5		phs000089.v3.p2	Parkinson Disease
			05/23/2012				./data/phs000409.v1.pht002735.v1.p1.WGS_Medulloblastoma_Subject.var_report.xml									phs000409.v1.p1	Medulloblastoma
			2020/11/19				./data/phs002202.v1.pht010547.v1.p1.Heterochromatin_Structure_Subject.var_report.xml									phs002202.v1.p1	Healthy Volunteers
			2020/04/24				./data/phs001829.v1.pht010165.v1.p1.Rectal_Chemoradiation_Subject.var_report.xml									phs001829.v1.p1	Rectal Neoplasms
			2021/09/13				./data/phs000095.v4.pht004353.v1.p2.GENEVA_DentalCaries_Sample_Attributes.var_report.xml									phs000095.v4.p2	Dental Caries
91.0	91.0		11/25/2013	27.0		59.0	./data/phs000682.v1.pht003597.v1.p1.Neuropsychiatric_Neurodevelopmental_Disorders_Subject_Phenotypes.var_report.xml	0.0	81.0	33.23	59.0			81.0		phs000682.v1.p1	Psychiatry and Psychology Category
			10/25/2012				./data/phs000445.v1.pht002507.v1.p1.HIV_SampleAttributesDS.var_report.xml									phs000445.v1.p1	HIV
			04/21/2017				./data/phs001344.v1.pht006286.v1.p1.PMDD_Subject_Phenotypes.var_report.xml									phs001344.v1.p1	Premenstrual Dysphoric Disorder
			11/16/2011				./data/phs000096.v4.pht001422.v4.p1.HAPO_Subject.var_report.xml									phs000096.v4.p1	Pregnancy Complications
			2020/07/24				./data/phs001194.v3.pht005823.v2.p2.Catheterization.var_report.xml									phs001194.v3.p2	Heart Defects, Congenital
1.0			2018/06/07	2.0			./data/phs001479.v1.pht008101.v1.p1.STAT5B_Pedigree.var_report.xml	0.0			1.0					phs001479.v1.p1	Lymphadenopathy
			04/03/2012				./data/phs000407.v1.pht002647.v1.p1.dbGaP_Sample.var_report.xml									phs000407.v1.p1	Attention Deficit Disorder with Hyperactivity
			2019/11/25				./data/phs001541.v1.pht008308.v1.p1.ANGI_Sample_Attributes.var_report.xml									phs001541.v1.p1	Anorexia Nervosa
			03/27/2012				./data/phs000331.v1.pht002093.v1.p1.PGRN_RIKEN_Sample.var_report.xml									phs000331.v1.p1	Long QT Syndrome
			2019/05/07				./data/phs001329.v2.pht007175.v2.p1.clinical_evaluations.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			03/11/2014				./data/phs000410.v1.pht002448.v1.p1.Colorectal_Cancer_Subject.var_report.xml									phs000410.v1.p1	Colorectal Neoplasms
			07/25/2013				./data/phs000293.v1.pht003363.v1.p1.Familial_Intracranial_Aneurysm_Subject.var_report.xml									phs000293.v1.p1	Intracranial Aneurysm
			12/16/2013				./data/phs000690.v1.pht003622.v1.p1.Multiplex_Epilepsy_Families_Sample_Attributes.var_report.xml									phs000690.v1.p1	Idiopathic generalized epilepsy
3.0	16.0		2021/05/18	19.0		3.0	./data/phs002416.v1.pht011229.v1.p1.LMD_Subject.var_report.xml	0.0	9.5	9.192	16.0			9.5		phs002416.v1.p1	Leptomeningeal Carcinomatosis
			2019/11/08				./data/phs001332.v2.pht007461.v2.p1.p7301_12628_sarascore.var_report.xml									phs001332.v2.p1	Spinocerebellar Ataxias
			07/06/2011				./data/phs000250.v1.pht002186.v1.p1.CALGB_80303_Subject.var_report.xml									phs000250.v1.p1	Pancreatic Neoplasms
			08/28/2012				./data/phs000448.v1.pht002509.v1.p1.AJ_SZ_Sample.var_report.xml									phs000448.v1.p1	Schizophrenia
			2021/08/31				./data/phs000663.v3.pht003553.v3.p3.DILIN_Sample_Attributes.var_report.xml									phs000663.v3.p3	Drug-Induced Liver Injury
			09/28/2012				./data/phs000549.v1.pht002993.v1.p1.AML_Clonal_Evolution_Sample_Attributes.var_report.xml									phs000549.v1.p1	Leukemia, Myeloid, Acute
21.0	21.0		02/27/2017	34.0		13.0	./data/phs001036.v1.pht005270.v1.p1.Acral_Melanoma_Subject_Phenotypes.var_report.xml	0.0	17.0	5.657	13.0			17.0		phs001036.v1.p1	Melanoma
			2020/07/17				./data/phs000481.v3.pht003163.v3.p2.Cholesterol_and_Pharmacogenetics_GEO.var_report.xml									phs000481.v3.p2	Hypercholesterolemia
419.0	419.0		2020/04/15	724.0		48.0	./data/phs001894.v1.pht009522.v1.p1.CCDG_HMCA_Pedigree.var_report.xml	0.0	362.0	80.61	48.0			362.0		phs001894.v1.p1	Autism Spectrum Disorder
			04/16/2012				./data/phs000476.v1.pht002669.v1.p1.Parathyroidism_Sample.var_report.xml									phs000476.v1.p1	Pseudohypoparathyroidism
			03/12/2013				./data/phs000343.v3.pht003159.v1.p1.rss.var_report.xml									phs000343.v3.p1	Stroke
			2020/12/21				./data/phs000007.v32.pht000017.v3.p13.ex0_15s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			05/24/2016				./data/phs001065.v1.pht005414.v1.p1.lab.var_report.xml									phs001065.v1.p1	Huntington Disease
			2019/03/28				./data/phs001743.v1.pht008921.v1.p1.Urothelial_Cancer_Subject.var_report.xml									phs001743.v1.p1	Urologic Neoplasms
			2019/01/07				./data/phs001733.v1.pht008619.v1.p1.Early_Onset_PTD_Sample_Attributes.var_report.xml									phs001733.v1.p1	Dystonia
			12/01/2015				./data/phs000571.v3.pht003193.v3.p2.PCGC_Sample_Attributes.var_report.xml									phs000571.v3.p2	Heart Defects, Congenital
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000454.v2.p3.simphen055.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			11/27/2013				./data/phs000504.v2.pht002821.v2.p2.Medulloblastoma_Sample.var_report.xml									phs000504.v2.p2	Medulloblastoma
559.0	559.0		Wed Nov 26 07:45:09 2008	1081.0		522.0	./data/phs000017.v3.pht000291.v1.p1.EA_GAIN_phenotype_controls_main_subset.var_report_2008_11_26.xml	0.0	540.5	26.16	522.0			540.5		phs000017.v3.p1	Bipolar Disorder
			06/20/2014				./data/phs000759.v1.pht003912.v1.p1.High_Risk_AML_Sample.var_report.xml									phs000759.v1.p1	Leukemia, Myeloid, Acute
2025.0	2025.0		2021/08/24	2939.0		914.0	./data/phs002185.v1.pht010968.v1.p1.Donor_Phenotype.var_report.xml	0.0	1470.0	785.6	914.0			1470.0		phs002185.v1.p1	Graft vs Host Disease
	12.0		05/09/2016	12.0		12.0	./data/phs001063.v1.pht005291.v1.p1.HER2_Positive_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0	12.0		12.0			12.0		phs001063.v1.p1	Breast Neoplasms
			2017/12/19				./data/phs001438.v1.pht007256.v1.p1.Cortical_Neurogenesis_Open_Chromatin_GEO.var_report.xml									phs001438.v1.p1	Chromatin
14.0	14.0		2020/06/15	22.0		4.0	./data/phs002008.v1.pht010201.v1.p1.Orofacial_Enhancers_Subject_Phenotypes.var_report.xml	0.0	7.332999999999999	5.774	4.0			4.0		phs002008.v1.p1	Embryonic and Fetal Development
46.0	52.0		05/11/2016	98.0		46.0	./data/phs000823.v1.pht005048.v1.p1.Melanoma_Predisposing_Mutations_Subject_Phenotypes.var_report.xml	0.0	49.0	4.243	52.0			49.0		phs000823.v1.p1	Melanoma
			04/18/2014				./data/phs000684.v1.pht003644.v1.p1.AMD_MMAP_Cohort_Sample.var_report.xml									phs000684.v1.p1	Macular Degeneration
			2021/06/02				./data/phs002428.v1.pht011268.v1.p1.hTERT_Tandem_Repeats_Subject_Phenotypes.var_report.xml									phs002428.v1.p1	Centenarian
			2020/09/18				./data/phs002015.v1.pht010379.v1.p1.AREDS2_ECAR2B.var_report.xml									phs002015.v1.p1	Macular Degeneration
			2020/11/30				./data/phs002283.v1.pht010684.v1.p1.Selenium_Chemoprevention_Subject_Phenotypes.var_report.xml									phs002283.v1.p1	
81.0	273.0		2019/11/27	354.0		81.0	./data/phs001884.v1.pht009640.v1.p1.Giftedness_Saudi_Arabia_Subject_Phenotypes.var_report.xml	0.0	177.0	135.8	273.0			177.0		phs001884.v1.p1	Intelligence
			11/02/2015				./data/phs000639.v1.pht004780.v1.p1.Autism_Spectrum_Disorder_Sample.var_report.xml									phs000639.v1.p1	Autism Spectrum Disorder
			10/18/2012				./data/phs000547.v1.pht003004.v1.p1.GARNET_SUCCESS_Subject.var_report.xml									phs000547.v1.p1	Breast Neoplasms
			2020/07/07				./data/phs001938.v2.pht009634.v2.p1.ADT_PC_Subject.var_report.xml									phs001938.v2.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht002573.v4.p13.t_echo_ex01_3_0042s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2019/11/01				./data/phs001005.v2.pht005039.v2.p1.Neoantigens_Stage3_Melanoma_Sample.var_report.xml									phs001005.v2.p1	
			2020/01/23				./data/phs000287.v7.pht001452.v1.p1.BASEBOTH.var_report.xml									phs000287.v7.p1	Cardiovascular Diseases
			2017/09/05				./data/phs000262.v3.pht001279.v3.p2.HMP_Gut_Ulcerative_Colitis_Subject.var_report.xml									phs000262.v3.p2	Pouchitis
408.0	628.0		2021/03/22	713.0		408.0	./data/phs001375.v2.pht006522.v2.p1.SIGMA_MCDS_Subject_Phenotypes.var_report.xml	0.0	518.0	44.55	628.0			518.0		phs001375.v2.p1	Diabetes Mellitus, Type 2
			05/05/2015				./data/phs000147.v3.pht003584.v1.p1.CGEMS_Breast_Cancer_Sample_Attributes.var_report.xml									phs000147.v3.p1	Breast Neoplasms
			2020/02/03				./data/phs001931.v1.pht009677.v1.p1.CMI_ASCproject_Sample.var_report.xml									phs001931.v1.p1	Sarcoma
			07/25/2014				./data/phs000560.v1.pht003068.v1.p1.DNHS_Subject_Phenotypes.var_report.xml									phs000560.v1.p1	Stress Disorders, Post-Traumatic
57.0	97.0		2021/01/12	47.0		57.0	./data/phs001697.v1.pht010576.v1.p1.EAGLE_Never_Smokers_Subject.var_report.xml	0.0	62.5	83.44	97.0			62.5		phs001697.v1.p1	Lung Neoplasms
			2020/06/18				./data/phs000280.v7.pht004092.v2.p1.FTRB02.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2017/12/20				./data/phs000577.v1.pht007268.v1.p1.drugandothertreatment.var_report.xml									phs000577.v1.p1	Urea Cycle Disorders, Inborn
			2018/03/30				./data/phs001108.v1.pht007712.v1.p1.physical_and_neurological_exam.var_report.xml									phs001108.v1.p1	Urea Cycle Disorders, Inborn
			07/28/2014				./data/phs000778.v1.pht003966.v1.p1.Vesicoureteral_Reflux_Subject.var_report.xml									phs000778.v1.p1	Vesico-Ureteral Reflux
			2019/07/26				./data/phs000588.v1.pht009291.v1.p1.baseline_vasculitis_med_form.var_report.xml									phs000588.v1.p1	Giant Cell Arteritis
			11/08/2013				./data/phs000200.v9.pht000997.v4.p3.f20_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2020/04/14				./data/phs001947.v1.pht010135.v1.p1.Melanoma_Hu14_18_IL2_Sample.var_report.xml									phs001947.v1.p1	Melanoma
94.0	91.0	1.0	11/05/2014	5.0	0.521	83.0	./data/phs000209.v13.pht003087.v1.p3.MESA_AncilMesaCTRead185.var_report.xml	9.0	87.0	7.071	91.0	0.0		87.0	1.0	phs000209.v13.p3	Cardiovascular Diseases
			04/10/2014				./data/phs000340.v3.pht002380.v1.p1.ETP_T_ALL_GEO.var_report.xml									phs000340.v3.p1	Leukemia, T-cell
612.0	3470.0		02/13/2014	6065.0		612.0	./data/phs000372.v1.pht002858.v1.p1.ADGC_Subject_Phenotypes.var_report.xml	0.0	880.5	618.7	3470.0			880.5		phs000372.v1.p1	Alzheimer Disease
	50.0		02/18/2015	50.0		50.0	./data/phs000857.v1.pht004489.v1.p1.ER_Positive_Breast_Cancer_Subject_Phenotypes.var_report.xml	0.0	50.0		50.0			50.0		phs000857.v1.p1	Breast Neoplasms
			2019/05/21				./data/phs001090.v1.pht009051.v1.p1.CIDR_OFC_African_Subject.var_report.xml									phs001090.v1.p1	Cleft Lip
			2020/05/13				./data/phs002024.v1.pht010232.v1.p1.DCCT_EDIC_DNAme_Sample.var_report.xml									phs002024.v1.p1	Diabetes Mellitus, Type 1
			2019/08/30				./data/phs001331.v2.pht006936.v2.p1.p6501_13168_eligibili.var_report.xml									phs001331.v2.p1	Graft vs Host Disease
			2021/05/21	118.0			./data/phs001040.v5.pht005682.v3.p1.TOPMed_WGS_WGHS_Subject_Phenotypes.var_report.xml	0.0			118.0					phs001040.v5.p1	Atrial Fibrillation
			2020/01/10				./data/phs001471.v1.pht009802.v1.p1.Subject_Phenotypes_TIME1.var_report.xml									phs001471.v1.p1	Cardiovascular Diseases
			2021/01/28				./data/phs002089.v1.pht010495.v1.p1.dMMR_Tumors_Sample.var_report.xml									phs002089.v1.p1	Small Cell Lung Carcinoma
			08/20/2013				./data/phs000285.v3.pht001833.v2.p2.F1F61.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2018/03/20				./data/phs000605.v1.pht007633.v1.p1.general_well_being_survey.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
			08/20/2013				./data/phs000285.v3.pht001756.v2.p2.E1ECHY10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/09/18				./data/phs002015.v1.pht010392.v1.p1.AREDS2_RCL.var_report.xml									phs002015.v1.p1	Macular Degeneration
			11/08/2013				./data/phs000200.v9.pht001027.v3.p3.outc_ct_os_rel1.var_report.xml									phs000200.v9.p3	Women&#39;s Health
			2019/03/27				./data/phs001286.v1.pht007888.v1.p1.PLCO_Sample.var_report.xml									phs001286.v1.p1	Neoplasms
			09/26/2013				./data/phs000519.v1.pht003247.v1.p1.MelanomaRisk_Sample.var_report.xml									phs000519.v1.p1	Melanoma
			08/20/2013				./data/phs000285.v3.pht001855.v2.p2.F2F03.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2017/12/12				./data/phs000295.v2.pht007243.v1.p1.Kabuki_Sample_Attributes.var_report.xml									phs000295.v2.p1	Kabuki syndrome
			02/23/2017				./data/phs001139.v1.pht006162.v1.p1.GENESiPS_Insulin_Resistance_Sample_Attributes.var_report.xml									phs001139.v1.p1	Insulin Resistance
419.0	419.0		07/26/2017	784.0		365.0	./data/phs000852.v1.pht006695.v1.p1.GEDI_SUDs_Subject_Phenotypes.var_report.xml	0.0	392.0	38.18	365.0			392.0		phs000852.v1.p1	Substance-Related Disorders
			Wed Nov 26 07:46:05 2008				./data/phs000017.v3.pht000318.v1.p1.DIGS4_DiagnosisPage2.var_report_2008_11_26.xml									phs000017.v3.p1	Bipolar Disorder
			2018/03/09				./data/phs000606.v1.pht007572.v1.p1.crf_postopdailyreport.var_report.xml									phs000606.v1.p1	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht005152.v3.p13.t_ctabaac_2011_m_0668s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/09/15				./data/phs002234.v1.pht010517.v1.p1.Xq28_Deletion_HH_Sample_Attributes.var_report.xml									phs002234.v1.p1	Hypogonadism
			09/12/2014				./data/phs000793.v1.pht004023.v1.p1.AML_Epigenetics_Sample_Attributes.var_report.xml									phs000793.v1.p1	Leukemia, Myeloid, Acute
			08/20/2013				./data/phs000285.v3.pht001573.v2.p2.A4F10.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2021/02/11				./data/phs001711.v1.pht008527.v1.p1.GI_Carcinomas_Subject.var_report.xml									phs001711.v1.p1	Gastrointestinal Neoplasms
			06/01/2012				./data/phs000484.v1.pht002682.v1.p1.Inherited_Kidney_Dysfunction_Sample.var_report.xml									phs000484.v1.p1	Glomerulosclerosis, Focal Segmental 
			2017/10/19				./data/phs001288.v1.pht006762.v1.p1.CLiC_6001_Subject.var_report.xml									phs001288.v1.p1	alpha 1-Antitrypsin Deficiency
			2021/04/07				./data/phs002304.v1.pht010851.v1.p1.GEARS_Subject_Phenotypes.var_report.xml									phs002304.v1.p1	Rhabdomyosarcoma
			10/24/2013				./data/phs000618.v1.pht003301.v1.p1.Hypertriglyceridemia_Mexican_Subject.var_report.xml									phs000618.v1.p1	Hypertriglyceridemia
			2021/09/30				./data/phs002614.v1.pht011589.v1.p1.BWS_HB_Sample.var_report.xml									phs002614.v1.p1	Beckwith-Wiedemann Syndrome
485.0	485.0		Tue Feb 26 18:05:10 2008	886.0		401.0	./data/phs000048.v1.pht000071.v1.p1.uploaddemo.var_report_2008_08_12.xml	0.0	443.0	70	401.0			443.0		phs000048.v1.p1	Parkinson Disease
			2020/02/27				./data/phs001213.v2.pht005840.v1.p1.Heroin_Dependence_China_Sample_Attributes.var_report.xml									phs001213.v2.p1	Drug Dependence
			2020/09/04				./data/phs001993.v1.pht010083.v1.p1.NF1_AtypicalNeurofibromas_Subject.var_report.xml									phs001993.v1.p1	Neurofibromatosis 1
8.0	35.0		04/15/2014	45.0		8.0	./data/phs000719.v1.pht003735.v1.p1.PNTM_Pedigree.var_report.xml	0.0	22.5	5.657	35.0			22.5		phs000719.v1.p1	Mycobacterium avium-intracellulare Infection
			2020/12/21				./data/phs000007.v32.pht000904.v7.p13.ctaopulm3_2005s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			09/25/2015				./data/phs000712.v1.pht003712.v1.p1.UIC_ACE_Subject_Phenotypes.var_report.xml									phs000712.v1.p1	Autistic Disorder
			2018/03/20				./data/phs000605.v1.pht007632.v1.p1.eligibility_checklist.var_report.xml									phs000605.v1.p1	Lymphangioleiomyomatosis
448.0	7441.0		2019/11/25	8075.0		448.0	./data/phs001541.v1.pht008307.v1.p1.ANGI_Subject_Phenotypes.var_report.xml	0.0	4469.0	5633	7441.0			489.0		phs001541.v1.p1	Anorexia Nervosa
			2017/11/01				./data/phs001305.v1.pht007110.v1.p1.registration.var_report.xml									phs001305.v1.p1	Urea Cycle Disorders, Inborn
			11/16/2015				./data/phs000980.v1.pht005053.v1.p1.NSCLC_Pembrolizumab_Subject_Phenotypes.var_report.xml									phs000980.v1.p1	Carcinoma, Non-Small-Cell Lung
			03/31/2015				./data/phs000832.v1.pht004426.v1.p1.Amphetamine_Sensitivity_Sample_Attributes.var_report.xml									phs000832.v1.p1	Dextroamphetamine
			08/20/2013				./data/phs000285.v3.pht001735.v2.p2.D1F9TOBA.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2019/11/19				./data/phs000572.v8.pht003394.v5.p4.ADSP_Sample_Attributes.var_report.xml									phs000572.v8.p4	Alzheimer Disease
			2021/08/19				./data/phs001662.v2.pht010055.v1.p1.LTRC_R040_subject_airwayfindings.var_report.xml									phs001662.v2.p1	Pulmonary Disease, Chronic Obstructive
			06/12/2017				./data/phs000594.v1.pht006504.v1.p1.EnrollmentMedicalIllness.var_report.xml									phs000594.v1.p1	Leukemia, Large Granular Lymphocytic
89.0			2019/07/29	927.0			./data/phs001736.v1.pht009329.v1.p1.RCC_European_Subject_Phenotypes.var_report.xml	0.0			881.0					phs001736.v1.p1	Carcinoma, Renal Cell
			06/07/2016				./data/phs001111.v1.pht005498.v1.p1.CRC_Mutation_Classification_Subject_Phenotypes.var_report.xml									phs001111.v1.p1	Colorectal Neoplasms
			07/29/2013				./data/phs000505.v2.pht002808.v2.p1.Glioblastoma_Stem_Cell_Lines_Sample.var_report.xml									phs000505.v2.p1	Glioblastoma
382.0	382.0		09/25/2015	633.0		41.0	./data/phs000712.v1.pht003710.v1.p1.UIC_ACE_Pedigree.var_report.xml	0.0	316.5	93.34	41.0			316.5		phs000712.v1.p1	Autistic Disorder
			08/18/2015				./data/phs000586.v1.pht004833.v1.p1.Alopecia_Areata_Sample_Attributes.var_report.xml									phs000586.v1.p1	Alopecia Areata
			2019/03/11				./data/phs000286.v6.pht008735.v1.p2.asn0041.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			06/14/2016				./data/phs001127.v1.pht005528.v1.p1.Endometrial_Cancer_Primaries_Metastases_Sample_Attributes.var_report.xml									phs001127.v1.p1	Endometrial Neoplasms
			2019/12/16				./data/phs000959.v1.pht009700.v1.p1.SCZ_Xhosa_Subject.var_report.xml									phs000959.v1.p1	Schizophrenia
			2021/05/07				./data/phs000956.v5.pht005000.v1.p1.TOPMed_WGS_Amish_Subject.var_report.xml									phs000956.v5.p1	Cardiovascular Diseases
			2018/05/15				./data/phs001311.v1.pht007932.v1.p1.eligibility_form.var_report.xml									phs001311.v1.p1	Myotonia
			2019/04/19				./data/phs001808.v1.pht008975.v1.p1.B_Lymphocytes_Aging_Sample_Attributes.var_report.xml									phs001808.v1.p1	Aging
			2018/11/30				./data/phs001578.v1.pht007874.v1.p1.Preterm_Infant_Microbiome_Subject.var_report.xml									phs001578.v1.p1	Microbiota
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000409.v2.p3.simphen010.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			2020/06/18				./data/phs000280.v7.pht004058.v5.p1.COCCPS16.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			03/04/2011				./data/phs000264.v2.pht001418.v1.p1.HMP_Virome_Febrile_Subject.var_report.xml									phs000264.v2.p1	Virus Diseases
			05/24/2017				./data/phs000576.v1.pht006155.v1.p1.p5203_12997_lifeskill.var_report.xml									phs000576.v1.p1	Angelman Syndrome
			2021/06/16				./data/phs001412.v3.pht006747.v1.p1.TOPMed_WGS_DHS_Sample_Attributes.var_report.xml									phs001412.v3.p1	Cardiovascular Disease
			08/20/2013				./data/phs000285.v3.pht001642.v2.p2.B2HEMO.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
			2020/12/21				./data/phs000007.v32.pht006023.v4.p13.vr_svstk_2018_a_1269s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			01/19/2010				./data/phs000219.v1.pht001069.v1.p1.d_csa04L1_trans.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
			2021/04/07				./data/phs002377.v1.pht011114.v1.p1.Ipilimumab_Nivolumab_HCT_Sample.var_report.xml									phs002377.v1.p1	Hematologic Malignancy
			11/16/2011				./data/phs000096.v4.pht001425.v2.p1.HAPO_Pedigree_CrypticHalfSibs.var_report.xml									phs000096.v4.p1	Pregnancy Complications
			01/05/2015				./data/phs000817.v1.pht004415.v1.p1.Varicella_Zoster_Vaccine_Sample.var_report.xml									phs000817.v1.p1	Varicella Vaccine
54.0	85.0		2020/04/29	139.0		54.0	./data/phs000185.v7.pht003718.v2.p1.Hutterites_Fecal_Microbiome_Subject_Phenotypes.var_report.xml	0.0	69.5	21.92	85.0			69.5		phs000185.v7.p1	Prospective
922.0	922.0		2021/05/13	1549.0		627.0	./data/phs001423.v3.pht006986.v3.p2.TIC_Genetics_Subject_Phenotypes.var_report.xml	0.0	774.5	208.6	627.0			774.5		phs001423.v3.p2	Tourette Disorder
257.0			12/01/2015	461.0			./data/phs000571.v3.pht003185.v3.p2.KaryotypeFormula.var_report.xml	0.0			203.0					phs000571.v3.p2	Heart Defects, Congenital
			2019/10/11				./data/phs001380.v1.pht009226.v1.p1.TS_Subject.var_report.xml									phs001380.v1.p1	Tourette Syndrome
			01/19/2010				./data/phs000219.v1.pht001083.v1.p1.d_gds.var_report_2010_01_19.xml									phs000219.v1.p1	Alzheimer Disease
1314.0	1481.0		2021/09/23	2795.0		1314.0	./data/phs001468.v3.pht009554.v1.p1.TOPMed_WGS_REDSIII_Brazil_SCD_Subject_Phenotypes.var_report.xml	0.0	1398.0	118.1	1481.0			1398.0		phs001468.v3.p1	Sickle Cell Anemia
			2020/12/21				./data/phs000007.v32.pht003628.v5.p13.l_hstn_ex01_3b_0832s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000493.v2.p3.simphen094.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
			03/13/2015				./data/phs000873.v1.pht004559.v1.p1.Bleeding_Disorders_Sample_Attributes.var_report.xml									phs000873.v1.p1	Thrombocytopenia
			09/14/2011				./data/phs000392.v1.pht002371.v1.p1.Exome_arPEO_Sample.var_report.xml									phs000392.v1.p1	Ophthalmoplegia, Chronic Progressive External
			03/03/2011				./data/phs000259.v2.pht001245.v2.p1.HMP_Urethral_Males_Demographics_Data.var_report.xml									phs000259.v2.p1	Urethritis
			11/25/2013				./data/phs000661.v1.pht003538.v1.p1.Aggressive_Prostate_Carcinoma_Subject.var_report.xml									phs000661.v1.p1	Neoplasms
			07/14/2014				./data/phs000714.v1.pht003750.v1.p1.Spontaneous_Preterm_Birth_Subject.var_report.xml									phs000714.v1.p1	Premature Birth
			2019/03/11				./data/phs000286.v6.pht008737.v1.p2.bcfa.var_report.xml									phs000286.v6.p2	Cardiovascular Diseases
			2019/03/20				./data/phs001715.v1.pht008841.v1.p1.change_of_information_form.var_report.xml									phs001715.v1.p1	Vasculitis
			2017/08/09				./data/phs001425.v1.pht006754.v1.p1.Melanoma_Immune_Checkpoint_Subject.var_report.xml									phs001425.v1.p1	Melanoma
			2018/07/23				./data/phs000742.v1.pht008109.v1.p1.7_2_Activities.var_report.xml									phs000742.v1.p1	Epilepsy
			2019/05/07				./data/phs001329.v2.pht009041.v1.p1.conclusionofstudyparticipation.var_report.xml									phs001329.v2.p1	Mucolipidosis IV
			2018/03/26				./data/phs000697.v1.pht007694.v1.p1.pastmedicalhistory.var_report.xml									phs000697.v1.p1	Myelodysplastic Syndromes
41.0	41.0		2021/07/09	82.0		41.0	./data/phs001772.v2.pht008633.v2.p1.NETs_Subject.var_report.xml	0.0	41.0	0	41.0			41.0		phs001772.v2.p1	Intestinal Neoplasms
41.0			03/06/2017	1013.0			./data/phs000574.v1.pht005865.v1.p1.demographicinfo.var_report.xml	1.0			972.0					phs000574.v1.p1	Rett Syndrome
			2020/12/21				./data/phs000007.v32.pht005147.v1.p13.l_rnapilot_ex08_1_0918s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
10.0	10.0		04/16/2012	20.0		10.0	./data/phs000476.v1.pht002670.v1.p1.Parathyroidism_Subject_Phenotypes.var_report.xml	0.0	10.0	0	10.0			10.0		phs000476.v1.p1	Pseudohypoparathyroidism
			2020/06/18				./data/phs000280.v7.pht004119.v2.p1.INFA04.var_report.xml									phs000280.v7.p1	Cardiovascular Diseases
			2018/05/03				./data/phs001264.v1.pht007901.v1.p1.CD47_Breast_Cancer_Subject_Phenotypes.var_report.xml									phs001264.v1.p1	Breast Neoplasms
			2019/10/15				./data/phs000256.v4.pht001238.v4.p3.HMP_Vaginal_Microbiome_Sample.var_report.xml									phs000256.v4.p3	Microbiomes, Human
			2020/12/21				./data/phs000007.v32.pht010743.v1.p13.t_physactf_ex03_3b_1007s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2020/01/30				./data/phs001698.v1.pht009603.v1.p1.BPH_Subject_Phenotypes.var_report.xml									phs001698.v1.p1	Prostatic Hyperplasia
			05/06/2016				./data/phs000911.v1.pht004975.v1.p1.T1DGC_ImmunoChip_Subject.var_report.xml									phs000911.v1.p1	Diabetes Mellitus, Type 1
			2019/08/01				./data/phs000222.v6.pht002875.v3.p2.Motor.var_report.xml									phs000222.v6.p2	Huntington Disease
			2020/09/18				./data/phs001087.v3.pht005758.v3.p1.UC_Subject.var_report.xml									phs001087.v3.p1	Carcinoma, Transitional Cell
5.0	6.0		2020/07/16	11.0		5.0	./data/phs001778.v1.pht009832.v1.p1.MDS_huM_Subject_Phenotypes.var_report.xml	0.0	5.5	0.7071	6.0			5.5		phs001778.v1.p1	Myelodysplastic Syndromes
			2020/12/21				./data/phs000007.v32.pht002895.v2.p13.l_mtbli3_ex05_1_0707s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
			2018/05/15				./data/phs001557.v1.pht007618.v1.p1.MADSEQ_Sample_Attributes.var_report.xml									phs001557.v1.p1	Hemihyperplasia
			2019/06/14				./data/phs001833.v1.pht009153.v1.p1.MS_Severity_Sample_Attributes.var_report.xml									phs001833.v1.p1	Multiple Sclerosis
			2020/02/27				./data/phs001213.v2.pht005836.v1.p1.Heroin_Dependence_China_Subject.var_report.xml									phs001213.v2.p1	Drug Dependence
			12/12/2014				./data/phs000699.v1.pht004382.v1.p1.Osteosarcoma_Genomics_Subject.var_report.xml									phs000699.v1.p1	Osteosarcoma
			2019/11/15				./data/phs000784.v3.pht004285.v1.p1.GenSalt_Sample.var_report.xml									phs000784.v3.p1	Arterial Pressure, Mean
			03/17/2017				./data/phs001121.v1.pht005709.v1.p1.Rare_Cancers_Sample.var_report.xml									phs001121.v1.p1	Sarcoma
4469.0	4469.0		04/10/2014	4469.0		4469.0	./data/phs000306.v4.pht001911.v1.p1.MEC_Prostate_Cancer_JALA_Subject_Phenotypes.var_report.xml	0.0	4469.0					4469.0		phs000306.v4.p1	Prostatic Neoplasms
			2020/12/21				./data/phs000007.v32.pht006010.v1.p13.l_fhslab_ex02_7_0561s.var_report.xml									phs000007.v32.p13	Cardiovascular Diseases
2943.0	3500.0		04/29/2016	6443.0		2943.0	./data/phs000128.v3.pht000415.v2.p3.simphen016.var_report.xml	0.0	3222.0	393.9	3500.0			3222.0		phs000128.v3.p3	Coronary Disease
597.0	597.0		2019/02/06	1103.0		506.0	./data/phs001745.v1.pht008600.v1.p1.Lung_eQTL_Subject_Phenotypes.var_report.xml	0.0	551.5	64.35	506.0			551.5		phs001745.v1.p1	Smoking
7253.0	7253.0		2020/07/24	54.0		23.0	./data/phs001194.v3.pht005822.v2.p2.Gender.var_report.xml	0.0	4571.0	5.657	6459.0			6459.0		phs001194.v3.p2	Heart Defects, Congenital
			2021/09/09				./data/phs001515.v2.pht009565.v2.p2.TOPMed_WGS_MLOF_Sample.var_report.xml									phs001515.v2.p2	Hemophilia
85.0			06/16/2017	196.0			./data/phs001278.v1.pht006267.v1.p1.demographics.var_report.xml	0.0			111.0					phs001278.v1.p1	Porphyrias
2.0			2018/10/30	3.0			./data/phs001724.v1.pht008507.v1.p1.Pain_Resilience_Subject_Phenotypes.var_report.xml	0.0			1.0					phs001724.v1.p1	Erythromelalgia
			08/04/2015				./data/phs000926.v1.pht004864.v1.p1.Crohn_Disease_Childhood_Onset_Subject.var_report.xml									phs000926.v1.p1	Crohn Disease
			08/20/2013				./data/phs000285.v3.pht001788.v2.p2.E1F36.var_report.xml									phs000285.v3.p2	Cardiovascular Diseases
